PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Luo, WF; Bentley, D				Luo, WF; Bentley, D			Ribonucleolytic rat torpedoes RNA polymerase II	CELL			English	Editorial Material							TRANSCRIPTION TERMINATION; NASCENT RNA; CLEAVAGE; DOMAIN; SITE	Three recent papers reveal a fascinating link between pol II termination and ribonucleolytic decay of the nascent transcript by a 5'-3' exonuclease (yeast Rat1 and human Xrn2). The exonuclease travels with pol II and gains access to the nascent RNA after endonucleolytic cleavage at the poly(A) site or at a second cotranscriptional cleavage site (CoTC). It is then thought to track in a 5'-3' direction like a guided torpedo that ultimately helps dissociate the RNA polymerase elongation complex.	Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Bentley, D (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	david.bentley@uchsc.edu		Bentley, David/0000-0002-8414-4647	NIGMS NIH HHS [R01 GM063873] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063873] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Dye MJ, 2001, CELL, V105, P669, DOI 10.1016/S0092-8674(01)00372-5; Gu WG, 1996, P NATL ACAD SCI USA, V93, P6935, DOI 10.1073/pnas.93.14.6935; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Liu MY, 1998, J BIOL CHEM, V273, P25541, DOI 10.1074/jbc.273.40.25541; Liu YM, 2003, RNA, V9, P677, DOI 10.1261/rna.2128903; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; OROZCO IJ, 2002, J BIOL CHEM, V23, P23; Osheim YN, 1999, MOL CELL, V3, P379, DOI 10.1016/S1097-2765(00)80465-7; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035	20	32	35	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					911	914		10.1016/j.cell.2004.11.041	http://dx.doi.org/10.1016/j.cell.2004.11.041			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620350	Bronze			2022-12-28	WOS:000226109700004
J	Garsin, DA				Garsin, DA			Peptide signals sense and destroy target cells	SCIENCE			English	Editorial Material							ENTEROCOCCUS-FAECALIS CYTOLYSIN; VIRULENCE; HEMOLYSIN; BACTERIA; TOXIN		Univ Texas, Hlth Sci Ctr, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Garsin, DA (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	danielle.a.garsin@uth.tmc.edu						CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Coburn PS, 2003, CELL MICROBIOL, V5, P661, DOI 10.1046/j.1462-5822.2003.00310.x; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; He SY, 1998, ANNU REV PHYTOPATHOL, V36, P363, DOI 10.1146/annurev.phyto.36.1.363; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; HUYCKE MM, 1991, ANTIMICROB AGENTS CH, V35, P1626, DOI 10.1128/AAC.35.8.1626; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; JETT BD, 1992, INFECT IMMUN, V60, P2445, DOI 10.1128/IAI.60.6.2445-2452.1992; Sturme MHJ, 2002, ANTON LEEUW INT J G, V81, P233, DOI 10.1023/A:1020522919555; Todd EW, 1934, J PATHOL BACTERIOL, V39, P299, DOI 10.1002/path.1700390207; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x	13	6	6	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2202	2203		10.1126/science.1107236	http://dx.doi.org/10.1126/science.1107236			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15619588				2022-12-28	WOS:000225950000030
J	Wu, T; Werner, HJ; Manthe, U				Wu, T; Werner, HJ; Manthe, U			First-principles theory for the H+CH4 -> H-2+CH3 reaction	SCIENCE			English	Article							TRANSITION-STATE THEORY; MULTIDIMENSIONAL TUNNELING CONTRIBUTIONS; POTENTIAL ENERGY SURFACES; THERMAL RATE CONSTANTS; REDUCED-DIMENSIONALITY; QUANTUM SCATTERING; WAVE-FUNCTIONS; BASIS-SETS; DYNAMICS; HYDROGEN	A full-dimensional. quantum dynamics simulation of a hydrogen atom reacting with methane on,an accurate ab initio potential energy surface is reported. Based on first-principles theory, thermal rate constants are predicted with an accuracy comparable to (or even exceeding) experimental precision. The theoretical prediction is within the range of the significantly varied experimental rate constants reported by different groups. This level of accuracy has previously been achieved only for smaller, three- or four-atom reactive systems. Comparison with classical transition state theory confirms the importance of quantum mechanical tunneling for the rate constant below 400 kelvin.	Univ Bielefeld, Fak Chem, D-33501 Bielefeld, Germany; Tech Univ Munich, D-85747 Garching, Germany; Univ Stuttgart, Inst Theoret Chem, D-70569 Stuttgart, Germany	University of Bielefeld; Technical University of Munich; University of Stuttgart	Manthe, U (corresponding author), Univ Bielefeld, Fak Chem, Postfach 100131, D-33501 Bielefeld, Germany.	uwe.manthe@uni-bielefeld.de	Werner, Hans-Joachim/G-9509-2011; Manthe, Uwe/A-5877-2011	Werner, Hans-Joachim/0000-0002-0435-539X; Manthe, Uwe/0000-0002-4845-9633				BAULCH DL, 1992, J PHYS CHEM REF DATA, V21, P411, DOI 10.1063/1.555908; BOWMAN JM, 1991, J PHYS CHEM-US, V95, P4960, DOI 10.1021/j100166a014; Bowman JM, 2001, J CHEM PHYS, V114, P9683, DOI 10.1063/1.1370944; DEEGAN MJO, 1994, CHEM PHYS LETT, V227, P321, DOI 10.1016/0009-2614(94)00815-9; Demore W., 1997, JPL PUBLICATION, V97-4; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Huarte-Larranaga F, 2000, J CHEM PHYS, V113, P5115, DOI 10.1063/1.1311802; Huarte-Larranaga F, 2002, J CHEM PHYS, V117, P4635, DOI 10.1063/1.1503309; JORDAN MJT, 1995, J CHEM PHYS, V102, P5647, DOI 10.1063/1.469296; JORDAN MJT, 1995, J CHEM PHYS, V102, P5669, DOI 10.1063/1.469298; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Kerkeni B, 2004, J CHEM PHYS, V120, P2308, DOI 10.1063/1.1635816; KNOWLES PJ, 1993, J CHEM PHYS, V99, P5219, DOI 10.1063/1.465990; Knowles PJ, 2000, J CHEM PHYS, V112, P3106, DOI 10.1063/1.480886; MANTHE U, 1992, J CHEM PHYS, V97, P3199, DOI 10.1063/1.463007; MANTHE U, 1993, J CHEM PHYS, V99, P10078, DOI 10.1063/1.465514; Manthe U, 2002, J THEOR COMPUT CHEM, V1, P153, DOI [10.1142/s0219633602000087, DOI 10.1142/S0219633602000087]; MARQUAIRE PM, 1994, CAN J CHEM, V72, P600, DOI 10.1139/v94-083; MEYER HD, 1990, CHEM PHYS LETT, V165, P73, DOI 10.1016/0009-2614(90)87014-I; MILLER WH, 1974, J CHEM PHYS, V61, P1823, DOI 10.1063/1.1682181; MILLER WH, 1983, J CHEM PHYS, V79, P4889, DOI 10.1063/1.445581; NEUHAUSER D, 1994, J CHEM PHYS, V100, P9272, DOI 10.1063/1.466681; Palma J, 2002, J PHYS CHEM A, V106, P8256, DOI 10.1021/jp014014i; Pu JZ, 2002, J CHEM PHYS, V117, P1479, DOI 10.1063/1.1485063; Pu JZ, 2001, J CHEM PHYS, V115, P6266, DOI 10.1063/1.1398581; SNADER SP, 2003, CHEM KINETICS PHOTOC; Sutherland JW, 2001, INT J CHEM KINET, V33, P669, DOI 10.1002/kin.1064; Takayanagi T, 1996, J CHEM PHYS, V104, P2237, DOI 10.1063/1.470920; Thompson KC, 1998, J CHEM PHYS, V108, P8302, DOI 10.1063/1.476259; Wang DY, 2001, J CHEM PHYS, V115, P2055, DOI 10.1063/1.1383048; Wang ML, 2000, J CHEM PHYS, V113, P1802, DOI 10.1063/1.482013; Wu T, 2003, J CHEM PHYS, V119, P14, DOI 10.1063/1.1577328; Yang MH, 2002, J CHEM PHYS, V117, P9539, DOI 10.1063/1.1524181; Yu HG, 1999, J CHEM PHYS, V111, P3508, DOI 10.1063/1.479634; Zhang DH, 2000, SCIENCE, V290, P961, DOI 10.1126/science.290.5493.961; ZHANG DH, 1994, J CHEM PHYS, V101, P1146, DOI 10.1063/1.467808; Zhao Y, 2004, J CHEM PHYS, V120, P3100, DOI 10.1063/1.1641006	38	228	232	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2227	2229		10.1126/science.1104085	http://dx.doi.org/10.1126/science.1104085			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618512				2022-12-28	WOS:000225950000037
J	Bettencourt-Dias, M; Giet, R; Sinka, R; Mazumdar, A; Lock, WG; Balloux, F; Zafiropoulos, PJ; Yamaguchi, S; Winter, S; Carthew, RW; Cooper, M; Jones, D; Frenz, L; Glover, DM				Bettencourt-Dias, M; Giet, R; Sinka, R; Mazumdar, A; Lock, WG; Balloux, F; Zafiropoulos, PJ; Yamaguchi, S; Winter, S; Carthew, RW; Cooper, M; Jones, D; Frenz, L; Glover, DM			Genome-wide survey of protein kinases required for cell cycle progression	NATURE			English	Article								Cycles of protein phosphorylation are fundamental in regulating the progression of the eukaryotic cell through its division cycle. Here we test the complement of Drosophila protein kinases (kinome) for cell cycle functions after gene silencing by RNA-mediated interference. We observed cell cycle dysfunction upon downregulation of 80 out of 228 protein kinases, including most kinases that are known to regulate the division cycle. We find new enzymes with cell cycle functions; some of these have family members already known to phosphorylate microtubules, actin or their associated proteins. Additionally, depletion of several signalling kinases leads to specificmitotic aberrations, suggesting novel roles for familiar enzymes. The survey reveals the inter-digitation of systems that monitor cellular physiology, cell size, cellular stress and signalling processes with the basic cell cycle regulatory machinery.	Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Res Grp, Cambridge CB2 3EH, England; Univ Rennes 1, Equipe Labellisee Ligue Natl Contre Canc, Grp Cycle Cellulaire, IFR97,CNRS UMR 6061, F-35043 Rennes, France; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Cyclacel Ltd, Polgen Div, Cambridge CB4 2AT, England	University of Cambridge; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Northwestern University; Cyclacel Pharmaceuticals Inc.	Bettencourt-Dias, M (corresponding author), Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Res Grp, Downing St, Cambridge CB2 3EH, England.	mbcd2@cam.ac.uk; dmg25@mole.bio.cam.ac.uk	Balloux, Francois/X-7856-2019; Sinka, Rita/ABA-8767-2021; Bettencourt-Dias, Monica/B-5176-2015; Balloux, Francois/D-4783-2009	Balloux, Francois/0000-0003-1978-7715; Bettencourt-Dias, Monica/0000-0003-1987-5598; Balloux, Francois/0000-0003-1978-7715; Glover, David/0000-0003-0956-0103; Sinka, Rita/0000-0003-4040-4184	NIGMS NIH HHS [R01 GM068743] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068743] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	278	291	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					980	987		10.1038/nature03160	http://dx.doi.org/10.1038/nature03160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616552				2022-12-28	WOS:000225887000031
J	Mullan, F				Mullan, F			Affirmative action, cuban style	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Project Hope, Hlth Affairs, Bethesda, MD USA		Mullan, F (corresponding author), Project Hope, Hlth Affairs, Bethesda, MD USA.							*I MED, 2002, UN TREATM CONFR RAC; *MINREX, 2004, COMPR HLTH PROGR; *SULL COMM DIV HEA, 2004, SULL COMM DIV HEALTH, P49; *WHO, 1997, WHO EST HLTH PERS PH	4	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2680	2682		10.1056/NEJMp048270	http://dx.doi.org/10.1056/NEJMp048270			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616202				2022-12-28	WOS:000225877300003
J	Beutler, E				Beutler, E			"Pumping" iron: The proteins	SCIENCE			English	Editorial Material							METABOLISM		Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Beutler, E (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	beutler@scripps.edu						Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan Adriana, 2004, Hematol J, V5, P373, DOI 10.1038/sj.thj.6200540; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; McCance RA, 1937, LANCET, V2, P680; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; NEMETH E, 2004, BLOOD            OCT; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Rouault TA, 2002, BLOOD CELL MOL DIS, V29, P309, DOI 10.1006/bcmd.2002.0571	10	38	39	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2004	306	5704					2051	2053		10.1126/science.1107224	http://dx.doi.org/10.1126/science.1107224			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604397				2022-12-28	WOS:000225841000049
J	Flood, AH; Stoddart, JF; Steuerman, DW; Heath, JR				Flood, AH; Stoddart, JF; Steuerman, DW; Heath, JR			Whence molecular electronics?	SCIENCE			English	Editorial Material							SELF-ASSEMBLED MONOLAYERS; RECTIFIERS; MOTION; SWITCH		Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Santa Barbara; California Institute of Technology	Flood, AH (corresponding author), Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA.	amarf@chem.ucta.edu; stoddart@chem.ucla.edu; dws@physics.ucsb.edu; heath@cattech.edu	Stoddart, James Fraser/H-1518-2011; Flood, Amar/B-3863-2016	Stoddart, James Fraser/0000-0003-3161-3697; Flood, Amar/0000-0002-2764-9155				Ashwell GJ, 2004, J AM CHEM SOC, V126, P7102, DOI 10.1021/ja049633u; AVIRAM A, 1974, CHEM PHYS LETT, V29, P277, DOI 10.1016/0009-2614(74)85031-1; Brouwer AM, 2001, SCIENCE, V291, P2124, DOI 10.1126/science.1057886; Collier CP, 2000, SCIENCE, V289, P1172, DOI 10.1126/science.289.5482.1172; Feldman B, 2000, Diabetes Technol Ther, V2, P221, DOI 10.1089/15209150050025177; Flood AH, 2004, CHEM-EUR J, V10, P6558, DOI 10.1002/chem.200401052; Jang YH, 2004, J AM CHEM SOC, V126, P12636, DOI 10.1021/ja0385437; Katz E, 2004, J AM CHEM SOC, V126, P15520, DOI 10.1021/ja045465u; Lau CN, 2004, NANO LETT, V4, P569, DOI 10.1021/nl035117a; Lee T, 2004, J PHYS CHEM B, V108, P8742, DOI 10.1021/jp049541r; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; Luo Y, 2002, CHEMPHYSCHEM, V3, P519, DOI 10.1002/1439-7641(20020617)3:6<519::AID-CPHC519>3.0.CO;2-2; MCCONNELL H, 1961, J CHEM PHYS, V35, P508, DOI 10.1063/1.1731961; Metzger RM, 2003, CHEM REV, V103, P3803, DOI 10.1021/cr020413d; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; Poleschak I, 2004, CHEM COMMUN, P474, DOI 10.1039/b315080a; POLYMEROPOULOS EE, 1978, J CHEM PHYS, V69, P1836, DOI 10.1063/1.436844; Service RF, 2003, SCIENCE, V302, P556, DOI 10.1126/science.302.5645.556	18	419	426	3	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2055	2056		10.1126/science.1106195	http://dx.doi.org/10.1126/science.1106195			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604399				2022-12-28	WOS:000225841000051
J	Fu, XD				Fu, XD			Towards a splicing code	CELL			English	Editorial Material							IDENTIFICATION	A combination of experimental and bioinformatics approaches leads Burge and colleagues (Wang et al., 2004 [this issue of Cell]) to a global view of how an RNA segment may be selected or avoided in mature mRNAs due to biased distributions of exonic enhancers and silencers, a process vital for genome evolution, developmental control, and disease onset.	Univ Calif San Diego, Dept Celluar & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Fu, XD (corresponding author), Univ Calif San Diego, Dept Celluar & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.							BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Zhang MQ, 1997, P NATL ACAD SCI USA, V94, P565, DOI 10.1073/pnas.94.2.565; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	7	59	64	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					736	738		10.1016/j.cell.2004.11.039	http://dx.doi.org/10.1016/j.cell.2004.11.039			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607969	Bronze			2022-12-28	WOS:000225907200003
J	Paschen, S; Luhmann, T; Wirth, S; Gegenwart, P; Trovarelli, O; Geibel, C; Steglich, F; Coleman, P; Si, Q				Paschen, S; Luhmann, T; Wirth, S; Gegenwart, P; Trovarelli, O; Geibel, C; Steglich, F; Coleman, P; Si, Q			Hall-effect evolution across a heavy-fermion quantum critical point	NATURE			English	Article							NORMAL-STATE; TEMPERATURE; BEHAVIOR; SURFACE; KONDO	Aquantum critical point (QCP) develops in a material at absolute zero when a new form of order smoothly emerges in its ground state. QCPs are of great current interest because of their singular ability to influence the finite temperature properties of materials. Recently, heavy-fermion metals have played a key role in the study of antiferromagnetic QCPs. To accommodate the heavy electrons, the Fermi surface of the heavy-fermion paramagnet is larger than that of an antiferromagnet(1-3). An important unsolved question is whether the Fermi surface transformation at the QCP develops gradually, as expected if the magnetism is of spin-density-wave (SDW) type(4,5), or suddenly, as expected if the heavy electrons are abruptly localized by magnetism(6-8). Here we report measurements of the low-temperature Hall coefficient R-H) - a measure of the Fermi surface volume - in the heavy-fermion metal YbRh2Si2 upon field-tuning it from an antiferromagnetic to a paramagnetic state. RH undergoes an increasingly rapid change near the QCP as the temperature is lowered, extrapolating to a sudden jump in the zero temperature limit. We interpret these results in terms of a collapse of the large Fermi surface and of the heavy-fermion state itself precisely at the QCP.	Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; Rutgers State Univ, Dept Phys & Astron, Ctr Mat Theory, Piscataway, NJ 08855 USA; Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Max Planck Society; Rutgers State University New Brunswick; Rice University	Paschen, S (corresponding author), Max Planck Inst Chem Phys Solids, Nothnitzer Str 40, D-01187 Dresden, Germany.	paschen@cpfs.mpg.de	Paschen, Silke/C-3841-2014; Gegenwart, Philipp/A-7291-2017	Paschen, Silke/0000-0002-3796-0713; Gegenwart, Philipp/0000-0003-4180-3785				ANDERSON PW, 1991, PHYS REV LETT, V67, P2092, DOI 10.1103/PhysRevLett.67.2092; Balakirev FF, 2003, NATURE, V424, P912, DOI 10.1038/nature01890; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; CUSTERS J, 2004, THESIS TU DRESDEN; FERT A, 1987, PHYS REV B, V36, P1907, DOI 10.1103/PhysRevB.36.1907; Fulde P., 1988, NATO ASI SER, P27; Gegenwart P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.056402; HALDANE FDM, 1981, J PHYS C SOLID STATE, V14, P2585, DOI 10.1088/0022-3719/14/19/010; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Ishida K, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.184401; Ishida K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.107202; Kontani H, 1997, J PHYS SOC JPN, V66, P2252, DOI 10.1143/JPSJ.66.2252; Kuchler R, 2004, J MAGN MAGN MATER, V272, P229, DOI 10.1016/j.jmmm.2003.11.094; Lee M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187201; MARTIN RM, 1982, PHYS REV LETT, V48, P362, DOI 10.1103/PhysRevLett.48.362; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; Nakajima Y, 2004, J PHYS SOC JPN, V73, P5, DOI 10.1143/JPSJ.73.5; Norman MR, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.116601; Paschen S, 2003, ACTA PHYS POL B, V34, P359; PASCHEN S, IN PRESS PHYS B; Schroder A, 2000, NATURE, V407, P351, DOI 10.1038/35030039; Senthil T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035111; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; Trovarelli O, 2000, PHYS REV LETT, V85, P626, DOI 10.1103/PhysRevLett.85.626; Valla T, 1999, SCIENCE, V285, P2110, DOI 10.1126/science.285.5436.2110; VARMA CM, 1989, PHYS REV LETT, V63, P1996, DOI 10.1103/PhysRevLett.63.1996; Yeh A, 2002, NATURE, V419, P459, DOI 10.1038/nature01044	30	379	381	4	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					881	885		10.1038/nature03129	http://dx.doi.org/10.1038/nature03129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602556	Green Submitted			2022-12-28	WOS:000225733500047
J	Fukamizu, R; Hayashi, S				Fukamizu, R; Hayashi, S			Diaphragmatic hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Natl Hosp Org, Kinki Chuo Chest Med Ctr, Osaka 5918555, Japan		Fukamizu, R (corresponding author), Natl Hosp Org, Kinki Chuo Chest Med Ctr, Osaka 5918555, Japan.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2004	351	24					E22	E22		10.1056/ENEJMicm031189	http://dx.doi.org/10.1056/ENEJMicm031189			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877TE	15590947				2022-12-28	WOS:000225593100009
J	Maddison, P; Jones, J; Breslin, A; Bargon, C; Fleur, J; Lewis, R; McSweeney, L; Norgain, C; Smith, S; Thomas, C; Tillson, C				Maddison, P; Jones, J; Breslin, A; Bargon, C; Fleur, J; Lewis, R; McSweeney, L; Norgain, C; Smith, S; Thomas, C; Tillson, C			Improved access and targeting of musculoskeletal services in northwest Wales: targeted early access to musculoskeletal services (TEAMS) programme	BRITISH MEDICAL JOURNAL			English	Article								Problem The hospital based musculoskeletal service in northwest Wales was unable to cope with the demand for referrals from general practitioners. Waiting times were long, duplicate referrals to other departments were common, and general practitioners were reluctant to refer patients with common problems because of the perceived lack of service. Many referrals were made to the inappropriate specialty, especially orthopaedics. At least part of this problem was due to a lack of coordination between the four hospital departments providing musculoskeletal services and the emphasis on district general hospital based rather than community provision. Design Review over 18 months of impact of the targeted early access to musculoskeletal services (TEAMS) programme on accessibility to musculoskeletal services. Setting Northwest Wales. Key measures for improvement Number of patients referred and seen with musculoskeletal problems, waiting times, number of duplicate referrals, and surgery conversion rates in orthopaedic clinics. Strategies for change Establishing with central clinical triage a common pathway for all musculoskeletal referrals so that patients attend the appropriate department. A back pain pathway led by extended scope physiotherapists was developed, and general practitioners with special interests and extended. scope physiotherapists were trained to provide services for patients with uncomplicated musculoskeletal problems in the Community. Effects of change Over 18 months the number of referrals more than doubled. Despite this, waiting times for musculoskeletal services fell; this was noticeable for rheumatology and pain management. Duplicate referrals were abolished. Surgery conversion rates did not, however, change. Questionnaires from the clinics showed a high level of patient satisfaction. Lessons learnt Integration of hospital services that traditionally have worked in isolation can result in greatly improved access to musculoskeletal services. Community based multidisciplinary clinics run by specially trained general practitioners with special interests and extended scope physiotherapists are an effective way of managing patients with uncomplicated musculoskeletal problems and have been well received by patients and general practitioners. The huge unmet burden of need was reflected by the great increase in musculoskeletal referrals. Other approaches are needed to meet this, including better education of general practitioners and methods for identifying and modifying psychosocial risk factors for chronic pain at an early stage.	NW Wales NHS Trust, Bangor LL57 2PW, Gwynedd, Wales; Gwynedd Local Hlth Board, Eryldon, Caernarfon, Wales	Bangor University	Maddison, P (corresponding author), NW Wales NHS Trust, Bangor LL57 2PW, Gwynedd, Wales.	peter.maddison@nww-tr.wales.nhs.uk						BURTON AK, 1995, SPINE, V20, P722, DOI 10.1097/00007632-199503150-00014; Department of Health/Royal College of General Practitioners, 2002, IMPL SCHEM GEN PRACT; *JOINT HLTH SURV U, 1997, HLTH SURV ENGL 1995, V1; MCCORMICK A, 1995, MORBIDITY STAT GEN P; *WELSH OFF, 1998, BETT HLTH BETT WAL C	5	76	76	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 4	2004	329	7478					1325	1327		10.1136/bmj.329.7478.1325	http://dx.doi.org/10.1136/bmj.329.7478.1325			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	878PC	15576743	Green Published			2022-12-28	WOS:000225657800021
J	Nielsen, OH; Vainer, B; de Muckadell, OBS				Nielsen, OH; Vainer, B; de Muckadell, OBS			Microscopic colitis: a missed diagnosis?	LANCET			English	Review							COLLAGENOUS-COLITIS; LYMPHOCYTIC COLITIS; CHRONIC DIARRHEA; EPIDEMIOLOGY; DISEASE	Context Collagenous colitis and lymphocytic colitis, collectively designated microscopic colitis, have until recently been considered as rare gastrointestinal disorders. New data suggest, however, that these disorders are relatively common, and to reach the correct diagnosis both the gastroenterologist and the pathologist must be aware of these diagnoses when evaluating patients with persistent watery non-bloody diarrhoea. Starting point In an epidemiological study of a well-defined Swedish population, Martin Olesen and colleagues show that microscopic colitis needs to be considered as a common gastrointestinal disorder (Gut 2004; 53: 346-50). In colonic biopsy specimens from 1018 patients who had a colonoscopy because of non-bloody diarrhoea in 1993-98, 97 patients (9.5%) were found to have microscopic colitis. In about a third of these cases, the diagnosis was missed in the primary histological evaluation. Median age at diagnosis was 64 years for collagenous colitis and 59 years for lymphocytic colitis. The annual incidence of the diseases was higher than previously considered and matched the incidence of Crohn's disease, and in combination they approached the incidence of ulcerative colitis. Where next The high regional incidence of microscopic colitis means that both clinicians and pathologists need to be more aware of the diagnosis, especially in the elderly female population with a clinical picture of watery non-bloody diarrhoea. Because of the potentially disabling symptoms, clinicians need to develop and evaluate new therapies.	Univ Copenhagen, Herlev Hosp, Dept Gastroenterol C, DK-2730 Herlev, Denmark; Univ Copenhagen, Herlev Hosp, Dept Pathol, DK-2730 Herlev, Denmark; Odense Univ Hosp, Dept Gastroenterol S, DK-5000 Odense, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; Odense University Hospital	Nielsen, OH (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Gastroenterol C, DK-2730 Herlev, Denmark.	ohn@dadlnet.dk	Nielsen, Ole Haagen/AAK-2482-2021	Nielsen, Ole Haagen/0000-0003-4612-8635; Schaffalitzky de Muckadell, Ove B/0000-0003-1969-2329				BOLINN GW, 1985, J CLIN INVEST, V75, P1559, DOI 10.1172/JCI111861; Chan JL, 1999, INFLAMM BOWEL DIS, V5, P40, DOI 10.1097/00054725-199902000-00006; CHANDE N, 2004, COCHRANE LIB; Fine KD, 2000, AM J GASTROENTEROL, V95, P1974; Goldstein NS, 1999, AM J SURG PATHOL, V23, P1075, DOI 10.1097/00000478-199909000-00010; HOWAT A, 2002, HISTOPATHOLOGY LTD N; JARNEROT G, 1995, GASTROENTEROLOGY, V109, P449, DOI 10.1016/0016-5085(95)90332-1; Koskela RM, 2004, SCAND J GASTROENTERO, V39, P837, DOI 10.1080/00365520410006468; LAZENBY AJ, 1989, HUM PATHOL, V20, P18, DOI 10.1016/0046-8177(89)90198-6; LINDSTROM CG, 1976, PATHOL EUR, V11, P87; Loftus EV, 2003, AM J GASTROENTEROL, V98, pS31, DOI 10.1016/j.amjgastroenterol.2003.10.008; Matteoni CA, 2001, J CLIN GASTROENTEROL, V32, P225, DOI 10.1097/00004836-200103000-00009; Offner FA, 1999, HUM PATHOL, V30, P451, DOI 10.1016/S0046-8177(99)90122-3; Olesen M, 2004, GUT, V53, P346, DOI 10.1136/gut.2003.014431; Pardi DS, 2004, GASTROENTEROLOGY, V126, pA124; Pokorny CS, 2001, J CLIN GASTROENTEROL, V32, P435, DOI 10.1097/00004836-200105000-00016; READ NW, 1980, GASTROENTEROLOGY, V78, P264; Robert ME, 2004, J CLIN GASTROENTEROL, V38, pS18, DOI 10.1097/01.mcg.0000124027.92823.b5; TANAKA M, 1992, GUT, V33, P65, DOI 10.1136/gut.33.1.65; Tremaine WJ, 2000, J CLIN GASTROENTEROL, V30, P245, DOI 10.1097/00004836-200004000-00008	20	36	36	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					2055	2057		10.1016/S0140-6736(04)17518-1	http://dx.doi.org/10.1016/S0140-6736(04)17518-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582063				2022-12-28	WOS:000225495700029
J	Squyres, SW; Arvidson, RE; Bell, JF; Bruckner, J; Cabrol, NA; Calvin, W; Carr, MH; Christensen, PR; Clark, BC; Crumpter, L; Des Marais, DJ; d'Uston, C; Economou, T; Farmer, J; Farrand, W; Folkner, W; Golombek, M; Gorevan, S; Grant, JA; Greeley, R; Grotzinger, J; Haskin, L; Herkenhoff, KE; Hviid, S; Johnson, J; Klingelhofer, G; Knoll, AH; Landis, G; Lemmon, M; Li, R; Madsen, MB; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Moersch, J; Morris, RV; Parker, T; Rice, JW; Richter, L; Rieder, R; Sims, M; Smith, M; Smith, P; Soderblom, LA; Sutlivan, R; Wanke, H; Wdowiak, T; Wolff, M; Yen, A				Squyres, SW; Arvidson, RE; Bell, JF; Bruckner, J; Cabrol, NA; Calvin, W; Carr, MH; Christensen, PR; Clark, BC; Crumpter, L; Des Marais, DJ; d'Uston, C; Economou, T; Farmer, J; Farrand, W; Folkner, W; Golombek, M; Gorevan, S; Grant, JA; Greeley, R; Grotzinger, J; Haskin, L; Herkenhoff, KE; Hviid, S; Johnson, J; Klingelhofer, G; Knoll, AH; Landis, G; Lemmon, M; Li, R; Madsen, MB; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Moersch, J; Morris, RV; Parker, T; Rice, JW; Richter, L; Rieder, R; Sims, M; Smith, M; Smith, P; Soderblom, LA; Sutlivan, R; Wanke, H; Wdowiak, T; Wolff, M; Yen, A			The Opportunity Rover's Athena science investigation at Meridiani Planum, Mars	SCIENCE			English	Article							X-RAY SPECTROMETER; EXPLORATION ROVERS; MOSSBAUER SPECTROMETER; MICROSCOPIC IMAGER; TERRA-MERIDIANI; MINI-TES; ART.; HEMATITE; MISSION; CRATER	The Mars Exploration Rover Opportunity has investigated the landing site in Eagle crater and the nearby plains within Meridiani Planum. The soils consist of fine-grained basaltic sand and a surface tag of hematite-rich spherules, spherule fragments, and other granules. Wind ripples are common. Underlying the thin soil layer, and exposed within small impact craters and troughs, are flat-lying sedimentary rocks. These rocks are finely laminated, are rich in sulfur, and contain abundant sulfate salts. Small-scale cross-lamination in some locations provides evidence for deposition in flowing liquid water. We interpret the rocks to be a mixture of chemical and silicictastic sediments formed by episodic inundation by shallow surface water, followed by evaporation, exposure, and desiccation. Hematite-rich spherules are embedded in the rock and eroding from them. We interpret these spherules to be concretions formed by postdepositional diagenesis, again involving liquid water.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Max Planck Inst Chem, D-55128 Mainz, Germany; NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; Univ Nevada, Dept Geol Sci, Reno, NV 89557 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Ctr Etud Spatiale Rayonnements, Toulouse, France; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Space Sci Inst, Boulder, CO 80301 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Honeybee Robot, New York, NY 10012 USA; Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Max Planck Inst Aeron, Katlenburg Lindau, Germany; Johannes Gutenberg Univ Mainz, D-55128 Mainz, Germany; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77843 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Univ Copenhagen, Niels Bohr Inst, Orsted Lab, DK-2100 Copenhagen, Denmark; Malin Space Sci Syst, San Diego, CA 92191 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; DLR, Inst Space Simulat, Cologne, Germany; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA; Space Sci Inst, Martinez, GA 30907 USA	Cornell University; Washington University (WUSTL); Max Planck Society; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Chicago; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Smithsonian Institution; Massachusetts Institute of Technology (MIT); United States Department of the Interior; United States Geological Survey; Max Planck Society; Johannes Gutenberg University of Mainz; Harvard University; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; University of Copenhagen; Niels Bohr Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; University of Alabama System; University of Alabama Birmingham	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Space Sci Bldg, Ithaca, NY 14853 USA.	squyres@astro.cornell.edu	Moersch, Jeffrey E/F-7189-2010; Madsen, Morten Bo/D-2082-2011; Lemmon, Mark T/E-9983-2010; Lemmon, Mark/X-2333-2019; Smith, Michael/C-8875-2012; Farmer, Jack D/B-9343-2019	Moersch, Jeffrey E/0000-0003-3433-9419; Madsen, Morten Bo/0000-0001-8909-5111; Lemmon, Mark T/0000-0002-4504-5136; Lemmon, Mark/0000-0002-4504-5136; McLennan, Scott/0000-0003-4259-7178				[Anonymous], 1982, STRUCTURES SEQUENCES; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; ARVIDSON RE, 2004, SCIENCE, V306, P1760; BANIN A, 1992, MARS, P584; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; CHOQUETTE PW, 1970, AM ASSOC PETR GEOL B, V54, P207; Christensen PR, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002233; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; CHRISTENSEN PR, 2000, J GEOPHYS RES, V105, P9632; Crisp JA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002038; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Lemmon MT, 2004, SCIENCE, V306, P1753, DOI 10.1126/science.1104474; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; Middleton G.V., 1984, SEPM SHORT COURSE 3, P401; Rieder R., 2003, Journal of Geophysical Research, V108, pROV7, DOI 10.1029/2003JE002150; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Smith MD, 2004, SCIENCE, V306, P1750, DOI 10.1126/science.1104257; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; SOUTHARD JB, 1990, J SEDIMENT PETROL, V60, P680, DOI 10.2110/jsr.60.680; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559	34	415	421	1	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1698	1703		10.1126/science.1106171	http://dx.doi.org/10.1126/science.1106171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576602				2022-12-28	WOS:000225630800034
J	Blum-Hareuveni, T; Rehany, U; Rumelt, S				Blum-Hareuveni, T; Rehany, U; Rumelt, S			Blinding endophthalmitis from orthodontic headgear	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							INJURIES		Western Galilee Nahariya Med Ctr, IL-22100 Nahariyya, Israel	Western Galilee Hospital	Blum-Hareuveni, T (corresponding author), Western Galilee Nahariya Med Ctr, IL-22100 Nahariyya, Israel.							HOLLAND GN, 1985, ARCH OPHTHALMOL-CHIC, V103, P649; SAMUELS RHA, 1994, EUR J ORTHODONT, V16, P385, DOI 10.1093/ejo/16.5.385; Zamir E, 1999, J PEDIAT OPHTH STRAB, V36, P224	3	6	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2774	2775		10.1056/NEJM200412233512623	http://dx.doi.org/10.1056/NEJM200412233512623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616219				2022-12-28	WOS:000225877300030
J	Gabrielli, P; Barbante, C; Plane, JMC; Varga, A; Hong, S; Cozzi, G; Gaspari, V; Planchon, FAM; Cairns, W; Ferrari, C; Crutzen, P; Cescon, P; Boutron, CF				Gabrielli, P; Barbante, C; Plane, JMC; Varga, A; Hong, S; Cozzi, G; Gaspari, V; Planchon, FAM; Cairns, W; Ferrari, C; Crutzen, P; Cescon, P; Boutron, CF			Meteoric smoke fallout over the Holocene epoch revealed by iridium and platinum in Greenland ice	NATURE			English	Article							ACCRETION RATE; ANTARCTIC ICE; PARTICLES; DUST; CORE; CLIMATE; POLAR; GISP2; FLUX	An iridium anomaly at the Cretaceous/Tertiary boundary layer has been attributed to an extraterrestrial body that struck the Earth some 65 million years ago(1). It has been suggested that, during this event, the carrier of iridium was probably a micrometre-sized silicate-enclosed aggregate(2) or the nanophase material of the vaporized impactor(3). But the fate of platinum-group elements ( such as iridium) that regularly enter the atmosphere via ablating meteoroids remains largely unknown. Here we report a record of iridium and platinum fluxes on a climatic-cycle timescale, back to 128,000 years ago, from a Greenland ice core(4). We find that unexpectedly constant fallout of extraterrestrial matter to Greenland occurred during the Holocene, whereas a greatly enhanced input of terrestrial iridium and platinum masked the cosmic flux in the dust-laden atmosphere of the last glacial age. We suggest that nanometresized meteoric smoke particles(5,6), formed from the recondensation of ablated meteoroids in the atmosphere at altitudes > 70 kilometres, are transported into the winter polar vortices by the mesospheric meridional circulation(7) and are preferentially deposited in the polar ice caps. This implies an average global fallout of 14 +/- 5 kilotons per year of meteoric smoke during the Holocene.	Univ Venice, Dept Environm Sci, I-30123 Venice, Italy; Univ Venice, Inst Dynam Environm Proc, CNR, I-30123 Venice, Italy; Univ Grenoble 1, UMR CNRS 5183, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Korea Ocean Res & Dev Inst, Korea Polar Res Inst, Seoul 425600, South Korea; Univ Grenoble 1, Inst Univ France, Ecole Polytech Univ Grenoble, F-38041 Grenoble, France; Max Planck Inst Chem, Atmospher Div, D-55128 Mainz, Germany; Univ Grenoble 1, Inst Univ France, Observ Sci Univers, F-38041 Grenoble, France; Univ Grenoble 1, Unite Format & Rech Phys, F-38041 Grenoble, France	Universita Ca Foscari Venezia; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Dinamica dei Processi Ambientali (IDPA-CNR); Universita Ca Foscari Venezia; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of East Anglia; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Institut Universitaire de France; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Max Planck Society; Institut Universitaire de France; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Barbante, C (corresponding author), Univ Venice, Dept Environm Sci, I-30123 Venice, Italy.	barbante@unive.it	Cairns, Warren/AAX-5018-2020; Cozzi, Giulio/F-6473-2010; Frederic, Planchon/A-8651-2010; Cozzi, Giulio/R-4554-2019; Crutzen, Paul J/F-6044-2012; Plane, John M C/C-7444-2015; Cozzi, Giulio/G-9037-2012; Barbante, Carlo/B-3195-2011	Cairns, Warren/0000-0002-7128-7753; Cozzi, Giulio/0000-0001-8796-4176; Plane, John M C/0000-0003-3648-6893; Cozzi, Giulio/0000-0001-8796-4176; Barbante, Carlo/0000-0003-4177-2288; Cescon, Paolo/0000-0003-1836-6759; Planchon, Frederic/0000-0003-1288-9698				ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Barbante C, 1999, ANAL CHEM, V71, P4125, DOI 10.1021/ac981437g; BOUTRON CF, 1986, NATURE, V323, P222, DOI 10.1038/323222a0; Brown P, 2002, NATURE, V420, P294, DOI 10.1038/nature01238; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Gabrielli P, 2004, J ANAL ATOM SPECTROM, V19, P831, DOI 10.1039/b316283d; Hong SM, 1997, ATMOS ENVIRON, V31, P2235, DOI 10.1016/S1352-2310(97)00029-0; Hong SM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018411; Hughes D. W., 1978, Cosmic dust, P123; HUNTEN DM, 1980, J ATMOS SCI, V37, P1342, DOI 10.1175/1520-0469(1980)037<1342:SADPOM>2.0.CO;2; JACOBSON MZ, 1994, ATMOS ENVIRON, V28, P1327, DOI 10.1016/1352-2310(94)90280-1; Johnsen SJ, 2001, J QUATERNARY SCI, V16, P299, DOI 10.1002/jqs.622; Karner DB, 2003, GEOCHIM COSMOCHIM AC, V67, P751, DOI 10.1016/S0016-7037(02)01145-6; LOVE SG, 1991, ICARUS, V89, P26, DOI 10.1016/0019-1035(91)90085-8; LOVE SG, 1993, SCIENCE, V262, P550, DOI 10.1126/science.262.5133.550; Manson A. H., 1990, Advances in Space Research, V10, P233, DOI 10.1016/0273-1177(90)90401-K; Mathews JD, 2001, GEOPHYS RES LETT, V28, P1929, DOI 10.1029/2000GL012621; MAURETTE M, 1987, NATURE, V328, P699, DOI 10.1038/328699a0; MULLER RA, 1995, NATURE, V377, P107, DOI 10.1038/377107b0; Peucker-Ehrenbrink B, 2000, GEOCHIM COSMOCHIM AC, V64, P1965, DOI 10.1016/S0016-7037(99)00429-9; Plane JMC, 2004, ATMOS CHEM PHYS, V4, P627, DOI 10.5194/acp-4-627-2004; PRATHER MJ, 1988, GEOPHYS RES LETT, V15, P1, DOI 10.1029/GL015i001p00001; Ravizza G, 1997, CHEM GEOL, V141, P251, DOI 10.1016/S0009-2541(97)00091-0; Schuraytz BC, 1996, SCIENCE, V271, P1573, DOI 10.1126/science.271.5255.1573; Svensson A, 2000, J GEOPHYS RES-ATMOS, V105, P4637, DOI 10.1029/1999JD901093; Taylor S, 1998, NATURE, V392, P899, DOI 10.1038/31894; Wdowiak TJ, 2001, METEORIT PLANET SCI, V36, P123, DOI 10.1111/j.1945-5100.2001.tb01814.x; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; ZOLLER WH, 1983, SCIENCE, V222, P1118, DOI 10.1126/science.222.4628.1118	30	113	114	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1011	1014		10.1038/nature03137	http://dx.doi.org/10.1038/nature03137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616558				2022-12-28	WOS:000225887000037
J	Jeng, MS; Ng, NK; Ng, PKL				Jeng, MS; Ng, NK; Ng, PKL			Feeding behaviour: Hydrothermal vent crabs feast on sea 'snow'	NATURE			English	Editorial Material									Acad Sinica, Inst Zool, Taipei 11529, Taiwan; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Academia Sinica - Taiwan; National University of Singapore	Jeng, MS (corresponding author), Acad Sinica, Inst Zool, Taipei 11529, Taiwan.	jengms@gatz.sinica.edu.tw	Ng, Peter/J-7393-2012					CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Dando P.R., 1995, Geological Society Special Publication, V87, P303, DOI 10.1144/GSL.SP.1995.087.01.23; Jeng MS, 2004, J CRUSTACEAN BIOL, V24, P188, DOI 10.1651/C-2359; KIDO TJ, 1975, TOKYO UNIV FISH, V61, P59; Kuo F.W, 2001, THESIS NATL SUN YAT; Liu C.C., 1995, J GEOL SOC CHINA, V38, P229; Ng N.K., 2000, National Taiwan Museum Special Publication Series, V10, P191; NG NK, UNPUB CRUSTACEANA; Southward AJ, 1997, J MAR BIOL ASSOC UK, V77, P753, DOI 10.1017/S0025315400036171; TAKEDA M, 1993, NATURE ENV SCI RES, V6, P59; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Turkay Michael, 1995, Senckenbergiana Maritima, V26, P25; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD	13	71	77	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2004	432	7020					969	969		10.1038/432969a	http://dx.doi.org/10.1038/432969a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616550				2022-12-28	WOS:000225887000029
J	Zhou, LQ; Mitra, R; Atkinson, PW; Hickman, AB; Dyda, F; Craig, NL				Zhou, LQ; Mitra, R; Atkinson, PW; Hickman, AB; Dyda, F; Craig, NL			Transposition of hAT elements links transposable elements and V(D)J recombination	NATURE			English	Article							SINGLE ACTIVE-SITE; MUTATIONAL ANALYSIS; MUSCA-DOMESTICA; STRAND TRANSFER; TRANSFER STEPS; RAG PROTEINS; AMINO-ACIDS; DNA; HERMES; RESIDUES	Transposons are DNA sequences that encode functions that promote their movement to new locations in the genome. If unregulated, such movement could potentially insert additional DNA into genes, thereby disrupting gene expression and compromising an organism's viability. Transposable elements are classified by their transposition mechanisms and by the transposases that mediate their movement. The mechanism of movement of the eukaryotic hAT superfamily elements was previously unknown, but the divergent sequence of hAT transposases from other elements suggested that these elements might use a distinct mechanism. Here we have analysed transposition of the insect hAT element Hermes in vitro. Like other transposons, Hermes excises from DNA via double-strand breaks between the donor-site DNA and the transposon ends, and the newly exposed transposon ends join to the target DNA. Interestingly, the ends of the donor double-strand breaks form hairpin intermediates, as observed during V(D)J recombination, the process which underlies the combinatorial formation of antigen receptor genes. Significant similarities exist in the catalytic amino acids of Hermes transposase, the V( D) J recombinase RAG, and retroviral integrase superfamily transposases, thereby linking the movement of transposable elements and V( D) J recombination.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Riverside; University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Craig, NL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	ncraig@jhmi.edu		Zhou, Li Qin/0000-0001-8900-2835	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036122] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Allingham JS, 1999, J MOL BIOL, V289, P1195, DOI 10.1006/jmbi.1999.2837; Ason B, 2002, J BIOL CHEM, V277, P11284, DOI 10.1074/jbc.M111119200; Bankhead T, 2004, P NATL ACAD SCI USA, V101, P13768, DOI 10.1073/pnas.0405762101; Bhasin A, 1999, J BIOL CHEM, V274, P37021, DOI 10.1074/jbc.274.52.37021; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; CALVI BR, 1991, CELL, V66, P465, DOI 10.1016/0092-8674(81)90010-6; COEN ES, 1986, CELL, V47, P285, DOI 10.1016/0092-8674(86)90451-4; CRAIG NL, 2002, MOBILE DNA, V2; Davies DR, 1999, J BIOL CHEM, V274, P11904, DOI 10.1074/jbc.274.17.11904; De P, 2004, IMMUNOL REV, V200, P70, DOI 10.1111/j.0105-2896.2004.00154.x; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Haren L, 1999, ANNU REV MICROBIOL, V53, P245, DOI 10.1146/annurev.micro.53.1.245; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Huye LE, 2002, MOL CELL BIOL, V22, P3460, DOI 10.1128/MCB.22.10.3460-3473.2002; Kennedy AK, 2000, CELL, V101, P295, DOI 10.1016/S0092-8674(00)80839-9; Kennedy AK, 1998, CELL, V95, P125, DOI 10.1016/S0092-8674(00)81788-2; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Kunze R., 2002, MOBILE DNA, P565, DOI DOI 10.1128/9781555817954.CH24; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Lewis SM, 1997, CELL, V88, P159, DOI 10.1016/S0092-8674(00)81833-4; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Michel K, 2003, INSECT BIOCHEM MOLEC, V33, P959, DOI 10.1016/S0965-1748(03)00102-4; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; Namgoong SY, 1998, EMBO J, V17, P3775, DOI 10.1093/emboj/17.13.3775; OBrochta DA, 1996, GENETICS, V142, P907; Okuda M, 1998, MOL GEN GENET, V258, P599, DOI 10.1007/s004380050773; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; Qiu JX, 2001, MOL CELL, V7, P77, DOI 10.1016/S1097-2765(01)00156-3; Rice PA, 2001, NAT STRUCT BIOL, V8, P302, DOI 10.1038/86166; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Robertson Hugh M., 2002, P1093; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Rubin E, 2001, GENETICS, V158, P949; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Sarkar A, 1997, GENETICA, V99, P15, DOI 10.1023/A:1018349803656; Sarnovsky RJ, 1996, EMBO J, V15, P6348, DOI 10.1002/j.1460-2075.1996.tb01024.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Walbot Virginia, 2002, P533; WARREN WD, 1994, GENET RES, V64, P87, DOI 10.1017/S0016672300032699; Weil CF, 2000, NAT GENET, V26, P187, DOI 10.1038/82827; Williams TL, 1999, GENE DEV, V13, P2725, DOI 10.1101/gad.13.20.2725; Yu JH, 2004, MOL CELL BIOL, V24, P1351, DOI 10.1128/MCB.24.3.1351-1364.2004	50	151	159	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					995	1001		10.1038/nature03157	http://dx.doi.org/10.1038/nature03157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616554				2022-12-28	WOS:000225887000033
J	Gallagher, AG; Cates, CU				Gallagher, AG; Cates, CU			Approval of virtual reality training for carotid stenting - What this means for procedural-based medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ENDARTERECTOMY; ANGIOPLASTY; RISK		Emory Univ, Dept Surg, Atlanta, GA 30322 USA; Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA; Emory Heart Ctr, Atlanta, GA USA	Emory University; Emory University	Cates, CU (corresponding author), Emory Univ Hosp, 1364 Clifton Rd NE,Suite C-430, Atlanta, GA 30322 USA.	christopher_cates@emoryhealthcare.org		Gallagher, Anthony G./0000-0003-0887-5613				Cotin S, 2000, Stud Health Technol Inform, V70, P59; GALLAGHER AG, IN PRESS ANN SURG; Gallagher Anthony G, 2003, Semin Laparosc Surg, V10, P127, DOI 10.1177/107155170301000306; Grantcharov TP, 2004, BRIT J SURG, V91, P146, DOI 10.1002/bjs.4407; Ouriel K, 2004, J VASC SURG, V39, P916, DOI 10.1016/j.jvs.2004.01.028; Ouriel K, 2004, J AM COLL SURGEONS, V199, P347, DOI 10.1016/j.jamcollsurg.2004.04.012; ROSENFIELD KM, IN PRESS CATHETER CA; Roubin GS, 2002, STROKE, V33, P2520, DOI 10.1161/01.STR.0000033490.22193.1A; SATAVA RM, 1993, SURG ENDOSC-ULTRAS, V7, P203, DOI 10.1007/BF00594110; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/00000658-200210000-00008; US Food and Drug Administration Center for Devices and Radiological Health Medical Devices Advisory Committee, CIRC SYST DEV PAN M; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; 2004, MEDICARE ANNOUNCES I	13	140	141	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					3024	3026		10.1001/jama.292.24.3024	http://dx.doi.org/10.1001/jama.292.24.3024			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613672				2022-12-28	WOS:000225841900038
J	Childs, JD; Fritz, JM; Flynn, TW; Irrgang, JJ; Johnson, KK; Majkowski, GR; Delitto, A				Childs, JD; Fritz, JM; Flynn, TW; Irrgang, JJ; Johnson, KK; Majkowski, GR; Delitto, A			A clinical prediction rule to identify patients with low back pain most likely to benefit from spinal manipulation: A validation study	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE; INTERRATER RELIABILITY; MEDICAL LITERATURE; USERS GUIDES; THERAPY; EXERCISES; COST; FEAR; IMPLEMENTATION; QUESTIONNAIRE	Background: Conflicting evidence exists about the effectiveness of spinal manipulation. Objective: To validate a manipulation clinical prediction rule. Design: Multicenter randomized, controlled trial. Setting: Physical therapy clinics. Patients: 131 consecutive patients with low back pain, 18 to 60 years of age, who were referred to physical therapy. Intervention: Patients were randomly assigned to receive manipulation plus exercise or exercise alone by a physical therapist for 4 weeks. Measurements: Patients were examined according to the clinical prediction rule criteria (symptom duration, symptom location, fear-avoidance beliefs, lumbar mobility, and hip rotation range of motion). Disability and pain at 1 and 4 weeks and 6 months were assessed. Results: Outcome from spinal manipulation depends on a patient's status on the prediction rule. Treatment effects are greatest for the subgroup of patients who were positive on the rule (at least 4 of 5 criteria met); health care utilization among this subgroup was decreased at 6 months. Compared with patients who were negative on the rule and received exercise, the odds of a successful outcome among patients who were positive on the rule and received manipulation were 60.8 (95% CI, 5.2 to 704.7). The odds were 2.4 (CI, 0.83 to 6.9) among patients who were negative on the rule and received manipulation and 1.0 (CI, 0.28 to 3.6) among patients who were positive on the rule and received exercise. A patient who was positive on the rule and received manipulation has a 92% chance of a successful outcome, with an associated number needed to treat for benefit at 4 weeks of 1.9 (CI, 1.4 to 3.5). Limitations: The response rate for the 6-month follow-up resulted in inadequate power to detect statistically significant differences for some comparisons. Conclusions: The spinal manipulation clinical prediction rule can be used to improve decision making for patients with low back pain.	Lackland AFB, Wilford Hall Med Ctr, San Antonio, TX USA; Univ Pittsburgh, Pittsburgh, PA USA; Baylor Univ, USA, Grad Program Phys Therapy, Houston, TX 77030 USA; Hill AFB, Med Clin, Ogden, UT USA; Luke AFB, Med Clin, Phoenix, AZ USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor University; United States Department of Defense; United States Air Force	Childs, JD (corresponding author), Lackland AFB, Wilford Hall Med Ctr, San Antonio, TX USA.	childsjd@sbcglobal.net		Flynn, Timothy/0000-0003-3122-2901				Albright J, 2001, PHYS THER, V81, P1641; Assendelft WJJ, 2003, ANN INTERN MED, V138, P871, DOI 10.7326/0003-4819-138-11-200306030-00008; BIGOS S, 1991, AHCPR PUBLICATION; BINKLEY J, 1995, PHYS THER, V75, P786, DOI 10.1093/ptj/75.9.786; BINKLEY J, 1995, PHYS THER, V75, P794, DOI 10.1093/ptj/75.9.794; Borkan JM, 1998, SPINE, V23, P1992, DOI 10.1097/00007632-199809150-00016; Bouter LM, 1998, SPINE, V23, P2014, DOI 10.1097/00007632-199809150-00019; CHAN CW, 1993, SPINE, V18, P1717, DOI 10.1097/00007632-199310000-00001; Cherkin DC, 2003, ANN INTERN MED, V138, P898, DOI 10.7326/0003-4819-138-11-200306030-00011; Childs JD, 2003, J ORTHOP SPORT PHYS, V33, P259, DOI 10.2519/jospt.2003.33.5.259; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Deyo RA, 1996, SPINE, V21, P2826, DOI 10.1097/00007632-199612150-00003; Ehrmann-Feldman D, 1996, PHYS THER, V76, P156; EhrmannFeldman D, 1996, PHYS THER, V76, P150, DOI 10.1093/ptj/76.2.150; ELLISON JB, 1990, PHYS THER, V70, P537, DOI 10.1093/ptj/70.9.537; ERHARD RE, 1994, PHYS THER, V74, P1093, DOI 10.1093/ptj/74.12.1093; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; FIARBANK JC, 2000, SPINE, V25, P2952; Flynn T, 2002, SPINE, V27, P2835, DOI 10.1097/00007632-200212150-00021; Frank JW, 1996, SPINE, V21, P2918, DOI 10.1097/00007632-199612150-00025; Freburger JK, 2001, PHYS THER, V81, P1135, DOI 10.1093/ptj/81.5.1135; Fritz JM, 2000, SPINE, V25, P106, DOI 10.1097/00007632-200001010-00018; Fritz JM, 2002, PHYS THER, V82, P973, DOI 10.1093/ptj/82.10.973; Fritz JM, 2001, PHYS THER, V81, P776, DOI 10.1093/ptj/81.2.776; Fritz JM, 2001, PHYS THER, V81, P1546, DOI 10.1093/ptj/81.9.1546; FRITZ JM, 2001, EXERCISE PRESCRIPTIO, P167; Glass G.V., 1996, STAT METHODS ED PSYC, V3; GONNELLA C, 1982, PHYS THER, V62, P436, DOI 10.1093/ptj/62.4.436; Guyatt G., 2015, USERS GUIDES MED LIT; Hagen KB, 2002, SPINE, V27, P1736, DOI 10.1097/00007632-200208150-00010; Hashemi L, 1998, J OCCUP ENVIRON MED, V40, P1110; Hiebert R, 2003, SPINE, V28, P722, DOI 10.1097/00007632-200304010-00019; Jacob T, 2001, ARCH PHYS MED REHAB, V82, P735, DOI 10.1053/apmr.2001.22623; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; JENSEN MP, 1994, PAIN, V58, P387, DOI 10.1016/0304-3959(94)90133-3; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lundberg G, 1999, SCAND J REHABIL MED, V31, P197; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; MAHER C, 1994, PHYS THER, V74, P801, DOI 10.1093/ptj/74.9.801; Maher CG, 1998, PHYS THER, V78, P829, DOI 10.1093/ptj/78.8.829; MAITLAND G, 1986, VERTEBRAL MANIPULATI; MALMIVAARA A, 1995, NEW ENGL J MED, V332, P351, DOI 10.1056/NEJM199502093320602; MANN NH, 1993, SPINE, V18, P41, DOI 10.1097/00007632-199301000-00008; McGill SM, 1998, PHYS THER, V78, P754, DOI 10.1093/ptj/78.7.754; McGinn T, 2002, USERS GUIDES MED LIT, P471; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; SHEKELLE PG, 1992, ANN INTERN MED, V117, P590, DOI 10.7326/0003-4819-117-7-590; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Stiell IG, 1997, JAMA-J AM MED ASSOC, V278, P2075, DOI 10.1001/jama.278.23.2075; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Strender LE, 1997, SPINE, V22, P814, DOI 10.1097/00007632-199704010-00021; UDEN A, 1988, SPINE, V13, P389, DOI 10.1097/00007632-198804000-00002; van Tulder M, 2000, SPINE, V25, P2784, DOI 10.1097/00007632-200011010-00011; van Tulder MW, 2000, SPINE, V25, P2501, DOI 10.1097/00007632-200010010-00013; van Tulder MW, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000335; vanTulder MW, 1997, SPINE, V22, P2128, DOI 10.1097/00007632-199709150-00012; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; WADDELL G, 1992, SPINE, V17, P617, DOI 10.1097/00007632-199206000-00001; WERNEKE MW, 1993, SPINE, V18, P2412, DOI 10.1097/00007632-199312000-00008	63	578	581	3	43	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2004	141	12					920	928		10.7326/0003-4819-141-12-200412210-00008	http://dx.doi.org/10.7326/0003-4819-141-12-200412210-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882EY	15611489				2022-12-28	WOS:000225923000003
J	Rule, AD; Larson, TS; Bergstralh, EJ; Slezak, JM; Jacobsen, SJ; Cosio, FG				Rule, AD; Larson, TS; Bergstralh, EJ; Slezak, JM; Jacobsen, SJ; Cosio, FG			Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease	ANNALS OF INTERNAL MEDICINE			English	Article							RENAL-FUNCTION; PREDICTION EQUATIONS; GFR; ISSUES; ADULTS; DIET	Background: The National Kidney Foundation has advocated the use of the abbreviated Modification of Diet in Renal Disease (MDRD) equation to estimate glomerular filtration rate (GFR) from serum creatinine measurements in clinical laboratories. However, healthy persons were not included in the development of the MDRD equation. Objectives: To assess the accuracy of the MDRD equation in patients with chronic kidney disease compared with healthy persons and to develop a new equation that uses both patients with chronic kidney disease and healthy persons. Design: Cross-sectional study. Setting: The Mayo Clinic, a tertiary-care medical center. Participants: Consecutive patients (n = 320) who had an iothalamate clearance test specifically for chronic kidney disease evaluation and consecutive healthy persons (n = 580) who had an iothalamate clearance test specifically for kidney donor evaluation. Measurements: Serum creatinine levels, GFR, demographic characteristics, and clinical characteristics were abstracted from the medical record. Results: The MDRD equation underestimated GFR by 6.2% in patients with chronic kidney disease and by 29% in healthy persons. Re-estimated coefficients for serum creatinine and sex were similar to the original MDRD equation in the chronic kidney disease series but not in the healthy series. At the same serum creatinine level, age, and sex, GFR was on average 26% higher in healthy persons than in patients with chronic kidney disease (P < 0.001). A quadratic GFR equation was developed to estimate logarithmic GFR from the following covariates: 1/SCr, 1/SCr2, age, and sex (where SCr = serum creatinine). Limitations: The new equation was not developed in a general population sample. Elderly and African-American persons were underrepresented. Conclusion: The MDRD equation systematically underestimates GFR in healthy persons. A new equation developed with patients who have chronic kidney disease and healthy persons may be a step toward accurately estimating GFR when the diagnosis of chronic kidney disease is unknown.	Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Cosio, FG (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	Cosio.Fernando@mayo.edu		Jacobsen, Steven/0000-0002-8174-8533	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007013] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK07013] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BECK GJ, 1991, CONTROL CLIN TRIALS, V12, P566, DOI 10.1016/0197-2456(91)90069-X; Bertolatus JA, 2001, TRANSPLANTATION, V71, P256, DOI 10.1097/00007890-200101270-00016; BUEHRIG CK, 2001, J AM SOC NEPHROL, V12, pA1005; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; HAND DJ, 1998, ENCY BIOSTATISTICS, V5, P3967; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hsu CY, 2002, KIDNEY INT, V61, P1567, DOI 10.1046/j.1523-1755.2002.00299.x; Johansen KL, 2003, KIDNEY INT, V63, P291, DOI 10.1046/j.1523-1755.2003.00704.x; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levey AS, 2000, J AM SOC NEPHROL, V11, pA0828; Lin J, 2003, J AM SOC NEPHROL, V14, P2573, DOI 10.1097/01.ASN.0000088721.98173.4B; Manjunath G, 2001, CURR OPIN NEPHROL HY, V10, P785, DOI 10.1097/00041552-200111000-00009; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Pierrat A, 2003, KIDNEY INT, V64, P1425, DOI 10.1046/j.1523-1755.2003.00208.x; Rule AD, 2004, AM J KIDNEY DIS, V43, P112, DOI 10.1053/j.ajkd.2003.09.026; Schuster V.L., 1992, KIDNEY PHYSL PATHOPH, P943; SLACK TK, 1976, MAYO CLIN PROC, V51, P296; Verhave JC, 2004, J AM SOC NEPHROL, V15, P1316; Vervoort G, 2002, NEPHROL DIAL TRANSPL, V17, P1909, DOI 10.1093/ndt/17.11.1909; Wilson DM, 1997, AM J KIDNEY DIS, V30, P646, DOI 10.1016/S0272-6386(97)90488-1	25	862	891	1	47	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2004	141	12					929	937		10.7326/0003-4819-141-12-200412210-00009	http://dx.doi.org/10.7326/0003-4819-141-12-200412210-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882EY	15611490				2022-12-28	WOS:000225923000004
J	Gudena, R; Luwemba, S; Williams, A; Jenkinson, LR				Gudena, R; Luwemba, S; Williams, A; Jenkinson, LR			Data protection gone too far: questionnaire survey of patients' and visitors' views about having their names displayed in hospital	BRITISH MEDICAL JOURNAL			English	Article									Dept Surg, Bangor LL57 2PW, Gwynedd, Wales		Gudena, R (corresponding author), Dept Surg, Bangor LL57 2PW, Gwynedd, Wales.	gudenar@msn.com						*INF COMM OFF, 2002, US DISCL HLTH DAT GU	1	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1491	1491		10.1136/bmj.329.7480.1491	http://dx.doi.org/10.1136/bmj.329.7480.1491			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604195	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000225965800038
J	Arnett, HA; Fancy, SPJ; Alberta, JA; Zhao, C; Plant, SR; Kaing, S; Raine, CS; Rowitch, DH; Franklin, RJM; Stiles, CD				Arnett, HA; Fancy, SPJ; Alberta, JA; Zhao, C; Plant, SR; Kaing, S; Raine, CS; Rowitch, DH; Franklin, RJM; Stiles, CD			bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS	SCIENCE			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; ETHIDIUM-BROMIDE; ADULT CNS; REMYELINATION; EXPRESSION	Olig1 and Olig2 are closely related basic helix-loop-helix (bHLH) transcription factors that are expressed in myelinating oligodendrocytes and their progenitor cells in the developing central nervous system (CNS). Olig2 is necessary for the specification of oligodendrocytes, but the biological functions of Otig1 during oligodendrocyte lineage development are poorly understood. We show here that Olig1 function in mice is required not to develop the brain but to repair it. Specifically, we demonstrate a genetic requirement for Olig1 in repairing the types of lesions that occur in patients with multiple sclerosis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB3 0ES, England; Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Albert Einstein Coll Med, Dept Pathol Neuropathol, Bronx, NY 10461 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Cambridge; University of Cambridge; University of North Carolina; University of North Carolina Chapel Hill; Yeshiva University; Albert Einstein College of Medicine	Franklin, RJM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	rjf1000@cam.ac.uk; charles-stiles@dfci.harvard.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Rowitch, David/0000-0002-0079-0060; Franklin, Robin/0000-0001-6522-2104	Multiple Sclerosis Society [689] Funding Source: Medline; NINDS NIH HHS [NS4051, NS11920, NS08952] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011920, R01NS008952, P01NS011920] Funding Source: NIH RePORTER	Multiple Sclerosis Society(National Multiple Sclerosis Society); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lu QR, 2001, NAT NEUROSCI, V4, P973, DOI 10.1038/nn718; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Penderis J, 2003, EUR J NEUROSCI, V18, P2253, DOI 10.1046/j.1460-9568.2003.02969.x; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Raine CS, 1997, J NEUROIMMUNOL, V77, P135, DOI 10.1016/S0165-5728(97)00073-8; RAINE CS, 1993, J NEUROPATH EXP NEUR, V52, P199, DOI 10.1097/00005072-199305000-00003; RAINE CS, 1997, TXB NEUROPATHOLOGY, P245; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Wolswijk G, 1998, J NEUROSCI, V18, P601; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L; Zamvil SS, 2003, NEURON, V38, P685, DOI 10.1016/S0896-6273(03)00326-X; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	28	334	352	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2111	2115		10.1126/science.1103709	http://dx.doi.org/10.1126/science.1103709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604411				2022-12-28	WOS:000225841000068
J	Saiardi, A; Bhandari, R; Resnick, AC; Snowman, AM; Snyder, SH				Saiardi, A; Bhandari, R; Resnick, AC; Snowman, AM; Snyder, SH			Phosphorylation of proteins by inositol pyrophosphates	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; HEXAKISPHOSPHATE KINASE; SUBUNIT; IDENTIFICATION; DICTYOSTELIUM; TRAFFICKING; ADAPTER; CELLS; YEAST	The inositol pyrophosphates IP7 and IP8 contain highly energetic pyrophosphate bonds. Although implicated in various biologic functions, their molecular sites of action have not been clarified. Using radiolabeled IP7, we detected phosphorylation of multiple eukaryotic proteins. We also observed phosphorylation of endogenous proteins by endogenous IP7 in yeast. Phosphorylation by IP7 is nonenzymatic and may represent a novel intracellular signaling mechanism.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@bs.jhmi.edu		Bhandari, Rashna/0000-0003-3101-0204	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501, P50MH068830] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00074] Funding Source: Medline; NIMH NIH HHS [MH068830-02, MH18501] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; Dixon J, 1996, NAT GENET, V12, P130; DUCLOS B, 1991, METHOD ENZYMOL, V201, P10; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Laussmann T, 1996, BIOCHEM J, V315, P715, DOI 10.1042/bj3150715; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Meier UT, 1996, J BIOL CHEM, V271, P19376; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Morrison BH, 2001, J BIOL CHEM, V276, P24965, DOI 10.1074/jbc.M101161200; Norbis F, 1997, J MEMBRANE BIOL, V156, P19, DOI 10.1007/s002329900183; Paznekas WA, 1997, BIOCHEM BIOPH RES CO, V238, P1, DOI 10.1006/bbrc.1997.7229; Safrany ST, 1999, J BIOL CHEM, V274, P21735, DOI 10.1074/jbc.274.31.21735; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; SAIARDI A, UNPUB; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; Stage-Zimmermann T, 2000, MOL BIOL CELL, V11, P3777, DOI 10.1091/mbc.11.11.3777; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; Voglmaier SM, 1996, P NATL ACAD SCI USA, V93, P4305, DOI 10.1073/pnas.93.9.4305; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xue Zhixiong, 1994, Trends in Cell Biology, V4, P414, DOI 10.1016/0962-8924(94)90095-7	25	226	233	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2101	2105		10.1126/science.1103344	http://dx.doi.org/10.1126/science.1103344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	881CM	15604408				2022-12-28	WOS:000225841000065
J	Khazipov, R; Sirota, A; Leinekugel, X; Holmes, GL; Ben-Arf, Y; Buzsaki, G				Khazipov, R; Sirota, A; Leinekugel, X; Holmes, GL; Ben-Arf, Y; Buzsaki, G			Early motor activity drives spindle bursts in the developing somatosensory cortex	NATURE			English	Article							THALAMOCORTICAL SYNAPSES; SYNAPTIC PLASTICITY; DEVELOPING NETWORKS; CORTICAL CIRCUITS; BARREL CORTEX; IN-VIVO; RAT; HIPPOCAMPUS; MECHANISMS; NEOCORTEX	Sensorimotor coordination emerges early in development. The maturation period is characterized by the establishment of somatotopic cortical maps(1,2), the emergence of long-range cortical connections(3), heightened experience-dependent plasticity(4-7) and spontaneous uncoordinated skeletal movement(8,9). How these various processes cooperate to allow the somatosensory system to form a three-dimensional representation of the body is not known. In the visual system, interactions between spontaneous network patterns and afferent activity have been suggested to be vital for normal development(10,11). Although several intrinsic cortical patterns of correlated neuronal activity have been described in developing somatosensory cortex in vitro(12-14), the in vivo patterns in the critical developmental period and the influence of physiological sensory inputs on these patterns remain unknown. We report here that in the intact somatosensory cortex of the newborn rat in vivo, spatially confined spindle bursts represent the first and only organized network pattern. The localized spindles are selectively triggered in a somatotopic manner by spontaneous muscle twitches(8,9), motor patterns analogous to human fetal movements(15,16). We suggest that the interaction between movement-triggered sensory feedback signals and self-organized spindle oscillations shapes the formation of cortical connections required for sensorimotor coordination.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; INMED, INSERM, U29, F-13273 Marseille, France; Dartmouth Coll Sch Med, Ctr Neurosci, Neurol Sect, Lebanon, NH 03756 USA; Univ Paris 06, INSERM, EMI 224, F-75013 Paris, France	Rutgers State University Newark; Rutgers State University New Brunswick; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Dartmouth College; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Sirota, Anton/G-1395-2011; Leinekugel, Xavier/F-4034-2014; Khazipov, Roustem/M-1834-2016; Leinekugel, Xavier/ABD-8347-2021	Leinekugel, Xavier/0000-0003-2878-3791; Khazipov, Roustem/0000-0002-6763-2841; Buzsaki, Gyorgy/0000-0002-3100-4800; Ben-Ari, Yehezkel/0000-0001-6208-8480				ARMSTRONGJAMES MA, 1970, J PHYSIOL-LONDON, V208, pP10; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BRAGIN A, 1995, J NEUROSCI, V15, P47; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; CHATRIAN GE, 1959, ELECTROEN CLIN NEURO, V11, P497, DOI 10.1016/0013-4694(59)90048-3; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Destexhe A., 2001, THALAMOCORTICAL ASSE, DOI [10.7554/elife.47314, DOI 10.7554/eLife.47314]; DEVRIES JIP, 1982, EARLY HUM DEV, V7, P301, DOI 10.1016/0378-3782(82)90033-0; Dreyfus-Brisac C, 1971, Rev Electroencephalogr Neurophysiol Clin, V1, P95, DOI 10.1016/S0370-4475(71)80022-9; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GRAMSBERGEN A, 1970, Developmental Psychobiology, V3, P267, DOI 10.1002/dev.420030407; Jain N, 2003, J NEUROSCI, V23, P10321; Karlsson KAE, 2003, J NEUROSCI, V23, P1114, DOI 10.1523/JNEUROSCI.23-04-01114.2003; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Petersson P, 2003, NATURE, V424, P72, DOI 10.1038/nature01719; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	30	397	402	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					758	761		10.1038/nature03132	http://dx.doi.org/10.1038/nature03132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592414				2022-12-28	WOS:000225597200049
J	Rose, GJ; Goller, F; Gritton, HJ; Plamondon, SL; Baugh, AT; Cooper, BG				Rose, GJ; Goller, F; Gritton, HJ; Plamondon, SL; Baugh, AT; Cooper, BG			Species-typical songs in white-crowned sparrows tutored with only phrase pairs	NATURE			English	Article							ZEBRA FINCH; ANTERIOR FOREBRAIN; NEURONS; SELECTIVITY; MECHANISMS; BIRDSONG; ORDER; SENSITIVITY; HVC	Modern theories of learned vocal behaviours, such as human speech and singing in songbirds(1), posit that acoustic communication signals are reproduced from memory, using auditory feedback(2). The nature of these memories, however, is unclear. Here we propose and test a model for how complex song structure can emerge from sparse sequence information acquired during tutoring. In this conceptual model, a population of combination-sensitive (phrase-pair) detectors is shaped by early exposure to song and serves as the minimal representation of the template necessary for generating complete song. As predicted by the model, birds that were tutored with only pairs of normally adjacent song phrases were able to assemble full songs in which phrases were placed in the correct order; birds that were tutored with reverse-ordered phrase pairs sang songs with reversed phrase order. Birds that were tutored with all song phrases, but presented singly, failed to produce normal, full songs. These findings provide the first evidence for a minimal requirement of sequence information in the acoustic model that can give rise to correct song structure.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Rose, GJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	rose@bioscience.utah.edu	Baugh, Alexander T/E-4777-2010	Baugh, Alexander T/0000-0003-2032-892X	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003788] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC003788] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aldridge JW, 1998, J NEUROSCI, V18, P2777; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hultsch H, 1996, J COMP PHYSIOL A, V179, P291; KLEIN D, 1994, NEUROREPORT, V5, P2295, DOI 10.1097/00001756-199411000-00022; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; KONISHI M, 1978, PERCEPTION EXPERIENC; Lewicki MS, 1996, J NEUROSCI, V16, P5854; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; Lewicki MS, 1996, J NEUROSCI, V16, P6987; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MARLER P, 1981, SCIENCE, V213, P780, DOI 10.1126/science.213.4509.780; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; MARLER P, 1962, CONDOR, V64, P363; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Soha JA, 2001, J COMP PSYCHOL, V115, P172, DOI 10.1037//0735-7036.115.2.172; Solis MM, 1997, J NEUROSCI, V17, P6447; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Thorpe WH., 1961, BIRDSONG; VOLMAN SF, 1993, J NEUROSCI, V13, P4737	24	39	39	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					753	758		10.1038/nature02992	http://dx.doi.org/10.1038/nature02992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592413				2022-12-28	WOS:000225597200048
J	Wallis, JW; Aerts, J; Groenen, MAM; Crooijmans, RPMA; Layman, D; Graves, TA; Scheer, DE; Kremitzki, C; Fedele, MJ; Mudd, NK; Cardenas, M; Higginbotham, J; Carter, J; McGrane, R; Gaige, T; Mead, K; Walker, J; Albracht, D; Davito, J; Yang, SP; Leong, S; Chinwalla, A; Sekhon, M; Wylie, K; Dodgson, J; Romanov, MN; Cheng, H; de Jong, PJ; Osoegawa, K; Nefedov, M; Zhang, HB; McPherson, JD; Krzywinski, M; Schein, J; Hillier, L; Mardis, ER; Wilson, RK; Warren, WC				Wallis, JW; Aerts, J; Groenen, MAM; Crooijmans, RPMA; Layman, D; Graves, TA; Scheer, DE; Kremitzki, C; Fedele, MJ; Mudd, NK; Cardenas, M; Higginbotham, J; Carter, J; McGrane, R; Gaige, T; Mead, K; Walker, J; Albracht, D; Davito, J; Yang, SP; Leong, S; Chinwalla, A; Sekhon, M; Wylie, K; Dodgson, J; Romanov, MN; Cheng, H; de Jong, PJ; Osoegawa, K; Nefedov, M; Zhang, HB; McPherson, JD; Krzywinski, M; Schein, J; Hillier, L; Mardis, ER; Wilson, RK; Warren, WC			A physical map of the chicken genome	NATURE			English	Article							MOUSE GENOME; BAC CLONES; INTEGRATION; SEQUENCE; SOFTWARE; LINKAGE	Strategies for assembling large, complex genomes have evolved to include a combination of whole-genome shotgun sequencing and hierarchal map-assisted sequencing(1,2). Whole-genome maps of all types can aid genome assemblies, generally starting with low-resolution cytogenetic maps and ending with the highest resolution of sequence. Fingerprint clone maps are based upon complete restriction enzyme digests of clones representative of the target genome, and ultimately comprise a near-contiguous path of clones across the genome. Such clone-based maps are used to validate sequence assembly order, supply long-range linking information for assembled sequences, anchor sequences to the genetic map and provide templates for closing gaps. Fingerprint maps are also a critical resource for subsequent functional genomic studies, because they provide a redundant and ordered sampling of the genome with clones(3). In an accompanying paper(4) we describe the draft genome sequence of the chicken, Gallus gallus, the first species sequenced that is both a model organism and a global food source. Here we present a clone-based physical map of the chicken genome at 20-fold coverage, containing 260 contigs of overlapping clones. This map represents approximately 91% of the chicken genome and enables identification of chicken clones aligned to positions in other sequenced genomes.	Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Univ Wageningen & Res Ctr, Anim Breeding & Genet Grp, NL-6709 PG Wageningen, Netherlands; Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; USDA ARS, Avian Dis & Oncol Lab, E Lansing, MI 48823 USA; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada	Washington University (WUSTL); Wageningen University & Research; Michigan State University; United States Department of Agriculture (USDA); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Baylor College of Medicine; British Columbia Cancer Agency	Warren, WC (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,4444 Forest Pk Ave, St Louis, MO 63108 USA.	wwarren@watson.wustl.edu	Romanov, Michael N/O-9419-2014; Schein, Jacquie E/G-3674-2015; Crooijmans, Richard PMA/E-2492-2012; Aerts, Jan/AAQ-6949-2020; Sekhon, Mandeep/L-4665-2018; Wilson, Richard K./AAF-4139-2019; Groenen, Martien/D-8408-2012; Aerts, Jan/C-4374-2008; McPherson, John D/D-2633-2017; Mardis, Elaine/W-2202-2019	Romanov, Michael N/0000-0003-3584-4644; Aerts, Jan/0000-0002-6416-2717; Sekhon, Mandeep/0000-0002-9993-6938; Wilson, Richard K./0000-0002-1992-1358; Groenen, Martien/0000-0003-0484-4545; McPherson, John D/0000-0001-8049-9347; Chinwalla, Asif/0000-0001-7831-3996; Cheng, Hans/0000-0003-2071-4644; Kremitzki, Colin/0000-0001-9175-3136				Aerts J, 2003, CYTOGENET GENOME RES, V102, P297, DOI 10.1159/000075766; Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; Flibotte S, 2004, BIOINFORMATICS, V20, P1264, DOI 10.1093/bioinformatics/bth079; Fuhrmann DR, 2003, GENOME RES, V13, P940, DOI 10.1101/gr.904303; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gregory SG, 2002, NATURE, V418, P743, DOI 10.1038/nature00957; Groenen M. A. M., 2003, Poultry genetics, breeding and biotechnology, P497, DOI 10.1079/9780851996608.0497; Groenen MAM, 2000, GENOME RES, V10, P137; Kelley JM, 1999, NUCLEIC ACIDS RES, V27, P1539, DOI 10.1093/nar/27.6.1539; Krzywinski M, 2004, NUCLEIC ACIDS RES, V32, P3651, DOI 10.1093/nar/gkh700; Krzywinski M, 2004, GENOME RES, V14, P766, DOI 10.1101/gr.2336604; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Meyers BC, 2004, NAT REV GENET, V5, P578, DOI 10.1038/nrg1404; Ren CW, 2003, GENOME RES, V13, P2754, DOI 10.1101/gr.1499303; Romanov MN, 2003, CYTOGENET GENOME RES, V102, P277, DOI 10.1159/000075763; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; SULSTON J, 1989, COMPUT APPL BIOSCI, V5, P101; SULSTON J, 1988, COMPUT APPL BIOSCI, V4, P125; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	19	144	155	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					761	764		10.1038/nature03030	http://dx.doi.org/10.1038/nature03030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592415	Bronze			2022-12-28	WOS:000225597200050
J	Schaumberg, DA; Mendes, F; Balaram, M; Dana, MR; Sparrow, D; Hu, H				Schaumberg, DA; Mendes, F; Balaram, M; Dana, MR; Sparrow, D; Hu, H			Accumulated lead exposure and risk of age-related cataract in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; BLOOD-PRESSURE; BONE LEAD; COGNITIVE FUNCTION; VISUAL IMPAIRMENT; OXIDATIVE STRESS; HUMAN LENSES; CADMIUM; HEALTH; COPPER	Context Low-level lead exposure may increase the risk for a number of chronic age-related diseases. Several studies have documented the presence of lead in lenses with cataract. The intrusion of lead into the lens may alter lens redox status and cause protein conformational changes that decrease lens transparency. Objective To determine the relationship of cumulative lead exposure with the development of cataract. Design, Setting, and Participants Tibial (cortical) and patellar (trabecular) bone lead levels were measured by K x-ray fluorescence between 1991 and 1999 in a subset of participants in the Normative Aging Study (NAS), a Boston-based longitudinal study of aging in men. Among the first 795 NAS participants to have bone lead levels measured, we reviewed eye examination data (collected routinely every 3-5 years) for the period after the bone lead measurements were taken. We limited the population to men Aged 60 years and older who had sufficient eye examination information Available (n=642). Blood lead levels were also measured. Main Outcome Measures Cataract assessment was done while masked to the lead level results. A participant was considered to have cataract if there was documentation for either eye of cataract surgery or a cataract graded clinically as 3+ or higher on a 4-point scale. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated as estimates of the magnitude and significance of the relationship of lead exposure with cataract, in logistic regression models. Results The mean age of the study participants was 69 years and cataract was identified in 1-22 men. The age-adjusted OR (95% CI) for cataract for men in the highest vs lowest quintile of tibia lead level was 2.68 (1.31-5.50). Further adjustment for pack-years of cigarette smoking, diabetes, blood lead levels, and intake of vitamin C, vitamin E, and carotenoids resulted in an OR of 3.19 (95% CI, 1.48-6.90). For patella lead level, there was an increased risk of cataract in the highest vs lowest quintile (OR, 1.88; 95% CI, 0.88-4.02), but the trend was not significant (P=.16). Blood lead levels, more indicative of short-term exposure levels, were not significantly associated with,cataract (OR, 0.89; 95% CI, 0.46-1.72; P=73). Conclusions These epidemiological data suggest that accumulated lead exposure, such as that commonly experienced by adults in the United States, may be an important unrecognized risk factor for cataract. This research suggests that reduction of lead exposure could help decrease the global burden of cataract.	Harvard Univ, Sch Med, Dept Ophthalmol,Schepens Eye Res Inst, Brigham & Womens Hosp,Div Prevent Med, E Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Ophthalmol,Schepens Eye Res Inst, Brigham & Womens Hosp,Channing Lab, E Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Normat Aging Study, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Normat Aging Study, Dept Environm Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Vet Affairs, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Schaumberg, DA (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol,Schepens Eye Res Inst, Brigham & Womens Hosp,Div Prevent Med, 900 Commonwealth Ave, E Boston, MA 02215 USA.	dschaumberg@dcs.bwh.harvard.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K23EY000365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R44ES003918, P42ES005947, P30ES000002, R01ES005257] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR02635] Funding Source: Medline; NEI NIH HHS [K23 EY000365-04, K23 EY000365-05] Funding Source: Medline; NIEHS NIH HHS [ES 05257-06A1, P42-ES05947, 2 P30 ES00002, 2R44 ES03918-02] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BELL B, 1972, AGING HUM DEVELOP, V3, P5, DOI 10.2190/GGVP-XLB5-PC3N-EF0G; Brannan S, 2003, BRIT J OPHTHALMOL, V87, P560, DOI 10.1136/bjo.87.5.560; Broman AT, 2002, INVEST OPHTH VIS SCI, V43, P3393; Burger D E, 1990, Basic Life Sci, V55, P287; Cekic O, 1998, BRIT J OPHTHALMOL, V82, P186, DOI 10.1136/bjo.82.2.186; Cekic O, 1998, OPHTHALMIC RES, V30, P49, DOI 10.1159/000055454; Cheng YW, 2001, AM J EPIDEMIOL, V153, P164, DOI 10.1093/aje/153.2.164; Cheng YW, 1998, AM J CARDIOL, V82, P594, DOI 10.1016/S0002-9149(98)00402-0; Chia EM, 2004, INVEST OPHTH VIS SCI, V45, P71, DOI 10.1167/iovs.03-0661; Gavaghan H, 2002, B WORLD HEALTH ORGAN, V80, P82; Glenn BS, 2003, EPIDEMIOLOGY, V14, P30, DOI 10.1097/00001648-200301000-00011; GLYNN RJ, 1982, CIRCULATION, V66, P724, DOI 10.1161/01.CIR.66.4.724; GRUBB BR, 1986, EXP EYE RES, V43, P259, DOI 10.1016/S0014-4835(86)80094-X; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P961, DOI 10.2307/3434138; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Hu H, 1996, JAMA-J AM MED ASSOC, V275, P1171, DOI 10.1001/jama.275.15.1171; Ivers RQ, 2003, J AM GERIATR SOC, V51, P356, DOI 10.1046/j.1532-5415.2003.51109.x; KALCHER K, 1993, SCI TOTAL ENVIRON, V128, P21, DOI 10.1016/0048-9697(93)90177-8; Korrick SA, 1999, AM J PUBLIC HEALTH, V89, P330, DOI 10.2105/AJPH.89.3.330; Landrigan PJ, 2002, B WORLD HEALTH ORGAN, V80, P768; LEGGETT RW, 1993, ENVIRON HEALTH PERSP, V101, P598, DOI 10.2307/3431645; Mangas S, 2003, B WORLD HEALTH ORGAN, V81, P847; Mecocci P, 2004, NEUROL RES, V26, P598, DOI 10.1179/016164104225017659; Neal R, 1999, FREE RADICAL BIO MED, V26, P239, DOI 10.1016/S0891-5849(98)00214-7; Neal R, 1998, TOXICOLOGY, V130, P167, DOI 10.1016/S0300-483X(98)00104-8; Nucci C, 2004, GRAEF ARCH CLIN EXP, V242, P289, DOI 10.1007/s00417-003-0837-z; OFLAHERTY EJ, 1993, TOXICOL APPL PHARM, V118, P16, DOI 10.1006/taap.1993.1004; Ottonello S, 2000, OPHTHALMOLOGICA, V214, P78, DOI 10.1159/000027474; Paterson CA, 1997, CURR EYE RES, V16, P333, DOI 10.1076/ceyr.16.4.333.10689; Payton M, 1998, NEUROTOXICOL TERATOL, V20, P19, DOI 10.1016/S0892-0362(97)00075-5; RACZ P, 1988, OPHTHALMIC RES, V20, P10, DOI 10.1159/000266248; RomeroAlvira D, 1996, MED HYPOTHESES, V46, P414, DOI 10.1016/S0306-9877(96)90196-6; Schwartz BS, 2000, NEUROLOGY, V55, P1144, DOI 10.1212/WNL.55.8.1144; Shukla N, 1996, SCI TOTAL ENVIRON, V181, P161, DOI 10.1016/0048-9697(95)05006-X; STEINBERG EP, 1993, ARCH OPHTHALMOL-CHIC, V111, P1041, DOI 10.1001/archopht.1993.01090080037016; Stewart WF, 1999, NEUROLOGY, V52, P1610, DOI 10.1212/WNL.52.8.1610; Taylor HR, 1999, EYE, V13, P445, DOI 10.1038/eye.1999.119; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; *US EPA, 1995, PUBL EPA; Vig EK, 2000, J AM GERIATR SOC, V48, P1501, DOI 10.1111/jgs.2000.48.11.1501; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268	41	65	66	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2004	292	22					2750	2754		10.1001/jama.292.22.2750	http://dx.doi.org/10.1001/jama.292.22.2750			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877CY	15585735	Bronze, Green Published			2022-12-28	WOS:000225546600024
J	Clark, DWJ; Harrison-Woolrych, M				Clark, DWJ; Harrison-Woolrych, M			Drug points - Sibutramine may be associated with memory impairment	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Otago, IMMP, New Zealand Pharmacovigilance Ctr, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago	Harrison-Woolrych, M (corresponding author), POB 913, Dunedin, New Zealand.	Mira.harrison-woolrych@stonebow.otago.ac.nz						BOHOT MC, 2000, ANN MED, V32, P210; Joss JD, 2003, ANN PHARMACOTHER, V37, P1800, DOI 10.1345/aph.1D154; 2004, PHYS DESK REFERENCE	3	15	17	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2004	329	7478					1316	1316		10.1136/bmj.329.7478.1316	http://dx.doi.org/10.1136/bmj.329.7478.1316			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	878PC	15576742	Green Published, Green Submitted			2022-12-28	WOS:000225657800018
J	Martrat, B; Grimalt, JO; Lopez-Martinez, C; Cacho, I; Sierro, FJ; Flores, JA; Zahn, R; Canals, M; Curtis, JH; Hodell, DA				Martrat, B; Grimalt, JO; Lopez-Martinez, C; Cacho, I; Sierro, FJ; Flores, JA; Zahn, R; Canals, M; Curtis, JH; Hodell, DA			Abrupt temperature changes in the Western Mediterranean over the past 250,000 years	SCIENCE			English	Article							NORTH-ATLANTIC; PLANKTONIC-FORAMINIFERA; RAPID CHANGES; THERMOHALINE CIRCULATION; CLIMATIC VARIABILITY; DANSGAARD-OESCHGER; IBERIAN MARGIN; ICE-CORE; LAST; RECORDS	A continuous high-resolution Western Mediterranean sea surface temperature (SST) alkenone record spanning the past 250,000 years shows that abrupt changes were more common at warming than at cooling. During marine isotope stage (MIS) 6, SST oscillated following a stadial-interstadial pattern but at lower intensities and rates of change than in the Dansgaard/Oeschger events of MIS 3. Some of the most prominent events occurred over MISs 5 and 7, after prolonged warm periods of high stability. Climate during the whole period was predominantly maintained in interglacial-interstadial conditions, whereas the duration of stadials was much shorter.	Inst Invest Quim & Ambientals Barcelona, Dept Environm Chem, CSIC, Barcelona 08034, Spain; Univ Barcelona, Dept Stratig Paleontol & Marine Geosci, E-08028 Barcelona, Spain; Univ Salamanca, Dept Geol, E-37008 Salamanca, Spain; Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA	Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona; University of Salamanca; State University System of Florida; University of Florida	Grimalt, JO (corresponding author), Inst Invest Quim & Ambientals Barcelona, Dept Environm Chem, CSIC, Barcelona 08034, Spain.	jgoqam@cid.csic.es	Cacho, Isabel/H-4402-2013; Grimalt, Joan O/E-2073-2011; Cacho, Isabel/AAX-2610-2021; Sierro, Francisco/A-4714-2008; Canals, Miquel/F-4922-2013; Martrat, Belen/I-5952-2015	Cacho, Isabel/0000-0002-6512-0770; Grimalt, Joan O/0000-0002-7391-5768; Cacho, Isabel/0000-0002-6512-0770; Sierro, Francisco/0000-0002-8647-456X; Canals, Miquel/0000-0001-5267-7601; Hodell, David/0000-0001-8537-1588; Martrat, Belen/0000-0001-9904-9178				Allen JRM, 1999, NATURE, V400, P740, DOI 10.1038/23432; Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Calvo E, 2001, EARTH PLANET SC LETT, V188, P509, DOI 10.1016/S0012-821X(01)00316-8; Cayre O, 1999, PALEOCEANOGRAPHY, V14, P384, DOI 10.1029/1998PA900027; Chiang JCH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000916; Clark PU, 2001, SCIENCE, V293, P283, DOI 10.1126/science.1062517; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; de Abreu L, 2003, MAR GEOL, V196, P1, DOI 10.1016/S0025-3227(03)00046-X; Dokken TM, 1999, NATURE, V401, P458, DOI 10.1038/46753; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Genty D, 2003, NATURE, V421, P833, DOI 10.1038/nature01391; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Hiscott RN, 2001, GLOBAL PLANET CHANGE, V28, P227, DOI 10.1016/S0921-8181(00)00075-8; Khodri M, 2001, NATURE, V410, P570, DOI 10.1038/35069044; Krinner G, 2004, NATURE, V427, P429, DOI 10.1038/nature02233; Lea DW, 2003, SCIENCE, V301, P1361, DOI 10.1126/science.1088470; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; McManus JF, 2002, QUATERNARY RES, V58, P17, DOI 10.1006/qres.2002.2367; MCMANUS JF, 1994, NATURE, V371, P326, DOI 10.1038/371326a0; Ohkouchi N, 2002, SCIENCE, V298, P1224, DOI 10.1126/science.1075287; OHKOUCHI N, 2002, SCIENCE         1010, DOI DOI 10.1126/SCIENCE.1075287; Pailler D, 2002, PALAEOGEOGR PALAEOCL, V181, P431, DOI 10.1016/S0031-0182(01)00444-8; Perez-Folgado M, 2003, MAR MICROPALEONTOL, V48, P49, DOI 10.1016/S0377-8398(02)00160-3; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Reille M, 2000, J QUATERNARY SCI, V15, P665, DOI 10.1002/1099-1417(200010)15:7<665::AID-JQS560>3.0.CO;2-G; Rind D, 2002, SCIENCE, V296, P673, DOI 10.1126/science.1069562; Sachs JP, 1999, SCIENCE, V286, P756, DOI 10.1126/science.286.5440.756; Sanchezgoni MF, 2002, CLIM DYNAM, V19, P95, DOI 10.1007/s00382-001-0212-x; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Svendsen JI, 1999, BOREAS, V28, P234, DOI 10.1111/j.1502-3885.1999.tb00217.x; Tzedakis PC, 2003, EARTH PLANET SC LETT, V212, P197, DOI 10.1016/S0012-821X(03)00233-4; vanKreveld SA, 1996, MAR GEOL, V131, P21, DOI 10.1016/0025-3227(95)00143-3; Walker MJC, 1999, QUATERNARY SCI REV, V18, P1143, DOI 10.1016/S0277-3791(99)00023-2	42	376	385	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1762	1765		10.1126/science.1101706	http://dx.doi.org/10.1126/science.1101706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576615				2022-12-28	WOS:000225630800048
J	Nishimune, H; Sanes, JR; Carlson, SS				Nishimune, H; Sanes, JR; Carlson, SS			A synaptic laminin-calcium channel interaction organizes active zones in motor nerve terminals	NATURE			English	Article							EATON MYASTHENIC SYNDROME; NEUROTRANSMITTER RELEASE; MICE LACKING; NEUROMUSCULAR-JUNCTIONS; CA2+ CHANNEL; DIFFERENTIATION; TRANSMISSION; EXPRESSION; AUTOIMMUNE; SUBUNITS	Synapse formation requires the differentiation of a functional nerve terminal opposite a specialized postsynaptic membrane. Here, we show that laminin beta2, a component of the synaptic cleft at the neuromuscular junction, binds directly to calcium channels that are required for neurotransmitter release from motor nerve terminals. This interaction leads to clustering of channels, which in turn recruit other presynaptic components. Perturbation of this interaction in vivo results in disassembly of neurotransmitter release sites, resembling defects previously observed in an autoimmune neuromuscular disorder, Lambert-Eaton myasthenic syndrome. These results identify an extracellular ligand of the voltage-gated calcium channel as well as a new laminin receptor. They also suggest a model for the development of nerve terminals, and provide clues to the pathogenesis of a synaptic disease.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Washington University (WUSTL); Harvard University; University of Washington; University of Washington Seattle	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	sanesj@mcb.harvard.edu	Nishimune, Hiroshi/B-7226-2013					Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.0.CO;2-6; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; FUKUOKA T, 1987, ANN NEUROL, V22, P193, DOI 10.1002/ana.410220203; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P785; HUNTER DD, 1989, CELL, V59, P905, DOI 10.1016/0092-8674(89)90613-2; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; MARTIN PT, 1995, SCIENCE, V269, P413, DOI 10.1126/science.7618109; Maximov A, 2002, J NEUROSCI, V22, P6939; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; NAGEL A, 1988, ANN NEUROL, V24, P552, DOI 10.1002/ana.410240412; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Pagani R, 2004, NEUROSCIENCE, V123, P75, DOI 10.1016/j.neuroscience.2003.09.019; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; Patton BL, 1998, NATURE, V393, P698, DOI 10.1038/31502; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Son YJ, 1999, EUR J NEUROSCI, V11, P3457, DOI 10.1046/j.1460-9568.1999.00766.x; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Sunderland WJ, 2000, J NEUROSCI, V20, P1009, DOI 10.1523/JNEUROSCI.20-03-01009.2000; Takamori M, 2000, NEUROSCI RES, V36, P183, DOI 10.1016/S0168-0102(99)00135-2; Urbano FJ, 2002, MOL MEMBR BIOL, V19, P293, DOI 10.1080/0968768021000035087; Urbano FJ, 2003, P NATL ACAD SCI USA, V100, P3491, DOI 10.1073/pnas.0437991100; Vincent A, 2000, EUR J BIOCHEM, V267, P6717, DOI 10.1046/j.1432-1327.2000.01785.x; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yin Y, 2003, GENESIS, V36, P114, DOI 10.1002/gene.10206	39	198	202	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					580	587		10.1038/nature03112	http://dx.doi.org/10.1038/nature03112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577901				2022-12-28	WOS:000225433200036
J	Kasting, JF				Kasting, JF			Palaeoclimatology - Archaean atmosphere and climate	NATURE			English	Editorial Material							CARBON-DIOXIDE CONCENTRATIONS		Penn State Univ, Dept Geosci, University Pk, PA 16801 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kasting, JF (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16801 USA.	kasting@geosc.psu.edu	Kasting, James/AAF-6851-2020					Broecker W.S., 1982, TRACERS SEA; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; KASTING JF, 1983, PRECAMBRIAN RES, V20, P121, DOI 10.1016/0301-9268(83)90069-4; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; Ohmoto H, 2004, NATURE, V429, P395, DOI 10.1038/nature02573; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Pavlov AA, 2001, J GEOPHYS RES-PLANET, V106, P23267, DOI 10.1029/2000JE001448; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71	11	14	14	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2004	432	7016								10.1038/nature03166	http://dx.doi.org/10.1038/nature03166			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874AA	15584095	Bronze			2022-12-28	WOS:000225322100033
J	Kanatsu-Shinohara, M; Inoue, K; Lee, J; Yoshimoto, M; Ogonuki, N; Miki, H; Baba, S; Kato, T; Kazuki, Y; Toyokuni, S; Toyoshima, M; Niwa, O; Oshimura, M; Heike, T; Nakahata, T; Ishino, F; Ogura, A; Shinohara, T				Kanatsu-Shinohara, M; Inoue, K; Lee, J; Yoshimoto, M; Ogonuki, N; Miki, H; Baba, S; Kato, T; Kazuki, Y; Toyokuni, S; Toyoshima, M; Niwa, O; Oshimura, M; Heike, T; Nakahata, T; Ishino, F; Ogura, A; Shinohara, T			Generation of pluripotent stem cells from neonatal mouse testis	CELL			English	Article							PRIMORDIAL GERM-CELLS; H19 METHYLATION IMPRINT; LONG-TERM PROLIFERATION; ES CELLS; PARENTAL ALLELES; DNA METHYLATION; GENE-EXPRESSION; CULTURE; MICE; LINE	Although germline cells can form multipotential embryonic stem (ES)/embryonic germ (EG) cells, these cells can be derived only from embryonic tissues, and such multipotent cells have not been available from neonatal gonads. Here we report the successful establishment of ES-like cells from neonatal mouse testis. These ES-like cells were phenotypically similar to ES/ EG cells except in their genomic imprinting pattern. They differentiated into various types of somatic cells in vitro under conditions used to induce the differentiation of ES cells and produced teratomas after inoculation into mice. Furthermore, these ES-like cells formed germline chimeras when injected into blastocysts. Thus, the capacity to form multipotent cells persists in neonatal testis. The ability to derive multipotential stem cells from the neonatal testis has important implications for germ cell biology and opens the possibility of using these cells for biotechnology and medicine.	Kyoto Univ, Horizontal Med Res Org, Kyoto 6068501, Japan; Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Kyoto 6068501, Japan; Kyoto Univ, Ctr Radiat Biol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan; RIKEN, Bioresource Ctr, Inst Phys & Chem Res, Ibaraki 3050074, Japan; Tokyo Med & Dent Univ, Med Res Inst, Tokyo 1010062, Japan; Tottori Univ, Fac Med, Sch Life Sci, Dept Mol & Cell Genet, Tottori 6838503, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; RIKEN; Tokyo Medical & Dental University (TMDU); Tottori University	Shinohara, T (corresponding author), Kyoto Univ, Horizontal Med Res Org, Kyoto 6068501, Japan.	takashi@mfour.med.kyoto-u.ac.jp	Yoshimoto, Momoko/AFP-3523-2022; Toyokuni, Shinya/ABE-7714-2021; Yoshimoto, Momoko/N-4238-2014; Toyokuni, Shinya/C-1358-2010; Ogura, Atsuo/J-3916-2014	Yoshimoto, Momoko/0000-0002-7272-6682; Toyokuni, Shinya/0000-0002-5757-1109; Yoshimoto, Momoko/0000-0002-7272-6682; Toyokuni, Shinya/0000-0002-5757-1109; Ogura, Atsuo/0000-0003-0447-1988				Ahn JI, 2004, DEV BIOL, V265, P491, DOI 10.1016/j.ydbio.2003.09.041; Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; De Rooij DG, 2000, J ANDROL, V21, P776; Dean W, 1998, DEVELOPMENT, V125, P2273; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Goolsby J, 2003, P NATL ACAD SCI USA, V100, P14926, DOI 10.1073/pnas.2434383100; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kanatsu M, 1996, DEVELOPMENT, V122, P823; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P167, DOI 10.1095/biolreprod.102.008516; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kimura C, 2001, DEV BIOL, V235, P12, DOI 10.1006/dbio.2001.0289; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; KOSHIMIZU U, 1995, MOL REPROD DEV, V40, P221, DOI 10.1002/mrd.1080400211; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Lam MYJ, 2003, APMIS, V111, P184, DOI 10.1034/j.1600-0463.2003.11101221.x; Lee J, 2002, DEVELOPMENT, V129, P1807; Liu X, 1997, DEV DYNAM, V209, P85; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Narasimha M, 1997, CURR BIOL, V7, P881, DOI 10.1016/S0960-9822(06)00377-0; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; ROBERTSON EJ, 1986, EXPT APPROACHES MAMM, P475; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; STEVENS LC, 1984, CELL DIFFER DEV, V15, P69, DOI 10.1016/0045-6039(84)90054-X; STEVENS LC, 1961, J NATL CANCER I, V27, P443; STEWART CL, 1994, DEV BIOL, V161, P626, DOI 10.1006/dbio.1994.1058; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; TSUKADA T, 1993, ONCOGENE, V8, P3313; Verfaillie CM, 2002, TRENDS CELL BIOL, V12, P502, DOI 10.1016/S0962-8924(02)02386-3; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	56	613	729	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					1001	1012		10.1016/j.cell.2004.11.011	http://dx.doi.org/10.1016/j.cell.2004.11.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620358	Bronze			2022-12-28	WOS:000226109700012
J	Bowers, PM; Cokus, SJ; Elsenberg, D; Yeates, TO				Bowers, PM; Cokus, SJ; Elsenberg, D; Yeates, TO			Use of logic relationships to decipher protein network organization	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC PROFILES; FUNCTIONAL LINKAGES; DATABASE; IDENTIFICATION; INTERACTOME; DISCOVERY; COMPLEXES; GENOMES; MAP	A major focus of genome research is to decipher the networks of molecular interactions that underlie cellular function. We describe a computational approach for identifying detailed relationships between proteins on the basis of genomic data. Logic analysis of phylogenetic profiles identifies triplets of proteins whose presence or absence obey certain logic relationships. For example, protein C may be present in a genome only if proteins A and B are both present. The method reveals many previously unidentified higher order relationships. These relationships illustrate the complexities that arise in cellular networks because of branching and alternate pathways, and they also facilitate assignment of cellular functions to uncharacterized proteins.	Univ Calif Los Angeles, Inst Genom & Proteom, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yeates, TO (corresponding author), Univ Calif Los Angeles, Inst Genom & Proteom, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu		Yeates, Todd/0000-0001-5709-9839				Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Ermolaeva MD, 2001, NUCLEIC ACIDS RES, V29, P1216, DOI 10.1093/nar/29.5.1216; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Morett E, 2003, NAT BIOTECHNOL, V21, P790, DOI 10.1038/nbt834; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pellegrini M, 2001, J CELL BIOCHEM, V84, P106, DOI 10.1002/jcb.10071; Strong M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r59; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; THEIL H, 1972, STUDIES MATH MANAGER, V14, P337; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187	24	116	123	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2246	2249		10.1126/science.1103330	http://dx.doi.org/10.1126/science.1103330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618515				2022-12-28	WOS:000225950000043
J	Schott, GD				Schott, GD			The Sick Durer - a Renaissance prototype pain map	BRITISH MEDICAL JOURNAL			English	Article									UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Schott, GD (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	geoffrey.schott@uclh.org						HUTCHISON JANE CAMPBELL, 1990, A DURER BIOGRAPHY, p[162, 162]; PALMER H, 1949, N Z Med J, V48, P187; Rankine JJ, 1998, SPINE, V23, P1668, DOI 10.1097/00007632-199808010-00011; STRAUSS WL, 1974, COMPLETE DRAWINGS A, V3, P1758; TIMKENZINKANN RF, 1974, P 23 INT C HIST MED, V2, P870	5	9	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1492	1492		10.1136/bmj.329.7480.1492	http://dx.doi.org/10.1136/bmj.329.7480.1492			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604197	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000225965800039
J	Yan, H				Yan, H			Nucleic acid nanotechnology	SCIENCE			English	Editorial Material							MOLECULAR LITHOGRAPHY; DNA		Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Yan, H (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	hao.yan@asu.edu						Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Deng ZX, 2004, ANGEW CHEM INT EDIT, V43, P4068, DOI 10.1002/anie.200460257; Kanan MW, 2004, NATURE, V431, P545, DOI 10.1038/nature02920; Keren K, 2002, SCIENCE, V297, P72, DOI 10.1126/science.1071247; Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+; Liao SP, 2004, SCIENCE, V306, P2072, DOI 10.1126/science.1104299; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Westhof E, 1996, FOLD DES, V1, pR78, DOI 10.1016/S1359-0278(96)00037-5; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Winfree E, 2004, LECT NOTES COMPUT SC, V2943, P126; Winfree E., 1996, DNA BASED COMPUTERS, P199; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	15	79	88	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2048	2049		10.1126/science.1106754	http://dx.doi.org/10.1126/science.1106754			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604395				2022-12-28	WOS:000225841000047
J	Moran, MA; Buchan, A; Gonzalez, JM; Heidelberg, JF; Whitman, WB; Kiene, RP; Henriksen, JR; King, GM; Belas, R; Fuqua, C; Brinkac, L; Lewis, M; Johri, S; Weaver, B; Pai, G; Eisen, JA; Rahe, E; Sheldon, WM; Ye, WY; Miller, TR; Carlton, J; Rasko, DA; Paulsen, IT; Ren, QH; Daugherty, SC; Deboy, RT; Dodson, RJ; Durkin, AS; Madupu, R; Nelson, WC; Sullivan, SA; Rosovitz, MJ; Haft, DH; Selengut, J; Ward, N				Moran, MA; Buchan, A; Gonzalez, JM; Heidelberg, JF; Whitman, WB; Kiene, RP; Henriksen, JR; King, GM; Belas, R; Fuqua, C; Brinkac, L; Lewis, M; Johri, S; Weaver, B; Pai, G; Eisen, JA; Rahe, E; Sheldon, WM; Ye, WY; Miller, TR; Carlton, J; Rasko, DA; Paulsen, IT; Ren, QH; Daugherty, SC; Deboy, RT; Dodson, RJ; Durkin, AS; Madupu, R; Nelson, WC; Sullivan, SA; Rosovitz, MJ; Haft, DH; Selengut, J; Ward, N			Genome sequence of Silicibacter pomeroyi reveals adaptations to the marine environment	NATURE			English	Article							ORGANIC-MATTER; BACTERIA; DIMETHYLSULFONIOPROPIONATE; SULFUR; BACTERIOPLANKTON; CULTURE; OCEANS; BLOOM; SNOW	Since the recognition of prokaryotes as essential components of the oceanic food web(1), bacterioplankton have been acknowledged as catalysts of most major biogeochemical processes in the sea. Studying heterotrophic bacterioplankton has been challenging, however, as most major clades have never been cultured(2) or have only been grown to low densities in sea water(3,4). Here we describe the genome sequence of Silicibacter pomeroyi, a member of the marine Roseobacter clade ( Fig. 1), the relatives of which comprise similar to10 - 20% of coastal and oceanic mixed-layer bacterioplankton(2,5,6,7). This first genome sequence from any major heterotrophic clade consists of a chromosome ( 4,109,442 base pairs) and megaplasmid ( 491,611 base pairs). Genome analysis indicates that this organism relies upon a lithoheterotrophic strategy that uses inorganic compounds ( carbon monoxide and sulphide) to supplement heterotrophy. Silicibacter pomeroyi also has genes advantageous for associations with plankton and suspended particles, including genes for uptake of algal-derived compounds, use of metabolites from reducing microzones, rapid growth and cell-density-dependent regulation. This bacterium has a physiology distinct from that of marine oligotrophs, adding a new strategy to the recognized repertoire for coping with a nutrient-poor ocean.	Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ La Laguna, Dept Microbiol & Biol Celular, E-38206 Tenerife, Spain; Inst Genom Res, Rockville, MD 20850 USA; Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA; Univ Maine, Darling Marine Ctr, Dept Biochem Microbiol & Mol Biol, Walpole, ME 04573 USA; Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Baltimore, MD 21202 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Yale University; Universidad de la Laguna; J. Craig Venter Institute; University of South Alabama; Dauphin Island Sea Lab; University of Maine System; University of Maine Orono; University System of Maryland; University of Maryland Baltimore; Indiana University System; Indiana University Bloomington; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Moran, MA (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.	mmoran@uga.edu	Buchan, Alison/A-9401-2010; Miller, Todd/Y-3612-2019; Whitman, William/AAC-5896-2020; Gonzalez, Jose M./C-3333-2013; Paulsen, Ian T/K-3832-2012; Nelson, William C/E-9263-2016; Eisen, Jonathan A./H-2706-2019	Gonzalez, Jose M./0000-0002-9926-3323; Paulsen, Ian T/0000-0001-9015-9418; Nelson, William C/0000-0002-1873-3929; Eisen, Jonathan A./0000-0002-0159-2197; Miller, Todd/0000-0002-2113-1662; Heidelberg, John/0000-0003-0673-3224; Whitman, William/0000-0003-1229-0423; Henriksen, James/0000-0003-2485-0889; Buchan, Alison/0000-0001-7420-985X; Moran, Mary Ann/0000-0002-0702-8167; David, Rasko/0000-0002-7337-7154				Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; BUTTON DK, 1993, APPL ENVIRON MICROB, V59, P881, DOI 10.1128/AEM.59.3.881-891.1993; Chan KL, 2002, APPL ENVIRON MICROB, V68, P2278, DOI 10.1128/AEM.68.5.2278-2284.2002; DELONG E, 2000, MONTEREY BAY MICROBI; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Giovannoni SJ., 2000, MICROBIAL ECOLOGY OC, P47; Gonzalez JM, 2003, INT J SYST EVOL MICR, V53, P1261, DOI 10.1099/ijs.0.02491-0; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; Gram L, 2002, APPL ENVIRON MICROB, V68, P4111, DOI 10.1128/AEM.68.8.4111-4116.2002; King GA, 2003, APPL ENVIRON MICROB, V69, P7257, DOI 10.1128/AEM.69.12.7257-7265.2003; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; MATRAI PA, 1994, MAR BIOL, V119, P61, DOI 10.1007/BF00350107; Moran MA, 1997, LIMNOL OCEANOGR, V42, P1307, DOI 10.4319/lo.1997.42.6.1307; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; SHANKS AL, 1993, MAR ECOL PROG SER, V96, P43, DOI 10.3354/meps096043; Sorokin DY, 2003, MICROBIOLOGY+, V72, P641, DOI 10.1023/B:MICI.0000008363.24128.e5; Suzuki MT, 2001, ENVIRON MICROBIOL, V3, P323, DOI 10.1046/j.1462-2920.2001.00198.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; Zafiriou OC, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001638; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Zhu J, 2003, APPL ENVIRON MICROB, V69, P6949, DOI 10.1128/AEM.69.11.6949-6953.2003	29	345	754	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2004	432	7019					910	913		10.1038/nature03170	http://dx.doi.org/10.1038/nature03170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602564	hybrid, Green Published			2022-12-28	WOS:000225733500055
J	Smith, AJF; Jackson, MW; Neufing, P; McEvoy, RD; Gordon, TP				Smith, AJF; Jackson, MW; Neufing, P; McEvoy, RD; Gordon, TP			A functional autoantibody in narcolepsy	LANCET			English	Article								Narcolepsy is widely believed to have an autoimmune basis, but conventional immunological approaches have failed to detect a serum autoantibody marker. Since cholinergic hyperactivity is a feature of narcolepsy-cataplexy, we transferred IgG from nine patients with narcolepsy and nine healthy controls to mice and assessed the effect on smooth muscle contractile responses to cholinergic stimulation. IgG from all narcolepsy patients significantly enhanced bladder contractile responses to the muscarinic agonist carbachol and to neuronally released acetylcholine compared with control IgG (p<0.0001), whereas contraction of the sympathetically innervated vas deferens was unaltered. Our findings provide direct evidence for the autoimmune hypothesis of narcolepsy.	Flinders Med Ctr, Dept Immunol Allergy & Arthrit, Bedford Pk, SA 5042, Australia; Repatriat Gen Hosp, Inst Sleep Hlth, Daw Pk, Australia; Flinders Univ S Australia, Bedford Pk, SA 5042, Australia	Flinders Medical Centre; Flinders University South Australia	Gordon, TP (corresponding author), Flinders Med Ctr, Dept Immunol Allergy & Arthrit, Bedford Pk, SA 5042, Australia.	t.gordon@flinders.edu.au	Smith, Ashley/GZB-0298-2022; McEvoy, Doug/ABB-8052-2020	Neufing, Petra/0000-0001-5740-5250; Gordon, Thomas/0000-0003-3232-8249				Guilleminault C, 1998, NEUROLOGY, V50, pS8, DOI 10.1212/WNL.50.2_Suppl_1.S8; Jackson MW, 2004, GASTROENTEROLOGY, V126, P819, DOI 10.1053/j.gastro.2003.12.015; MIGNOT E, 1995, ADV NEUROIMMUNOL, V5, P23, DOI 10.1016/0960-5428(94)00043-N; Scammell TE, 2003, ANN NEUROL, V53, P154, DOI 10.1002/ana.10444; Waterman SA, 2000, ARTHRITIS RHEUM, V43, P1647; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7	6	60	62	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2004	364	9451					2122	2124		10.1016/S0140-6736(04)17553-3	http://dx.doi.org/10.1016/S0140-6736(04)17553-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589310				2022-12-28	WOS:000225742300025
J	Eisenstein, JP; MacDonald, AH				Eisenstein, JP; MacDonald, AH			Bose-Einstein condensation of excitons in bilayer electron systems	NATURE			English	Article							QUANTUM; PHASE; COHERENCE	An exciton is the particle-like entity that forms when an electron is bound to a positively charged 'hole'. An ordered electronic state in which excitons condense into a single quantum state was proposed as a theoretical possibility many years ago. We review recent studies of semiconductor bilayer systems that provide clear evidence for this phenomenon and explain why exciton condensation in the quantum Hall regime, where these experiments were performed, is as likely to occur in electron - electron bilayers as in electron - hole bilayers. In current quantum Hall excitonic condensates, disorder induces mobile vortices that flow in response to a supercurrent and limit the extremely large bilayer counterflow conductivity.	CALTECH, Dept Phys, Pasadena, CA 91125 USA; Univ Texas, Dept Phys, Austin, TX 78712 USA	California Institute of Technology; University of Texas System; University of Texas Austin	Eisenstein, JP (corresponding author), CALTECH, Dept Phys, Pasadena, CA 91125 USA.	jpe@caltech.edu	MacDonald, Allan/GPF-8212-2022; MacDonald, Allan/M-9883-2019	MacDonald, Allan/0000-0003-3561-3379; 				Abolfath M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.155318; Butov LV, 2003, SOLID STATE COMMUN, V127, P89, DOI 10.1016/S0038-1098(03)00312-0; Butov LV, 2002, NATURE, V418, P751, DOI 10.1038/nature00943; BUTOV LV, 1994, PHYS REV LETT, V73, P304, DOI 10.1103/PhysRevLett.73.304; EISENSTEIN JP, 1990, APPL PHYS LETT, V57, P2324, DOI 10.1063/1.103882; EISENSTEIN JP, 1992, PHYS REV LETT, V68, P1383, DOI 10.1103/PhysRevLett.68.1383; FERTIG HA, 1989, PHYS REV B, V40, P1087, DOI 10.1103/PhysRevB.40.1087; Keldysh L. V., 1964, FIZ TVERD TELA, V6, P2791; Kellogg M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036801; KOHN W, 1970, REV MOD PHYS, V42, P1, DOI 10.1103/RevModPhys.42.1; Konig J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.187202; KURAMOTO Y, 1978, SOLID STATE COMMUN, V25, P713, DOI 10.1016/0038-1098(78)90796-2; Lozovik Y. E., 1976, SOV PHYS JETP, V44, P389; MACDONALD AH, 1990, PHYS REV B, V42, P3224, DOI 10.1103/PhysRevB.42.3224; Shevchenko S. I., 1976, FIZ NIZK TEMP+, V2, P505; SHEVCHENKO SI, 1994, PHYS REV LETT, V72, P3242, DOI 10.1103/PhysRevLett.72.3242; Snoke D, 2002, SCIENCE, V298, P1368, DOI 10.1126/science.1078082; Spielman IB, 2000, PHYS REV LETT, V84, P5808, DOI 10.1103/PhysRevLett.84.5808; Tutuc E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036802; WEN XG, 1992, PHYS REV LETT, V69, P1811, DOI 10.1103/PhysRevLett.69.1811; YOSHIOKA D, 1990, J PHYS SOC JPN, V59, P4211, DOI 10.1143/JPSJ.59.4211	23	608	617	7	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					691	694		10.1038/nature03081	http://dx.doi.org/10.1038/nature03081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592403	Green Accepted, Green Submitted			2022-12-28	WOS:000225597200037
J	Goldstein, NE; Lampert, R; Bradley, E; Lynn, J; Krumholz, HM				Goldstein, NE; Lampert, R; Bradley, E; Lynn, J; Krumholz, HM			Management of implantable cardioverter defibrillators in end-of-life care	ANNALS OF INTERNAL MEDICINE			English	Article							FAMILY-MEMBERS; DEATH; VALIDATION	Background: Implantable cardioverter defibrillators (ICDs) can prevent premature death from an arrhythmia but may also prolong the dying process and make it more distressing. Objective: To describe the frequency, timing, and correlates of discussions about deactivating ICDs. Design: Retrospective cohort study. Setting: Telephone survey. Participants: Next of kin of patients with ICDs who died of any cause. Of 136 next of kin contacted, 100 (74%) participated. Measurements: incidence of discussions about deactivating ICDs and timing of last shock from ICD. Results: Next of kin reported that clinicians discussed deactivating the ICD in only 27 of the 100 cases. Most discussions occurred in the last few days of life. Family members reported that 8 patients received a shock from their ICD in the minutes before death. Limitations: This retrospective survey relied on the reports of next of kin. Conclusions: Next of kin reported that clinicians discussed deactivating ICDs with few patients. Individuals who choose to receive this device should have the opportunity to choose to discontinue it as death approaches.	Yale Univ, Robert Wood Johnson Clin Scholars Program, Sch Med, New Haven, CT USA; Washington Home Ctr Palliat Care Studies, Washington, DC USA	Yale University	Goldstein, NE (corresponding author), CUNY, Mt Sinai Med Ctr, Dept Geriatr, Box 1070,1 Gustave L Levy Pl, New York, NY 10029 USA.	nathan.goldstein@mssm.edu	, Harlan/AAI-2875-2020		NIA NIH HHS [P30AG21342] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG021342] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Addington-Hall J, 2001, J PAIN SYMPTOM MANAG, V22, P784, DOI 10.1016/S0885-3924(01)00330-X; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Eckert Marion, 2002, Int J Nurs Pract, V8, P152, DOI 10.1046/j.1440-172X.2002.00357.x; Foley KM, 2001, IMPROVING PALLIATIVE; Glikson M, 2001, LANCET, V357, P1107, DOI 10.1016/S0140-6736(00)04263-X; HIGGINSON I, 1994, SOC SCI MED, V38, P553, DOI 10.1016/0277-9536(94)90251-8; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; Hinton J, 1996, SOC SCI MED, V43, P1229, DOI 10.1016/0277-9536(95)00437-8; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Lynn J, 1997, New Horiz, V5, P56; LYNN J, 1995, WESTERN J MED, V163, P250; LYNN J, 2000, IMPROVING CARE END L; Pentz RD, 2002, SUPPORT CARE CANCER, V10, P573, DOI 10.1007/s00520-002-0374-z; TENO J, TIME TOOLKIT INSTRUM; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P752, DOI 10.1016/S0885-3924(01)00331-1; TULSKY JA, 1995, J GEN INTERN MED, V10, P436, DOI 10.1007/BF02599915	20	204	204	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2004	141	11					835	838		10.7326/0003-4819-141-11-200412070-00006	http://dx.doi.org/10.7326/0003-4819-141-11-200412070-00006			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876WZ	15583224				2022-12-28	WOS:000225530700002
J	Horton, R				Horton, R			Vioxx, the implosion of Merck, and aftershocks at the FDA	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 2004, LANCET, V364, P1287; MATTHEWS AW, 2004, WALL STREET J   1101, pA1; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286	3	92	95	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					1995	1996		10.1016/S0140-6736(04)17523-5	http://dx.doi.org/10.1016/S0140-6736(04)17523-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582041				2022-12-28	WOS:000225495700003
J	Kenyon, SJ; Bromley, BC				Kenyon, SJ; Bromley, BC			Stellar encounters as the origin of distant Solar System objects in highly eccentric orbits	NATURE			English	Article							KUIPER-BELT; SIZE DISTRIBUTION; PLANET; ANALOG; DISKS; DUST	The Kuiper belt(1) extends from the orbit of Neptune at 30 AU to an abrupt outer edge about 50 AU from the Sun(2). Beyond the edge is a sparse population of objects with large orbital eccentricities(3,4). Neptune shapes the dynamics of most Kuiper belt objects, but the recently discovered planet 2003 VB12 (Sedna(5)) has an eccentric orbit with a perihelion distance of 70 AU, far beyond Neptune's gravitational influence(6-8). Although influences from passing stars could have created the Kuiper belt's outer edge and could have scattered objects into large, eccentric orbits(9,10), no model currently explains the properties of Sedna. Here we show that a passing star probably scattered Sedna from the Kuiper belt into its observed orbit. The likelihood that a planet at 60-80 AU can be scattered into Sedna's orbit is about 50 per cent; this estimate depends critically on the geometry of the fly-by. Even more interesting is the similar to10 per cent chance that Sedna was captured from the outer disk of the passing star. Most captures have very high inclination orbits; detection of such objects would confirm the presence of extrasolar planets in our own Solar System.	Smithsonian Astrophys Observ, Cambridge, MA 02138 USA; Univ Utah, Dept Phys, JFB 201, Salt Lake City, UT 84112 USA	Harvard University; Smithsonian Institution; Utah System of Higher Education; University of Utah	Kenyon, SJ (corresponding author), Smithsonian Astrophys Observ, 60 Garden St, Cambridge, MA 02138 USA.	skenyon@cfa.harvard.edu	Bromley, Benjamin/AAZ-7908-2020	Kenyon, Scott/0000-0003-0214-609X; Bromley, Benjamin/0000-0001-7558-343X				Adams FC, 2004, ASTROPHYS J, V611, P360, DOI 10.1086/421989; Adams FC, 2001, ICARUS, V150, P151, DOI 10.1006/icar.2000.6567; Allen RL, 2001, ASTROPHYS J, V549, pL241, DOI 10.1086/319165; Barton EJ, 1999, ASTROPHYS J, V511, pL25, DOI 10.1086/311830; Bernstein GM, 2004, ASTRON J, V128, P1364, DOI 10.1086/422919; Brown ME, 2001, ASTRON J, V121, P2804, DOI 10.1086/320391; BROWN ME, 2004, DISCOVERY CANDIDATE; Brunini A, 2002, ICARUS, V160, P32, DOI 10.1006/icar.2002.6935; Fernandez JA, 2000, ICARUS, V145, P580, DOI 10.1006/icar.2000.6348; Garcia-Sanchez J, 1999, ASTRON J, V117, P1042, DOI 10.1086/300723; GIRARD TM, 1989, ASTRON J, V98, P227, DOI 10.1086/115139; Gladman B, 2002, ICARUS, V157, P269, DOI 10.1006/icar.2002.6860; Greaves JS, 2004, MON NOT R ASTRON SOC, V351, pL54, DOI 10.1111/j.1365-2966.2004.07957.x; Greaves JS, 1998, ASTROPHYS J, V506, pL133, DOI 10.1086/311652; Ida S, 2000, ASTROPHYS J, V528, P351, DOI 10.1086/308179; Kenyon SJ, 1999, ASTROPHYS J, V524, pL119, DOI 10.1086/312313; Kenyon SJ, 2004, ASTRON J, V127, P513, DOI 10.1086/379854; Kenyon SJ, 2004, ASTRON J, V128, P1916, DOI 10.1086/423697; Kenyon SJ, 2002, PUBL ASTRON SOC PAC, V114, P265, DOI 10.1086/339188; Levison HF, 2003, NATURE, V426, P419, DOI 10.1038/nature02120; Levison HF, 1997, ICARUS, V127, P13, DOI 10.1006/icar.1996.5637; Luu JX, 2002, ANNU REV ASTRON ASTR, V40, P63, DOI 10.1146/annurev.astro.40.060401.093818; Safronov V S., 1969, EVOLUTION PROTOPLANE; TOOMRE A, 1972, ASTROPHYS J, V178, P623, DOI 10.1086/151823; TRIJILLO C, 2002, ASTROPHYS J, V102, P529; Weidenschilling SJ, 2003, ICARUS, V165, P438, DOI 10.1016/S0019-1035(03)00169-6; Wyatt MC, 2003, MON NOT R ASTRON SOC, V342, P876, DOI 10.1046/j.1365-8711.2003.06595.x; Youdin AN, 2002, ASTROPHYS J, V580, P494, DOI 10.1086/343109	30	111	112	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					598	602		10.1038/nature03136	http://dx.doi.org/10.1038/nature03136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577903				2022-12-28	WOS:000225433200039
J	Fukuhara, A; Matsuda, M; Nishizawa, M; Segawa, K; Tanaka, M; Kishimoto, K; Matsuki, Y; Murakami, M; Ichisaka, T; Murakami, H; Watanabe, E; Takagi, T; Akiyoshi, M; Ohtsubo, T; Kihara, S; Yamashita, S; Makishima, M; Funahashi, T; Yamanaka, S; Hiramatsu, R; Matsuzawa, Y; Shimomura, I				Fukuhara, A; Matsuda, M; Nishizawa, M; Segawa, K; Tanaka, M; Kishimoto, K; Matsuki, Y; Murakami, M; Ichisaka, T; Murakami, H; Watanabe, E; Takagi, T; Akiyoshi, M; Ohtsubo, T; Kihara, S; Yamashita, S; Makishima, M; Funahashi, T; Yamanaka, S; Hiramatsu, R; Matsuzawa, Y; Shimomura, I			RETRACTED: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)	SCIENCE			English	Article; Retracted Publication							COLONY-ENHANCING FACTOR; DIABETES-MELLITUS; OBESITY; EXPRESSION; RESISTANCE; ADIPOSE; CLONING; LEPTIN; ALPHA; MICE	Fat tissue produces a variety of secreted proteins (adipocytokines) with important roles in metabolism. We isolated a newly identified adipocytokine, visfatin, that is highly enriched in the visceral fat of both humans and mice and whose expression level in plasma increases during the development of obesity. Visfatin corresponds to a protein identified previously as pre-B cell colony-enhancing factor (PBEF), a 52-kilodalton cytokine expressed in lymphocytes. Visfatin exerted insulin-mimetic effects in cultured cells and lowered plasma glucose levels in mice. Mice heterozygous for a targeted mutation in the visfatin gene had modestly higher levels of plasma glucose relative to wild-type littermates. Surprisingly, visfatin binds to and activates the insulin receptor. Further study of visfatin's physiological role may lead to new insights into glucose homeostasis and/or new therapies for metabolic disorders such as diabetes.	Osaka Univ, Grad Sch Med, Dept Med & Pathophysiol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Dept Organismal Biosyst, Suita, Osaka 5650871, Japan; Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028471, Japan; Sumitomo Pharmaceut Co Ltd, Genom Sci Labs, Takarazuka, Hyogo 6650051, Japan; Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Lab Anim Mol Technol, JST,CREST, Nara 6300192, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci, Suita, Osaka 5650871, Japan; Sumitomo Hosp, Kita Ku, Osaka 5300005, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Osaka University; Osaka University; Japan Society for the Promotion of Science; Japan Science & Technology Agency (JST); Nara Institute of Science & Technology; Osaka University; Sumitomo Hospital; Japan Science & Technology Agency (JST)	Shimomura, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Med & Pathophysiol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ichi@imed2.med.osaka-u.ac.jp	Takagi, Toshiyuki/S-9785-2019; SEGAWA, Kouji/D-4204-2014	Takagi, Toshiyuki/0000-0003-1283-4320; SEGAWA, Kouji/0000-0002-3633-4809				Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; FUKUHARA A, UNPUB; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; KADOWAKI T, 1990, J BIOL CHEM, V265, P19143; KISSEBAH AH, 1989, DIABETES METAB REV, V5, P83, DOI 10.1002/dmr.5610050202; LANDRETH KS, 1992, BLOOD, V80, P1207; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; MATSUZAWA Y, 1993, ANN NY ACAD SCI, V676, P270; Ognjanovic S, 2001, J MOL ENDOCRINOL, V26, P107, DOI 10.1677/jme.0.0260107; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000	18	1473	1778	5	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					426	430		10.1126/science.1097243	http://dx.doi.org/10.1126/science.1097243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15604363				2022-12-28	WOS:000226492300048
J	Verlet, JRR; Bragg, AE; Kammrath, A; Cheshnovsky, O; Neumark, DM				Verlet, JRR; Bragg, AE; Kammrath, A; Cheshnovsky, O; Neumark, DM			Observation of large water-cluster anions with surface-bound excess electrons	SCIENCE			English	Article							HYDRATED-ELECTRON; PHOTOELECTRON-SPECTROSCOPY; DYNAMICS; ION; SPECTRA; ENERGETICS; ISOMERS; BULK; TIME	Anionic water clusters have long been studied to infer properties of the bulk hydrated electron. We used photoelectron imaging to characterize a class of (H2O)(n)(-) and (D2O)(n)(-) cluster anions (n less than or equal to 200 molecules) with vertical binding energies that are significantly lower than those previously recorded. The data are consistent with a structure in which the excess electron is bound to the surface of the cluster. This result implies that the excess electron in previously observed water-cluster anions, with higher vertical binding energies, was internally solvated. Thus, the properties of those clusters could be extrapolated to those of the bulk hydrated electron.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Tel Aviv Univ, Sackler Fac Exact Sci, Sch Chem, IL-69978 Tel Aviv, Israel; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Tel Aviv University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Neumark, DM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	dneumark@berkeley.edu	Neumark, Daniel M/B-9551-2009; Verlet, Jan RR/G-5940-2012	Neumark, Daniel M/0000-0002-3762-9473; Verlet, Jan RR/0000-0002-9480-432X				Ayotte P, 1997, J CHEM PHYS, V106, P811, DOI 10.1063/1.473167; Bailey CG, 1997, CHEM PHYS LETT, V265, P185, DOI 10.1016/S0009-2614(96)01413-3; BARNETT RN, 1988, CHEM PHYS LETT, V145, P382, DOI 10.1016/0009-2614(88)80195-7; BARNETT RN, 1988, J CHEM PHYS, V88, P4429, DOI 10.1063/1.453801; BARNETT RN, 1990, J CHEM PHYS, V93, P6226, DOI 10.1063/1.458992; Bragg AE, 2004, SCIENCE, V306, P669, DOI 10.1126/science.1103527; Bragg AE, 2004, J CHEM PHYS, V121, P3515, DOI 10.1063/1.1769368; BRAGG AE, UNPUB; Buck U, 2001, CHEM REV, V101, P205, DOI 10.1021/cr000704r; COE JV, 1990, J CHEM PHYS, V92, P3980, DOI 10.1063/1.457805; Coe JV, 2001, INT REV PHYS CHEM, V20, P33, DOI 10.1080/01442350010008589; Dribinski V, 2002, REV SCI INSTRUM, V73, P2634, DOI 10.1063/1.1482156; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Even U, 2000, J CHEM PHYS, V112, P8068, DOI 10.1063/1.481405; HABERLAND H, 1984, J CHEM PHYS, V81, P3742, DOI 10.1063/1.448127; Hammer NI, 2004, SCIENCE, V306, P675, DOI 10.1126/science.1102792; HAN P, 1991, J PHYS CHEM-US, V95, P5367, DOI 10.1021/j100167a001; HART EJ, 1962, J AM CHEM SOC, V84, P4090, DOI 10.1021/ja00880a025; Jungwirth P, 2002, J PHYS CHEM B, V106, P6361, DOI 10.1021/jp020242g; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Kim J, 1998, CHEM PHYS LETT, V297, P90, DOI 10.1016/S0009-2614(98)01109-9; Lee HM, 2003, J CHEM PHYS, V118, P9981, DOI 10.1063/1.1571515; Lee HM, 2003, J CHEM PHYS, V119, P187, DOI 10.1063/1.1576757; MARKOVICH G, 1994, J CHEM PHYS, V101, P9344, DOI 10.1063/1.467965; Paik DH, 2004, SCIENCE, V306, P672, DOI 10.1126/science.1102827; Pshenichnikov MS, 2004, CHEM PHYS LETT, V389, P171, DOI 10.1016/j.cplett.2004.03.107; Robertson WH, 2003, ANNU REV PHYS CHEM, V54, P173, DOI 10.1146/annurev.physchem.54.011002.103801	28	343	350	6	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2005	307	5706					93	96		10.1126/science.1106719	http://dx.doi.org/10.1126/science.1106719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886GG	15604360				2022-12-28	WOS:000226214300043
J	Okie, S				Okie, S			Illness and secrecy on the supreme court	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Garrow DJ, 2000, U CHICAGO LAW REV, V67, P995, DOI 10.2307/1600454; GREENHOUSE L, 2004, NY TIMES        1106, P25; HUTCHINSON DJ, 1998, MAN WHO ONCE WHIZZER, P463; Ward Artemus, 2000, J SUPREME COURT HIST, V25, P296; WHITE B, 1975, COMMUNICATION   1020	5	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2675	2678		10.1056/NEJMp048339	http://dx.doi.org/10.1056/NEJMp048339			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	881OR	15616200				2022-12-28	WOS:000225877300001
J	Jonsson, S; Thorsteinsdottir, U; Gudbjartsson, DF; Jonsson, HH; Kristjansson, K; Arnason, S; Gudnason, V; Isaksson, HJ; Hallgrimsson, J; Gulcher, JR; Amundadottir, LT; Kong, A; Stefansson, K				Jonsson, S; Thorsteinsdottir, U; Gudbjartsson, DF; Jonsson, HH; Kristjansson, K; Arnason, S; Gudnason, V; Isaksson, HJ; Hallgrimsson, J; Gulcher, JR; Amundadottir, LT; Kong, A; Stefansson, K			Familial risk of lung carcinoma in the Icelandic population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANCER SUSCEPTIBILITY; DISEASE; AGGREGATION; SURVIVAL; SMOKING; REPAIR	Context The dominant role of tobacco smoke as a causative factor in lung carcinoma is well established; however, an inherited predisposition may also be an important factor in the susceptibility to lung carcinoma. Objective To investigate the contribution of genetic factors to the risk of developing lung carcinoma in the Icelandic population. Design, Setting, and Participants Risk ratios (RRs) of lung carcinoma for first-, second-, and third-degree relatives of patients with lung carcinoma were estimated by linking records from the Icelandic Cancer Registry (ICR) of all 2756 patients diagnosed with lung carcinoma within the Icelandic population from January 1, 1955, to February 28, 2002, with an extensive genealogical database containing all living Icelanders and most of their ancestors since the settlement of Iceland. The RR for smoking was similarly estimated using a random population-based cohort of 10541 smokers from the Reykjavik Heart Study who had smoked for more than 10 years. Of these smokers, 562 developed lung cancer based on the patients with lung cancer list from the ICR. Main Outcome Measures Estimation of RRs of close and distant relatives of patients with lung carcinoma and comparison with RRs for close and distant relatives of smokers. Results A familial factor for lung carcinoma was shown to extend beyond the nuclear family, as evidenced by significantly increased RR for first-degree relatives (for parents: RR, 2.69; 95% confidence interval [CI], 2.20-3.23; for siblings: RR, 2.02; 95% CI,1.77-2.23; and for children: RR, 1.96; 95% CI,1.53-2.39), second-degree relatives (for uncles/aunts: RR, 1.34; 95% CI, 1.15-1.49; and for nephews/nieces: RR, 1.28; 95% CI, 1.10-1.43), and third-degree relatives (for cousins: RR, 1.14; 95% CI,1.05-1.22) of patients with lung carcinoma. This effect was stronger for relatives of patients with early-onset disease vc (age at onset less than or equal to60 years) (for parents: RR, 3.48; 95% CI,1.83-8.21; for siblings: RR, 3.30; 95% CI, 2.19-4.58; and for children: RR, 2.84; 95% CI, 1.34-7.21). The hypothesis that this increased risk is solely due to the effects of smoking was rejected for all relationships, except cousins and spouses, with a single-sided test of the RRs for lung carcinoma vs RRs for smoking. Conclusions These results underscore the importance of genetic predisposition in the development of lung carcinoma, with its strongest effect in patients with early-onset disease. However, tobacco smoke plays a dominant role in the pathogenesis of this disease, even among those individuals who are genetically predisposed to lung carcinoma.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland; Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; Icelandic Heart Assoc, Reykjavik, Iceland	Landspitali National University Hospital; Landspitali National University Hospital; Icelandic Heart Association	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	unnur.thorsteinsdottir@decode.is; kari.stefansson@decode.is	Amundadottir, Laufey T/L-7656-2016; Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019; Stefansson, Kari/AAE-7187-2019	Amundadottir, Laufey T/0000-0003-1859-8971; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Gudbjartsson, Daniel/0000-0002-5222-9857				Amos CI, 1999, RECENT RESULTS CANC, V151, P3; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; Bosken CH, 2002, JNCI-J NATL CANCER I, V94, P1091; CANNONALBRIGHT LA, 1994, CANCER RES, V54, P2378; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Dong CH, 2001, INT J CANCER, V92, P144; Gauderman WJ, 2000, AM J EPIDEMIOL, V151, P41, DOI 10.1093/oxfordjournals.aje.a010120; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Guo SW, 1998, AM J HUM GENET, V63, P252, DOI 10.1086/301928; Hemminki K, 2002, BRIT J CANCER, V86, P1737, DOI 10.1038/sj.bjc.6600302; Hemminki K, 2001, GENET EPIDEMIOL, V20, P107, DOI 10.1002/1098-2272(200101)20:1<107::AID-GEPI9>3.0.CO;2-4; KHOURY MJ, 1988, AM J EPIDEMIOL, V127, P674, DOI 10.1093/oxfordjournals.aje.a114842; Khuder SA, 2001, LUNG CANCER, V31, P139, DOI 10.1016/S0169-5002(00)00181-1; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; MACK W, 1990, ENVIRON HEALTH PERSP, V87, P27, DOI 10.2307/3431002; Mannino DM, 1998, INT J EPIDEMIOL, V27, P159, DOI 10.1093/ije/27.2.159; OOI WL, 1986, J NATL CANCER I, V76, P217; Parkin DM, 1997, CANC INCIDENCE 5 CON, VVII; SAMET JM, 1986, AM REV RESPIR DIS, V134, P466; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; Spitz MR, 1999, CANCER INVEST, V17, P645, DOI 10.3109/07357909909032849; Sveinbjornsdottir S, 2000, NEW ENGL J MED, V343, P1765, DOI 10.1056/NEJM200012143432404; Thomas A, 1999, COMPUT BIOMED RES, V32, P517, DOI 10.1006/cbmr.1999.1525; TOKUHATA GEORGE K., 1963, JOUR NATL CANCER INST, V30, P289; Travis WD, 1999, INT HISTOLOGICAL CLA; Tulinius H, 1997, CANCER EPIDEM BIOMAR, V6, P863; Wei QY, 2000, J NATL CANCER I, V92, P1764; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681; Zatloukal P, 2003, LUNG CANCER-J IASLC, V41, P283, DOI 10.1016/S0169-5002(03)00234-4	32	84	90	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					2977	2983		10.1001/jama.292.24.2977	http://dx.doi.org/10.1001/jama.292.24.2977			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613665	Bronze			2022-12-28	WOS:000225841900031
J	Wilson, JF				Wilson, JF			Balancing the risks and benefits of fish consumption	ANNALS OF INTERNAL MEDICINE			English	Editorial Material												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Hightower JM, 2003, ENVIRON HEALTH PERSP, V111, P604, DOI 10.1289/ehp.5837; Hites RA, 2004, SCIENCE, V303, P226, DOI 10.1126/science.1091447; Kales SN, 2002, J OCCUP ENVIRON MED, V44, P143, DOI 10.1097/00043764-200202000-00009; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Schantz SL, 2001, ENVIRON HEALTH PERSP, V109, P605, DOI 10.2307/3455035	5	23	24	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2004	141	12					977	980		10.7326/0003-4819-141-12-200412210-00024	http://dx.doi.org/10.7326/0003-4819-141-12-200412210-00024			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882EY	15611502				2022-12-28	WOS:000225923000016
J	Greenwald, SE				Greenwald, SE			Commentary: Modelling emboli with floating fir cones	BRITISH MEDICAL JOURNAL			English	Editorial Material									Barts & London Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AD, England	University of London; Queen Mary University London	Greenwald, SE (corresponding author), Barts & London Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AD, England.	s.e.greenwald@qmul.ac.uk	Greenwald, Stephen E/C-6928-2012	Greenwald, Stephen/0000-0002-8471-7070				Knight R, 2004, BRIT MED J, V329, P1432, DOI 10.1136/bmj.329.7480.1432; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1433	1434		10.1136/bmj.329.7480.1433	http://dx.doi.org/10.1136/bmj.329.7480.1433			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604174	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000225965800017
J	Hesketh, T; Zhu, WX				Hesketh, T; Zhu, WX			Effect of restricted freedom on health in China	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, Inst Child Hlth, London WC1 N1EH, England; Zhejiang Normal Univ, Hangzhou 310006, Peoples R China	University of London; University College London; Zhejiang Normal University	Hesketh, T (corresponding author), UCL, Inst Child Hlth, London WC1 N1EH, England.	t.hesketh@ich.ucl.ac.uk		Hesketh, Therese/0000-0002-7564-9221				Cook IG, 2004, HEALTH POLICY, V67, P329, DOI 10.1016/j.healthpol.2003.07.005; Franco A, 2004, BMJ-BRIT MED J, V329, P1421, DOI 10.1136/bmj.329.7480.1421; *FREED HOUS, FREED WORLD COUNTR R; Hesketh T, 1997, BRIT MED J, V314, P1543, DOI 10.1136/bmj.314.7093.1543; Sidel Victor W., 1982, HLTH CHINA	5	5	5	2	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1427	1427		10.1136/bmj.329.7480.1427	http://dx.doi.org/10.1136/bmj.329.7480.1427			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604169	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000225965800012
J	Hirsch, LJ; Hauser, WA				Hirsch, LJ; Hauser, WA			Can sudden unexplained death in epilepsy be prevented?	LANCET			English	Editorial Material							UNEXPECTED DEATH; RISK-FACTORS		Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA	Columbia University; Columbia University	Hauser, WA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.	hausera@sergievsky.cpmc.columbia.edu	Hauser, W Allen/AAB-5277-2020	Hirsch, Lawrence/0000-0002-6333-832X				Annegers JF, 1999, SEIZURE-EUR J EPILEP, V8, P347, DOI 10.1053/seiz.1999.0306; BJORNSTAD H, 1994, CARDIOLOGY, V84, P42, DOI 10.1159/000176327; Chrysostomakis SI, 2002, EUROPACE, V4, P211, DOI 10.1053/eupc.2002.0229; Nilsson L, 1999, LANCET, V353, P888, DOI 10.1016/S0140-6736(98)05114-9; SHEN WK, 1995, AM J CARDIOL, V76, P148, DOI 10.1016/S0002-9149(99)80047-2; Sperling MR, 1999, ANN NEUROL, V46, P45, DOI 10.1002/1531-8249(199907)46:1<45::AID-ANA8>3.0.CO;2-I; Walczak TS, 2001, NEUROLOGY, V56, P519, DOI 10.1212/WNL.56.4.519	7	33	33	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2004	364	9452					2157	2158		10.1016/S0140-6736(04)17605-8	http://dx.doi.org/10.1016/S0140-6736(04)17605-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610785				2022-12-28	WOS:000225799700005
J	McKee, M; Nolte, E				McKee, M; Nolte, E			Lessons from health during the transition from communism	BRITISH MEDICAL JOURNAL			English	Editorial Material							CHANGING LIFE EXPECTANCY; MORTALITY; TRENDS; POLAND		Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, Keppel St, London WC1E 7HT, England.	martin.mckee@Ishtm.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Nolte, Ellen/0000-0002-2289-117X				Andreev EM, 2003, INT J EPIDEMIOL, V32, P437, DOI 10.1093/ije/dyg085; Chenet L, 1996, J PUBLIC HEALTH MED, V18, P329, DOI 10.1093/oxfordjournals.pubmed.a024514; Dolea C, 2002, J EPIDEMIOL COMMUN H, V56, P444, DOI 10.1136/jech.56.6.444; Franco A, 2004, BMJ-BRIT MED J, V329, P1421, DOI 10.1136/bmj.329.7480.1421; Gilmore AB, 2004, TOB CONTROL, V13, P136, DOI 10.1136/tc.2002.002667; KREMENTOSOV N, 1997, STALINIST SCI; McKee M, 2003, INT J EPIDEMIOL, V32, P1087, DOI 10.1093/ije/dyg299; McKee M, 2004, HLTH POLICY EUROPEAN, P24; McMichael AJ, 2004, LANCET, V363, P1155, DOI 10.1016/S0140-6736(04)15902-3; Nolte E, 2000, J EPIDEMIOL COMMUN H, V54, P899, DOI 10.1136/jech.54.12.899; VINOGRADOV NA, 1947, HLTH PROTECTION WORK; Zatonski WA, 1998, BMJ-BRIT MED J, V316, P1047	12	22	22	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1428	1429		10.1136/bmj.329.7480.1428	http://dx.doi.org/10.1136/bmj.329.7480.1428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604170	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000225965800013
J	Muller, UK; Lentink, D				Muller, UK; Lentink, D			Physiology - Turning on a dime	SCIENCE			English	Editorial Material							LIFT		Univ Wageningen & Res Ctr, Dept Expt Zool, NL-6700 HB Wageningen, Netherlands	Wageningen University & Research	Muller, UK (corresponding author), Univ Wageningen & Res Ctr, Dept Expt Zool, NL-6700 HB Wageningen, Netherlands.	ulrike.muller@wur.nl		Lentink, David/0000-0003-4717-6815				Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; Lehmann FO, 2004, NATURWISSENSCHAFTEN, V91, P101, DOI 10.1007/s00114-004-0502-3; POLHAMUS EC, 1981, TM83121 NASA; Sane SP, 2001, J EXP BIOL, V204, P2607; Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223; Usherwood JR, 2002, J EXP BIOL, V205, P1547; Videler JJ, 2004, SCIENCE, V306, P1960, DOI 10.1126/science.1104682	8	11	12	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1899	1900		10.1126/science.1107070	http://dx.doi.org/10.1126/science.1107070			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591191				2022-12-28	WOS:000225695600031
J	Fletcher, KE; Davis, SQ; Underwood, W; Mangrulkar, RS; McMahon, LF; Saint, S				Fletcher, KE; Davis, SQ; Underwood, W; Mangrulkar, RS; McMahon, LF; Saint, S			Systematic review: Effects of resident work hours on patient safety	ANNALS OF INTERNAL MEDICINE			English	Article							NIGHT-FLOAT SYSTEM; SLEEP-DEPRIVATION; DUTY HOURS; CARE; FATIGUE; CALL; SATISFACTION; PERFORMANCE; INTERN	Background: The Accreditation Council for Graduate Medical Education (ACGME) mandated new work hours rules for all residency programs in July 2003. Purpose: To critically evaluate the evidence that adhering to the ACGME standards will improve patient safety. Data Sources: Searches of electronic databases (MEDLINE, EMBASE, PREMEDLINE, and Current Contents) and other methods to identify the English-language literature for studies on resident work hours for the years 1966 to 2004. Study Selection: Studies that assessed a system change designed to counteract the effects of work hours, fatigue, or sleep deprivation and that included an outcome related to patient safety were included. Seven studies met these criteria. Data Extraction: Two investigators abstracted data from all included studies by using a standard data abstraction form; each study was rated according to established criteria to assess study design quality. Data Synthesis: Interventions used were float systems, other cross-coverage systems, or unspecified schedule changes. Outcomes included mortality, adverse events, and medication errors. The results suggest that introducing such interventions has an unclear effect on selected patient safety indicators. Specifically, some indicators (such as mortality) may not change after interventions, while other indicators may improve or worsen. Limitations: This analysis is limited by the study designs of the included studies, the diversity of interventions in the studies, and the possibility of publication bias favoring studies that demonstrated statistically significant differences. Conclusion: Evidence on patient safety is insufficient to inform the process of reducing resident work hours.	Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Chicago	Fletcher, KE (corresponding author), Zablocki Vet Adm Med Ctr, Primary Care Div, 5000 W Natl Ave, Milwaukee, WI 53295 USA.	kathlyn.fletcher@med.va.gov	Saint, Sanjay/AAF-5126-2019		AHRQ HHS [P20-HS11540] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011540] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM MED STUD ASS, 2003, RES WORK HOUR ISS; Bero LA, 1997, ANN INTERN MED, V127, P37, DOI 10.7326/0003-4819-127-1-199707010-00007; BUFF DD, 1995, J GEN INTERN MED, V10, P400, DOI 10.1007/BF02599842; Charap M, 2004, ANN INTERN MED, V140, P814, DOI 10.7326/0003-4819-140-10-200405180-00011; Cook RI, 2000, BRIT MED J, V320, P791, DOI 10.1136/bmj.320.7237.791; DAIGLER GE, 1990, AM J DIS CHILD, V144, P799, DOI 10.1001/archpedi.1990.02150310067030; Denisco R A, 1987, J Clin Monit, V3, P22, DOI 10.1007/BF00770879; Drazen JM, 2002, NEW ENGL J MED, V347, P1271, DOI 10.1056/NEJMe020110; FLETCHER KE, IN PRESS ACAD MED; FRIEDMAN RC, 1971, NEW ENGL J MED, V285, P201, DOI 10.1056/NEJM197107222850405; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; GOTTLIEB DJ, 1991, ARCH INTERN MED, V151, P2065, DOI 10.1001/archinte.151.10.2065; Griffith CH, 1997, J GEN INTERN MED, V12, P308, DOI 10.1046/j.1525-1497.1997.012005308.x; Howard DL, 2004, J GEN INTERN MED, V19, P1, DOI 10.1111/j.1525-1497.2004.30336.x; HULLEY SB, 2001, DESIGNING CLIN RES E, P125; LAINE C, 1993, JAMA-J AM MED ASSOC, V269, P374, DOI 10.1001/jama.269.3.374; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; LIEU TA, 1992, AM J DIS CHILD, V146, P307, DOI 10.1001/archpedi.1992.02160150047018; LINGENFELSER T, 1994, MED EDUC, V28, P566, DOI 10.1111/j.1365-2923.1994.tb02737.x; LOFGREN RP, 1990, J GEN INTERN MED, V5, P501, DOI 10.1007/BF02600880; Mann F A, 1993, Invest Radiol, V28, P92, DOI 10.1097/00004424-199301000-00032; NAGOURNEY E, 2003, NY TIMES        0513, pF6; Ozuah PO, 2001, ARCH PEDIAT ADOL MED, V155, P1073; PACIO N, 2002, ANN ARBOR NEWS  0613, pA1; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; *PUBL CIT HLTH RES, MED RES WORK HOURS; SAMKOFF JS, 1991, ACAD MED, V66, P687, DOI 10.1097/00001888-199111000-00013; SHOJANIA K, 2001, AHRQ PUBLICATION; Skeff KM, 2004, ANN INTERN MED, V140, P816, DOI 10.7326/0003-4819-140-10-200405180-00012; Steinbrook R, 2002, NEW ENGL J MED, V347, P1296, DOI 10.1056/NEJMhpr022383; STORER JS, 1989, ACAD MED, V64, P29, DOI 10.1097/00001888-198901000-00013; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; Veasey S, 2002, JAMA-J AM MED ASSOC, V288, P1116, DOI 10.1001/jama.288.9.1116; Weinstein DF, 2002, NEW ENGL J MED, V347, P1275, DOI 10.1056/NEJMsb022065	36	156	158	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2004	141	11					851	857		10.7326/0003-4819-141-11-200412070-00009	http://dx.doi.org/10.7326/0003-4819-141-11-200412070-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876WZ	15583227				2022-12-28	WOS:000225530700005
J	Kargel, JS				Kargel, JS			Proof for water, hints of life?	SCIENCE			English	Editorial Material							MARS EXPLORATION ROVERS; MERIDIANI-PLANUM; OPPORTUNITY ROVER; SCIENCE; CHEMISTRY; SOILS		US Geol Survey, Flagstaff, AZ 86001 USA	United States Department of the Interior; United States Geological Survey	Kargel, JS (corresponding author), US Geol Survey, Flagstaff, AZ 86001 USA.	jkargel@usgs.gov						Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Benison KC, 2003, ASTROBIOLOGY, V3, P609, DOI 10.1089/153110703322610690; Burns R.G., 1988, LUNAR PLANET SCI, V18, P713; Catling DC, 2004, NATURE, V429, P707, DOI 10.1038/429707a; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Dutrizac JE, 2000, REV MINERAL GEOCHEM, V40, P405, DOI 10.2138/rmg.2000.40.8; Feldman WC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020661; FERNANDEZREMOLA.DC, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2003JE001918; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; JAMBOR JL, 2000, REV MINERAL GEOCHEM, P303; Kargel JS, 2000, ICARUS, V148, P226, DOI 10.1006/icar.2000.6471; KARGEL JS, 2004, WARMER WETTER PLANET; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Lane MD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021231; Lemmon MT, 2004, SCIENCE, V306, P1753, DOI 10.1126/science.1104474; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; Marion GM, 2003, GEOCHIM COSMOCHIM AC, V67, P4251, DOI 10.1016/S0016-7037(03)00372-7; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; Pellenbarg RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001901; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Smith MD, 2004, SCIENCE, V306, P1750, DOI 10.1126/science.1104257; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559	28	21	22	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1689	1691		10.1126/science.1105533	http://dx.doi.org/10.1126/science.1105533			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576596				2022-12-28	WOS:000225630800028
J	Honjo, T				Honjo, T			Yasutomi Nishizuka (1932-2004) - Obituary	NATURE			English	Biographical-Item									Kyoto Univ, Fac Med, Dept Med Chem & Mol Biol, Kyoto 6068501, Japan	Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Fac Med, Dept Med Chem & Mol Biol, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016						0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2004	432	7020					966	966		10.1038/432966a	http://dx.doi.org/10.1038/432966a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616548				2022-12-28	WOS:000225887000028
J	Franco, A; Alvarez-Dardet, C; Ruiz, MT				Franco, A; Alvarez-Dardet, C; Ruiz, MT			Effect of democracy on health: ecological study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Alicante, Observ Publ Policies & Hlth, Dept Salud Publ, Edificio Ciencias Sociales, E-03080 Alicante, Spain	Universitat d'Alacant	Alvarez-Dardet, C (corresponding author), Univ Alicante, Observ Publ Policies & Hlth, Dept Salud Publ, Edificio Ciencias Sociales, APDO 99, E-03080 Alicante, Spain.	carlos.alvarez@ua.es		Alvarez-Dardet, Carlos/0000-0003-3530-7451				[Anonymous], 1982, POVERTY FAMINES ESSA; Baum F, 2001, J EPIDEMIOL COMMUN H, V55, P290, DOI 10.1136/jech.55.5.290; Baum FE, 2003, J EPIDEMIOL COMMUN H, V57, P320, DOI 10.1136/jech.57.5.320; Benaroyo L, 1998, ENDEAVOUR, V22, P114, DOI 10.1016/S0160-9327(98)01136-3; Franco A., 2003, Gac Sanit, V17, P157, DOI 10.1157/13046574; *FREED HOUS, FREED WORLD 2003 SUR; *FREED HOUS, FREED WORLD COUNTR R; Kelleher CC, 2002, J EPIDEMIOL COMMUN H, V56, P726, DOI 10.1136/jech.56.10.726; Lake DA, 2001, COMP POLIT STUD, V34, P587, DOI 10.1177/0010414001034006001; Navarro V, 2003, INT J HEALTH SERV, V33, P419, DOI 10.2190/R7GE-8DWK-YY6C-183U; Porta M, 1998, J EPIDEMIOL COMMUN H, V52, P605, DOI 10.1136/jech.52.10.605; WILKINSON RG, 1992, BRIT MED J, V304, P165, DOI 10.1136/bmj.304.6820.165; Wilkinson RG, 1997, BRIT MED J, V314, P591, DOI 10.1136/bmj.314.7080.591; WOODWARD D, 2002, B WORLD HEALTH ORGAN, V32, P32	14	145	153	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1421	1423		10.1136/bmj.329.7480.1421	http://dx.doi.org/10.1136/bmj.329.7480.1421			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	882VB	15604165	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000225965800008
J	Goldbloom, DS				Goldbloom, DS			Meeting mania 2004	BRITISH MEDICAL JOURNAL			English	Article									Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada	University of Toronto; Centre for Addiction & Mental Health - Canada	Goldbloom, DS (corresponding author), Ctr Addict & Mental Hlth, 250 Coll St, Toronto, ON M5T 1R8, Canada.	david_goldbloom@camh.net						BERGMAN AB, 1994, NEW ENGL J MED, V330, P1622, DOI 10.1056/NEJM199406023302223; Tufte E. R., 2003, COGNITIVE STYLE POWE	2	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1467	1469		10.1136/bmj.329.7480.1467	http://dx.doi.org/10.1136/bmj.329.7480.1467			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604186	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000225965800029
J	Wilkinson, KD				Wilkinson, KD			Ubiquitin: A nobel protein	CELL			English	Editorial Material							DEPENDENT PROTEOLYTIC SYSTEM; HEAT-STABLE POLYPEPTIDE; CYCLE MUTANT TS85; ACTIVATING ENZYME; ABNORMAL PROTEINS; ATP; RETICULOCYTES; DEGRADATION; PURIFICATION; CONJUGATION		Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Wilkinson, KD (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	keith.Wilkinson@emory.edu						BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1992, J BIOL CHEM, V267, P23364; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; CIECHANOYER A, 1980, J BIOL CHEM, V255, P7525; DAHLMANN B, 1985, BIOCHEM J, V228, P161, DOI 10.1042/bj2280161; ETLINGER JD, 1977, P NATL ACAD SCI USA, V74, P54, DOI 10.1073/pnas.74.1.54; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P884; GOLDSTEI.G, 1974, NATURE, V247, P11, DOI 10.1038/247011a0; HAAS AL, 1985, J BIOL CHEM, V260, P4694; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; HAAS AL, 1982, J BIOL CHEM, V257, P329; HERSHKO A, 1982, J BIOL CHEM, V257, P3964; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; HOUGH R, 1987, J BIOL CHEM, V262, P8303; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; MCGUIRE MJ, 1988, BIOCHIM BIOPHYS ACTA, V967, P195, DOI 10.1016/0304-4165(88)90009-8; PICKART CM, 1985, J BIOL CHEM, V260, P1573; PICKART CM, 1985, J BIOL CHEM, V260, P7903; PINE MJ, 1972, ANNU REV MICROBIOL, V26, P103, DOI 10.1146/annurev.mi.26.100172.000535; ROSE IA, 1983, BIOCHEMISTRY-US, V22, P4234, DOI 10.1021/bi00287a012; SCHIMKE RT, 1976, CIRC RES, V38, P1131; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; SIMPSON MV, 1953, J BIOL CHEM, V201, P143; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529	36	27	29	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 17	2004	119	6					741	745		10.1016/S0092-8674(04)01154-7	http://dx.doi.org/10.1016/S0092-8674(04)01154-7			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607971	Bronze			2022-12-28	WOS:000225907200005
J	Emery, NJ; Clayton, NS				Emery, NJ; Clayton, NS			The mentality of crows: Convergent evolution of intelligence in corvids and apes	SCIENCE			English	Review							OBSERVATIONAL SPATIAL MEMORY; EPISODIC-LIKE MEMORY; CLARKS NUTCRACKERS; CHIMPANZEES KNOW; MANUFACTURE; RAVENS; TOOLS; FOOD; CONSPECIFICS; STRATEGIES		Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge; University of Cambridge	Emery, NJ (corresponding author), Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England.	nje23@cam.ac.uk	Clayton, Nicola s/A-2891-2010	Clayton, Nicola/0000-0003-1835-423X				BALDA RP, 1992, ANIM BEHAV, V44, P761, DOI 10.1016/S0003-3472(05)80302-1; Balda Russell P., 1996, Current Ornithology, V13, P33; Bednekoff PA, 1996, ANIM BEHAV, V52, P833, DOI 10.1006/anbe.1996.0228; Bednekoff PA, 1996, BEHAVIOUR, V133, P807, DOI 10.1163/156853996X00251; Bennett ATD, 1996, J EXP BIOL, V199, P219; Bond AB, 2003, ANIM BEHAV, V65, P479, DOI 10.1006/anbe.2003.2101; Bugnyar T, 2002, ANIM BEHAV, V64, P185, DOI 10.1006/anbe.2002.3056; Bugnyar T, 2004, ANIM COGN, V7, P69, DOI 10.1007/s10071-003-0189-4; Byrne R., 1988, MACHIAVELLIAN INTELL; Chappell J, 2002, ANIM COGN, V5, P71, DOI 10.1007/s10071-002-0130-2; Chappell J, 2004, ANIM COGN, V7, P121, DOI 10.1007/s10071-003-0202-y; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Clayton NS, 1999, J COMP PSYCHOL, V113, P403, DOI 10.1037/0735-7036.113.4.403; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Clayton NS, 2003, J EXP PSYCHOL-ANIM B, V29, P14, DOI 10.1037//0097-7403.29.1.14; Clayton NS, 2001, PHILOS T R SOC B, V356, P1483, DOI 10.1098/rstb.2001.0947; Clayton NS, 2001, J EXP PSYCHOL-ANIM B, V27, P17, DOI 10.1037//0097-7403.27.1.17; DALLY JM, IN PRESS P R SOC B; DEKORT SR, IN PRESS COMP COGNIT; Diamond J, 2003, BEHAVIOUR, V140, P1091, DOI 10.1163/156853903322589650; Emery N. J., 2004, COMP ANAL MINDS, P181, DOI DOI 10.1098/RSTB.2006.1991; Emery Nathan J., 2004, P3; Emery NJ, 2004, ANIM COGN, V7, P37, DOI 10.1007/s10071-003-0178-7; Emery NJ, 2001, NATURE, V414, P443, DOI 10.1038/35106560; Gibson BM, 2001, J COMP PSYCHOL, V115, P403, DOI 10.1037//0735-7036.115.4.403; Hare B, 2000, ANIM BEHAV, V59, P771, DOI 10.1006/anbe.1999.1377; Hare B, 2001, ANIM BEHAV, V61, P139, DOI 10.1006/anbe.2000.1518; Heinrich B, 1998, ANIM BEHAV, V56, P1083, DOI 10.1006/anbe.1998.0906; Heinrich B, 1995, AUK, V112, P994, DOI 10.2307/4089030; Heinrich B., 1999, MIND RAVEN; Heyes CM, 1998, BEHAV BRAIN SCI, V21, P101, DOI 10.1017/S0140525X98000703; Humphrey NK., 1976, GROWING POINTS ETHOL, P303; Hunt GR, 2000, P ROY SOC B-BIOL SCI, V267, P403, DOI 10.1098/rspb.2000.1015; Hunt GR, 2001, NATURE, V414, P707, DOI 10.1038/414707a; Hunt GR, 2004, P ROY SOC B-BIOL SCI, V271, pS88, DOI 10.1098/rsbl.2003.0085; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Hunt GR, 2003, P ROY SOC B-BIOL SCI, V270, P867, DOI 10.1098/rspb.2002.2302; HUNTER MW, 1971, PSYCHON SCI, V22, P271, DOI 10.3758/BF03335950; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kohler W., 1927, MENTALITY APES, V2nd ed.; Lefebvre L, 2002, BEHAVIOUR, V139, P939, DOI 10.1163/156853902320387918; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Marino L, 2002, BRAIN BEHAV EVOLUT, V59, P21, DOI 10.1159/000063731; Paz-y-Mino G, 2004, NATURE, V430, P778, DOI 10.1038/nature02723; Pollok B, 2000, J COMP PSYCHOL, V114, P148, DOI 10.1037/0735-7036.114.2.148; POVINELLI DJ, 1992, ANIM BEHAV, V43, P633, DOI 10.1016/0003-3472(92)90085-N; POVINELLI DJ, 1992, ANIM BEHAV, V44, P269, DOI 10.1016/0003-3472(92)90033-6; Povinelli DJ, 2000, FOLK PHYS APES; Reader S. M., 2003, ANIMAL INNOVATION, P3, DOI DOI 10.1093/ACPROF:OSO/9780198526223.001.0001; REHKAMPER G, 1991, BRAIN BEHAV EVOLUT, V37, P125, DOI 10.1159/000114353; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Rutledge R, 2004, ANIM BEHAV, V67, P327, DOI 10.1016/j.anbehav.2003.07.002; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Templeton JJ, 1999, J COMP PSYCHOL, V113, P450, DOI 10.1037/0735-7036.113.4.450; Tomasello M, 1997, PRIMATE COGNITION; van Lawick-Goodall J., 1970, Adv. Stud. Behav., V3, P195; Vander Wall S.B., 1990, FOOD HOARDING ANIMAL; Weir AAS, 2004, P ROY SOC B-BIOL SCI, V271, pS344, DOI 10.1098/rsbl.2004.0183; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WILSON B, 1985, Q J EXP PSYCHOL-B, V37, P313, DOI 10.1080/14640748508401173; [No title captured]; [No title captured]	63	692	706	30	591	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1903	1907		10.1126/science.1098410	http://dx.doi.org/10.1126/science.1098410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591194	Green Submitted			2022-12-28	WOS:000225695600034
J	Redish, AD				Redish, AD			Addiction as a computational process gone awry	SCIENCE			English	Article							REINFORCED BEHAVIOR; RATIONAL ADDICTION; DOPAMINE NEURONS; DRUG-ADDICTION; COCAINE; REWARD; RECEPTORS; NICOTINE; MAINTENANCE; ACQUISITION	Addictive drugs have been hypothesized to access the same neurophysiological mechanisms as natural learning systems. These natural learning systems can be modeled through temporal-difference reinforcement learning (TDRL), which requires a reward-error signal that has been hypothesized to be carried by dopamine. TDRL learns to predict reward by driving that reward-error signal to zero. By adding a noncompensable drug-induced dopamine increase to a TDRL model, a computational model of addiction is constructed that over-selects actions leading to drug receipt. The model provides an explanation for important aspects of the addiction literature and provides a theoretic viewpoint with which to address other aspects.	Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Redish, AD (corresponding author), Univ Minnesota, Dept Neurosci, 6-145 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	redish@ahc.umn.edu						Ainslie G., 1992, PICOECONOMICS; BECKER GS, 1988, J POLIT ECON, V96, P675, DOI 10.1086/261558; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Bradberry CW, 2002, NEUROSCIENTIST, V8, P315, DOI 10.1177/107385840200800407; CARROLL ME, 1993, DRUG ALCOHOL DEPEN, V33, P201, DOI 10.1016/0376-8716(93)90061-T; CARROLL ME, 1989, PSYCHOPHARMACOLOGY, V97, P23, DOI 10.1007/BF00443407; Daw N., 2003, THESIS CARNEGIE MELL; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; Dickinson A., 1980, CONT ANIMAL LEARNING; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Grossman M, 1998, J HEALTH ECON, V17, P427, DOI 10.1016/S0167-6296(97)00046-5; Higgins ST, 2004, ANNU REV PSYCHOL, V55, P431, DOI 10.1146/annurev.psych.55.090902.142033; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Laviolette SR, 2004, NAT NEUROSCI, V7, P160, DOI 10.1038/nn1182; Letchworth SR, 2001, J NEUROSCI, V21, P2799, DOI 10.1523/JNEUROSCI.21-08-02799.2001; Mazur JE, 2001, PSYCHOL REV, V108, P96, DOI 10.1037/0033-295X.108.1.96; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; NADER MA, 1991, PSYCHOPHARMACOLOGY, V105, P169, DOI 10.1007/BF02244304; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Picciotto MR, 1998, DRUG ALCOHOL DEPEN, V51, P165, DOI 10.1016/S0376-8716(98)00074-X; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Volkow ND, 2002, BEHAV PHARMACOL, V13, P355, DOI 10.1097/00008877-200209000-00008; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; Wolf ME, 2003, ANN NY ACAD SCI, V1003, P241, DOI 10.1196/annals.1300.015; WOODWARD M, 1993, ADDICTION, V88, P821, DOI 10.1111/j.1360-0443.1993.tb02096.x; [No title captured]	39	324	329	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2004	306	5703					1944	1947		10.1126/science.1102384	http://dx.doi.org/10.1126/science.1102384			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591205				2022-12-28	WOS:000225695600047
J	Hohnloser, SH; Kuck, KH; Dorian, P; Roberts, RS; Hampton, JR; Hatala, R; Fain, E; Gent, M; Connolly, SJ				Hohnloser, SH; Kuck, KH; Dorian, P; Roberts, RS; Hampton, JR; Hatala, R; Fain, E; Gent, M; Connolly, SJ		DINAMIT Investigators	Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-RATE-VARIABILITY; VENTRICULAR-ARRHYTHMIAS; BAROREFLEX SENSITIVITY; RISK STRATIFICATION; EJECTION FRACTION; RANDOMIZED-TRIAL; TIME-DEPENDENCE; MORTALITY	Background: Implantable cardioverter-defibrillator (ICD) therapy has been shown to improve survival in patients with various heart conditions who are at high risk for ventricular arrhythmias. Whether benefit occurs in patients early after myocardial infarction is unknown. Methods: We conducted the Defibrillator in Acute Myocardial Infarction Trial, a randomized, open-label comparison of ICD therapy (in 332 patients) and no ICD therapy (in 342 patients) 6 to 40 days after a myocardial infarction. We enrolled patients who had reduced left ventricular function (left ventricular ejection fraction, 0.35 or less) and impaired cardiac autonomic function (manifested as depressed heart-rate variability or an elevated average 24-hour heart rate on Holter monitoring). The primary outcome was mortality from any cause. Death from arrhythmia was a predefined secondary outcome. Results: During a mean (+/-SD) follow-up period of 30+/-13 months, there was no difference in overall mortality between the two treatment groups: of the 120 patients who died, 62 were in the ICD group and 58 in the control group (hazard ratio for death in the ICD group, 1.08; 95 percent confidence interval, 0.76 to 1.55; P=0.66). There were 12 deaths due to arrhythmia in the ICD group, as compared with 29 in the control group (hazard ratio in the ICD group, 0.42; 95 percent confidence interval, 0.22 to 0.83; P=0.009). In contrast, there were 50 deaths from nonarrhythmic causes in the ICD group and 29 in the control group (hazard ratio in the ICD group, 1.75; 95 percent confidence interval, 1.11 to 2.76; P=0.02). Conclusions: Prophylactic ICD therapy does not reduce overall mortality in high-risk patients who have recently had a myocardial infarction. Although ICD therapy was associated with a reduction in the rate of death due to arrhythmia, that was offset by an increase in the rate of death from nonarrhythmic causes.	Goethe Univ Frankfurt, Dept Med, Div Cardiol, D-60590 Frankfurt, Germany; St George Hosp, Hamburg, Germany; St Michaels Hosp, Toronto, ON M5B 1W8, Canada; Hamilton Civ Hosp, Res Ctr, Hamilton, ON, Canada; McMaster Univ, Hamilton, ON, Canada; Univ Hosp, Nottingham, England; Slovak Cardiovasc Inst, Bratislava, Slovakia; St Jude Med, Sunnyvale, CA USA	Goethe University Frankfurt; Asklepios Klinik St. Georg; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; McMaster University; Nottingham University Hospital NHS Trust; University of Nottingham	Hohnloser, SH (corresponding author), Goethe Univ Frankfurt, Dept Med, Div Cardiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	hohnloser@em.uni-frankfurt.de	Hatala, Robert/ABV-9334-2022; Sassone, Biagio/ABH-1547-2020					BARDY G, 2004, AM COLL CARD 53 ANN; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; BIGGER JT, 1984, CIRCULATION, V69, P250, DOI 10.1161/01.CIR.69.2.250; Cairns JA, 1997, LANCET, V349, P675, DOI 10.1016/S0140-6736(96)08171-8; Cairns JA, 1997, LANCET, V349, P1776; Camm AJ, 2004, CIRCULATION, V109, P990, DOI 10.1161/01.CIR.0000117090.01718.2A; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; Copie X, 1996, J AM COLL CARDIOL, V27, P270, DOI 10.1016/0735-1097(95)00454-8; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; Hohnloser SH, 2000, AM HEART J, V140, P735, DOI 10.1067/mhj.2000.110088; Hohnloser SH, 2003, CIRCULATION, V107, P941, DOI 10.1161/01.CIR.0000054211.00668.9B; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; La Rovere MT, 2001, CIRCULATION, V103, P2072; La Rovere MT, 1998, LANCET, V351, P478; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; MYERBURG RJ, 1992, CIRCULATION, V85, P2; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115; Zuanetti G, 1999, EUR HEART J SUPPL, V1, pH52	23	990	1023	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2004	351	24					2481	2488		10.1056/NEJMoa041489	http://dx.doi.org/10.1056/NEJMoa041489			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877TE	15590950				2022-12-28	WOS:000225593100003
J	Wang, XF; Auler, AS; Edwards, RL; Cheng, H; Cristalli, PS; Smart, PL; Richards, DA; Shen, CC				Wang, XF; Auler, AS; Edwards, RL; Cheng, H; Cristalli, PS; Smart, PL; Richards, DA; Shen, CC			Wet periods in northeastern Brazil over the past 210 kyr linked to distant climate anomalies	NATURE			English	Article							TROPICAL ATLANTIC; NORTH-ATLANTIC; GREENLAND ICE; MONSOON; CIRCULATION; VARIABILITY; RESOLUTION; DYNAMICS; ARIDITY; RECORD	The tropics are the main source of the atmosphere's sensible and latent heat, and water vapour, and are therefore important for reconstructions of past climate(1). But long, accurately dated records of southern tropical palaeoclimate, which would allow the establishment of climatic connections to distant regions, have not been available. Here we present a 210,000-year (210-kyr) record of wet periods in tropical northeastern Brazil - a region that is currently semi-arid. The record is obtained from speleothems and travertine deposits that are accurately dated using the U/Th method. We find wet periods that are synchronous with periods of weak East Asian summer monsoons(2), cold periods in Greenland(3), Heinrich events in the North Atlantic(4) and periods of decreased river runoff to the Cariaco basin(5). We infer that the wet periods may be explained with a southward displacement of the Intertropical Convergence Zone. This widespread synchroneity of climate anomalies suggests a relatively rapid global reorganization of the ocean - atmosphere system. We conclude that the wet periods probably affected rainforest distribution, as plant fossils show that forest expansion occurred during these intermittent wet intervals, and opened a forest corridor(6-8) between the Amazonian and Atlantic rainforests.	Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA; Univ Fed Minas Gerais, Inst Geociencias, CPMTC, BR-31270901 Belo Horizonte, MG, Brazil; Univ Sao Paulo, Inst Geociencias, BR-05508080 Sao Paulo, Brazil; Univ Mogi das Cruzes, Lab Ciencias Terra, Mogi Das Cruzes, SP, Brazil; Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; Natl Taiwan Univ, Dept Geosci, Taipei 106, Taiwan	University of Minnesota System; University of Minnesota Twin Cities; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade de Mogi das Cruzes; University of Bristol; National Taiwan University	Wang, XF (corresponding author), Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA.	wang0452@umn.edu	Richards, David A/B-7298-2008; Edwards, R. Lawrence/I-3124-2014; Shen, Chuan-Chou/H-9642-2013; CHENG, HAI/H-3413-2017; Wang, Xianfeng/F-1233-2014; lin, ke/GZM-8300-2022	Richards, David A/0000-0001-8389-8079; Edwards, R. Lawrence/0000-0002-7027-5881; Shen, Chuan-Chou/0000-0003-2833-2771; CHENG, HAI/0000-0002-5305-9458; Wang, Xianfeng/0000-0002-8614-5627; Auler, Augusto/0000-0002-8454-3381				Arz HW, 1998, QUATERNARY RES, V50, P157, DOI 10.1006/qres.1998.1992; Auler AS, 2001, QUATERNARY RES, V55, P159, DOI 10.1006/qres.2000.2213; Ayliffe LK, 1998, GEOLOGY, V26, P147, DOI 10.1130/0091-7613(1998)026<0147:KPRFSA>2.3.CO;2; Baker PA, 2001, NATURE, V409, P698, DOI 10.1038/35055524; Bard E, 2002, EARTH PLANET SC LETT, V196, P135, DOI 10.1016/S0012-821X(01)00600-8; Behling H, 2000, QUATERNARY SCI REV, V19, P981, DOI 10.1016/S0277-3791(99)00046-3; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Chang P, 1997, NATURE, V385, P516, DOI 10.1038/385516a0; Chiang JCH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000916; Clement AC, 2004, CLIM DYNAM, V22, P327, DOI 10.1007/s00382-003-0375-8; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; De Oliveira PE, 1999, PALAEOGEOGR PALAEOCL, V152, P319, DOI 10.1016/S0031-0182(99)00061-9; EDWARDS RL, 1986, EARTH PLANET SC LETT, V81, P175; Gadgil S, 2003, ANNU REV EARTH PL SC, V31, P429, DOI 10.1146/annurev.earth.31.100901.141251; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; Haffer J., 1982, P6; HASTENRATH S, 1991, CLIMATE DYNAMICS TRO, P302; Lydolph P.E., 1985, CLIMATE EARTH, P103; McManus JF, 1998, EARTH PLANET SC LETT, V155, P29, DOI 10.1016/S0012-821X(97)00201-X; Meese DA, 1997, J GEOPHYS RES-OCEANS, V102, P26411, DOI 10.1029/97JC00269; MOURA AD, 1981, J ATMOS SCI, V38, P2653, DOI 10.1175/1520-0469(1981)038<2653:OTDODI>2.0.CO;2; Nobre P, 1996, J CLIMATE, V9, P2464, DOI 10.1175/1520-0442(1996)009<2464:VOSSTW>2.0.CO;2; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Por F.D., 1992, SOORETAMA ATLANTIC R, P130; Shen CC, 2002, CHEM GEOL, V185, P165, DOI 10.1016/S0009-2541(01)00404-1; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220	30	580	622	4	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					740	743		10.1038/nature03067	http://dx.doi.org/10.1038/nature03067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592409	Green Published			2022-12-28	WOS:000225597200044
J	Haddow, AM; Harris, DV; Wilson, M; Logie, H				Haddow, AM; Harris, DV; Wilson, M; Logie, H			Lesson of the week - Clomipramine induced neuroleptic malignant syndrome and pyrexia of unknown origin	BRITISH MEDICAL JOURNAL			English	Review							SEROTONIN SYNDROME; ANTIDEPRESSANTS; INPATIENTS; FREQUENCY; RISK		Royal Cornwall Hosp, Aberdeen AB25 2ZH, Scotland; Woodend Gen Hosp, Aberdeen, Scotland		Haddow, AM (corresponding author), Royal Cornwall Hosp, Aberdeen AB25 2ZH, Scotland.	alison.haddow@gpct.grampian.scot.nhs.uk						Adnet P, 2000, BRIT J ANAESTH, V85, P129, DOI 10.1093/bja/85.1.129; AMES D, 1993, JAMA-J AM MED ASSOC, V269, P869, DOI 10.1001/jama.269.7.869; ANSSEAU M, 1986, J CLIN PSYCHIAT, V47, P320; Ballard C, 1998, LANCET, V351, P1032, DOI 10.1016/S0140-6736(05)78999-6; DENG MZ, 1990, AM J PSYCHIAT, V147, P1149; GELENBERG AJ, 1988, AM J PSYCHIAT, V145, P4517; HERMESH H, 1992, BRIT J PSYCHIAT, V161, P254, DOI 10.1192/bjp.161.2.254; *INF STAT DIV COMM, 2004, PRESCR COST AN SCOTL; Kawanishi Chiaki, 2003, Am J Pharmacogenomics, V3, P89, DOI 10.2165/00129785-200303020-00002; KECK PE, 1989, J CLIN PSYCHIAT, V50, P352; Kontaxakis VP, 2003, J CLIN PSYCHOPHARM, V23, P671, DOI 10.1097/01.jcp.0000096245.29231.a8; Lane R, 1997, J CLIN PSYCHOPHARM, V17, P208, DOI 10.1097/00004714-199706000-00012; LEVENSON JL, 1985, AM J PSYCHIAT, V142, P1137; NAGANUMA H, 1994, ACTA PSYCHIAT SCAND, V90, P424, DOI 10.1111/j.1600-0447.1994.tb01618.x; RICHELSON E, 1984, J PHARMACOL EXP THER, V230, P94; SHALEV A, 1989, J CLIN PSYCHIAT, V50, P18; Spivak B, 2000, EUR PSYCHIAT, V15, P330, DOI 10.1016/S0924-9338(00)00402-8; STEINBACH H, 1991, AM J PSYCHIAT, V148, P705; Stevens E, 1998, INTENS CARE MED, V24, P369, DOI 10.1007/s001340050583; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9	20	15	16	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 4	2004	329	7478					1333	1335		10.1136/bmj.329.7478.1333	http://dx.doi.org/10.1136/bmj.329.7478.1333			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	878PC	15576745	Green Published			2022-12-28	WOS:000225657800023
J	Sharp, D				Sharp, D			Women are catching up, fast - perhaps	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							*HICK SPORTS, 2004, IND OL HIST; Holden C, 2004, SCIENCE, V305, P639, DOI 10.1126/science.305.5684.639; SLATER CA, 2002, FEMALE ATHLETE, P7; Tatem AJ, 2004, NATURE, V431, P525, DOI 10.1038/431525a; WOMEN OLYMPIC GAMES	5	0	0	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					2006	2006		10.1016/S0140-6736(04)17530-2	http://dx.doi.org/10.1016/S0140-6736(04)17530-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582048				2022-12-28	WOS:000225495700010
J	Bell, JF; Squyres, SW; Arvidson, RE; Arneson, HM; Bass, D; Calvin, W; Farrand, WH; Goetz, W; Gotombek, M; Greeley, R; Grotzinger, J; Guinness, E; Hayes, AG; Hubbard, MYH; Herkenhoff, KE; Johnson, MJ; Johnson, JR; Joseph, J; Kinch, KM; Lemmon, MT; Li, R; Madsen, MB; Maki, JN; Malin, M; McCartney, E; McLennan, S; McSween, HY; Ming, DW; Morris, RV; Dobrea, EZN; Sullivan, RJ; Weitz, CM; Wolff, MJ				Bell, JF; Squyres, SW; Arvidson, RE; Arneson, HM; Bass, D; Calvin, W; Farrand, WH; Goetz, W; Gotombek, M; Greeley, R; Grotzinger, J; Guinness, E; Hayes, AG; Hubbard, MYH; Herkenhoff, KE; Johnson, MJ; Johnson, JR; Joseph, J; Kinch, KM; Lemmon, MT; Li, R; Madsen, MB; Maki, JN; Malin, M; McCartney, E; McLennan, S; McSween, HY; Ming, DW; Morris, RV; Dobrea, EZN; Sullivan, RJ; Weitz, CM; Wolff, MJ			Pancam multispectral imaging results from the Opportunity Rover at Meridiani Planum	SCIENCE			English	Article							MARS PATHFINDER; REFLECTANCE SPECTRA; HEMATITE; SOILS; PYROXENE; CRATER; ROCKS	Panoramic Camera (Pancam) images from Meridiani Planum reveal a low-albedo, generally flat, and relatively rock-free surface. Within and around impact craters and fractures, laminated outcrop rocks with higher albedo are observed. Fine-grained materials include dark sand, bright ferric iron-rich dust, angular rock clasts, and millimeter-size spheroidal granules that are eroding out of the laminated rocks. Spectra of sand, clasts, and one dark plains rock are consistent with mafic silicates such as pyroxene and olivine. Spectra of both the spherules and the laminated outcrop materials indicate the presence of crystalline ferric oxides or oxyhydroxides. Atmospheric observations show a steady decline in dust opacity during the mission. Astronomical observations captured solar transits by Phobos and Deimos and time-lapse observations of sunsets.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Nevada, Dept Geol Sci, Reno, NV 89501 USA; Space Sci Inst, Boulder, CO 80301 USA; Univ Copenhagen, DK-2100 Copenhagen O, Denmark; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Aarhus Univ, DK-8000 Aarhus C, Denmark; Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77843 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Malin Space Sci Syst Inc, San Diego, CA 92191 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Planetary Sci Inst, Tucson, AZ 85719 USA	Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Copenhagen; Arizona State University; Arizona State University-Tempe; Massachusetts Institute of Technology (MIT); United States Department of the Interior; United States Geological Survey; Aarhus University; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Bell, JF (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	jfb8@cornell.edu	Johnson, Jeffrey R/F-3972-2015; Lemmon, Mark T/E-9983-2010; Seelos, Frank/C-7875-2016; Lemmon, Mark/X-2333-2019; Hayes, Alexander G/P-2024-2014; Kinch, Kjartan Bergeron/C-5742-2015; Madsen, Morten Bo/D-2082-2011	Johnson, Jeffrey R/0000-0002-5586-4901; Lemmon, Mark T/0000-0002-4504-5136; Seelos, Frank/0000-0001-9721-941X; Lemmon, Mark/0000-0002-4504-5136; Hayes, Alexander G/0000-0001-6397-2630; Kinch, Kjartan Bergeron/0000-0002-4629-8880; Madsen, Morten Bo/0000-0001-8909-5111; Soderblom, Jason/0000-0003-3715-6407; McLennan, Scott/0000-0003-4259-7178				ADAMS JB, 1974, J GEOPHYS RES, V79, P4829, DOI 10.1029/JB079i032p04829; Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; ARVIDSON RE, 2003, J GEOPHYS RES, V108; BELL JA, UNPUB; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bell JF, 2000, J GEOPHYS RES-PLANET, V105, P1721, DOI 10.1029/1999JE001060; BELL JF, 2003, J GEOPHYS RES, V108; Bishop JL, 1998, J GEOPHYS RES-PLANET, V103, P31457, DOI 10.1029/1998JE900008; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Cloutis EA, 2004, ICARUS, V172, P233, DOI 10.1016/j.icarus.2004.06.002; CLOUTIS EA, 1986, J GEOPHYS RES-SOLID, V91, P1641, DOI 10.1029/JB091iB11p11641; GOLOMBEK MP, 2003, J GEOPHYS RES, V108; Greeley R., 2003, J GEOPHYS RES, V108; GREELEY R, 2004, LUN PLAN SCI C, V35; Hapke B., 1993, THEORY REFLECTANCE E; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Johnson JR, 1999, J GEOPHYS RES-PLANET, V104, P8809, DOI 10.1029/98JE02247; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Lemmon MT, 2004, SCIENCE, V306, P1753, DOI 10.1126/science.1104474; MORRIS RV, 1995, J GEOPHYS RES-PLANET, V100, P5319, DOI 10.1029/94JE01500; Morris RV, 1998, ICARUS, V134, P1, DOI 10.1006/icar.1998.5939; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 1993, GEOCHIM COSMOCHIM AC, V57, P4597, DOI 10.1016/0016-7037(93)90185-Y; MORRIS RV, 1996, MINERAL SPECTROSCOPY, P327; Reid RJ, 1999, J GEOPHYS RES-PLANET, V104, P8907, DOI 10.1029/1998JE900011; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559	29	104	109	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1703	1709		10.1126/science.1105245	http://dx.doi.org/10.1126/science.1105245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576603				2022-12-28	WOS:000225630800035
J	Varnik, A; Kolves, K; Wasserman, D				Varnik, A; Kolves, K; Wasserman, D			Suicide among Russians in Estonia: database study before and after independence	BRITISH MEDICAL JOURNAL			English	Article									Estonian Swedish Inst Suicidol, EE-10119 Tallinn, Estonia; Karolinska Inst, Swedish Natl & Stockholm Cty Ctr Suicide Res & Pr, Stockholm, Sweden	Karolinska Institutet	Varnik, A (corresponding author), Estonian Swedish Inst Suicidol, Hariduse 6, EE-10119 Tallinn, Estonia.	Airi.Varnik@ipm.ki.se	Kolves, Kairi/ABE-7564-2020	Kolves, Kairi/0000-0002-1638-8981				BURWILL PW, 1998, PSYCHOL MED, V28, P201; Hovey JD, 2000, SUICIDE LIFE-THREAT, V30, P125; Varnik A, 2001, EUR J PUBLIC HEALTH, V11, P84, DOI 10.1093/eurpub/11.1.84; VARNIK A, 2001, ESTONIANS NONESTONIA, P14; Wasserman D, 1998, ACTA PSYCHIAT SCAND, V98, P1, DOI 10.1111/j.1600-0447.1998.tb10758.x	5	20	20	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 22	2005	330	7484					176	177		10.1136/bmj.38328.454294.55	http://dx.doi.org/10.1136/bmj.38328.454294.55			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891OQ	15601680	Green Published, Bronze			2022-12-28	WOS:000226590800018
J	Andries, K; Verhasselt, P; Guillemont, J; Gohlmann, HWH; Neefs, JM; Winkler, H; Van Gestel, J; Timmerman, P; Zhu, M; Lee, E; Williams, P; de Chaffoy, D; Huitric, E; Hoffner, S; Cambau, E; Truffot-Pernot, C; Lounis, N; Jarlier, V				Andries, K; Verhasselt, P; Guillemont, J; Gohlmann, HWH; Neefs, JM; Winkler, H; Van Gestel, J; Timmerman, P; Zhu, M; Lee, E; Williams, P; de Chaffoy, D; Huitric, E; Hoffner, S; Cambau, E; Truffot-Pernot, C; Lounis, N; Jarlier, V			A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis	SCIENCE			English	Article							ANTITUBERCULOSIS AGENTS	The incidence of tuberculosis has been increasing substantially on a worldwide basis over the past decade, but no tuberculosis-specific drugs have been discovered in 40 years. We identified a diarylquinoline, R207910, that potently inhibits both drug-sensitive and drug-resistant Mycobacterium tuberculosis in vitro (minimum inhibitory concentration 0.06 mug/ml). In mice, R207910 exceeded the bactericidal activities of isoniazid and rifampin by at least 1 log unit. Substitution of drugs included in the World Health Organization's first-line tuberculosis treatment regimen (rifampin, isoniazid, and pyrazinamide) with R207910 accelerated bactericidal activity, leading to complete culture conversion after 2 months of treatment in some combinations. A single dose of R207910 inhibited mycobacterial growth for 1 week. Plasma levels associated with efficacy in mice were well tolerated in healthy human volunteers. Mutants selected in vitro suggest that the drug targets the proton pump of adenosine triphosphate (ATP) synthase.	Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium; Johnson & Johnson Pharmaceut Res & Dev, F-27106 Val de Reuil, France; Johnson & Johnson Pharmaceut Res & Dev, Raritan, NJ 08869 USA; Johnson & Johnson Pharmaceut Res & Dev, High Wycombe HP12 4DP, Bucks, England; Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden; Univ Paris 06, Pitie Salpetriere Sch Med, F-75634 Paris, France	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson USA; Johnson & Johnson; Swedish Institute for Infectious Disease Control; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Andries, K (corresponding author), Johnson & Johnson Pharmaceut Res & Dev, Turnhoutseweg 30, B-2340 Beerse, Belgium.	kandries@prdbe.jnj.com	Cambau, Emmanuelle/G-7385-2014; Göhlmann, Hinrich/T-9848-2019	Cambau, Emmanuelle/0000-0001-5944-2530; Zhu, Min/0000-0002-5669-9602				BARBACHYN MR, 1993, Patent No. 9309103; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; DECKERSHEBESTREIT, 1996, ANNU REV MICROBIOL, V50, P791; GODFREY K, 1985, NEW ENGL J MED, V313, P1450, DOI 10.1056/NEJM198512053132305; Guillemont J. E. G., 2004, PCT Int. Appl, Patent No. [WO2004011436A1, 2004011436]; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jain R, 2003, BIOORG MED CHEM LETT, V13, P1051, DOI 10.1016/S0960-894X(03)00074-X; Kunin CM, 2000, ANTIMICROB AGENTS CH, V44, P848, DOI 10.1128/AAC.44.4.848-852.2000; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; O'Brien RJ, 2001, AM J RESP CRIT CARE, V163, P1055, DOI 10.1164/ajrccm.163.5.2007122; Rao M, 2001, MICROBIOL-UK, V147, P1017, DOI 10.1099/00221287-147-4-1017; Savini L, 2002, BIOORGAN MED CHEM, V10, P2193, DOI 10.1016/S0968-0896(02)00071-8; SIDDIQI SH, 1981, J CLIN MICROBIOL, V13, P908, DOI 10.1128/JCM.13.5.908-912.1981; *UNAIDS, AIDS EP UPD 2004; Vangapandu S, 2004, BIOORGAN MED CHEM, V12, P2501, DOI 10.1016/j.bmc.2004.03.045; World Health Organization, TREATM TUB	17	1586	1689	5	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2005	307	5707					223	227		10.1126/science.1106753	http://dx.doi.org/10.1126/science.1106753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	888GJ	15591164				2022-12-28	WOS:000226361900033
J	Salter, R; Maconochie, IK				Salter, R; Maconochie, IK			Implementation of recommendations for the care of children in UK emergency departments: national postal questionnaire survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article									St Marys Hosp, Dept Paediat Accid & Emergency, London W2 1NY, England	Imperial College London	Salter, R (corresponding author), St Marys Hosp, Dept Paediat Accid & Emergency, Praed St, London W2 1NY, England.	beckyparas@aol.com		Maconochie, Ian/0000-0001-6319-8550				*ACT SICK CHILDR, 1997, EM HLTH SERV CHILDR; Carley S, 1996, BRIT MED J, V313, P1242, DOI 10.1136/bmj.313.7067.1242; Department of Health, 2003, GETT RIGHT START NAT; *ROYAL COLL PAED C, 1999, ACC EM SERV CHILDR R; *ROYAL COLL PAED C, 2003, PROV SERV CHILDR WOR	5	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2005	330	7482					73	74		10.1136/bmj.38313.580324.F7	http://dx.doi.org/10.1136/bmj.38313.580324.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887GR	15579478	Green Published, Bronze			2022-12-28	WOS:000226294300014
J	Timonen, M; Laakso, M; Jokelainen, J; Rajala, U; Meyer-Rochow, VB; Keinanen-Kiukaanniemi, S				Timonen, M; Laakso, M; Jokelainen, J; Rajala, U; Meyer-Rochow, VB; Keinanen-Kiukaanniemi, S			Insulin resistance anddepression: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEPRESSION		Oulu Univ Hosp, Unit Gen Practice, Oys 90029, Finland; Int Univ Bremen, Sch Sci & Engn, D-28725 Bremen, Germany; Oulu Hlth Ctr, FIN-90015 Oulu, Finland	University of Oulu; Jacobs University		markku.timonen@oulu.fi	MEYER-ROCHOW, Victor Benno/AAJ-7258-2020	MEYER-ROCHOW, V. Benno/0000-0003-1531-9244; Jokelainen, Jari/0000-0003-4629-0560				BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Lawlor DA, 2003, BRIT MED J, V327, P1383, DOI 10.1136/bmj.327.7428.1383; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Rajala U, 2002, J CLIN ENDOCR METAB, V87, P5092, DOI 10.1210/jc.2002-020703; Rasgon NL, 2003, J AFFECT DISORDERS, V74, P299, DOI 10.1016/S0165-0327(02)00117-9	5	95	101	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 1	2005	330	7481					17	18		10.1136/bmj.38313.513310.F71	http://dx.doi.org/10.1136/bmj.38313.513310.F71			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885SH	15604155	Bronze, Green Published			2022-12-28	WOS:000226176700011
J	Chou, S; Huang, L; Liu, HP				Chou, S; Huang, L; Liu, HP			Fus3-regulated Tec1 degradation throulah SCFCdc4 determines MAPK signaling specificity during mating in yeast	CELL			English	Article							TRANSCRIPTION FACTOR; FILAMENTOUS-GROWTH; STRUCTURAL BASIS; GENE-EXPRESSION; INVASIVE GROWTH; KINASE; PHEROMONE; PATHWAY; CASCADE; CYCLIN	Signaling specificity is fundamental for parallel mitogen-activated protein kinase (MAPK) cascades that control growth and differentiation in response to different stimuli. In Saccharomyces cerevisiae, components of the pheromone-responsive MAPK cascade activate Fus3 and Kss1 MAPKs to induce mating and Kss1 to promote filamentation. Active Fus3 is required to prevent the activation of the filamentation program during pheromone response. How Fus3 prevents the crossactivation is not clear. Here we show that Tec1, a cofactor of Ste12 for the expression of filamentation genes, is rapidly degraded during pheromone response. Fus3 but not Kss1 induces Tec1 ubiquination and degradation through the SCFCdc4 ubiquitin ligase. T273 in a predicted high-affinity Cdc4 binding motif is phosphorylated by Fus3 both in vitro and in vivo. Tec1(T273V) blocks Tec1 ubiquitination and degradation and allows the induction of filamentation genes in response to pheromone. Thus, Fus3 inhibits filamentous growth during mating by degrading Tec1.	Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92687 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92687 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Liu, HP (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	h4liu@uci.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055155] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55155, R01 GM055155] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; BRILL JA, 1994, MOL BIOL CELL, V5, P297, DOI 10.1091/mbc.5.3.297; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; ELION EA, 1991, COLD SPRING HARB SYM, V56, P41; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Huang L, 2001, J BIOL CHEM, V276, P28327, DOI 10.1074/jbc.M008342200; Kaiser P, 1998, GENE DEV, V12, P2587, DOI 10.1101/gad.12.16.2587; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Kohler T, 2002, EUKARYOT CELL, V1, P673, DOI 10.1128/EC.1.5.673-686.2002; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Matheos D, 2004, J CELL BIOL, V165, P99, DOI 10.1083/jcb.200309089; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Mosch HU, 1997, GENETICS, V145, P671; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Oehlen L, 1998, FEBS LETT, V429, P83, DOI 10.1016/S0014-5793(98)00568-7; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Palecek SP, 2000, GENETICS, V156, P1005; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; SIKORSKI RS, 1989, GENETICS, V122, P19; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Yamano H, 2000, MOL CELL, V6, P1377, DOI 10.1016/S1097-2765(00)00135-0; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; Zhang RB, 1999, MAT SCI ENG C-BIO S, V10, P13, DOI 10.1016/S0928-4931(99)00099-5	43	106	107	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					981	990		10.1016/j.cell.2004.11.053	http://dx.doi.org/10.1016/j.cell.2004.11.053			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620356	Bronze			2022-12-28	WOS:000226109700010
J	Moore, MJ; Early, GA				Moore, MJ; Early, GA			Cumulative sperm whale bone damage and the bends	SCIENCE			English	Article									Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Moore, MJ (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	mmoore@whoi.edu	Moore, Michael/E-1707-2015	Moore, Michael/0000-0003-3074-6631				Flower WH., 1868, T ZOOLOGICAL SOC LON, V6, P309; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Resnick D., 2002, DIAGNOSIS BONE JOINT; ROTHSCHILD B, 1987, SCIENCE, V236, P75, DOI 10.1126/science.236.4797.75; Rothschild BM, 2003, J VERTEBR PALEONTOL, V23, P324, DOI 10.1671/0272-4634(2003)023[0324:DSIPSR]2.0.CO;2; Watkins WA, 2002, MAR MAMMAL SCI, V18, P55, DOI 10.1111/j.1748-7692.2002.tb01018.x	6	56	61	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2215	2215		10.1126/science.1105452	http://dx.doi.org/10.1126/science.1105452			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618509				2022-12-28	WOS:000225950000033
J	Weiss, G; Skurnick, JH; Goldsmith, LT; Santoro, NF; Park, SJ				Weiss, G; Skurnick, JH; Goldsmith, LT; Santoro, NF; Park, SJ			Menopause and hypothalamic-pituitary sensitivity to estrogen	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LUTEINIZING-HORMONE SECRETION; PREMENOPAUSAL WOMEN; MENSTRUAL-CYCLE; AGE; POPULATION; TRANSITION; INDUCTION; ESTRADIOL; SYMPTOMS; DYNAMICS	Context The onset of human menopause is thought to be caused solely by ovarian failure and oocyte depletion. However, clinical symptoms and certain recent data in perimenopausal women suggest central nervous system involvement. Objective To determine if modifications of hypothalamic-pituitary response to estrogen feedback mechanisms occur in older reproductive-age women as a mechanism of the onset of menopause. Design, Setting, and Participants The Study of Women's Health Across the Nation (SWAN) is a multiethnic observational cohort study of the menopausal transition in 3302 women at 7 US sites. Of the subcohort of 840 women who participated in the Daily Hormone Study between 1997 and 1999, 680 women had evidence of luteal activity. The remaining 160 women (19%) did not have luteal activity and are the subject of this report. Main Outcome Measures Daily urinary hormone levels of estrogen and progesterone metabolites, luteinizing hormone (LH), and follicle-stimulating hormone (FSH). Results Three groups of women were studied: those with estrogen increases with an LH surge, those with estrogen increases without an LH surge, and those with neither. There were no differences in age or ethnicity among the 3 groups of women. Women in the third group (no increases) experienced more menopausal symptoms (hot flashes) than did women in the other groups with estrogen increases. In older reproductive-age women, the frequent existence of anovulatory cycles with estrogen peaks, equivalent to those that result in LH surges in younger women, yet in which no LH surges occur, indicates failure of estrogen-positive feedback on LH secretion. In other anovulatory cycles, follicular-phase estrogen levels did not lower LH secretion as occurs in cycles of younger women, indicating decreased estrogen-negative feedback on LH secretion. Conclusion Our findings are compatible with hypothalamic-pituitary insensitivity to estrogen in aging perimenopausal women.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Obstet Gynecol & Womens Hlth, Newark, NJ 07103 USA; Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, New York, NY USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Yeshiva University	Goldsmith, LT (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Obstet Gynecol & Womens Hlth, 185 S Orange Ave, Newark, NJ 07103 USA.	goldsmit@umdnj.edu			NATIONAL INSTITUTE OF NURSING RESEARCH [U01NR004061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG012546, U01AG012539, U01AG012505, U01AG012495, U01AG012531, U01AG012535, U01AG012554, U01AG012553] Funding Source: NIH RePORTER; NIA NIH HHS [U01 AG012546, U01 AG012535, U01 AG012495, U01 AG012505, U01 AG012531, U01 AG012539, U01 AG012554, U01 AG012553] Funding Source: Medline; NINR NIH HHS [U01 NR04061] Funding Source: Medline	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Berkow Robert., 1992, MERCK MANUAL DIAGNOS, V16th; Brown J, 1993, ENDOCR J, V1, P467; BURGER HG, 1995, J CLIN ENDOCR METAB, V80, P3537, DOI 10.1210/jc.80.12.3537; Chakraborty TR, 2003, ENDOCRINOLOGY, V144, P4164, DOI 10.1210/en.2003-0052; Gold EB, 2000, AM J EPIDEMIOL, V152, P463, DOI 10.1093/aje/152.5.463; Grumbach M, 1990, CONTROL ONSET PUBERT, P1; HILLIER SG, 1981, J CLIN ENDOCR METAB, V52, P847, DOI 10.1210/jcem-52-5-847; LIU JH, 1983, J CLIN ENDOCR METAB, V57, P797; Matt DW, 1998, AM J OBSTET GYNECOL, V178, P504, DOI 10.1016/S0002-9378(98)70429-6; Reame NE, 1996, J CLIN ENDOCR METAB, V81, P1512, DOI 10.1210/jc.81.4.1512; Santoro N, 1996, J CLIN ENDOCR METAB, V81, P1495, DOI 10.1210/jc.81.4.1495; Santoro N, 2004, J CLIN ENDOCR METAB, V89, P2622, DOI 10.1210/jc.2003-031578; Santoro N, 2003, AM J PHYSIOL-ENDOC M, V284, pE521, DOI 10.1152/ajpendo.00381.2002; Santoro NF, 2004, MENOPAUSE, V11, P11; SOWERS MF, 2000, MENOPAUSE BIOL PATHO; Vande Wiele R L, 1970, Recent Prog Horm Res, V26, P63; WEISS G, 1976, OBSTET GYNECOL, V47, P415; Wise PM, 1996, SCIENCE, V273, P67, DOI 10.1126/science.273.5271.67; World Health Organisation [WHO, 1996, WHO TECHN REP SER, V866; YEN SSC, 1972, J CLIN ENDOCR METAB, V35, P897, DOI 10.1210/jcem-35-6-897; YOUNG JR, 1976, J CLIN ENDOCR METAB, V42, P432, DOI 10.1210/jcem-42-3-432	21	120	127	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					2991	2996		10.1001/jama.292.24.2991	http://dx.doi.org/10.1001/jama.292.24.2991			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613667				2022-12-28	WOS:000225841900033
J	Raja, AJ; Singer, PA				Raja, AJ; Singer, PA			Transatlantic divide in publication of content relevant to developing countries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Aga Khan Univ, Dept Surg, Nairobi, Kenya; Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada	Aga Khan University; University of Toronto	Raja, AJ (corresponding author), Aga Khan Univ, Dept Surg, Nairobi, Kenya.	Asad.Raia@akhskenya.org						Dickson D, 2004, SCIDEVNET       0719; Flanagin A, 2003, JAMA-J AM MED ASSOC, V290, P1382, DOI 10.1001/jama.290.10.1382; *GLOB FOR HLTH RES, 2000, 1090 WHO GLOB FOR HL; Keiser J, 2004, BMJ-BRIT MED J, V328, P1229, DOI 10.1136/bmj.38069.518137.F6; OBUAYA CC, 2002, EURO SCI EDIT, V28, P72	5	11	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1429	1430		10.1136/bmj.329.7480.1429	http://dx.doi.org/10.1136/bmj.329.7480.1429			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604171	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000225965800014
J	Nemoto, S; Fergusson, MM; Finkel, T				Nemoto, S; Fergusson, MM; Finkel, T			Nutrient availability regulates SIRT1 through a forkhead-dependent pathway	SCIENCE			English	Article							LIFE-SPAN; CALORIE RESTRICTION; CELL-SURVIVAL; FHA DOMAIN; P53; DEATH; MDC1; NAD	Nutrient availability regulates life-span in a wide range of organisms. We demonstrate that in mammalian cells, acute nutrient withdrawal simultaneously augments expression of the SIRT1 deacetylase and activates the Forkhead transcription factor Foxo3a. Knockdown of Foxo3a expression inhibited the starvation-induced increase in SIRT1 expression. Stimulation of SIRT1 transcription by Foxo3a was mediated through two p53 binding sites present in the SIRT1 promoter, and a nutrient-sensitive physical interaction was observed between Foxo3a and p53. SIRT1 expression was not induced in starved p53-deficient mice. Thus, in mammalian cells, p53, Foxo3a, and SIRT1, three proteins separately implicated in aging, constitute a nutrient-sensing pathway.	NHLBI, Cardiovasc Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Finkel, T (corresponding author), NHLBI, Cardiovasc Branch, Bldg 10, Bethesda, MD 20892 USA.	finkelt@nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005012, Z01HL005012] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Falck J, 2001, ONCOGENE, V20, P5503, DOI 10.1038/sj.onc.1204811; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Patterson GI, 2003, CURR BIOL, V13, pR279, DOI 10.1016/S0960-9822(03)00201-X; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X	23	544	568	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2105	2108		10.1126/science.1101731	http://dx.doi.org/10.1126/science.1101731			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604409				2022-12-28	WOS:000225841000066
J	Pirrotta, V				Pirrotta, V			The ways of PARP	CELL			English	Editorial Material								Two papers in this issue of Cell describe two roles of poly(ADP-ribose) polymerase (PARP) in modulating chromatin structure: as a structural component replacing linker histone (Kim et al., 2004) and as a constituent of a corepressor complex poised to dismiss repression upon receipt of an activating signal (Ju et al., 2004).	Rutgers State Univ, Nelson Labs, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Pirrotta, V (corresponding author), Rutgers State Univ, Nelson Labs, Dept Mol Biol & Biochem, 604 Allison Rd, Piscataway, NJ 08854 USA.							D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764	6	13	13	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 17	2004	119	6					735	736		10.1016/j.cell.2004.12.002	http://dx.doi.org/10.1016/j.cell.2004.12.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607968	Bronze			2022-12-28	WOS:000225907200002
J	Rhoten, D; Parker, A				Rhoten, D; Parker, A			Risks and rewards of an interdisciplinary research path	SCIENCE			English	Editorial Material									Stanford Univ, Dept Sociol, Stanford, CA 94305 USA; Social Sci Res Council, Knowledge Inst & Innovat, New York, NY 10019 USA	Stanford University	Rhoten, D (corresponding author), Social Sci Res Council, Knowledge Inst & Innovat, New York, NY 10019 USA.	rhoten@ssrc.org; anparker@stanford.edu	Parker, Andrew/AAQ-9130-2020	Parker, Andrew/0000-0002-6643-4878				CUMMINGS J, IN PRESS SOC STUD SC; Kessel F, 2003, EXPANDING BOUNDARIES; Klein J. T., 1996, CROSSING BOUNDARIES; Lattuca L. R., 2001, CREATING INTERDISCIP; RHOTEN D, UNPUB; Salter L., 1996, OUTSIDE LINES ISSUES; Stokols Daniel, 2003, Nicotine Tob Res, V5 Suppl 1, pS21; Sung NS, 2003, SCIENCE, V301, P1485, DOI 10.1126/science.1086133; Weingart P., 2000, PRACTISING INTERDISC; 2000, BRIDGING DISCIPLINES	10	210	214	9	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2046	2046		10.1126/science.1103628	http://dx.doi.org/10.1126/science.1103628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604393				2022-12-28	WOS:000225841000045
J	van Attikum, H; Fritsch, O; Hohn, B; Gasser, SM				van Attikum, H; Fritsch, O; Hohn, B; Gasser, SM			Recruitment of the INO80 complex by H2A phosphorylation links ATP-dependent chromatin remodeling with DNA double-strand break repair	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; HISTONE H2A; CHECKPOINT PROTEINS; S-PHASE; DAMAGE; YEAST; ARREST; LIGASE; IDENTIFICATION; INVOLVEMENT	The budding yeast INO80 complex is a conserved ATP-dependent nucleosome remodeler containing actin-related proteins Arp5 and Arp8. Strains lacking INO80, ARP5, or ARP8 have defects in transcription. Here we show that these mutants are hypersensitive to DNA damaging agents and to double-strand breaks (DSBs) induced by the HO endonuclease. The checkpoint response and most transcriptional modulation associated with induction of DNA damage are unaffected by these mutations. Using chromatin immunoprecipitation we show that Ino80, Arp5, and Arp8 are recruited to an HO-induced DSB, where a phosphorylated form of H2A accumulates. Recruitment of Ino80 is compromised in cells lacking the H2A phosphoacceptor S129. Finally, we demonstrate that conversion of the DSB into ssDNA is compromised in arp8 and H2A mutants, which are both deficient for INO80 activity at the site of damage. These results implicate INO80-mediated chromatin remodeling directly at DSBs, where it appears to facilitate processing of the lesion.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; NCCR Frontiers Genet Program, CH-1211 Geneva 4, Switzerland; Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	University of Geneva; Friedrich Miescher Institute for Biomedical Research	Gasser, SM (corresponding author), Univ Geneva, Dept Mol Biol, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.	susan.gasser@fmi.ch	van Attikum, Haico/A-4596-2010; Fritsch, Olivier/L-9829-2019	Van Attikum, Haico/0000-0001-8590-0240; Gasser, Susan/0000-0003-3610-9123; Fritsch, Olivier/0000-0001-6756-9654				Bakshi R, 2004, BIOCHEM BIOPH RES CO, V320, P197, DOI 10.1016/j.bbrc.2004.05.147; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Booth C, 2001, NUCLEIC ACIDS RES, V29, P4414, DOI 10.1093/nar/29.21.4414; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Foss EJ, 2001, GENETICS, V157, P567; Frank-Vaillant M, 2002, MOL CELL, V10, P1189, DOI 10.1016/S1097-2765(02)00705-0; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; Fritsch O, 2004, MOL CELL, V16, P479, DOI 10.1016/j.molcel.2004.09.034; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Paciotti V, 2000, GENE DEV, V14, P2046; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Reagan MS, 1997, NUCLEIC ACIDS RES, V25, P4257, DOI 10.1093/nar/25.21.4257; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Schar P, 1997, GENE DEV, V11, P1912, DOI 10.1101/gad.11.15.1912; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	49	469	476	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					777	788		10.1016/j.cell.2004.11.033	http://dx.doi.org/10.1016/j.cell.2004.11.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607975	Bronze			2022-12-28	WOS:000225907200009
J	Shoichet, BK				Shoichet, BK			Virtual screening of chemical libraries	NATURE			English	Article							STRUCTURE-BASED DESIGN; INHIBITORS; DISCOVERY; SITE; COMPUTATION; REDUCTASE; STRATEGY; DOCKING; MODEL	Virtual screening uses computer-based methods to discover new ligands on the basis of biological structures. Although widely heralded in the 1970s and 1980s, the technique has since struggled to meet its initial promise, and drug discovery remains dominated by empirical screening. Recent successes in predicting new ligands and their receptor-bound structures, and better rates of ligand discovery compared to empirical screening, have re-ignited interest in virtual screening, which is now widely used in drug discovery, albeit on a more limited scale than empirical screening.	Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA 94143 USA.	shoichet@cgl.ucsf.edu			NIGMS NIH HHS [R01 GM059957] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059957] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEDDELL CR, 1976, BRIT J PHARMACOL, V57, P201, DOI 10.1111/j.1476-5381.1976.tb07468.x; Brik A, 2003, CHEMBIOCHEM, V4, P1246, DOI 10.1002/cbic.200300724; COHEN SS, 1977, SCIENCE, V197, P431, DOI 10.1126/science.195340; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; Evers A, 2004, ANGEW CHEM INT EDIT, V43, P248, DOI 10.1002/anie.200352776; Gradler U, 2001, J MOL BIOL, V306, P455, DOI 10.1006/jmbi.2000.4256; Gruneberg S, 2002, J MED CHEM, V45, P3588, DOI 10.1021/jm011112j; Horn JR, 2004, J MOL BIOL, V336, P1283, DOI 10.1016/j.jmb.2003.12.068; IPEPER U, 2002, NUCLEIC ACIDS RES, V30, P255; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Kaiser J, 2004, SCIENCE, V304, P1728; KALYANARAMAN C, IN PRESS BIOCHEMISTR; Kick EK, 1997, CHEM BIOL, V4, P297, DOI 10.1016/S1074-5521(97)90073-9; Kraemer O, 2004, PROTEINS, V55, P814, DOI 10.1002/prot.20057; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Oprea TI, 2000, MOL DIVERS, V5, P199, DOI 10.1023/A:1021368007777; Paiva AM, 2001, BBA-PROTEIN STRUCT M, V1545, P67, DOI 10.1016/S0167-4838(00)00262-4; PERUTZ MF, 1964, SCI AM, V211, P64, DOI 10.1038/scientificamerican1164-64; Powers RA, 2002, STRUCTURE, V10, P1013, DOI 10.1016/S0969-2126(02)00799-2; Rizzo RC, 2000, J AM CHEM SOC, V122, P12898, DOI 10.1021/ja003113r; Rosenfeld RJ, 2003, J COMPUT AID MOL DES, V17, P525, DOI 10.1023/B:JCAM.0000004604.87558.02; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; Schneidman-Duhovny D, 2004, CURR MED CHEM, V11, P91, DOI 10.2174/0929867043456223; Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3; Stahura FL, 2004, COMB CHEM HIGH T SCR, V7, P259; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921; VARNEY MD, 1992, J MED CHEM, V35, P663, DOI 10.1021/jm00082a006; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wei BQQ, 2002, J MOL BIOL, V322, P339, DOI 10.1016/S0022-2836(02)00777-5; Wyss PC, 2003, J MED CHEM, V46, P2304, DOI 10.1021/jm020495y	32	953	978	9	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					862	865		10.1038/nature03197	http://dx.doi.org/10.1038/nature03197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602552	Green Accepted			2022-12-28	WOS:000225733500043
J	Green, AD; Colon-Emeric, CS; Bastian, L; Drake, MT; Lyles, KW				Green, AD; Colon-Emeric, CS; Bastian, L; Drake, MT; Lyles, KW			Does this woman have osteoporosis?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; HIP FRACTURE; TOOTH LOSS; VERTEBRAL FRACTURES; GRIP STRENGTH; ELDERLY-WOMEN; OLDER WOMEN; PHYSICAL-EXAMINATION	Context Although recent US Preventive Services Task Force guidelines recommend bone densitometry for all women older than 65 years, identifying younger women at increased risk for osteoporosis and women with occult vertebral fractures remains a clinical challenge. We investigated whether physical signs are useful as a screening tool either for early referral to bone densitometry or for occult spinal fractures. Objective To review the accuracy and precision of physical examination findings for the diagnosis of osteopenia, osteoporosis, or spinal fracture. Data Sources We conducted a MEDLINE search for articles published from 1966 through August 2004, manually reviewed bibliographies, consulted 4 clinical skills textbooks, and contacted experts in the field. Study Selection Studies were included if they contained adequate original data on the accuracy or precision of physical examination for diagnosing osteopenia, osteoporosis, or spinal fracture. Two authors screened abstracts found by the search. Fourteen of 191 full articles reviewed met inclusion criteria. Data Extraction Two authors independently abstracted data from the included studies. Disagreements were resolved by discussion. Data Synthesis No single maneuver is sufficient to rule in or rule out osteoporosis or spinal fracture without further testing. The following yielded the greatest positive likelihood ratios (LR+): weight less than 51 kg, LR+, 7.3 (95% confidence interval [CI], 5.0-10.8); tooth count less than 20, LR+, 3.4 (95% Cl, 1.4-8.0); rib-pelvis distance less than 2 finger breadths, LR+, 3.8 (95% Cl, 2.9-5.1); wall-occiput distance greater than 0 cm, LR+, 4.6 (95% Cl, 2.9-7.3), and self-reported humped back, LR+, 3.0 (95% Cl, 2.2-4.1). Conclusions In patients who do not meet current bone mineral density screening recommendations, several convenient examination maneuvers, especially low weight, can significantly change the pretest probability of osteoporosis and suggest the need for earlier screening. Wall-occiput distance greater than 0 cm and rib-pelvis distance less than 2 fingerbreadths suggest the presence of occult spinal fracture.	Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; Durham Vet Affairs Med Ctr, Ambulatory Care Serv, Durham, NC USA; Durham Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC USA; Duke Univ, Med Ctr, Dept Internal Med, Durham, NC 27710 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Colon-Emeric, CS (corresponding author), Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Box 3003, Durham, NC 27710 USA.	Colon001@mc.duke.edu			DIVISION OF ASSOCIATED, DENTAL HEALTH PROFESSIONS [D31AH094004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG011268, K23AG024787] Funding Source: NIH RePORTER; NIA NIH HHS [AG11268, AG024787] Funding Source: Medline; BHP HRSA HHS [2031AH94004] Funding Source: Medline	DIVISION OF ASSOCIATED, DENTAL HEALTH PROFESSIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BHP HRSA HHS		ASTROM J, 1990, J BONE JOINT SURG BR, V72, P324, DOI 10.1302/0301-620X.72B2.2312583; Balzini L, 2003, J AM GERIATR SOC, V51, P1419, DOI 10.1046/j.1532-5415.2003.51460.x; BAUER DC, 1993, ANN INTERN MED, V118, P657, DOI 10.7326/0003-4819-118-9-199305010-00001; Bedogni G, 1999, ANN HUM BIOL, V26, P561, DOI 10.1080/030144699282471; BICKLEY LS, 1999, BATES GUIDE PHYS EXA; CABOT RC, 1942, CABOT ADAMS PHYS DIA; Cadarette SM, 2000, CAN MED ASSOC J, V162, P1289; Cadarette SM, 2001, JAMA-J AM MED ASSOC, V286, P57, DOI 10.1001/jama.286.1.57; CHAPPARD D, 1991, ACTA ANAT, V141, P239; CHOW RK, 1987, AM J PHYS MED REHAB, V66, P219; Cortet B, 1999, SPINE, V24, P1921, DOI 10.1097/00007632-199909150-00010; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; DANIELL HW, 1983, ARCH INTERN MED, V143, P1678, DOI 10.1001/archinte.143.9.1678; Dargent-Molina P, 2000, OSTEOPOROSIS INT, V11, P881, DOI 10.1007/s001980070048; DeGowin R. L., 1994, DEGOWIN DEGOWINS DIA; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; DELP MH, 1981, MAJORS PHYS DIAGNOSI; Di Monaco M, 2000, CLIN RHEUMATOL, V19, P473, DOI 10.1007/s100670070009; Earnshaw SA, 1998, INT J EPIDEMIOL, V27, P479, DOI 10.1093/ije/27.3.479; EASTELL R, 1991, J BONE MINER RES, V6, P207; ELDERS PJM, 1992, J CLIN PERIODONTOL, V19, P492, DOI 10.1111/j.1600-051X.1992.tb01162.x; ETTINGER B, 1994, OSTEOPOROSIS INT, V4, P55, DOI 10.1007/BF02352262; Foley KT, 1999, CALCIFIED TISSUE INT, V64, P291, DOI 10.1007/s002239900621; Goddard D, 1998, POSTGRAD MED, V104, P54, DOI 10.3810/pgm.1998.10.441; HABETS LLMH, 1988, INT J ORAL MAX SURG, V17, P208, DOI 10.1016/S0901-5027(88)80035-3; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Inagaki K, 2001, J DENT RES, V80, P1818, DOI 10.1177/00220345010800090901; JETTE AM, 1987, ARCH PHYS MED REHAB, V68, P735; Kantor SM, 2004, J CLIN DENSITOM, V7, P65, DOI 10.1385/JCD:7:1:65; Kaufman JM, 2000, ANN RHEUM DIS, V59, P765, DOI 10.1136/ard.59.10.765; KLEMETTI E, 1993, J PROSTHET DENT, V70, P21, DOI 10.1016/0022-3913(93)90032-J; KRALL EA, 1994, OSTEOPOROSIS INT, V4, P104, DOI 10.1007/BF01623233; Krall EA, 1996, CALCIFIED TISSUE INT, V59, P433, DOI 10.1007/BF00369206; Kramer AM, 1997, JAMA-J AM MED ASSOC, V277, P396, DOI 10.1001/jama.277.5.396; KRIBBS PJ, 1989, J PROSTHET DENT, V62, P703, DOI 10.1016/0022-3913(89)90596-9; KRITZSILVERSTEIN D, 1994, J BONE MINER RES, V9, P45, DOI 10.1002/jbmr.5650090107; Lydick E, 1998, AM J MANAG CARE, V4, P37; LYLES KW, 1993, AM J MED, V94, P595, DOI 10.1016/0002-9343(93)90210-G; MAGAZINER J, 1990, J GERONTOL, V45, pM101, DOI 10.1093/geronj/45.3.M101; MAY H, 1994, AGE AGEING, V23, P235, DOI 10.1093/ageing/23.3.235; MAY H, 1995, AGE AGEING, V24, P217, DOI 10.1093/ageing/24.3.217; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271; Melton LJ, 1997, SPINE, V22, p2S, DOI 10.1097/00007632-199712151-00002; MELTON LJ, 1990, ANN INTERN MED, V112, P516, DOI 10.7326/0003-4819-112-7-516; MERCIER P, 1981, J PROSTHET DENT, V46, P250, DOI 10.1016/0022-3913(81)90209-2; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; Michaelsson K, 1996, OSTEOPOROSIS INT, V6, P120, DOI 10.1007/BF01623934; Must A, 2002, AM J EPIDEMIOL, V155, P672, DOI 10.1093/aje/155.7.672; MUST A, 1993, AM J EPIDEMIOL, V138, P56, DOI 10.1093/oxfordjournals.aje.a116777; *NAT OST FDN, 2000, PHYS GUID PREV TREAT; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; NELSON HD, 2002, AHRQ PUBLICATION; Nguyen TV, 2004, OSTEOPOROSIS INT, V15, P49, DOI 10.1007/s00198-003-1511-3; Norgan NG, 2000, INT J OBESITY, V24, P1695, DOI 10.1038/sj.ijo.0801463; ORME SM, 1994, CLIN ENDOCRINOL, V41, P283, DOI 10.1111/j.1365-2265.1994.tb02546.x; Pachucki-Hyde L, 2001, NURS CLIN N AM, V36, P401; Payette H, 2000, J Nutr Health Aging, V4, P223; PHILLIPS HB, 1973, BRIT DENT J, V134, P237, DOI 10.1038/sj.bdj.4802984; Randell AG, 2000, OSTEOPOROSIS INT, V11, P460, DOI 10.1007/s001980070115; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Riggs B.L., 1995, OSTEOPOROSIS ETIOLOG, V2nd; Robinson RJ, 1997, EUR J GASTROEN HEPAT, V9, P945, DOI 10.1097/00042737-199710000-00005; SANILA M, 1994, CLIN RHEUMATOL, V13, P256; Siminoski K, 2003, AM J MED, V115, P233, DOI 10.1016/S0002-9343(03)00299-7; SIMINOSKI K, 2003, J BONE MINER RES S2, V18, pF284; Sinaki M, 1998, AM J PHYS MED REHAB, V77, P470, DOI 10.1097/00002060-199811000-00002; SINAKI M, 1989, ARCH PHYS MED REHAB, V70, P823; Snelling AM, 2001, J WOMEN HEALTH GEN-B, V10, P57, DOI 10.1089/152460901750067124; TAAFFE DR, 1995, J SPORT MED PHYS FIT, V35, P136; Verhaar HJJ, 1998, OSTEOPOROSIS INT, V8, P174, DOI 10.1007/BF02672515; Versluis RGJA, 1999, OSTEOPOROSIS INT, V9, P129, DOI 10.1007/s001980050125; Vogt TM, 2000, MAYO CLIN PROC, V75, P888, DOI 10.4065/75.9.888; Wang XF, 2004, OSTEOPOROSIS INT, V15, P43, DOI 10.1007/s00198-003-1496-y; Weinstein L, 2000, AM J OBSTET GYNECOL, V183, P547, DOI 10.1067/mob.2000.106594; Zimmerman SI, 1999, OSTEOPOROSIS INT, V9, P151	75	53	56	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2004	292	23					2890	2900		10.1001/jama.292.23.2890	http://dx.doi.org/10.1001/jama.292.23.2890			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879CR	15598921				2022-12-28	WOS:000225694500027
J	Ahmed, SH				Ahmed, SH			Neuroscience - Addiction as compulsive reward prediction	SCIENCE			English	Editorial Material							RATIONAL ADDICTION; DRUG-ABUSE; DOPAMINE; SUBSTRATE		Univ Bordeaux 2, CNRS, UMR 5541, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Ahmed, SH (corresponding author), Univ Bordeaux 2, CNRS, UMR 5541, F-33076 Bordeaux, France.	sahmed@lnpb.u-bordeaux2.fr	AHMED, Serge H/D-5236-2014	Ahmed, Serge/0000-0002-1225-9234				Ahmed SH, 1998, BEHAV NEUROSCI, V112, P1167; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; BECKER GS, 1988, J POLIT ECON, V96, P675, DOI 10.1086/261558; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Bridges JFP, 2001, EUR ADDICT RES, V7, P78, DOI 10.1159/000050720; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; Egelman DM, 1998, J COGNITIVE NEUROSCI, V10, P623, DOI 10.1162/089892998563022; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; HERMSTEIN RJ, 1991, J ECON PERSPECT, V5, P137; Heyman GM, 1996, BEHAV BRAIN SCI, V19, P561, DOI 10.1017/S0140525X00042990; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; STIGLER GJ, 1977, AM ECON REV, V67, P78; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507	22	27	27	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2004	306	5703					1901	1902		10.1126/science.1107071	http://dx.doi.org/10.1126/science.1107071			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591193				2022-12-28	WOS:000225695600033
J	Przyborski, J; Lanzer, M				Przyborski, J; Lanzer, M			Parasitology - The malarial secretome	SCIENCE			English	Editorial Material							TARGETING SIGNAL; PLASMODIUM; VIRULENCE; PROTEINS		Univ Klinikum Heidelberg, Dept Parasitol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Przyborski, J (corresponding author), Univ Klinikum Heidelberg, Dept Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	michael_lanzer@med.uni-heidelberg.de	Lanzer, Michael/E-9752-2013; Przyborski, Jude/A-5634-2009	Lanzer, Michael/0000-0002-0220-6526; Przyborski, Jude/0000-0002-3494-7767				Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; PAPAKRIVOS J, IN PRESS MOL MICROBI; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	9	15	17	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1897	1898		10.1126/science.1107072	http://dx.doi.org/10.1126/science.1107072			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591189				2022-12-28	WOS:000225695600029
J	Naumov, II; Bellaiche, L; Fu, HX				Naumov, II; Bellaiche, L; Fu, HX			Unusual phase transitions in ferroelectric nanodisks and nanorods	NATURE			English	Article							ULTRATHIN FILMS; SOLID-SOLUTION; PRINCIPLES; BEHAVIOR; MODELS; PBTIO3	Bulk ferroelectrics undergo structural phase transformations at low temperatures, giving multi-stable ( that is, multiple-minimum) degenerate states with spontaneous polarization. Accessing these states by applying, and varying the direction of, an external electric field is a key principle for the operation of devices such as non-volatile ferroelectric random access memories(1) (NFERAMs). Compared with bulk ferroelectrics, low-dimensional finite ferroelectric structures promise to increase the storage density of NFERAMs 10,000-fold(2). But this anticipated benefit hinges on whether phase transitions and multi-stable states still exist in low-dimensional structures. Previous studies have suggested that phase transitions are impossible in one-dimensional systems(3-5), and become increasingly less likely as dimensionality further decreases(3-6). Here we perform ab initio studies of ferroelectric nanoscale disks and rods of technologically important Pb(Zr, Ti) O-3 solid solutions, and demonstrate the existence of previously unknown phase transitions in zero-dimensional ferroelectric nanoparticles. The minimum diameter of the disks that display low-temperature structural bistability is determined to be 3.2 nm, enabling an ultimate NFERAM density of 60 x 10(12) bits per square inch that is, five orders of magnitude larger than those currently available(7). Our results suggest an innovative use of ferroelectric nanostructures for data storage, and are of fundamental value for the theory of phase transition in systems of low dimensionality.	Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Fu, HX (corresponding author), Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA.	hfu@uark.edu						Ahn CH, 1997, SCIENCE, V276, P1100, DOI 10.1126/science.276.5315.1100; BATRA IP, 1973, PHYS REV LETT, V30, P384, DOI 10.1103/PhysRevLett.30.384; Bellaiche L, 2000, PHYS REV LETT, V84, P5427, DOI 10.1103/PhysRevLett.84.5427; Cardy J, 1997, PHYS REV LETT, V79, P4063, DOI 10.1103/PhysRevLett.79.4063; COHEN RE, 1992, NATURE, V358, P136, DOI 10.1038/358136a0; Dawber M, 2003, J PHYS-CONDENS MAT, V15, pL393, DOI 10.1088/0953-8984/15/24/106; de Gennes P. G., 1993, PHYS LIQUID CRYSTALS; DEMCZYK BG, 1990, J AM CERAM SOC, V73, P615, DOI 10.1111/j.1151-2916.1990.tb06561.x; DUBOVIK VM, 1995, J MAGN MAGN MATER, V150, P105, DOI 10.1016/0304-8853(95)00091-7; EDWARDS SF, 1975, J PHYS F MET PHYS, V5, P965, DOI 10.1088/0305-4608/5/5/017; Fu HX, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.257601; Ghosez P, 2000, APPL PHYS LETT, V76, P2767, DOI 10.1063/1.126469; Glass A.M., 1979, PRINCIPLES APPL FERR; Gorbatsevich A. A., 1994, Ferroelectrics, V161, P321, DOI 10.1080/00150199408213381; Grinberg I, 2002, NATURE, V419, P909, DOI 10.1038/nature01115; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Kim SH, 2003, J KOREAN PHYS SOC, V42, pS1417; KORNEV I, 2004, ULTRATHIN FILMS FERR; Landau L., 2000, STAT PHYS; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; Meyer B, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.104111; Meyer B, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.205426; Morrison F. D., 2003, REV ADV MATER SCI, V4, P114; Noheda B, 1999, APPL PHYS LETT, V74, P2059, DOI 10.1063/1.123756; SCOTT JF, 1989, SCIENCE, V246, P1400, DOI 10.1126/science.246.4936.1400; SICRON N, 1994, PHYS REV B, V50, P13168, DOI 10.1103/PhysRevB.50.13168; Yun WS, 2002, NANO LETT, V2, P447, DOI 10.1021/nl015702g; ZHONG W, 1994, PHYS REV LETT, V73, P1861, DOI 10.1103/PhysRevLett.73.1861	29	691	697	10	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					737	740		10.1038/nature03107	http://dx.doi.org/10.1038/nature03107			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592408				2022-12-28	WOS:000225597200043
J	Pierrehumbert, RT				Pierrehumbert, RT			Warming the world	NATURE			English	Editorial Material									Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Pierrehumbert, RT (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.			Pierrehumbert, Raymond/0000-0002-5887-1197				Bard E, 2004, CR GEOSCI, V336, P603, DOI 10.1016/j.crte.2004.02.005; FOURIER JBJ, 1827, MEMOIRES ACAD ROYALE, V7, P570	2	17	18	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					677	677		10.1038/432677a	http://dx.doi.org/10.1038/432677a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592390	Bronze			2022-12-28	WOS:000225597200026
J	Bybee, KA; Kara, T; Prasad, A; Lerman, A; Barsness, GW; Wright, RS; Rihal, CS				Bybee, KA; Kara, T; Prasad, A; Lerman, A; Barsness, GW; Wright, RS; Rihal, CS			Systematic review: Transient left ventricular apical ballooning: A syndrome that mimics ST-segment elevation myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Review							TIMI FRAME COUNT; WALL-MOTION ABNORMALITIES; CORONARY-ARTERY STENOSIS; TAKOTSUBO CARDIOMYOPATHY; SUBARACHNOID HEMORRHAGE; AMPULLA CARDIOMYOPATHY; ENDOTHELIAL DYSFUNCTION; SYSTOLIC DYSFUNCTION; CLINICAL-FEATURES; ANIMAL-MODEL	The transient left ventricular apical ballooning syndrome, also known as takotsubo cardiomyopathy, is characterized by transient wall-motion abnormalities involving the left ventricular apex and mid-ventricle in the absence of obstructive epicardial coronary disease. In this paper, we review case series that report on patients with the transient left ventricular apical ballooning syndrome to better characterize patients presenting with the syndrome. We identified 7 case series that reported on at least 5 consecutive patients with the transient left ventricular apical ballooning syndrome. The syndrome more often affects postmenopausal women (82% to 100%) (mean age, 62 to 75 years). Patients commonly present with ST-segment elevation in the precordial leads, chest pain, relatively minor elevation of cardiac enzyme and biomarker levels, and transient apical systolic left ventricular dysfunction despite the absence of obstructive epicardial coronary disease. An episode of emotional or physiologic stress frequently precedes presentation with the syndrome. The in-hospital mortality rate seems to be low, as does the risk for recurrence.	Mayo Clin & Mayo Fdn, Cardiac Catheterizat Lab, Coll Med, Rochester, MN 55905 USA	Mayo Clinic	Rihal, CS (corresponding author), Mayo Clin & Mayo Fdn, Cardiac Catheterizat Lab, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	Rihal@mayo.edu						Abe Y, 2003, J AM COLL CARDIOL, V41, P737, DOI 10.1016/S0735-1097(02)02925-X; Akashi YJ, 2004, J NUCL MED, V45, P1121; Akashi YJ, 2004, MAYO CLIN PROC, V79, P821; Akashi YJ, 2003, QJM-INT J MED, V96, P563, DOI 10.1093/qjmed/hcg096; Ako J, 2001, JPN HEART J, V42, P355, DOI 10.1536/jhj.42.355; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Barcin C, 2003, AM J CARDIOL, V91, P466, DOI 10.1016/S0002-9149(02)03250-2; Bybee KA, 2004, AM J CARDIOL, V94, P343, DOI 10.1016/j.amjcard.2004.04.030; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Chang PC, 1998, INT J CARDIOL, V63, P189; Desmet WJR, 2003, HEART, V89, P1027, DOI 10.1136/heart.89.9.1027; Dote K, 1991, J Cardiol, V21, P203; Dujardin KS, 2001, J HEART LUNG TRANSPL, V20, P350, DOI 10.1016/S1053-2498(00)00193-5; Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473; Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879; Haley JH, 1999, MAYO CLIN PROC, V74, P901, DOI 10.4065/74.9.901; Ito K, 2003, ANN NUCL MED, V17, P115, DOI 10.1007/BF02988449; Ito K, 2001, ANN NUCL MED, V15, P351, DOI 10.1007/BF02988242; Kawai S, 2000, JPN CIRC J, V64, P156, DOI 10.1253/jcj.64.156; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; Kume Teruyoshi, 2004, J Cardiol, V43, P123; Kurisu S, 2002, AM HEART J, V143, P448, DOI 10.1067/mhj.2002.120403; Kurisu S, 2003, J AM COLL CARDIOL, V41, P743, DOI 10.1016/S0735-1097(02)02924-8; Kyuma M, 2002, CIRC J, V66, P1181, DOI 10.1253/circj.66.1181; MORI H, 1993, CARDIOVASC RES, V27, P192, DOI 10.1093/cvr/27.2.192; Ogura R, 2003, CIRC J, V67, P687; Owa M, 2001, JPN CIRC J, V65, P349, DOI 10.1253/jcj.65.349; Pavin D, 1997, HEART, V78, P509, DOI 10.1136/hrt.78.5.509; POLLICK C, 1988, J AM COLL CARDIOL, V12, P600, DOI 10.1016/S0735-1097(88)80044-5; SCOTT IU, 1995, AM HEART J, V130, P909, DOI 10.1016/0002-8703(95)90096-9; Seth PS, 2003, CARDIOLOGY, V100, P61, DOI 10.1159/000073040; Sharkey SW, 1998, CHEST, V114, P98, DOI 10.1378/chest.114.1.98; Spieker LE, 2002, CIRCULATION, V105, P2817, DOI 10.1161/01.CIR.0000021598.15895.34; Tanedo JS, 2001, CATHETER CARDIO INTE, V53, P459, DOI 10.1002/ccd.1203; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Ueyama T, 2003, J CARDIOVASC PHARM, V42, pS117, DOI 10.1097/00005344-200312001-00024; Ueyama T, 2002, CIRC J, V66, P712, DOI 10.1253/circj.66.712; Yanagi Shiro, 2002, J Cardiol, V39, P305; Yasuga Yuji, 2004, J Cardiol, V43, P75; Yoshikawa D, 1999, ANESTH ANALG, V89, P962; Zaroff JG, 2000, J AM SOC ECHOCARDIOG, V13, P774, DOI 10.1067/mje.2000.105763	41	1048	1119	1	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2004	141	11					858	865		10.7326/0003-4819-141-11-200412070-00010	http://dx.doi.org/10.7326/0003-4819-141-11-200412070-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876WZ	15583228				2022-12-28	WOS:000225530700006
J	Soderblom, LA; Anderson, RC; Arvidson, RE; Bell, JF; Cabrol, NA; Calvin, W; Christensen, PR; Clark, BC; Economou, T; Ehlmann, BL; Farrand, WH; Fike, D; Gellert, R; Glotch, TD; Golombek, MP; Greeley, R; Grotzinger, JP; Herkenhoff, KE; Jerolmack, DJ; Johnson, JR; Jolliff, B; Klingelhofer, G; Knoll, AH; Learner, ZA; Li, R; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Morris, RV; Rice, JW; Richter, L; Rieder, R; Rodionov, D; Schroder, C; Seelos, FP; Soderblom, JM; Squyres, SW; Sullivan, R; Watters, WA; Weitz, CM; Wyatt, MB; Yen, A; Zipfel, J				Soderblom, LA; Anderson, RC; Arvidson, RE; Bell, JF; Cabrol, NA; Calvin, W; Christensen, PR; Clark, BC; Economou, T; Ehlmann, BL; Farrand, WH; Fike, D; Gellert, R; Glotch, TD; Golombek, MP; Greeley, R; Grotzinger, JP; Herkenhoff, KE; Jerolmack, DJ; Johnson, JR; Jolliff, B; Klingelhofer, G; Knoll, AH; Learner, ZA; Li, R; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Morris, RV; Rice, JW; Richter, L; Rieder, R; Rodionov, D; Schroder, C; Seelos, FP; Soderblom, JM; Squyres, SW; Sullivan, R; Watters, WA; Weitz, CM; Wyatt, MB; Yen, A; Zipfel, J			Soils of eagle crater and Meridiani Planum at the Opportunity Rover landing site	SCIENCE			English	Article							X-RAY SPECTROMETER; GUSEV CRATER; MOSSBAUER SPECTROMETER; CHEMICAL-COMPOSITION; PATHFINDER SITE; SPIRIT ROVER; MARS; ROCKS; CHEMISTRY; LOCALIZATION	The soils at the Opportunity site are fine-grained basaltic sands mixed with dust and sulfate-rich outcrop debris. Hematite is concentrated in spherules eroded from the strata. Ongoing saltation exhumes the spherules and their fragments, concentrating them at the surface. Spherules emerge from soils coated, perhaps from subsurface cementation, by salts. Two types of vesicular clasts may represent basaltic sand sources. Eolian ripples, armored by well-sorted hematite-rich grains, pervade Meridiani Planum. The thickness of the soil on the plain is estimated to be about a meter. The flatness and thin cover suggest that the plain may represent the original sedimentary surface.	US Geol Survey, Flagstaff, AZ 86001 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; NASA, Ames SETI Inst, Moffett Field, CA 94035 USA; Univ Nevada, Reno, NV 89557 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Space Sci Inst, Boulder, CO 80301 USA; MIT, Cambridge, MA 02139 USA; Max Planck Inst Chem, D-55128 Mainz, Germany; Johannes Gutenberg Univ Mainz, D-55128 Mainz, Germany; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Malin Space Sci Syst, San Diego, CA 92191 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; DLR Inst Space Simulat, D-51147 Cologne, Germany; Planetary Sci Inst, Tucson, AZ 85719 USA	United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Washington University (WUSTL); Cornell University; National Aeronautics & Space Administration (NASA); Nevada System of Higher Education (NSHE); University of Nevada Reno; Arizona State University; Arizona State University-Tempe; Lockheed Martin; University of Chicago; Massachusetts Institute of Technology (MIT); Max Planck Society; Johannes Gutenberg University of Mainz; Harvard University; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Helmholtz Association; German Aerospace Centre (DLR)	Soderblom, LA (corresponding author), US Geol Survey, Flagstaff, AZ 86001 USA.	lsoderblom@usgs.gov	Schröder, Christian/B-3870-2009; Fike, David A/D-3634-2011; Sullivan, Robert/AAR-8193-2020; Glotch, Timothy/B-6829-2008; Seelos, Frank/C-7875-2016; Johnson, Jeffrey R/F-3972-2015	Schröder, Christian/0000-0002-7935-6039; Fike, David A/0000-0003-2848-0328; Seelos, Frank/0000-0001-9721-941X; Johnson, Jeffrey R/0000-0002-5586-4901; Soderblom, Jason/0000-0003-3715-6407; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; CHRISTENSEN PR, 1988, J GEOPHYS RES-SOLID, V93, P7611, DOI 10.1029/JB093iB07p07611; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; CLARK BC, 1981, ICARUS, V45, P370, DOI 10.1016/0019-1035(81)90041-5; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Golombek MP, 1999, J GEOPHYS RES-PLANET, V104, P8523, DOI 10.1029/98JE02554; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; GREELEY R, 1980, GEOPHYS RES LETT, V7, P121, DOI 10.1029/GL007i002p00121; Greeley R, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002110; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Moore H. J., 1977, Journal of Geophysical Research, V82, P4497, DOI 10.1029/JS082i028p04497; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; SHARP RP, 1963, J GEOL, V71, P617, DOI 10.1086/626936; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645	25	119	120	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1723	1726		10.1126/science.1105127	http://dx.doi.org/10.1126/science.1105127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576606	Green Submitted, Green Published			2022-12-28	WOS:000225630800038
J	Garg, S; Garg, M				Garg, S; Garg, M			Benign hepatic cyst	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Providence Hosp & Med Ctr, Southfield, MI 48075 USA		Garg, S (corresponding author), Providence Hosp & Med Ctr, Southfield, MI 48075 USA.								0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2004	351	23					2428	2428		10.1056/NEJMicm990645	http://dx.doi.org/10.1056/NEJMicm990645			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875OC	15575059				2022-12-28	WOS:000225429000012
J	Kwak, SH; Shen, R; Schiefelbein, J				Kwak, SH; Shen, R; Schiefelbein, J			Positional signaling mediated by a receptor-like kinase in Arabidopsis	SCIENCE			English	Article							EPIDERMAL-CELL DIFFERENTIATION; ROOT EPIDERMIS; THALIANA; GENE; REGULATOR; PROTEIN; FATE	The position-dependent specification of root epidermal cells in Arabidopsis provides an elegant paradigm for cell patterning during development. Here, we describe a new gene, SCRAMBLED (SCM), required for cells to appropriately interpret their location within the developing root epidermis. SCM encodes a receptor-like kinase protein with a predicted extracellular domain of six leucine-rich repeats and an intracellular serine-threonine kinase domain. SCM regulates the expression of the GLABRA2, CAPRICE, WEREWOLF, and ENHANCER OF GLABRA3 transcription factor genes that define the cell fates. Further, the SCM gene is expressed throughout the developing root. Therefore, SCM likely enables developing epidermal cells to detect positional cues and establish an appropriate cell-type pattern.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Schiefelbein, J (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	schiefel@umich.edu						Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Berger F, 1998, DEV BIOL, V194, P235, DOI 10.1006/dbio.1997.8813; DOLAN L, 1994, DEVELOPMENT, V120, P2465; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; GALWAY ME, 1994, DEV BIOL, V166, P740, DOI 10.1006/dbio.1994.1352; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Larkin JC, 2003, ANNU REV PLANT BIOL, V54, P403, DOI 10.1146/annurev.arplant.54.031902.134823; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Scheres B, 2002, CURR BIOL, V12, pR804, DOI 10.1016/S0960-9822(02)01313-1; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111	15	167	174	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1111	1113		10.1126/science.1105373	http://dx.doi.org/10.1126/science.1105373			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15618487				2022-12-28	WOS:000227197300049
J	Watson, M; Kendrick, D; Coupland, C; Woods, A; Futers, D; Robinson, J				Watson, M; Kendrick, D; Coupland, C; Woods, A; Futers, D; Robinson, J			Providing child safety equipment to prevent injuries: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PATIENT EDUCATION; RISK-FACTORS; METAANALYSIS	Objective To assess the effectiveness of safety advice and safety equipment in reducing unintentional injuries for families with children aged under 5 years and living in deprived areas. Design Randomised controlled trial. Setting 47 general practices in Nottingham. Participants 3428 families with children under 5. Intervention A standardised safety consultation and provision of free and fitted stair gates, fire guards, smoke alarms, cupboard locks, and window locks. Main outcome measures Primary outcome measures were whether a child in the family had at least one injury that required medical attendance and rates of attendance in primary and secondary care and of hospital admission for injury over a two year period. Secondary. outcome measures included possession of safety equipment and safety practices. Results No significant difference was found in the proportion of families. in which a child had a medically attended injury (odds ratio 1.14, 95% confidence interval 0.98 to 1.50) or in the rates of attendance in secondary care (incidence rate ratio 1.02, 0.90 to 1.13) or admission to hospital (1.02, 0.70 to 1.48). However, children in the intervention arm had a significantly higher attendance rate for injuries in primary care (1.37, 1.11 to 1.70, P = 0.003). At both one and two years' follow up, families in the intervention arm were significantly more likely to have a range of safety practices, but absolute differences in the percentages were relatively small. Conclusions The intervention resulted in significant improvements in safety practices for up to two years but did not reduce injuries that necessitated medical attendance. Although equipment was provided and fitted free of charge, the observed changes in safety practices may not have been large enough to affect injury rates.	Univ Nottingham, Queens Med Ctr, Sch Nursing, Fac Med & Hlth Sci, Nottingham NG7 2HA, England; Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; Rushcliffe Primary Care Trust, Nottingham NG2 6BT, England; Nottingham City Primary Care Trust, Nottingham Hlth Informat Serv, Nottingham NG1 6GN, England	University of Nottingham; University of Nottingham	Watson, M (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Nursing, Fac Med & Hlth Sci, Nottingham NG7 2HA, England.	michael.watson@nottingham.ac.uk	Mason-Jones, Amanda/ABF-1565-2020; Watson, Michael Craig/B-9331-2008	Mason-Jones, Amanda/0000-0002-4292-3183; Coupland, Carol/0000-0002-2327-3306; Watson, Michael Craig/0000-0003-1628-2746; Kendrick, Denise/0000-0003-3603-6542				ALWASH R, 1988, ARCH DIS CHILD, V63, P635, DOI 10.1136/adc.63.6.635; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Azizi B H, 1994, Med J Malaysia, V49, P132; *BRIT MED ASS, 2001, INJ PREV; Carter Y H, 1995, Inj Prev, V1, P164, DOI 10.1136/ip.1.3.164; Clamp M, 1998, BRIT MED J, V316, P1576, DOI 10.1136/bmj.316.7144.1576; *DEP HLTH, 2002, PREV ACC INJ PRIOR A; DiGuiseppi C, 2000, FUTURE CHILD, V10, P53, DOI 10.2307/1602825; DiGuiseppi C, 1999, ARCH DIS CHILD, V81, P400, DOI 10.1136/adc.81.5.400; DiGuiseppi C, 2000, ARCH DIS CHILD, V82, P341, DOI 10.1136/adc.82.5.341; Elkington J, 1999, NSW PUBLIC HLTH B, V10, P82, DOI DOI 10.1071/NB99037; Hedlund J, 2000, Inj Prev, V6, P82, DOI 10.1136/ip.6.2.82; KENDRICK D, 1994, BRIT J GEN PRACT, V44, P372; Kendrick D, 1999, BRIT MED J, V318, P980, DOI 10.1136/bmj.318.7189.980; Kendrick D, 2001, J EPIDEMIOL COMMUN H, V55, P845, DOI 10.1136/jech.55.11.845; King WJ, 2001, PEDIATRICS, V108, P382, DOI 10.1542/peds.108.2.382; Lovato LC, 1997, CONTROL CLIN TRIALS, V18, P328, DOI 10.1016/S0197-2456(96)00236-X; Lyons RA, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD0036001; Mallia-Milanes V, 2000, J MEDITERR STUD, V10, P1; Mullen PD, 1997, PATIENT EDUC COUNS, V32, P157; MULLEN PD, 1985, PREV MED, V14, P753, DOI 10.1016/0091-7435(85)90070-2; Petridou E, 1998, BURNS, V24, P123, DOI 10.1016/S0305-4179(97)00095-8; Towner E, 2001, WHAT WORKS PREVENTIN; Townsend PP., 1988, HLTH DEPRIVATION INE; VANRIJN OJL, 1991, BURNS, V17, P364, DOI 10.1016/S0305-4179(05)80068-3; Watson M, 2003, INJ PREV, V9, P180, DOI 10.1136/ip.9.2.180; WATSON M, IN PRESS INJURY CONT; Watson M, 2002, COMMUNITY PRACTITION, V75, P172; Watson MC, 1994, PRACT NURS, V5, P20; WOOLF AD, 1992, PEDIATRICS, V90, P867	30	65	67	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2005	330	7484					178	181		10.1136/bmj.38309.664444.8F	http://dx.doi.org/10.1136/bmj.38309.664444.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891OQ	15604156	Green Published, Bronze			2022-12-28	WOS:000226590800019
J	Green, MA; Fry, SC				Green, MA; Fry, SC			Vitamin C degradation in plant cells via enzymatic hydrolysis of 4-O-oxalyl-L-threonate	NATURE			English	Article							L-ASCORBIC-ACID; PELARGONIUM-CRISPUM; TARTARIC-ACIDS; OXALIC-ACID; ELONGATION; METABOLISM; OXALATE; OXIDASE; OXYGEN; OXIDATION	Increasing the L-ascorbate (vitamin C) content of crops could in principle involve promoting its biosynthesis or inhibiting its degradation. Recent progress has revealed biosynthetic pathways for ascorbate(1-3), but the degradative pathways remain unclear. The elucidation of such pathways could promote an understanding of the roles of ascorbate in plants(4), and especially of the intriguing positive correlation between growth rate and ascorbate oxidase(5,6) (or its products(7)). In some plants (Vitaceae), ascorbate is degraded via L-idonate to L-threarate (L-tartrate), with the latter arising from carbons 1-4 of ascorbate(3,8-11). In most plants, however (including Vitaceae)(11), ascorbate degradation can occur via dehydroascorbate, yielding oxalate(12) plus L-threonate, with the latter from carbons 3-6 of ascorbate(3,10,13). The metabolic steps between ascorbate and oxalate/L-threonate, and their subcellular location, were unknown. Here we show that this pathway operates extracellularly in cultured Rosa cells, proceeds via several novel intermediates including 4-O-oxalyl-L-threonate, and involves at least one new enzyme activity. The pathway can also operate non-enzymatically, potentially accounting for vitamin losses during cooking. Several steps in the pathway may generate peroxide; this may contribute to the role of ascorbate as a pro-oxidant(14,15) that is potentially capable of loosening the plant cell wall and/or triggering an oxidative burst.	Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh Cell Wall Grp, Edinburgh EH9 3JH, Midlothian, Scotland	University of Edinburgh	Fry, SC (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh Cell Wall Grp, Daniel Rutherford Bldg,Kings Bldg, Edinburgh EH9 3JH, Midlothian, Scotland.	S.Fry@Ed.Ac.UK						Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Asard H., 2004, VITAMIN C FUNCTION B; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; DeBolt S, 2004, AUST J GRAPE WINE R, V10, P134, DOI 10.1111/j.1755-0238.2004.tb00016.x; Dekker AO, 1940, J AM CHEM SOC, V62, P2165, DOI 10.1021/ja01865a070; Deutsch JC, 1998, ANAL BIOCHEM, V265, P238, DOI 10.1006/abio.1998.2940; Dumville JC, 2003, PLANTA, V217, P951, DOI 10.1007/s00425-003-1061-0; Fry SC, 1998, BIOCHEM J, V332, P507, DOI 10.1042/bj3320507; FRY SC, 1980, PLANT PHYSIOL, V65, P472, DOI 10.1104/pp.65.3.472; Fry SC., 2000, GROWING PLANT CELL W; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HELSPER JP, 1982, PLANT PHYSIOL, V69, P1365, DOI 10.1104/pp.69.6.1365; HIDALGO A, 1991, BOT GAZ, V152, P282, DOI 10.1086/337891; Keates SE, 2000, PHYTOCHEMISTRY, V53, P433, DOI 10.1016/S0031-9422(99)00448-3; LANE BG, 1993, J BIOL CHEM, V268, P12239; LIN LS, 1991, PLANT PHYSIOL, V96, P159, DOI 10.1104/pp.96.1.159; OFFORD RE, 1966, NATURE, V211, P591, DOI 10.1038/211591a0; Pignocchi C, 2003, PLANT PHYSIOL, V132, P1631, DOI 10.1104/pp.103.022798; Plochl M, 2000, PLANTA, V210, P454, DOI 10.1007/PL00008153; Podmore ID, 1998, NATURE, V392, P559, DOI 10.1038/33308; Rodriguez AA, 2002, PLANT PHYSIOL, V129, P1627, DOI 10.1104/pp.001222; SAITO K, 1992, PHYTOCHEMISTRY, V31, P1219, DOI 10.1016/0031-9422(92)80264-F; SAITO K, 1984, PLANT PHYSIOL, V76, P170, DOI 10.1104/pp.76.1.170; Saito K, 1997, PHYTOCHEMISTRY, V44, P805, DOI 10.1016/S0031-9422(96)00642-5; Schopfer P, 2001, PLANT J, V28, P679, DOI 10.1046/j.1365-313x.2001.01187.x; Smirnoff N, 1996, ANN BOT-LONDON, V78, P661, DOI 10.1006/anbo.1996.0175; TAKAHAMA U, 1993, PHYSIOL PLANTARUM, V89, P791, DOI 10.1111/j.1399-3054.1993.tb05286.x; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; WILLIAMS M, 1978, PLANT PHYSIOL, V61, P672, DOI 10.1104/pp.61.4.672; YANG JC, 1975, PLANT PHYSIOL, V56, P283, DOI 10.1104/pp.56.2.283	30	202	221	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2005	433	7021					83	87		10.1038/nature03172	http://dx.doi.org/10.1038/nature03172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	884WJ	15608627				2022-12-28	WOS:000226117100040
J	Halloran, PF				Halloran, PF			Immunosuppressive drugs for kidney transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RENAL-ALLOGRAFT REJECTION; STEROID-FREE IMMUNOSUPPRESSION; ACUTE CELLULAR REJECTION; MYCOPHENOLATE-MOFETIL; MONOCLONAL-ANTIBODY; RANDOMIZED-TRIAL; SPHINGOSINE 1-PHOSPHATE; IMMUNOLOGICAL SYNAPSE; DIABETES-MELLITUS; GRAFT-SURVIVAL		Univ Alberta, Div Nephrol & Transplantat Immunol, Edmonton, AB, Canada	University of Alberta	Halloran, PF (corresponding author), 250 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.	phil.halloran@ualberta.ca	Halloran, Philip F/J-1390-2012	Halloran, Philip F/0000-0003-1371-1947				Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Ahsan N, 2001, TRANSPLANTATION, V72, P245, DOI 10.1097/00007890-200107270-00014; ALLISON AC, 1975, LANCET, V2, P1179; Auchincloss H, 2001, AM J TRANSPLANT, V1, P6, DOI 10.1034/j.1600-6143.2001.010103.x; BATIUK TD, 1995, TRANSPLANTATION, V59, P1400, DOI 10.1097/00007890-199505270-00007; Becker YT, 2004, AM J TRANSPLANT, V4, P996, DOI 10.1111/j.1600-6143.2004.00454.x; Behbod F, 2001, J IMMUNOL, V166, P3724, DOI 10.4049/jimmunol.166.6.3724; Biedermann BC, 1998, J IMMUNOL, V161, P4679; Blum CB, 2002, AM J TRANSPLANT, V2, P551, DOI 10.1034/j.1600-6143.2002.20610.x; BOGMAN MJJT, 1989, LANCET, V2, P235; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Brennan DC, 1999, TRANSPLANTATION, V67, P1011, DOI 10.1097/00007890-199904150-00013; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brinkmann V, 2002, CURR OPIN IMMUNOL, V14, P569, DOI 10.1016/S0952-7915(02)00374-6; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Budde K, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341073; BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110; Calne R, 1998, LANCET, V352, P408; Cattaneo D, 2004, AM J TRANSPLANT, V4, P299, DOI 10.1111/j.1600-6143.2004.00312.x; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Clase CM, 2002, AM J TRANSPLANT, V2, P789, DOI 10.1034/j.1600-6143.2002.20814.x; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Cole E, 2003, TRANSPLANTATION, V75, P2086, DOI 10.1097/01.TP.0000068868.01424.61; Cole E, 2001, TRANSPLANTATION, V72, P845, DOI 10.1097/00007890-200109150-00018; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; Dharnidharka VR, 2004, AM J TRANSPLANT, V4, P384, DOI 10.1111/j.1600-6143.2004.00350.x; Eisen HJ, 2003, NEW ENGL J MED, V349, P847, DOI 10.1056/NEJMoa022171; ELION GB, 1993, ANN NY ACAD SCI, V685, P401, DOI 10.1111/j.1749-6632.1993.tb35897.x; Feucht HE, 2003, AM J TRANSPLANT, V3, P646, DOI 10.1034/j.1600-6143.2003.00171.x; Flechner SM, 2002, TRANSPLANTATION, V74, P1070, DOI 10.1097/00007890-200210270-00002; FLOREY HW, 1946, LANCET, V250, P46; Fredericks Salim, 2003, Am J Pharmacogenomics, V3, P291, DOI 10.2165/00129785-200303050-00001; Fritsche L, 2004, AM J TRANSPLANT, V4, P738, DOI 10.1111/j.1600-6143.2004.00431.x; Fritsche L, 2004, AM J TRANSPLANT, V4, P130, DOI 10.1046/j.1600-6135.2003.00279.x; Gabardi S, 2003, ANN PHARMACOTHER, V37, P1685, DOI 10.1345/aph.1D063; GIBLETT ER, 1972, LANCET, V2, P1067; GOLDSTEIN G, 1985, NEW ENGL J MED, V313, P337; Gonwa T, 2003, TRANSPLANTATION, V75, P1213, DOI 10.1097/01.TP.0000062837.99400.60; Gosio B., 1896, RIV DIGIENE SANITA P, V7, P825; GOTO T, 1987, J AM CHEM SOC, V109, P5031; Gourishankar S, 2003, J AM SOC NEPHROL, V14, P2387, DOI 10.1097/01.ASN.0000085019.95339.F0; Gregoor PJHS, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013298.11876.BF; GRINYO J, 1995, LANCET, V345, P1321; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Halloran P, 1997, TRANSPLANTATION, V63, P39, DOI 10.1097/00007890-199701150-00008; Halloran P, 1997, TRANSPLANTATION, V63, P618; Halloran PF, 2004, AM J TRANSPLANT, V4, P705, DOI 10.1111/j.1600-6143.2004.00421.x; HALLORAN PF, 1990, TRANSPLANTATION, V49, P85, DOI 10.1097/00007890-199001000-00019; Halloran PF, 2002, AM J TRANSPLANT, V2, P195, DOI 10.1034/j.1600-6143.2002.20301.x; Halloran PF, 1999, J AM SOC NEPHROL, V10, P167; Hardinger KL, 2002, AM J TRANSPLANT, V2, P867, DOI 10.1034/j.1600-6143.2002.20909.x; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Hariharan S, 2003, AM J TRANSPLANT, V3, P933, DOI 10.1034/j.1600-6143.2003.00176.x; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hricik DE, 2002, AM J TRANSPLANT, V2, P19, DOI 10.1034/j.1600-6143.2002.020105.x; Johnson RWG, 2001, TRANSPLANTATION, V72, P777, DOI 10.1097/00007890-200109150-00007; Kahan BD, 2003, TRANSPLANTATION, V76, P1079, DOI 10.1097/01.TP.0000084822.01372.AC; Kahan BD, 1999, TRANSPLANTATION, V67, P276, DOI 10.1097/00007890-199901270-00016; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Karin M, 1998, CELL, V93, P487, DOI 10.1016/S0092-8674(00)81177-0; Kasiske B, 2004, AM J TRANSPLANT, V4, P13, DOI 10.1111/j.1600-6135.2004.0355.x; Kasiske BL, 2004, AM J TRANSPLANT, V4, P905, DOI 10.1111/j.1600-6143.2004.00450.x; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Kazatchkine M D, 2000, Mult Scler, V6 Suppl 2, pS24; Keown P, 1996, TRANSPLANTATION, V61, P1029; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; Kirk AD, 2003, TRANSPLANTATION, V76, P120, DOI 10.1097/01.TP.0000071362.99021.D9; Knechtle SJ, 2003, AM J TRANSPLANT, V3, P722, DOI 10.1034/j.1600-6143.2003.00120.x; Kobashigawa J, 1998, TRANSPLANTATION, V66, P507, DOI 10.1097/00007890-199808270-00016; Kreis H, 2000, TRANSPLANTATION, V69, P1252, DOI 10.1097/00007890-200004150-00009; Lakkis FG, 2000, NAT MED, V6, P686, DOI 10.1038/76267; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; LOMBARDI G, 1990, INT IMMUNOL, V2, P9, DOI 10.1093/intimm/2.1.9; MacDonald AS, 2001, TRANSPLANTATION, V71, P271, DOI 10.1097/00007890-200101270-00019; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; MacPhee IAM, 2004, AM J TRANSPLANT, V4, P914, DOI 10.1111/j.1600-6143.2004.00435.x; Macphee IAM, 2002, TRANSPLANTATION, V74, P1486, DOI 10.1097/00007890-200212150-00002; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matas AJ, 2003, AM J TRANSPLANT, V3, P1465, DOI 10.1046/j.1600-6135.2003.00285.x; Matthews JB, 2003, AM J TRANSPLANT, V3, P794, DOI 10.1046/j.1600-6135.2003.0154.x; McAlister VC, 2000, LANCET, V355, P376, DOI 10.1016/S0140-6736(99)03882-9; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Meier-Kriesche HU, 2003, AM J TRANSPLANT, V3, P68, DOI 10.1034/j.1600-6143.2003.30112.x; Meier-Kriesche HU, 2002, AM J TRANSPLANT, V2, P100, DOI 10.1034/j.1600-6143.2002.020116.x; MITSUI A, 1969, J ANTIBIOT, V22, P358, DOI 10.7164/antibiotics.22.358; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Morris R.E., 1992, TRANSPLANT REV-ORLAN, P39; Nashan B, 1997, LANCET, V350, P1484; Nashan B, 1997, LANCET, V350, P1193, DOI 10.1016/S0140-6736(97)09278-7; Nashan B, 1999, TRANSPLANTATION, V67, P110, DOI 10.1097/00007890-199901150-00019; NEUHAUS P, 1994, LANCET, V344, P423; Nickeleit V, 2000, NEW ENGL J MED, V342, P1309, DOI 10.1056/NEJM200005043421802; NORMAN DJ, 1993, TRANSPLANTATION, V55, P44, DOI 10.1097/00007890-199301000-00009; Norman DJ, 2000, TRANSPLANTATION, V70, P1707, DOI 10.1097/00007890-200012270-00008; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Opelz G, 2004, AM J TRANSPLANT, V4, P222, DOI 10.1046/j.1600-6143.2003.00325.x; Oz HS, 1997, J INFECT DIS, V175, P901, DOI 10.1086/513988; Port FK, 2003, AM J TRANSPLANT, V3, P7, DOI 10.1034/j.1600-6143.3.s4.2.x; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Robertson H, 2004, J AM SOC NEPHROL, V15, P390, DOI 10.1097/01.ASN.0000108521.39082.E1; ROSENBERG AS, 1992, ANNU REV IMMUNOL, V10, P333, DOI 10.1146/annurev.immunol.10.1.333; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sarwal M, 2003, NEW ENGL J MED, V349, P125, DOI 10.1056/NEJMoa035588; SCHWARTZ R, 1959, NATURE, V183, P1682, DOI 10.1038/1831682a0; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SCHWARTZ SM, 1996, J HYPERTENS        S, V14, P71; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sharples LD, 2002, J HEART LUNG TRANSPL, V21, P271, DOI 10.1016/S1053-2498(01)00360-6; SOLLINGER HW, 1995, TRANSPLANTATION, V60, P225, DOI 10.1097/00007890-199508000-00003; Stalder M, 2003, J HEART LUNG TRANSPL, V22, P1343, DOI 10.1016/S1053-2498(03)00033-0; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P385; Starzl TE, 2003, LANCET, V361, P1502, DOI 10.1016/S0140-6736(03)13175-3; Stewart KC, 2001, AM J TRANSPLANT, V1, P204, DOI 10.1034/j.1600-6143.2001.001003204.x; SWINNEN LJ, 1990, NEW ENGL J MED, V323, P1723, DOI 10.1056/NEJM199012203232502; Terasaki PI, 2003, AM J TRANSPLANT, V3, P665, DOI 10.1034/j.1600-6143.2003.00135.x; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; *US REN DAT SYST, 2003, USRDS 2003 ANN DAT R; Vanrenterghem Y, 2003, AM J TRANSPLANT, V3, P835, DOI 10.1034/j.1600-6143.2003.00133.x; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Vincenti F, 2002, AM J TRANSPLANT, V2, P898, DOI 10.1034/j.1600-6143.2002.21005.x; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Warren DS, 2004, AM J TRANSPLANT, V4, P561, DOI 10.1111/j.1600-6143.2004.00364.x; Zhou P, 2003, AM J TRANSPLANT, V3, P259, DOI 10.1034/j.1600-6143.2003.00067.x	126	1031	1067	1	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2715	2729		10.1056/NEJMra033540	http://dx.doi.org/10.1056/NEJMra033540			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616206				2022-12-28	WOS:000225877300007
J	Gollapudi, RR; Teirstein, PS; Stevenson, DD; Simon, RA				Gollapudi, RR; Teirstein, PS; Stevenson, DD; Simon, RA			Aspirin sensitivity - Implications for patients with coronary artery disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PRACTICE GUIDELINES COMMITTEE; ASSOCIATION TASK-FORCE; ST-SEGMENT ELEVATION; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; ACC/AHA GUIDELINES; AMERICAN-COLLEGE; ORAL CHALLENGE; INDUCED ASTHMA; PREVENTION	Context Although acetylsalicylic acid (aspirin) is commonly used for patients with chronic cardiovascular disease, a minority of patients have a sensitivity to acetylsalicylic acid and other nonsteroidal anti-inflammatory drugs. Objective To provide a diagnostic strategy for evaluating and treating patients with aspirin sensitivity, with additional consideration for issues specific to patients with coronary artery disease (CAD). Evidence Acquisition Published articles were identified through a search of MEDLINE and the Cochrane databases using the dates 1966 to June 2004 and the search terms aspirin allergy, coronary artery disease, aspirin desensitization, and aspirin sensitivity. References of retrieved articles were also reviewed for pertinent studies. Articles were included in this review if they were controlled studies, published in the English language, and appeared in a peer-reviewed journal. Evidence Synthesis The prevalence of aspirin-exacerbated respiratory tract disease is approximately 10% and for aspirin-induced urticaria the prevalence varies from 0.07% to 0.2% of the general population. Aspirin sensitivity is most often manifested as rhinitis and asthma or urticaria/angioedema induced by cross-reacting nonsteroidal anti-inflammatory drugs that inhibit cyclooxygenase 1. The primary mechanism of sensitivity is less often related to drug-specific IgE antibody production leading to urticaria/angioedema and rarely to anaphylaxis. Most patients with acetylsalicylic acid sensitivity are able to undergo desensitization therapy safely and successfully except in cases of chronic idiopathic urticaria. However, there have not been any randomized trials that specifically focus on the efficacy of aspirin desensitization. Furthermore, experience with acetylsalicylic acid desensitization in patients with CAD is very limited. After successful desensitization, acetylsalicylic acid therapy must be indefinitely continued to prevent resensitization. Conclusions Acetylsalicylic acid sensitivity is common and desensitization can be performed safely in many patients. Large-scale trials are warranted to determine the safety and efficacy of acetylsalicylic acid desensitization therapy in patients with concomitant CAD because data are currently limited to small case series.	Scripps Clin, Div Allergy Asthma & Immunol, La Jolla, CA 92037 USA; Scripps Clin, Div Cardiovasc Dis, La Jolla, CA 92037 USA; Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Simon, RA (corresponding author), Scripps Clin, Div Allergy Asthma & Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rsimon@scrippsclinic.com						[Anonymous], 2003, J AM COLL CARDIOL, V41, P159; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BLANCA M, 1989, ANN ALLERGY, V62, P295; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; DOEGLAS HMG, 1975, BRIT J DERMATOL, V93, P135, DOI 10.1111/j.1365-2133.1975.tb06732.x; Fahrenholz JM, 2003, CLIN REV ALLERG IMMU, V24, P113, DOI 10.1385/CRIAI:24:2:113; Gaspoz J, 2002, NEW ENGL J MED, V346, P1800, DOI 10.1056/NEJM200206063462309; Grattan CEH, 2003, CLIN EXP DERMATOL, V28, P123, DOI 10.1046/j.1365-2230.2003.01228.x; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Jenkins C, 2004, BMJ-BRIT MED J, V328, P434, DOI 10.1136/bmj.328.7437.434; Machraoui A, 2001, J Invasive Cardiol, V13, P431; MATHISON D A, 1982, Journal of Allergy and Clinical Immunology, V69, P135; MCDONALD JR, 1972, J ALLERGY CLIN IMMUN, V50, P198, DOI 10.1016/0091-6749(72)90014-0; Mehran R, 2003, CIRCULATION, V108, P1078, DOI 10.1161/01.CIR.0000086347.31341.F9; MOOREROB.M, 1967, BRIT MED J, V4, P262, DOI 10.1136/bmj.4.5574.262; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Namazy JA, 2002, ANN ALLERG ASTHMA IM, V89, P542, DOI 10.1016/S1081-1206(10)62099-6; PLESKOW WW, 1982, J ALLERGY CLIN IMMUN, V69, P11, DOI 10.1016/0091-6749(82)90081-1; RAMANUJA S, 2004, CIRCULATION, V6, P110; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Schaefer OP, 1999, CARDIOLOGY, V91, P8, DOI 10.1159/000006871; Simon RA, 2003, CLIN REV ALLERG IMMU, V24, P189, DOI 10.1385/CRIAI:24:2:189; Solensky R, 2004, IMMUNOL ALLERGY CLIN, V24, P425, DOI 10.1016/j.iac.2004.03.008; SOLENSKY R, 2004, ALLERGENS ALLERGEN I, P585; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stevenson DD, 2001, J ALLERGY CLIN IMMUN, V108, P47, DOI 10.1067/mai.2001.116290; Stevenson DD, 2004, IMMUNOL ALLERGY CLIN, V24, P491, DOI 10.1016/j.iac.2004.03.001; Stevenson DD, 2003, MIDDLETONS ALLERGY P, P1695; Szczeklik A, 2003, J ALLERGY CLIN IMMUN, V111, P913, DOI 10.1067/mai.2003.1487; Tendera M, 2003, THROMB RES, V110, P355, DOI 10.1016/j.thromres.2003.08.003; Wong JT, 2000, J ALLERGY CLIN IMMUN, V105, P997, DOI 10.1067/mai.2000.104571; Yusuf S, 2001, NEW ENGL J MED, V345, P494	33	113	118	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					3017	3023		10.1001/jama.292.24.3017	http://dx.doi.org/10.1001/jama.292.24.3017			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613671	Bronze			2022-12-28	WOS:000225841900037
J	Pollitt, RJ; Sharrard, MJ				Pollitt, RJ; Sharrard, MJ			Treating rare inborn errors of metabolism	LANCET			English	Editorial Material							DEHYDROGENASE-DEFICIENCY		Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital	Pollitt, RJ (corresponding author), Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England.	Rodney.Pollitt@sch.nhs.uk						ALLAN JD, 1958, LANCET, V1, P182; Bonham JR, 1999, J INHERIT METAB DIS, V22, P174, DOI 10.1023/A:1005406205548; Clayton PT, 2003, LANCET, V361, P1614, DOI 10.1016/S0140-6736(03)13312-0; Dezateux C, 1998, BRIT MED BULL, V54, P877; Jaeken J, 1996, J INHERIT METAB DIS, V19, P223, DOI 10.1007/BF01799435; Lilford RJ, 1995, BMJ-BRIT MED J, V311, P1621, DOI 10.1136/bmj.311.7020.1621; MILLS PB, 2004, J INHERIT METAB DIS, V27, P244; Parker M, 2004, BRIT MED J, V329, P288, DOI 10.1136/bmj.329.7460.288; Pollitt RJ, 1999, ACTA PAEDIATR, V88, P110, DOI 10.1080/080352599750029538; Van Hove JLK, 2003, LANCET, V361, P1433, DOI 10.1016/S0140-6736(03)13105-4	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2004	364	9452					2158	2160		10.1016/S0140-6736(04)17606-X	http://dx.doi.org/10.1016/S0140-6736(04)17606-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610786				2022-12-28	WOS:000225799700006
J	Scott, T; Stanford, N; Thompson, DR				Scott, T; Stanford, N; Thompson, DR			Killing me softly: myth in pharmaceutical advertising	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADVERTISEMENTS		Univ St Andrews, Sch Management, St Andrews KY16 9AJ, Fife, Scotland; Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Chinese Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of St Andrews; University of York - UK; Chinese University of Hong Kong	Scott, T (corresponding author), Univ St Andrews, Sch Management, St Andrews KY16 9AJ, Fife, Scotland.	jts1@st-andrews.ac.uk	Thompson, David R/E-2431-2018; Thompson, David R/C-6320-2009	Thompson, David R/0000-0001-8518-6307; 				Barthes Roland, 1993, MYTHOLOGIES; Baudrillard Jean., 1970, SOC CONSOMMATION; Derrida Jacques., 1981, DISSEMINATION; FARRELL L, 2000, BRIT MED J, V321, P578; GOLDMAN R, 1986, SOC SCI MED, V22, P1047, DOI 10.1016/0277-9536(86)90205-4; HUTCHEON L, 1987, QUEENS QUART, V94, P904; LANDGREN FT, 1988, MED J AUSTRALIA, V149, P595, DOI 10.5694/j.1326-5377.1988.tb120797.x; LEXCHIN J, DRUG PROMOTION DATAB; Mansfield P R, 1991, Int J Risk Saf Med, V2, P171, DOI 10.3233/JRS-1991-2401; Mansfield PR, 2003, MED J AUSTRALIA, V179, P644, DOI 10.5694/j.1326-5377.2003.tb05730.x; MANSFIELD PR, 2003, HLTH SKEPTICISM INT, V1, P10; Morgan S, 2000, HEALTH ECON, V9, P659, DOI 10.1002/1099-1050(200012)9:8<659::AID-HEC578>3.0.CO;2-0; Saussure F. de., 1983, COURSE GEN LINGUISTI; SCOTT DK, 1994, BRIT J CLIN PHARMACO, V37, P217, DOI 10.1111/j.1365-2125.1994.tb04265.x; Sontag S, 2002, ILLNESS METAPHOR AID; STIMSON GV, 1975, J COMMUN, V25, P153, DOI 10.1111/j.1460-2466.1975.tb00618.x; Sutherland Max, 1993, ADVERTISING MIND CON; WADE VA, 1989, LANCET, V2, P1261; WILKES MS, 1992, ANN INTERN MED, V116, P912, DOI 10.7326/0003-4819-116-11-912	19	15	17	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1484	1487		10.1136/bmj.329.7480.1484	http://dx.doi.org/10.1136/bmj.329.7480.1484			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604192	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000225965800035
J	Zambon, MC				Zambon, MC			Ethics versus evidence in influenza vaccination	LANCET			English	Editorial Material									Hlth Protect Agcy Ctr Infect, Virus Reference Lab, London NW9 5HT, England	Health Protection Agency	Zambon, MC (corresponding author), Hlth Protect Agcy Ctr Infect, Virus Reference Lab, London NW9 5HT, England.	maria.zambon@hpa.org.uk						*CDCP, 2004, INT EST POP TARG INF; DONALDSON L, 2004, UPDATE INFLUENZA PNE; Fedson DS, 2003, CLIN INFECT DIS, V36, P1552, DOI 10.1086/375056; Fleming D M, 2000, Commun Dis Public Health, V3, P32; GIBBENS A, 1999, REITH LECT, V2; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; HARRIS G, 2004, NY TIMES        1028, P18; IRISH C, 1998, HLTH TRENDS, V30, P51; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Mitka M, 2004, JAMA-J AM MED ASSOC, V292, P1670, DOI 10.1001/jama.292.14.1670; PIEDRA PA, 2004, VACCINE         1102; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; SAINSBURY J, 2001, PLC ARCH FARE SHARES; Stephenson I, 2002, Commun Dis Public Health, V5, P247; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor J, 2004, NEW ENGL J MED, V351, P2037, DOI 10.1056/NEJMp048290; van Essen GA, 2003, VACCINE, V21, P1780, DOI 10.1016/S0264-410X(03)00072-0; WILSON LE, 2004, EUR VIR C MADR SEP; 2001, MMWR MORBID MORTAL W, V50, P582	19	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2004	364	9452					2161	2163		10.1016/S0140-6736(04)17608-3	http://dx.doi.org/10.1016/S0140-6736(04)17608-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610788				2022-12-28	WOS:000225799700008
J	Li, Z; Okamoto, K; Hayashi, Y; Sheng, M				Li, Z; Okamoto, K; Hayashi, Y; Sheng, M			The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses	CELL			English	Article							FLUORESCENT PROTEIN; MORPHOLOGY; OPA1; ORGANIZATION; INHERITANCE; PARKINSONS; MECHANISMS; MACHINERY; TRANSPORT; DYNAMICS	The proper intracellular distribution of mitochondria is assumed to be critical for normal physiology of neuronal cells, but direct evidence for this idea is lacking. Extension or movement of mitochondria into dendritic protrusions correlates with the development and morphological plasticity of spines. Molecular manipulations of dynamin-like GTPases Drp1 and OPA1 that reduce dendritic mitochondria content lead to loss of synapses and dendritic spines, whereas increasing dendritic mitochondrial content or mitochondrial activity enhances the number and plasticity of spines and synapses. Thus, the dendritic distribution of mitochondria is essential and limiting for the support of synapses. Reciprocally, synaptic activity modulates the motility and fusion/fission balance of mitochondria and controls mitochondrial distribution in dendrites.	MIT, Picower Ctr Learning & Memory, RIKEN, Ctr Res Neurosci, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sheng, M (corresponding author), MIT, Picower Ctr Learning & Memory, RIKEN, Ctr Res Neurosci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msheng@mit.edu	Hayashi, Yasunori/AAF-1408-2019; Li, Zheng/I-8016-2014; Hayashi, Yasunori/C-2249-2008; Okamoto, Kenichi/E-4582-2013	Hayashi, Yasunori/0000-0002-7560-3004; Li, Zheng/0000-0002-2978-2531; Hayashi, Yasunori/0000-0002-7560-3004; Okamoto, Kenichi/0000-0001-9527-2444	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS046126] Funding Source: NIH RePORTER; NINDS NIH HHS [F32-NS046126] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS I, 1982, BRAIN RES, V239, P349, DOI 10.1016/0006-8993(82)90514-5; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; CAMERON HA, 1991, SYNAPSE, V8, P107, DOI 10.1002/syn.890080205; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Inoue A, 2003, CURR OPIN NEUROBIOL, V13, P332, DOI 10.1016/S0959-4388(03)00077-1; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; MORRIS RL, 1993, J CELL SCI, V104, P917; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Overly CC, 1996, J CELL SCI, V109, P971; Perkins GA, 2001, J NEUROSCI RES, V66, P857, DOI 10.1002/jnr.10050; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Rintoul GL, 2003, J NEUROSCI, V23, P7881; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; Rowland KC, 2000, J NEUROSCI, V20, P9135; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333; Walsh B, 2001, J PHYSIOL-LONDON, V537, P971; Westermann B, 2002, EMBO REP, V3, P527, DOI 10.1093/embo-reports/kvf113; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Yoon Y, 2001, CURR BIOL, V11, pR67, DOI 10.1016/S0960-9822(01)00011-2	38	1060	1083	2	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					873	887		10.1016/j.cell.2004.11.003	http://dx.doi.org/10.1016/j.cell.2004.11.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607982	Bronze			2022-12-28	WOS:000225907200016
J	de Moura, CGG; de Souza, SP				de Moura, CGG; de Souza, SP			"Shoulder pad'' sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hosp Santo Antonio, BR-40420000 Salvador, BA, Brazil		de Moura, CGG (corresponding author), Hosp Santo Antonio, BR-40420000 Salvador, BA, Brazil.								0	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					E23	E23		10.1056/ENEJMicm040061	http://dx.doi.org/10.1056/ENEJMicm040061			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602014				2022-12-28	WOS:000225726100012
J	Jenkyns, HC; Forster, A; Schouten, S; Damste, JSS				Jenkyns, HC; Forster, A; Schouten, S; Damste, JSS			High temperatures in the Late Cretaceous Arctic Ocean	NATURE			English	Article							SEA-SURFACE TEMPERATURES; HIGH-LATITUDES; ALPHA RIDGE; BLACK MUD; WARM; ISOTOPE	To understand the climate dynamics of the warm, equable greenhouse world of the Late Cretaceous period, it is important to determine polar palaeotemperatures. The early palaeoceanographic history of the Arctic Ocean has, however, remained largely unknown, because the sea floor and underlying deposits are usually inaccessible beneath a cover of floating ice. A shallow piston core taken from a drifting ice island in 1970 fortuitously retrieved unconsolidated Upper Cretaceous organic-rich sediment from Alpha ridge(1-4), a submarine elevated feature of probable oceanic origin(5). A lack of carbonate in the sediments from this core has prevented the use of traditional oxygenisotope palaeothermometry. Here we determine Arctic palaeotemperatures from these Upper Cretaceous deposits using TEX86, a new palaeothermometer that is based on the composition of membrane lipids derived from a ubiquitous component of marine plankton, Crenarchaeota(6). From these analyses we infer an average sea surface temperature of similar to15 degreesC for the Arctic Ocean about 70 million years ago(7). This calibration point implies an Equator-to-pole gradient in sea surface temperatures of similar to15degreesC during this interval and, by extrapolation, we suggest that polar waters were generally warmer than 20 degreesC during the middle Cretaceous (similar to90 million years ago).	Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Texel, Netherlands	University of Oxford; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Jenkyns, HC (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	hughj@earth.ox.ac.uk	Damste, Jaap S Sinninghe/F-6128-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854; Jenkyns, Hugh/0000-0002-2728-0984				Barrera E, 1999, GEOL S AM S, P245; BARRETT KE, 1985, J INVEST DERMATOL, V84, P22, DOI 10.1111/1523-1747.ep12274607; BARRON EJ, 1983, EARTH-SCI REV, V19, P305, DOI 10.1016/0012-8252(83)90001-6; Bukry D., 1985, INITIAL GEOLOGICAL R, P125; Clark DL, 1986, PALEOCEANOGRAPHY, V1, P265, DOI 10.1029/PA001i003p00265; Clark DL, 1988, PALEOCEANOGRAPHY, V3, P539, DOI 10.1029/PA003i005p00539; Clarke LJ, 1999, GEOLOGY, V27, P699, DOI 10.1130/0091-7613(1999)027<0699:NOIEFL>2.3.CO;2; Damste JSS, 2004, SCIENCE, V304, P584, DOI 10.1126/science.1096806; DELLAGNESE DJ, 1994, J PALEONTOL, V68, P31, DOI 10.1017/S0022336000025580; Firth JV, 1998, MAR MICROPALEONTOL, V34, P1, DOI 10.1016/S0377-8398(97)00046-7; GRADSTEIN FM, 1994, J GEOPHYS RES-SOL EA, V99, P24051, DOI 10.1029/94JB01889; Hay W.W., 1993, EVOLUTION W INTERIOR, P297; Herman AB, 1996, NATURE, V380, P330, DOI 10.1038/380330a0; Holba AG, 1998, ORG GEOCHEM, V29, P1269, DOI 10.1016/S0146-6380(98)00184-3; Huber BT, 1998, SCIENCE, V282, P2199, DOI 10.1126/science.282.5397.2199; HUBER BT, 1995, GEOL SOC AM BULL, V107, P1164, DOI 10.1130/0016-7606(1995)107<1164:MLCCOT>2.3.CO;2; JENKYNS HC, 1994, GEOL MAG, V131, P1, DOI 10.1017/S0016756800010451; Jokat W, 2003, GEOPHYS J INT, V152, P185, DOI 10.1046/j.1365-246X.2003.01839.x; KITCHELL JA, 1982, PALAEOGEOGR PALAEOCL, V40, P135, DOI 10.1016/0031-0182(82)90087-6; Morton F, 1987, FRUITS WARM CLIMATES; MUDIE PJ, 1985, INITIAL GEOLOGICAL R, P148; MUDIE PJ, 1985, INITIAL GEOLOGICAL R, P59; Nathorst AG., 1890, KONGL SVENSKA VETENS, V24, P2; Schouten S, 2004, ORG GEOCHEM, V35, P567, DOI 10.1016/j.orggeochem.2004.01.012; Schouten S, 2003, GEOLOGY, V31, P1069, DOI 10.1130/G19876.1; Schouten S, 2002, EARTH PLANET SC LETT, V204, P265, DOI 10.1016/S0012-821X(02)00979-2; SPICER RA, 1990, J GEOL SOC LONDON, V147, P329, DOI 10.1144/gsjgs.147.2.0329; STOFFYNEGLI P, 1987, GEO-MAR LETT, V7, P223, DOI 10.1007/BF02242775; Tarduno JA, 1998, SCIENCE, V282, P2241, DOI 10.1126/science.282.5397.2241; Wilson PA, 1996, GEOLOGY, V24, P555, DOI 10.1130/0091-7613(1996)024<0555:ESSTFT>2.3.CO;2; WUCHTER C, IN PRESS PALEOCEANOG	31	226	241	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					888	892		10.1038/nature03143	http://dx.doi.org/10.1038/nature03143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602558				2022-12-28	WOS:000225733500049
J	Valdes-Socin, H; Salvi, R; Daly, AF; Gaillard, RC; Quatresooz, P; Tebeu, P; Pralong, FP; Beckers, A				Valdes-Socin, H; Salvi, R; Daly, AF; Gaillard, RC; Quatresooz, P; Tebeu, P; Pralong, FP; Beckers, A			Brief report: Hypogonadism in a patient with a mutation in the luteinizing hormone beta-subunit gene	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOLLICLE-STIMULATING-HORMONE; HUMAN CHORIONIC-GONADOTROPIN; TESTOSTERONE; SUBSTITUTION; INFERTILITY; DEFICIENCY; LUTROPIN; PUBERTY; CELLS; MICE	A 30-year-old man who presented with delayed puberty and infertility was found to have hypogonadism associated with an absence of circulating luteinizing hormone. The patient had a homozygous missense mutation in the gene that encodes the beta subunit of luteinizing hormone (Gly36Asp), a mutation that disrupted a vital cystine knot motif and abrogated the heterodimerization and secretion of luteinizing hormone. Treatment with human chorionic gonadotropin increased circulating testosterone, promoted virilization, and was associated with the appearance of normal spermatozoa in low concentrations. This case illustrates the important physiological role that luteinizing hormone plays in male sexual maturation and fertility.	Ctr Hosp Liege, Dept Endocrinol, B-4000 Liege, Belgium; Ctr Hosp Liege, Dept Dermatopathol, B-4000 Liege, Belgium; Univ Hosp, Div Endocrinol Diabetol & Metab, Lausanne, Switzerland; Univ Yaounde, Dept Obstet & Gynecol, Yaounde, Cameroon	University of Liege; University of Liege; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Yaounde I	Beckers, A (corresponding author), Ctr Hosp Liege, Dept Endocrinol, Domaine Sart Tilman, B-4000 Liege, Belgium.	albert.beckers@chu.ulg.ac.be	Daly, Adrian F/E-2178-2011; VALDES-SOCIN, Hernan/AAH-5066-2021	Daly, Adrian F/0000-0001-6130-2975; Beckers, Albert/0000-0001-6351-1367				Achermann JC, 1999, MOL ENDOCRINOL, V13, P812, DOI 10.1210/me.13.6.812; Alevizaki Maria, 2002, Hormones (Athens), V1, P224; Anderson RA, 2002, ENDOCR REV, V23, P735, DOI 10.1210/er.2002-0002; AXELROD L, 1979, J CLIN ENDOCR METAB, V48, P279, DOI 10.1210/jcem-48-2-279; BERTHEZENE F, 1976, NEW ENGL J MED, V295, P969, DOI 10.1056/NEJM197610282951801; CORLESS CL, 1987, J BIOL CHEM, V262, P14197; DANESHDOOST L, 1991, NEW ENGL J MED, V324, P589, DOI 10.1056/NEJM199102283240904; Darling RJ, 2000, J BIOL CHEM, V275, P15413, DOI 10.1074/jbc.275.20.15413; Darling RJ, 2001, J BIOL CHEM, V276, P10692, DOI 10.1074/jbc.M010168200; Garcia-Campayo V, 2001, TRENDS ENDOCRIN MET, V12, P72, DOI 10.1016/S1043-2760(00)00338-6; HAYASHIZAKI Y, 1989, EMBO J, V8, P3542; HAYASHIZAKI Y, 1989, EMBO J, V8, P2291, DOI 10.1002/j.1460-2075.1989.tb08355.x; Layman LC, 1997, NEW ENGL J MED, V337, P607, DOI 10.1056/NEJM199708283370905; Lejeune H, 1998, J MOL ENDOCRINOL, V20, P1, DOI 10.1677/jme.0.0200001; Lindstedt G, 1998, CLIN CHEM LAB MED, V36, P663, DOI 10.1515/CCLM.1998.118; MATTHEWS CH, 1993, NAT GENET, V5, P83, DOI 10.1038/ng0993-83; MATZUK MM, 1989, J CELL BIOL, V109, P1429, DOI 10.1083/jcb.109.4.1429; Phillip M, 1998, NEW ENGL J MED, V338, P1729, DOI 10.1056/NEJM199806113382404; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; WEISS J, 1992, NEW ENGL J MED, V326, P179, DOI 10.1056/NEJM199201163260306; Zhang FP, 2004, ENDOCRINOLOGY, V145, P1453, DOI 10.1210/en.2003-1049; Zhang FP, 2003, P NATL ACAD SCI USA, V100, P13692, DOI 10.1073/pnas.2232815100; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	25	79	89	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2619	2625		10.1056/NEJMoa040326	http://dx.doi.org/10.1056/NEJMoa040326			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602022	Green Published			2022-12-28	WOS:000225726100009
J	Thomas, NK				Thomas, NK			Resident burnout	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FAMILY-PRACTICE RESIDENTS; WORKING-CONDITIONS; MEDICAL-EDUCATION; NURSE BURNOUT; STRESS; PHYSICIANS; SATISFACTION; INTERNSHIP	intense work demands, limited control, and a high degree of work-home interference abound in residency training programs and should strongly predispose resident physicians to burnout as they do other health care professionals. This article reviews studies in the medical literature that address the level of burnout and associated personal and work factors, health and performance issues, and resources and interventions in residents. MEDLINE and PubMed databases were searched for peer-reviewed, English-language studies reporting primary data on burnout or dimensions of burnout among residents, published between 1983 and 2004, using combinations of the Medical Subject Heading terms burnout, professional, emotional exhaustion, cynicism, depersonalization and internship and residency, housestaff, intern, resident, or physicians in training and by examining reference lists of retrieved articles for relevant studies. A total of 15 heterogeneous articles on resident burnout were thus identified. The studies suggest that burnout levels are high among residents and may be associated with depression and problematic patient care. However, currently available data are insufficient to identify causal relationships and do not support using demographic or personality characteristics to identify at-risk residents. Moreover, given the heterogeneous nature and limitations of the available studies, as well as the importance of having rigorous data to understand and prevent resident burnout, large, prospective studies are needed.	Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Thomas, NK (corresponding author), 1229 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	niku@mail.med.upenn.edu						Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Baldwin PJ, 1997, SOC SCI MED, V45, P35, DOI 10.1016/S0277-9536(96)00306-1; Bellini LM, 2002, JAMA-J AM MED ASSOC, V287, P3143, DOI 10.1001/jama.287.23.3143; Bertakis KD, 2001, J WOMEN HEALTH GEN-B, V10, P689, DOI 10.1089/15246090152563579; Biaggi P, 2003, SWISS MED WKLY, V133, P339; Campbell DA, 2001, SURGERY, V130, P696, DOI 10.1067/msy.2001.116676; Carney PA, 2004, JAMA-J AM MED ASSOC, V292, P1044, DOI 10.1001/jama.292.9.1044; Cohen JJ, 2002, ANN INTERN MED, V136, P394, DOI 10.7326/0003-4819-136-5-200203050-00013; Collier VU, 2002, ANN INTERN MED, V136, P384, DOI 10.7326/0003-4819-136-5-200203050-00011; Daly MG, 2002, MED J AUSTRALIA, V177, pS14; Daugherty SR, 1998, JAMA-J AM MED ASSOC, V279, P1194, DOI 10.1001/jama.279.15.1194; Elliot D L, 1986, J Am Med Womens Assoc (1972), V41, P54; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; Gelfand DV, 2004, ARCH SURG-CHICAGO, V139, P933, DOI 10.1001/archsurg.139.9.933; Geurts S, 1999, SOC SCI MED, V48, P1135, DOI 10.1016/S0277-9536(98)00425-0; Holzman IR, 2000, MT SINAI J MED, V67, P136; Leiter MP, 1998, SOC SCI MED, V47, P1611, DOI 10.1016/S0277-9536(98)00207-X; LEMKAU JP, 1988, J MED EDUC, V63, P682; Levey RE, 2001, ACAD MED, V76, P142, DOI 10.1097/00001888-200102000-00010; Linzer M, 2001, AM J MED, V111, P170, DOI 10.1016/S0002-9343(01)00814-2; Lurie SJ, 2003, JAMA-J AM MED ASSOC, V290, P1210, DOI 10.1001/jama.290.9.1210; Maslach C, 2003, CURR DIR PSYCHOL SCI, V12, P189, DOI 10.1111/1467-8721.01258; Maslach C., 1997, EVALUATING STRESS BO, P191; MCCUE JD, 1985, AM J MED, V78, P985, DOI 10.1016/0002-9343(85)90222-0; MCCUE JD, 1991, ARCH INTERN MED, V151, P2273, DOI 10.1001/archinte.151.11.2273; Michels PJ, 2003, ACAD MED, V78, P69, DOI 10.1097/00001888-200301000-00013; Nash IS, 2002, ANN INTERN MED, V137, P698, DOI 10.7326/0003-4819-137-8-200210150-00019; Nyssen AS, 2003, BRIT J ANAESTH, V90, P333, DOI 10.1093/bja/aeg058; Ospina-Kammerer Veronika, 2003, Int J Emerg Ment Health, V5, P29; Purdy R R, 1987, Fam Med, V19, P203; RAFFERTY JP, 1986, J CLIN PSYCHOL, V42, P488, DOI 10.1002/1097-4679(198605)42:3<488::AID-JCLP2270420315>3.0.CO;2-S; Sargent MC, 2004, J BONE JOINT SURG AM, V86A, P1579, DOI 10.2106/00004623-200407000-00032; Schaufeli WB, 1999, STRESS HLTH PROFESSI; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Spickard A, 2002, JAMA-J AM MED ASSOC, V288, P1447, DOI 10.1001/jama.288.12.1447; Tzischinsky O, 2001, J Hum Ergol (Tokyo), V30, P357; Veasey S, 2002, JAMA-J AM MED ASSOC, V288, P1116, DOI 10.1001/jama.288.9.1116	38	583	618	3	66	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2004	292	23					2880	2889		10.1001/jama.292.23.2880	http://dx.doi.org/10.1001/jama.292.23.2880			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879CR	15598920	Bronze			2022-12-28	WOS:000225694500026
J	Colvin, M; McGuire, W; Fowlie, PW				Colvin, M; McGuire, W; Fowlie, PW			ABC of preterm birth: Neurodevelopmental outcomes after preterm birth	BRITISH MEDICAL JOURNAL			English	Review							CHILDREN; BORN		Stirling Royal Infirm, Stirling, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Tayside Inst Child Hlth, Dundee DD1 4HN, Scotland	University of Dundee	Colvin, M (corresponding author), Stirling Royal Infirm, Stirling, Scotland.			McGuire, William/0000-0001-8572-3467				Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; Donohue PK, 2002, MENT RETARD DEV D R, V8, P293, DOI 10.1002/mrdd.10041; Saigal S, 2000, Semin Neonatol, V5, P107, DOI 10.1053/siny.1999.0003; Varughese LA, 2002, ARCH DIS CHILD, V87, P78, DOI 10.1136/adc.87.1.78; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	6	64	67	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 11	2004	329	7479					1390	1393		10.1136/bmj.329.7479.1390	http://dx.doi.org/10.1136/bmj.329.7479.1390			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880JB	15591566	Green Published			2022-12-28	WOS:000225785000025
J	Moura, ACD; Lee, PC				Moura, ACD; Lee, PC			Capuchin stone tool use in Caatinga dry forest	SCIENCE			English	Article							MONKEYS		Univ Cambridge Darwin Coll, Cambridge CB3 9EU, England; Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England	University of Cambridge; University of Cambridge	Moura, ACD (corresponding author), Univ Cambridge Darwin Coll, Silver St, Cambridge CB3 9EU, England.	acdam2@cam.ac.uk	Moura, Antonio/V-6323-2017	Moura, Antonio/0000-0002-7225-2245; Lee, Phyllis/0000-0002-4296-3513				FRAGASZY D, IN PRESS AM J PRIMAT; Langguth Alfredo, 1997, Neotropical Primates, V5, P77; Lanjouw A, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P52, DOI 10.1017/CBO9780511606397.006; Moura ACdeA, 2004, THESIS U CAMBRIDGE; Ottoni EB, 2001, INT J PRIMATOL, V22, P347, DOI 10.1023/A:1010747426841; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; Reis AC., 1976, AN ACAD BRAS CIENC, V48, P325; VISALBERGHI E, 1987, FOLIA PRIMATOL, V49, P168, DOI 10.1159/000156320; WESTERGAARD GC, 1995, J ANTHROPOL RES, V51, P1; Yamakoshi G, 1998, AM J PHYS ANTHROPOL, V106, P283, DOI 10.1002/(SICI)1096-8644(199807)106:3<283::AID-AJPA2>3.0.CO;2-O	10	157	163	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1909	1909		10.1126/science.1102558	http://dx.doi.org/10.1126/science.1102558			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591195				2022-12-28	WOS:000225695600035
J	Videler, JJ; Stamhuis, EJ; Povel, GDE				Videler, JJ; Stamhuis, EJ; Povel, GDE			Leading-edge vortex lifts swifts	SCIENCE			English	Article							PARTICLE IMAGE VELOCIMETRY; INSECT FLIGHT; WIND-TUNNEL; SPEEDS	The current understanding of how birds fly must be revised, because birds use their hand-wings in an unconventional way to generate lift and drag. Physical models of a common swift wing in gliding posture with a 60degrees sweep of the sharp hand-wing leading edge were tested in a water tunnel. Interactions with the flow were measured quantitatively with digital particle image velocimetry at Reynolds numbers realistic for the gliding flight of a swift between 3750 and 37,500. The results show that gliding swifts can generate stable leading-edge vortices at small (5degrees to 10degrees) angles of attack. We suggest that the flow around the arm-wings of most birds can remain conventionally attached, whereas the swept-back hand-wings generate lift with leading-edge vortices.	Univ Groningen, Dept Marine Biol, Expt Marine Zool Grp, NL-9750 AA Haren, Netherlands; Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands	University of Groningen; Leiden University; Leiden University - Excl LUMC	Videler, JJ (corresponding author), Univ Groningen, Dept Marine Biol, Expt Marine Zool Grp, POB 14, NL-9750 AA Haren, Netherlands.	j.j.videler@biol.rug.nl	tay, wee beng/B-1095-2010	Videler, John/0000-0003-1226-9528				Bruderer B, 2001, IBIS, V143, P178, DOI 10.1111/j.1474-919X.2001.tb04475.x; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; LOWSON MV, 1995, J AIRCRAFT, V32, P832, DOI 10.2514/3.46798; PENNYCUICK CJ, 1968, J EXP BIOL, V49, P509; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223; Stamhuis EJ, 2002, EXP FLUIDS, V33, P801, DOI [10.1007/s00348-002-0520-x, 10.1007/s00348-002-0520-X]; STAMHUIS EJ, 1995, J EXP BIOL, V198, P283	9	106	112	4	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2004	306	5703					1960	1962		10.1126/science.1104682	http://dx.doi.org/10.1126/science.1104682			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591209				2022-12-28	WOS:000225695600052
J	Huxley, R; Owen, CG; Whincup, PH; Cook, DG; Colman, S; Collins, R				Huxley, R; Owen, CG; Whincup, PH; Cook, DG; Colman, S; Collins, R			Birth weight and subsequent cholesterol levels - Exploration of the "fetal origins" hypothesis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE SYNDROME; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; INTRAUTERINE GROWTH-RETARDATION; SERUM-LIPID CONCENTRATIONS; FOR-GESTATIONAL-AGE; CATCH-UP GROWTH; BLOOD-PRESSURE; CHILDREN BORN	Context Inverse associations between birth weight and subsequent blood cholesterol levels have been used to support the "fetal origins" hypothesis of the relevance of fetal nutrition to adult disease. Objectives To perform a systematic review of the association between birth weight and total blood cholesterol levels, and to explore the impact of including unpublished results, adjusting for potential confounders. Data Sources and Study Selection Relevant studies published by September 30, 2004, were identified through literature searches using EMBASE and MEDLINE and MeSH heading search strategy (using terms such as birth weight, intrauterine growth retardation, fetal growth retardation and cholesterol, lipoprotein, lipid). Studies that reported qualitative or quantitative estimates of the association between birth weight and total blood cholesterol, or had recorded both measures but not reported on their associations, were included. Data Extraction A total of 79 relevant studies involving a total of 74122 individuals were identified; 65 had reported on the direction of the association between birth weight and total blood cholesterol. Although regression coefficients were published for only 11 studies and other quantitative estimates for 3 other studies, regression coefficients (published or unpublished) were obtained for 58 studies among 68974 individuals. Data Synthesis Inverse associations were observed in 11 of 14 studies that had previously published quantitative estimates but in only 18 of the remaining 51 that had reported on the direction of this association (heterogeneity P=.004). Similarly, the weighted estimate for the 11 studies was -1.89 mg/dL (-0.049 mmol/L) total cholesterol per kilogram birth weight compared with -0.69 mg/dL (-0.018 mmol/L) per kilogram for 47 studies that provided unpublished regression coefficients (heterogeneity P=.009). Overall, the weighted estimate from the 58 contributing studies was -1.39 mg/dL (-0.036 mmol/L) per kilogram (95% confidence interval, -1.81 to -0.97 mg/dL [-0.047 to -0.025 mmol/L]), but there was significant heterogeneity between their separate results (P<.001). Part of this heterogeneity appears to reflect stronger associations reported from smaller studies and studies of cholesterol levels in infants. Conclusion These findings suggest that impaired fetal growth does not have effects on blood cholesterol levels that would have a material impact on Vascular disease risk.	Univ Sydney, George Inst, Sydney, NSW 2006, Australia; St Georges Hosp Med Sch, Dept Community Hlth Sci, London, England; Univ Oxford, Clin Trial Serv Unit, Oxford, England; Univ Oxford, Epidemiol Studies Unit, Oxford, England	University of Sydney; St Georges University London; University of Oxford; University of Oxford	Huxley, R (corresponding author), Royal Prince Alfred Hosp, George Inst, Level 10,King George V Bldg,Missenden Rd, Sydney, NSW 2050, Australia.	rhuxley@thegeorgeinstitute.org	Huxley, Rachel R/J-4638-2013; Huxley, Rachel R/C-7032-2013	Huxley, Rachel R/0000-0002-2705-6616; Huxley, Rachel R/0000-0002-2705-6616; Cook, Derek/0000-0002-9723-5759; Whincup, Peter/0000-0002-5589-4107; Owen, Christopher/0000-0003-1135-5977				ANDERSEN GE, 1977, ACTA PAEDIATR SCAND, V66, P355, DOI 10.1111/j.1651-2227.1977.tb07907.x; Antal M, 1998, Z ERNAHRUNGSWISS, V37, P131; Barker DJP, 2003, INT J EPIDEMIOL, V32, P876, DOI 10.1093/ije/dyg293; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Barker DJP, 1999, ACTA PAEDIATR, V88, P483, DOI 10.1080/08035259950169431; BARKER DJP, 1993, ACTA PAEDIATR, V82, P93, DOI 10.1111/j.1651-2227.1993.tb12938.x; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; Bennett FI, 2002, ACTA PAEDIATR, V91, P903, DOI 10.1080/080352502760272560; BERGSTROM E, 1995, ATHEROSCLEROSIS, V117, P1, DOI 10.1016/0021-9150(95)05549-C; Bo S, 2000, DIABETIC MED, V17, P365, DOI 10.1046/j.1464-5491.2000.00288.x; Boulton TJ, 1999, ANN MED, V31, P7, DOI 10.1080/07853890.1999.11904393; BOULTON TJC, 1979, AUST NZ J MED, V9, P57, DOI 10.1111/j.1445-5994.1979.tb04114.x; BUCHER HC, 1995, AM J PUBLIC HEALTH, V85, P1231, DOI 10.2105/AJPH.85.9.1231; Byberg L, 2000, DIABETOLOGIA, V43, P54, DOI 10.1007/s001250050007; Cianfarani S, 2002, PEDIATR RES, V51, P94, DOI 10.1203/00006450-200201000-00017; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Clausen JO, 1997, AM J EPIDEMIOL, V146, P23, DOI 10.1093/oxfordjournals.aje.a009188; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cowin I, 2000, INT J OBESITY, V24, P330, DOI 10.1038/sj.ijo.0801133; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Davies AA, 2004, CIRCULATION, V110, P1258, DOI 10.1161/01.CIR.0000140980.61294.4D; de Onis M, 1998, EUR J CLIN NUTR, V52, pS83; Decsi T, 1999, ACTA PAEDIATR, V88, P500, DOI 10.1080/08035259950169495; DIAZ M, 1989, METABOLISM, V38, P435, DOI 10.1016/0026-0495(89)90194-7; Donker GA, 1997, AM J EPIDEMIOL, V145, P398, DOI 10.1093/oxfordjournals.aje.a009121; Eriksson JG, 2002, DIABETOLOGIA, V45, P342, DOI 10.1007/s00125-001-0757-6; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Forrester TE, 1996, BRIT MED J, V312, P156; Forsen T, 1998, J HUM HYPERTENS, V12, P397, DOI 10.1038/sj.jhh.1000643; Frankel S, 1996, PUBLIC HEALTH, V110, P139, DOI 10.1016/S0033-3506(96)80066-7; Gale CR, 2002, ATHEROSCLEROSIS, V163, P141, DOI 10.1016/S0021-9150(01)00760-2; Garces C, 2002, PEDIATR RES, V52, P873, DOI 10.1203/01.PDR.0000037140.57784.8B; Garnett SP, 2001, INT J OBESITY, V25, P1667, DOI 10.1038/sj.ijo.0801821; Godfrey KM, 1998, EUR J OBSTET GYN R B, V78, P141, DOI 10.1016/S0301-2115(98)00060-8; Hajek Z, 2000, Ceska Gynekol, V65, P123; Hegele RA, 1999, CLIN BIOCHEM, V32, P429, DOI 10.1016/S0009-9120(99)00035-1; Houang M, 1999, PEDIATR RES, V46, P189, DOI 10.1203/00006450-199908000-00011; Hoy WE, 1999, KIDNEY INT, V56, P1072, DOI 10.1046/j.1523-1755.1999.00633.x; Hulman S, 1998, J PEDIATR-US, V132, P90, DOI 10.1016/S0022-3476(98)70491-3; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Ibanez L, 2001, CLIN ENDOCRINOL, V55, P667, DOI 10.1046/j.1365-2265.2001.01399.x; Ijzerman RG, 2001, J CLIN ENDOCR METAB, V86, P5479, DOI 10.1210/jc.86.11.5479; Irving RJ, 2000, LANCET, V355, P2135, DOI 10.1016/S0140-6736(00)02384-9; Jaquet D, 1999, J CLIN ENDOCR METAB, V84, P1949, DOI 10.1210/jc.84.6.1949; Jensen CB, 2002, DIABETES, V51, P1271, DOI 10.2337/diabetes.51.4.1271; Karon J, 1996, Ginekol Pol, V67, P394; Kawabe H, 1999, HYPERTENS RES-CLIN E, V22, P169, DOI 10.1291/hypres.22.169; Kessel I, 1966, J Obstet Gynaecol Br Commonw, V73, P800; KESTELOOT H, 1975, European Journal of Cardiology, V2, P285; KOLACEK S, 1993, ACTA PAEDIATR, V82, P699, DOI 10.1111/j.1651-2227.1993.tb18044.x; Koziel Slawomir, 2001, Acta Medica Auxologica (Milan), V33, P31; Krishnaswamy K, 2002, NUTR REV, V60, pS35, DOI 10.1301/00296640260130713; Kuh D, 2002, INT J OBESITY, V26, P40, DOI 10.1038/sj.ijo.0801861; KUMAR A, 1989, Indian Pediatrics, V26, P571; Kuzawa CW, 2003, AM J CLIN NUTR, V77, P960, DOI 10.1093/ajcn/77.4.960; LANE DM, 1983, PEDIATR RES, V17, P83, DOI 10.1203/00006450-198302000-00001; Lauren L, 2003, INT J EPIDEMIOL, V32, P862, DOI 10.1093/ije/dyg201; LAUREN L, 2002, INT J CIRCUMPOLAR S, V61, pS116; Law CM, 1996, J HYPERTENS, V14, P935; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lawlor DA, 2003, DIABETES CARE, V26, P97, DOI 10.2337/diacare.26.1.97; Lawlor DA, 2002, AM J EPIDEMIOL, V156, P1100, DOI 10.1093/aje/kwf154; Leeson CPM, 1997, CIRCULATION, V96, P2233; Leger J, 1997, BRIT MED J, V315, P341; Levitt NS, 2000, J CLIN ENDOCR METAB, V85, P4611, DOI 10.1210/jc.85.12.4611; Lucas A, 1996, BRIT J NUTR, V76, P605, DOI 10.1079/BJN19960066; LUEPKER RV, 1993, CIRCULATION, V88, P2172, DOI 10.1161/01.CIR.88.5.2172; MacGillivray I, 1988, TWINNING TWINS; Martyn CN, 1998, LANCET, V352, P173, DOI 10.1016/S0140-6736(97)10404-4; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; Miura K, 2001, AM J EPIDEMIOL, V153, P783, DOI 10.1093/aje/153.8.783; Mogren I, 2001, INT J EPIDEMIOL, V30, P853, DOI 10.1093/ije/30.4.853; Morley R, 2000, ACTA PAEDIATR, V89, P703, DOI 10.1080/080352500750044043; Mortaz M, 2001, ARCH DIS CHILD, V84, P212, DOI 10.1136/adc.84.3.212; Murtaugh MA, 2003, DIABETES CARE, V26, P187, DOI 10.2337/diacare.26.1.187; OKORO BA, 1985, TROP GEOGR MED, V37, P356; Ortega RM, 1996, INT J VITAM NUTR RES, V66, P250; Owen CG, 2003, PEDIATRICS, V111, P1081, DOI 10.1542/peds.111.5.1081; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Robinson R, 2001, BRIT MED J, V322, P375, DOI 10.1136/bmj.322.7283.375; RODGERS A, 1995, THROMB HAEMOSTASIS, V73, P167; Rona RJ, 1996, J EPIDEMIOL COMMUN H, V50, P512, DOI 10.1136/jech.50.5.512; Roseboom TJ, 2000, AM J CLIN NUTR, V72, P1101; Shadish W. R., 1994, HDB RES SYNTHESIS; Singhal A, 2004, LANCET, V363, P1571, DOI 10.1016/S0140-6736(04)16198-9; Spencer JAD, 1997, ARCH DIS CHILD-FETAL, V76, pF21, DOI 10.1136/fn.76.1.F21; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Stein AD, 2002, J NUTR, V132, P2208, DOI 10.1093/jn/132.8.2208; Stern MP, 2000, DIABETES-METAB RES, V16, P88, DOI 10.1002/(SICI)1520-7560(200003/04)16:2<88::AID-DMRR81>3.0.CO;2-M; Steyn K, 2000, S AFR MED J, V90, P719; Suzuki T, 2000, AM J HYPERTENS, V13, P907, DOI 10.1016/S0895-7061(00)00276-4; SVEGER T, 1989, J PEDIATR GASTR NUTR, V9, P497, DOI 10.1097/00005176-198911000-00017; Tang JL, 1998, BMJ-BRIT MED J, V316, P1213, DOI 10.1136/bmj.316.7139.1213; Tenhola S, 2000, PEDIATR RES, V48, P623, DOI 10.1203/00006450-200011000-00012; Vanhala MJ, 1999, INT J OBESITY, V23, P656, DOI 10.1038/sj.ijo.0800898; Vestbo E, 1996, DIABETOLOGIA, V39, P1598, DOI 10.1007/s001250050620; Yarbrough DE, 1998, DIABETES CARE, V21, P1652, DOI 10.2337/diacare.21.10.1652; Ziegler B, 2000, SCAND CARDIOVASC J, V34, P584	99	116	121	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2004	292	22					2755	2764		10.1001/jama.292.22.2755	http://dx.doi.org/10.1001/jama.292.22.2755			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877CY	15585736				2022-12-28	WOS:000225546600025
J	Moores, LK; Jackson, WL; Shorr, AF; Jackson, JL				Moores, LK; Jackson, WL; Shorr, AF; Jackson, JL			Meta-analysis: Outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography	ANNALS OF INTERNAL MEDICINE			English	Review							NEGATIVE SPIRAL CT; VENTILATION-PERFUSION SCINTIGRAPHY; DEEP VENOUS THROMBOSIS; MULTIDETECTOR ROW CT; HELICAL CT; DIAGNOSTIC STRATEGY; CLINICAL-OUTCOMES; PREDICTIVE VALUE; D-DIMER; OUTPATIENTS	Background: Spiral computed tomographic pulmonary angiography (CTPA) is increasingly being used in the evaluation of patients with clinically suspected pulmonary embolism (PE). However, CTPA as a definitive diagnostic test may be limited by inadequate sensitivity, especially in instances of isolated subsegmental emboli. Purpose: To assess the safety of withholding anticoagulation in patients with suspected PE and negative results on CTPA. Data Sources: All relevant studies identified in MEDLINE (1966 to March 2004) and EMBASE (1974 to 2004) and in bibliographies of key articles. The search was not limited to the English language. Study Selection: The authors selected all published studies that used CTPA to evaluate suspected PE and reported at least 3 months of follow-up in patients not receiving anticoagulation on the basis of a negative CTPA result. Data Extraction: Two reviewers independently rated study quality on the basis of predetermined criteria. Data were extracted on participants, CTPA technique, diagnostic studies performed, prevalence of PE, number of patients with negative or indeterminate CTPA results who were followed, and subsequent rates of venous thromboembolism and fatal PE. Data Synthesis: Twenty-three studies reported on 4657 patients with negative CTPA results who did not receive anticoagulation. The 3-month rate of subsequent venous thromboembolic events was 1.4% (95% Cl, 1.1 % to 1.8%), and the 3-month rate of fatal PE was 0.51% (Cl, 0.33% to 0.76%). Limitations: The CTPA technology used varied across studies and was not applied uniformly in the same step of diagnostic algorithms. Only 1 study used CTPA as the sole diagnostic test. Conclusion: The rate of subsequent venous thromboembolism after negative results on CTPA is similar to that seen after negative results on conventional pulmonary angiography. It appears to be safe to withhold anticoagulation after negative CTPA results.	Uniformed Serv Univ Hlth Sci, Walter Reed Army Med Ctr, Washington, DC 20307 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA	Moores, LK (corresponding author), Uniformed Serv Univ Hlth Sci, Walter Reed Army Med Ctr, 6900 Georgia Ave NW, Washington, DC 20307 USA.	Lisa.Moores@na.amedd.army.mil	Jackson, Jeffrey/AAA-3519-2019; Moores, Lisa/AAH-2018-2021	Moores, Lisa/0000-0002-7117-9824; Jackson, Jeffrey/0000-0002-9820-5834				Bates SM, 2000, ANN INTERN MED, V132, P240, DOI 10.7326/0003-4819-132-3-200002010-00012; Blachere H, 2000, AM J ROENTGENOL, V174, P1041, DOI 10.2214/ajr.174.4.1741041; Bourriot K, 2003, CHEST, V123, P359, DOI 10.1378/chest.123.2.359; Cham MD, 2000, RADIOLOGY, V216, P744, DOI 10.1148/radiology.216.3.r00se44744; Chunilal SD, 2003, JAMA-J AM MED ASSOC, V290, P2849, DOI 10.1001/jama.290.21.2849; Cross JJL, 1998, CLIN RADIOL, V53, P177, DOI 10.1016/S0009-9260(98)80097-4; Donato AA, 2003, ARCH INTERN MED, V163, P2033, DOI 10.1001/archinte.163.17.2033; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2001, SYSTEMATIC REV HLTH; Ferretti GR, 1997, RADIOLOGY, V205, P453, DOI 10.1148/radiology.205.2.9356628; Ferretti GR, 1998, J RADIOL, V79, P327; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Garg K, 1998, RADIOLOGY, V208, P201, DOI 10.1148/radiology.208.1.9646814; Garg K, 1999, AM J ROENTGENOL, V172, P1627, DOI 10.2214/ajr.172.6.10350303; Ghaye B, 2002, EUR RADIOL, V12, P1906, DOI 10.1007/s00330-002-1505-0; Ghaye B, 2001, RADIOLOGY, V219, P629, DOI 10.1148/radiology.219.3.r01jn32629; Goldhaber SZ, 1998, NEW ENGL J MED, V339, P93, DOI 10.1056/NEJM199807093390207; Goodman LR, 2000, RADIOLOGY, V215, P535, DOI 10.1148/radiology.215.2.r00ma23535; Goodman LR, 1996, RADIOLOGY, V199, P25, DOI 10.1148/radiology.199.1.8633154; Gottsater A, 2001, EUR RADIOL, V11, P65, DOI 10.1007/s003300000539; GURNEY JW, 1993, RADIOLOGY, V188, P618, DOI 10.1148/radiology.188.3.8351321; Kavanagh EC, 2004, AM J ROENTGENOL, V182, P499, DOI 10.2214/ajr.182.2.1820499; Kim KI, 1999, RADIOLOGY, V210, P693, DOI 10.1148/radiology.210.3.r99mr01693; Krestan CR, 2004, EUR RADIOL, V14, P93, DOI 10.1007/s00330-003-2016-3; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; Lawler LP, 2001, RADIOGRAPHICS, V21, P1257, DOI 10.1148/radiographics.21.5.g01se021257; Lombard J, 2003, CAN ASSOC RADIOL J, V54, P147; Lomis NNT, 1999, J VASC INTERV RADIOL, V10, P707, DOI 10.1016/S1051-0443(99)70104-1; Lorut C, 2000, AM J RESP CRIT CARE, V162, P1413, DOI 10.1164/ajrccm.162.4.9909109; Loud PA, 2001, RADIOLOGY, V219, P498, DOI 10.1148/radiology.219.2.r01ma26498; Mayo JR, 1997, RADIOLOGY, V205, P447, DOI 10.1148/radiology.205.2.9356627; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Nilsson T, 2002, ACTA RADIOL, V43, P486; Ost D, 2001, AM J MED, V110, P16, DOI 10.1016/S0002-9343(00)00641-0; Patel S, 2003, RADIOLOGY, V227, P455, DOI 10.1148/radiol.2272011139; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Perrier A, 2001, ANN INTERN MED, V135, P88, DOI 10.7326/0003-4819-135-2-200107170-00008; Qanadli SD, 2000, RADIOLOGY, V217, P447, DOI 10.1148/radiology.217.2.r00nv01447; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; Remy-Jardin M, 2000, AM J ROENTGENOL, V175, P407, DOI 10.2214/ajr.175.2.1750407; Remy-Jardin M, 1999, RADIOLOGY, V212, P615, DOI 10.1148/radiology.212.3.r99se02615; Remy-Jardin M, 2002, EUR RADIOL, V12, P1971, DOI 10.1007/s00330-002-1485-0; RemyJardin M, 1997, J THORAC IMAG, V12, P103, DOI 10.1097/00005382-199704000-00009; RemyJardin M, 1997, RADIOLOGY, V204, P157, DOI 10.1148/radiology.204.1.9205239; REMYJARDIN M, 1992, RADIOLOGY, V185, P381, DOI 10.1148/radiology.185.2.1410342; Safriel Y, 2002, CLIN IMAG, V26, P101, DOI 10.1016/S0899-7071(01)00366-7; SAUTTER RD, 1987, ARCH INTERN MED, V147, P202, DOI 10.1001/archinte.1987.00370020022012; Simon M, 2001, AM J ROENTGENOL, V177, P195, DOI 10.2214/ajr.177.1.1770195; STEIN PD, 1992, CIRCULATION, V85, P462, DOI 10.1161/01.CIR.85.2.462; Swensen SJ, 2002, MAYO CLIN PROC, V77, P130; Tillie-Leblond I, 2002, RADIOLOGY, V223, P461, DOI 10.1148/radiol.2232010913; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; van Strijen MJL, 2003, ANN INTERN MED, V138, P307, DOI 10.7326/0003-4819-138-4-200302180-00009; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; 1990, JAMA, V263, P2753	61	116	124	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2004	141	11					866	874		10.7326/0003-4819-141-11-200412070-00011	http://dx.doi.org/10.7326/0003-4819-141-11-200412070-00011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876WZ	15583229				2022-12-28	WOS:000225530700007
J	Chen, GYJ; Yao, SQ				Chen, GYJ; Yao, SQ			Lighting up cancer cells with "dots"	LANCET			English	Editorial Material							SEMICONDUCTOR QUANTUM DOTS; IN-VIVO		Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore; National University of Singapore	Yao, SQ (corresponding author), Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.	chmyaosq@nus.edu.sg	Yao, Shao Q/B-8825-2008					Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Srinivasan R, 2004, COMB CHEM HIGH T SCR, V7, P597; Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764	10	12	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2004	364	9450					2001	2003		10.1016/S0140-6736(04)17527-2	http://dx.doi.org/10.1016/S0140-6736(04)17527-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582045				2022-12-28	WOS:000225495700007
J	Rosenthal, J; Rymer, J; Jones, R; Haldane, S; Cohen, S; Bartholomew, J				Rosenthal, J; Rymer, J; Jones, R; Haldane, S; Cohen, S; Bartholomew, J			Chaperones for intimate examinations: cross sectional survey of attitudes and practices of general practitioners	BRITISH MEDICAL JOURNAL			English	Article									UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Obstet & Gynaecol, London SE11 6SP, England	University of London; University College London; University of London; King's College London; University of London; King's College London	Rosenthal, J (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England.	j.rosenthal@pcps.ucl.ac.uk	Rosenthal, Joe/C-1610-2008					JONES RH, 1983, J ROY COLL GEN PRACT, V33, P25; *ROYAL COLL OBSTET, 2002, GYN EX GUID SPEC PRA; SPEELMAN A, 1993, BRIT MED J, V307, P986, DOI 10.1136/bmj.307.6910.986; Stern V, 2001, LANCET, V358, P1896, DOI 10.1016/S0140-6736(01)06892-1; Whitford DL, 2001, BRIT J GEN PRACT, V51, P381	5	20	20	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 29	2005	330	7485					234	235		10.1136/bmj.38315.646053.F7	http://dx.doi.org/10.1136/bmj.38315.646053.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894GR	15579477	Green Published, Bronze			2022-12-28	WOS:000226779400022
J	Moffett, JAK; Jackson, DA; Richmond, S; Hahn, S; Coulton, S; Farrin, A; Manca, A; Torgerson, DJ				Moffett, JAK; Jackson, DA; Richmond, S; Hahn, S; Coulton, S; Farrin, A; Manca, A; Torgerson, DJ			Randomised trial of a brief physiotherapy intervention compared with usual physiotherapy for neck pain patients: outcomes and patients' preference	BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN; CLINICAL-TRIALS; QUESTIONNAIRE; MANAGEMENT; DISABILITY; CARE	Objectives Firstly, to compare the effectiveness of a brief physiotherapy intervention with "usual" physiotherapy for patients with neck pain. Secondly, to evaluate the effect of patients' preferences on outcome. Design Non-inferiority randomised controlled trial eliciting preferences independently of randomisation. Setting Physiotherapy departments in a community setting in Yorkshire and north Lincolnshire. Participants 268 patients (mean age 48 years) with subacute and chronic neck pain, who were referred by their general practitioner quid randomly assigned to a brief physiotherapy intervention (one to three sessions) using cognitive behaviour principles to encourage self management and return to normal function or usual physiotherapy, at the discretion of the physiotherapist concerned. Main outcome measures The Northwick Park neck pain questionnaire (NPQ), a specific measure of functional disability resulting from neck pain. Also, the short form 36 (SF-36) questionnaire, a generic, health related. quality of life measure; and the Tampa scale for kinesophobia, a treasure of fear and avoidance of movement. Results At 12 months, patients allocated to usual physiotherapy had a small but significant improvement in NPQ scores compared with patients in the brief intervention group (mean difference 1.99, 95% confidence interval 0.45 to 3.52; P = 0.01). Although the result shows a significant inferiority of the intervention, the confidence interval shows that the effect could be in the lion-inferiority range for the brief intervention (below 1.2 points of NPQ score). Patients who preferred the brief intervention and received this treatment had similar outcomes to patients receiving usual physiotherapy. Conclusions Usual physiotherapy array be only marginally better than a brief physiotherapy intervention for neck pain. Patients with a preference for die brief intervention may do at least as well with this approach. Additional training for the physiotherapists in cognitive behaviour techniques might improve this approach further.	Univ Hull, Inst Rehabil, Kingston Upon Hull HU3 2PG, N Humberside, England; Univ Hull, Hull & E Riding Community NHS Hlth Trust, Kingston Upon Hull HU3 2PG, N Humberside, England; Univ Hull, Dept Publ Hlth & Primary Care, Kingston Upon Hull HU6 7RX, N Humberside, England; Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Univ York, York Trials Unit, York YO10 5DD, N Yorkshire, England; Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England	University of Hull; University of Hull; University of Hull; University of York - UK; University of York - UK; University of York - UK	Moffett, JAK (corresponding author), Univ Hull, Inst Rehabil, Kingston Upon Hull HU3 2PG, N Humberside, England.	j.k.moffett@hull.ac.uk	Hahn, Seokyung/J-5705-2012; Torgerson, David/L-4566-2019; Kovacs, Francisco/L-9083-2014	Torgerson, David/0000-0002-1667-4275; Kovacs, Francisco/0000-0002-2984-4800; Coulton, Simon/0000-0002-7704-3274; Hahn, Seokyung/0000-0002-4684-4917; Farrin, Amanda/0000-0002-2876-0584				BATTIE MC, 1994, PHYS THER, V74, P219, DOI 10.1093/ptj/74.3.219; BOVIM G, 1994, SPINE, V19, P1307, DOI 10.1097/00007632-199406000-00001; BREWIN CR, 1989, BRIT MED J, V299, P313, DOI 10.1136/bmj.299.6694.313; Cote P, 1998, SPINE, V23, P1689, DOI 10.1097/00007632-199808010-00015; Croft PR, 2001, PAIN, V93, P317, DOI 10.1016/S0304-3959(01)00334-7; Foster NE, 2003, RHEUMATOLOGY, V42, P401, DOI 10.1093/rheumatology/keg165; Foster NE, 1999, SPINE, V24, P1332, DOI 10.1097/00007632-199907010-00011; GROSS AR, 2000, COCHRANE DB SYST REV; HACKETT GI, 1993, BRIT J GEN PRACT, V43, P61; KLABERMOFFETT J, 1999, BRIT MED J, V319, P279; Kori S, 1990, PAIN MANAG, V3, P35; LEAK AM, 1994, BRIT J RHEUMATOL, V33, P469; McPherson K, 1998, BRIT MED J, V317, P78, DOI 10.1136/bmj.317.7150.78; METCALFE C, 2003, THESIS U HULL HULL; MYNORSWALLIS LM, 1995, BMJ-BRIT MED J, V310, P441, DOI 10.1136/bmj.310.6977.441; RUTA A, 1994, QUAL HEALTH CARE, V3, P186; Torgerson D J, 1996, J Health Serv Res Policy, V1, P194; Torgerson DJ, 1998, BRIT MED J, V316, P360, DOI 10.1136/bmj.316.7128.360; Walker LG, 1996, EUR J CANCER, V32A, P1457, DOI 10.1016/0959-8049(96)00151-7	19	83	84	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 8	2005	330	7482					75	78A		10.1136/bmj.38286.493206.82	http://dx.doi.org/10.1136/bmj.38286.493206.82			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887GR	15585539	Green Published, Bronze			2022-12-28	WOS:000226294300016
J	Kittler, R; Putz, G; Pelletier, L; Poser, I; Heninger, AK; Drechsel, D; Fischer, S; Konstantinova, I; Habermann, B; Grabner, H; Yaspo, ML; Himmelbauer, H; Korn, B; Neugebauer, K; Pisabarro, MT; Buchholz, F				Kittler, R; Putz, G; Pelletier, L; Poser, I; Heninger, AK; Drechsel, D; Fischer, S; Konstantinova, I; Habermann, B; Grabner, H; Yaspo, ML; Himmelbauer, H; Korn, B; Neugebauer, K; Pisabarro, MT; Buchholz, F			An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division	NATURE			English	Article							SMALL INTERFERING RNAS; FUNCTIONAL GENOMIC ANALYSIS; CULTURED-MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; SPINDLE FORMATION; EXPRESSION; COMPONENTS; DUPLEXES; CYCLE	RNA interference (RNAi) is an evolutionarily conserved defence mechanism whereby genes are specifically silenced through degradation of messenger RNAs; this process is mediated by homologous double-stranded (ds) RNA molecules(1-4). In invertebrates, long dsRNAs have been used for genome-wide screens and have provided insights into gene functions(5-8). Because long dsRNA triggers a nonspecific interferon response in many vertebrates, short interfering ( si) RNA or short hairpin (sh) RNAs must be used for these organisms to ensure specific gene silencing(9-11). Here we report the generation of a genome-scale library of endoribonuclease-prepared short interfering (esi) RNAs12 from a sequence-verified complementary DNA collection representing 15,497 human genes. We used 5,305 esiRNAs from this library to screen for genes required for cell division in HeLa cells. Using a primary high-throughput cell viability screen followed by a secondary high content videomicroscopy assay, we identified 37 genes required for cell division. These include several splicing factors for which knockdown generates mitotic spindle defects. In addition, a putative nuclear-export terminator was found to speed up cell proliferation and mitotic progression after knockdown. Thus, our study uncovers new aspects of cell division and establishes esiRNA as a versatile approach for genomic RNAi screens in mammalian cells.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Scion Comp Innovat GmbH, D-01307 Dresden, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; RZPD Ressourcenzentrum Genomforsch, D-69120 Heidelberg, Germany	Max Planck Society; Max Planck Society	Buchholz, F (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	buchholz@mpi-cbg.de	Pisabarro, M. Teresa/D-4270-2012; Buchholz, Frank/B-4700-2017; Kittler, Ralf/I-4662-2013; Habermann, Bianca/N-4886-2016; Kittler, Ralf/AAD-4258-2020; Pelletier, Laurence/F-8858-2013	Buchholz, Frank/0000-0002-4577-3344; Kittler, Ralf/0000-0002-0098-6792; Habermann, Bianca/0000-0002-2457-7504; Kittler, Ralf/0000-0002-0098-6792; Himmelbauer, Heinz/0000-0001-8897-2928; Heninger, Anne-Kristin/0000-0003-3151-826X				Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Biggins S, 2001, GENETICS, V159, P453; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burns CG, 2002, MOL CELL BIOL, V22, P801, DOI 10.1128/MCB.22.3.801-815.2002; Calegari F, 2002, P NATL ACAD SCI USA, V99, P14236, DOI 10.1073/pnas.192559699; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Harborth J, 2001, J CELL SCI, V114, P4557; Henschel A, 2004, NUCLEIC ACIDS RES, V32, pW113, DOI 10.1093/nar/gkh408; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kronke J, 2004, J VIROL, V78, P3436, DOI 10.1128/JVI.78.7.3436-3446.2004; Liebel U, 2004, BIOINFORMATICS, V20, P1962, DOI 10.1093/bioinformatics/bth146; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100	30	322	343	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1036	1040		10.1038/nature03159	http://dx.doi.org/10.1038/nature03159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616564				2022-12-28	WOS:000225887000044
J	Metzger, CH; Karrai, K				Metzger, CH; Karrai, K			Cavity cooling of a microlever	NATURE			English	Article							RADIATION PRESSURE; CONFINEMENT; DETECTORS; MIRROR	The prospect of realizing entangled quantum states between macroscopic objects and photons(1) has recently stimulated interest in new laser-cooling schemes(2,3). For example, laser-cooling of the vibrational modes of a mirror can be achieved by subjecting it to a radiation(2) or photothermal(4) pressure, actively controlled through a servo loop adjusted to oppose its brownian thermal motion within a preset frequency window. In contrast, atoms can be laser-cooled passively without such active feedback, because their random motion is intrinsically damped through their interaction with radiation(5-8). Here we report direct experimental evidence for passive ( or intrinsic) optical cooling of a micromechanical resonator. We exploit cavity-induced photothermal pressure to quench the brownian vibrational fluctuations of a gold-coated silicon microlever from room temperature down to an effective temperature of 18 K. Extending this method to optical-cavity-induced radiation pressure might enable the quantum limit to be attained, opening the way for experimental investigations of macroscopic quantum superposition states(1) involving numbers of atoms of the order of 10(14).	Univ Munich, Ctr Nanosci, D-80539 Munich, Germany; Univ Munich, Sekt Phys, D-80539 Munich, Germany	University of Munich; University of Munich	Karrai, K (corresponding author), Univ Munich, Ctr Nanosci, Geschwister Scholl Pl 1, D-80539 Munich, Germany.	karrai@lmu.de						BARNES JR, 1994, NATURE, V372, P79, DOI 10.1038/372079a0; Braginsky V. B., 1977, MEASUREMENTS WEAK FO; BRAGINSKY VB, 1970, SOV PHYS JETP-USSR, V31, P829; CHU S, 1985, PHYS REV LETT, V55, P48, DOI 10.1103/PhysRevLett.55.48; Cohadon PF, 1999, PHYS REV LETT, V83, P3174, DOI 10.1103/PhysRevLett.83.3174; COHENTANNOUDJI CN, 1990, PHYS TODAY, V43, P33, DOI 10.1063/1.881239; Datskos PG, 2004, REV SCI INSTRUM, V75, P1134, DOI 10.1063/1.1667257; DORSEL A, 1983, PHYS REV LETT, V51, P1550, DOI 10.1103/PhysRevLett.51.1550; EPSTEIN RI, 1995, NATURE, V377, P500, DOI 10.1038/377500a0; Gillespie DT, 1996, AM J PHYS, V64, P225, DOI 10.1119/1.18210; GIMZEWSKI JK, 1994, CHEM PHYS LETT, V217, P589, DOI 10.1016/0009-2614(93)E1419-H; HANSCH TW, 1975, OPT COMMUN, V13, P68, DOI 10.1016/0030-4018(75)90159-5; Marshall W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130401; MERTZ J, 1993, APPL PHYS LETT, V62, P2344, DOI 10.1063/1.109413; Pai A, 2000, EUR PHYS J D, V8, P333, DOI 10.1007/s100530050043; Sarid D., 1991, SCANNING FORCE MICRO; Vogel M, 2003, APPL PHYS LETT, V83, P1337, DOI 10.1063/1.1600513; Wilson-Rae I, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.075507; Yang JL, 2000, APPL PHYS LETT, V77, P3860, DOI 10.1063/1.1330225	19	527	542	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1002	1005		10.1038/nature03118	http://dx.doi.org/10.1038/nature03118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616555				2022-12-28	WOS:000225887000034
J	Schweinfest, R; Paxton, AT; Finnis, MW				Schweinfest, R; Paxton, AT; Finnis, MW			Bismuth embrittlement of copper is an atomic size effect	NATURE			English	Article							GRAIN-BOUNDARY EMBRITTLEMENT; SEGREGATION; INTERFACES; METALS; ENERGY	Embrittlement by the segregation of impurity elements to grain boundaries is one of a small number of phenomena that can lead to metallurgical failure by fast fracture(1). Here we settle a question that has been debated for over a hundred years(2): how can minute traces of bismuth in copper cause this ductile metal to fail in a brittle manner? Three hypotheses for Bi embrittlement of Cu exist: two assign an electronic effect to either a strengthening(3) or weakening(4) of bonds, the third postulates a simple atomic size effect(5). Here we report first principles quantum mechanical calculations that allow us to reject the electronic hypotheses, while supporting a size effect. We show that upon segregation to the grain boundary, the large Bi atoms weaken the interatomic bonding by pushing apart the Cu atoms at the interface. The resolution of the mechanism underlying grain boundary weakening should be relevant for all cases of embrittlement by oversize impurities.	Queens Univ Belfast, Dept Phys & Astron, Atom Simulat Ctr, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Paxton, AT (corresponding author), Queens Univ Belfast, Dept Phys & Astron, Atom Simulat Ctr, Belfast BT7 1NN, Antrim, North Ireland.	Tony.Paxton@QUB.ac.uk	Finnis, Michael W/I-8095-2015; Finnis, Michael William/AGX-6318-2022	Finnis, Michael W/0000-0002-5999-7576; Paxton, Anthony/0000-0003-4182-8210				Alber U, 1999, ACTA MATER, V47, P4047, DOI 10.1016/S1359-6454(99)00265-7; ANDERSON PM, 1986, SCRIPTA METALL MATER, V20, P1467, DOI 10.1016/0036-9748(86)90377-7; Bruley J, 1999, ACTA MATER, V47, P4009, DOI 10.1016/S1359-6454(99)00261-X; Duscher G, 2004, NAT MATER, V3, P621, DOI 10.1038/nmat1191; Finnis MW, 1996, J PHYS-CONDENS MAT, V8, P5811, DOI 10.1088/0953-8984/8/32/003; FINNIS MW, 1974, J PHYS F MET PHYS, V4, P1645, DOI 10.1088/0305-4608/4/10/012; GOODWIN L, 1988, PHYS REV LETT, V60, P2050, DOI 10.1103/PhysRevLett.60.2050; Gray J. L., 1972, P I MECH ENG, V186, P379; HAMPE W, 1874, Z BERG HUTTEN SALINE, V23, P93; HAYDOCK R, 1981, J PHYS C SOLID STATE, V14, P3807, DOI 10.1088/0022-3719/14/26/016; JOKL ML, 1980, ACTA METALL MATER, V28, P1479, DOI 10.1016/0001-6160(80)90048-6; KANZAKI H, 1957, J PHYS CHEM SOLIDS, V2, P24, DOI 10.1016/0022-3697(57)90003-3; KELLER J, 1986, Mycologia Helvetica, V2, P1; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Lawn P.R, 1993, CAMBRIDGE SOLID STAT, Vsecond; MESSMER RP, 1982, ACTA METALL MATER, V30, P457, DOI 10.1016/0001-6160(82)90226-7; Muller DA, 1999, ULTRAMICROSCOPY, V78, P163, DOI 10.1016/S0304-3991(99)00029-7; OZAKAYA D, 1995, J MICROSC-OXFORD, V180, P300; PAXTON AT, 1991, PHIL MAG LETT, V63, P267, DOI 10.1080/09500839108214654; POWELL BD, 1973, ACTA METALL MATER, V21, P1151, DOI 10.1016/0001-6160(73)90031-X; RICE JR, 1992, J MECH PHYS SOLIDS, V40, P239, DOI 10.1016/S0022-5096(05)80012-2; RICE JR, 1989, MAT SCI ENG A-STRUCT, V107, P23, DOI 10.1016/0921-5093(89)90372-9; SAQI MAS, 1987, PHIL MAG LETT, V56, P245, DOI 10.1080/09500838708225375; Sigle W, 2002, PHILOS MAG A, V82, P1595, DOI 10.1080/01418610210128113; SUTTON AP, 1982, ACTA METALL MATER, V30, P2011, DOI 10.1016/0001-6160(82)90105-5; SUTTON AP, 1995, INTERFACES CRYSTALLI, pCH7; Warke W.R, 2002, ASM HDB ASM INT, V11, P861, DOI [10.31399/asm.hb.v11.a0003554, DOI 10.31399/ASM.HB.V11.A0003554]	27	144	145	4	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1008	1011		10.1038/nature03198	http://dx.doi.org/10.1038/nature03198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616557				2022-12-28	WOS:000225887000036
J	Sjostrom, L; Lindroos, AK; Peltonen, M; Torgerson, J; Bouchard, C; Carlsson, B; Dahlgren, S; Larsson, B; Narbro, K; Sjostrom, CD; Sullivan, M; Wedel, H				Sjostrom, L; Lindroos, AK; Peltonen, M; Torgerson, J; Bouchard, C; Carlsson, B; Dahlgren, S; Larsson, B; Narbro, K; Sjostrom, CD; Sullivan, M; Wedel, H		Swedish Obese Subjects Study Scien	Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEIGHT-LOSS; BODY-WEIGHT; NATIONAL-HEALTH; HYPERTENSION; OBESE; REDUCTION; SOS; INTERVENTION; LIPOPROTEINS; PREVENTION	BACKGROUND Weight loss is associated with short-term amelioration and prevention of metabolic and cardiovascular risk, but whether these benefits persist over time is unknown. METHODS The prospective, controlled Swedish Obese Subjects Study involved obese subjects who underwent gastric surgery and contemporaneously matched, conventionally treated obese control subjects. We now report follow-up data for subjects ( mean age, 48 years; mean body-mass index, 41) who had been enrolled for at least 2 years ( 4047 subjects) or 10 years ( 1703 subjects) before the analysis ( January 1, 2004). The follow-up rate for laboratory examinations was 86.6 percent at 2 years and 74.5 percent at 10 years. RESULTS After two years, the weight had increased by 0.1 percent in the control group and had decreased by 23.4 percent in the surgery group (P< 0.001). After 10 years, the weight had increased by 1.6 percent and decreased by 16.1 percent, respectively ( P< 0.001). Energy intake was lower and the proportion of physically active subjects higher in the surgery group than in the control group throughout the observation period. Two- and 10-year rates of recovery from diabetes, hypertriglyceridemia, low levels of high-density lipoprotein cholesterol, hypertension, and hyperuricemia were more favorable in the surgery group than in the control group, whereas recovery from hypercholesterolemia did not differ between the groups. The surgery group had lower 2- and 10-year incidence rates of diabetes, hypertriglyceridemia, and hyperuricemia than the control group; differences between the groups in the incidence of hypercholesterolemia and hypertension were undetectable. CONCLUSIONS As compared with conventional therapy, bariatric surgery appears to be a viable option for the treatment of severe obesity, resulting in long-term weight loss, improved lifestyle, and, except for hypercholesterolemia, amelioration in risk factors that were elevated at baseline.	Sahlgrens Univ Hosp, SOS Secretariat, Dept Body Composit & Metab, S-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Anesthesiol, S-41345 Gothenburg, Sweden; Nord Univ Publ Hlth, Gothenburg, Sweden; Norra Alvsborgs Lans Hosp, Dept Med, Trollhattan, Sweden; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland; Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Sahlgrenska University Hospital; Sahlgrenska University Hospital; NU Hospital Group; Finland National Institute for Health & Welfare; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Sjostrom, L (corresponding author), Sahlgrens Univ Hosp, SOS Secretariat, Dept Body Composit & Metab, S-41345 Gothenburg, Sweden.		Bouchard, Claude/A-7637-2009; Peltonen, Markku/F-3037-2015; Bouchard, Claude/AAE-2035-2019; Kohn, Geoffrey P/A-9056-2009	Bouchard, Claude/0000-0002-0048-491X; Peltonen, Markku/0000-0002-3767-4223; 				BJORNTORP P, 1970, METABOLIS, V19, P631, DOI 10.1016/0026-0495(70)90020-X; BROLIN RE, 1987, GASTROENTEROL CLIN N, V16, P317; CARSON JL, 1994, ARCH INTERN MED, V154, P193, DOI 10.1001/archinte.154.2.193; CARSON JL, 1994, ARCH INTERN MED, V154, P1770, DOI 10.1001/archinte.1994.00420150146016; Chalmers J, 1999, J HYPERTENS, V17, P151; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; *COLL STAT, 2001, STAT STAT SOFTW REL; CORNONIHUNTLEY JC, 1991, J CLIN EPIDEMIOL, V44, P743, DOI 10.1016/0895-4356(91)90126-T; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; FOLEY EF, 1992, AM J SURG, V163, P294, DOI 10.1016/0002-9610(92)90005-C; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fruhbeck G, 2004, NEW ENGL J MED, V350, P308, DOI 10.1056/NEJM200401153500323; HIGGINS M, 1993, ANN INTERN MED, V119, P1055, DOI 10.7326/0003-4819-119-10-199311150-00032; HIGGINS M, 1993, ANN INTERN MED, V119, P758, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00025; Huang ZP, 1998, ANN INTERN MED, V128, P81, DOI 10.7326/0003-4819-128-2-199801150-00001; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Larsson I., 2004, Scandinavian Journal of Nutrition, V48, P165, DOI 10.1080/11026480410003785; Lindroos AK, 1999, EUR J CLIN NUTR, V53, P375, DOI 10.1038/sj.ejcn.1600732; LINDROOS AK, 1993, EUR J CLIN NUTR, V47, P461; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moore LL, 2000, EPIDEMIOLOGY, V11, P269, DOI 10.1097/00001648-200005000-00007; Nakanishi N, 2000, IND HEALTH, V38, P233, DOI 10.2486/indhealth.38.233; PAMUK ER, 1993, ANN INTERN MED, V119, P744, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00023; PAMUK ER, 1992, AM J EPIDEMIOL, V136, P686, DOI 10.1093/oxfordjournals.aje.a116548; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; SAUDICANI P, 1997, J CARDIOVASC RISK, V4, P25; SIDNEY S, 1987, AM J PUBLIC HEALTH, V77, P317, DOI 10.2105/AJPH.77.3.317; Sjostrom CD, 1997, OBES RES, V5, P519; Sjostrom CD, 1999, OBES RES, V7, P477; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Sjostrom L, 2000, ENDOCRINE, V13, P213, DOI 10.1385/ENDO:13:2:213; SJOSTROM L V, 1992, American Journal of Clinical Nutrition, V55, p516S, DOI 10.1093/ajcn/55.2.516s; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wadden TA, 1999, OBES RES, V7, P170, DOI 10.1002/j.1550-8528.1999.tb00699.x; Ware JH, 2003, NEW ENGL J MED, V348, P2136, DOI 10.1056/NEJMe030054; WOOD PD, 1988, NEW ENGL J MED, V319, P1173, DOI 10.1056/NEJM198811033191801	42	3063	3180	6	210	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2683	2693		10.1056/NEJMoa035622	http://dx.doi.org/10.1056/NEJMoa035622			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616203				2022-12-28	WOS:000225877300004
J	Baxendale, S				Baxendale, S			Memories aren't made of this: amnesia at the movies	BMJ-BRITISH MEDICAL JOURNAL			English	Article									UCL Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Baxendale, S (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, Box 37, London WC1N 3BG, England.	sallieb@ion.ucl.ac.uk	Baxendale, Sallie/AAN-8312-2020	Baxendale, Sallie/0000-0002-9930-6469					0	33	33	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1480	1483		10.1136/bmj.329.7480.1480	http://dx.doi.org/10.1136/bmj.329.7480.1480			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604191	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000225965800034
J	Maruenda, FB				Maruenda, FB			Can the human eye detect an offside position during a football match?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VELOCITY		Ctr Salud Alquerias, Murcia 30580, Spain		Maruenda, FB (corresponding author), Ctr Salud Alquerias, C-R Fernandez Minarro No 1, Murcia 30580, Spain.	fbeldam@meditex.es						ARROYO RO, 1992, TEORIA FUTBOL; BURDE RM, 1988, FISIOLOGIA OJO ADLER, P122; GAVILAN C, 1987, FISIOLOGIA FISIOPATO, P56; GAVILAN J, 1983, ACTA OTO-LARYNGOL, V96, P429, DOI 10.3109/00016488309132729; *INT FOOTB ASS BOA, 2003, LAWS GAM, V24; LEIGH RJ, 1983, NEUROLOGY EYE MOVEME, P39; MOSES RA, 1988, FISIOLOGIA OJO ADLER, P285; PUJOL MM, 1987, FISIOLOGIA FISIOPATO, P43; SCHALEN L, 1984, ACTA OTO-LARYNGOL, P212; SCHMIDT D, 1979, AVIAT SPACE ENVIR MD, V50, P393; SHICKMAN GM, 1988, FISIOLOGIA OJO ADLER, P591	11	27	27	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1470	1472		10.1136/bmj.329.7480.1470	http://dx.doi.org/10.1136/bmj.329.7480.1470			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604187	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000225965800030
J	Pimpalnerkar, A; Datta, A; Longhino, D; Mohtadi, N				Pimpalnerkar, A; Datta, A; Longhino, D; Mohtadi, N			An unusual complication of Kocher's manoeuvre	BRITISH MEDICAL JOURNAL			English	Article							ANTERIOR DISLOCATION; SHOULDER; REDUCTION		Royal Ctr Def Med, Birmingham B29 6JD, W Midlands, England; Ctr Sports Med, Calgary, AB T2N 1N4, Canada	Royal Centre for Defence Medicine	Pimpalnerkar, A (corresponding author), Royal Ctr Def Med, Birmingham B29 6JD, W Midlands, England.							Bak K, 2000, KNEE SURG SPORT TR A, V8, P113, DOI 10.1007/s001670050197; BEATTIE TF, 1986, INJURY, V17, P349, DOI 10.1016/0020-1383(86)90161-0; Kocher T, 1870, BERLINER KLIN WEHNSC, V7, P101; Mattick A, 2000, J ROY COLL SURG EDIN, V45, P312; MCNAMARA RM, 1993, ANN EMERG MED, V22, P1140, DOI 10.1016/S0196-0644(05)80979-5; Milch H, 1938, SURGERY, V3, P732; Patissier P., 1882, TRAITE MALADIES ARTI, P162; RIEBEL GD, 1991, AM J EMERG MED, V9, P180, DOI 10.1016/0735-6757(91)90187-O; STIMSON LA, 1900, MED REC, P356	9	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1472	1473		10.1136/bmj.329.7480.1472	http://dx.doi.org/10.1136/bmj.329.7480.1472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604188	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000225965800031
J	Schuman, E; Chan, D				Schuman, E; Chan, D			Fueling synapses	CELL			English	Editorial Material							MICROTUBULES; MITOCHONDRIA; NEURONS; ACTIN	The transmission of information across neuronal synapses is an energetically taxing business. Sheng and colleagues monitored the localization of mitochondria following different levels of synaptic activation and discovered that these organelles change their distribution in interesting ways, stalling near synapses when neurons are activated and increasing their movement when neurons are silent (Li et al., 2004 [this issue of Cell]).	CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA	California Institute of Technology	Schuman, E (corresponding author), CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA.		Schuman, Erin M/D-6204-2011					Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Ligon LA, 2000, J COMP NEUROL, V427, P351, DOI 10.1002/1096-9861(20001120)427:3<351::AID-CNE3>3.0.CO;2-R; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Stewart JJ, 2000, J CLIN PHARMACOL, V40, P347, DOI 10.1177/00912700022009044; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yang F, 2003, J CELL BIOL, V163, P511, DOI 10.1083/jcb.200307027; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	10	11	11	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 17	2004	119	6					738	740		10.1016/j.cell.2004.12.003	http://dx.doi.org/10.1016/j.cell.2004.12.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607970	Bronze			2022-12-28	WOS:000225907200004
J	Stockwell, BR				Stockwell, BR			Exploring biology with small organic molecules	NATURE			English	Article							DIVERSITY-ORIENTED SYNTHESIS; REFLECTOMETRIC INTERFERENCE SPECTROSCOPY; FOCUSED COMBINATORIAL LIBRARIES; PROTEIN-PROTEIN INTERACTIONS; DRUG DISCOVERY; CHEMICAL GENETICS; RNA INTERFERENCE; TARGET IDENTIFICATION; GLOBAL ANALYSIS; SOLID-PHASE	Small organic molecules have proven to be invaluable tools for investigating biological systems, but there is still much to learn from their use. To discover and to use more effectively new chemical tools to understand biology, strategies are needed that allow us to systematically explore 'biological-activity space'. Such strategies involve analysing both protein binding of, and phenotypic responses to, small organic molecules. The mapping of biological-activity space using small molecules is akin to mapping the stars - uncharted territory is explored using a system of coordinates that describes where each new feature lies.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University; Columbia University	Stockwell, BR (corresponding author), Columbia Univ, Dept Biol Sci, 614 Fairchild Ctr,MC 2406, New York, NY 10027 USA.	stockwell@biology.columbia.edu	Stockwell, Brent R/AAE-7200-2019	Stockwell, Brent R/0000-0002-3532-3868	NCI NIH HHS [R01 CA097061, R01 CA097061-02, R01 CA097061-01, R01 CA097061-03, R01 CA097061-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA097061] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; Arya P, 2004, J COMB CHEM, V6, P65, DOI 10.1021/cc0340067; Bajorath F, 2002, NAT REV DRUG DISCOV, V1, P882, DOI 10.1038/nrd941; Birkert O, 2002, ANAL CHEM, V74, P834, DOI 10.1021/ac0106952; Birkert O, 2002, ANAL BIOANAL CHEM, V372, P141, DOI 10.1007/s00216-001-1196-4; BRENNER S, 1974, GENETICS, V77, P71; Bulseco Dylan A, 2003, Methods Cell Biol, V72, P465, DOI 10.1016/S0091-679X(03)72022-6; Burke MD, 2003, SCIENCE, V302, P613, DOI 10.1126/science.1089946; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Burke TJ, 2003, COMB CHEM HIGH T SCR, V6, P183, DOI 10.2174/138620703106298365; Couve-Bonnaire S, 2004, J COMB CHEM, V6, P73, DOI 10.1021/cc030026x; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Greenbaum DC, 2002, CHEM BIOL, V9, P1085, DOI 10.1016/S1074-5521(02)00238-7; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hann MM, 2004, CURR OPIN CHEM BIOL, V8, P255, DOI 10.1016/j.cbpa.2004.04.003; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HARTWELL LH, 1991, GENETICS, V129, P975; Hicks RP, 2001, CURR MED CHEM, V8, P627, DOI 10.2174/0929867013373237; Homola J, 2003, ANAL BIOANAL CHEM, V377, P528, DOI 10.1007/s00216-003-2101-0; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jimonet P, 2004, CURR OPIN DRUG DISC, V7, P325; Jona G, 2003, CURR OPIN MOL THER, V5, P271; Kapur R, 2002, ANN NY ACAD SCI, V961, P196, DOI 10.1111/j.1749-6632.2002.tb03081.x; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kauvar LM, 1998, J CHROMATOGR B, V715, P93, DOI 10.1016/S0378-4347(98)00045-0; Kelley BP, 2004, CHEM BIOL, V11, P1495, DOI 10.1016/j.chembiol.2004.08.026; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; Kubota H, 2002, CHEM BIOL, V9, P265, DOI 10.1016/S1074-5521(02)00099-6; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Lakey JH, 1998, CURR OPIN STRUC BIOL, V8, P119, DOI 10.1016/S0959-440X(98)80019-5; LASSUS P, 2002, SCI STKE, V147, pPL13; Lefurgy S, 2004, CHEM BIOL, V11, P151, DOI 10.1016/j.chembiol.2004.02.005; Liberles SD, 1997, P NATL ACAD SCI USA, V94, P7825, DOI 10.1073/pnas.94.15.7825; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; MacBeath G, 1999, J AM CHEM SOC, V121, P7967, DOI 10.1021/ja991083q; Misra R, 1998, MED RES REV, V18, P383, DOI 10.1002/(SICI)1098-1128(199811)18:6&lt;383::AID-MED3&gt;3.0.CO;2-A; Moore P, 2003, NATURE, V426, P725, DOI 10.1038/426725a; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Oprea TI, 2004, CURR OPIN CHEM BIOL, V8, P349, DOI 10.1016/j.cbpa.2004.06.008; Osterberg F, 2002, PROTEINS, V46, P34, DOI 10.1002/prot.10028; Peng H, 2003, BIOORG MED CHEM LETT, V13, P3693, DOI 10.1016/j.bmcl.2003.08.014; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Reid RC, 2004, J MED CHEM, V47, P1641, DOI 10.1021/jm030337m; Root DE, 2003, CHEM BIOL, V10, P881, DOI 10.1016/j.chembiol.2003.08.009; Root DE, 2002, CURR OPIN DRUG DISC, V5, P355; Salemme FR, 2003, PHARMACOGENOMICS, V4, P257, DOI 10.1517/phgs.4.3.257.22692; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Schreiber SL, 1998, BIOORGAN MED CHEM, V6, P1127, DOI 10.1016/S0968-0896(98)00126-6; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Siegel Marshall M., 2002, Current Topics in Medicinal Chemistry, V2, P13, DOI 10.2174/1568026023394551; Sodeoka M, 2001, J MED CHEM, V44, P3216, DOI 10.1021/jm0100741; Spring DR, 2003, ORG BIOMOL CHEM, V1, P3867, DOI 10.1039/b310752n; Stahura FL, 1999, J MOL GRAPH MODEL, V17, P1, DOI 10.1016/S1093-3263(99)00015-7; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Stockwell BR, 2000, TRENDS BIOTECHNOL, V18, P449, DOI 10.1016/S0167-7799(00)01499-2; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Stockwell BR, 2002, NEURON, V36, P559, DOI 10.1016/S0896-6273(02)01056-5; TIMASHEFF SN, 1991, PHARMACOL THERAPEUT, V52, P191, DOI 10.1016/0163-7258(91)90008-A; Tuschl T, 2002, NAT BIOTECHNOL, V20, P446, DOI 10.1038/nbt0502-446; Vangrevelinghe E, 2003, J MED CHEM, V46, P2656, DOI 10.1021/jm030827e; Vetter D, 2002, J CELL BIOCHEM, P79, DOI 10.1002/jcb.10408; Wang J, 2001, J BIOL CHEM, V276, P9599, DOI 10.1074/jbc.M009162200; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Winssinger N, 2002, P NATL ACAD SCI USA, V99, P11139, DOI 10.1073/pnas.172286899; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Young SS, 2004, CURR OPIN DRUG DISC, V7, P318; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	75	361	387	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					846	854		10.1038/nature03196	http://dx.doi.org/10.1038/nature03196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602550	Green Accepted			2022-12-28	WOS:000225733500041
J	Wolfer, DP; Litvin, O; Morf, S; Nitsch, RM; Lipp, HP; Wurbel, H				Wolfer, DP; Litvin, O; Morf, S; Nitsch, RM; Lipp, HP; Wurbel, H			Cage enrichment and-mouse behaviour - Test responses by laboratory mice are unperturbed by more entertaining housing.	NATURE			English	Editorial Material							ENVIRONMENTAL ENRICHMENT; STANDARDIZATION		Univ Zurich, Inst Anat, Div Neuroanat & Behav, CH-8057 Zurich, Switzerland; Univ Zurich, Div Psychiat Res, CH-8008 Zurich, Switzerland; Univ Giessen, Inst Vet Physiol, Anim Welf & Ethol Grp, D-35392 Giessen, Germany	University of Zurich; University of Zurich; Justus Liebig University Giessen	Wolfer, DP (corresponding author), Univ Zurich, Inst Anat, Div Neuroanat & Behav, CH-8057 Zurich, Switzerland.	hanno.wurbel@vetmed.uni-giessen.de	Würbel, Hanno/D-6281-2012; Wolfer, David P/B-3293-2016	Würbel, Hanno/0000-0002-2934-3010; Wolfer, David P/0000-0002-5957-1401				Chapillon P, 1999, BEHAV GENET, V29, P41, DOI 10.1023/A:1021437905913; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Gartner K., 1999, P INT JOINT M 12 ICL, P207; van der Staay FJ, 2002, GENES BRAIN BEHAV, V1, P9, DOI 10.1046/j.1601-1848.2001.00007.x; Van Loo PLP, 2003, LAB ANIM-UK, V37, P300, DOI 10.1258/002367703322389870; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wurbel H, 2002, GENES BRAIN BEHAV, V1, P3, DOI 10.1046/j.1601-1848.2001.00006.x; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5	8	183	187	3	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					821	822		10.1038/432821a	http://dx.doi.org/10.1038/432821a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602544				2022-12-28	WOS:000225733500035
J	Wade, DT; Halligan, PW				Wade, DT; Halligan, PW			Do biomedical models of illness make for good healthcare systems?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICALLY UNEXPLAINED SYMPTOMS; STROKE PATIENTS; DISABILITY; SOMATIZATION; REFERRALS; DISORDER; CONTEXT; DISEASE; BURDEN; GIVERS		Oxford Ctr Enablement, Oxford OX3 7LD, England; Cardiff Univ, Cardiff CF10 3YG, S Glam, Wales	University of Oxford; Cardiff University	Wade, DT (corresponding author), Oxford Ctr Enablement, Oxford OX3 7LD, England.	derick.wade@dsl.pipex.com	Halligan, Peter W/A-1669-2010	Halligan, Peter W/0000-0003-2784-6690; Wade, Derick/0000-0002-1188-8442				*AUD COMM, 2002, AUD COMM FULL EQ 200; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; BRODY H, 1973, PERSPECT BIOL MED, V17, P71; Buchbinder R, 2001, BRIT MED J, V322, P1516, DOI 10.1136/bmj.322.7301.1516; Carson AJ, 2000, J NEUROL NEUROSUR PS, V68, P207, DOI 10.1136/jnnp.68.2.207; Carson AJ, 2000, J NEUROL NEUROSUR PS, V68, P202, DOI 10.1136/jnnp.68.2.202; Chin N P, 2000, Educ Health (Abingdon), V13, P317; de Jonge P, 2004, GEN HOSP PSYCHIAT, V26, P147, DOI 10.1016/j.genhosppsych.2003.09.001; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Eriksen HR, 1998, EUR J PUBLIC HEALTH, V8, P294, DOI 10.1093/eurpub/8.4.294; Evers S, 2002, HEALTH POLICY, V61, P21, DOI 10.1016/S0168-8510(01)00219-6; Gabbard GO, 2001, AM J PSYCHIAT, V158, P1956, DOI 10.1176/appi.ajp.158.12.1956; Halligan PW, 2003, MALINGERING ILLNESS; Hymovich DP, 1992, CHRONIC ILLNESS CHIL; *INT WORK PART STR, 2000, NAT CLIN GUID STROK; Kalra L, 2004, BMJ-BRIT MED J, V328, P1099, DOI 10.1136/bmj.328.7448.1099; KARJALAINEN K, 2004, COCHRANE LIB; KIELHOFNER G, 1978, AM J OCCUP THER, V32, P637; KIRMAYER LJ, 1994, CAN J PSYCHIAT, V39, P584, DOI 10.1177/070674379403901002; Ladwig KH, 2001, PSYCHOSOMATICS, V42, P511, DOI 10.1176/appi.psy.42.6.511; Maiden NL, 2003, RHEUMATOLOGY, V42, P750, DOI 10.1093/rheumatology/keg211; Malleson A., 2002, WHIPLASH OTHER USEFU; Mann WC, 1999, ARCH FAM MED, V8, P210, DOI 10.1001/archfami.8.3.210; *NAT COLL CTR CHRO, 2003, NAT CLIN GUID DIAGN; Oliver, 1983, SOCIAL WORK DISABLED; Parsons T., 1951, SOCIAL SYSTEM; Patel A, 2004, BMJ-BRIT MED J, V328, P1102, DOI 10.1136/bmj.328.7448.1102; Piazza D, 1990, Rehabil Nurs, V15, P254; Porter R., 1997, GREATEST BENEFIT MAN; Post MWM, 1999, CLIN REHABIL, V13, P5, DOI 10.1191/026921599701532072; PRICE JR, 2004, COCHRANE LIB; Sharpe M, 2001, ANN INTERN MED, V134, P926, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00018; Smith R, 2002, BRIT MED J, V324, P883, DOI 10.1136/bmj.324.7342.883; Stone J, 2002, BRIT MED J, V325, P1449, DOI 10.1136/bmj.325.7378.1449; *STROK UN TRIAL CO, 2004, COCHR LIB; Turner J, 2001, BRIT MED J, V322, P745, DOI 10.1136/bmj.322.7289.745; Wade DT, 2003, CLIN REHABIL, V17, P349, DOI 10.1191/0269215503cr619ed; Wade DT, 2000, CLIN REHABIL, V14, P115, DOI 10.1191/026921500672636483; Wade DT, 2001, CLIN REHABIL, V15, P343, DOI 10.1191/026921501678310144; Wade DT, 2001, CLIN REHABIL, V15, P459, DOI 10.1191/026921501680425171; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; WHO, 2001, WHO INT CLASS FUNCT; World Health Organization, 1980, INT CLASS IMP DIS HA; Zimmermann C, 1996, J PSYCHOSOM RES, V40, P351, DOI 10.1016/0022-3999(95)00536-6	45	229	235	0	48	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2004	329	7479					1398	1401		10.1136/bmj.329.7479.1398	http://dx.doi.org/10.1136/bmj.329.7479.1398			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	880JB	15591570	Green Published, Green Accepted			2022-12-28	WOS:000225785000029
J	Hiller, NL; Bhattacharjee, S; van Ooij, C; Liolios, K; Harrison, T; Lopez-Estrano, C; Haldar, K				Hiller, NL; Bhattacharjee, S; van Ooij, C; Liolios, K; Harrison, T; Lopez-Estrano, C; Haldar, K			A host-targeting signal in virulence proteins reveals a secretome in malarial infection	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; TRAFFICKING; CYTOADHERENCE; ANTIGEN; SURFACE	Malaria parasites secrete proteins across the vacuolar membrane into the erythrocyte, inducing modifications linked to disease and parasite survival. We identified an 11-amino acid signal required for the secretion of proteins from the Plasmodium falciparum vacuole to the human erythrocyte, Bioinformatics predicted a secretome of >320 proteins and conservation of the signal across parasite species. Functional studies indicated the predictive value of the signal and its role in targeting virulence proteins to the erythrocyte and implicated its recognition by a receptor/transporter. Erythrocyte modification by the parasite may involve plasmodial heat shock proteins and be vastly more complex than hitherto realized.	Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Immunol Microbiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Haldar, K (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	k-haldar@northwestern.edu	Hiller, N. Luisa/A-3739-2016; Estrano, Carlos E./B-3576-2009; Haldar, Kasturi/C-6685-2014	Hiller, N. Luisa/0000-0001-6572-1368; 	NHLBI NIH HHS [HL69630] Funding Source: Medline; NIAID NIH HHS [AI39071] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039071] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cheresh P, 2002, J BIOL CHEM, V277, P16265, DOI 10.1074/jbc.M109331200; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; Haeggstrom M, 2004, MOL BIOCHEM PARASIT, V133, P1, DOI 10.1016/j.molbiopara.2003.07.006; Haldar K, 2002, CELL MICROBIOL, V4, P383, DOI 10.1046/j.1462-5822.2002.00204.x; Kaviratne M, 2002, EUKARYOT CELL, V1, P926, DOI 10.1128/EC.1.6.926-935.2002; Kun JFJ, 1997, MOL BIOCHEM PARASIT, V85, P41, DOI 10.1016/S0166-6851(96)02805-8; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100; LUSTIGMAN S, 1990, MOL BIOCHEM PARASIT, V38, P261, DOI 10.1016/0166-6851(90)90029-L; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Nirmalan N, 2004, MOL MICROBIOL, V52, P1187, DOI 10.1111/j.1365-2958.2004.04049.x; PERKINS M, 1988, EXP PARASITOL, V65, P61, DOI 10.1016/0014-4894(88)90107-5; Rasti N, 2004, FEMS IMMUNOL MED MIC, V41, P9, DOI 10.1016/j.femsim.2004.01.010; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	21	612	638	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1934	1937		10.1126/science.1102737	http://dx.doi.org/10.1126/science.1102737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591203				2022-12-28	WOS:000225695600044
J	Chaer, RA; Lipnick, S				Chaer, RA; Lipnick, S			Cylindroma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Illinois, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chaer, RA (corresponding author), Univ Illinois, Chicago, IL 60612 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2004	351	24					2530	2530		10.1056/NEJMicm040316	http://dx.doi.org/10.1056/NEJMicm040316			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877TE	15590955				2022-12-28	WOS:000225593100008
J	Kohls-Gatzoulis, J; Angel, JC; Singh, D; Haddad, F; Livingstone, J; Berry, G				Kohls-Gatzoulis, J; Angel, JC; Singh, D; Haddad, F; Livingstone, J; Berry, G			Tibialis posterior dysfunction: a common and treatable cause of adult acquired flatfoot	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TENDON DYSFUNCTION; SURGICAL-TREATMENT; RUPTURE; INSUFFICIENCY; FOOT; ETIOLOGY		Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England; Middlesex Hosp, London W1N 8AA, England; Barnet Gen Hosp, Barnet EN5 3DJ, England; McGill Univ, Montreal Gen Hosp, Ctr Hlth, Montreal, PQ H3G 1A4, Canada	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; McGill University	Kohls-Gatzoulis, J (corresponding author), Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England.	gatzoulis@ntlworld.com						BASMAJIAN JV, 1963, J BONE JOINT SURG AM, V45, P1189, DOI 10.2106/00004623-196345060-00006; Beals TC, 1998, FOOT ANKLE INT, V19, P177, DOI 10.1177/107110079801900313; Borton DC, 1997, J BONE JOINT SURG BR, V79B, P641, DOI 10.1302/0301-620X.79B4.7396; Chao W, 1996, FOOT ANKLE INT, V17, P736, DOI 10.1177/107110079601701204; Dyal CM, 1997, FOOT ANKLE INT, V18, P85, DOI 10.1177/107110079701800208; FREY C, 1990, J BONE JOINT SURG AM, V72A, P884, DOI 10.2106/00004623-199072060-00014; Haddad FS, 2000, J BONE JOINT SURG BR, V82B, P807, DOI 10.1302/0301-620X.82B6.10486; HOLMES GB, 1992, FOOT ANKLE, V13, P70, DOI 10.1177/107110079201300204; JOHNSON KA, 1989, CLIN ORTHOP RELAT R, V239, P196; JOHNSON KA, 1983, CLIN ORTHOP RELAT R, V177, P140; Kohls-Gatzoulis J., 2004, FOOT, V14, P207, DOI [10.1016/j.foot.2004.06.003, DOI 10.1016/J.FOOT.2004.06.003]; Kohls-Gatzoulis JA, 2001, FOOT ANKLE INT, V22, P950, DOI 10.1177/107110070102201203; MANN RA, 1985, J BONE JOINT SURG AM, V67A, P556, DOI 10.2106/00004623-198567040-00009; MANN RA, 1983, CLIN ORTHOP RELAT R, V181, P46; Mizel MS, 1999, FOOT ANKLE INT, V20, P285, DOI 10.1177/107110079902000502; MONTO RR, 1991, FOOT ANKLE, V11, P400, DOI 10.1177/107110079101100612; Mosier SM, 1999, CLIN ORTHOP RELAT R, P12; Mosier SM, 1998, FOOT ANKLE INT, V19, P520, DOI 10.1177/107110079801900803; MYERSON M, 1989, FOOT ANKLE, V9, P219, DOI 10.1177/107110078900900503; Myerson MS, 1996, J BONE JOINT SURG AM, V78A, P780, DOI 10.2106/00004623-199605000-00020; Pomeroy GC, 1999, J BONE JOINT SURG AM, V81A, P1173, DOI 10.2106/00004623-199908000-00014; TEASDALL RD, 1994, FOOT ANKLE INT, V15, P646, DOI 10.1177/107110079401501203; Wacker JT, 2002, J BONE JOINT SURG BR, V84B, P54, DOI 10.1302/0301-620X.84B1.11847; Wapner KL, 1999, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199908000-00005; Yeap JS, 2001, FOOT ANKLE INT, V22, P51, DOI 10.1177/107110070102200108	25	86	88	2	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2004	329	7478					1328	1333		10.1136/bmj.329.7478.1328	http://dx.doi.org/10.1136/bmj.329.7478.1328			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	878PC	15576744	Green Published			2022-12-28	WOS:000225657800022
J	Wu, CW; Miloslavskaya, I; Demontis, S; Maestro, R; Galaktionov, K				Wu, CW; Miloslavskaya, I; Demontis, S; Maestro, R; Galaktionov, K			Regulation of cellular response to oncogenic and oxidative stress by Seladin-1	NATURE			English	Article							TRANSCRIPTIONAL ACTIVITY; ALZHEIMERS-DISEASE; INDUCED SENESCENCE; CELLS; MDM2; P53; FIBROBLASTS; RESISTANCE; ONCOPROTEIN; SUPPRESSOR	Expression of multiple oncogenes and inactivation of tumour suppressors is required to transform primary mammalian cells into cancer cells(1-3). Activated Ha-RasV12 (Ras) is usually associated with cancer, but it also produces paradoxical premature senescence(4) in primary cells by inducing reactive oxygen species(5) followed by accumulation of tumour suppressors p53 and p16(INK4a) (ref. 4). Here we identify, using a direct genetic screen, Seladin-1 (also known as Dhcr24) as a key mediator of Ras-induced senescence. Following oncogenic and oxidative stress, Seladin-1 binds p53 amino terminus and displaces E3 ubiquitin ligase Mdm2 from p53, thus resulting in p53 accumulation. Additionally, Seladin-1 associates with Mdm2 independently of p53, potentially affecting other Mdm2 targets. Ablation of Seladin-1 causes the bypass of Ras-induced senescence in rodent and human fibroblasts, and allows Ras to transform these cells. Wild-type Seladin-1, but not mutants that disrupt its association with either p53 or Mdm2, suppresses the transformed phenotype. The same mutants are also inactive in directing p53-dependent oxidative stress response. These results show an unanticipated role for Seladin-1, previously implicated in Alzheimer's disease(6) and cholesterol metabolism(7), in integrating cellular response to oncogenic and oxidative stress.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; CRO IRCCS Aviano Natl Canc Inst, Dept Expt Oncol, MMNP Unit, I-33081 Aviano, PN, Italy	Baylor College of Medicine; IRCCS Aviano (CRO)	Galaktionov, K (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	kgalakt@bcm.tmc.edu	Maestro, Roberta/P-9748-2019; Maestro, Roberta/M-1846-2015	Maestro, Roberta/0000-0002-6642-5592; Maestro, Roberta/0000-0002-6642-5592				ANGULI G, 2003, MOL CANCER RES, V1, P1027; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cadet J, 1997, Rev Physiol Biochem Pharmacol, V131, P1; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Greeve I, 2000, J NEUROSCI, V20, P7345; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; TAKAHASHI T, 1995, GENE DEV, V9, P97, DOI 10.1101/gad.9.1.97; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016	27	161	169	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					640	645		10.1038/nature03173	http://dx.doi.org/10.1038/nature03173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577914	Bronze			2022-12-28	WOS:000225433200050
J	Esposito, LW; Colwell, JE; Larsen, K; McClintock, WE; Stewart, AIF; Hallett, JT; Shemansky, DE; Ajello, JM; Hansen, CJ; Hendrix, AR; West, RA; Keller, HU; Korth, A; Pryor, WR; Reulke, R; Yung, YL				Esposito, LW; Colwell, JE; Larsen, K; McClintock, WE; Stewart, AIF; Hallett, JT; Shemansky, DE; Ajello, JM; Hansen, CJ; Hendrix, AR; West, RA; Keller, HU; Korth, A; Pryor, WR; Reulke, R; Yung, YL			Ultraviolet Imaging Spectroscopy shows an active saturnian system	SCIENCE			English	Article							SPACE-TELESCOPE; GAS-DRAG; E-RING; MAGNETOSPHERE; ENCOUNTER; SATELLITE; ACCRETION; EVOLUTION; EMISSION; HYDROGEN	Neutral oxygen in the Saturnian system shows variability, and the total number of oxygen atoms peaks at 4 x 10(34). Saturn's aurora brightens in response to solar-wind forcing, and the auroral spectrum resembles Jupiter's. Phoebe's surface shows variabie water-ice content, and the data indicate it originated in the outer solar system. Saturn's rings also show variable water abundance, with the purest ice in the outermost A ring. This radial variation is consistent with initially pure water ice bombarded by meteors, but smaller radial structures may indicate collisional transport and recent renewal events in the past 10(7) to 10(8) years.	Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; Univ So Calif, Los Angeles, CA 90089 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Cent Arizona Coll, Coolidge, AZ 85228 USA; Univ Stuttgart, Inst Photogrammetry, D-70174 Stuttgart, Germany; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	University of Colorado System; University of Colorado Boulder; University of Southern California; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; University of Stuttgart; California Institute of Technology	Esposito, LW (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, 234 Innovat Dr, Boulder, CO 80303 USA.	larry.esposito@lasp.colorado.edu	ESPOSITO, LARRY W/AAB-3673-2021; Colwell, Joshua/AAP-2692-2020; Yung, Yuk/AAM-4850-2021	ESPOSITO, LARRY W/0000-0003-3381-2016; Colwell, Joshua/0000-0001-8269-6408; Yung, Yuk/0000-0002-4263-2562				Barbara JM, 2002, ICARUS, V160, P161, DOI 10.1006/icar.2002.6962; BROADFOOT AL, 1981, SCIENCE, V212, P206, DOI 10.1126/science.212.4491.206; Canup RM, 1996, ICARUS, V119, P427, DOI 10.1006/icar.1996.0028; COLWELL JE, 1993, J GEOPHYS RES-PLANET, V98, P7387, DOI 10.1029/93JE00329; Colwell JE, 2000, J GEOPHYS RES-PLANET, V105, P17589, DOI 10.1029/1999JE001209; Cowley SWH, 2004, ANN GEOPHYS-GERMANY, V22, P1379, DOI 10.5194/angeo-22-1379-2004; Cuk M, 2004, ICARUS, V167, P369, DOI 10.1016/j.icarus.2003.09.026; Cuzzi JN, 1998, ICARUS, V132, P1, DOI 10.1006/icar.1997.5863; DONES L, 1993, ICARUS, V105, P184, DOI 10.1006/icar.1993.1118; ESPOSITO LW, 1983, ICARUS, V56, P439, DOI 10.1016/0019-1035(83)90165-3; ESPOSITO LW, 1986, ICARUS, V67, P345, DOI 10.1016/0019-1035(86)90119-3; ESPOSITO LW, IN PRESS SPACE SCI R; ESPOSITO LW, 2003, M AM GEOPH UN SAN FR; Gerard JC, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010513; Gurnett DA, 2002, NATURE, V415, P985, DOI 10.1038/415985a; Jonin C, 2000, ASTROPHYS J SUPPL S, V129, P247, DOI 10.1086/313414; Juhasz A, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000182; Jurac S, 2001, ICARUS, V149, P384, DOI 10.1006/icar.2000.6528; McClintock WE, 2000, P SOC PHOTO-OPT INS, V4135, P225, DOI 10.1117/12.494220; POLLACK JB, 1979, ICARUS, V37, P587, DOI 10.1016/0019-1035(79)90016-2; PRANGE R, IN PRESS NATURE; PRYOR WA, UNPUB; SANDEL BR, 1982, SCIENCE, V215, P548, DOI 10.1126/science.215.4532.548; SHEMANSKY D, 2004, M COMM SPAC RES PAR; SHEMANSKY DE, 1992, J GEOPHYS RES-SPACE, V97, P4143, DOI 10.1029/91JA02805; SHEMANSKY DE, 1993, NATURE, V363, P329, DOI 10.1038/363329a0; SHEMANSKY DE, UNPUB; SHOWALTER MR, 1991, NATURE, V351, P709, DOI 10.1038/351709a0; Trauger JT, 1998, J GEOPHYS RES-PLANET, V103, P20237, DOI 10.1029/98JE01324; WAGENER R, 1988, ESA SPECIAL PUBLICAT, V1, P85; WAGNER JK, 1987, ICARUS, V69, P14, DOI 10.1016/0019-1035(87)90003-0; WARREN SG, 1986, APPL OPTICS, V25, P2650, DOI 10.1364/AO.25.002650; Young DT, 2005, SCIENCE, V307, P1262, DOI 10.1126/science.1106151	33	108	108	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1251	1255		10.1126/science.1105606	http://dx.doi.org/10.1126/science.1105606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15604361				2022-12-28	WOS:000227313200042
J	Gray, PA; Fu, H; Luo, P; Zhao, Q; Yu, J; Ferrari, A; Tenzen, T; Yuk, DI; Tsung, EF; Cai, ZH; Alerta, JA; Cheng, LP; Liu, Y; Stenman, JM; Valerius, MT; Billings, N; Kim, HA; Greenberg, ME; McMahon, AP; Rowitch, DH; Stiles, CD; Ma, QF				Gray, PA; Fu, H; Luo, P; Zhao, Q; Yu, J; Ferrari, A; Tenzen, T; Yuk, DI; Tsung, EF; Cai, ZH; Alerta, JA; Cheng, LP; Liu, Y; Stenman, JM; Valerius, MT; Billings, N; Kim, HA; Greenberg, ME; McMahon, AP; Rowitch, DH; Stiles, CD; Ma, QF			Mouse brain organization revealed through direct genome-scale TF expression analysis	SCIENCE			English	Article							GENE; MUTATIONS; PROFILES; SEQUENCE; DISORDER	In the developing brain, transcription factors (TFs) direct the formation of a diverse array of neurons and glia. We identified 1445 putative TFs in the mouse genome. We used in situ hybridization to map the expression of over 1000 of these TFs and TF-coregulator genes in the brains of developing mice. We found that 349 of these genes showed restricted expression patterns that were adequate to describe the anatomical organization of the brain. We provide a comprehensive inventory of murine TFs and their expression patterns in a searchable brain atlas database.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Childrens Hosp, Informat Program, Boston, MA 02115 USA; Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Stiles, CD (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	Charles-Stiles@dfci.harvard.edu; Qiufu_Ma@dfci.harvard.edu	Fu, Hui/O-5811-2019; McMahon, Andrew P/ABE-7520-2020; Fu, Hui/C-2881-2011	Fu, Hui/0000-0003-0252-6009; Fu, Hui/0000-0003-0252-6009; Liu, Yang/0000-0002-0396-3844; Rowitch, David/0000-0002-0079-0060				Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Gharani N, 2004, MOL PSYCHIATR, V9, P474, DOI 10.1038/sj.mp.4001498; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; Holder JL, 2000, HUM MOL GENET, V9, P101; Kandel E., 2000, PRINCIPLES NEURAL SC; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DL, 2004, NUCLEIC ACIDS RES, V32, pD35, DOI 10.1093/nar/gkh073	18	329	334	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2255	2257		10.1126/science.1104935	http://dx.doi.org/10.1126/science.1104935			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618518				2022-12-28	WOS:000225950000046
J	Wood, KE; Becker, BN; McCartney, JG; D'Alessandro, AM; Coursin, DB				Wood, KE; Becker, BN; McCartney, JG; D'Alessandro, AM; Coursin, DB			Care of the potential organ donor	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRANSPLANT TUMOR REGISTRY; EXPERIMENTAL BRAIN-DEATH; DELAYED GRAFT FUNCTION; RENAL-TRANSPLANTATION; HEART-TRANSPLANTATION; LIVER-TRANSPLANTATION; LUNG TRANSPLANTATION; MULTIORGAN DONORS; CADAVER DONOR; RISK-FACTORS		Univ Wisconsin Hosp & Clin, Dept Med, Madison, WI 53792 USA; Univ Wisconsin Hosp & Clin, Dept Surg, Madison, WI 53792 USA; Univ Wisconsin Hosp & Clin, Dept Anesthesiol, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wood, KE (corresponding author), Univ Wisconsin Hosp & Clin, Dept Med, 600 Highland Ave,Rm K4-930, Madison, WI 53792 USA.	kew@medicine.wisc.edu			NIDDK NIH HHS [1K24DK616962-02] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMADO JA, 1995, METABOLISM, V44, P812, DOI 10.1016/0026-0495(95)90198-1; Angelis M, 2003, LIVER TRANSPLANT, V9, P451, DOI 10.1053/jlts.2003.50094; Baroldi G, 1997, J HEART LUNG TRANSPL, V16, P994; Buell JF, 2003, TRANSPLANTATION, V76, P340, DOI 10.1097/01.TP.0000076094.64973.D8; Cantin B, 2003, TRANSPLANTATION, V76, P1275, DOI 10.1097/01.TP.0000093445.50624.5A; Cittanova ML, 1996, LANCET, V348, P1620, DOI 10.1016/S0140-6736(96)07588-5; COOPER DKC, 1989, ANN ROY COLL SURG, V71, P261; Cummings J, 1995, J TRANSPLANT COORDIN, V5, P103; DeVita MA, 2001, CRIT CARE MED, V29, P1826; Finfer S, 1996, INTENS CARE MED, V22, P1424, DOI 10.1007/BF01709564; Follette D, 1999, TRANSPLANT P, V31, P169, DOI 10.1016/S0041-1345(98)01487-0; Follette DM, 1998, J HEART LUNG TRANSPL, V17, P423; Freeman RB, 1999, TRANSPLANTATION, V68, P1107, DOI 10.1097/00007890-199910270-00008; Gabbay E, 1999, AM J RESP CRIT CARE, V160, P265, DOI 10.1164/ajrccm.160.1.9811017; GASSER M, 2001, TRANSPLANT REV, V15, P1; Goarin JP, 1996, ANESTH ANALG, V83, P41, DOI 10.1097/00000539-199607000-00008; GORES PF, 1992, ANN SURG, V215, P217, DOI 10.1097/00000658-199203000-00005; Gortmaker S L, 1998, J Transpl Coord, V8, P210; GRAMM HJ, 1992, TRANSPLANTATION, V54, P851, DOI 10.1097/00007890-199211000-00016; GROSSMAN MD, 1996, CRIT CARE MED, V24, P76; HEFTY TR, 1993, TRANSPLANTATION, V55, P442, DOI 10.1097/00007890-199302000-00042; HOWLETT TA, 1989, TRANSPLANTATION, V47, P828, DOI 10.1097/00007890-198905000-00016; Jenkins, 1997, Crit Care, V1, P65, DOI 10.1186/cc105; Jenkins DH, 1999, WORLD J SURG, V23, P644, DOI 10.1007/PL00012362; Kauffman HM, 2002, TRANSPLANTATION, V74, P358, DOI 10.1097/00007890-200208150-00011; Kauffman HM, 2000, TRANSPLANTATION, V70, P1747, DOI 10.1097/00007890-200012270-00014; KOLIN A, 1984, STROKE, V15, P990, DOI 10.1161/01.STR.15.6.990; Koning OHJ, 1997, TRANSPLANTATION, V63, P1620, DOI 10.1097/00007890-199706150-00015; Kono T, 1999, AM J CARDIOL, V84, P578, DOI 10.1016/S0002-9149(99)00382-3; Lopez-Navidad A, 2003, CLIN TRANSPLANT, V17, P308, DOI 10.1034/j.1399-0012.2003.00119.x; Lopez-Navidad A, 2001, TRANSPLANT P, V33, P795, DOI 10.1016/S0041-1345(00)02259-4; LopezNavidad A, 1997, TRANSPL P, V29, P1607, DOI 10.1016/S0041-1345(96)00689-6; Lutz-Dettinger N, 2001, PEDIATR CLIN N AM, V48, P715, DOI 10.1016/S0031-3955(05)70336-9; Marik PE, 2002, CHEST, V122, P1784, DOI 10.1378/chest.122.5.1784; MASSON F, 1993, TRANSPLANTATION, V56, P363, DOI 10.1097/00007890-199308000-00022; MILANO A, 1993, TRANSPL P, V25, P3158; NOVITZKY D, 1989, TRANSPLANT P, V21, P2567; Novitzky D, 1997, TRANSPLANT P, V29, P3773, DOI 10.1016/S0041-1345(97)01150-0; NOVITZKY D, 1988, TRANSPLANTATION, V45, P32; NOVITZKY D, 1987, TRANSPLANTATION, V43, P852, DOI 10.1097/00007890-198743060-00016; NOVITZKY D, 1987, ANN THORAC SURG, V43, P288, DOI 10.1016/S0003-4975(10)60615-7; NYGAARD CE, 1990, J TRAUMA, V30, P728, DOI 10.1097/00005373-199006000-00013; *ORG DON BREAKTHR, 2003, BEST PRACT FIN REP; Parry A, 1999, J HEART LUNG TRANSPL, V18, P121, DOI 10.1016/S1053-2498(98)00026-6; PENNEFATHER SH, 1993, TRANSPLANTATION, V56, P1418, DOI 10.1097/00007890-199312000-00028; PENNEFATHER SH, 1995, TRANSPLANTATION, V59, P58, DOI 10.1097/00007890-199501150-00011; POTTER CDO, 1995, J HEART LUNG TRANSPL, V14, P59; POWER BM, 1995, ANAESTH INTENS CARE, V23, P26, DOI 10.1177/0310057X9502300107; POWNER DJ, 1990, CRIT CARE MED, V18, P702; RANDELL TT, 1992, TRANSPLANTATION, V54, P736, DOI 10.1097/00007890-199210000-00034; Reilly PM, 1996, CHEST, V110, p222S; RICHARDSON DW, 1985, ANN INTERN MED, V103, P228, DOI 10.7326/0003-4819-103-2-228; Rosendale JD, 2003, TRANSPLANTATION, V75, P482, DOI 10.1097/01.TP.0000045683.85282.93; Rosendale JD, 2002, AM J TRANSPLANT, V2, P761, DOI 10.1034/j.1600-6143.2002.20810.x; Rosengard BR, 2002, AM J TRANSPLANT, V2, P701, DOI 10.1034/j.1600-6143.2002.20804.x; Sakuma T, 1997, AM J RESP CRIT CARE, V155, P506, DOI 10.1164/ajrccm.155.2.9032186; Salim A, 2001, ARCH SURG-CHICAGO, V136, P1377, DOI 10.1001/archsurg.136.12.1377; Sarmento A, 2000, TRANSPLANT P, V32, P2571, DOI 10.1016/S0041-1345(00)01793-0; Schnuelle P, 1999, KIDNEY INT, V56, P738, DOI 10.1046/j.1523-1755.1999.00567.x; Schnuelle P, 2001, TRANSPLANTATION, V72, P455, DOI 10.1097/00007890-200108150-00017; Sheehy E, 2003, NEW ENGL J MED, V349, P667, DOI 10.1056/NEJMsa021271; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; Stangl M, 2001, TRANSPL P, V33, P1284, DOI 10.1016/S0041-1345(00)02479-9; SUNDARESAN S, 1995, J THORAC CARDIOV SUR, V109, P1075, DOI 10.1016/S0022-5223(95)70190-7; Tilney NL, 2001, TRANSPL P, V33, P843, DOI 10.1016/S0041-1345(00)02341-1; Totsuka E, 2000, TRANSPLANT P, V32, P322, DOI 10.1016/S0041-1345(99)00969-0; Ueno T, 2000, TRANSPLANTATION, V70, P436, DOI 10.1097/00007890-200008150-00008; WHEELDON DR, 1995, J HEART LUNG TRANSPL, V14, P734; WHELCHEL JD, 1986, TRANSPLANT P, V18, P523; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20; Wilhelm MJ, 2000, J HEART LUNG TRANSPL, V19, P414, DOI 10.1016/S1053-2498(00)00073-5; Williams MA, 2003, CRIT CARE MED, V31, P1568, DOI 10.1097/01.CCM.0000063090.21056.A6; YOSHIOKA T, 1986, NEUROSURGERY, V18, P565, DOI 10.1227/00006123-198605000-00009	74	230	245	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2730	2739		10.1056/NEJMra013103	http://dx.doi.org/10.1056/NEJMra013103			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616207				2022-12-28	WOS:000225877300008
J	Fisher, AE; Barnes, GR; Hillebrand, A; Burrow, C; Furlong, PL; Holliday, IE				Fisher, AE; Barnes, GR; Hillebrand, A; Burrow, C; Furlong, PL; Holliday, IE			Can you tell your clunis from your cubitus? A benchmark for functional imaging	BRITISH MEDICAL JOURNAL			English	Article							SOMATOSENSORY HOMUNCULUS; HUMANS; CORTEX		Aston Univ, Neurosci Res Inst, Birmingham B4 7ET, W Midlands, England	Aston University	Barnes, GR (corresponding author), Aston Univ, Neurosci Res Inst, Birmingham B4 7ET, W Midlands, England.	barnesgr@aston.ac.uk	Barnes, Gareth/ABB-7650-2020	Barnes, Gareth/0000-0002-5396-7712; Furlong, Paul/0000-0002-9840-8586; Hillebrand, Arjan/0000-0002-8508-3532				Itomi K, 2001, BRAIN TOPOGR, V14, P15, DOI 10.1023/A:1012511621766; NARICI L, 1991, NEUROSCI LETT, V121, P51, DOI 10.1016/0304-3940(91)90647-C; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; YANG TT, 1993, P NATL ACAD SCI USA, V90, P3098, DOI 10.1073/pnas.90.7.3098; 2003, CAMBRIDGE INT DICT I	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1492	1493		10.1136/bmj.329.7480.1492-a	http://dx.doi.org/10.1136/bmj.329.7480.1492-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604196	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000225965800040
J	Ozolins, M; Eady, EA; Avery, AJ; Cunliffe, WJ; Po, ALW; O'Neill, C; Simpson, NB; Walters, CE; Carnegie, E; Lewis, JB; Dada, J; Haynes, M; Williams, K; Williams, HC				Ozolins, M; Eady, EA; Avery, AJ; Cunliffe, WJ; Po, ALW; O'Neill, C; Simpson, NB; Walters, CE; Carnegie, E; Lewis, JB; Dada, J; Haynes, M; Williams, K; Williams, HC			Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial	LANCET			English	Article							PROPIONIBACTERIUM-ACNES; RESISTANT PROPIONIBACTERIA; ANTIBIOTICS; SKIN	Background We investigated the efficacy and cost-effectiveness of five antimicrobial regimens for mild to moderate facial acne and whether propionibacterial antibiotic resistance affects treatment response. Methods in this randomised, observer-masked trial, 649 community participants were allocated one of five antibacterial regimens. Primary outcomes were patients' self-assessed improvement and reduction in inflamed lesions at 18 weeks. Analyses were by intention to treat. Findings Moderate or greater improvement at 18 weeks was reported in 72 (55%) of 131 participants assigned oral oxytetracycline plus topical placebo, 70 (54%) of 130 assigned oral minocycline plus topical placebo, 78 (60%) of 130 assigned topical benzoyl peroxide plus oral placebo, 84 (66%) of 127 assigned topical erythromycin and benzoyl peroxide in a combined formulation plus oral placebo, and 82 (63%) of 131 assigned topical erythromycin and benzoyl peroxide separately plus oral placebo. Most improvement occurred in the first 6 weeks. Treatment differences for the proportion of people with at least moderate improvement were: minocycline versus oxytetracycline -1.2% (unadjusted 95% CI -13.3 to 10.9); combined erythromycin and benzoyl peroxide versus oxytetracycline 11.1% (-0.7 to 22.9) and versus minocycline 12.3% (0.4 to 24.2); erythromycin and benzoyl peroxide separately versus combined formulation -3.5% (-15.2 to 8.2); benzoyl peroxide versus oxytetracycline 5.0% (-7.0 to 17.0), versus minocycline 6.2% (-5.8 to 18.2), and versus combined formulation -6.1% (-17.9 to 5.7). Benzoyl peroxide was the most cost-effective treatment. Efficacy of both tetracyclines was reduced by pre-existing tetracycline resistance. Interpretation Topical benzoyl peroxide and benzoyl peroxide/erythromycin combinations are similar in efficacy to oral oxytetracycline and minocycline and are not affected by propionibacterial antibiotic resistance.	Queens Med Ctr, Ctr Evidenc Based Dermatol, Nottingham NG7 2UH, England; Univ Leeds, Sch Biochem & Microbiol, Leeds, W Yorkshire, England; Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; Leeds Gen Infirm, Dept Dermatol, Leeds, W Yorkshire, England; Aston Univ, Ctr Evidence Based Pharmacotherapy, Birmingham B4 7ET, W Midlands, England; Univ Ulster, Sch Policy Studies, Newtownabbey, North Ireland; Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of Nottingham; University of Leeds; University of Nottingham; Leeds General Infirmary; University of Leeds; Aston University; Ulster University; Newcastle University - UK	Williams, HC (corresponding author), Queens Med Ctr, Ctr Evidenc Based Dermatol, Nottingham NG7 2UH, England.	Hywel.Williams@Nottingham.ac.uk		Avery, Anthony/0000-0001-7591-4438; williams, hywel/0000-0002-5646-3093				BALRISHNAN R, 2003, J DERMATOL TREAT, V14, P172; BURKE BM, 1984, BRIT J DERMATOL, V111, P83, DOI 10.1111/j.1365-2133.1984.tb04020.x; Coates P, 2002, BRIT J DERMATOL, V146, P840, DOI 10.1046/j.1365-2133.2002.04690.x; Cooper AJ, 1998, MED J AUSTRALIA, V169, P259, DOI 10.5694/j.1326-5377.1998.tb140250.x; Department of Health and Social Care (DHSC), 2000, UK ANT RES STRAT ACT; Eady AE, 2003, AM J CLIN DERMATOL, V4, P813, DOI 10.2165/00128071-200304120-00002; Eady E A, 2000, Am J Clin Dermatol, V1, P201, DOI 10.2165/00128071-200001040-00001; EADY EA, 1989, BRIT J DERMATOL, V121, P51, DOI 10.1111/j.1365-2133.1989.tb01399.x; EADY EA, 1990, J DERMATOL TREAT, V1, P215, DOI DOI 10.3109/09546639009086737; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Garner S E, 2000, COCHRANE DB SYST REV, V02; GARRATT AM, 1993, BMJ-BRIT MED J, V306, P1440, DOI 10.1136/bmj.306.6890.1440; Gollnick H, 2003, DRUGS, V63, P1579, DOI 10.2165/00003495-200363150-00005; Ingham E, 1999, CURR OPIN INFECT DIS, V12, P191, DOI 10.1097/00001432-199906000-00006; Jeremy AHT, 2003, J INVEST DERMATOL, V121, P20, DOI 10.1046/j.1523-1747.2003.12321.x; LEHMANN H, 2000, 17 J HOPK EV BAS PRA; Lehmann HP, 2002, J AM ACAD DERMATOL, V47, P231, DOI 10.1067/mjd.2002.120912; LEWISJONES MS, 1995, BRIT J DERMATOL, V132, P942; LEYDEN JJ, 1983, J AM ACAD DERMATOL, V8, P41, DOI 10.1016/S0190-9622(83)70005-8; Morgan M, 1997, BRIT J DERMATOL, V136, P202; MOTLEY RJ, 1989, CLIN EXP DERMATOL, V14, P194, DOI 10.1111/j.1365-2230.1989.tb00930.x; PLEWIG G, 1975, J INVEST DERMATOL, V65, P532, DOI 10.1111/1523-1747.ep12610281; Ross JI, 2003, BRIT J DERMATOL, V148, P467, DOI 10.1046/j.1365-2133.2003.05067.x; Shalita A, 2001, J EUR ACAD DERMATOL, V15, P43, DOI 10.1046/j.0926-9959.2001.00012.x; Stathakis V, 1997, Australas J Dermatol, V38, P115; Wise P, 1996, BRIT MED J, V313, P1245, DOI 10.1136/bmj.313.7067.1245	26	121	121	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2004	364	9452					2188	2195		10.1016/S0140-6736(04)17591-0	http://dx.doi.org/10.1016/S0140-6736(04)17591-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610805				2022-12-28	WOS:000225799700027
J	Guogas, LM; Filman, DJ; Hogle, JM; Gehrke, L				Guogas, LM; Filman, DJ; Hogle, JM; Gehrke, L			Cofolding organizes alfalfa mosaic virus RNA and coat protein for replication	SCIENCE			English	Article							NUCLEOTIDE-SEQUENCE; BINDING-SITES; AMINO-ACIDS; VIRAL RNAS; DETERMINANTS; RECOGNITION; INITIATION; RESOLUTION; INFECTION; CONTAINS	Alfalfa mosaic virus genomic RNAs are infectious only when the viral coat protein binds to the RNA 3' termini. The crystal structure of an alfalfa mosaic virus RNA-peptide complex reveals that conserved AUGC repeats and Pro-Thr-x-Arg-Ser-x-x-Tyr coat protein amino acids cofold upon interacting. Alternating AUGC residues have opposite orientation, and they base pair in different adjacent duplexes. Localized RNA backbone reversals stabilized by arginine-guanine interactions place the adenosines and guanines in reverse order in the duplex. The results suggest that a uniform, organized 3' conformation, similar to that found on viral RNAs with transfer RNA-like ends, may be essential for replication.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	Hogle, JM (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	James_Hogle@hms.harvard.edu; Lee_Gehrke@hms.harvard.edu	Hogle, James/HIG-9121-2022	filman, david/0000-0002-8714-1644; Hogle, James/0000-0002-3655-1504	NIAID NIH HHS [AI20566, R01 AI020566] Funding Source: Medline; NIGMS NIH HHS [R01 GM042504, GM42504] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020566, R21AI020566, R01AI020566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042504] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ansel-McKinney P, 1998, J MOL BIOL, V278, P767, DOI 10.1006/jmbi.1998.1656; AnselMcKinney P, 1996, EMBO J, V15, P5077, DOI 10.1002/j.1460-2075.1996.tb00888.x; BAER ML, 1994, EMBO J, V13, P727, DOI 10.1002/j.1460-2075.1994.tb06312.x; BOL JF, 1971, VIROLOGY, V46, P73, DOI 10.1016/0042-6822(71)90007-9; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Chapman MR, 1999, J MOL BIOL, V286, P709, DOI 10.1006/jmbi.1998.2503; DREHER TW, 1984, NATURE, V311, P171, DOI 10.1038/311171a0; FUKUYAMA K, 1983, J MOL BIOL, V167, P873, DOI 10.1016/S0022-2836(83)80116-8; HouserScott F, 1997, J VIROL, V71, P2310, DOI 10.1128/JVI.71.3.2310-2319.1997; HOUSERSCOTT F, 1994, J VIROL, V68, P2194, DOI 10.1128/JVI.68.4.2194-2205.1994; HOUWING CJ, 1982, BIOCHEMISTRY-US, V21, P3408, DOI 10.1021/bi00257a025; HOUWING CJ, 1978, BIOCHEMISTRY-US, V17, P2927, DOI 10.1021/bi00607a035; JASPARS EMJ, 1985, MOL PLANT VIROLOGY, V1, P155; KOPERZWARTHOFF EC, 1980, NUCLEIC ACIDS RES, V8, P3307, DOI 10.1093/nar/8.15.3307; Kumar A, 1997, J VIROL, V71, P7911, DOI 10.1128/JVI.71.10.7911-7916.1997; Laforest SM, 2004, RNA, V10, P48, DOI 10.1261/rna.5154104; PETRILLO JE, UNPUB; QUIGLEY GJ, 1984, NUCLEIC ACIDS RES, V12, P347, DOI 10.1093/nar/12.1Part1.347; REUSKEN CBEM, 1994, NUCLEIC ACIDS RES, V22, P1346, DOI 10.1093/nar/22.8.1346; Reusken CBEM, 1996, NUCLEIC ACIDS RES, V24, P2660, DOI 10.1093/nar/24.14.2660; Rocheleau G, 2004, J VIROL, V78, P8036, DOI 10.1128/JVI.78.15.8036-8046.2004; Yusibov V, 1998, VIROLOGY, V242, P1, DOI 10.1006/viro.1997.8973; YUSIBOV VM, 1995, VIROLOGY, V208, P405, DOI 10.1006/viro.1995.1168	23	29	31	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2108	2111		10.1126/science.1103399	http://dx.doi.org/10.1126/science.1103399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604410	Green Accepted			2022-12-28	WOS:000225841000067
J	Smeeth, L; Thomas, SL; Hall, AJ; Hubbard, R; Farrington, P; Vallance, P				Smeeth, L; Thomas, SL; Hall, AJ; Hubbard, R; Farrington, P; Vallance, P			Risk of myocardial infarction and stroke after acute infection or vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CASE SERIES; INFLAMMATION; ASSOCIATION; HYPERTENSION; DATABASE; MARKERS; HEALTH	BACKGROUND: There is evidence that chronic inflammation may promote atherosclerotic disease. We tested the hypothesis that acute infection and vaccination increase the short-term risk of vascular events. METHODS: We undertook within-person comparisons, using the case-series method, to study the risks of myocardial infarction and stroke after common vaccinations and naturally occurring infections. The study was based on the United Kingdom General Practice Research Database, which contains computerized medical records of more than 5 million patients. RESULTS: A total of 20,486 persons with a first myocardial infarction and 19,063 persons with a first stroke who received influenza vaccine were included in the analysis. There was no increase in the risk of myocardial infarction or stroke in the period after influenza, tetanus, or pneumococcal vaccination. However, the risks of both events were substantially higher after a diagnosis of systemic respiratory tract infection and were highest during the first three days (incidence ratio for myocardial infarction, 4.95; 95 percent confidence interval, 4.43 to 5.53; incidence ratio for stroke, 3.19; 95 percent confidence interval, 2.81 to 3.62). The risks then gradually fell during the following weeks. The risks were raised significantly but to a lesser degree after a diagnosis of urinary tract infection. The findings for recurrent myocardial infarctions and stroke were similar to those for first events. CONCLUSIONS: Our findings provide support for the concept that acute infections are associated with a transient increase in the risk of vascular events. By contrast, influenza, tetanus, and pneumococcal vaccinations do not produce a detectable increase in the risk of vascular events.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Nottingham, Div Resp Med, Nottingham NG7 2RD, England; Open Univ, Div Stat, Milton Keynes MK7 6AA, Bucks, England; UCL, Ctr Clin Pharmacol, British Heart Fdn Labs, Div Med, London WC1E 6BT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Nottingham; Open University - UK; University of London; University College London	Smeeth, L (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	liam.smeeth@lshtm.ac.uk	Greiver, Michelle/N-8764-2015; Smeeth, Liam/X-5862-2018	Greiver, Michelle/0000-0001-8957-0285; Farrington, Conor Patrick/0000-0002-7148-2612; Smeeth, Liam/0000-0002-9168-6022	MRC [G108/492] Funding Source: UKRI; Medical Research Council [G108/492] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alber DG, 2000, CIRCULATION, V102, P779, DOI 10.1161/01.CIR.102.7.779; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Chan NN, 2001, J AM COLL CARDIOL, V38, P1814, DOI 10.1016/S0735-1097(01)01669-2; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Farrington CP, 1998, AM J EPIDEMIOL, V147, P93; Gibbs RGJ, 2001, STROKE, V32, P1085, DOI 10.1161/01.STR.32.5.1085; Grau AJ, 2004, STROKE, V35, P1147, DOI 10.1161/01.STR.0000124122.71702.64; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Hollowell J, 1997, Popul Trends, P36; Jick H, 1996, PHARMACOTHERAPY, V16, P321; Jick H, 1997, EPIDEMIOLOGY, V8, P446, DOI 10.1097/00001648-199707000-00017; Keaney JF, 2002, NEW ENGL J MED, V347, P55, DOI 10.1056/NEJM200207043470112; KINLAY S, 1997, AM J CARDIOL, V80, P11; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; MATTILA KJ, 1989, J INTERN MED, V225, P293, DOI 10.1111/j.1365-2796.1989.tb00084.x; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Melbye H, 2004, BRIT J GEN PRACT, V54, P653; *OFF NAT STAT, 1998, KEY HLTH STAT GE MB6, V1; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; SPODICK DH, 1984, AM J CARDIOL, V53, P481, DOI 10.1016/0002-9149(84)90016-X; SYRJANEN J, 1988, BRIT MED J, V296, P1156, DOI 10.1136/bmj.296.6630.1156; Tata LJ, 2003, THORAX, V58, P835, DOI 10.1136/thorax.58.10.835; VALTONEN V, 1993, EUR HEART J, V14, P20; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; WOODHOUSE PR, 1994, LANCET, V343, P435, DOI 10.1016/S0140-6736(94)92689-1	30	973	1005	0	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2611	2618		10.1056/NEJMoa041747	http://dx.doi.org/10.1056/NEJMoa041747			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602021	Green Published, Green Accepted			2022-12-28	WOS:000225726100008
J	Yanik, MF; Cinar, H; Cinar, HN; Chisholm, AD; Jin, YS; Ben-Yakar, A				Yanik, MF; Cinar, H; Cinar, HN; Chisholm, AD; Jin, YS; Ben-Yakar, A			Neurosurgery - Functional regeneration after laser axotomy	NATURE			English	Editorial Material							NERVOUS-SYSTEM; CAENORHABDITIS-ELEGANS		Stanford Univ, Ginzton Lab, Dept Appl Phys, Stanford, CA 94305 USA; Univ Calif Santa Cruz, Sinsheimer Labs, Dept MCD Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Univ Texas, Dept Mech Engn, Austin, TX 78712 USA	Stanford University; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of Texas System; University of Texas Austin	Yanik, MF (corresponding author), Stanford Univ, Ginzton Lab, Dept Appl Phys, Stanford, CA 94305 USA.	ben-yakar@mail.utexas.edu		Chisholm, Andrew/0000-0001-5091-0537; Jin, Yishi/0000-0002-9371-9860; Yanik, Mehmet/0000-0002-8963-2893				Bhatt DH, 2004, SCIENCE, V305, P254, DOI 10.1126/science.1098439; Colombelli J, 2004, REV SCI INSTRUM, V75, P472, DOI 10.1063/1.1641163; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Perry MD, 1999, J APPL PHYS, V85, P6803, DOI 10.1063/1.370197; SHEN N, 2003, THESIS HARVARD U; Tirlapur UK, 2002, NATURE, V418, P290, DOI 10.1038/418290a; Vogel A, 1999, APPL PHYS B-LASERS O, V68, P271, DOI 10.1007/s003400050617; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	10	445	460	3	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					822	822		10.1038/432822a	http://dx.doi.org/10.1038/432822a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602545				2022-12-28	WOS:000225733500036
J	Wise, MS				Wise, MS			A functional autoantibody in human narcolepsy?	LANCET			English	Editorial Material							HYPOCRETIN NEURONS; ONSET		Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Wise, MS (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	mswise@bcm.tmc.edu						Boehmer LN, 2004, EXP NEUROL, V188, P292, DOI 10.1016/j.expneurol.2004.04.006; Carlander B, 2001, REV NEUROL-FRANCE, V157, pS97; Gerashchenko D, 2004, BRAIN RES, V1019, P162, DOI 10.1016/j.brainres.2004.06.016; Jackson MW, 2004, GASTROENTEROLOGY, V126, P819, DOI 10.1053/j.gastro.2003.12.015; Lagrange AH, 2003, EPILEPSY BEHAV, V4, P788, DOI 10.1016/j.yebeh.2003.08.030; Lodi R, 2004, NEUROLOGY, V63, P1513; Nishino S, 2001, ANN NEUROL, V50, P381, DOI 10.1002/ana.1130; PEYRON C, 2003, REV NEUROL S11, V159; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; Scammell TE, 2003, ANN NEUROL, V53, P154, DOI 10.1002/ana.10444; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Wang Chuan-Yu, 1998, No To Hattatsu, V30, P300; Waterman SA, 2000, ARTHRITIS RHEUM, V43, P1647	13	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	2004	364	9451					2076	2077		10.1016/S0140-6736(04)17562-4	http://dx.doi.org/10.1016/S0140-6736(04)17562-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589294				2022-12-28	WOS:000225742300005
J	Horner-Devine, MC; Lage, M; Hughes, JB; Bohannan, BJM				Horner-Devine, MC; Lage, M; Hughes, JB; Bohannan, BJM			A taxa-area relationship for bacteria	NATURE			English	Article							POPULATIONS; DNA	A positive power-law relationship between the number of species in an area and the size of that area has been observed repeatedly in plant and animal communities(1). This species - area relationship, thought to be one of the few laws in ecology(2), is fundamental to our understanding of the distribution of global biodiversity. However, such a relationship has not been reported for bacteria, and little is known regarding the spatial distribution of bacteria, relative to what is known of plants and animals(3). Here we describe a taxa - area relationship for bacteria over a scale of centimetres to hundreds of metres in salt marsh sediments. We found that bacterial communities located close together were more similar in composition than communities located farther apart, and we used the decay of community similarity with distance to show that bacteria can exhibit a taxa - area relationship. This relationship was driven primarily by environmental heterogeneity rather than geographic distance or plant composition.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Stanford University; Brown University	Horner-Devine, MC (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	mchd@u.washington.edu	Martiny, Jennifer/AAB-9323-2019; Bohannan, Brendan J. M./R-1582-2017	Bohannan, Brendan J. M./0000-0003-2907-1016; Horner-Devine, Claire/0000-0002-0783-3406; Martiny, Jennifer/0000-0002-2415-1247				Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Baas-Becking LGM., 1934, GEOLOGIE INLEIDING M; Bennett JP, 1997, RHODORA, V99, P241; BERTNESS MD, 1999, ECOLOGY ATLANTIC SHO, P313; Burke DJ, 2002, APPL ENVIRON MICROB, V68, P1157, DOI 10.1128/AEM.68.3.1157-1164.2002; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Harcourt AH, 1999, GLOBAL ECOL BIOGEOGR, V8, P55, DOI 10.1046/j.1365-2699.1999.00125.x; Harte J, 1999, OIKOS, V86, P45, DOI 10.2307/3546568; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Legendre P., 1998, NUMERICAL ECOLOGY, P33; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MAGURRAN AE, 2004, MEASURING BIOL DIVER, P175; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; MCCAIG AE, 1994, FEMS MICROBIOL LETT, V120, P363, DOI 10.1016/0378-1097(94)90497-9; PEITINGER M, 2003, BASIC APPL ECOL, V4, P385; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Roberts MS, 1995, EVOLUTION, V49, P1081, DOI 10.1111/j.1558-5646.1995.tb04435.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; SCHLOSS PD, IN PRESS APPL ENV MI; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	29	519	552	13	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					750	753		10.1038/nature03073	http://dx.doi.org/10.1038/nature03073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592412				2022-12-28	WOS:000225597200047
J	DeLong, EF				DeLong, EF			Microbial life breathes deep	SCIENCE			English	Editorial Material							SEDIMENTS; PROKARYOTES; BIOSPHERE; DIVERSITY		MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; MIT, Div Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DeLong, EF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	delong@mit.edu						CANFIELD DE, 1993, MAR GEOL, V113, P27, DOI 10.1016/0025-3227(93)90147-N; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; Newberry CJ, 2004, ENVIRON MICROBIOL, V6, P274, DOI 10.1111/j.1462-2920.2004.00568.x; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Sturt HF, 2004, RAPID COMMUN MASS SP, V18, P617, DOI 10.1002/rcm.1378; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	8	28	31	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2198	2200		10.1126/science.1107241	http://dx.doi.org/10.1126/science.1107241			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15622564				2022-12-28	WOS:000225950000027
J	Jennerjahn, TC; Ittekkot, V; Arz, HW; Behling, H; Patzold, J; Wefer, G				Jennerjahn, TC; Ittekkot, V; Arz, HW; Behling, H; Patzold, J; Wefer, G			Asynchronous terrestrial and marine signals of climate change during Heinrich events	SCIENCE			English	Article							LAST GLACIAL MAXIMUM; NORTHEASTERN BRAZIL; TROPICAL ATLANTIC; ORGANIC-MATTER; NORTH-ATLANTIC; SEA-LEVEL; OCEAN; PALEOCLIMATE; DEGLACIATION; CIRCULATION	Tropical regions have been reported to play a key role in climate dynamics. To date, however, there are uncertainties in the timing and the amplitude of the response of tropical ecosystems to millennial-scale climate change. We present evidence of an asynchrony between terrestrial and marine signals of climate change during Heinrich events preserved in marine sediment cores from the Brazilian continental margin. The inferred time tag of about 1000 to 2000 years is much larger than the ecological response to recent climate change and appears to be related to the nature of hydrological changes.	Zentrum Marine Trop Okol, D-28359 Bremen, Germany; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Deutsch Forschungsgemeinsch, Forschungszentrum Ozeanrander RCOM, D-28359 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; German Research Foundation (DFG)	Jennerjahn, TC (corresponding author), Zentrum Marine Trop Okol, Fahrenheitstr 6, D-28359 Bremen, Germany.	tim.jennerjahn@zmt-bremen.de	Arz, Helge/A-6659-2013; Ittekkot, Venugopalan/AAC-3437-2022; Gerold, Wefer/S-2291-2016; Jennerjahn, Tim/AAE-9146-2020; Patzold, Jurgen/D-5111-2017	Gerold, Wefer/0000-0002-6803-2020; Jennerjahn, Tim/0000-0003-1022-5126; Ittekkot, Venugopalan/0000-0003-2667-5068; Patzold, Jurgen/0000-0001-8074-4103; Arz, Helge Wolfgang/0000-0002-1997-1718				ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; Arz HW, 1998, QUATERNARY RES, V50, P157, DOI 10.1006/qres.1998.1992; Arz HW, 1999, EARTH PLANET SC LETT, V167, P105, DOI 10.1016/S0012-821X(99)00025-4; Baker PA, 2001, NATURE, V409, P698, DOI 10.1038/35055524; Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; BARRETTO HT, 1975, J SEDIMENT PETROL, V45, P822; Behling H, 2000, QUATERNARY SCI REV, V19, P981, DOI 10.1016/S0277-3791(99)00046-3; BRADLEY RS, 1991, PALEOCLIMATOLOGY; Broccoli AJ, 2000, J CLIMATE, V13, P951, DOI 10.1175/1520-0442(2000)013<0951:TCATLG>2.0.CO;2; Broecker WS, 2001, SCIENCE, V294, P2308, DOI 10.1126/science.1068389; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Crowley TJ, 1999, PALEOCEANOGRAPHY, V14, P271, DOI 10.1029/1999PA900003; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Farrera I, 1999, CLIM DYNAM, V15, P823, DOI 10.1007/s003820050317; FISCHER G, 1991, MAR CHEM, V35, P581, DOI 10.1016/S0304-4203(09)90044-5; Galimov E.M, 1985, BIOL FRACTIONATION I; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hostetler SW, 1999, NATURE, V399, P673, DOI 10.1038/21401; Hughen KA, 2004, SCIENCE, V304, P1955, DOI 10.1126/science.1092995; Jansen JHF, 1998, MAR GEOL, V151, P143, DOI 10.1016/S0025-3227(98)00074-7; Jennerjahn TC, 1999, MAR GEOL, V161, P129, DOI 10.1016/S0025-3227(99)00045-6; JENNERJAHN TC, UNPUB; Kerr RA, 2001, SCIENCE, V292, P660, DOI 10.1126/science.292.5517.660; Ledru MP, 2002, GEOLOGY, V30, P275, DOI 10.1130/0091-7613(2002)030<0275:TCITGO>2.0.CO;2; MCMANUS JF, 1994, NATURE, V371, P326, DOI 10.1038/371326a0; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Sarnthein M., 2000, EOS T AM GEOPHYS UN, V81, P625; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; Vidal L, 1997, EARTH PLANET SC LETT, V146, P13, DOI 10.1016/S0012-821X(96)00192-6; WADA E, 1991, NITROGEN SEA FORMS A; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	32	117	122	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2236	2239		10.1126/science.1102490	http://dx.doi.org/10.1126/science.1102490			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15576572	Green Submitted			2022-12-28	WOS:000225950000040
J	Benford, G				Benford, G			Reality is wilder	NATURE			English	Editorial Material									Univ Calif Irvine, Dept Phys, Irvine, CA 92697 USA	University of California System; University of California Irvine	Benford, G (corresponding author), Univ Calif Irvine, Dept Phys, Irvine, CA 92697 USA.							1971, PHYS REV D, V2, P263	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2004	432	7020					955	955		10.1038/432955a	http://dx.doi.org/10.1038/432955a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616538	Bronze			2022-12-28	WOS:000225887000019
J	Hunt, J; Brooks, R; Jennions, MD; Smith, MJ; Bentsen, CL; Bussiere, LF				Hunt, J; Brooks, R; Jennions, MD; Smith, MJ; Bentsen, CL; Bussiere, LF			High-quality male field crickets invest heavily in sexual display but die young	NATURE			English	Article							LEK PARADOX; PHENOTYPIC PLASTICITY; TRADE-OFFS; GOOD GENES; LIFE-SPAN; OLD-AGE; SELECTION; TRAITS; RESTRICTION; HANDICAP	Only high-quality males can bear the costs of an extreme sexual display(1-4). As a consequence, such males are not only more attractive, but they often live longer than average(5). Recent theory predicts, however, that high-quality males should sometimes invest so heavily in sexual displays that they die sooner than lower quality males(2,6-9). We manipulated the phenotypic quality of field crickets, Teleogryllus commodus, by altering the protein content of their diet. Here we show that nymphs and adult females reared on a high-protein diet lived longer than those on a low-protein diet. In contrast, adult males reared on a high-protein diet died sooner than those on low-protein diets because they invested more energy in calling during early adulthood. Our findings uphold the theoretical prediction that the relationship between longevity and sexual advertisement may be dynamic(2,3,6-8) (that is, either positive or negative), depending on local conditions(3,6) such as resource availability. Moreover, they caution the use of longevity as a proxy for fitness in sexual selection studies, and suggest avenues for future research on the relationship between sexual attractiveness and ageing.	Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia; Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia	University of New South Wales Sydney; Australian National University	Hunt, J (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia.	john.hunt@unsw.edu.au	Hunt, John/F-1279-2014; Jennions, Michael D/C-7560-2009; Bussiere, Luc/T-2134-2018; Brooks, Robert/A-1251-2008	Jennions, Michael D/0000-0001-9221-2788; Bussiere, Luc/0000-0001-8937-8381; Brooks, Robert/0000-0001-6926-0781; Hunt, John/0000-0002-4962-8750				Candolin U, 2000, P ROY SOC B-BIOL SCI, V267, P2425, DOI 10.1098/rspb.2000.1301; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Eshel I, 2000, EVOL ECOL RES, V2, P509; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; GUSTAFSSON L, 1995, NATURE, V375, P311, DOI 10.1038/375311a0; Hansen TF, 1995, J EVOLUTION BIOL, V8, P759, DOI 10.1046/j.1420-9101.1995.8060759.x; Hoglund J, 1998, OIKOS, V83, P478, DOI 10.2307/3546675; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P2109, DOI 10.1098/rspb.1999.0895; Kokko H, 1998, EVOL ECOL, V12, P739, DOI 10.1023/A:1006541701002; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kotiaho J, 1998, J ANIM ECOL, V67, P287, DOI 10.1046/j.1365-2656.1998.00192.x; Kotiaho JS, 2001, NATURE, V410, P684, DOI 10.1038/35070557; Kotiaho JS, 2000, BEHAV ECOL SOCIOBIOL, V48, P188, DOI 10.1007/s002650000221; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Muller HG, 1997, P NATL ACAD SCI USA, V94, P2762, DOI 10.1073/pnas.94.6.2762; NUR N, 1984, J THEOR BIOL, V110, P275, DOI 10.1016/S0022-5193(84)80059-4; Roff Derek, 2002, pi; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Wagner WE, 1999, ANIM BEHAV, V57, P89, DOI 10.1006/anbe.1998.0964; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	30	377	381	0	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2004	432	7020					1024	1027		10.1038/nature03084	http://dx.doi.org/10.1038/nature03084			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616562				2022-12-28	WOS:000225887000041
J	Shorr, AF; Scoville, SL; Cersovsky, SB; Shanks, GD; Ockenhouse, CF; Smoak, BL; Carr, WW; Petruccelli, BP				Shorr, AF; Scoville, SL; Cersovsky, SB; Shanks, GD; Ockenhouse, CF; Smoak, BL; Carr, WW; Petruccelli, BP			Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CIGARETTE-SMOKING	Context Acute eosinophilic pneumonia (AEP) is a rare disease of unknown etiology characterized by respiratory failure, radiographic infiltrates, and eosinophilic infiltration of the lung. Objectives To describe a case series of AEP, illustrate the clinical features of this syndrome, and report the results of an epidemiologic investigation. Design, Setting, and Participants Epidemiologic investigation of cases of AEP identified both retrospectively and prospectively from March 2003 through March 2004 among US military personnel deployed in or near Iraq. Survivors were offered a follow-up evaluation. Main Outcome Measure Morbidity and mortality related to AEP. Results There were 18 cases of AEP identified among 183000 military personnel deployed in or near Iraq during the study period, yielding an AEP incidence of 9.1 per 100000 person-years (95% confidence interval, 4.3-13.3). The majority of patients (89%) were men and the median age was 22 (range, 19-47) years. All patients used tobacco, with 78% recently beginning to smoke. All but 1 reported significant exposure to fine airborne sand or dust. Known causes of pulmonary eosinophilia (eg, drug exposures or parasitic disease) were not identified. Epidemiologic investigation revealed no evidence of a common source exposure, temporal or geographic clustering, person-to-person transmission, or an association with recent vaccination. Six patients underwent bronchoalveolar lavage (median eosinophilia of 40.5%). All patients developed peripheral eosinophilia (range, 8%-42%). Mechanical ventilation was required in 67% for a median of 7 (range, 2-16) days. Two Soldiers died; the remainder responded to corticosteroids and/or supportive care. Twelve individuals were reevaluated a median of 3 months after diagnosis. At that point, 3 patients reported mild dyspnea and 1 reported wheezing. All patients had finished treatment and had either normal or nearly normal spirometry results. None had recurrent eosinophilia. Conclusions AEP occurred at an increased rate among this deployed military population and resulted in 2 deaths. Failure to consider AEP in the differential diagnosis of respiratory failure in military personnel can result in missing this syndrome and possibly death. The etiology of AEP remains unclear, but the association with new-onset smoking suggests a possible link.	Walter Reed Army Med Ctr, Pulm Crit Care & Sleep Med Serv, Washington, DC 20307 USA; Walter Reed Army Med Ctr, Allergy & Immunol Serv, Washington, DC 20307 USA; USA, Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD USA; Walter Reed Army Inst Res, Dept Communicable Dis & Immunol, Silver Spring, MD USA; Walter Reed Army Inst Res, Dept Prevent Med, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Shorr, AF (corresponding author), Walter Reed Army Med Ctr, Pulm Crit Care & Sleep Med Serv, 6900 Georgia Ave, Washington, DC 20307 USA.	afshorr@dnamail.com	Shanks, George Dennis/F-4056-2014	Shanks, George Dennis/0000-0001-5763-8660				Allen JN, 2004, CLIN CHEST MED, V25, P77, DOI 10.1016/S0272-5231(03)00141-2; ALLEN JN, 1994, AM J RESP CRIT CARE, V150, P1423, DOI 10.1164/ajrccm.150.5.7952571; ALLEN JN, 1989, NEW ENGL J MED, V321, P569, DOI 10.1056/NEJM198908313210903; BADESCH DB, 1989, AM REV RESPIR DIS, V139, P249, DOI 10.1164/ajrccm/139.1.249; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Blanchet MR, 2004, AM J RESP CRIT CARE, V169, P903, DOI 10.1164/rccm.200210-1154OC; *CDC, 2003, MMWR-MORBID MORTAL W, V52, P857; Degler DA, 1999, MIL MED, V164, P911, DOI 10.1093/milmed/164.12.911; Marchand E, 1998, MEDICINE, V77, P299, DOI 10.1097/00005792-199809000-00001; MIYAZAKI E, 1995, AM J RESP CRIT CARE, V151, P541, DOI 10.1164/ajrccm.151.2.7842218; Nakajima M, 1998, RADIOLOGY, V207, P829, DOI 10.1148/radiology.207.3.829-b; Philit F, 2002, AM J RESP CRIT CARE, V166, P1235, DOI 10.1164/rccm.2112056; PopeHarman AL, 1996, MEDICINE, V75, P334, DOI 10.1097/00005792-199611000-00004; Rom WN, 2002, AM J RESP CRIT CARE, V166, P797, DOI 10.1164/rccm.200206-576OC; Shintani H, 2000, CHEST, V117, P277, DOI 10.1378/chest.117.1.277; Shintani H, 2000, INTERNAL MED, V39, P66, DOI 10.2169/internalmedicine.39.66; Tazelaar HD, 1997, AM J RESP CRIT CARE, V155, P296, DOI 10.1164/ajrccm.155.1.9001328; *US DEP DEF, 2003, WORLDW MANP DISTR GE	18	157	166	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					2997	3005		10.1001/jama.292.24.2997	http://dx.doi.org/10.1001/jama.292.24.2997			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613668	Bronze			2022-12-28	WOS:000225841900034
J	Lid, TG; Eraker, R; Malterud, K				Lid, TG; Eraker, R; Malterud, K			"I recognise myself in that situation ..." - Using photographs to encourage reflection in general practitioners	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Eiganes Legekontor, N-4005 Stavanger, Norway; Univ Bergen, Sect Gen Practice, Dept Publ Hlth & Primary Hlth Care, N-5018 Bergen, Norway	University of Bergen	Lid, TG (corresponding author), Eiganes Legekontor, Olavsgt 9B, N-4005 Stavanger, Norway.	giljelid@online.no	Lid, Torgeir Gilje/H-2400-2011	Lid, Torgeir Gilje/0000-0003-0088-411X				Balint M., 2000, DOCTOR HIS PATIENT I; BECKER HS, 1998, IMASGE BASED RES SOU; Bolton G, 1999, LANCET, V354, P243, DOI 10.1016/S0140-6736(98)06443-5; HUNTER KM, 1991, NARRATIVE STRUCTURE; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Meinhof U., 2000, DISCOURSE STUDIES, V2, P323, DOI DOI 10.1177/1461445600002003004; More ES, 1996, THEOR MED, V17, P243, DOI 10.1007/BF00489448; Pellegrino E D, 2000, J Am Board Fam Pract, V13, P147; Schon D. A., 1991, REFLECTIVE PRACTITIO; Sontag S., 1979, PHOTOGRAPHY	10	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1488	1490		10.1136/bmj.329.7480.1488	http://dx.doi.org/10.1136/bmj.329.7480.1488			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604194	Green Submitted, Green Published			2022-12-28	WOS:000225965800037
J	Jackson, DE; Holcombe, M; Ratnieks, FLW				Jackson, DE; Holcombe, M; Ratnieks, FLW			Trail geometry gives polarity to ant foraging networks	NATURE			English	Article							GENERAL-MODEL; ORIENTATION; HYMENOPTERA	Pheromone trails are used by many ants to guide foragers between nest and food(1-4). But how does a forager that has become displaced from a trail know which way to go on rejoining the trail? A laden forager, for example, should walk towards the nest. Polarized trails would enable ants to choose the appropriate direction, thereby saving time and reducing predation risk. However, previous research has found no evidence that ants can detect polarity from the pheromone trail alone(3,5-7). Pharaoh's ants (Monomorium pharaonis) produce elaborate trail networks throughout their foraging environment(8). Here we show that by using information from the geometry of trail bifurcations within this network, foragers joining a trail can adaptively reorientate themselves if they initially walk in the wrong direction. The frequency of correct reorientations is maximized when the trail bifurcation angle is approximately 60 degrees, as found in natural networks. These are the first data to demonstrate how ant trails can themselves provide polarity information. They also demonstrate previously unsuspected sophistication in the organization and information content of networks in insect societies.	Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S1 4DP, S Yorkshire, England	University of Sheffield; University of Sheffield	Jackson, DE (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England.	duncan@dcs.sheffield.ac.uk						ACOSTA FJ, 1993, J THEOR BIOL, V160, P297, DOI 10.1006/jtbi.1993.1020; ARON S, 1993, INSECT SOC, V40, P369, DOI 10.1007/BF01253900; Banks AN, 2003, ETHOLOGY, V109, P835, DOI 10.1046/j.0179-1613.2003.00927.x; BARKER SB, 1973, J THEOR BIOL, V40, P33, DOI 10.1016/0022-5193(73)90163-X; CAMAZINE S, 2001, SELF ORG BIOL SYSTEM, P217; CARTHY JD, 1951, BEHAVIOUR, V3, P304, DOI 10.1163/156853951X00313; CARTHY JD, 1950, NATURE, V166, P154, DOI 10.1038/166154a0; CARTHY JD, 1951, BEHAVIOUR, V3, P275, DOI 10.1163/156853951X00304; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; Feynman RP., 1985, SURELY YOURE JOKING; FOURCASSIE V, 1994, PHYSIOL ENTOMOL, V19, P291, DOI 10.1111/j.1365-3032.1994.tb01055.x; FOWLER HG, 1978, J NEW YORK ENTOMOL S, V86, P132; HOLLDOBLER B, 1974, P NATL ACAD SCI USA, V71, P3274, DOI 10.1073/pnas.71.8.3274; Holldobler B., 1990, pi; Jeanson R, 2003, PHYSIOL ENTOMOL, V28, P192, DOI 10.1046/j.1365-3032.2003.00332.x; LEOPOLD LB, 1971, J THEOR BIOL, V31, P339, DOI 10.1016/0022-5193(71)90192-5; QUINET Y, 1991, BELG J ZOOL, V121, P55; RETTENMEYER CARL W., 1963, UNIV KANSAS SCI BULL, V44, P281; Schu┬ne H., 1984, SPATIAL ORIENTATION; SUDD J. H., 1960, ANIMAL BEHAVIOUR, V8, P67, DOI 10.1016/0003-3472(60)90011-7; SUDD JH, 1967, INTRO BEHAV ANTS, pCH6; TENNANT LE, 1991, J ENTOMOL SCI, V26, P450, DOI 10.18474/0749-8004-26.4.450; Thompson D.W, 1917, GROWTH FORM; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WILSON EDWARD O., 1962, ANIMAL BEHAVIOR, V10, P134, DOI 10.1016/0003-3472(62)90141-0	26	130	144	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					907	909		10.1038/nature03105	http://dx.doi.org/10.1038/nature03105			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602563				2022-12-28	WOS:000225733500054
J	Jarman, B; Aylin, P				Jarman, B; Aylin, P			Dr Foster's case notes - Death rates in England and Wales and the United States: variation with age, sex, and race	BRITISH MEDICAL JOURNAL			English	Article									Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England	Imperial College London	Jarman, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England.		Aylin, Paul/A-1073-2014	Aylin, Paul/0000-0003-4589-1743					0	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 11	2004	329	7479					1367	+		10.1136/bmj.329.7479.1367	http://dx.doi.org/10.1136/bmj.329.7479.1367			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880JB	15591562	Green Published			2022-12-28	WOS:000225785000015
J	Oakley, GP; Mandel, JS				Oakley, GP; Mandel, JS			Commentary: Folic acid fortification remains an urgent health priority	BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER; FOLATE; RISK		Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Oakley, GP (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd, Atlanta, GA 30322 USA.	gpoakley@mindspring.com						Cabelof DC, 2004, J BIOL CHEM, V279, P36504, DOI 10.1074/jbc.M405185200; Charles D, 2004, BMJ-BRIT MED J, V329, P1375, DOI 10.1136/bmj.329.7479.1375; Shrubsole MJ, 2001, CANCER RES, V61, P7136; Wang X, 2003, MUTAGENESIS, V18, P81, DOI 10.1093/mutage/18.1.81; Zhang SM, 2003, J NATL CANCER I, V95, P373, DOI 10.1093/jnci/95.5.373	5	8	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 11	2004	329	7479					1376	1376		10.1136/bmj.329.7479.1376	http://dx.doi.org/10.1136/bmj.329.7479.1376			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880JB	15591564	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000225785000019
J	Arvidson, RE; Anderson, RC; Bartlett, P; Bell, JF; Christensen, PR; Chu, P; Davis, K; Ehlmann, BL; Golombek, MP; Gorevan, S; Guinness, EA; Haldemann, AFC; Herkenhoff, KE; Landis, G; Li, R; Lindemann, R; Ming, DW; Myrick, T; Parker, T; Richter, L; Seelos, FP; Soderblom, LA; Squyres, SW; Sullivan, RJ; Wilson, J				Arvidson, RE; Anderson, RC; Bartlett, P; Bell, JF; Christensen, PR; Chu, P; Davis, K; Ehlmann, BL; Golombek, MP; Gorevan, S; Guinness, EA; Haldemann, AFC; Herkenhoff, KE; Landis, G; Li, R; Lindemann, R; Ming, DW; Myrick, T; Parker, T; Richter, L; Seelos, FP; Soderblom, LA; Squyres, SW; Sullivan, RJ; Wilson, J			Localization and physical property experiments conducted by opportunity at Meridiani Planum	SCIENCE			English	Article							MARS; ROVER; SPECTROMETER; HEMATITE	The location of the Opportunity landing site was determined to better than 10-m absolute accuracy from analyses of radio tracking data. We determined Rover locations during traverses with an error as small as several centimeters using engineering telemetry and overlapping images. Topographic profiles generated from rover data show that the plains are very smooth from meter- to centimeter-length scales, consistent with analyses of orbital observations. Solar cell output decreased because of the deposition of airborne dust on the panels. The lack of dust-covered surfaces on Meridiani Planum indicates that high velocity winds must remove this material on a continuing basis. The low mechanical strength of the evaporitic rocks as determined from grinding experiments, and the abundance of coarse-grained surface particles argue for differential erosion of Meridiani Planum.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Honeybee Robot, New York, NY 10012 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; US Geol Survey, Flagstaff, AZ 86001 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Deutsch Zentrun Luft & Raumfahrt, Inst Raumsimulat, D-51170 Cologne, Germany	Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; Arizona State University; Arizona State University-Tempe; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; University System of Ohio; Ohio State University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Helmholtz Association; German Aerospace Centre (DLR)	Arvidson, RE (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.	arvidson@wunder.wustl.edu	Seelos, Frank/C-7875-2016; Haldemann, Albert F C/I-9224-2012	Seelos, Frank/0000-0001-9721-941X; Haldemann, Albert F C/0000-0003-3741-8841				Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002041; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; ARVIDSON RE, 2004, SCIENCE, V305, P5685; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Li RX, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001443; MYNCK TM, 2004, AIAA SPAC 2004 C EXH; Neumann GA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017048; RICHTER L, 1999, 13 C INT SOC TERR VE; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121	16	98	106	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1730	1733		10.1126/science.1104211	http://dx.doi.org/10.1126/science.1104211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576608				2022-12-28	WOS:000225630800040
J	Pernet, B				Pernet, B			The cryptic filtering house of an invertebrate larva	SCIENCE			English	Article							ZOOPLANKTON; FLOW		Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	California State University System; California State University Long Beach	Pernet, B (corresponding author), Calif State Univ Long Beach, Dept Biol Sci, 1250 Bellflower Blvd, Long Beach, CA 90840 USA.	bpernet@csulb.edu		Pernet, Bruno/0000-0002-6200-5654				Abelson A, 1997, ANNU REV ECOL SYST, V28, P317, DOI 10.1146/annurev.ecolsys.28.1.317; AKESSON BERTIL, 1961, ACTA ZOOL, V42, P177; Brainerd EL, 2001, NATURE, V412, P387, DOI 10.1038/35086666; EMLET RB, 1985, SCIENCE, V228, P1016, DOI 10.1126/science.228.4702.1016; Flood Per R., 1998, P105; HAMNER WM, 1975, LIMNOL OCEANOGR, V20, P907, DOI 10.4319/lo.1975.20.6.0907; Strathmann R.R., 1987, P465; TRANTER PRG, 1982, J MAR BIOL ASSOC UK, V62, P845, DOI 10.1017/S0025315400070387	8	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1757	1757		10.1126/science.1104279	http://dx.doi.org/10.1126/science.1104279			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576614				2022-12-28	WOS:000225630800046
J	Gurnett, DA; Kurth, WS; Hospodarsky, GB; Persoon, AM; Averkamp, TF; Cecconi, B; Lecacheux, A; Zarka, P; Canu, P; Cornilleau-Wehrlin, N; Galopeau, P; Roux, A; Harvey, C; Louarn, P; Bostrom, R; Gustafsson, G; Wahlund, JE; Desch, MD; Farrell, WM; Kaiser, ML; Goetz, K; Kellogg, PJ; Fischer, G; Ladreiter, HP; Rucker, H; Alleyne, H; Pedersen, A				Gurnett, DA; Kurth, WS; Hospodarsky, GB; Persoon, AM; Averkamp, TF; Cecconi, B; Lecacheux, A; Zarka, P; Canu, P; Cornilleau-Wehrlin, N; Galopeau, P; Roux, A; Harvey, C; Louarn, P; Bostrom, R; Gustafsson, G; Wahlund, JE; Desch, MD; Farrell, WM; Kaiser, ML; Goetz, K; Kellogg, PJ; Fischer, G; Ladreiter, HP; Rucker, H; Alleyne, H; Pedersen, A			Radio and plasma wave observations at Saturn from Cassini's approach and first orbit	SCIENCE			English	Article							ASTRONOMY OBSERVATIONS; VOYAGER-2; ROTATION	We report data from the Cassini radio and plasma wave instrument during the approach and first orbit at Saturn. During the approach, radio emissions from Saturn showed that the radio rotation period is now 10 hours 45 minutes 45 +/- 36 seconds, about 6 minutes longer than measured by Voyager in 1980 to 1981. In addition, many intense impulsive radio signals were detected from Saturn lightning during the approach and first orbit. Some of these have been linked to storm systems observed by the Cassini imaging instrument. Within the magnetosphere, whistler-mode aurora[ hiss emissions were observed near the rings, suggesting that a strong electrodynamic interaction is occurring in or near the rings.	Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; Observ Paris, F-92195 Meudon, France; CETP, Inst Pierre Simon La Pl, F-78140 Velizy Villacoublay, France; Ctr Etud Spatiale Rayonnements, CNRS, F-31028 Toulouse, France; Swedish Inst Space Phys, SE-75121 Uppsala, Sweden; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Minnesota, Dept Phys & Astron, Minneapolis, MN 55455 USA; Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria; Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield S1 4DU, S Yorkshire, England; Univ Oslo, Dept Phys, N-0316 Oslo, Norway	University of Iowa; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Centre National de la Recherche Scientifique (CNRS); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Minnesota System; University of Minnesota Twin Cities; Austrian Academy of Sciences; University of Sheffield; University of Oslo	Gurnett, DA (corresponding author), Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA.	donald-gurnett@uiowa.edu	Hospodarsky, George B/A-7996-2015; Kurth, William/AAA-7334-2019; Cecconi, Baptiste/ABF-3912-2020; Farrell, William/I-4865-2013; Wahlund, Jan-Erik/AAL-6439-2021	Hospodarsky, George B/0000-0001-9200-9878; Kurth, William/0000-0002-5471-6202; Cecconi, Baptiste/0000-0001-7915-5571; 				AUBIER MG, 1983, GEOPHYS RES LETT, V10, P5, DOI 10.1029/GL010i001p00005; BURNS JA, 1983, ICARUS, V54, P280, DOI 10.1016/0019-1035(83)90198-7; CONNERNEY JEP, 1984, SATURN, P354; Davies M., 1996, CELESTIAL MECH, V63, P127, DOI DOI 10.1007/BF00693410; DESSLER AJ, 1985, GEOPHYS RES LETT, V12, P299, DOI 10.1029/GL012i005p00299; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; Galopeau PHM, 1995, J GEOPHYS RES-PLANET, V100, P26397, DOI 10.1029/95JE02132; Galopeau PHM, 2000, J GEOPHYS RES-SPACE, V105, P13089, DOI 10.1029/1999JA005089; Goertz C. K., 1984, SATURN, P546; GURNETT DA, 1981, SCIENCE, V212, P235, DOI 10.1126/science.212.4491.235; Gurnett DA, 2004, SPACE SCI REV, V114, P395, DOI 10.1007/s11214-004-1434-0; Gurnett DA, 2001, NATURE, V409, P313, DOI 10.1038/35053009; GURNETT DA, 1983, ICARUS, V53, P236, DOI 10.1016/0019-1035(83)90145-8; GURNETT DA, 1983, HIGH LATITUDE SPACE, P355; Kaiser M. L., 1984, SATURN, P378; KAISER ML, 1980, SCIENCE, V209, P1238, DOI 10.1126/science.209.4462.1238; KAISER ML, 1983, NATURE, V303, P50, DOI 10.1038/303050a0; KENNEL CF, 1966, J GEOPHYS RES, V71, P1, DOI 10.1029/JZ071i001p00001; KURTH WS, 1991, J GEOPHYS RES-PLANET, V96, P18977, DOI 10.1029/91JA01819; Lecacheux A, 1997, PLANETARY RADIO EMISSIONS IV, P313; Meyer-Vernet N, 1998, ICARUS, V132, P311, DOI 10.1006/icar.1998.5895; OBERC P, 1990, ICARUS, V86, P314, DOI 10.1016/0019-1035(90)90221-T; PERSOON AM, 1983, J GEOPHYS RES-SPACE, V88, P123, DOI 10.1029/JA088iA12p10123; Porco CC, 2005, SCIENCE, V307, P1243, DOI 10.1126/science.1107691; SCARF FL, 1982, SCIENCE, V215, P587, DOI 10.1126/science.215.4532.587; Tsurutani BT, 2004, ICARUS, V167, P89, DOI 10.1016/j.icarus.2003.08.021; WARWICK JW, 1981, SCIENCE, V212, P239, DOI 10.1126/science.212.4491.239; WARWICK JW, 1982, SCIENCE, V215, P582, DOI 10.1126/science.215.4532.582; WOLFE JH, 1980, SCIENCE, V207, P403, DOI 10.1126/science.207.4429.403; ZARKA P, 1983, J GEOPHYS RES-SPACE, V88, P9007, DOI 10.1029/JA088iA11p09007	30	215	215	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1255	1259		10.1126/science.1105356	http://dx.doi.org/10.1126/science.1105356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15604362				2022-12-28	WOS:000227313200043
J	Silva-Santos, B; Pennington, DJ; Hayday, AC				Silva-Santos, B; Pennington, DJ; Hayday, AC			Lymphotoxin-mediated regulation of gamma delta cell differentiation by alpha beta T cell progenitors	SCIENCE			English	Article							LYMPHOID ORGAN DEVELOPMENT; THYMOCYTE DEVELOPMENT; ABNORMAL-DEVELOPMENT; MICE LACKING; ROR-GAMMA; RECEPTOR; GENE; EXPRESSION; TISSUES; MICROENVIRONMENTS	The thymus gives rise to two T cell lineages, alphabeta and gammadelta, that are thought to develop independently of one another. Hence, double positive (DP) thymocytes expressing CD4 and CD8 coreceptors are usually viewed simply as progenitors of CD4(+) and CD8(+) alphabeta T cells. Instead we report that DIP cells regulate the differentiation of early thymocyte progenitors and gammadelta cells, by a mechanism dependent on the transcription factor RORgammat, and the lymphotoxin (Lt) beta receptor (LTbetaR). This finding provokes a revised view of the thymus, in which lymphoid-tissue induction-type processes coordinate the developmental and functional integration of the two T cell lineages.	Univ London Kings Coll, Guys Hosp, Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Pennington, DJ (corresponding author), Univ London Kings Coll, Guys Hosp, Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England.	daniel.pennington@kcl.ac.uk; hayday@kcl.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793; Silva-Santos, Bruno/0000-0003-4141-9302; Pennington, Daniel/0000-0001-7889-9923	Wellcome Trust [071534] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bruno L, 1999, CURR BIOL, V9, P559, DOI 10.1016/S0960-9822(99)80259-0; Cuff CA, 1998, J IMMUNOL, V161, P6853; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; Lambolez F, 2002, J EXP MED, V195, P437, DOI 10.1084/jem.20010798; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; MARTH JD, 1987, EMBO J, V6, P2727, DOI 10.1002/j.1460-2075.1987.tb02566.x; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; Poussier P, 2002, J EXP MED, V195, P1491, DOI 10.1084/jem.20011793; Rooney IA, 2000, J BIOL CHEM, V275, P14307, DOI 10.1074/jbc.275.19.14307; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; VONBOEHMER H, 1988, P NATL ACAD SCI USA, V85, P9729, DOI 10.1073/pnas.85.24.9729	28	123	125	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2005	307	5711					925	928		10.1126/science.1103978	http://dx.doi.org/10.1126/science.1103978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15591166				2022-12-28	WOS:000226985100054
J	Corwin, P; Toop, L; McGeoch, G; Than, M; Wynn-Thomas, S; Wells, JE; Dawson, R; Abernethy, P; Pithie, A; Chambers, S; Fletcher, L; Richards, D				Corwin, P; Toop, L; McGeoch, G; Than, M; Wynn-Thomas, S; Wells, JE; Dawson, R; Abernethy, P; Pithie, A; Chambers, S; Fletcher, L; Richards, D			Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital	BRITISH MEDICAL JOURNAL			English	Article							THERAPY; CARE; SATISFACTION; CEFAZOLIN	Objectives To compare the efficacy, safety, and acceptability of treatment with intravenous antibiotics for cellulitis at home and in hospital. Design Prospective randomised controlled trial. Setting Christchurch, New Zealand. Participants 200 patients presenting or referred to the only emergency department in Christchurch who were thought to require intravenous antibiotic treatment for cellulitis and who did not have any contraindications to home care were randomly assigned to receive treatment either at home or in hospital. Main outcome measures Days to no advancement of cellulitis was the, primary outcome measure. Days on intravenous and oral antibiotics, days in hospital or in the home care programme, complications, degree of functioning and pain, and satisfaction with site of care were also recorded. Results The two treatment groups did not differ significantly for the primary outcome of days to no advancement of cellulitis, with a mean of 1.5 days (SD 0.11) for die group receiving treatment at home and 1.49 days (SD 0.10) for. the group receiving treatment in hospital (mean difference 0.01 days, 95% confidence interval -0.3 to 0.28). None of the other outcome measures differed significantly except for patients' satisfaction, which was greater in patients treated at home. Conclusions Treatment of cellulitis requiring intravenous antibiotics can be safely delivered at home. Patients prefer home treatment, but in this study only about one third of patients presenting at hospital for intravenous treatment of cellulitis were considered suitable for home treatment.	Christchurch Sch Med & Hlth Sci, Dept Publ Hlth & Gen Practice, Christchurch, New Zealand; Pegasus Hlth, Christchurch, New Zealand; Christchurch Hosp, Christchurch, New Zealand	University of Otago; Christchurch Hospital New Zealand	Corwin, P (corresponding author), Christchurch Sch Med & Hlth Sci, Dept Publ Hlth & Gen Practice, POB 4345, Christchurch, New Zealand.	paul.corwin@chmeds.ac.nz		Mangin, Dee/0000-0003-2149-9376; Chambers, Stephen/0000-0002-0698-3285				Board N, 2000, AUST NZ J PUBL HEAL, V24, P305, DOI 10.1111/j.1467-842X.2000.tb01573.x; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Caplan GA, 1999, MED J AUSTRALIA, V170, P156, DOI 10.5694/j.1326-5377.1999.tb127711.x; Dall L, 2003, INFECT MED, V20, P379; Dubois A, 2001, EVAL HEALTH PROF, V24, P84, DOI 10.1177/01632780122034812; Eron LJ, 2001, ARCH INTERN MED, V161, P61, DOI 10.1001/archinte.161.1.61; GRAYSON ML, 1995, MED J AUSTRALIA, V162, P249, DOI 10.5694/j.1326-5377.1995.tb139878.x; Grayson ML, 2002, CLIN INFECT DIS, V34, P1440, DOI 10.1086/340056; Leder K, 1998, MED J AUSTRALIA, V169, P519, DOI 10.5694/j.1326-5377.1998.tb123398.x; *MED OUTC TRUST, 1994, AUSTR NZ STAND SF 36; Montalto M, 1996, INT J QUAL HEALTH C, V8, P243; Montalto M, 1997, AUST NZ J MED, V27, P19, DOI 10.1111/j.1445-5994.1997.tb00908.x; Nathwani D, 2002, J ANTIMICROB CHEMOTH, V49, P149, DOI 10.1093/jac/49.1.149; TICE AD, 1995, EUR J CLIN MICROBIOL, V14, P655, DOI 10.1007/BF01690748; OPAT OUTCOMES REGIST	15	114	115	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 15	2005	330	7483					129	132B		10.1136/bmj.38309.447975.EB	http://dx.doi.org/10.1136/bmj.38309.447975.EB			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889PM	15604157	Green Published, Bronze			2022-12-28	WOS:000226454900020
J	Etminan, M; Takkouche, B; Isorna, FC; Samii, A				Etminan, M; Takkouche, B; Isorna, FC; Samii, A			Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							YOUNG-WOMEN; ORAL-CONTRACEPTIVES; CEREBRAL-ISCHEMIA; HETEROGENEITY; ASSOCIATION	Objective To explore the association between migraine and risk of ischaemic stroke. Design Systematic review and meta-analysis. Data sources Observational studies published between 1966 and June 2004 (identified through Medline and Embase) that examined the association between migraine and risk of ischaemic stroke. Results 14 studies (11 case-control studies and 3 cohort studies) were identified. These studies suggest. that the risk of stroke is increased in people with migraine (relative risk 2.16. 95% confidence interval 1.89 to 2.48). This increase in risk was consistent in people who had migraine with aura (relative risk 2.88, 1.89 to 4.39) and migraine without aura (relative risk 1.56, 1.03 to 2.36), as well as in those taking oral contraceptives (relative risk 8.72, 5.05 to 15.05). Conclusions Data from observational studies suggest that migraine may be a risk factor in developing stroke. More studies are needed to explore tine mechanism of this potential association. In addition, the risk of migraine among users of oral contraceptives must be further investigated.	Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; Vancouver Hosp, Div Epidemiol, Vancouver, BC, Canada; Univ Santiago de Compostela, Dept Prevent Med, Santiago De Compostela, Spain; Univ Washington, Dept Neurol, Seattle, WA 98195 USA	McGill University; Royal Victoria Hospital; University of British Columbia; Universidade de Santiago de Compostela; University of Washington; University of Washington Seattle	Etminan, M (corresponding author), Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada.	mahyar.etminan@mail.mcgill.ca	Caamano-Isorna, Francisco/AAL-3770-2020	Caamano-Isorna, Francisco/0000-0001-8995-3673				[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P718; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; BURING JE, 1995, ARCH NEUROL-CHICAGO, V52, P129, DOI 10.1001/archneur.1995.00540260031012; Carolei A, 1996, LANCET, V347, P1503, DOI 10.1016/S0140-6736(96)90669-8; Chang CL, 1999, BMJ-BRIT MED J, V318, P13; Costa-Bouzas J, 2001, COMPUT METH PROG BIO, V64, P101, DOI 10.1016/S0169-2607(00)00087-0; Donaghy M, 2002, J NEUROL NEUROSUR PS, V73, P747, DOI 10.1136/jnnp.73.6.747; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FRIBERG L, 1987, BRAIN, V110, P917, DOI 10.1093/brain/110.4.917; Haapaniemi H, 1997, STROKE, V28, P26, DOI 10.1161/01.STR.28.1.26; HENRICH JB, 1989, J CLIN EPIDEMIOL, V42, P773, DOI 10.1016/0895-4356(89)90075-9; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; LIDEGAARD O, 1995, BRIT J OBSTET GYNAEC, V102, P153, DOI 10.1111/j.1471-0528.1995.tb09070.x; Lidegaard O, 2002, CONTRACEPTION, V65, P197, DOI 10.1016/S0010-7824(01)00306-7; MARINI C, 1993, NEUROEPIDEMIOLOGY, V12, P70, DOI 10.1159/000110303; Merikangas KR, 1997, ARCH NEUROL-CHICAGO, V54, P362, DOI 10.1001/archneur.1997.00550160012009; Nightingale AL, 2004, STROKE, V35, P1574, DOI 10.1161/01.STR.0000129789.58837.e4; PETTY GW, 1994, MAYO CLIN PROC, V69, P632, DOI 10.1016/S0025-6196(12)61338-X; RIDKER PM, 1994, LANCET, V343, P940, DOI 10.1016/S0140-6736(94)90064-7; Schwaag S, 2003, HEADACHE, V43, P90, DOI 10.1046/j.1526-4610.2003.03023.x; Schwartz SM, 1998, STROKE, V29, P2277, DOI 10.1161/01.STR.29.11.2277; Silberstein SD, 2004, LANCET, V363, P381, DOI 10.1016/S0140-6736(04)15440-8; Takkouche B, 1999, AM J EPIDEMIOL, V150, P206; Tietjen GE, 1998, NEUROLOGY, V50, P1433, DOI 10.1212/WNL.50.5.1433; TZOURIO C, 1993, BMJ-BRIT MED J, V307, P289, DOI 10.1136/bmj.307.6899.289; TZOURIO C, 1995, BMJ-BRIT MED J, V310, P830, DOI 10.1136/bmj.310.6983.830; WOODS RP, 1994, NEW ENGL J MED, V331, P1689, DOI 10.1056/NEJM199412223312505	28	408	423	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2005	330	7482					63	65		10.1136/bmj.38302.504063.8F	http://dx.doi.org/10.1136/bmj.38302.504063.8F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887GR	15596418	Green Published, Bronze			2022-12-28	WOS:000226294300010
J	Bao, MZ; Schwartz, MA; Cantin, GT; Yates, JR; Madhani, HD				Bao, MZ; Schwartz, MA; Cantin, GT; Yates, JR; Madhani, HD			Pheromone-dependent destruction of the Tec1 transcription factor is required for MAP kinase signaling specificity in yeast	CELL			English	Article							GENE-EXPRESSION; COMBINATORIAL CONTROL; FILAMENTOUS GROWTH; CYCLIN-E; PROTEOLYSIS; COMPLEXES; CASCADE; TRANSDUCTION; SCF	The yeast MAPK pathways required for mating versus filamentous growth share multiple components yet specify distinct programs. The mating-specific MAPK, Fus3, prevents crosstalk between the two pathways by unknown mechanisms. Here we show that pheromone signaling induces Fus3-dependent degradation of Tec1, the transcription factor specific to the filamentation pathway. Degradation requires Fus3 kinase activity and a MAPK phosphorylation site in Tec1 at threonine 273. Fus3 associates with Tec1 in unstimulated cells, and active Fus3 phosphorylates Tec1 on T273 in vitro. Destruction of Tec1 requires the F box protein Dia2 (Digs-into-agar-2), and Cdc53, the Cullin of SCIF (Skp1 Cdc53-F box) ubiquitin ligases. Notably, mutation of the phosphoacceptor site in Tec1, deletion of FUS3, or deletion of DIA2 results in a loss of signaling specificity such that pheromone pathway signaling erroneously activates filamentation pathway gene expression and invasive growth. Signal-induced destruction of a transcription factor for a competing pathway provides a mechanism for signaling specificity.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of California System; University of California San Francisco; Scripps Research Institute	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th st, San Francisco, CA 94143 USA.	hiten@biochem.ucsf.edu		Madhani, Hiten/0000-0001-7400-6657	NIGMS NIH HHS [R01-GM63670-01, R01-GM067880] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063670] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Baur M, 1997, MOL CELL BIOL, V17, P4330, DOI 10.1128/MCB.17.8.4330; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cherkasova VA, 2003, CURR BIOL, V13, P1220, DOI 10.1016/S0960-9822(03)00490-1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Gavrias V, 1996, MOL MICROBIOL, V19, P1255, DOI 10.1111/j.1365-2958.1996.tb02470.x; Kohler T, 2002, EUKARYOT CELL, V1, P673, DOI 10.1128/EC.1.5.673-686.2002; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; MacKay VL, 2004, MOL CELL PROTEOMICS, V3, P478, DOI 10.1074/mcp.M300129-MCP200; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Madhani HD, 1999, P NATL ACAD SCI USA, V96, P12530, DOI 10.1073/pnas.96.22.12530; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Mosch HU, 1997, GENETICS, V145, P671; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Palecek SP, 2000, GENETICS, V156, P1005; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	33	104	107	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					991	1000		10.1016/j.cell.2004.11.052	http://dx.doi.org/10.1016/j.cell.2004.11.052			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620357	Bronze			2022-12-28	WOS:000226109700011
J	Hu, FB; Willett, WC; Li, T; Stampfer, MJ; Colditz, GA; Manson, JE				Hu, FB; Willett, WC; Li, T; Stampfer, MJ; Colditz, GA; Manson, JE			Adiposity as compared with physical activity in predicting mortality among women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; US ADULTS; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR-DISEASE; WEIGHT; RISK; VALIDITY; WALKING; MEN; REPRODUCIBILITY	BACKGROUND Whether higher levels of physical activity can counteract the elevated risk of death associated with adiposity is controversial. METHODS We examined the associations of the body-mass index and physical activity with death among 116,564 women who, in 1976, were 30 to 55 years of age and free of known cardiovascular disease and cancer. RESULTS During 24 years of follow-up, 10,282 deaths occurred - 2370 from cardiovascular disease, 5223 from cancer, and 2689 from other causes. Mortality rates increased monotonically with higher body-mass-index values among women who had never smoked ( P for trend < 0.001). In combined analyses of all participants, adiposity predicted a higher risk of death regardless of the level of physical activity. Higher levels of physical activity appeared to be beneficial at all levels of adiposity but did not eliminate the higher risk of death associated with obesity. As compared with women who were lean (i.e., they had a body-mass index lower than 25) and active ( they spent 3.5 or more hours exercising per week), the multivariate relative risks of death were 1.55 ( 95 percent confidence interval, 1.42 to 1.70) for lean and inactive women, 1.91 ( 95 percent confidence interval, 1.60 to 2.30) for women who were obese ( defined as a body-mass index of 30 or higher) but active, and 2.42 ( 95 percent confidence interval, 2.14 to 2.73) for inactive, obese women. Even modest weight gain during adulthood, independent of physical activity, was associated with a higher risk of death. We estimate that excess weight ( defined as a body-mass index of 25 or higher) and physical inactivity ( less than 3.5 hours of exercise per week) together could account for 31 percent of all premature deaths, 59 percent of deaths from cardiovascular disease, and 21 percent of deaths from cancer among nonsmoking women. CONCLUSIONS Both increased adiposity and reduced physical activity are strong and independent predictors of death.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Div Prevent Med, Boston, MA USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Colditz, Graham/A-3963-2009; Hu, Frank/C-1919-2013	Colditz, Graham/0000-0002-7307-0291; 	NCI NIH HHS [CA87969] Funding Source: Medline; NHLBI NIH HHS [HL24074, HL34594] Funding Source: Medline; NIDDK NIH HHS [P30 DK46200] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cox DR O, 1987, ANAL SURVIVAL DATA; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Hu FB, 2000, JAMA-J AM MED ASSOC, V283, P2961, DOI 10.1001/jama.283.22.2961; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rockhill B, 2001, AM J PUBLIC HEALTH, V91, P578, DOI 10.2105/AJPH.91.4.578; Rothman K., 1998, MODERN EPIDEMIOLOGY; Simpson ME, 2003, AM J PREV MED, V25, P95, DOI 10.1016/S0749-3797(03)00112-0; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stevens J, 2002, AM J EPIDEMIOL, V156, P832, DOI 10.1093/aje/kwf114; Stevens J, 2000, NUTR REV, V58, P346, DOI 10.1111/j.1753-4887.2000.tb01832.x; Stofan JR, 1998, AM J PUBLIC HEALTH, V88, P1807, DOI 10.2105/AJPH.88.12.1807; TROY LM, 1995, INT J OBESITY, V19, P570; Wessel TR, 2004, JAMA-J AM MED ASSOC, V292, P1179, DOI 10.1001/jama.292.10.1179; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	30	558	571	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2694	2703		10.1056/NEJMoa042135	http://dx.doi.org/10.1056/NEJMoa042135			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616204	Bronze			2022-12-28	WOS:000225877300005
J	Tamura, S; Onishi, S				Tamura, S; Onishi, S			Laterally spreading colon cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Kochi Med Sch, Nanko Ku, Kochi 7838505, Japan	Kochi University	Tamura, S (corresponding author), Kochi Med Sch, Nanko Ku, Kochi 7838505, Japan.								0	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					E24	E24		10.1056/ENEJMicm040418	http://dx.doi.org/10.1056/ENEJMicm040418			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616199				2022-12-28	WOS:000225877300010
J	Cavazzana-Calvo, M; Fischer, A				Cavazzana-Calvo, M; Fischer, A			Efficacy of gene therapy for SCID is being confirmed	LANCET			English	Editorial Material							SEVERE COMBINED IMMUNODEFICIENCY; TRANSPLANTATION; SURVIVAL		Hop Necker Enfants Malad, Dept Biotherapie, F-75015 Paris, France; Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Cavazzana-Calvo, M (corresponding author), Hop Necker Enfants Malad, Dept Biotherapie, F-75015 Paris, France.	m.cavazzana@nck.ap-hop-paris.fr						Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; CAVAZZANACALVO M, IN PRESS ANN REV MED; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Sarzotti M, 2003, J IMMUNOL, V170, P2711, DOI 10.4049/jimmunol.170.5.2711	8	23	24	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2155	2156		10.1016/S0140-6736(04)17603-4	http://dx.doi.org/10.1016/S0140-6736(04)17603-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610783				2022-12-28	WOS:000225799700003
J	Smith, GD				Smith, GD			Lifestyle, health, and health promotion in Nazi Germany	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Smith, GD (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	zetkin@bristol.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314				Gumpert M., 1940, HEIL HUNGER HLTH HIT; Proctor Robert N., 1988, RACIAL HYGIENE MED N; Schairer E, 2001, INT J EPIDEMIOL, V30, P24, DOI 10.1093/ije/30.1.24; SMITH GD, 1994, J EPIDEMIOL COMMUN H, V48, P220, DOI 10.1136/jech.48.3.220	4	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1424	1425		10.1136/bmj.329.7480.1424	http://dx.doi.org/10.1136/bmj.329.7480.1424			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604167	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000225965800010
J	Motamedi, MR; Verdel, A; Colmenares, SU; Gerber, SA; Gygi, SP; Moazed, D				Motamedi, MR; Verdel, A; Colmenares, SU; Gerber, SA; Gygi, SP; Moazed, D			Two RNAi complexes, RITS and RDRC, physically interact and localize to noncoding centromeric RNAs	CELL			English	Article							NASCENT MESSENGER-RNA; DOUBLE-STRANDED-RNA; GENE; HETEROCHROMATIN; INTERFERENCE; POLYMERASE; CLEAVAGE; PROTEIN; LINK; ESTABLISHMENT	RNAi-mediated heterochromatin assembly in fission yeast requires the RNA-induced transcriptional silencing (RITS) complex and a putative RNA-directed RNA polymerase (Rdp1). Here we show that Rdp1 is associated with two conserved proteins, Hrr1, an RNA helicase, and Cid12, a member of the polyA polymerase family, in a complex that has RNA-directed RNA polymerase activity (RDRC, RNA-directed RNA polymerase complex). RDRC physically interacts with RITS in a manner that requires the Dicer ribonuclease (Dcr1) and the Clr4 histone methyltransferase. Moreover, both complexes are localized to the nucleus and associate with noncoding centromeric RNAs in a Dcr1-dependent manner. In cells lacking Rdp1, Hrr1, or Cid12, RITS complexes are devoid of siRNAs and fail to localize to centromeric DNA repeats to initiate heterochromatin assembly. These findings reveal a physical and functional link between Rdp1 and RITS and suggest that noncoding RNAs provide a platform for siRNA-dependent localization of RNAi complexes to specific chromosome regions.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Verdel, André/M-5201-2013	VERDEL, Andre/0000-0001-6048-3794; Gerber, Scott/0000-0002-2964-5051				Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barabino SML, 2000, EMBO J, V19, P3778, DOI 10.1093/emboj/19.14.3778; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Doe CL, 1998, NUCLEIC ACIDS RES, V26, P4222, DOI 10.1093/nar/26.18.4222; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Ekwall K, 2004, MOL CELL, V13, P304, DOI 10.1016/S1097-2765(04)00057-7; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Hurt E, 2004, P NATL ACAD SCI USA, V101, P1858, DOI 10.1073/pnas.0308663100; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Justesen J, 2000, CELL MOL LIFE SCI, V57, P1593, DOI 10.1007/PL00000644; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Matzke M, 2004, BBA-GENE STRUCT EXPR, V1677, P129, DOI 10.1016/j.bbaexp.2003.10.015; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; VERDEL A, 2004, IN PRESS METH ENZYMO; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	51	434	463	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					789	802		10.1016/j.cell.2004.11.034	http://dx.doi.org/10.1016/j.cell.2004.11.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607976	Bronze			2022-12-28	WOS:000225907200010
J	Breidenbach, MA; Brunger, AT				Breidenbach, MA; Brunger, AT			Substrate recognition strategy for botulinum neurotoxin serotype A	NATURE			English	Article							BLOCK NEUROTRANSMITTER RELEASE; LIGHT-CHAIN; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; SNARE MOTIF; TETANUS; COMPLEX; CLEAVAGE; SYNAPTOBREVIN; PROTEOLYSIS	Clostridal neurotoxins (CNTs) are the causative agents of the neuroparalytic diseases botulism and tetanus(1,2). CNTs impair neuronal exocytosis through specific proteolysis of essential proteins called SNAREs(3). SNARE assembly into a low-energy ternary complex is believed to catalyse membrane fusion, precipitating neurotransmitter release; this process is attenuated in response to SNARE proteolysis(4-7). Site-specific SNARE hydrolysis is catalysed by the CNT light chains, a unique group of zinc-dependent endopeptidases(3). The means by which a CNT properly identifies and cleaves its target SNARE has been a subject of much speculation; it is thought to use one or more regions of enzyme substrate interaction remote from the active site (exosites)(8-10). Here we report the first structure of a CNT endopeptidase in complex with its target SNARE at a resolution of 2.1 Angstrom: botulinum neurotoxin serotype A (BoNT/A) protease bound to human SNAP-25. The structure, together with enzyme kinetic data, reveals an array of exosites that determine substrate specificity. Substrate orientation is similar to that of the general zinc-dependent metalloprotease thermolysin(11). We observe significant structural changes near the toxin's catalytic pocket upon substrate binding, probably serving to render the protease competent for catalysis. The novel structures of the substrate-recognition exosites could be used for designing inhibitors specific to BoNT/A.	Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Brunger, AT (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	brunger@stanford.edu	Sandstedt, Sara A/A-3001-2010	Brunger, Axel/0000-0001-5121-2036				Agarwal R, 2004, BIOCHEMISTRY-US, V43, P6637, DOI 10.1021/bi036278w; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Brooijmans N, 2002, PROTEINS, V48, P645, DOI 10.1002/prot.10139; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Cornille F, 1997, J BIOL CHEM, V272, P3459, DOI 10.1074/jbc.272.6.3459; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; Debnath AK, 1999, J MED CHEM, V42, P3203, DOI 10.1021/jm990154t; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; FORAN P, 1994, BIOCHEMISTRY-US, V33, P15365, DOI 10.1021/bi00255a017; Hanson MA, 2000, NAT STRUCT BIOL, V7, P687, DOI 10.1038/77997; HOLDEN HM, 1987, BIOCHEMISTRY-US, V26, P8542, DOI 10.1021/bi00400a008; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Li L, 2000, BIOCHEMISTRY-US, V39, P2399, DOI 10.1021/bi992321x; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; Pellizzari R, 1996, J BIOL CHEM, V271, P20353, DOI 10.1074/jbc.271.34.20353; ROSSETTO O, 1994, NATURE, V372, P415, DOI 10.1038/372415a0; Rupp B, 2001, NAT STRUCT BIOL, V8, P663, DOI 10.1038/90361; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schmidt JJ, 1995, J PROTEIN CHEM, V14, P703, DOI 10.1007/BF01886909; Segelke B, 2004, P NATL ACAD SCI USA, V101, P6888, DOI 10.1073/pnas.0400584101; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sukonpan C, 2004, J PEPT RES, V63, P181, DOI 10.1111/j.1399-3011.2004.00124.x; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Washbourne P, 1997, FEBS LETT, V418, P1, DOI 10.1016/S0014-5793(97)01328-8; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642	30	254	272	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					925	929		10.1038/nature03123	http://dx.doi.org/10.1038/nature03123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15592454				2022-12-28	WOS:000225733500059
J	Morris, SS; Flores, R; Olinto, P; Medina, JM				Morris, SS; Flores, R; Olinto, P; Medina, JM			Monetary incentives in primary health care and effects on use and coverage of preventive health care interventions in rural Honduras: cluster randomised trial	LANCET			English	Article							PUBLIC-HEALTH; MORTALITY	Background Scaling-up of effective preventive interventions in child and maternal health is constrained in many developing countries by lack of demand. In Latin America, some governments have been trying to increase demand for health interventions by making direct payments to poor households contingent on them keeping up-to-date with preventive health services. We undertook a public health programme effectiveness trial in Honduras to assess this approach, contrasting it with a direct transfer of resources to local health teams. Methods 70 municipalities were selected because they had the country's highest prevalence of malnutrition. They were allocated at random to four groups: money to households; resources to local health teams combined with a community-based nutrition intervention; both packages; and neither. Evaluation surveys of about 5600 households were undertaken at baseline and roughly 2 years later. Pregnant women and mothers of children younger than 3 years old were asked about use of health services (primary outcome) and coverage of interventions such as immunisation and growth monitoring (secondary outcome). Reports were supplemented with data from children's health cards and government service utilisation data. Analysis was by mixed effects regression, accounting for the municipality-level randomisation. Findings The household-level intervention had a large impact (15-20 percentage points; p<0.01) on the reported coverage of antenatal care and well-child check-ups. Childhood immunisation. series could thus be started more opportunely, and the coverage of growth monitoring was markedly increased (15-21 percentage points; p<0.01. Measles and tetanus toxoid immunisation were not affected. The transfer of resources to local health teams could not be implemented properly because of legal complications.	London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; Int Food Policy Res Inst, Food Consumpt & Nutr Div, Washington, DC 20036 USA	University of London; London School of Hygiene & Tropical Medicine; Emory University; Rollins School Public Health; CGIAR; International Food Policy Research Institute (IFPRI)	Morris, SS (corresponding author), EMAD, Dept Int Dev DFID, 1 Palace St, London SW1E 5HE, England.	s-morris@dfid.gov.uk	Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984; Morris, Saul/0000-0002-9372-7342				Brown LD, 1998, QUALITY ASSURANCE HL; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; GERTLER PJ, EXPT INCENTIVE BASED; *GOV HOND, 1997, 7 CENS NAC TALL ESC; HANSON K, 2001, 14 WG5 WHO; *I NAC EST, PUBL CENS 2001; *INT DEV BANK RES, 2003, NEW GEN SOC PROGR ID, V1, P1; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; MALUCCIO J, 2000, FINAL REPORT NICARAG; MORRIS SS, 2004, NUTRITION, V134; MURRAY DM, 1994, J COMMUNITY PSYCHOL, P140; Murray DM, 1998, DESIGN ANAL GROUP RA; Tsu VD, 2004, LANCET, V363, P75, DOI 10.1016/S0140-6736(03)15180-X; VANROEKEL K, 2002, BASICS 2 MIDTERM EVA; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400	15	157	158	0	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					2030	2037		10.1016/S0140-6736(04)17515-6	http://dx.doi.org/10.1016/S0140-6736(04)17515-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582060				2022-12-28	WOS:000225495700026
J	Pearcy, M; Aron, S; Doums, C; Keller, L				Pearcy, M; Aron, S; Doums, C; Keller, L			Conditional use of sex and parthenogenesis for worker and queen production in ants	SCIENCE			English	Article							HYMENOPTERA; FEMALES; CASTE; CYCLE	The near-ubiquity of sexual reproduction in animal species has long been considered a paradox because sexually reproducing individuals transmit only half of their genome to their progeny. Here, we show that the ant Cataglyphis cursor circumvents this cost by using alternative modes of reproduction for the production of reproductive and nonreproductive offspring. New queens are almost exclusively produced by parthenogenesis, whereas workers are produced by normal sexual reproduction. By selectively using sex for somatic growth and parthenogenesis for germline production, C. cursor has taken advantage of the ant caste system to benefit from the advantages of both sexual and asexual reproduction.	Free Univ Brussels, B-1050 Brussels, Belgium; Univ Paris 06, F-75252 Paris 05, France; Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	Universite Libre de Bruxelles; Vrije Universiteit Brussel; UDICE-French Research Universities; Sorbonne Universite	Aron, S (corresponding author), Free Univ Brussels, CP 160-12,Av FD Roosevelt 50, B-1050 Brussels, Belgium.	saron@ulb.ac.be	keller, laurent/AAI-7175-2020; Doums, Claudie/S-4054-2019	Doums, Claudie/0000-0001-6284-2412; keller, laurent/0000-0002-5046-9953				[Anonymous], 1971, INSECT SOC; BAUDRY E, IN PRESS GENETICS; BELL G, 1982, MASTERPIECE NATURE E; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; CAGNIANT H, 1979, INSECT SOC, V26, P51, DOI 10.1007/BF02283912; Cahan SH, 2003, NATURE, V424, P306, DOI 10.1038/nature01744; Cahan SH, 2002, P ROY SOC B-BIOL SCI, V269, P1871, DOI 10.1098/rspb.2002.2061; Cole BJ, 1999, SCIENCE, V285, P891, DOI 10.1126/science.285.5429.891; Crozier R.H., 1996, EVOLUTION SOCIAL INS; CROZIER RH, 1985, BEHAV ECOL SOCIOBIOL, V18, P105, DOI 10.1007/BF00299039; Grasso DA, 2000, ETHOL ECOL EVOL, V12, P309; Hartmann A, 2003, P NATL ACAD SCI USA, V100, P12836, DOI 10.1073/pnas.2132993100; HEINZE J, 1995, NATURWISSENSCHAFTEN, V82, P40, DOI 10.1007/s001140050139; ITOW T, 1984, INSECT SOC, V31, P87, DOI 10.1007/BF02223694; Julian GE, 2002, P NATL ACAD SCI USA, V99, P8157, DOI 10.1073/pnas.112222099; KELLER L, 1991, ETHOL ECOL EVOL, V3, P307, DOI 10.1080/08927014.1991.9525359; LENOIR A, 1988, Psyche (Cambridge), V95, P21, DOI 10.1155/1988/54685; MAYNARD SMITH J., 1978, EVOLUTION SEX; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; SHERMAN PW, 1988, AM NAT, V131, P602, DOI 10.1086/284809; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Strassmann J, 2001, INSECT SOC, V48, P1, DOI 10.1007/PL00001737; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; TSUJI K, 1995, INSECT SOC, V42, P333, DOI 10.1007/BF01240430; VERMA S, 1983, APIDOLOGIE, V14, P41, DOI 10.1051/apido:19830104; Volny VP, 2002, P NATL ACAD SCI USA, V99, P6108, DOI 10.1073/pnas.092066699; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	28	140	144	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1780	1783		10.1126/science.1105453	http://dx.doi.org/10.1126/science.1105453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576621	Green Published			2022-12-28	WOS:000225630800054
J	Rieder, R; Gellert, R; Anderson, RC; Bruckner, J; Clark, BC; Dreibus, G; Economou, T; Klingelhoffer, G; Lugmair, GW; Ming, DW; Squyres, SW; d'Uston, C; Wanke, H; Yen, A; Zipfel, J				Rieder, R; Gellert, R; Anderson, RC; Bruckner, J; Clark, BC; Dreibus, G; Economou, T; Klingelhoffer, G; Lugmair, GW; Ming, DW; Squyres, SW; d'Uston, C; Wanke, H; Yen, A; Zipfel, J			Chemistry of rocks and soils at Meridiani Planum from the alpha particle X-ray spectrometer	SCIENCE			English	Article							CHEMICAL-COMPOSITION; GUSEV CRATER; MARS; HEMATITE; ROVERS	The Alpha Particle X-ray Spectrometer on the Opportunity rover determined major and minor elements of soils and rocks in Meridiani Planum. Chemical compositions differentiate between basaltic rocks, evaporite-rich rocks, basaltic soils, and hematite-rich soils. Although soils are compositionally similar to those at previous landing sites, differences in iron and some minor element concentrations signify the addition of local components. Rocky outcrops are rich in sulfur and variably enriched in bromine relative to chlorine. The interaction with water in the past is indicated by the chemical features in rocks and soils at this site.	Max Planck Inst Chem, D-55128 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; Enrico Fermi Inst, Lab Astrophys & Space Res, Chicago, IL 60637 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France	Max Planck Society; Johannes Gutenberg University of Mainz; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Cornell University	Rieder, R (corresponding author), Max Planck Inst Chem, JJ Becher Weg 27, D-55128 Mainz, Germany.	rieder@mpch-mainz.mpg.de						BANIN A., 2000, MARS, P594; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; DREIBUS G, COMMUNICATION; Feldman WC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020181; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; GOREVAN SP, 2003, J GEOPHYS RES-PLANET, V108; KARGEL JS, 1965, LUNAR PLANET SCI, V35; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Rieder R., 2003, Journal of Geophysical Research, V108, pROV7, DOI 10.1029/2003JE002150; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; Zeh H. D, 1981, LANDOLTBORNSTEIN A, V2, P257; Zipfel J, 2004, METEORIT PLANET SCI, V39, pA118	16	305	315	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1746	1749		10.1126/science.1104358	http://dx.doi.org/10.1126/science.1104358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576611				2022-12-28	WOS:000225630800043
J	Montori, VM; Wilczynski, NL; Morgan, D; Haynes, RB				Montori, VM; Wilczynski, NL; Morgan, D; Haynes, RB		Hedges Team	Optimal search strategies for retrieving systematic reviews from Medline: analytical survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To develop optimal search strategies in Medline for retrieving systematic reviews. Design Analytical survey. Data sources 161 journals published in 2000 indexed in Medline. Main outcome measures The sensitivity, specificity, and precision of retrieval of systematic reviews of 4862 unique terms in 782 485 combinations of one to five terms were determined by comparison with a hand search of all articles (the criterion standard) in 161 journals published during 2000 (49 028 articles). Results Only 753 (1.5%) of the 49 028 articles were systematic reviews. The most, sensitive strategy included five terms and had a sensitivity of 99.9% (95% confidence interval 99.6% to 100%) and a specificity of 52% (51.6% to 52.5%). The strategy that best minimised the difference between sensitivity and specificity had a sensitivity of 98% (97% to 99%) and specificity of 90.8% (90.5% to 91.1%). Highest precision for multiterm strategies, 57% (54% to 60%), was achieved at a sensitivity of 71% (68% to 74%). The term "cochrane database of systematic reviews.jn." was the most precise single term search strategy (sensitivity of 56% (52% to 60%) and precision of 96% (94% to 98%)). These strategies are available through the "limit" screen of Ovid's search interface for Medline. Conclusions Systematic reviews can be retrieved from Medline with close to perfect sensitivity or specificity, or with high precision, by using empirical search strategies.	McMaster Univ, Fac Hlth Sci, Hlth Sci Ctr 2C10B,Hlth Informat Res Unit, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3J5, Canada; Mayo Clin Coll Med, Dept Med, Rochester, MN 55905 USA	McMaster University; Mayo Clinic	Haynes, RB (corresponding author), McMaster Univ, Fac Hlth Sci, Hlth Sci Ctr 2C10B,Hlth Informat Res Unit, Dept Clin Epidemiol & Biostat, 1200 Main St W, Hamilton, ON L8N 3J5, Canada.	bhaynes@mcmaster.ca		Montori, Victor/0000-0003-0595-2898; Haynes, Robert Brian/0000-0002-1453-3196	NLM NIH HHS [1 R01 LM06866] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [R01LM006866] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		DICKERSIN K, 1990, CONTROL CLIN TRIALS, V11, P52, DOI 10.1016/0197-2456(90)90032-W; HAYNES RB, 1994, J AM MED INFORM ASSN, V1, P447, DOI 10.1136/jamia.1994.95153434; Hunt DL, 1997, ANN INTERN MED, V126, P532, DOI 10.7326/0003-4819-126-7-199704010-00006; McKibbon KA, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-33; Montori VM, 2003, BMC MED, V1, DOI 10.1186/1741-7015-1-2; Montori VM, 2003, CLIN ORTHOP RELAT R, P43, DOI 10.1097/01.blo.0000079322.41006.5b; Shojania K G, 2001, Eff Clin Pract, V4, P157; White VJ, 2001, J INFORM SCI, V27, P357, DOI 10.1177/016555150102700601; Wilczynski NL, 2001, STUD HEALTH TECHNOL, V84, P390	9	271	274	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2005	330	7482					68	71		10.1136/bmj.38336.804167.47	http://dx.doi.org/10.1136/bmj.38336.804167.47			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887GR	15619601	Green Published, Bronze			2022-12-28	WOS:000226294300012
J	Stohr, K; Esveld, M				Stohr, K; Esveld, M			Will vaccines be available for the next influenza pandemic?	SCIENCE			English	Editorial Material									WHO, Influenza Programme, CH-1211 Geneva, Switzerland	World Health Organization	Stohr, K (corresponding author), WHO, Influenza Programme, CH-1211 Geneva, Switzerland.							Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; MELTZER MI, 2004, WHO CONS PRIOR PUBL; 2004, WHO M INFL PAND VACC; 2004, WHO WKLY EPIDEMIOL R, V79, P366	5	77	82	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2195	2196		10.1126/science.1108165	http://dx.doi.org/10.1126/science.1108165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618505				2022-12-28	WOS:000225950000025
J	O'Donnell, WJ; Kradin, RL; Evins, AE; Wittram, C				O'Donnell, WJ; Kradin, RL; Evins, AE; Wittram, C			Case 39-2004: A 52-year-old woman with recurrent episodes of atypical pneumonia - Smoking-related interstitial lung disease (respiratory bronchiolitis with interstitial lung disease desquamative interstitial pneumonitis)	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CIGARETTE-SMOKING; CESSATION; NICOTINE; SCHIZOPHRENIA; SPECTRUM; SMOKERS; TRIAL		Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Psychiat, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	O'Donnell, WJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA.							Addington J, 1998, AM J PSYCHIAT, V155, P974, DOI 10.1176/ajp.155.7.974; ADESINA AM, 1991, AM REV RESPIR DIS, V143, P144, DOI 10.1164/ajrccm/143.1.144; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Agusti C, 2002, AM J RESP CRIT CARE, V166, P426; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; CARRINGTON CB, 1978, NEW ENGL J MED, V298, P801, DOI 10.1056/NEJM197804132981501; Centers for Disease Control and Prevention (CDC), 2002, MMWR-MORBID MORTAL W, V51, P642; DELEON J, 1995, AM J PSYCHIAT, V152, P453; Depatie L, 2002, NEUROPSYCHOPHARMACOL, V27, P1056, DOI 10.1016/S0893-133X(02)00372-X; Epler GR, 2001, ARCH INTERN MED, V161, P158, DOI 10.1001/archinte.161.2.158; Evins A E, 2001, Nicotine Tob Res, V3, P397, DOI 10.1080/14622200110073920; Evins AE, 2004, J CLIN PSYCHIAT, V65, P307; EVINS AE, IN PRESS J CLIN PSYC; FIORE MC, 2000, TREATING TOBACCO DEP; Fraig M, 2002, AM J SURG PATHOL, V26, P647, DOI 10.1097/00000478-200205000-00011; GAENSLER EA, 1966, NEW ENGL J MED, V274, P113, DOI 10.1056/NEJM196601202740301; George TP, 2002, BIOL PSYCHIAT, V52, P53, DOI 10.1016/S0006-3223(02)01339-2; George TP, 2000, AM J PSYCHIAT, V157, P1835, DOI 10.1176/appi.ajp.157.11.1835; GOFF DC, IN PRESS J CLIN PSYC; Heyneman LE, 1999, AM J ROENTGENOL, V173, P1617, DOI 10.2214/ajr.173.6.10584810; Johkoh T, 1999, RADIOLOGY, V211, P155, DOI 10.1148/radiology.211.1.r99ap10155; Joukamaa M, 2001, BRIT J PSYCHIAT, V179, P498, DOI 10.1192/bjp.179.6.498; Leonard S, 2000, EUR J PHARMACOL, V393, P237, DOI 10.1016/S0014-2999(00)00035-2; Moon J, 1999, THORAX, V54, P1009, DOI 10.1136/thx.54.11.1009; MURCH CR, 1989, CLIN RADIOL, V40, P240, DOI 10.1016/S0009-9260(89)80180-1; MYERS JL, 1987, AM REV RESPIR DIS, V135, P880, DOI 10.1164/arrd.1987.135.4.880; Nagamoto HT, 1999, NEUROPSYCHOBIOLOGY, V39, P10, DOI 10.1159/000026553; NIEWOEHNER DE, 1974, NEW ENGL J MED, V291, P755, DOI 10.1056/NEJM197410102911503; Olincy A, 1997, BIOL PSYCHIAT, V42, P1, DOI 10.1016/S0006-3223(96)00302-2; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Ryu JH, 2001, EUR RESPIR J, V17, P122, DOI 10.1183/09031936.01.17101220; SANDYK R, 1993, INT J NEUROSCI, V70, P193, DOI 10.3109/00207459309000574; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Thorndike A N, 2001, Nicotine Tob Res, V3, P85, DOI 10.1080/14622200020032132; Yang YK, 2002, NEUROPSYCHOPHARMACOL, V27, P684; YOUSEM SA, 1989, MAYO CLIN PROC, V64, P1373, DOI 10.1016/S0025-6196(12)65379-8	36	8	8	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2741	2749		10.1056/NEJMcpc049030	http://dx.doi.org/10.1056/NEJMcpc049030			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616209				2022-12-28	WOS:000225877300011
J	Tian, JD; Gong, H; Sheng, NJ; Zhou, XC; Gulari, E; Gao, XL; Church, G				Tian, JD; Gong, H; Sheng, NJ; Zhou, XC; Gulari, E; Gao, XL; Church, G			Accurate multiplex gene synthesis from programmable DNA microchips	NATURE			English	Article							POLYMERASE CHAIN-REACTION; CHEMICAL SYNTHESIS; AMPLIFICATION; SEQUENCES; PROTEINS; GENOME	Testing the many hypotheses from genomics and systems biology experiments demands accurate and cost-effective gene and genome synthesis. Here we describe a microchip-based technology for multiplex gene synthesis. Pools of thousands of 'construction' oligonucleotides and tagged complementary 'selection' oligonucleotides are synthesized on photo-programmable microfluidic chips(1), released, amplified and selected by hybridization to reduce synthesis errors ninefold. A one-step polymerase assembly multiplexing reaction assembles these into multiple genes. This technology enabled us to synthesize all 21 genes that encode the proteins of the Escherichia coli 30S ribosomal subunit, and to optimize their translation efficiency in vitro through alteration of codon bias. This is a significant step towards the synthesis of ribosomes in vitro and should have utility for synthetic biology in general.	Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Houston, Dept Chem, Houston, TX 77004 USA; Atact Technol Inc, Houston, TX 77054 USA; Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; University of Houston System; University of Houston; University of Michigan System; University of Michigan	Church, G (corresponding author), Harvard Univ, Sch Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	glmlcl@arep.med.harvard.edu	Feng, Miao/B-8220-2012	church, george/0000-0001-6232-9969				BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; CARR PA, IN PRESS NUCL ACIDS; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; Eason RG, 2004, P NATL ACAD SCI USA, V101, P11046, DOI 10.1073/pnas.0403672101; ESPELUND M, 1990, NUCLEIC ACIDS RES, V18, P6157, DOI 10.1093/nar/18.20.6157; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; FORSTER AC, UNPUB NATURE; Gao XL, 2001, NUCLEIC ACIDS RES, V29, P4744, DOI 10.1093/nar/29.22.4744; IOST I, 1992, J BACTERIOL, V174, P619, DOI 10.1128/jb.174.2.619-622.1992; IOST I, 1994, NATURE, V372, P193, DOI 10.1038/372193a0; Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511; Liu D, 2004, P NATL ACAD SCI USA, V101, P717, DOI 10.1073/pnas.0305860101; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Richmond KE, 2004, NUCLEIC ACIDS RES, V32, P5011, DOI 10.1093/nar/gkh793; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Smith J, 1997, P NATL ACAD SCI USA, V94, P6847, DOI 10.1073/pnas.94.13.6847; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Zhou XC, 2004, NUCLEIC ACIDS RES, V32, P5409, DOI 10.1093/nar/gkh879	21	284	406	6	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1050	1054		10.1038/nature03151	http://dx.doi.org/10.1038/nature03151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616567	Green Published			2022-12-28	WOS:000225887000047
J	Mansfield, P				Mansfield, P			Commentary: Accepting what we can learn from advertising's mirror of desire	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Healthy Skepticism, Willunga, SA 5172, Australia		Mansfield, P (corresponding author), Healthy Skepticism, 34 Methodist St, Willunga, SA 5172, Australia.	peter@healthyskepticism.org	Mansfield, Peter/Q-8707-2019					Black H, 2004, LANCET, V364, P1655, DOI 10.1016/S0140-6736(04)17375-3; Mansfield PR, 2003, MED J AUSTRALIA, V179, P644, DOI 10.5694/j.1326-5377.2003.tb05730.x; OGILVY D, 1995, OGILVY ADVERTISING; Sagarin BJ, 2002, J PERS SOC PSYCHOL, V83, P526, DOI 10.1037//0022-3514.83.3.526; SCOTT DK, 1994, BRIT J CLIN PHARMACO, V37, P217, DOI 10.1111/j.1365-2125.1994.tb04265.x; Scott T, 2004, BMJ-BRIT MED J, V329, P1484, DOI 10.1136/bmj.329.7480.1484; Sweet M, 2004, BRIT MED J, V329, P998, DOI 10.1136/bmj.329.7473.998	7	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1487	1488		10.1136/bmj.329.7480.1487	http://dx.doi.org/10.1136/bmj.329.7480.1487			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604193	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000225965800036
J	Baker, DN; Kanekal, SG; Li, X; Monk, SP; Goldstein, J; Burch, JL				Baker, DN; Kanekal, SG; Li, X; Monk, SP; Goldstein, J; Burch, JL			An extreme distortion of the Van Allen belt arising from the 'Hallowe'en' solar storm in 2003	NATURE			English	Article							RELATIVISTIC ELECTRONS; ACCELERATION; SAMPEX; MODEL	The Earth's radiation belts - also known as the Van Allen belts(1) contain high-energy electrons trapped on magnetic field lines(2,3). The centre of the outer belt is usually 20,000 - 25,000 km from Earth. The region between the belts is normally devoid of particles(2-4), and is accordingly favoured as a location for spacecraft operation because of the benign environment(5). Here we report that the outer Van Allen belt was compressed dramatically by a solar storm known as the 'Hallowe'en storm' of 2003. From 1 to 10 November, the outer belt had its centre only similar to10,000 km from Earth's equatorial surface, and the plasmasphere was similarly displaced inwards. The region between the belts became the location of high particle radiation intensity. This remarkable deformation of the entire magnetosphere implies surprisingly powerful acceleration and loss processes deep within the magnetosphere.	Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; SW Res Inst, San Antonio, TX 78284 USA	University of Colorado System; University of Colorado Boulder; Southwest Research Institute	Baker, DN (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, 1234 Innovat Dr, Boulder, CO 80303 USA.	daniel.baker@lasp.colorado.edu						Baker DN, 2002, SCIENCE, V297, P1486, DOI 10.1126/science.1074956; BAKER DN, 1993, IEEE T GEOSCI REMOTE, V31, P531, DOI 10.1109/36.225519; Baker DN, 1999, GEOPHYS RES LETT, V26, P3193, DOI 10.1029/1999GL003638; Blake JB, 1996, ADV SPACE RES-SERIES, V18, P171, DOI 10.1016/0273-1177(95)00969-8; BRAUTIGAM DH, 1992, IEEE T NUCL SCI, V39, P1797, DOI 10.1109/23.211369; Burch JL, 2001, SCIENCE, V291, P619, DOI 10.1126/science.291.5504.619; CARPENTER DL, 1973, REV GEOPHYS, V11, P133, DOI 10.1029/RG011i001p00133; Goldstein J, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010281; GREBOWSKY JM, 1970, J GEOPHYS RES, V75, P4329, DOI 10.1029/JA075i022p04329; LI X, 2000, I&CS-INSTR CON SYST, V6, P305; LI X, 2003, EOS T AGU, V84, P369, DOI DOI 10.1029/2003EO370002; LI X, 2003, EOS, V84, P361; LI XL, 1993, GEOPHYS RES LETT, V20, P2423, DOI 10.1029/93GL02701; Liu WW, 1999, J GEOPHYS RES-SPACE, V104, P17391, DOI 10.1029/1999JA900168; LOOPER MD, 1994, GEOPHYS RES LETT, V21, P2079, DOI 10.1029/94GL01586; Lopez R.E., 2004, EOS T AM GEOPHYS UN, V85, P105, DOI [10.1029/2004EO110002, DOI 10.1029/2004EO110002]; LOPEZ RE, 2004, EOS, V85, P108; Lorentzen KR, 2001, J GEOPHYS RES-SPACE, V106, P6017, DOI 10.1029/2000JA003018; LYONS LR, 1973, J GEOPHYS RES, V78, P2142, DOI 10.1029/JA078i013p02142; RUSSELL CT, IN PRESS ADV SPACE R; Sandel BR, 2003, SPACE SCI REV, V109, P25, DOI 10.1023/B:SPAC.0000007511.47727.5b; Summers D, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009489; Summers D, 1998, J GEOPHYS RES-SPACE, V103, P20487, DOI 10.1029/98JA01740; THORNE RM, 1973, J GEOPHYS RES, V78, P1581, DOI 10.1029/JA078i010p01581; VANALLEN JA, 1997, HIST GEOPHYSICS, V7, P235, DOI DOI 10.1029/HG007P0235; VETTE JI, 1991, WDCARS9124 NSSDC NAS; Webb DF, 2004, SPACE WEATHER, V2	27	262	269	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					878	881		10.1038/nature03116	http://dx.doi.org/10.1038/nature03116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602555				2022-12-28	WOS:000225733500046
J	Neuenschwander, P				Neuenschwander, P			Harnessing nature in Africa - Biological pest control can benefit the pocket, health and the environment.	NATURE			English	Editorial Material							MEALYBUG; IMPACT; BENIN		Int Inst Trop Agr, Biol Control Ctr Africa, Cotonou, Benin		Neuenschwander, P (corresponding author), Int Inst Trop Agr, Biol Control Ctr Africa, 08 BP 0932, Cotonou, Benin.							Bokonon-Ganta AH, 2002, AGR ECOSYST ENVIRON, V93, P367, DOI 10.1016/S0167-8809(01)00337-1; De Groote H, 2003, ECOL ECON, V45, P105, DOI 10.1016/S0921-8009(03)00006-5; EVENSON RE, 2003, CROP IMPROVEMENT ITS, pCH8; Kfir R, 2002, ANNU REV ENTOMOL, V47, P701, DOI 10.1146/annurev.ento.47.091201.145254; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Lynch Liam D., 2000, Biocontrol News and Information, V21, p117N; McConnachie AJ, 2003, BIOL CONTROL, V28, P25, DOI 10.1016/S1049-9644(03)00056-2; Neuenschwander P, 2003, BIOL CONTROL IPM SYS; Schmutterer H., 2002, NEEM TREE; Zeddies J, 2001, AGR ECON, V24, P209, DOI 10.1111/j.1574-0862.2001.tb00024.x	10	16	21	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2004	432	7019					801	802		10.1038/432801a	http://dx.doi.org/10.1038/432801a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602524				2022-12-28	WOS:000225733500019
J	Reilley, B; Morote, S				Reilley, B; Morote, S			International medical aid - Caught in Colombia's crossfire	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Med Frontieres, Bogota, Colombia		Reilley, B (corresponding author), Med Frontieres, New York, NY USA.								0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2576	2578		10.1056/NEJMp048293	http://dx.doi.org/10.1056/NEJMp048293			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602017				2022-12-28	WOS:000225726100003
J	Wassertheil-Smoller, S; Psaty, B; Greenland, P; Oberman, A; Kotchen, T; Mouton, C; Black, H; Aragaki, A; Trevisan, M				Wassertheil-Smoller, S; Psaty, B; Greenland, P; Oberman, A; Kotchen, T; Mouton, C; Black, H; Aragaki, A; Trevisan, M			Association between cardiovascular outcomes and antihypertensive drug treatment in older women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOXAZOSIN ARM; DISCONTINUATION; METAANALYSIS; REGIMENS; TRIALS	Context Diuretic-based therapy is at least as effective as newer classes of agents for hypertension. However, many patients with hypertension require treatment with more than 1 drug class to achieve blood pressure control. The relative benefits or risks of 2-drug-class combinations are not well known. Objective To prospectively evaluate if there are differences in cardiovascular mortality among postmenopausal women with hypertension but no history of cardiovascular disease (CVD) treated with different classes of anti hypertensive agents, singly or in combination. Design, Setting, and Participants Women with hypertension enrolled in the Women's Health Initiative Observational Study, a longitudinal multicenter cohort study of 93 676 women aged 50 to 79 years at baseline (1994-1998), assessed for a mean of 5.9 years. Main Outcome Measures Relationship between baseline use of ACE inhibitors, beta-blockers, calcium channel blockers, or diuretics, or a combination of these, and incidence of coronary heart disease, stroke, and CVD mortality. Results Among 30 219 women with hypertension but no history of CVD, 11294 (57%) were receiving monotherapy with an ACE inhibitor, p-blocker, calcium channel blocker, or diuretic, and 4493 (23%) were treated at baseline with a combination of diuretic plus either ACE inhibitor, p-blocker, or calcium channel blocker or ACE inhibitor plus calcium channel blocker. Monotherapy with calcium channel blockers vs diuretics was associated with greater risk of CVD death (hazard ratio, 1.55; 95% confidence interval, 1.02-2.35), controlling for multiple covariates. Women treated with a diuretic plus a calcium channel blocker had an 85% greater risk of CVD death vs those treated with a diuretic plus a p-blocker, after adjustment for age, race, smoking, high cholesterol levels requiring medication, body mass index, physical activity, use of hormone therapy, and diabetes. After exclusion of women with diabetes the hazard ratio was 2.16 (95% confidence interval, 1.16-4.03). Analyses adjusting for propensity to be receiving a particular treatment did not change the results. For morbid events of coronary heart disease or stroke, diuretics plus. ACE inhibitors or calcium channel blockers did not differ from diuretics plus beta-blockers. Conclusions Among women with hypertension but no history of CVD, a 2-drug-class regimen of calcium channel blockers plus diuretics was associated with a higher risk of CVD mortality vs beta-blockers plus diuretics. Risks were similar for ACE inhibitors plus diuretics and beta-blockers plus diuretics. Monotherapy with diuretics was equal or superior to other monotherapy in preventing CVD complications of high blood pressure.	Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; Univ Washington, Seattle, WA 98195 USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Alabama Birmingham, Birmingham, AL USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Howard Univ, Coll Med, Washington, DC USA; Rush Univ, Med Ctr, Chicago, IL 60612 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Buffalo, Buffalo, NY USA	Yeshiva University; Albert Einstein College of Medicine; University of Washington; University of Washington Seattle; Northwestern University; University of Alabama System; University of Alabama Birmingham; Medical College of Wisconsin; Howard University; Rush University; Fred Hutchinson Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wassertheil-Smoller, S (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Morris Pk Ave,Room 1312,Belfer Bldg, Bronx, NY 10461 USA.	smoller@aecom.yu.edu	Greenland, Philip/ABD-5528-2021					AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; Ball SG, 2000, LANCET, V355, P1558, DOI 10.1016/S0140-6736(05)74613-4; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; *HYP DET FOLL UP P, 1979, JAMA-J AM MED ASSOC, V242, P2562; Joint National Committee on Prevention Detection evaluation and treatment of high blood pressure, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Messerli FH, 2000, LANCET, V355, P863, DOI 10.1016/S0140-6736(00)00092-1; Opie LH, 2001, AM J HYPERTENS, V14, P1074, DOI 10.1016/S0895-7061(01)02215-4; Pahor M, 2000, LANCET, V356, P1949, DOI 10.1016/S0140-6736(00)03306-7; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; PSATY BM, 1995, JAMA-J AM MED ASSOC, V273, P1436, DOI 10.1001/jama.273.18.1436; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; RUBIN DB, 1997, INT C NONR COMP CLIN; Siegel D, 1997, JAMA-J AM MED ASSOC, V278, P1745, DOI 10.1001/jama.278.21.1745; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Turnbull F, 2003, LANCET, V362, P1527; Wassertheil-Smoller S, 2000, HYPERTENSION, V36, P780, DOI 10.1161/01.HYP.36.5.780; *WHI STUD GROUP, 1988, CONTROL CLIN TRIALS, V19, P61	24	76	80	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2004	292	23					2849	2859		10.1001/jama.292.23.2849	http://dx.doi.org/10.1001/jama.292.23.2849			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879CR	15598916	Bronze			2022-12-28	WOS:000225694500022
J	Crabbe, L; Verdun, RE; Haggblom, CI; Karlseder, J				Crabbe, L; Verdun, RE; Haggblom, CI; Karlseder, J			Defective telomere lagging strand synthesis in cells lacking WRN helicase activity	SCIENCE			English	Article							WERNER-SYNDROME; PROTEIN; LENGTH; GENE; EXONUCLEASE; SENESCENCE; TRF1; P53; ATM	Cells from Werner syndrome patients are characterized by slow growth rates, premature senescence, accelerated telomere shortening rates, and genome instability. The syndrome is caused by the loss of the RecQ helicase WRN, but the underlying molecular mechanism is unclear. Here we report that cells lacking WRN exhibit deletion of telomeres from single sister chromatids. Only telomeres replicated by lagging strand synthesis were affected, and prevention of loss of individual telomeres was dependent on the helicase activity of WRN. Telomere toss could be counteracted by telomerase activity. We propose that WRN is necessary for efficient replication of G-rich telomeric DNA, preventing telomere dysfunction and consequent genomic instability.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Karlseder, J (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Karlseder@salk.edu	Crabbé, Laure/P-8955-2014	Crabbé, Laure/0000-0001-7764-3600	NIGMS NIH HHS [GM069525] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069525] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai YL, 2003, HUM GENET, V113, P337, DOI 10.1007/s00439-003-0972-y; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Baird DM, 2004, HUM MOL GENET, V13, P1515, DOI 10.1093/hmg/ddh159; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Chang CC, 2004, ANAL CHEM, V76, P4490, DOI 10.1021/ac049510s; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2003, CARCINOGENESIS, V24, P791, DOI 10.1093/carcin/bgg034; Pascolo E, 2002, J BIOL CHEM, V277, P15566, DOI 10.1074/jbc.M201266200; RHODES D, 1995, CURR OPIN STRUC BIOL, V5, P311, DOI 10.1016/0959-440X(95)80092-1; Schulz VP, 1996, HUM GENET, V97, P750; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wang L, 2000, GENETICS, V154, P357; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630	27	470	479	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1951	1953		10.1126/science.1103619	http://dx.doi.org/10.1126/science.1103619			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591207				2022-12-28	WOS:000225695600049
J	Guo, Y; Zhang, YF; Bao, XY; Han, TZ; Tang, Z; Zhang, LX; Zhu, WG; Wang, EG; Niu, Q; Qiu, ZQ; Jia, JF; Zhao, ZX; Xue, QK				Guo, Y; Zhang, YF; Bao, XY; Han, TZ; Tang, Z; Zhang, LX; Zhu, WG; Wang, EG; Niu, Q; Qiu, ZQ; Jia, JF; Zhao, ZX; Xue, QK			Superconductivity modulated by quantum size effects	SCIENCE			English	Article							TRANSITION-TEMPERATURE OSCILLATIONS; FILMS; STATES; GROWTH; ONSET; PB	We have fabricated ultrathin lead films on silicon substrates with atomic-scale control of the thickness over a macroscopic area. We observed oscillatory behavior of the superconducting transition temperature when the film thickness was increased by one atomic layer at a time. This oscillating behavior was shown to be a manifestation of the Fabry-Perot interference modes of electron de Broglie waves (quantum well states) in the films, which modulate the electron density of states near the Fermi level and the electron-phonon coupling, which are the two factors that control superconductivity transitions. This result suggests the possibility of modifying superconductivity and other physical properties of a thin film by exploiting well-controlled and thickness-dependent quantum size effects.	Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100080, Peoples R China; Univ Texas, Dept Phys, Austin, TX 78712 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Institute of Physics, CAS; University of Texas System; University of Texas Austin; University of California System; University of California Berkeley	Xue, QK (corresponding author), Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, POB 603, Beijing 100080, Peoples R China.	qkxue@aphy.iphy.ac.cn	zhang, yanfeng/N-3760-2013; Qiu, Zi Qiang/O-4421-2016; Bao, Xinyu/C-1226-2008; Qiu, Z. Q./AAZ-5044-2020; Zhu, Wenguang/F-4224-2011; Niu, Qian/G-9908-2013	Qiu, Zi Qiang/0000-0003-0680-0714; Qiu, Z. Q./0000-0003-0680-0714; Zhu, Wenguang/0000-0003-0819-595X; 				Balasubramanian T, 1998, PHYS REV B, V57, pR6866, DOI 10.1103/PhysRevB.57.R6866; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BARDEEN J, 1991, RECENT DEV SUPERCOND; BLATT JM, 1963, PHYS REV LETT, V10, P332, DOI 10.1103/PhysRevLett.10.332; Chiang TC, 2000, SURF SCI REP, V39, P181, DOI 10.1016/S0167-5729(00)00006-6; Crottini A, 1997, PHYS REV LETT, V79, P1527, DOI 10.1103/PhysRevLett.79.1527; Frydman A, 2003, PHYSICA C, V391, P189, DOI 10.1016/S0921-4534(03)00895-5; GRIMVALL G, 1981, ELECT PHON INTERACTI; HAVILAND DB, 1989, PHYS REV LETT, V62, P2180, DOI 10.1103/PhysRevLett.62.2180; JAEGER HM, 1989, PHYS REV B, V40, P182, DOI 10.1103/PhysRevB.40.182; JALOCHOWSKI M, 1988, PHYS REV B, V38, P5272, DOI 10.1103/PhysRevB.38.5272; Luh DA, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.256802; ORR BG, 1984, PHYS REV LETT, V53, P2046, DOI 10.1103/PhysRevLett.53.2046; Paggel JJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.186803; Paggel JJ, 1999, SCIENCE, V283, P1709, DOI 10.1126/science.283.5408.1709; PASKIN A, 1985, PHYS REV LETT, V55, P139, DOI 10.1103/PhysRevLett.55.139; Pfennigstorf O, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.045412; Sadovskii M V, 2000, SUPERCONDUCTIVITY LO; SKOCPOL WJ, 1975, REP PROG PHYS, V38, P1049, DOI 10.1088/0034-4885/38/9/001; Su WB, 2001, PHYS REV LETT, V86, P5116, DOI 10.1103/PhysRevLett.86.5116; Upton MH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.026802; Vilfan I, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.241306; YU M, 1976, PHYS REV B, V14, P996, DOI 10.1103/PhysRevB.14.996; Zhang ZY, 1998, PHYS REV LETT, V80, P5381, DOI 10.1103/PhysRevLett.80.5381	25	497	511	18	346	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1915	1917		10.1126/science.1105130	http://dx.doi.org/10.1126/science.1105130			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591197				2022-12-28	WOS:000225695600038
J	Mehlmann, LM; Saeki, Y; Tanaka, S; Brennan, TJ; Evsikov, AV; Pendola, FL; Knowles, BB; Eppig, JJ; Jaffe, LA				Mehlmann, LM; Saeki, Y; Tanaka, S; Brennan, TJ; Evsikov, AV; Pendola, FL; Knowles, BB; Eppig, JJ; Jaffe, LA			The G(s)-linked receptor GPR3 maintains meiotic arrest in mammalian oocytes	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTOR; MOLECULAR-CLONING; MOUSE OOCYTES; G(S) PROTEIN; KINASE; PHOSPHORYLATION; LOCALIZATION; MATURATION; ACTIVATION	Mammalian oocytes are held in prophase arrest by an unknown signal from the surrounding somatic tells. Here we show that the orphan G(s)-linked receptor GPR3, which is localized in the oocyte, maintains this arrest. Oocytes from Gpr3 knockout mice resume meiosis within antral follicles, independently of an increase in luteinizing hormone, and this phenotype can be reversed by injection of Gpr3 RNA into the oocytes. Thus, the GPR3 receptor is a link in communication between the somatic cells and oocyte of the ovarian follicle and, is crucial for the regulation of meiosis.	Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06032 USA; Massachusetts Gen Hosp, Charlestown, MA 02129 USA; Deltagen Inc, San Carlos, CA 94070 USA; Jackson Lab, Bar Harbor, ME 04609 USA	University of Connecticut; Harvard University; Massachusetts General Hospital; Jackson Laboratory	Mehlmann, LM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06032 USA.	lmehlmann@neuron.uchc.edu; ljaffe@neuron.uchc.edu	Evsikov, Alexei/E-2577-2012; Tanaka, Shigeru/O-3908-2015	Tanaka, Shigeru/0000-0003-3247-9098; Knowles, Barbara B./0000-0002-2597-5619; Evsikov, Alexei/0000-0003-2138-5440				BORNSLAEGER E A, 1988, Molecular Reproduction and Development, V1, P19, DOI 10.1002/mrd.1080010105; BORNSLAEGER EA, 1986, DEV BIOL, V114, P453, DOI 10.1016/0012-1606(86)90209-5; Bresnick JN, 2003, ASSAY DRUG DEV TECHN, V1, P239, DOI 10.1089/15406580360545053; CHOI T, 1991, DEVELOPMENT, V113, P789; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; Eppig J. J., 2004, OVARY, P113, DOI DOI 10.1016/B978-012444562-8/50008-2; EPPIG JJ, 1982, DEV BIOL, V89, P268, DOI 10.1016/0012-1606(82)90314-1; ERICKSON GF, 1974, J EXP ZOOL, V190, P123, DOI 10.1002/jez.1401900112; Horner K, 2003, DEV BIOL, V258, P385, DOI 10.1016/S0012-1606(03)00134-9; IISMAA TP, 1994, GENOMICS, V24, P391, DOI 10.1006/geno.1994.1635; Kalinowski RR, 2004, DEV BIOL, V267, P1, DOI 10.1016/j.ydbio.2003.11.011; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; LIRI T, 1994, NATURE, V371, P164; Mehlmann LM, 2002, SCIENCE, V297, P1343, DOI 10.1126/science.1073978; MEHLMANN LM, UNPUB; NAYUDU PL, 1992, J REPROD FERTIL, V95, P349, DOI 10.1530/jrf.0.0950349; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665; Russell DL, 2003, ENDOCRINOLOGY, V144, P1020, DOI 10.1210/en.2002-220434; SAEKI Y, 1993, FEBS LETT, V336, P317, DOI 10.1016/0014-5793(93)80828-I; Tanaka S., UNPUB; TSAFRIRI A, 1993, OVARY, P227; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4	24	237	253	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1947	1950		10.1126/science.1103974	http://dx.doi.org/10.1126/science.1103974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591206				2022-12-28	WOS:000225695600048
J	Papke, RT; Koenig, JE; Rodriguez-Valera, F; Doolittle, WF				Papke, RT; Koenig, JE; Rodriguez-Valera, F; Doolittle, WF			Frequent recombination in a saltern population of Halorubrum	SCIENCE			English	Article							HYPERTHERMOPHILIC ARCHAEON; GENETIC DIVERSITY; SALINITY GRADIENT; SOLAR SALTERN; SYSTEM; TRANSFORMATION; SULFOLOBUS; BACTERIAL	Sex and recombination are driving forces in the evolution of eukaryotes. Homologous recombination is known to be the dominant process in the divergence of many bacterial. species. For Archaea, the only direct evidence bearing on the importance or natural occurrence of homologous recombination is anecdotal reports of mosaicism from comparative genomic studies. Genetic studies, however, reveal that recombination may play a significant role in generating diversity among members of at least one archaeal group, the haloarchaea. We used multi-locus sequence typing to demonstrate that haloarchaea exchange genetic information promiscuously, exhibiting a degree of linkage equilibrium approaching that of a sexual population.	Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada; Univ Miguel Hernandez, Div Microbiol, Alacant 03550, Spain	Dalhousie University; Universidad Miguel Hernandez de Elche	Papke, RT (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, 5859 Univ Ave, Halifax, NS B3H 4H7, Canada.	rpapke@dal.ca	; Rodriguez-Valera, Francisco/M-2782-2013	Doolittle, W. Ford/0000-0002-4675-8832; Rodriguez-Valera, Francisco/0000-0002-9809-2059; Papke, Robertson/0000-0003-1371-2341				Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; Boucher Y, 2004, J BACTERIOL, V186, P3980, DOI 10.1128/JB.186.12.3980-3990.2004; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; Cline S. W., 1995, P197; CLINE SW, 1992, J BACTERIOL, V174, P1076, DOI 10.1128/jb.174.3.1076-1080.1992; Dyall-Smith M, 2003, RES MICROBIOL, V154, P309, DOI 10.1016/S0923-2508(03)00076-7; Feil EJ, 2000, GENETICS, V154, P1439; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; *GENBANK, AJ851932AJ852003 GEN; *GENBANK, AJ851333AJ851368 GEN; *GENBANK, AJ851294AJ851329 GEN; *GENBANK, AJ851895AJ851930 GEN; Jonuscheit M, 2003, MOL MICROBIOL, V48, P1241, DOI 10.1046/j.1365-2958.2003.03509.x; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; MUKOHATA Y, 1988, BIOCHEM BIOPH RES CO, V151, P1339, DOI 10.1016/S0006-291X(88)80509-6; Prangishvili D, 1998, PLASMID, V40, P190, DOI 10.1006/plas.1998.1363; Reilly MS, 2001, J BACTERIOL, V183, P2943, DOI 10.1128/JB.183.9.2943-2946.2001; ROSENSHINE I, 1989, SCIENCE, V245, P1387, DOI 10.1126/science.2818746; SELANDER RK, 1980, SCIENCE, V210, P545, DOI 10.1126/science.6999623; Wang GJ, 2004, J BACTERIOL, V186, P3187, DOI 10.1128/JB.186.10.3187-3194.2004	21	121	127	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2004	306	5703					1928	1929		10.1126/science.1103289	http://dx.doi.org/10.1126/science.1103289			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591201				2022-12-28	WOS:000225695600042
J	Hillier, LW; Miller, W; Birney, E; Warren, W; Hardison, RC; Ponting, CP; Bork, P; Burt, DW; Groenen, MAM; Delany, ME; Dodgson, JB; Chinwalla, AT; Cliften, PF; Clifton, SW; Delehaunty, KD; Fronick, C; Fulton, RS; Graves, TA; Kremitzki, C; Layman, D; Magrini, V; McPherson, JD; Miner, TL; Minx, P; Nash, WE; Nhan, MN; Nelson, JO; Oddy, LG; Pohl, CS; Randall-Maher, J; Smith, SM; Wallis, JW; Yang, SP; Romanov, MN; Rondelli, CM; Paton, B; Smith, J; Morrice, D; Daniels, L; Tempest, HG; Robertson, L; Masabanda, JS; Griffin, DK; Vignal, A; Fillon, V; Jacobbson, L; Kerje, S; Andersson, L; Crooijmans, RPM; Aerts, J; van der Poel, JJ; Ellegren, H; Caldwell, RB; Hubbard, SJ; Grafham, DV; Kierzek, AM; McLaren, SR; Overton, IM; Arakawa, H; Beattie, KJ; Bezzubov, Y; Boardman, PE; Bonfield, JK; Croning, MDR; Davies, RM; Francis, MD; Humphray, SJ; Scott, CE; Taylor, RG; Tickle, C; Brown, WRA; Rogers, J; Buerstedde, JM; Wilson, SA; Stubbs, L; Ovcharenko, I; Gordon, L; Lucas, S; Miller, MM; Inoko, H; Shiina, T; Kaufman, J; Salomonsen, J; Skjoedt, K; Wong, GKS; Wang, J; Liu, B; Wang, J; Yu, J; Yang, HM; Nefedov, M; Koriabine, M; deJong, PJ; Goodstadt, L; Webber, C; Dickens, NJ; Letunic, I; Suyama, M; Torrents, D; von Mering, C; Zdobnov, EM; Makova, K; Nekrutenko, A; Elnitski, L; Eswara, P; King, DC; Yang, S; Tyekucheva, S; Radakrishnan, A; Harris, RS; Chiaromonte, F; Taylor, J; He, JB; Rijnkels, M; Griffiths-Jones, S; Ureta-Vidal, A; Hoffman, MM; Severin, J; Searle, SMJ; Law, AS; Speed, D; Waddington, D; Cheng, Z; Tuzun, E; Eichler, E; Bao, ZR; Flicek, P; Shteynberg, DD; Brent, MR; Bye, JM; Huckle, EJ; Chatterji, S; Dewey, C; Pachter, L; Kouranov, A; Mourelatos, Z; Hatzigeorgiou, AG; Paterson, AH; Ivarie, R; Brandstrom, M; Axelsson, E; Backstrom, N; Berlin, S; Webster, MT; Pourquie, O; Reymond, A; Ucla, C; Antonarakis, SE; Long, MY; Emerson, JJ; Betran, E; Dupanloup, I; Kaessmann, H; Hinrichs, AS; Bejerano, G; Furey, TS; Harte, RA; Raney, B; Siepel, A; Kent, WJ; Haussler, D; Eyras, E; Castelo, R; Abril, JF; Castellano, S; Camara, F; Parra, G; Guigo, R; Bourque, G; Tesler, G; Pevzner, PA; Smit, A; Fulton, LA; Mardis, ER; Wilson, RK				Hillier, LW; Miller, W; Birney, E; Warren, W; Hardison, RC; Ponting, CP; Bork, P; Burt, DW; Groenen, MAM; Delany, ME; Dodgson, JB; Chinwalla, AT; Cliften, PF; Clifton, SW; Delehaunty, KD; Fronick, C; Fulton, RS; Graves, TA; Kremitzki, C; Layman, D; Magrini, V; McPherson, JD; Miner, TL; Minx, P; Nash, WE; Nhan, MN; Nelson, JO; Oddy, LG; Pohl, CS; Randall-Maher, J; Smith, SM; Wallis, JW; Yang, SP; Romanov, MN; Rondelli, CM; Paton, B; Smith, J; Morrice, D; Daniels, L; Tempest, HG; Robertson, L; Masabanda, JS; Griffin, DK; Vignal, A; Fillon, V; Jacobbson, L; Kerje, S; Andersson, L; Crooijmans, RPM; Aerts, J; van der Poel, JJ; Ellegren, H; Caldwell, RB; Hubbard, SJ; Grafham, DV; Kierzek, AM; McLaren, SR; Overton, IM; Arakawa, H; Beattie, KJ; Bezzubov, Y; Boardman, PE; Bonfield, JK; Croning, MDR; Davies, RM; Francis, MD; Humphray, SJ; Scott, CE; Taylor, RG; Tickle, C; Brown, WRA; Rogers, J; Buerstedde, JM; Wilson, SA; Stubbs, L; Ovcharenko, I; Gordon, L; Lucas, S; Miller, MM; Inoko, H; Shiina, T; Kaufman, J; Salomonsen, J; Skjoedt, K; Wong, GKS; Wang, J; Liu, B; Wang, J; Yu, J; Yang, HM; Nefedov, M; Koriabine, M; deJong, PJ; Goodstadt, L; Webber, C; Dickens, NJ; Letunic, I; Suyama, M; Torrents, D; von Mering, C; Zdobnov, EM; Makova, K; Nekrutenko, A; Elnitski, L; Eswara, P; King, DC; Yang, S; Tyekucheva, S; Radakrishnan, A; Harris, RS; Chiaromonte, F; Taylor, J; He, JB; Rijnkels, M; Griffiths-Jones, S; Ureta-Vidal, A; Hoffman, MM; Severin, J; Searle, SMJ; Law, AS; Speed, D; Waddington, D; Cheng, Z; Tuzun, E; Eichler, E; Bao, ZR; Flicek, P; Shteynberg, DD; Brent, MR; Bye, JM; Huckle, EJ; Chatterji, S; Dewey, C; Pachter, L; Kouranov, A; Mourelatos, Z; Hatzigeorgiou, AG; Paterson, AH; Ivarie, R; Brandstrom, M; Axelsson, E; Backstrom, N; Berlin, S; Webster, MT; Pourquie, O; Reymond, A; Ucla, C; Antonarakis, SE; Long, MY; Emerson, JJ; Betran, E; Dupanloup, I; Kaessmann, H; Hinrichs, AS; Bejerano, G; Furey, TS; Harte, RA; Raney, B; Siepel, A; Kent, WJ; Haussler, D; Eyras, E; Castelo, R; Abril, JF; Castellano, S; Camara, F; Parra, G; Guigo, R; Bourque, G; Tesler, G; Pevzner, PA; Smit, A; Fulton, LA; Mardis, ER; Wilson, RK			Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution	NATURE			English	Review							NON-LTR RETROTRANSPOSONS; MAJOR HISTOCOMPATIBILITY COMPLEX; RECENT SEGMENTAL DUPLICATIONS; TISSUE-SPECIFIC GENES; BROWN-NORWAY RAT; ALCOHOL-DEHYDROGENASE; MAMMALIAN EVOLUTION; OLFACTORY RECEPTOR; MOUSE GENOME; PHYLOGENETIC ANALYSIS	We present here a draft genome sequence of the red jungle fowl, Gallus gallus. Because the chicken is a modern descendant of the dinosaurs and the first non-mammalian amniote to have its genome sequenced, the draft sequence of its genome - composed of approximately one billion base pairs of sequence and an estimated 20,000 - 23,000 genes - provides a new perspective on vertebrate genome evolution, while also improving the annotation of mammalian genomes. For example, the evolutionary distance between chicken and human provides high specificity in detecting functional elements, both non-coding and coding. Notably, many conserved non-coding sequences are far from genes and cannot be assigned to defined functional classes. In coding regions the evolutionary dynamics of protein domains and orthologous groups illustrate processes that distinguish the lineages leading to birds and mammals. The distinctive properties of avian microchromosomes, together with the inferred patterns of conserved synteny, provide additional insights into vertebrate chromosome architecture.	Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Penn State Univ, Dept Biol, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Penn State Univ, Dept Stat, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; Penn State Univ, Dept Hlth Evaluat Sci, University Pk, PA 16802 USA; EMBL, EBI, Cambridge CB10 1SD, England; Univ Oxford, Dept Human Anat & Genet, MRC, Funct Genet Unit, Oxford OX1 3QX, England; Max Delbruck Ctr Mol Med, D-13025 Berlin, Germany; European Mol Biol Lab, D-69012 Heidelberg, Germany; Roslin Inst Edinburgh, Roslin EH25 9PS, Midlothian, Scotland; Univ Wageningen & Res Ctr, Anim Breeding & Genet Grp, NL-6709 PG Wageningen, Netherlands; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; INRA, Ctr Toulouse, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France; Brunel Univ, Dept Biol Sci, Cell & Chromosome Biol Grp, Uxbridge UB8 3PH, Middx, England; Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Miocrobiol, SE-75124 Uppsala, Sweden; Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, SE-75236 Uppsala, Sweden; GSF, Forschungszentrum, Inst Mol Strahlenbiol, D-85764 Neuherberg, Germany; Univ Manchester, Dept Biomol Sci, Manchester M60 1QD, Lancs, England; Sanger Inst, Hinxton CB10 1SA, Cambs, England; Polish Acad Sci, Inst Biochem & Biophys, Lab Syst Biol, PL-02106 Warsaw, Poland; Univ Dundee, Sch Life Sci, Div Cell & Dev Biol, Dundee DD1 5EH, Scotland; Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Lawrence Livermore Natl Lab, EEBI Div, Livermore, CA 94550 USA; Lawrence Livermore Natl Lab, Genome Biol Div, Livermore, CA 94550 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Biol, Duarte, CA 91010 USA; Tokai Univ, Sch Med, Div Basic Med Sci & Mol Med, Dept Mol Life Sci, Isehara, Kanagawa 2591143, Japan; Inst Anim Hlth, Compton RG20 7NN, Berks, England; Royal Vet & Agr Univ, Dept Vet Pathobiol, Immunol Lab, DK-1870 Copenhagen, Denmark; Odense Univ, Dept Immunol & Med Microbiol, DK-5000 Odense, Denmark; Chinese Acad Sci, Beijing Inst Genom, Beijing Proteom Inst, Beijing 101300, Peoples R China; Zhejiang Univ, Hangzhou Genom Inst, James D Watson Inst Genome Sci, Key Lab Bioinformat Zhejiang Prov, Hangzhou 310007, Peoples R China; Univ Washington, Dept Med, Genome Ctr, Seattle, WA 98195 USA; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; Univ Washington, Sch Med, Seattle, WA 98195 USA; Washington Univ, Lab Computat Genom, St Louis, MO 63130 USA; Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; Univ Penn, Sch Med, Dept Genet, Ctr Bioinformat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; Univ Georgia, Dept Genet, Athens, GA 30602 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Texas, Dept Biol, Arlington, TX 76019 USA; Univ Lausanne, BEP, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; Univ Calif Santa Cruz, Baskin Sch Engn, Ctr Biomol Sci & Engn, Genome Bioinformat Grp, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Baskin Sch Engn, Ctr Biomol Sci & Engn, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Univ Pompeu Fabra, Inst Municipal Invest Med, Grp Recerca Informat Biomed, Barcelona 08003, Catalonia, Spain; Ctr Regulacio Genom, Programa Bioinformat & Genom, Barcelona 08003, Catalonia, Spain; Genome Inst Singapore, Singapore 138672, Singapore; Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; Inst Syst Biol, Computat Biol Grp, Seattle, WA USA	Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; European Molecular Biology Laboratory (EMBL); University of Oxford; Helmholtz Association; Max Delbruck Center for Molecular Medicine; European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; Wageningen University & Research; University of California System; University of California Davis; Michigan State University; INRAE; Brunel University; Uppsala University; Uppsala University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Manchester; Wellcome Trust Sanger Institute; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Dundee; University of Nottingham; University of Sheffield; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; City of Hope; Beckman Research Institute of City of Hope; Tokai University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Copenhagen; University of Southern Denmark; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Zhejiang University; University of Washington; University of Washington Seattle; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Baylor College of Medicine; University of Washington; University of Washington Seattle; Washington University (WUSTL); University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Pennsylvania; University of Pennsylvania; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Stowers Institute for Medical Research; University of Geneva; University of Chicago; University of Texas System; University of Texas Arlington; University of Lausanne; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California San Diego; University of California System; University of California San Diego; Institute for Systems Biology (ISB)	Wilson, RK (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,4444 Forest Pk Ave, St Louis, MO 63108 USA.	rwilson@watson.wustl.edu	Magrini, Vincent/AAT-5830-2020; Wilson, Richard K./AAF-4139-2019; Smith, Jacqueline/C-7719-2013; Severin, Jessica/AAQ-2723-2020; Overton, Ian/A-5911-2011; Groenen, Martien/D-8408-2012; Ponting, Chris/AAV-2621-2021; Elnitski, Laura/AAD-3595-2021; Tuzun, Eray/B-5949-2018; Tuzun, Eray/AAD-7282-2021; Brent, Michael/AAK-3702-2020; Gasull, Martina/J-4076-2019; Bork, Peer/F-1813-2013; Kaessmann, Henrik/B-4989-2013; van der Poel, Jan/E-5104-2012; Zdobnov, Evgeny/AAB-2745-2022; Eyras, Eduardo/A-1560-2010; Crooijmans, Richard PMA/E-2492-2012; Fillon, Valerie/GWR-2196-2022; Dupanloup, Isabelle/AAD-5372-2020; Aerts, Jan/C-4374-2008; McPherson, John D/D-2633-2017; Antonarakis, Stylianos E/N-8866-2014; 郑, 征/C-8514-2011; Taylor, James/F-1026-2011; Brandström Durling, Mikael/C-1213-2008; Castelo, Robert/A-4679-2010; Ferreira, Francisco Câmara/G-9841-2015; Dupanloup, Isabelle/O-8609-2017; Eyras, Eduardo/ABG-7144-2020; Guigo, Roderic/D-1303-2010; Aerts, Jan/AAQ-6949-2020; Smith, Jane/B-6254-2009; Letunic, Ivica/K-1102-2019; Raney, Brian/ABE-6267-2020; Pourquié, Olivier/CAJ-5443-2022; Hubbard, Simon J/B-9006-2009; Bourque, Guillaume/AFR-2927-2022; von Mering, Christian/B-3300-2008; Emerson, J.J./D-8955-2011; Letunic, Ivica/A-6032-2009; WONG, Gane Ka-Shu/G-5784-2013; Vignal, Alain/AAJ-5697-2021; Vignal, Alain/I-6253-2017; Hardison, Ross C/G-1142-2010; Backström, Niclas/C-8425-2012; Zdobnov, Evgeny M/K-1133-2012; Mardis, Elaine/W-2202-2019; Hoffman, Michael M./I-1924-2012; Romanov, Michael N/O-9419-2014; Ferrando, Josep F Abril/B-3877-2014; Axelsson, Erik/A-6119-2009; Burt, David W/C-7802-2013; Hatzigeorgiou, Artemis/Z-1976-2019; Castellano, Sergi/A-7437-2016; Torrents, David/G-5785-2015; Wang, Jun/B-9503-2016; Dickens, Nicholas/G-1445-2013; Wang, Jun/C-8434-2016	Magrini, Vincent/0000-0002-2019-4872; Wilson, Richard K./0000-0002-1992-1358; Smith, Jacqueline/0000-0002-2813-7872; Severin, Jessica/0000-0003-1274-208X; Groenen, Martien/0000-0003-0484-4545; Tuzun, Eray/0000-0002-5550-7816; Tuzun, Eray/0000-0002-5550-7816; Brent, Michael/0000-0002-8689-0299; Bork, Peer/0000-0002-2627-833X; Kaessmann, Henrik/0000-0001-7563-839X; Zdobnov, Evgeny/0000-0002-5178-1498; McPherson, John D/0000-0001-8049-9347; Antonarakis, Stylianos E/0000-0001-8907-5823; Taylor, James/0000-0001-5079-840X; Brandström Durling, Mikael/0000-0001-6485-197X; Castelo, Robert/0000-0003-2229-4508; Ferreira, Francisco Câmara/0000-0002-1971-5466; Dupanloup, Isabelle/0000-0002-9258-6963; Eyras, Eduardo/0000-0003-0793-6218; Guigo, Roderic/0000-0002-5738-4477; Aerts, Jan/0000-0002-6416-2717; Letunic, Ivica/0000-0003-3560-4288; Pourquié, Olivier/0000-0001-5189-1227; Bourque, Guillaume/0000-0002-3933-9656; von Mering, Christian/0000-0001-7734-9102; WONG, Gane Ka-Shu/0000-0001-6108-5560; Vignal, Alain/0000-0002-6797-2125; Vignal, Alain/0000-0002-6797-2125; Hardison, Ross C/0000-0003-4084-7516; Hoffman, Michael M./0000-0002-4517-1562; Romanov, Michael N/0000-0003-3584-4644; Ferrando, Josep F Abril/0000-0001-7793-589X; Burt, David W/0000-0002-9991-1028; wilson, stuart/0000-0003-3073-258X; King, David/0000-0003-1601-1612; Emerson, James/0000-0001-9474-0891; Furey, Terry/0000-0001-5546-9672; Webber, Caleb/0000-0001-8063-7674; Castellano, Sergi/0000-0002-5819-4210; Rondelli, Catherine/0000-0002-5264-6714; Skjodt, Karsten/0000-0002-9161-8185; Caldwell, Randolph/0000-0003-3933-3243; Suyama, Mikita/0000-0001-9526-3193; Hubbard, Simon/0000-0002-8601-9524; Pachter, Lior/0000-0002-9164-6231; Siepel, Adam/0000-0002-3557-7219; Betran, Esther/0000-0002-4742-7963; Shiina, Takashi/0000-0002-2067-6708; Torrents, David/0000-0002-6086-9037; Nekrutenko, Anton/0000-0002-5987-8032; Wang, Jun/0000-0002-2113-5874; Hinrichs, Angie/0000-0002-1697-1130; Bonfield, James/0000-0002-6447-4112; Dickens, Nicholas/0000-0003-0492-5855; Stubbs, Lisa/0000-0002-9556-1972; Wang, Jun/0000-0002-8540-8931; Flicek, Paul/0000-0002-3897-7955; Overton, Ian/0000-0003-1158-8527; Stromstedt, Lina/0000-0002-9317-7651	Biotechnology and Biological Sciences Research Council [BBS/B/13462] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ABRIL JF, IN PRESS GENOME RES; ADEY NB, 1994, P NATL ACAD SCI USA, V91, P1569, DOI 10.1073/pnas.91.4.1569; Alcock J., 1989, ANIMAL BEHAV; Altmann SM, 2003, J VIROL, V77, P1992, DOI 10.1128/JVI.77.3.1992-2002.2003; Amadou C, 2003, HUM MOL GENET, V12, P3025, DOI 10.1093/hmg/ddg317; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Andreozzi L, 2001, CHROMOSOME RES, V9, P521, DOI 10.1023/A:1012436900788; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Aruscavage PJ, 2000, RNA, V6, P257, DOI 10.1017/S1355838200991921; Ashurst JL, 2003, ANNU REV GENOM HUM G, V4, P69, DOI 10.1146/annurev.genom.4.070802.110300; AXELSSON E, IN PRESS GENOME RES; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BATESON W, 1902, REP EVOL COMM R SOC, V1, P1; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Benton M. J., 2000, VERTEBRATE PALAEONTO; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Bitgood J. J, 1993, GENETIC MAPS, P4333; BLOOM SE, 1993, CONSTANT VARIABLE FE; Bourque G, 2004, GENOME RES, V14, P507, DOI 10.1101/gr.1975204; Bourque G, 2002, GENOME RES, V12, P26; BOURQUE G, IN PRESS GENOME RES; Bradbury J, 2004, PLOS BIOL, V2, P295, DOI 10.1371/journal.pbio.0020064; Brown WRA, 2003, NAT REV GENET, V4, P87, DOI 10.1038/nrg998; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; BURCH JBE, 1993, P NATL ACAD SCI USA, V90, P8199, DOI 10.1073/pnas.90.17.8199; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; BURT DW, 2003, COMP GENOMICS POULTR; CALDWELL R, IN PRESS GENOME BIOL; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r47; CHIAROMONTE F, 2003, GENOME HOMO SAPIENS, V68; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75; Copley RR, 2003, CURR OPIN GENET DEV, V13, P623, DOI 10.1016/j.gde.2003.10.004; CORDONNIER A, 1995, J VIROL, V69, P5890, DOI 10.1128/JVI.69.9.5890-5897.1995; CRAWFORD RD, 1995, POULTRY BREEDING GEN; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Darwin Charles, 1896, VARIATION ANIMALS PL; DELEON FAP, 1992, J HERED, V83, P36, DOI 10.1093/oxfordjournals.jhered.a111154; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Dunham A, 2004, NATURE, V428, P522, DOI 10.1038/nature02379; DURET L, 1995, J MOL EVOL, V40, P308, DOI 10.1007/BF00163235; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Duret L, 1997, CURR OPIN STRUC BIOL, V7, P399, DOI 10.1016/S0959-440X(97)80058-9; Elnitski L, 2003, GENOME RES, V13, P64, DOI 10.1101/gr.817703; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; ESTONIUS M, 1990, EUR J BIOCHEM, V194, P593, DOI 10.1111/j.1432-1033.1990.tb15657.x; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Fickenscher H, 2004, INT IMMUNOPHARMACOL, V4, P609, DOI 10.1016/j.intimp.2004.01.004; FITZPATRICK DM, 2000, DOWN EARTH, V9, P28; Flicek P, 2003, GENOME RES, V13, P46, DOI 10.1101/gr.830003; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gottgens B, 2000, NAT BIOTECHNOL, V18, P181, DOI 10.1038/72635; Gregory TR, 2004, GENE, V324, P15, DOI 10.1016/j.gene.2003.09.030; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Groenen MAM, 2000, GENOME RES, V10, P137; Grutzner F, 2001, CYTOGENET CELL GENET, V93, P265, DOI 10.1159/000056996; Haas NB, 1997, GENE, V197, P305, DOI 10.1016/S0378-1119(97)00276-X; Haas NB, 2001, GENE, V265, P175, DOI 10.1016/S0378-1119(01)00344-4; Habermann FA, 2001, CHROMOSOME RES, V9, P569, DOI 10.1023/A:1012447318535; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hirose T, 2001, P NATL ACAD SCI USA, V98, P12914, DOI 10.1073/pnas.231490998; HJELMQVIST L, 1995, P NATL ACAD SCI USA, V92, P10904, DOI 10.1073/pnas.92.24.10904; HOLMQUIST GP, 1989, J MOL EVOL, V28, P469, DOI 10.1007/BF02602928; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; HUBBARD SJ, IN PRESS GENOME RES; Hughes AL, 2004, P ROY SOC B-BIOL SCI, V271, pS107, DOI 10.1098/rsbl.2003.0124; Hughes AL, 2000, J INTERF CYTOK RES, V20, P737, DOI 10.1089/10799900050116444; Hurst LD, 1999, TRENDS GENET, V15, P437, DOI 10.1016/S0168-9525(99)01832-6; Hutt F.B., 1949, GENETICS OF THE FOWL; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jones RB, 1997, PHYSIOL BEHAV, V62, P1009, DOI 10.1016/S0031-9384(97)00207-2; Kang WQ, 2003, FEBS LETT, V540, P21, DOI 10.1016/S0014-5793(03)00217-5; Kapitonov VV, 2003, MOL BIOL EVOL, V20, P38, DOI 10.1093/molbev/msg011; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Kedishvili NY, 1997, J BIOL CHEM, V272, P7494, DOI 10.1074/jbc.272.11.7494; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Koonin EV, 2004, CELL CYCLE, V3, P280; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; McQueen HA, 1998, GENOME RES, V8, P621, DOI 10.1101/gr.8.6.621; McQueen HA, 1996, NAT GENET, V12, P321, DOI 10.1038/ng0396-321; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Mefford HC, 2001, HUM MOL GENET, V10, P2363, DOI 10.1093/hmg/10.21.2363; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; Montoya-Burgos JI, 2003, TRENDS GENET, V19, P128, DOI 10.1016/S0168-9525(03)00021-0; MUIR WM, 2003, IND PERSPECTIVE PROB; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Murphy William J., 2003, Human Genomics, V1, P30; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nordling E, 2002, CELL MOL LIFE SCI, V59, P1070, DOI 10.1007/s00018-002-8487-6; Ohshima K, 1996, MOL CELL BIOL, V16, P3756; OLOFSSON B, 1983, BIOCHIM BIOPHYS ACTA, V740, P339, DOI 10.1016/0167-4781(83)90143-4; OSTROM JH, 1975, ANNU REV EARTH PL SC, V3, P55, DOI 10.1146/annurev.ea.03.050175.000415; OVCHARENKO I, IN PRESS GENOME RES; Parra G, 2003, GENOME RES, V13, P108, DOI 10.1101/gr.871403; Pevzner P, 2003, GENOME RES, V13, P37, DOI 10.1101/gr.757503; Pisenti JM, 2001, AVIAN POULT BIOL REV, V12, P1; Pruitt KD, 2003, NUCLEIC ACIDS RES, V31, P34, DOI 10.1093/nar/gkg111; Punnett R. C, 1923, HEREDITY POULTRY HEREDITY POULTRY; Reisz RR, 2004, TRENDS GENET, V20, P237, DOI 10.1016/j.tig.2004.03.007; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; Reymond A, 2002, GENOMICS, V79, P824, DOI 10.1006/geno.2002.6781; Rodionov AV, 1996, GENETIKA+, V32, P597; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; Romanov MN, 2003, CYTOGENET GENOME RES, V102, P277, DOI 10.1159/000075763; Sander TL, 2003, GENE, V310, P29, DOI 10.1016/S0378-1119(03)00509-2; SCHMID M, 1989, CYTOGENET CELL GENET, V52, P139, DOI 10.1159/000132864; Schmid M, 2000, CYTOGENET CELL GENET, V90, P169, DOI 10.1159/000056772; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Shiina T, 2001, GENOME RES, V11, P789, DOI 10.1101/gr.175801; Smale L, 2003, J BIOL RHYTHM, V18, P356, DOI 10.1177/0748730403256651; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Smit AFA, 1999, REPEATMASKER; Smith J, 2000, ANIM GENET, V31, P96, DOI 10.1046/j.1365-2052.2000.00565.x; Stanyon R, 2003, GENOMICS, V82, P245, DOI 10.1016/S0888-7543(03)00109-5; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; TAMIR H, 1963, ARCH BIOCHEM BIOPHYS, V102, P249, DOI 10.1016/0003-9861(63)90178-4; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; Tuzun E, 2004, GENOME RES, V14, P493, DOI 10.1101/gr.1907504; VANDERGON TL, 1994, MOL BIOL EVOL, V11, P886; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vogt PK, 1997, HIST INTRO GEN PROPE; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; Williams AJ, 1999, MOL CELL BIOL, V19, P8526; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Wu JQ, 2004, GENOME RES, V14, P665, DOI 10.1101/gr.1959604; Yang S, 2004, GENOME RES, V14, P517, DOI 10.1101/gr.1984404; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; [No title captured]	165	2020	2337	19	340	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					695	716		10.1038/nature03154	http://dx.doi.org/10.1038/nature03154			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592404	Green Published, Bronze			2022-12-28	WOS:000225597200038
J	Juni, P; Nartey, L; Reichenbach, S; Sterchi, R; Dieppe, PA; Egger, M				Juni, P; Nartey, L; Reichenbach, S; Sterchi, R; Dieppe, PA; Egger, M			Risk of cardiovascular events and rofecoxib: cumulative meta-analysis	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SELECTIVE CYCLOOXYGENASE-2 INHIBITORS; ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; DOUBLE-BLIND; GASTROINTESTINAL TOXICITY; RHEUMATOID-ARTHRITIS; THROMBOTIC EVENTS; COX-2 INHIBITORS; RANDOMIZED-TRIAL	Background The cyclo-oxygenase 2 inhibitor rofecoxib was recently withdrawn because of cardiovascular adverse effects. An increased risk of myocardial infarction had been observed in 2000 in the Vioxx Gastrointestinal Outcomes Research study (VIGOR), but was attributed to cardioprotection of naproxen rather than a cardiotoxic effect of rofecoxib. We used standard and cumulative random-effects meta-analyses of randomised controlled trials and observational studies to establish whether robust evidence on the adverse effects of rofecoxib was available before September, 2004. Methods We searched bibliographic databases and relevant files of the US Food and Drug Administration. We included all randomised controlled trials in patients with chronic musculoskeletal disorders that compared rofecoxib with other non-steroidal anti-inflammatory drugs (NSAIDs) or placebo, and cohort and case-control studies of cardiovascular risk and naproxen. Myocardial infarction was the primary endpoint. Findings We identified 18 randomised controlled trials and 11 observational studies. By the end of 2000 (52 myocardial infarctions, 20 742 patients) the relative risk from randomised controlled trials was 2.30 (95% Cl 1.22-4.33, p=0.010), and 1 year later (64 events, 21432 patients) it was 2.24 (1.24-4.02, p=0.007). There was little evidence that the relative risk differed depending on the control group (placebo, non-naproxen NSAID, or naproxen; p=0.41) or trial duration (p=0.82). In observational studies, the cardioprotective effect of naproxen was small (combined estimate 0.86 [95% Cl 0.75-0.99]) and could not have explained the findings of the VIGOR trial. Interpretation Our findings indicate that rofecoxib should have been withdrawn several years earlier. The reasons why manufacturer and drug licensing authorities did not continuously monitor and summarise the accumulating evidence need to be clarified.	Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Bern, Inselspital, Dept Rheumatol & Clin Immunol, CH-3010 Bern, Switzerland; Univ Bristol, Dept Social Med, MRC Hlth Serv Res Collaborat, Bristol, Avon, England	University of Bern; University of Bern; University Hospital of Bern; University of Bristol	Egger, M (corresponding author), Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland.	egger@ispm.unibe.ch	Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670; Reichenbach, Stephan/0000-0001-8098-6567; Egger, Matthias/0000-0001-7462-5132				Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 2004, LANCET, V364, P1287; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Cannon GW, 2000, ARTHRITIS RHEUM-US, V43, P978, DOI 10.1002/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO;2-0; Catella-Lawson Francesca, 2001, American Journal of Medicine, V110, p28S; Dalen JE, 2002, ARCH INTERN MED, V162, P1091, DOI 10.1001/archinte.162.10.1091; Day R, 2000, ARCH INTERN MED, V160, P1781, DOI 10.1001/archinte.160.12.1781; Dieppe PA, 2004, BRIT MED J, V329, P867, DOI 10.1136/bmj.329.7471.867; Ehrich EW, 1999, J RHEUMATOL, V26, P2438; Ehrich EW, 2001, AM J MANAG CARE, V7, P609; Geba G, 2001, J AM GERIATR SOC, V49, pS126; Geusens PP, 2002, SCAND J RHEUMATOL, V31, P230, DOI 10.1080/030097402320318431; GRAHAM DJ, 2004, 20 ANN M INT SOC PHA; Hawkey C, 2000, ARTHRITIS RHEUM-US, V43, P370, DOI 10.1002/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D; Hawkey CJ, 2003, GUT, V52, P820, DOI 10.1136/gut.52.6.820; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hochberg MC, 2003, ARTHRITIS RES THER, V5, P28, DOI 10.1186/ar617; Horton R, 1999, LANCET, V353, P164, DOI 10.1016/S0140-6736(05)77210-X; Jick SS, 2000, PHARMACOTHERAPY, V20, P741, DOI 10.1592/phco.20.9.741.35209; Juni P, 2002, ARCH INTERN MED, V162, P2639, DOI 10.1001/archinte.162.22.2639-a; Katz N, 2004, CURR MED RES OPIN, V20, P651, DOI 10.1185/030079904125003160; Kimmel SE, 2004, J AM COLL CARDIOL, V43, P985, DOI 10.1016/j.jacc.2003.08.064; Kivitz AJ, 2004, J AM GERIATR SOC, V52, P666, DOI 10.1111/j.1532-5415.2004.52201.x; Konstam MA, 2001, CIRCULATION, V104, P2280, DOI 10.1161/hc4401.100078; Laine L, 1999, GASTROENTEROLOGY, V117, P776, DOI 10.1016/S0016-5085(99)70334-3; Lisse JR, 2003, ANN INTERN MED, V139, P539, DOI 10.7326/0003-4819-139-7-200310070-00005; Mamdani M, 2003, ARCH INTERN MED, V163, P481, DOI 10.1001/archinte.163.4.481; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Merck, MERCK ANN VOL WORLDW; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Petitti D, 2004, INT J EPIDEMIOL, V33, P461, DOI 10.1093/ije/dyh192; Rahme E, 2002, ARCH INTERN MED, V162, P1111, DOI 10.1001/archinte.162.10.1111; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; Reicin AS, 2002, AM J CARDIOL, V89, P204, DOI 10.1016/S0002-9149(01)02201-9; Rodriguez LAG, 2004, CIRCULATION, V109, P3000, DOI 10.1161/01.CIR.0000132491.96623.04; Saag K, 2000, ARCH FAM MED, V9, P1124, DOI 10.1001/archfami.9.10.1124; Schlienger RG, 2002, BRIT J CLIN PHARMACO, V54, P327, DOI 10.1046/j.1365-2125.2002.01637.x; Schnitzer TJ, 1999, CLIN THER, V21, P1688, DOI 10.1016/S0149-2918(99)80048-4; Solomon DH, 2004, CIRCULATION, V109, P2068, DOI 10.1161/01.CIR.0000127578.21885.3E; Solomon DH, 2002, ARCH INTERN MED, V162, P1099, DOI 10.1001/archinte.162.10.1099; TARGUM SL, 2001, FOOD DRUG ADM CARDIO; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Truitt KE, 2001, AGING-CLIN EXP RES, V13, P112, DOI 10.1007/BF03351533; Truitt KE, 2001, ARTHRITIS RHEUM, V44, pS369; Van Hecken A, 2000, J CLIN PHARMACOL, V40, P1109; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Watson DJ, 2002, ARCH INTERN MED, V162, P1105, DOI 10.1001/archinte.162.10.1105	49	651	684	0	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2004	364	9450					2021	2029		10.1016/S0140-6736(04)17514-4	http://dx.doi.org/10.1016/S0140-6736(04)17514-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582059				2022-12-28	WOS:000225495700025
J	Bargheer, M; Zhavoronkov, N; Gritsai, Y; Woo, JC; Kim, DS; Woerner, M; Elsaesser, T				Bargheer, M; Zhavoronkov, N; Gritsai, Y; Woo, JC; Kim, DS; Woerner, M; Elsaesser, T			Coherent atomic motions in a nanostructure studied by femtosecond x-ray diffraction	SCIENCE			English	Article							MULTIPLE-QUANTUM WELLS; ACOUSTIC PHONONS; LATTICE-DYNAMICS; STREAK-CAMERA; PULSES; SUPERLATTICES; GENERATION; EXCITATION; CRYSTAL	Reversible structural changes of a nanostructure were measured non-destructively with subpicometer spatial and subpicosecond temporal resolution via x-ray diffraction (XRD). The spatially periodic femtosecond excitation of a gallium arsenide/aluminum gallium arsenide superlattice results in coherent lattice motions with a 3.5-picosecond period, which was directly monitored by femtosecond x-ray pulses at a 1-kilohertz repetition rate. Small changes (DeltaR/R=0.01) of weak Bragg reflexes (R=0.005) were detected. The phase and amplitude of the oscillatory XRD signal around a new equilibrium demonstrate that displacive excitation of the zone-folded acoustic phonons is the dominant mechanism for strong excitation.	Max Born Inst Nuchtlineare Opt & Kurzzeitspektros, D-12489 Berlin, Germany; Seoul Natl Univ, Sch Phys, Seoul 151742, South Korea	Max Born Institute for Nonlinear Optics & Short Term Spectroscopy; Seoul National University (SNU)	Woerner, M (corresponding author), Max Born Inst Nuchtlineare Opt & Kurzzeitspektros, D-12489 Berlin, Germany.	woerner@mbi-berlin.de	Kim, DaiSik/D-5159-2009; Elsaesser, Thomas/P-7608-2014	Elsaesser, Thomas/0000-0003-3056-6665				Bartels A, 1999, PHYS REV LETT, V82, P1044, DOI 10.1103/PhysRevLett.82.1044; Bucksbaum PH, 1999, SOLID STATE COMMUN, V111, P535, DOI 10.1016/S0038-1098(99)00235-5; Cavalleri A, 2000, PHYS REV LETT, V85, P586, DOI 10.1103/PhysRevLett.85.586; Chang Z, 1996, APPL PHYS LETT, V69, P133, DOI 10.1063/1.118099; Collet E, 2003, SCIENCE, V300, P612, DOI 10.1126/science.1082001; COLVARD C, 1985, PHYS REV B, V31, P2080, DOI 10.1103/PhysRevB.31.2080; DeCamp MF, 2001, NATURE, V413, P825, DOI 10.1038/35101560; DURBIN SM, 1995, PHYS REV B, V51, P10127, DOI 10.1103/PhysRevB.51.10127; GONI AR, 1987, PHYS REV B, V36, P1581, DOI 10.1103/PhysRevB.36.1581; KROST A, 1996, OPT CHAR EP SEM, P287; Larsson J, 1997, OPT LETT, V22, P1012, DOI 10.1364/OL.22.001012; Lindenberg AM, 2000, PHYS REV LETT, V84, P111, DOI 10.1103/PhysRevLett.84.111; Ozgur U, 2001, PHYS REV LETT, V86, P5604, DOI 10.1103/PhysRevLett.86.5604; Reis DA, 2001, PHYS REV LETT, V86, P3072, DOI 10.1103/PhysRevLett.86.3072; Rischel C, 1997, NATURE, V390, P490, DOI 10.1038/37317; Rose-Petruck C, 1999, NATURE, V398, P310, DOI 10.1038/18631; Rousse A, 2001, NATURE, V410, P65, DOI 10.1038/35065045; Schoenlein RW, 1996, SCIENCE, V274, P236, DOI 10.1126/science.274.5285.236; Schoenlein RW, 2000, SCIENCE, V287, P2237, DOI 10.1126/science.287.5461.2237; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Siders CW, 1999, SCIENCE, V286, P1340, DOI 10.1126/science.286.5443.1340; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490; Sokolowski-Tinten K, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.225701; Stevens TE, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144304; Sun CK, 2000, PHYS REV LETT, V84, P179, DOI 10.1103/PhysRevLett.84.179; TAPFER L, 1986, PHYS REV B, V33, P5565, DOI 10.1103/PhysRevB.33.5565; Trigo M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.227402; Yee KJ, 2001, PHYS REV LETT, V86, P1630, DOI 10.1103/PhysRevLett.86.1633; ZEIGER HJ, 1992, PHYS REV B, V45, P768, DOI 10.1103/PhysRevB.45.768	29	218	221	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1771	1773		10.1126/science.1104739	http://dx.doi.org/10.1126/science.1104739			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576618				2022-12-28	WOS:000225630800051
J	Hrdy, I; Hirt, RP; Dolezal, P; Bardonova, L; Foster, PG; Tachezy, J; Embley, TM				Hrdy, I; Hirt, RP; Dolezal, P; Bardonova, L; Foster, PG; Tachezy, J; Embley, TM			Trichomonas hydrogenosomes contain the NADH dehydrogenase module of mitochondrial complex I	NATURE			English	Article							PYRUVATE METABOLISM; VAGINALIS; EVOLUTION; EUKARYOTE; CHLOROPLASTS; DNA	Hydrogenosomes are double-membraned ATP-producing and hydrogen-producing organelles of diverse anaerobic eukaryotes(1). In some versions of endosymbiotic theory they are suggested to be homologues of mitochondria(2-4), but alternative views suggest they arose from an anaerobic bacterium that was distinct from the mitochondrial endosymbiont(5,6). Here we show that the 51-kDa and 24-kDa subunits of the NADH dehydrogenase module in complex I, the first step in the mitochondrial respiratory chain(7), are active in hydrogenosomes of Trichomonas vaginalis. Like mitochondrial NADH dehydrogenase, the purified Trichomonas enzyme can reduce a variety of electron carriers including ubiquinone, but unlike the mitochondrial enzyme it can also reduce ferredoxin, the electron carrier used(1) for hydrogen production. The presence of NADH dehydrogenase solves the long-standing conundrum of how hydrogenosomes regenerate NAD(+) after malate oxidation. Phylogenetic analyses show that the Trichomonas 51-kDa homologue shares common ancestry with the mitochondrial enzyme. Recruitment of complex I subunits into a H-2-producing pathway provides evidence that mitochondria and hydrogenosomes are aerobic and anaerobic homologues of the same endosymbiotically derived organelle.	Charles Univ Prague, Dept Parasitol, CR-12844 Prague 2, Czech Republic; Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Nat Hist Museum, Dept Zool, London SW7 5BD, England	Charles University Prague; Newcastle University - UK; Natural History Museum London	Tachezy, J (corresponding author), Charles Univ Prague, Dept Parasitol, Vinicna 7, CR-12844 Prague 2, Czech Republic.	tachezy@natur.cuni.cz; martin.embley@ncl.ac.uk	Tachezy, Jan/R-4945-2017; Dolezal, Pavel/V-1907-2017; Hirt, Robert/R-5429-2017; Hrdý, Ivan/K-8931-2017	Tachezy, Jan/0000-0001-6976-8446; Dolezal, Pavel/0000-0003-1285-9026; Hirt, Robert/0000-0002-3760-9958; Hrdý, Ivan/0000-0002-5595-9177; Embley, Thomas Martin/0000-0002-1484-340X; Foster, Peter/0000-0003-0194-9237				Benchimol M, 1996, BIOL CELL, V87, P197, DOI 10.1016/S0248-4900(97)89276-3; Biagini GA, 1997, FEMS MICROBIOL LETT, V155, P133, DOI 10.1016/S0378-1097(97)00333-9; Clemens DL, 2000, MOL BIOCHEM PARASIT, V106, P307, DOI 10.1016/S0166-6851(99)00220-0; Dayhoff M, 1978, ATLAS PROTEIN SEQ ST, P345; Delsuc F, 2003, SCIENCE, V301, P1482; Drmota T, 1996, MOL BIOCHEM PARASIT, V83, P221, DOI 10.1016/S0166-6851(96)02777-6; Dyall SD, 2000, MOL CELL BIOL, V20, P2488, DOI 10.1128/MCB.20.7.2488-2497.2000; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Embley TM, 2003, IUBMB LIFE, V55, P387, DOI 10.1080/15216540310001592834; Embley TM, 1997, TRENDS ECOL EVOL, V12, P437, DOI 10.1016/S0169-5347(97)01208-1; EMBLEY TM, 1995, P ROY SOC B-BIOL SCI, V262, P87, DOI 10.1098/rspb.1995.0180; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; Gaziova I, 2003, J BIOL CHEM, V278, P10900, DOI 10.1074/jbc.M202347200; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MULLER M, 1993, J GEN MICROBIOL, V139, P2879, DOI 10.1099/00221287-139-12-2879; OWEN R, 1843, LECT COMP PHYSL INVE; PILKINGTON SJ, 1991, BIOCHEMISTRY-US, V30, P2166, DOI 10.1021/bi00222a021; Plumper E, 1998, PROTIST, V149, P303, DOI 10.1016/S1434-4610(98)70037-9; Rasoloson D, 2002, MICROBIOL-SGM, V148, P2467, DOI 10.1099/00221287-148-8-2467; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rotte C, 2001, MOL BIOL EVOL, V18, P710, DOI 10.1093/oxfordjournals.molbev.a003853; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; STEINBUCHEL A, 1986, MOL BIOCHEM PARASIT, V20, P57, DOI 10.1016/0166-6851(86)90142-8; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; WHATLEY JM, 1979, PROC R SOC SER B-BIO, V204, P165, DOI 10.1098/rspb.1979.0020; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yano T, 2002, MOL ASPECTS MED, V23, P345, DOI 10.1016/S0098-2997(02)00011-0	30	201	206	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					618	622		10.1038/nature03149	http://dx.doi.org/10.1038/nature03149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577909				2022-12-28	WOS:000225433200045
J	Paik, S; Shak, S; Tang, G; Kim, C; Baker, J; Cronin, M; Baehner, FL; Walker, MG; Watson, D; Park, T; Hiller, W; Fisher, ER; Wickerham, DL; Bryant, J; Wolmark, N				Paik, S; Shak, S; Tang, G; Kim, C; Baker, J; Cronin, M; Baehner, FL; Walker, MG; Watson, D; Park, T; Hiller, W; Fisher, ER; Wickerham, DL; Bryant, J; Wolmark, N			A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE-EXPRESSION PATTERNS; SURGICAL ADJUVANT BREAST; PROGNOSTIC-FACTORS; ESTROGEN; SURVIVAL; INTEROBSERVER; CHEMOTHERAPY; CARCINOMAS; STATEMENT; THERAPY	BACKGROUND: The likelihood of distant recurrence in patients with breast cancer who have no involved lymph nodes and estrogen-receptor-positive tumors is poorly defined by clinical and histopathological measures. METHODS: We tested whether the results of a reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay of 21 prospectively selected genes in paraffin-embedded tumor tissue would correlate with the likelihood of distant recurrence in patients with node-negative, tamoxifen-treated breast cancer who were enrolled in the National Surgical Adjuvant Breast and Bowel Project clinical trial B-14. The levels of expression of 16 cancer-related genes and 5 reference genes were used in a prospectively defined algorithm to calculate a recurrence score and to determine a risk group (low, intermediate, or high) for each patient. RESULTS: Adequate RT-PCR profiles were obtained in 668 of 675 tumor blocks. The proportions of patients categorized as having a low, intermediate, or high risk by the RT-PCR assay were 51, 22, and 27 percent, respectively. The Kaplan-Meier estimates of the rates of distant recurrence at 10 years in the low-risk, intermediate-risk, and high-risk groups were 6.8 percent (95 percent confidence interval, 4.0 to 9.6), 14.3 percent (95 percent confidence interval, 8.3 to 20.3), and 30.5 percent (95 percent confidence interval, 23.6 to 37.4). The rate in the low-risk group was significantly lower than that in the high-risk group (P<0.001). In a multivariate Cox model, the recurrence score provided significant predictive power that was independent of age and tumor size (P<0.001). The recurrence score was also predictive of overall survival (P<0.001) and could be used as a continuous function to predict distant recurrence in individual patients. CONCLUSIONS: The recurrence score has been validated as quantifying the likelihood of distant recurrence in tamoxifen-treated patients with node-negative, estrogen-receptor-positive breast cancer.	Natl Surg Adjuvant Breast & Bowel Project, Operat Ctr, Div Pathol, Pittsburgh, PA USA; Natl Surg Adjuvant Breast & Bowel Project, Ctr Biostat, Pittsburgh, PA USA; Genom Hlth, Redwood City, CA USA; Univ Pittsburgh, Dept Stat, Pittsburgh, PA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Genomic Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco	Paik, S (corresponding author), BSABP, Div Pathol, 4 Allegheny Ctr,5th Fl,E Commons Profess Bldg, Pittsburgh, PA 15212 USA.	spaik.nejm@nsabp.org	Kim, Chungyeul/AAX-7124-2020	Paik, Soonmyung/0000-0001-9688-6480; kim, chungyeul/0000-0002-9636-5228; , Gong/0000-0002-6247-4338				Anderson WF, 2002, BREAST CANCER RES TR, V76, P27, DOI 10.1023/A:1020299707510; Bast RC, 1996, J CLIN ONCOL, V14, P2843; Bast RC, 2002, J CLIN ONCOL, V20, P2213; Bast RC, 2001, J CLIN ONCOL, V19, P4185; Bast RC, 2001, J CLIN ONCOL, V19, P1865, DOI 10.1200/JCO.2001.19.6.1865; Bryant J, 1998, BREAST CANCER RES TR, V51, P239, DOI 10.1023/A:1006184428857; Buetow KH, 2002, CANCER CELL, V1, P315, DOI 10.1016/S1535-6108(02)00065-X; Carlson R W, 2001, Cancer Control, V8, P54; Cobleigh M.B. P, 2003, PROG P AM SOC CLIN O, V22, P850; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; DAVIS BW, 1986, CANCER-AM CANCER SOC, V58, P2662, DOI 10.1002/1097-0142(19861215)58:12<2662::AID-CNCR2820581219>3.0.CO;2-Y; Davis RE, 2002, CURR OPIN HEMATOL, V9, P333, DOI 10.1097/00062752-200207000-00011; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Esteban Jr J.B., 2003, PROG P AM SOC CLIN O, V22, P850; Esteva FJ, 2003, BREAST CANCER RES TR, V82, pS11; Esteva FJ, 2004, BREAST CANCER RES, V6, P109, DOI 10.1186/bcr777; FISHER B, 1990, J CLIN ONCOL, V8, P1005, DOI 10.1200/JCO.1990.8.6.1005; Fisher B, 1997, JNCI-J NATL CANCER I, V89, P1673, DOI 10.1093/jnci/89.22.1673; FISHER B, 1983, J CLIN ONCOL, V1, P349, DOI 10.1200/JCO.1983.1.6.349; Fisher B, 2004, LANCET, V364, P858, DOI 10.1016/S0140-6736(04)16981-X; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GRAY RJ, 1992, J AM STAT ASSOC, V87, P942, DOI 10.2307/2290630; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; HAHN WC, 2003, NEW ENGL J MED, V348, P674; Hayes DF, 2000, EUR J CANCER, V36, P302, DOI 10.1016/S0959-8049(99)00303-2; Henderson IC, 1998, BREAST CANCER RES TR, V52, P261, DOI 10.1023/A:1006141703224; HOPTON DS, 1989, EUR J SURG ONCOL, V15, P21; Paik S, 2003, BREAST CANCER RES TR, V82, pS10; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; THEISSIG F, 1990, PATHOL RES PRACT, V186, P732, DOI 10.1016/S0344-0338(11)80263-3; Valenta Z, 2002, STAT MED, V21, P717, DOI 10.1002/sim.1061; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	41	4398	4611	8	257	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2004	351	27					2817	2826		10.1056/NEJMoa041588	http://dx.doi.org/10.1056/NEJMoa041588			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	883IH	15591335	Bronze			2022-12-28	WOS:000226004300006
J	Franco, OH; Bonneux, L; de Laet, C; Peeters, A; Steyerberg, EW; Mackenbach, JP				Franco, OH; Bonneux, L; de Laet, C; Peeters, A; Steyerberg, EW; Mackenbach, JP			The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular, disease by more than 75%	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; RISK-FACTORS; LIPOPROTEINS; METAANALYSIS; CONSUMPTION; ALMONDS	Objective Although the Polypill concept (proposed in 2003) is promising in terms of benefits for cardiovascular risk management, the potential costs and adverse effects are its main pitfalls. The objective of this study was to identify a tastier and safer alternative to the Polypill: the Polymeal. Methods Data on the ingredients of the Polymeal were taken from the literature. The evidence based recipe included wine, fish, dark,chocolate, fruits, vegetables, garlic, and almonds. Data from the Framingham heart study and the Framingham offspring study were used to build life tables to model the benefits of the Polymeal in the general population from age 50, assuming multiplicative correlations. Results Combining the ingredients of the Polymeal would reduce cardiovascular disease events by 76%. For men, taking the Polymeal daily represented an increase in total life expectancy of 6.6 years, an increase in life expectancy free from cardiovascular disease of 9.0 years, and a decrease in life expectancy with cardiovascular disease of 2.4 years. The corresponding differences for women were 4.8, 8. 1, and 3.3 years.. Conclusion The Polymeal promises to be an effective, non-pharmacological, safe, cheap, and tasty alternative to reduce cardiovascular morbidity and increase life expectancy in the general population.	Erasmus MC Univ, Med Ctr Rotterdam, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands; Belgian Hlth Care Knowledge Ctr KCE, B-1040 Brussels, Belgium; Monash Univ, Cent & Eastern Clin Sch, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Erasmus University Rotterdam; Erasmus MC; Monash University	Franco, OH (corresponding author), Erasmus MC Univ, Med Ctr Rotterdam, Dept Publ Hlth, POB 1738, NL-3000 DR Rotterdam, Netherlands.	o.francoduran@erasmusmc.nl	Peeters, Anna/M-8284-2019; Franco, Óscar H/ABE-2305-2020; PEETERS, ANNA/B-3663-2013; Steyerberg, Ewout/C-1509-2018	Peeters, Anna/0000-0003-4340-9132; Franco, Óscar H/0000-0002-4606-4929; PEETERS, ANNA/0000-0003-4340-9132; Steyerberg, Ewout/0000-0002-7787-0122; De Laet, Chris/0000-0002-1951-2079				Ackermann RT, 2001, ARCH INTERN MED, V161, P813, DOI 10.1001/archinte.161.6.813; Berthold HK, 1998, JAMA-J AM MED ASSOC, V279, P1900, DOI 10.1001/jama.279.23.1900; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01; Gluckman TJ, 2004, ARCH INTERN MED, V164, P1490, DOI 10.1001/archinte.164.14.1490; Jenkins DJA, 2002, CIRCULATION, V106, P1327, DOI 10.1161/01.CIR.0000028421.91733.20; John JH, 2002, LANCET, V359, P1969, DOI 10.1016/S0140-6736(02)98858-6; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Neal B, 2000, LANCET, V356, P1955; *OXF CTR EV BAS ME, LEV EV GRAD REC; Peeters A, 2002, EUR HEART J, V23, P458, DOI 10.1053/euhj.2001.2838; Sabate J, 2003, AM J CLIN NUTR, V77, P1379, DOI 10.1093/ajcn/77.6.1379; SACKET DL, 2000, EVIDENCE BASED MED P; SILAGY CA, 1994, J ROY COLL PHYS LOND, V28, P39; STOKES J, 1987, CIRCULATION, V75, P65; Taubert D, 2003, JAMA-J AM MED ASSOC, V290, P1029, DOI 10.1001/jama.290.8.1029; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Whelton SP, 2004, AM J CARDIOL, V93, P1119, DOI 10.1016/j.amjcard.2004.01.038; 2003, BMJ, V327, P807	21	86	94	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1447	1450		10.1136/bmj.329.7480.1447	http://dx.doi.org/10.1136/bmj.329.7480.1447			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604180	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000225965800023
J	Paul, C				Paul, C			The relentless therapeutic imperative	BRITISH MEDICAL JOURNAL			English	Article									Univ Otago, Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago	Paul, C (corresponding author), Univ Otago, Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand.	charlotte.paul@stonebow.otago.ac.nz							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1457	1459		10.1136/bmj.329.7480.1457	http://dx.doi.org/10.1136/bmj.329.7480.1457			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604183	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000225965800026
J	Dauphas, N; van Zuilen, M; Wadhwa, M; Davis, AM; Marty, B; Janney, PE				Dauphas, N; van Zuilen, M; Wadhwa, M; Davis, AM; Marty, B; Janney, PE			Clues from Fe isotope variations on the origin of early Archean BIFs from Greenland	SCIENCE			English	Article							ISUA SUPRACRUSTAL BELT; WEST GREENLAND; IRON; FRACTIONATION; EARTH; ROCKS; METAMORPHISM; CONSTRAINTS; SEDIMENTS; AKILIA	Archean rocks may provide a record of early Earth environments. However, such rocks have often been metamorphosed by high pressure and temperature, which can overprint the signatures of their original formation. Here, we show that the early Archean banded rocks from Isua, Akilia, and Innersuartuut, Greenland, are enriched in heavy iron isotopes by 0.1 to 0.5 per mil per atomic mass unit relative to igneous rocks worldwide. The observed enrichments are compatible with the transport, oxidation, and subsequent precipitation of ferrous iron emanating from hydrothermal vents and thus suggest that the original rocks were banded iron formations (BIFs). These variations therefore support a sedimentary origin for the Akilia banded rocks, which represent one of the oldest known occurrences of water-laid deposits on Earth.	Univ Chicago, Dept Geophys Sci, Origins Lab, Chicago, IL 60637 USA; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Field Museum, Dept Geol, Chicago, IL 60604 USA; Univ Chicago, Chicago Ctr Cosmochem, Chicago, IL 60637 USA; CNRS, Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; Ecole Natl Super Geol, F-54501 Vandoeuvre Les Nancy, France	University of Chicago; University of Chicago; Field Museum of Natural History (Chicago); University of Chicago; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Universite de Lorraine	Dauphas, N (corresponding author), Univ Chicago, Dept Geophys Sci, Origins Lab, 5734 S Ellis Ave, Chicago, IL 60637 USA.	dauphas@uchicago.edu	Janney, Philip/K-2733-2013; Dauphas, Nicolas/E-4568-2011	Janney, Philip/0000-0001-5740-4266; Davis, Andrew/0000-0001-7955-6236				Anbar AD, 2004, EARTH PLANET SC LETT, V217, P223, DOI 10.1016/S0012-821X(03)00572-7; Beard BL, 2004, REV MINERAL GEOCHEM, V55, P319, DOI 10.2138/gsrmg.55.1.319; Beard BL, 2003, GEOLOGY, V31, P629, DOI 10.1130/0091-7613(2003)031<0629:IICOFC>2.0.CO;2; Beard BL, 2004, GEOCHIM COSMOCHIM AC, V68, P4727, DOI 10.1016/j.gca.2004.04.023; Beard BL, 2003, CHEM GEOL, V195, P87, DOI 10.1016/S0009-2541(02)00390-X; BOAK JL, 1982, EARTH PLANET SC LETT, V59, P155, DOI 10.1016/0012-821X(82)90123-6; Bolhar R, 2004, EARTH PLANET SC LETT, V222, P43, DOI 10.1016/j.epsl.2004.02.016; Brantley SL, 2001, GEOLOGY, V29, P535, DOI 10.1130/0091-7613(2001)029<0535:FOFIBS>2.0.CO;2; BRATERMAN PS, 1983, NATURE, V303, P163, DOI 10.1038/303163a0; Bullen TD, 2001, GEOLOGY, V29, P699, DOI 10.1130/0091-7613(2001)029<0699:DOSAII>2.0.CO;2; CLOUD PE, 1983, IRON FORMATION FACTS, P401; Croal LR, 2004, GEOCHIM COSMOCHIM AC, V68, P1227, DOI 10.1016/j.gca.2003.09.011; Dauphas N, 2004, ANAL CHEM, V76, P5855, DOI 10.1021/ac0497095; DYMEK RF, 1988, PRECAMBRIAN RES, V39, P247, DOI 10.1016/0301-9268(88)90022-8; Fedo CM, 2002, SCIENCE, V298, P961; Fedo CM, 2002, SCIENCE, V296, P1448, DOI 10.1126/science.1070336; Friend CRL, 2002, SCIENCE, V298; GRIFFIN WL, 1980, EARTH PLANET SC LETT, V50, P59, DOI 10.1016/0012-821X(80)90119-3; Johnson CM, 2003, CONTRIB MINERAL PETR, V144, P523, DOI 10.1007/s00410-002-0418-x; Johnson CM, 2004, REV MINERAL GEOCHEM, V55, P359, DOI 10.2138/gsrmg.55.1.359; Kerr RA, 2002, SCIENCE, V296, P1384, DOI 10.1126/science.296.5572.1384; Manning CE, 2003, GEOCHIM COSMOCHIM AC, V67, pA271; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Mojzsis SJ, 2002, SCIENCE, V298; Mojzsis SJ, 2003, GEOCHIM COSMOCHIM AC, V67, P1635, DOI 10.1016/S0016-7037(03)00059-0; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Nutman AP, 1997, GEOCHIM COSMOCHIM AC, V61, P2475, DOI 10.1016/S0016-7037(97)00097-5; Poitrasson F, 2004, EARTH PLANET SC LETT, V223, P253, DOI 10.1016/j.epsl.2004.04.032; Rose NM, 1996, AM J SCI, V296, P1004, DOI 10.2475/ajs.296.9.1004; Rouxel O, 2003, CHEM GEOL, V202, P155, DOI 10.1016/j.chemgeo.2003.08.011; Severmann S, 2004, EARTH PLANET SC LETT, V225, P63, DOI 10.1016/j.epsl.2004.06.001; Sharma M, 2001, EARTH PLANET SC LETT, V194, P39, DOI 10.1016/S0012-821X(01)00538-6; WIDDEL F, 1993, NATURE, V362, P834, DOI 10.1038/362834a0; Williams HM, 2004, SCIENCE, V304, P1656, DOI 10.1126/science.1095679; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724	35	204	223	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2077	2080		10.1126/science.1104639	http://dx.doi.org/10.1126/science.1104639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604404				2022-12-28	WOS:000225841000058
J	Wilkinson, P				Wilkinson, P			Commentary: a controversy too far?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADOLESCENTS; DEPRESSION		Univ Cambridge, Sect Dev Psychiat, Cambridge CB2 2AH, England	University of Cambridge	Wilkinson, P (corresponding author), Univ Cambridge, Sect Dev Psychiat, Cambridge CB2 2AH, England.	pow@fsmail.net						Goode J, 2000, INT PERS HI EDUC RES, V1, P243; Goodyer IM, 2003, PSYCHOL MED, V33, P601, DOI 10.1017/S0033291702007286; Lewinsohn PM, 1999, J AM ACAD CHILD PSY, V38, P56, DOI 10.1097/00004583-199901000-00020; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Pickles A, 2001, BRIT J PSYCHIAT, V179, P230, DOI 10.1192/bjp.179.3.230	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2004	329	7479					1397	1397		10.1136/bmj.329.7479.1397	http://dx.doi.org/10.1136/bmj.329.7479.1397			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880JB	15591569	Green Published			2022-12-28	WOS:000225785000028
J	Wong, GKS; Liu, B; Wang, J; Zhang, Y; Yang, X; Zhang, ZJ; Meng, QS; Zhou, J; Li, DW; Zhang, JJ; Ni, PX; Li, SG; Ran, LH; Li, H; Zhang, JG; Li, RQ; Li, ST; Zheng, HK; Lin, W; Li, GY; Wang, XL; Zhao, WM; Li, J; Ye, C; Dai, MT; Ruan, J; Zhou, Y; Li, YZ; He, XM; Zhang, YZ; Wang, J; Huang, XG; Tong, W; Chen, J; Ye, J; Chen, C; Wei, N; Li, GQ; Dong, L; Lan, FD; Sun, YQ; Zhang, ZP; Yang, Z; Yu, YP; Huang, YQ; He, DD; Xi, Y; Wei, D; Qi, QH; Li, WJ; Shi, JP; Wang, MH; Xie, F; Wang, JJ; Zhang, XW; Wang, P; Zhao, YQ; Li, N; Yang, N; Dong, W; Hu, SN; Zeng, CQ; Zheng, WM; Hao, BL; Hillier, LW; Yang, SP; Warren, WC; Wilson, RK; Brandstrom, M; Ellegren, H; Crooijmans, RPMA; van der Poel, JJ; Bovenhuis, H; Groenen, MAM; Ovcharenko, I; Gordon, L; Stubbs, L; Lucas, S; Glavina, T; Aerts, A; Kaiser, P; Rothwell, L; Young, JR; Rogers, S; Walker, BA; van Hateren, A; Kaufman, J; Bumstead, N; Lamont, SJ; Zhou, HJ; Hocking, PM; Morrice, D; de Koning, DJ; Law, A; Bartley, N; Burt, DW; Hunt, H; Cheng, HH; Gunnarsson, U; Wahlberg, P; Andersson, L; Kindlund, E; Tammi, MT; Andersson, B; Webber, C; Ponting, CP; Overton, IM; Boardman, PE; Tang, HZ; Hubbard, SJ; Wilson, SA; Yu, J; Wang, J; Yang, HM				Wong, GKS; Liu, B; Wang, J; Zhang, Y; Yang, X; Zhang, ZJ; Meng, QS; Zhou, J; Li, DW; Zhang, JJ; Ni, PX; Li, SG; Ran, LH; Li, H; Zhang, JG; Li, RQ; Li, ST; Zheng, HK; Lin, W; Li, GY; Wang, XL; Zhao, WM; Li, J; Ye, C; Dai, MT; Ruan, J; Zhou, Y; Li, YZ; He, XM; Zhang, YZ; Wang, J; Huang, XG; Tong, W; Chen, J; Ye, J; Chen, C; Wei, N; Li, GQ; Dong, L; Lan, FD; Sun, YQ; Zhang, ZP; Yang, Z; Yu, YP; Huang, YQ; He, DD; Xi, Y; Wei, D; Qi, QH; Li, WJ; Shi, JP; Wang, MH; Xie, F; Wang, JJ; Zhang, XW; Wang, P; Zhao, YQ; Li, N; Yang, N; Dong, W; Hu, SN; Zeng, CQ; Zheng, WM; Hao, BL; Hillier, LW; Yang, SP; Warren, WC; Wilson, RK; Brandstrom, M; Ellegren, H; Crooijmans, RPMA; van der Poel, JJ; Bovenhuis, H; Groenen, MAM; Ovcharenko, I; Gordon, L; Stubbs, L; Lucas, S; Glavina, T; Aerts, A; Kaiser, P; Rothwell, L; Young, JR; Rogers, S; Walker, BA; van Hateren, A; Kaufman, J; Bumstead, N; Lamont, SJ; Zhou, HJ; Hocking, PM; Morrice, D; de Koning, DJ; Law, A; Bartley, N; Burt, DW; Hunt, H; Cheng, HH; Gunnarsson, U; Wahlberg, P; Andersson, L; Kindlund, E; Tammi, MT; Andersson, B; Webber, C; Ponting, CP; Overton, IM; Boardman, PE; Tang, HZ; Hubbard, SJ; Wilson, SA; Yu, J; Wang, J; Yang, HM		Int Chicken Polymorphism Map Conso	A genetic variation map for chicken with 2.8 million single-nucleotide polymorphisms	NATURE			English	Article							QUANTITATIVE TRAIT LOCI; DIVERSITY; SEQUENCE; MUTATION; MARKERS; GROWTH; SNP	We describe a genetic variation map for the chicken genome containing 2.8 million single-nucleotide polymorphisms ( SNPs). This map is based on a comparison of the sequences of three domestic chicken breeds ( a broiler, a layer and a Chinese silkie) with that of their wild ancestor, red jungle fowl. Subsequent experiments indicate that at least 90% of the variant sites are true SNPs, and at least 70% are common SNPs that segregate in many domestic breeds. Mean nucleotide diversity is about five SNPs per kilobase for almost every possible comparison between red jungle fowl and domestic lines, between two different domestic lines, and within domestic lines - in contrast to the notion that domestic animals are highly inbred relative to their wild ancestors. In fact, most of the SNPs originated before domestication, and there is little evidence of selective sweeps for adaptive alleles on length scales greater than 100 kilobases.	Chinese Acad Sci, Beijing Inst Genom, Beijing Proteom Inst, Beijing 101300, Peoples R China; Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou Genom Inst, Key Lab Genom Bioinformat Zhejiang Prov, Hangzhou 310008, Peoples R China; Univ Washington, Dept Med, UW Genome Ctr, Seattle, WA 98195 USA; Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; Beijing N Computat Ctr, Beijing 100091, Peoples R China; Chinese Acad Sci, Inst Theoret Phys, Beijing 100080, Peoples R China; China Agr Univ, Beijing 100094, Peoples R China; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionay Biol, SE-75234 Uppsala, Sweden; Univ Wageningen & Res Ctr, Anim Breeding & Genet Grp, NL-6709 PG Wageningen, Netherlands; Lawrence Livermore Natl Lab, Genome Biol Div, Livermore, CA 94550 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Inst Anim Hlth, Compton RG20 7NN, Berks, England; Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; Roslin Inst Edinburgh, Roslin EH25 9PS, Midlothian, Scotland; USDA ARS, Avian Dis & Oncol Lab, E Lansing, MI 48823 USA; Uppsala Univ, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; Karolinska Inst, Ctr Genom & Bioinformat, SE-17177 Stockholm, Sweden; Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; Univ Oxford, Dept Human Anat & Genet, MRC, Funct Gent Unit, Oxford OX1 3QX, England; Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, Manchester M60 1QD, Lancs, England; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Zhejiang University; University of Washington; University of Washington Seattle; Peking University; Chinese Academy of Sciences; Institute of Theoretical Physics, CAS; China Agricultural University; Washington University (WUSTL); Uppsala University; Wageningen University & Research; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Iowa State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; United States Department of Agriculture (USDA); Uppsala University; Swedish University of Agricultural Sciences; Karolinska Institutet; National University of Singapore; National University of Singapore; University of Oxford; University of Manchester; University of Sheffield	Wong, GKS (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing Proteom Inst, Beijing 101300, Peoples R China.	gksw@genomics.org.cn; leif.andersson@imbim.uu.se; hyang@genomics.org.cn	Hubbard, Simon J/B-9006-2009; Li, Heng/D-9344-2011; Burt, David W/C-7802-2013; Ponting, Chris/AAV-2621-2021; Bovenhuis, Henk/E-4750-2012; He, Ximiao/C-1292-2010; de Koning, Dirk Jan/F-3399-2013; Wilson, Richard K./AAF-4139-2019; van der Poel, Jan/E-5104-2012; Brandström Durling, Mikael/C-1213-2008; Walker, Brian/A-4984-2013; Andersson, Bjorn/G-9832-2013; Wang, Jun/A-7261-2013; Overton, Ian/A-5911-2011; Crooijmans, Richard PMA/E-2492-2012; Groenen, Martien/D-8408-2012; 郑, 征/C-8514-2011; Tammi, Martti T/C-1115-2008; Bartley, Nicci/AAJ-3341-2021; WONG, Gane Ka-Shu/G-5784-2013; He, Ximiao/AFM-6566-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; Hu, Songnian/C-6509-2013	Li, Heng/0000-0003-4874-2874; Burt, David W/0000-0002-9991-1028; He, Ximiao/0000-0003-1253-5275; de Koning, Dirk Jan/0000-0001-6343-8155; Wilson, Richard K./0000-0002-1992-1358; Brandström Durling, Mikael/0000-0001-6485-197X; Andersson, Bjorn/0000-0002-4624-0259; Groenen, Martien/0000-0003-0484-4545; WONG, Gane Ka-Shu/0000-0001-6108-5560; He, Ximiao/0000-0003-1253-5275; Kaufman, Jim/0000-0002-7216-8422; Yang, Ning/0000-0001-5772-3320; Rogers, Sally/0000-0002-4901-4740; Hubbard, Simon/0000-0002-8601-9524; Wang, Jun/0000-0002-2113-5874; Overton, Ian/0000-0003-1158-8527; Ruan, Jue/0000-0003-3713-3192; Zhang, Jianguo/0000-0003-0723-1701; Ponting, Chris/0000-0003-0202-7816; Wang, Jun/0000-0002-8540-8931; Hu, Songnian/0000-0003-3966-3111; van Hateren, Andy/0000-0002-3915-0239; Webber, Caleb/0000-0001-8063-7674; Stubbs, Lisa/0000-0002-9556-1972; Li, Jun/0000-0001-7218-429X; Cheng, Hans/0000-0003-2071-4644; Walker, Brian/0000-0002-8615-6254	Biotechnology and Biological Sciences Research Council [BBS/B/13497] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Arthur J. A., 2003, Poultry genetics, breeding and biotechnology, P1, DOI 10.1079/9780851996608.0001; Axelsson E, 2004, MOL BIOL EVOL, V21, P1538, DOI 10.1093/molbev/msh157; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Berlin S, 2004, P NATL ACAD SCI USA, V101, P15967, DOI 10.1073/pnas.0405126101; BUMSTEAD N, 2000, PL961502 EU PROJ FAI; CALDWELL R, IN PRESS GENOME BIOL; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Crawford R.D, 1990, POULTRY BREEDING GEN; Crooijmans RPMA, 2000, MAMM GENOME, V11, P360, DOI 10.1007/s003350010068; DODGSON JB, 2004, CURRENT PROTOCOLS HU; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Gallagher G, 2003, CYTOKINE HDB; GilbertDussardier B, 1996, HUM MUTAT, V8, P74, DOI 10.1002/(SICI)1098-1004(1996)8:1<74::AID-HUMU11>3.0.CO;2-O; GREEN P, 2004, CROSSMATCH; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Groenen M. A. M., 2003, Poultry genetics, breeding and biotechnology, P497, DOI 10.1079/9780851996608.0497; Groenen MAM, 2000, GENOME RES, V10, P137; HUBBARD SJ, IN PRESS GENOME RES; Ikeobi CON, 2004, LIVEST PROD SCI, V87, P143, DOI 10.1016/j.livprodsci.2003.09.020; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Li H, 2003, POULTRY SCI, V82, P347, DOI 10.1093/ps/82.3.347; LILJEDAHL LE, 1979, ACTA AGR SCAND, V29, P273, DOI 10.1080/00015127909435238; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Mason I., 1984, EVOLUTION DOMESTICAT; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nicholas FW, 2003, NUCLEIC ACIDS RES, V31, P275, DOI 10.1093/nar/gkg074; Niu D, 2002, BIOCHEM GENET, V40, P163, DOI 10.1023/A:1015832108669; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pisenti JM, 2001, AVIAN POULT BIOL REV, V12, P1; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sewalem A, 2002, POULTRY SCI, V81, P1775, DOI 10.1093/ps/81.12.1775; Sundstrom H, 2004, GENETICS, V167, P377, DOI 10.1534/genetics.167.1.377; TAMIR H, 1963, ARCH BIOCHEM BIOPHYS, V102, P249, DOI 10.1016/0003-9861(63)90178-4; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; *WAG U AN BREED GE, 2004, CHICKACE; WANG J, IN PRESS NUCL ACIDS; Yu N, 2004, GENETICS, V166, P1375, DOI 10.1534/genetics.166.3.1375; Zhou H, 2003, POULTRY SCI, V82, P699, DOI 10.1093/ps/82.5.699	47	373	407	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					717	722		10.1038/nature03156	http://dx.doi.org/10.1038/nature03156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592405	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000225597200039
J	Fowlie, PW; McHaffie, H				Fowlie, PW; McHaffie, H			ABC of preterm birth - Supporting parents in the neonatal unit	BRITISH MEDICAL JOURNAL			English	Review									Perth Royal Infirm, Dundee, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; Inst Med Eth, Loanhead, Midlothian, Scotland	University of Dundee	Fowlie, PW (corresponding author), Perth Royal Infirm, Dundee, Scotland.							Affleck G, 1991, Child Health Care, V20, P6, DOI 10.1207/s15326888chc2001_2; HARRISON H, 1993, PEDIATRICS, V92, P643; McHaffie Hazel, 2001, CRUCIAL DECISIONS BE; MCHAFFIE HE, 1996, LIFE DEATH DECISIONS; Miles MS, 1997, SEMIN PERINATOL, V21, P254, DOI 10.1016/S0146-0005(97)80067-5; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799	6	50	53	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 4	2004	329	7478					1336	1338		10.1136/bmj.329.7478.1336	http://dx.doi.org/10.1136/bmj.329.7478.1336			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	878PC	15576746	Green Published			2022-12-28	WOS:000225657800024
J	McMichael, AJ; Butler, CD				McMichael, AJ; Butler, CD			Climate change, health, and development goals	LANCET			English	Editorial Material									Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au	Butler, Colin D./H-2267-2019	Butler, Colin D./0000-0002-2942-5294				Birdsall N., 2001, POPULATION MATTERS; *INT PAN CLIM CHAN, 2001, 3 INT PAN CLIM CHANG, V1; Loh J., 2004, LIVING PLANET REPORT; Schellnhuber HJ, 2002, GLOB CHANGE IGBP SER, P151; SIMMS A, 2004, WORKING GROUP CLIMAT; WALTER J, 2002, END DEV GLOBAL WARMI; *WSSD, 2002, MILL DEV GOALS	7	21	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					2004	2006		10.1016/S0140-6736(04)17529-6	http://dx.doi.org/10.1016/S0140-6736(04)17529-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582047				2022-12-28	WOS:000225495700009
J	Meyboom, RHB; Edwards, IR				Meyboom, RHB; Edwards, IR			Rosuvastatin and the statin wars - the way to peace	LANCET			English	Editorial Material							RISK; FDA		Univ Utrecht, Fac Pharmaceut Sci, Dept Pharmacoepidemiol, NL-3508 TB Utrecht, Netherlands; WHO Uppsala Monitoring Ctr, Uppsala, Sweden	Utrecht University	Meyboom, RHB (corresponding author), Univ Utrecht, Fac Pharmaceut Sci, Dept Pharmacoepidemiol, NL-3508 TB Utrecht, Netherlands.	r.meyboom@who-umc.org						ABRAHAM J, 2000, THERAPEUTIC NIGHTMAR; *ASTRAZENECA, ASTRAZENECA DEAR DOC; Begaud B, 2002, JAMA-J AM MED ASSOC, V288, P1588, DOI 10.1001/jama.288.13.1588; Cohen JS, 2004, LANCET, V364, P1579, DOI 10.1016/S0140-6736(04)17304-2; Edwards IR, 2000, J ROY COLL PHYS LOND, V34, P48; *EUDRAVIGILANCE, 2004, PHARM EUR EC AR; Florentinus SR, 2004, LANCET, V364, P1577, DOI 10.1016/S0140-6736(04)17301-7; Griffin MR, 2004, CLIN PHARMACOL THER, V75, P491, DOI 10.1016/j.clpt.2004.01.017; Horton R, 2001, LANCET, V357, P1544, DOI 10.1016/S0140-6736(00)04776-0; *ICH SECR, 2003, ICH E2E PHARM PLANN; INMAN WHW, 1999, DONT TELL PATIENT; *INSP GEZ, 2004, 0450090 IGZHRT; Medawar C, 2004, MED OUT CONTROL; Medawar C, 2002, INT J RISK SAFETY ME, V15, P161; Meyboom RHB, 1999, THERAPIE, V54, P29; Uhl K, 2001, PHARMACOEPIDEM DR S, V10, P205, DOI 10.1002/pds.594; *US FDA, 2004, FDA PUBL HLTH ADV CR; VANEGMONDVETTEN.JS, 2001, MARKETINGPLANNEN UR; WITTS LJ, 1965, BRIT MED J, V5470, P1081; MED PRODUCTS HUMAN U, V9; 2004, LANCET, V362, P1341	21	10	10	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					1997	1999		10.1016/S0140-6736(04)17525-9	http://dx.doi.org/10.1016/S0140-6736(04)17525-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582043				2022-12-28	WOS:000225495700005
J	Ziegler, A; Idrobo, JC; Cinibulk, MK; Kisielowski, C; Browning, ND; Ritchie, RO				Ziegler, A; Idrobo, JC; Cinibulk, MK; Kisielowski, C; Browning, ND; Ritchie, RO			Interface structure and atomic bonding characteristics in silicon nitride ceramics	SCIENCE			English	Article							INTERGRANULAR FILM THICKNESS; ELECTRONIC-STRUCTURE; GRAIN-BOUNDARIES; BETA-SIALONS; MICROSTRUCTURE; BETA-SI3N4; FRACTURE; STRENGTH; SI3N4	Direct atomic resolution images have been obtained that illustrate how a range of rare-earth atoms bond to the interface between the intergranular phase and the matrix grains in an advanced silicon nitride ceramic. It has been found that each rare-earth atom bonds to the interface at a different location, depending on atom size, electronic configuration, and the presence of oxygen at the interface. This is the key factor to understanding the origin of the mechanical properties in these ceramics and will enable precise tailoring in the future to critically improve the materials' performance in wide-ranging applications.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; Lawrence Livermore Natl Lab, Mat Sci & Technol Div, Chem & Mat Sci Directorate, Livermore, CA 94551 USA; Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; USAF, Mat & Mfg Directorate, Res Lab, Wright Patterson AFB, OH 45433 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA; Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; United States Department of Defense; United States Air Force; US Air Force Research Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Berkeley	Ziegler, A (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	aziegler@lbl.gov	Ritchie, Robert O/A-8066-2008; Idrobo, Juan Carlos/H-4896-2015	Ritchie, Robert O/0000-0002-0501-6998; Idrobo, Juan Carlos/0000-0001-7483-9034; Browning, Nigel/0000-0003-0491-251X; Ziegler, Alexander/0000-0001-9115-1709				BECHER PF, 1995, MRS BULL, V20, P23, DOI 10.1557/S0883769400049174; Benco L, 2003, J AM CERAM SOC, V86, P1162, DOI 10.1111/j.1151-2916.2003.tb03442.x; BENCO L, 1995, SURF SCI, V327, P274, DOI 10.1016/0039-6028(95)00021-6; BROWNING ND, 1993, NATURE, V366, P143, DOI 10.1038/366143a0; Ching WY, 2000, J AM CERAM SOC, V83, P780, DOI 10.1111/j.1151-2916.2000.tb01274.x; CINIBULK MK, 1992, J AM CERAM SOC, V75, P2050, DOI 10.1111/j.1151-2916.1992.tb04464.x; CLARKE DR, 1987, J AM CERAM SOC, V70, P15, DOI 10.1111/j.1151-2916.1987.tb04846.x; Garofalini SH, 2003, J AM CERAM SOC, V86, P1741, DOI 10.1111/j.1151-2916.2003.tb03549.x; Gu H, 1998, J MATER RES, V13, P376, DOI 10.1557/JMR.1998.0050; James EM, 1999, ULTRAMICROSCOPY, V78, P125, DOI 10.1016/S0304-3991(99)00018-2; KLEEBE HJ, 1993, J AM CERAM SOC, V76, P1969, DOI 10.1111/j.1151-2916.1993.tb08319.x; LANGE FF, 1983, J MATER SCI, V18, P1497, DOI 10.1007/BF01111970; Nakayasu T, 1998, J AM CERAM SOC, V81, P565, DOI 10.1111/j.1151-2916.1998.tb02375.x; Nellist PD, 1999, ULTRAMICROSCOPY, V78, P111, DOI 10.1016/S0304-3991(99)00017-0; PENNYCOOK SJ, 1990, PHYS REV LETT, V64, P939; SANDERS WA, 1985, AM CERAM SOC BULL, V64, P304; Satet RL, 2004, J EUR CERAM SOC, V24, P3437, DOI 10.1016/j.jeurceramsoc.2003.10.034; Shibata N, 2004, NATURE, V428, P730, DOI 10.1038/nature02410; Sun EY, 1998, J AM CERAM SOC, V81, P2831, DOI 10.1111/j.1151-2916.1998.tb02703.x; TANAKA I, 1994, J AM CERAM SOC, V77, P911, DOI 10.1111/j.1151-2916.1994.tb07246.x; TANAKA I, 1992, ACTA METALL MATER, V40, P1995, DOI 10.1016/0956-7151(92)90185-H; Voyles PM, 2002, NATURE, V416, P826, DOI 10.1038/416826a; Wang CM, 1996, J AM CERAM SOC, V79, P788, DOI 10.1111/j.1151-2916.1996.tb07946.x; WIEDERHORN SM, 1984, ANNU REV MATER SCI, V14, P373; Yoshiya M, 2002, J AM CERAM SOC, V85, P109, DOI 10.1111/j.1151-2916.2002.tb00049.x; Ziegler A, 2003, J AM CERAM SOC, V86, P1777, DOI 10.1111/j.1151-2916.2003.tb03554.x	26	199	210	7	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1768	1770		10.1126/science.1104173	http://dx.doi.org/10.1126/science.1104173			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576617	Green Submitted			2022-12-28	WOS:000225630800050
J	Haferkamp, I; Schmitz-Esser, S; Linka, N; Urbany, C; Collingro, A; Wagner, M; Horn, M; Neuhaus, HE				Haferkamp, I; Schmitz-Esser, S; Linka, N; Urbany, C; Collingro, A; Wagner, M; Horn, M; Neuhaus, HE			A candidate NAD(+) transporter in an intracellular bacterial symbiont related to Chlamydiae	NATURE			English	Article							PLASTIDIC ATP/ADP TRANSPORTER; RICKETTSIA-PROWAZEKII; ADENINE-NUCLEOTIDE; ENDOSYMBIONTS; PERMEABILITY; ARABIDOPSIS; EXPRESSION; PROTEINS	Bacteria living within eukaryotic cells can be essential for the survival or reproduction of the host(1,2) but in other cases are among the most successful pathogens(3,4). Environmental Chlamydiae, including strain UWE25, thrive as obligate intracellular symbionts within protozoa; are recently discovered relatives of major bacterial pathogens of humans; and also infect human cells(4-7). Genome analysis of UWE25 predicted that this symbiont is unable to synthesize the universal electron carrier nicotinamide adenine dinucleotide (NAD(+))(7). Compensation of limited biosynthetic capacity in intracellular bacteria is usually achieved by import of primary metabolites(8-11). Here, we report the identification of a candidate transporter protein from UWE25 that is highly specific for import of NAD(+) when synthesized heterologously in Escherichia coli. The discovery of this candidate NAD(+)/ADP exchanger demonstrates that intact NAD(+) molecules can be transported through cytoplasmic membranes. This protein acts together with a newly discovered nucleotide transporter and an ATP/ADP translocase(12), and allows UWE25 to exploit its host cell by means of a sophisticated metabolic parasitism.	Univ Kaiserslautern, D-67653 Kaiserslautern, Germany; Univ Vienna, Inst Okol & Nat Schutz, Abt Mikrobielle Okol, A-1090 Vienna, Austria	University of Kaiserslautern; University of Vienna	Neuhaus, HE (corresponding author), Univ Kaiserslautern, D-67653 Kaiserslautern, Germany.	neuhaus@rhrk.uni-kl.de	Collingro, Astrid/ABA-2082-2021; Schmitz-Esser, Stephan/AAA-7287-2019; Wagner, Michael/A-7801-2011; Horn, Matthias/G-1136-2011	Collingro, Astrid/0000-0002-4100-832X; Schmitz-Esser, Stephan/0000-0002-1907-0709; Wagner, Michael/0000-0002-9778-7684; Horn, Matthias/0000-0002-8309-5855; Linka, Nicole/0000-0002-1400-717X				ATKINSON WH, 1989, J BACTERIOL, V171, P761, DOI 10.1128/jb.171.2.761-766.1989; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Coffe V, 2004, J NEUROCHEM, V88, P885, DOI 10.1046/j.1471-4159.2003.02207.x; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Fritsche TR, 2000, APPL ENVIRON MICROB, V66, P2613, DOI 10.1128/AEM.66.6.2613-2619.2000; GAUTOM RK, 1995, J EUKARYOT MICROBIOL, V42, P452, DOI 10.1111/j.1550-7408.1995.tb05890.x; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; HATCH TP, 1982, J BACTERIOL, V150, P662, DOI 10.1128/JB.150.2.662-670.1982; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; KRAUSE DC, 1985, P NATL ACAD SCI USA, V82, P3015, DOI 10.1073/pnas.82.9.3015; Linka N, 2003, GENE, V306, P27, DOI 10.1016/S0378-1119(03)00429-3; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MAHONY JB, 2003, MANUAL CLIN MICROBIO, P991; MANGOLD HK, 1967, DUNNSCHICHT CHROMATO, P749; Mohlmann T, 1998, EUR J BIOCHEM, V252, P353, DOI 10.1046/j.1432-1327.1998.2520353.x; Moulder J. W., 1962, BIOCH INTRACELLULAR; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tjaden J, 1999, J BACTERIOL, V181, P1196, DOI 10.1128/JB.181.4.1196-1202.1999; Tjaden J, 1998, J BIOL CHEM, V273, P9630, DOI 10.1074/jbc.273.16.9630; Trentmann O, 2000, EUR J BIOCHEM, V267, P4098, DOI 10.1046/j.1432-1033.2000.01468.x; Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6; WINKLER HH, 1976, J BIOL CHEM, V251, P389; Zhang QH, 2002, SCIENCE, V295, P1895	27	84	86	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					622	625		10.1038/nature03131	http://dx.doi.org/10.1038/nature03131			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577910				2022-12-28	WOS:000225433200046
J	Nurse, P				Nurse, P			Wee beasties	NATURE			English	Editorial Material									Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Nurse, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.								0	11	14	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2004	432	7017					557	557		10.1038/432557a	http://dx.doi.org/10.1038/432557a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577889	Bronze			2022-12-28	WOS:000225433200022
J	Nishimura, EK; Granter, SR; Fisher, DE				Nishimura, EK; Granter, SR; Fisher, DE			Mechanisms of hair graying: Incomplete melanocyte stem cell maintenance in the niche	SCIENCE			English	Article							OUTER ROOT SHEATH; BCL-2-DEFICIENT MICE; FOLLICLE; MITF; TRANSCRIPTION; SENESCENCE; DEFICIENT; APOPTOSIS; NETWORK; CYCLE	Hair graying is the most obvious sign of aging in humans, yet its mechanism is largely unknown. Here, we used melanocyte-tagged transgenic mice and aging human hair follicles to demonstrate that hair graying is caused by defective self-maintenance of melanocyte stem cells. This process is accelerated dramatically with Bcl2 deficiency, which causes selective apoptosis of melanocyte stem cells, but not of differentiated melanocytes, within the niche at their entry into the dormant state. Furthermore, physiologic aging of melanocyte stem cells was associated with ectopic pigmentation or differentiation within the niche, a process accelerated by mutation of the melanocyte master transcriptional regulator Mitf.	Harvard Univ, Sch Med, Boston Childrens Hosp,Dana Farber Canc Inst, Dept Pediat Hematol Oncol,Melanoma Program Med On, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Nishimura, EK (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan.	emi_k_nishimura@yahoo.co.jp; David_Fisher@dfci.harvard.edu			NIAMS NIH HHS [AR43369] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Commo S, 2004, BRIT J DERMATOL, V150, P435, DOI 10.1046/j.1365-2133.2004.05787.x; Commo S, 2000, PIGM CELL RES, V13, P253, DOI 10.1034/j.1600-0749.2000.130407.x; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Fuchs E, 2001, DEV CELL, V1, P13, DOI 10.1016/S1534-5807(01)00022-3; Horikawa T, 1996, J INVEST DERMATOL, V106, P28, DOI 10.1111/1523-1747.ep12326989; JOHNSON R, 1992, NAT GENET, V1, P226, DOI 10.1038/ng0692-226; LERNER AB, 1986, J INVEST DERMATOL, V87, P299, DOI 10.1111/1523-1747.ep12524353; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; MEDRANO EE, 1994, MOL BIOL CELL, V5, P497, DOI 10.1091/mbc.5.4.497; MONTAGNA W, 1956, AM J ANAT, V99, P415, DOI 10.1002/aja.1000990304; Narisawa Y, 1997, ACTA DERM-VENEREOL, V77, P97; NISHIMURA E, UNPUB; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Ortonne J. P., 1998, PIGMENTARY SYSTEM PH, P489; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Price ER, 2001, NEURON, V30, P15, DOI 10.1016/S0896-6273(01)00259-8; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; STARICCO RG, 1963, ANN NY ACAD SCI, V100, P239; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Sussman MA, 2004, ANNU REV PHYSIOL, V66, P29, DOI 10.1146/annurev.physiol.66.032102.140723; Tobin DJ, 2001, EXP GERONTOL, V36, P29, DOI 10.1016/S0531-5565(00)00210-2; URABE K, 1994, BBA-MOL CELL RES, V1221, P272, DOI 10.1016/0167-4889(94)90250-X; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yamamura K, 1996, CANCER RES, V56, P3546	31	504	545	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					720	724		10.1126/science.1099593	http://dx.doi.org/10.1126/science.1099593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15618488				2022-12-28	WOS:000226814900042
J	Mueller, AK; Labaied, M; Kappe, SHI; Matuschewski, K				Mueller, AK; Labaied, M; Kappe, SHI; Matuschewski, K			Genetically modified Plasmodium parasites as a protective experimental malaria vaccine	NATURE			English	Article							SPOROZOITE STAGE; GENOME SEQUENCE; BERGHEI; FALCIPARUM; LIVER	Malaria is a mosquito-borne disease that is transmitted by inoculation of the Plasmodium parasite sporozoite stage. Sporozoites invade hepatocytes(1), transform into liver stages, and subsequent liver-stage development ultimately results in release of pathogenic merozoites(2). Liver stages of the parasite are a prime target for malaria vaccines because they can be completely eliminated by sterilizing immune responses, thereby preventing malarial infection(3). Using expression profiling, we previously identified genes that are only expressed in the pre-erythrocytic stages of the parasite(4,5). Here, we show by reverse genetics that one identified gene, UIS3 (upregulated in infective sporozoites gene 3), is essential for early liver-stage development. uis3-deficient sporozoites infect hepatocytes but are unable to establish blood-stage infections in vivo, and thus do not lead to disease. Immunization with uis3-deficient sporozoites confers complete protection against infectious sporozoite challenge in a rodent malaria model. This protection is sustained and stage specific. Our findings demonstrate that a safe and effective, genetically attenuated whole-organism malaria vaccine is possible.	Seattle Biomed Res Inst, Seattle, WA 98109 USA; Univ Heidelberg, Sch Med, Dept Parasitol, D-69120 Heidelberg, Germany; Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA	Center for Infectious Disease Research; Ruprecht Karls University Heidelberg; University of Washington; University of Washington Seattle	Kappe, SHI (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	Stefan.Kappe@sbri.org; Kai_Matuschewski@med.uni-heidelberg.de		Matuschewski, Kai/0000-0001-6147-8591				Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hoffman S, 2004, NATURE, V430, P940, DOI 10.1038/430940a; Hoffman SL, 2000, NAT MED, V6, P1218, DOI 10.1038/81315; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Kaiser K, 2004, MOL MICROBIOL, V51, P1221, DOI 10.1046/j.1365-2958.2003.03909.x; Kappe SHI, 2003, TRENDS PARASITOL, V19, P135, DOI 10.1016/S1471-4922(03)00007-2; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; MEIS JFGM, 1983, NATURE, V302, P424, DOI 10.1038/302424a0; MEIS JFGM, 1985, CELL TISSUE RES, V241, P353, DOI 10.1007/BF00217180; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; RENIA L, 1988, J IMMUNOL METHODS, V112, P201, DOI 10.1016/0022-1759(88)90358-4; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SHORTT HE, 1948, NATURE, V161, P126, DOI 10.1038/161126a0; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Thathy Vandana, 2002, Methods Mol Med, V72, P317, DOI 10.1385/1-59259-271-6:317; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618	18	376	407	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					164	167		10.1038/nature03188	http://dx.doi.org/10.1038/nature03188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15580261				2022-12-28	WOS:000226252200039
J	Kubicek, S; Jenuwein, T				Kubicek, S; Jenuwein, T			A crack in histone lysine methylation	CELL			English	Editorial Material							OXIDATIVE DEMETHYLATION; DNA; INHERITANCE; GENES; YEAST	Histone lysine methylation is regarded as a very stable modification with important functions in epigenetic gene control and for organizing chromatin domains. While more robust modifications of the chromatin template are essential to stabilize epigenetic information, there is now the first evidence for a histone lysine demethylase that reverts an activating methyl mark to the unmodified state (Shi et al., 2004 [this issue of Ceff]).	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Jenuwein, T (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	jenuwein@imp.univie.ac.at	Kubicek, Stefan/C-2089-2017	Kubicek, Stefan/0000-0003-0855-8343				Ahmad K, 2002, CELL, V111, P281, DOI 10.1016/S0092-8674(02)01081-4; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Landry J, 2003, BIOCHEM BIOPH RES CO, V303, P771, DOI 10.1016/S0006-291X(03)00416-9; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; O'Neill LP, 2003, HUM MOL GENET, V12, P1783, DOI 10.1093/hmg/ddg193; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400	19	123	129	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					903	906		10.1016/j.cell.2004.12.006	http://dx.doi.org/10.1016/j.cell.2004.12.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620348	Bronze			2022-12-28	WOS:000226109700002
J	Dietl, GP; Herbert, GS; Vermeij, GJ				Dietl, GP; Herbert, GS; Vermeij, GJ			Reduced competition and altered feeding behavior among marine snails after a mass extinction	SCIENCE			English	Article							CARIBBEAN NEOGENE; DIVERSITY; SEA; GASTROPODS; EVOLUTION; MOLLUSKS; ATLANTIC; FLORIDA; PANAMA; TOOTH	Extinction may alter competitive interactions among surviving species, affecting their subsequent recovery and evolution, but these processes remain poorly understood. Analysis of predation traces produced by shell-drilling muricid snails on bivalve prey reveals that species interactions were substantially different before and after a Plio-Pleistocene mass extinction in the westerm Atlantic. Muricids edge- and wall-drilled their prey in the Pliocene, but Pleistocene and Recent snails attacked prey only through the shell wait. Experiments with living animals suggest that intense competition induces muricid snails to attack shell edges. Pliocene predators, therefore, probably competed for resources more intensely than their post-extinction counterparts.	Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28409 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of North Carolina; University of North Carolina Wilmington; University of California System; University of California Davis; University of California System; University of California Davis	Dietl, GP (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.							Allmon Warren D., 1996, P271; Allmon WD, 1996, J GEOL, V104, P143, DOI 10.1086/629811; Allmon WD, 2001, PALAEOGEOGR PALAEOCL, V166, P9, DOI 10.1016/S0031-0182(00)00199-1; ALLMON WD, 1993, SCIENCE, V260, P1626, DOI 10.1126/science.260.5114.1626; DIETL GP, 2002, AM MAL SOC ABS PROG, V44; Domning DP, 2001, PALAEOGEOGR PALAEOCL, V166, P27, DOI 10.1016/S0031-0182(00)00200-5; Ishida S, 2004, J EXP MAR BIOL ECOL, V305, P233, DOI 10.1016/j.jembe.2003.12.012; JACKSON JBC, 1993, SCIENCE, V260, P1624, DOI 10.1126/science.260.5114.1624; Morissette S, 2000, ANIM BEHAV, V60, P531, DOI 10.1006/anbe.2000.1500; Nesbitt HW, 1997, J GEOL, V105, P531, DOI 10.1086/515954; PAINE RT, 1963, ECOLOGY, V44, P63, DOI 10.2307/1933181; PETUCH EJ, 1995, SCIENCE, V270, P275, DOI 10.1126/science.270.5234.275; PETUCH EJ, 1982, PALAEOGEOGR PALAEOCL, V37, P277, DOI 10.1016/0031-0182(82)90041-4; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; ROLLER R A, 1984, American Malacological Bulletin, V2, P63; STANLEY S M, 1986, Palaios, V1, P17, DOI 10.2307/3514456; Todd JA, 2002, P ROY SOC B-BIOL SCI, V269, P571, DOI 10.1098/rspb.2001.1923; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; Vermeij G.J., 1993, NATURAL HIST SHELLS; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT; Vermeij GJ, 1998, J PALEONTOL, V72, P465, DOI 10.1017/S0022336000024215; Vermeij GJ, 2001, BIOL J LINN SOC, V72, P461, DOI 10.1006/bijl.2001.0524; WOODRING WP, 1966, P AM PHILOS SOC, V110, P425	23	63	64	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2229	2231		10.1126/science.1106182	http://dx.doi.org/10.1126/science.1106182			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618513				2022-12-28	WOS:000225950000038
J	O'Neill, E; Rushworth, L; Baccarini, M; Kolch, W				O'Neill, E; Rushworth, L; Baccarini, M; Kolch, W			Rote of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1	SCIENCE			English	Article							CELL-CYCLE EXIT; PROMOTES APOPTOSIS; PROTEIN INTERACTIONS; C-RAF-1 GENE; ACTIVATION; PROLIFERATION; DROSOPHILA; HIPPO; RAS; SALVADOR	The ablation of the protein kinase Raf-1 renders cells hypersensitive to apoptosis despite normal regulation of extracellular signal-regulated kinases, which suggests that apoptosis protection is mediated by a distinct pathway. We used proteomic analysis of Raf-1 signaling complexes to show that Raf-1 counteracts apoptosis by suppressing the activation of mammalian sterile 20-like kinase (MST2). Raf-1 prevents dimerization and phosphorylation of the activation loop of MST2 independently of its protein kinase activity. Depletion of MST2 from Raf-1(-1-) mouse or human cells abrogated sensitivity to apoptosis, whereas overexpression of MST2 induced apoptosis. Conversely, depletion of Raf-1 from Raf-l(+/+) mouse or human cells led to MST2 activation and apoptosis. The concomitant depletion of both Raf-1 and MST2 prevented apoptosis.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Sir Henry Wellcome Funct Genom Facil, Glasgow G12 8QQ, Lanark, Scotland; Univ Vienna, Max F Perutz Labs, Univ Dept Vienna Bioctr, Dept Genet & Microbiol, A-1030 Vienna, Austria	Beatson Institute; University of Glasgow; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Kolch, W (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	wkolch@beatson.gla.ac.uk	Admin, SBI/HGB-2738-2022; Baccarini, Manuela/B-6481-2014; Kolch, Walter/ABF-2102-2021	Baccarini, Manuela/0000-0002-3033-391X; Rushworth, Linda/0000-0003-0654-8766; Kolch, Walter/0000-0001-5777-5016				Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; Baccarini M, 2002, CELL DEATH DIFFER, V9, P783, DOI 10.1038/sj.cdd.4401070; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; PIAZZOLLA D, UNPUB; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yuryev A, 2003, GENOMICS, V81, P112, DOI 10.1016/S0888-7543(02)00008-3	25	236	243	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2267	2270		10.1126/science.1103233	http://dx.doi.org/10.1126/science.1103233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618521				2022-12-28	WOS:000225950000050
J	Somerville, C; Bauer, S; Brininstool, G; Facette, M; Hamann, T; Milne, J; Osborne, E; Paredez, A; Persson, S; Raab, T; Vorwerk, S; Youngs, H				Somerville, C; Bauer, S; Brininstool, G; Facette, M; Hamann, T; Milne, J; Osborne, E; Paredez, A; Persson, S; Raab, T; Vorwerk, S; Youngs, H			Toward a systems approach to understanding plant-cell walls	SCIENCE			English	Review							MEMBRANE-BOUND ENDO-1,4-BETA-GLUCANASE; CELLULOSE-SYNTHESIS; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; POLYSACCHARIDE COMPOSITION; SACCHAROMYCES-CEREVISIAE; PECTIC POLYSACCHARIDE; RHAMNOGALACTURONAN-II; ORIENTED DEPOSITION; FUCOSYL-TRANSFERASE	one of the defining features of plants is a body plan based on the physical properties of cell walls. Structural analyses of the polysaccharide components, combined with high-resolution imaging, have provided the basis for much of the current understanding of cell walls. The application of genetic methods has begun to provide new insights into how walls are made, how they are controlled, and how they function. However, progress in integrating biophysical, developmental, and genetic information into a useful model will require a system-based approach.	Carnegie Inst, Dept Plant Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University	Somerville, C (corresponding author), Carnegie Inst, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA.	crs@stanford.edu	Paredez, Alexander/E-7171-2014; 1.4, ALS Beamline/I-1886-2014; Paredez, Alexander R/B-9799-2009; Raab, Ted K./A-7478-2008; Somerville, Christopher R/A-4048-2009; Facette, Michelle/K-6603-2019; Facette, Michelle/E-6114-2015; Persson, Staffan/S-8399-2016	Paredez, Alexander/0000-0002-9298-3264; Paredez, Alexander R/0000-0002-9298-3264; Raab, Ted K./0000-0002-3965-8729; Somerville, Christopher R/0000-0003-4647-0094; Facette, Michelle/0000-0002-6214-9359; Facette, Michelle/0000-0002-6214-9359; Persson, Staffan/0000-0002-6377-5132; Osborne Nishimura, Erin/0000-0002-4313-4573				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Bootten TJ, 2004, J EXP BOT, V55, P571, DOI 10.1093/jxb/erh065; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Burk DH, 2002, PLANT CELL, V14, P2145, DOI 10.1105/tpc.003947; Burn JE, 2002, PLANT J, V32, P949, DOI 10.1046/j.1365-313X.2002.01483.x; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Chanliaud E, 2004, PLANT J, V38, P27, DOI 10.1111/j.1365-313X.2004.02018.x; Cutler SR, 2002, P NATL ACAD SCI USA, V99, P2812, DOI 10.1073/pnas.052712299; de Groot PWJ, 2001, COMP FUNCT GENOM, V2, P124, DOI 10.1002/cfg.85; Demura T, 2002, P NATL ACAD SCI USA, V99, P15794, DOI 10.1073/pnas.232590499; Dhugga KS, 2004, SCIENCE, V303, P363, DOI 10.1126/science.1090908; Dumville JC, 2000, PLANT PHYSIOL BIOCH, V38, P125, DOI 10.1016/S0981-9428(00)00163-7; Edwards ME, 1999, PLANT J, V19, P691, DOI 10.1046/j.1365-313x.1999.00566.x; Fagard M, 2000, PLANT PHYSIOL BIOCH, V38, P15, DOI 10.1016/S0981-9428(00)00171-6; Favery B, 2001, GENE DEV, V15, P79, DOI 10.1101/gad.188801; Fisher DD, 1998, PLANT PHYSIOL, V116, P1043, DOI 10.1104/pp.116.3.1043; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; Freshour G, 2003, PLANT PHYSIOL, V131, P1602, DOI 10.1104/pp.102.016444; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Fujino T, 2000, PLANT CELL PHYSIOL, V41, P486, DOI 10.1093/pcp/41.4.486; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Gillmor CS, 2002, J CELL BIOL, V156, P1003, DOI 10.1083/jcb.200111093; Goubet F, 2003, PLANT PHYSIOL, V131, P547, DOI 10.1104/pp.014555; GREEN PB, 1962, SCIENCE, V138, P1404, DOI 10.1126/science.138.3548.1404; Hall Q, 2002, PLANT CELL, V14, P1161, DOI 10.1105/tpc.010477; Henrissat B, 2001, PLANT MOL BIOL, V47, P55, DOI 10.1023/A:1010667012056; Himmelspach R, 2003, PLANT J, V36, P565, DOI 10.1046/j.1365-313X.2003.01906.x; His I, 2001, PLANTA, V212, P348, DOI 10.1007/s004250000437; Iwai H, 2002, P NATL ACAD SCI USA, V99, P16319, DOI 10.1073/pnas.252530499; Jarvis MC, 2003, PLANT CELL ENVIRON, V26, P977, DOI 10.1046/j.1365-3040.2003.01034.x; Kerr EM, 2003, PLANTA, V217, P327, DOI 10.1007/s00425-003-1027-2; Kimura S, 1999, PLANT CELL, V11, P2075, DOI 10.1105/tpc.11.11.2075; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; KNOX JP, 1990, PLANTA, V181, P512, DOI 10.1007/BF00193004; Lai-Kee-Him J, 2002, J BIOL CHEM, V277, P36931, DOI 10.1074/jbc.M203530200; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Madson M, 2003, PLANT CELL, V15, P1662, DOI 10.1105/tpc.009837; Manfield IW, 2004, PLANT J, V40, P260, DOI 10.1111/j.1365-313X.2004.02208.x; Mayer U, 2004, CURR OPIN PLANT BIOL, V7, P599, DOI 10.1016/j.pbi.2004.07.008; McCann MC, 2001, PHYTOCHEMISTRY, V57, P811, DOI 10.1016/S0031-9422(01)00144-3; MCCANN MC, 1990, J CELL SCI, V96, P323; McCann MC, 1991, CYTOSKELETAL BASIS P, P109; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; Milioni D, 2002, PLANT CELL, V14, P2813, DOI 10.1105/tpc.005231; Motose H, 2004, NATURE, V429, P873, DOI 10.1038/nature02613; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Nishitani K, 2002, J PLANT RES, V115, P303, DOI 10.1007/s10265-002-0032-z; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; OKUDA K, 1993, PLANT PHYSIOL, V101, P1131, DOI 10.1104/pp.101.4.1131; Pagant S, 2002, PLANT CELL, V14, P2001, DOI 10.1105/tpc.002873; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; Perrin RM, 1999, SCIENCE, V284, P1976, DOI 10.1126/science.284.5422.1976; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Pilling E, 2003, CURR OPIN PLANT BIOL, V6, P611, DOI 10.1016/j.pbi.2003.09.004; Redman JC, 2004, PLANT J, V38, P545, DOI 10.1111/j.1365-313X.2004.02061.x; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; Rhee SY, 2003, PLANT PHYSIOL, V133, P1170, DOI 10.1104/pp.103.028266; Richmond TA, 2001, PLANT MOL BIOL, V47, P131, DOI 10.1023/A:1010627314782; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; Salnikov VV, 2001, PHYTOCHEMISTRY, V57, P823, DOI 10.1016/S0031-9422(01)00045-0; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Seifert GJ, 2002, CURR BIOL, V12, P1840, DOI 10.1016/S0960-9822(02)01260-5; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; SHEDLETZKY E, 1992, PLANT PHYSIOL, V100, P120, DOI 10.1104/pp.100.1.120; Smits GJ, 1999, CURR OPIN MICROBIOL, V2, P348; Sugimoto K, 2003, PLANT CELL, V15, P1414, DOI 10.1105/tpc.011593; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Tsekos I, 1996, PROTOPLASMA, V193, P33, DOI 10.1007/BF01276632; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; Vanzin GF, 2002, P NATL ACAD SCI USA, V99, P3340, DOI 10.1073/pnas.052450699; Vincken JP, 2003, PLANT PHYSIOL, V132, P1781, DOI 10.1104/pp.103.022350; Vissenberg K, 2003, J EXP BOT, V54, P335, DOI 10.1093/jxb/erg024; Vogel JP, 2002, PLANT CELL, V14, P2095, DOI 10.1105/tpc.003509; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; Wang ZY, 2004, TRENDS PLANT SCI, V9, P91, DOI 10.1016/j.tplants.2003.12.009; Whitney SEC, 2000, PLANT J, V22, P327, DOI 10.1046/j.1365-313x.2000.00742.x; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Williams MNV, 1996, PLANT CELL, V8, P673, DOI 10.1105/tpc.8.4.673; Williamson RE, 2001, CELL MOL LIFE SCI, V58, P1475, DOI 10.1007/PL00000790; Zhong RQ, 2002, PLANT CELL, V14, P3101, DOI 10.1105/tpc.005801; Zhong RQ, 2002, PLANT CELL, V14, P165, DOI 10.1105/tpc.010278; Zhu YM, 2003, PLANT PHYSIOL, V132, P494, DOI 10.1104/pp.103.020420	90	883	936	22	393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2206	2211		10.1126/science.1102765	http://dx.doi.org/10.1126/science.1102765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618507	Green Submitted			2022-12-28	WOS:000225950000031
J	Julius, D; Katz, LC				Julius, D; Katz, LC			A nobel for smell	CELL			English	Editorial Material							OLFACTORY SENSORY NEURONS; SENSITIVE ADENYLATE-CYCLASE; RECEPTOR GENE CHOICE; ODORANT RECEPTORS; FUNCTIONAL EXPRESSION; MOUSE; PROTEIN; FAMILY; BULB; MAP		Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Duke Univ, Ctr Med, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Ctr Med, Dept Neurobiol, Durham, NC 27710 USA	University of California System; University of California San Francisco; Duke University; Howard Hughes Medical Institute; Duke University	Julius, D (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu; katz@neuro.duke.edu						AMOORE JE, 1967, NATURE, V214, P1095, DOI 10.1038/2141095a0; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Hudspeth AJ, 1997, NEURON, V19, P947, DOI 10.1016/S0896-6273(00)80385-2; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; KAUER JS, 1991, TRENDS NEUROSCI, V14, P79, DOI 10.1016/0166-2236(91)90025-P; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; LIBERT F, 1989, SCIENCE, V244, P569, DOI 10.1126/science.2541503; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NATHANS J, 1987, ANNU REV NEUROSCI, V10, P163; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; SHEPHERD G M, 1991, Current Biology, V1, P204, DOI 10.1016/0960-9822(91)90056-3; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	35	7	7	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					747	752		10.1016/j.cell.2004.12.004	http://dx.doi.org/10.1016/j.cell.2004.12.004			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607972	Bronze			2022-12-28	WOS:000225907200006
J	Lang, GA; Iwakuma, T; Suh, YA; Liu, G; Rao, VA; Parant, JM; Valentin-Vega, YA; Terzian, T; Caldwell, LC; Strong, LC; El-Naggar, AK; Lozano, G				Lang, GA; Iwakuma, T; Suh, YA; Liu, G; Rao, VA; Parant, JM; Valentin-Vega, YA; Terzian, T; Caldwell, LC; Strong, LC; El-Naggar, AK; Lozano, G			Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome	CELL			English	Article							WILD-TYPE P53; TUMOR-SUPPRESSOR; P53-DEFICIENT MICE; EMBRYONIC LETHALITY; BREAST-CANCER; CHEMICAL CARCINOGENESIS; MDM2-DEFICIENT MICE; FAMILIAL SYNDROME; GENE-EXPRESSION; MUTANT	Individuals with Li-Fraumeni syndrome carry inherited mutations in the p53 tumor suppressor gene and are predisposed to tumor development. To examine the mechanistic nature of these p53 missense mutations, we generated mice harboring a G-to-A substitution at nucleotide 515 of p53 (p53(+/515A)) corresponding to the p53R175H hot spot mutation in human cancers. Although p53(+/515A) mice display a similar tumor spectrum and survival curve as p53(+/-) mice, tumors from p53(+/515A) mice metastasized with high frequency. Correspondingly, the embryonic fibroblasts from the p53(515A/515A) mutant mice displayed enhanced cell proliferation, DNA synthesis, and transformation potential. The disruption of p63 and p73 in p53(-/-) cells increased transformation capacity and reinitiated DNA synthesis to levels observed in p53(515A/515A) cells. Additionally, p63 and p73 were functionally inactivated in p53(515A) cells. These results provide in vivo validation for the gain-of-function properties of certain p53 missense mutations and suggest a mechanistic basis for these phenotypes.	Univ Texas, Grad Sch Biomed Sci, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA; Univ Texas, Grad Sch Biomed Sci, Dept Expt Therapeut, Houston, TX 77030 USA; Univ Texas, Grad Sch Biomed Sci, Dept Pathol, Houston, TX 77030 USA	University of Texas System; University of Texas System; University of Texas System	Lozano, G (corresponding author), Univ Texas, Grad Sch Biomed Sci, Dept Mol Genet, Sect Canc Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gglozano@mdanderson.org	Rao, V Ashutosh/A-3569-2013	Rao, V Ashutosh/0000-0001-6817-8049	NCI NIH HHS [P01 CA34936] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA034936] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Asher G, 2003, P NATL ACAD SCI USA, V100, P15065, DOI 10.1073/pnas.2436329100; BARTEK J, 1991, ONCOGENE, V6, P1699; Bataille F, 2003, J CLIN PATHOL-MOL PA, V56, P286; Benard J, 2003, HUM MUTAT, V21, P182, DOI 10.1002/humu.10172; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; Concin N, 2004, CANCER RES, V64, P2449, DOI 10.1158/0008-5472.CAN-03-1060; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Evans SC, 2001, ONCOGENE, V20, P4041, DOI 10.1038/sj.onc.1204533; Evans SC, 1997, MOL MED TODAY, V3, P390, DOI 10.1016/S1357-4310(97)01105-2; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; Fillippovich I, 2001, ONCOGENE, V20, P514, DOI 10.1038/sj.onc.1204118; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; GREENBLATT MS, 1994, CANCER RES, V54, P4855; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, ONCOGENE, V8, P2457; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; Hwang SJ, 2003, AM J HUM GENET, V72, P975, DOI 10.1086/374567; Iacopetta B, 2003, HUM MUTAT, V21, P271, DOI 10.1002/humu.10175; Ishimoto O, 2002, CANCER RES, V62, P636; Iwakuma T, 2004, ONCOGENE, V23, P7644, DOI 10.1038/sj.onc.1207793; Iwakuma T, 2003, MOL CANCER RES, V1, P993; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Lai SL, 2000, J BIOMED SCI, V7, P64, DOI 10.1007/BF02255920; Lane DR, 2003, DRUG DISCOV TODAY, V8, P347, DOI 10.1016/S1359-6446(03)02669-2; LEVINE AJ, 1993, ANNU REV BIOCHEM, V62, P623, DOI 10.1146/annurev.bi.62.070193.003203; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; LI FP, 1988, CANCER RES, V48, P5358; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; LI FP, 1969, J NATL CANCER I, V43, P1365; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; LUNA RMD, 1995, NATURE, V378, P203; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MILNER J, 1991, MOL CELL BIOL, V11, P12, DOI 10.1128/MCB.11.1.12; Powell B, 2000, CLIN CANCER RES, V6, P443; Pugacheva EN, 2002, ONCOGENE, V21, P4595, DOI 10.1038/sj.onc.1205704; Sigal A, 2000, CANCER RES, V60, P6788; Skaug V, 2000, CLIN CANCER RES, V6, P1031; SLINGERLAND JM, 1993, EMBO J, V12, P1029, DOI 10.1002/j.1460-2075.1993.tb05744.x; Soussi T, 2003, CANCER CELL, V3, P303, DOI 10.1016/S1535-6108(03)00081-3; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; Stiewe T, 2002, J BIOL CHEM, V277, P14177, DOI 10.1074/jbc.M200480200; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; STURZBECHER HW, 1992, ONCOGENE, V7, P1513; Wang XJ, 1998, MOL CARCINOGEN, V23, P185, DOI 10.1002/(SICI)1098-2744(199811)23:3<185::AID-MC7>3.0.CO;2-5; Wang XJ, 1998, ONCOGENE, V17, P35, DOI 10.1038/sj.onc.1201890; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhivotovsky B, 1999, EXP CELL RES, V248, P10, DOI 10.1006/excr.1999.4452	64	780	797	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					861	872		10.1016/j.cell.2004.11.006	http://dx.doi.org/10.1016/j.cell.2004.11.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607981	Bronze			2022-12-28	WOS:000225907200015
J	Fahn, S; Shoulson, I; Kieburtz, K; Rudolph, A; Lang, A; Olanow, CW; Tanner, C; Marek, K				Fahn, S; Shoulson, I; Kieburtz, K; Rudolph, A; Lang, A; Olanow, CW; Tanner, C; Marek, K		Parkinson Study Grp	Levodopa and the progression of Parkinson's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STRIATAL DOPAMINE TRANSPORTER; BENEFIT FOLLOWING WITHDRAWAL; NIGROSTRIATAL LESIONS; OXIDATIVE STRESS; TIME-COURSE; NEURONS; TOXICITY; THERAPY; BROMOCRIPTINE; PRAMIPEXOLE	Background: Despite the known benefit of levodopa in reducing the symptoms of Parkinson's disease, concern has been expressed that its use might hasten neurodegeneration. This study assessed the effect of levodopa on the rate of progression of Parkinson's disease. Methods: In this randomized, double-blind, placebo-controlled trial, we evaluated 361 patients with early Parkinson's disease who were assigned to receive carbidopa-levodopa at a daily dose of 37.5 and 150 mg, 75 and 300 mg, or 150 and 600 mg, respectively, or a matching placebo for a period of 40 weeks, and then to undergo withdrawal of treatment for 2 weeks. The primary outcome was a change in scores on the Unified Parkinson's Disease Rating Scale (UPDRS) between baseline and 42 weeks. Neuroimaging studies of 142 subjects were performed at baseline and at week 40 to assess striatal dopamine-transporter density with the use of iodine-123-labeled 2-beta-carboxymethoxy-3-beta-(4-iodophenyl)tropane ([I-123]beta-CIT) uptake. Results: The severity of parkinsonism increased more in the placebo group than in all the groups receiving levodopa: the mean difference between the total score on the UPDRS at baseline and at 42 weeks was 7.8 units in the placebo group, 1.9 units in the group receiving levodopa at a dose of 150 mg daily, 1.9 in those receiving 300 mg daily, and -1.4 in those receiving 600 mg daily (P<0.001). In contrast, in a substudy of 116 patients the mean percent decline in the [I-123]beta-CIT uptake was significantly greater with levodopa than placebo (-6 percent among those receiving levodopa at 150 mg daily, -4 percent in those receiving it at 300 mg daily, and -7.2 percent among those receiving it at 600 mg daily, as compared with -1.4 percent among those receiving placebo; 19 patients with no dopaminergic deficits on the baseline scans were excluded from the analysis) (P=0.036). The subjects receiving the highest dose of levodopa had significantly more dyskinesia, hypertonia, infection, headache, and nausea than those receiving placebo. Conclusions: The clinical data suggest that levodopa either slows the progression of Parkinson's disease or has a prolonged effect on the symptoms of the disease. In contrast, the neuroimaging data suggest either that levodopa accelerates the loss of nigrostriatal dopamine nerve terminals or that its pharmacologic effects modify the dopamine transporter. The potential long-term effects of levodopa on Parkinson's disease remain uncertain.	Columbia Univ, New York, NY USA; Univ Rochester, Rochester, NY USA; Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; Mt Sinai Sch Med, New York, NY USA; Parkinsons Inst, Sunnyvale, CA USA; Inst Neurodgenerat Disorders, New Haven, CT USA	Columbia University; University of Rochester; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Icahn School of Medicine at Mount Sinai	Fahn, S (corresponding author), Neurol Inst, 710 W 168Th St, New York, NY 10032 USA.	fahn@neuro.columbia.edu	Lang, Anthony/ABF-8114-2021	Marek, Kenneth/0000-0002-4197-5627; Standaert, David/0000-0003-2921-8348; Lang, Anthony/0000-0003-1229-3667; Miyasaki, Janis/0000-0002-6372-6007; Martin, WR Wayne/0000-0002-3416-691X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034796] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR-02066] Funding Source: Medline; NINDS NIH HHS [NS34796] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agid Y, 1998, NEUROLOGY, V50, P858, DOI 10.1212/WNL.50.4.858; Barzilai A, 2001, CELL MOL NEUROBIOL, V21, P215, DOI 10.1023/A:1010991020245; COTZIAS GC, 1967, NEW ENGL J MED, V276, P374, DOI 10.1056/NEJM196702162760703; Datla KP, 2001, MOVEMENT DISORD, V16, P424, DOI 10.1002/mds.1091; Desagher S, 1996, J NEUROSCI, V16, P2553; Fahn S, 1999, ARCH NEUROL-CHICAGO, V56, P529, DOI 10.1001/archneur.56.5.529; Fahn S, 1996, NEUROLOGY, V47, pS184, DOI 10.1212/WNL.47.6_Suppl_3.184S; Fahn S, 1997, CNS DRUGS, V8, P376, DOI 10.2165/00023210-199708050-00004; Fahn S., 1987, RECENT DEV PARKINSON, P153; Fahn S., 1987, RECENT DEV PARK DIS, V2, P293; FRIEDMAN JH, 1985, JAMA-J AM MED ASSOC, V254, P2792, DOI 10.1001/jama.254.19.2792; Gordon PH, 2001, MOVEMENT DISORD, V16, P960, DOI 10.1002/mds.1166; Guttman M, 2001, NEUROLOGY, V56, P1559, DOI 10.1212/WNL.56.11.1559; Han SK, 1996, J NEUROCHEM, V66, P501; Hauser RA, 2002, MOVEMENT DISORD, V17, P961, DOI 10.1002/mds.10226; Hauser RA, 2000, MOVEMENT DISORD, V15, P485, DOI 10.1002/1531-8257(200005)15:3<485::AID-MDS1010>3.0.CO;2-F; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Innis RB, 1999, MOVEMENT DISORD, V14, P436, DOI 10.1002/1531-8257(199905)14:3<436::AID-MDS1008>3.0.CO;2-J; Marek K, 2002, JAMA-J AM MED ASSOC, V287, P1653; Marek K, 2001, NEUROLOGY, V57, P2089, DOI 10.1212/WNL.57.11.2089; MAREK K, 2003, NEUROLOGY S1, V60, pA298; Mena MA, 1997, J NEUROCHEM, V69, P1398; Mena MA, 1997, J NEURAL TRANSM, V104, P317, DOI 10.1007/BF01277654; MUENTER MD, 1971, MAYO CLIN PROC, V46, P231; Murer MG, 1998, ANN NEUROL, V43, P561, DOI 10.1002/ana.410430504; MYTILINEOU C, 1993, J NEUROCHEM, V61, P1470, DOI 10.1111/j.1471-4159.1993.tb13642.x; Mytilineou C, 2003, J PHARMACOL EXP THER, V304, P792, DOI 10.1124/jpet.102.042267; Nurmi E, 2000, J CEREBR BLOOD F MET, V20, P1604, DOI 10.1097/00004647-200011000-00010; OLANOW CW, 1995, ANN NEUROL, V38, P771, DOI 10.1002/ana.410380512; PAULSON G, 1993, NEUROLOGY, V43, P1296; Quinn N, 1986, Mov Disord, V1, P65, DOI 10.1002/mds.870010109; Rajput AH, 1997, MOVEMENT DISORD, V12, P634, DOI 10.1002/mds.870120503; RIEDERER P, 1976, J NEURAL TRANSM, V38, P277, DOI 10.1007/BF01249445; SEIBYL JP, 1995, ANN NEUROL, V38, P589, DOI 10.1002/ana.410380407; SHOULSON I, 1993, NEW ENGL J MED, V328, P176, DOI 10.1056/NEJM199301213280305; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609	36	1238	1307	1	150	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2004	351	24					2498	2508						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877TE	15590952				2022-12-28	WOS:000225593100005
J	Bach, PB; Schrag, D; Begg, CB				Bach, PB; Schrag, D; Begg, CB			Resurrecting treatment histories of dead patients - A study design that should be laid to rest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TERMINAL CANCER-PATIENTS; LAST YEAR; MEDICAL EXPENDITURES; MANAGED CARE; UNITED-STATES; OLDER-ADULTS; HOSPICE USE; LIFE; END; COSTS	In this article we address whether studies of care rendered to patients prior to their death ("studies of decedents") produce an accurate portrait of care provided to patients who are dying. Studies of decedents typically analyze the care provided to patients over a defined interval antecedent to death. Studies of dying patients analyze care provided to patients subsequent to the time that their terminal status is perceived. We address whether 2 fundamental differences between studies of decedents and studies of the dying-the Ways that subjects are identified and the time periods that are examined-lead to differences in interpretation of study results. Using examples from population-based cohorts of individuals with cancer, we show that both the differences in subject selection and time period introduce very substantial biases into studies of decedents. We conclude that studying care received prior to death can lead to invalid conclusions about the quality or type of care provided to dying patients.	Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, Dept Epidemiol & Biostat, 1275 York Ave,Box 221, New York, NY 10021 USA.	bachp@mskcc.org		Schrag, Deborah/0000-0002-4334-5717	NCI NIH HHS [K23CA86968, R01CA090226] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090226, K23CA086968] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bach PB, 1998, AM J RESP CRIT CARE, V158, P1410, DOI 10.1164/ajrccm.158.5.9804042; Bird Chloe E, 2002, J Palliat Med, V5, P705, DOI 10.1089/109662102320880525; Christakis N A, 1998, Hosp J, V13, P71; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Collett D, 1994, MODELLING SURVIVAL D; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2002, J CLIN ONCOL, V20, P1786, DOI 10.1200/JCO.2002.07.142; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Emanuel EJ, 2002, ARCH INTERN MED, V162, P1722, DOI 10.1001/archinte.162.15.1722; Greiner KA, 2003, J AM GERIATR SOC, V51, P970, DOI 10.1046/j.1365-2389.2003.51310.x; Hefflin BJ, 1998, J AM GERIATR SOC, V46, P1396, DOI 10.1111/j.1532-5415.1998.tb06006.x; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Hoover DR, 2002, HEALTH SERV RES, V37, P1625, DOI 10.1111/1475-6773.01113; Levinsky NG, 1999, J AM GERIATR SOC, V47, P553, DOI 10.1111/j.1532-5415.1999.tb02569.x; Levinsky NG, 2001, JAMA-J AM MED ASSOC, V286, P1349, DOI 10.1001/jama.286.11.1349; Lin DY, 1997, BIOMETRICS, V53, P419, DOI 10.2307/2533947; Lipton H L, 1987, Compr Gerontol B, V1, P89; LONG SH, 1984, INQUIRY-J HEALTH CAR, V21, P315; Lubitz J, 1984, Health Care Financ Rev, V5, P117; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lynn J, 1997, New Horiz, V5, P56; MCCALL N, 1984, MED CARE, V22, P329, DOI 10.1097/00005650-198404000-00004; McCarthy EP, 2003, JAMA-J AM MED ASSOC, V289, P2238, DOI 10.1001/jama.289.17.2238; Mukamel DB, 2002, MED CARE, V40, P1136, DOI 10.1097/00005650-200212000-00002; *NAT CANC POL BOAR, 2003, DESCR DEATH AM WHAT; Ngo-Metzger Q, 2003, AM J MED, V115, P47, DOI 10.1016/S0002-9343(03)00258-4; RILEY G, 1987, INQUIRY-J HEALTH CAR, V24, P233; SCITOVSKY AA, 1988, MILBANK Q, V66, P640, DOI 10.2307/3349934; SPECTOR WD, 1984, INQUIRY-J HEALTH CAR, V21, P328; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Warren JL, 2002, MED CARE, V40, P3; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607	35	198	198	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2004	292	22					2765	2770		10.1001/jama.292.22.2765	http://dx.doi.org/10.1001/jama.292.22.2765			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877CY	15585737				2022-12-28	WOS:000225546600026
J	Ducharme, FM; Rowe, BH				Ducharme, FM; Rowe, BH			Intramuscular versus oral methylprednisolone in asthma	LANCET			English	Editorial Material							CLINICAL-TRIAL; DEXAMETHASONE; EMERGENCY; PHARMACOKINETICS; EXACERBATIONS; PREDNISONE; DISCHARGE; CHILDREN		Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada; Univ Alberta, Div Emergency Med, Edmonton, AB, Canada	McGill University; University of Alberta	Ducharme, FM (corresponding author), Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada.	francine.ducharme@muhc.mcgill.ca	Ducharme, Francine/N-8332-2013	Ducharme, Francine/0000-0001-5096-0614				[Anonymous], COCHRANE LIB; Bucher HC, 1999, JAMA-J AM MED ASSOC, V282, P771, DOI 10.1001/jama.282.8.771; Cooper WO, 2001, ARCH PEDIAT ADOL MED, V155, P1111, DOI 10.1001/archpedi.155.10.1111; Elliott CL, 1996, ACTA OBSTET GYN SCAN, V75, P213, DOI 10.3109/00016349609047089; FLETCHER RH, 2004, CLIN EPIDEMIOLOGY TH, P132; Gries DM, 2000, J PEDIATR-US, V136, P298, DOI 10.1067/mpd.2000.103353; Klig JE, 1997, J ASTHMA, V34, P419, DOI 10.3109/02770909709055384; Lahn M, 2004, CHEST, V126, P362, DOI 10.1378/chest.126.2.362; LOEW D, 1986, EUR J CLIN PHARMACOL, V30, P225, DOI 10.1007/BF00614309; SAUNDERS CE, 1987, AM J EMERG MED, V5, P283, DOI 10.1016/0735-6757(87)90351-2	10	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					2000	2001		10.1016/S0140-6736(04)17526-0	http://dx.doi.org/10.1016/S0140-6736(04)17526-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582044				2022-12-28	WOS:000225495700006
J	Godfrey, DI; Petticci, DG; Smyth, MJ				Godfrey, DI; Petticci, DG; Smyth, MJ			The elusive NKT cell antigen - Is the search over?	SCIENCE			English	Editorial Material							EXPRESSION		Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; Peter MacCallum Canc Inst, Canc Immunol Program, Melbourne, Vic 3000, Australia	University of Melbourne; Peter Maccallum Cancer Center	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	godfrey@unimelb.edu.au	Smyth, Mark J/H-8709-2014	Smyth, Mark J/0000-0001-7098-7240; Pellicci, Daniel/0000-0001-5305-2398; Godfrey, Dale/0000-0002-3009-5472				Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; GALILI U, 1993, BLOOD, V82, P2485, DOI 10.1182/blood.V82.8.2485.bloodjournal8282485; GALILI U, 1988, J BIOL CHEM, V263, P17755; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Jeyakumar M, 2002, NEUROPATH APPL NEURO, V28, P343, DOI 10.1046/j.1365-2990.2002.00422.x; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Keusch JJ, 2000, J BIOL CHEM, V275, P25308, DOI 10.1074/jbc.M002629200; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Sandrin MS, 1999, CURR OPIN IMMUNOL, V11, P527, DOI 10.1016/S0952-7915(99)00011-4; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	12	26	38	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1687	+		10.1126/science.1106932	http://dx.doi.org/10.1126/science.1106932			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576595				2022-12-28	WOS:000225630800027
J	Janssen, WJ; Dhaliwal, G; Collard, HR; Saint, S				Janssen, WJ; Dhaliwal, G; Collard, HR; Saint, S			Clinical problem-solving - Why "why'' matters	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMOLYTIC-ANEMIA; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; INDUCED METHEMOGLOBINEMIA		Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USA; San Francisco Vet Affairs Med Ctr, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA; Ann Arbor Vet Affairs Med Ctr, Patient Safety Enhancement Program, Ann Arbor Vet Affairs Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Janssen, WJ (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm Sci & Crit Care Med, 4200 E 9th Ave,Box C-272, Denver, CO 80262 USA.	janssen@uchsc.edu	Saint, Sanjay/AAF-5126-2019		AHRQ HHS [P20-HS11540] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011540] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], 2002, MMWR-MORBID MORTAL W, V51, P639; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; BEUTLER E, 1990, SEMIN HEMATOL, V27, P137; BEUTLER E, 1991, NEW ENGL J MED, V324, P169; BRANDES JC, 1989, AM J MED, V86, P252, DOI 10.1016/0002-9343(89)90284-2; Chan Thomas Y. K., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P189; Costello C, 2000, INT J STD AIDS, V11, P334, DOI 10.1258/0956462001915822; Liao YP, 2002, VET HUM TOXICOL, V44, P19; MANSOURI A, 1993, AM J HEMATOL, V42, P7, DOI 10.1002/ajh.2830420104; Neuberger A, 2002, ISR MED ASSOC J, V4, P1085; ROSEN PJ, 1971, ANN INTERN MED, V75, P83, DOI 10.7326/0003-4819-75-1-83; Verle P, 2000, TROP MED INT HEALTH, V5, P203, DOI 10.1046/j.1365-3156.2000.00542.x; VOYTOVICH AE, 1985, J MED EDUC, V60, P302; WALLEY T, 1987, POSTGRAD MED J, V63, P643, DOI 10.1136/pgmj.63.742.643; Wright RO, 1999, ANN EMERG MED, V34, P646, DOI 10.1016/S0196-0644(99)70167-8	15	14	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2004	351	23					2429	2434		10.1056/NEJMcps040669	http://dx.doi.org/10.1056/NEJMcps040669			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875OC	15575060				2022-12-28	WOS:000225429000014
J	Wager, E				Wager, E		BMJ Ethics Comm	Experiences of the BMJ ethics committee	BMJ-BRITISH MEDICAL JOURNAL			English	Article											Wager, E (corresponding author), Sideview, Princes Risborough HP27 9DE, Bucks, England.	liz@sideview.demon.co.uk		Wager, Elizabeth/0000-0002-4202-7813				Al-Shahi R, 2000, BMJ-BRIT MED J, V321, P1031, DOI 10.1136/bmj.321.7268.1031; Meux CJ, 1996, BRIT MED J, V313, P1265, DOI 10.1136/bmj.313.7067.1265a; Smith AM, 2000, BRIT MED J, V321, P720; Strobl J, 2000, BMJ-BRIT MED J, V321, P890, DOI 10.1136/bmj.321.7265.890; VENTERS G, 2001, BRIT MED J, V322, P7281; 1996, BMJ, V313, P240; DRAFT GUIDELINES CON	7	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2004	329	7464					510	512		10.1136/bmj.329.7464.510	http://dx.doi.org/10.1136/bmj.329.7464.510			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KS	15612090	Green Published			2022-12-28	WOS:000223684600029
J	Anderson, HR; Ayres, JG; Sturdy, PM; Bland, JM; Butland, BK; Peckitt, C; Taylor, JC; Victor, CR				Anderson, HR; Ayres, JG; Sturdy, PM; Bland, JM; Butland, BK; Peckitt, C; Taylor, JC; Victor, CR		Mortality Severe Morbidity Grp Nat	Bronchodilator treatment and deaths from asthma: case-control study	BRITISH MEDICAL JOURNAL			English	Article							INHALED CORTICOSTEROIDS; BETA-AGONISTS; MORTALITY; RISK; PREVENTION; DEBATE; UK	Objective To investigate the association between bronchodilator treatment and death from asthma. Design Case-control study. Setting 33 health authorities or health boards in Great Britain. Participants 532 patients under age 65 who died from asthma and 532 controls with a hospital admission for asthma matched for period, age, mid area. Main outcome measures Odds ratios for deaths from asthma associated with prescription of bronchodilators and other treatment, with sensitivity analyses adjusting for age at onset, previous hospital admissions, associated chronic obstructive lung, disease, mid number of other drug categories. Results After full adjustment, there were no significant associations with drugs prescribed in the 4-12 months before the index date. For prescriptions in the 1-5 years before, mortality was positively associated with inhaled short acting beta(2) agonists (odds ratio 2.05, 95% confidence interval 1.26 to 3.33) mid inversely associated with antibiotics (0.59, 0.39 to 0.89). The former association seemed to be confined to those aged 45-64, and the association with antibiotics was more pronounced in those under 45. Significant age interactions across all periods suggested inverse associations with oral steroids confined to the under 45 age group. An inverse association with Ion acting beta(2) agonists and a positive association with methylxanthines in the 1-5 year period were non-significant. Conclusion There was no evidence of adverse effects on mortality with medium to long term use of inhaled long acting beta(2) agonist drugs. The association with short acting beta(2) agonists has several explanations, only one of which may be a direct adverse effect.	St George Hosp, Sch Med, Dept Community Hlth Sci, London SW17 0RE, England; Univ Aberdeen, Liberty Safe Work Res Ctr, Dept Environm & Occupat Med, Aberdeen AB25 2ZP, Scotland	St Georges University London; University of Aberdeen	Anderson, HR (corresponding author), St George Hosp, Sch Med, Dept Community Hlth Sci, London SW17 0RE, England.	r.anderson@sghm.ac.uk	Anderson, Hugh R/A-7417-2016	Victor, Christina/0000-0002-4213-3974; Butland, Barbara/0000-0001-9952-3108				BEASLEY R, 1991, AUST NZ J MED, V21, P753, DOI 10.1111/j.1445-5994.1991.tb01385.x; Blais L, 1996, AM J EPIDEMIOL, V144, P1161; *BRIT THOR SOC, 1984, THORAX, V39, P505; CHUNG KF, 1993, J ROY SOC MED, V86, P96; CRANE J, 1995, THORAX, V50, pS5, DOI 10.1136/thx.50.Suppl_1.S5; Dennis SM, 2000, LANCET, V355, P1675, DOI 10.1016/S0140-6736(00)02238-8; Graham V., 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002741; GRAINGER J, 1991, THORAX, V46, P105, DOI 10.1136/thx.46.2.105; Guite HF, 1996, THORAX, V51, P924, DOI 10.1136/thx.51.9.924; Guite HF, 1999, THORAX, V54, P301, DOI 10.1136/thx.54.4.301; INMAN WHW, 1969, LANCET, V2, P279; Lanes SF, 2002, THORAX, V57, P683, DOI 10.1136/thorax.57.8.683; Meier CR, 1997, THORAX, V52, P612, DOI 10.1136/thx.52.7.612; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SEARS MR, 1990, LANCET, V336, P1591; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; STOLLEY PD, 1972, AM REV RESPIR DIS, V105, P883; Sturdy PM, 2002, THORAX, V57, P1034, DOI 10.1136/thorax.57.12.1034; Suissa S, 1996, AM J RESP CRIT CARE, V154, P1598, DOI 10.1164/ajrccm.154.6.8970341; Suissa S, 2002, THORAX, V57, P880, DOI 10.1136/thorax.57.10.880; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; VANSCHAYCK CP, 1981, BRIT MED J, V1, P4256; VATHENEN AS, 1988, LANCET, V1, P554; Williams C, 1998, THORAX, V53, P7, DOI 10.1136/thx.53.1.7	24	91	95	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 15	2005	330	7483					117	120		10.1136/bmj.38316.729907.8F	http://dx.doi.org/10.1136/bmj.38316.729907.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889PM	15618231	Green Published, Bronze			2022-12-28	WOS:000226454900015
J	Impey, S; McCorkle, SR; Cha-Molstad, H; Dwyer, JM; Yochum, GS; Boss, JM; McWeeney, S; Dunn, JJ; Mandel, G; Goodman, RH				Impey, S; McCorkle, SR; Cha-Molstad, H; Dwyer, JM; Yochum, GS; Boss, JM; McWeeney, S; Dunn, JJ; Mandel, G; Goodman, RH			Defining the CREB regulon: A genome-wide analysis of transcription factor regulatory regions	CELL			English	Article							CELL LEUKEMIA-VIRUS; BINDING-PROTEIN; CHROMATIN IMMUNOPRECIPITATION; PROMOTER; ACTIVATION; EXPRESSION; REVEALS; ELEMENT; GENES; PHOSPHORYLATION	The CREB transcription factor regulates differentiation, survival, and synaptic plasticity. The complement of CREB targets responsible for these responses has not been identified, however. We developed a novel approach to identify CREB targets, termed serial analysis of chromatin occupancy (SACO), by combining chromatin immunoprecipitation (ChIP) with a modification of SAGE. Using a SACO library derived from rat PC12 cells, we identified similar to41,000 genomic signature tags (GSTs) that mapped to unique genomic loci. CREB binding was confirmed for all loci supported by multiple GSTs. Of the 6302 loci identified by multiple GSTs, 40% were within 2 kb of the transcriptional start of an annotated gene, 49% were within 1 kb of a CpG island, and 72% were within 1 kb of a putative cAMP-response element (CRE). A large fraction of the SACO loci delineated bidirectional promoters and novel antisense transcripts. This study represents the most comprehensive definition of transcription factor binding sites in a metazoan species.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; Emory Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; SUNY Stony Brook, Howard Hughes Med Inst, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Oregon Health & Science University; United States Department of Energy (DOE); Brookhaven National Laboratory; Oregon Health & Science University; Emory University; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Impey, S (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	impeys@ohsu.edu		McWeeney, Shannon/0000-0001-8333-6607; McCorkle, Sean/0000-0003-1126-4071				Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Cox JM, 1995, CHEM BIOL, V2, P819, DOI 10.1016/1074-5521(95)90088-8; Craig JC, 2001, J BIOL CHEM, V276, P11719, DOI 10.1074/jbc.M010263200; Dunn JJ, 2002, GENOME RES, V12, P1756, DOI 10.1101/gr.306102; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fass DM, 2003, J BIOL CHEM, V278, P43014, DOI 10.1074/jbc.M305905200; FINK JS, 1991, J BIOL CHEM, V266, P3882; Giebler HA, 2000, MOL CELL BIOL, V20, P4849, DOI 10.1128/MCB.20.13.4849-4858.2000; Hiroi H, 2004, MOL ENDOCRINOL, V18, P791, DOI 10.1210/me.2003-0305; Hug BA, 2004, J BIOL CHEM, V279, P825, DOI 10.1074/jbc.M309524200; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Momota R, 1998, FEBS LETT, V424, P11, DOI 10.1016/S0014-5793(98)00128-8; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; PACAUCCARALERTKUN S, 1994, MOL CELL BIOL, V14, P456, DOI 10.1128/MCB.14.1.456; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; SchildPoulter C, 1996, NUCLEIC ACIDS RES, V24, P4751, DOI 10.1093/nar/24.23.4751; Schuettengruber B, 2003, J BIOL CHEM, V278, P1784, DOI 10.1074/jbc.M204843200; Shendure J, 2002, GENOME BIOL, V3; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Van Orden K, 1999, J BIOL CHEM, V274, P26321, DOI 10.1074/jbc.274.37.26321; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wolfl S, 1999, MOL ENDOCRINOL, V13, P659, DOI 10.1210/me.13.5.659; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	39	584	617	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					1041	1054		10.1016/j.cell.2004.10.032	http://dx.doi.org/10.1016/j.cell.2004.10.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620361	Bronze			2022-12-28	WOS:000226109700015
J	Maslin, M				Maslin, M			Ecological versus climatic thresholds	SCIENCE			English	Editorial Material									UCL, Environm Change Res Ctr, Dept Geog, London WC1H 0AP, England	University of London; University College London	Maslin, M (corresponding author), UCL, Environm Change Res Ctr, Dept Geog, London WC1H 0AP, England.	mmaslin@geog.ucl.ac.uk		Maslin, Mark/0000-0001-9957-3463	Natural Environment Research Council [NER/A/S/2001/01160] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Cowling SA, 2001, QUATERNARY RES, V55, P140, DOI 10.1006/qres.2000.2197; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Hughen KA, 2004, SCIENCE, V304, P1955, DOI 10.1126/science.1092995; Jennerjahn TC, 2004, SCIENCE, V306, P2236, DOI 10.1126/science.1102490; Maslin M, 2001, GEOPH MONOG SERIES, V126, P9; MASLIN MA, 2004, GLOBAL WARMING VERY, P162; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; McCarthy J.J., 2001, CLIMATE CHANGE 2001; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Tzedakis PC, 2004, SCIENCE, V306, P2231, DOI 10.1126/science.1102398	10	42	43	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2197	2198		10.1126/science.1107481	http://dx.doi.org/10.1126/science.1107481			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15622563				2022-12-28	WOS:000225950000026
J	Dengler, M; Schott, FA; Eden, C; Brandt, P; Fischer, J; Zantopp, RJ				Dengler, M; Schott, FA; Eden, C; Brandt, P; Fischer, J; Zantopp, RJ			Break-up of the Atlantic deep western boundary current into eddies at 8 degrees S	NATURE			English	Article							CURRENT VARIABILITY; CIRCULATION; BRAZIL; TRANSPORT; OCEAN; FLOW; HEAT	The existence in the ocean of deep western boundary currents, which connect the high-latitude regions where deep water is formed with upwelling regions as part of the global ocean circulation, was postulated more than 40 years ago(1). These ocean currents have been found adjacent to the continental slopes of all ocean basins, and have core depths between 1,500 and 4,000 m. In the Atlantic Ocean, the deep western boundary current is estimated to carry (10 - 40) x 10(6) m(3) s(-1) of water(2-5), transporting North Atlantic Deep Water - from the overflow regions between Greenland and Scotland and from the Labrador Sea - into the South Atlantic and the Antarctic circumpolar current. Here we present direct velocity and water mass observations obtained in the period 2000 to 2003, as well as results from a numerical ocean circulation model, showing that the Atlantic deep western boundary current breaks up at 8degrees S. Southward of this latitude, the transport of North Atlantic Deep Water into the South Atlantic Ocean is accomplished by migrating eddies, rather than by a continuous flow. Our model simulation indicates that the deep western boundary current breaks up into eddies at the present intensity of meridional overturning circulation. For weaker overturning, continuation as a stable, laminar boundary flow seems possible.	Leibniz Inst Meereswissensch, D-24105 Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Dengler, M (corresponding author), Leibniz Inst Meereswissensch, Dusternbrooker Weg 20, D-24105 Kiel, Germany.	mdengler@ifm-geomar.de	Dengler, Marcus/A-7327-2014; Brandt, Peter/C-8254-2013	Dengler, Marcus/0000-0001-5993-9088; Brandt, Peter/0000-0002-9235-955X				Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; Eden C, 2002, J PHYS OCEANOGR, V32, P3346, DOI 10.1175/1520-0485(2002)032<3346:SOEKEI>2.0.CO;2; Edwards CA, 1998, J PHYS OCEANOGR, V28, P2382, DOI 10.1175/1520-0485(1998)028<2382:DONCEF>2.0.CO;2; Fischer J, 1997, J GEOPHYS RES-OCEANS, V102, P27751, DOI 10.1029/97JC02327; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; HOGG NG, 1992, DEEP-SEA RES, V39, P1231, DOI 10.1016/0198-0149(92)90066-3; JOHNS WE, 1990, J GEOPHYS RES-OCEANS, V95, P22103, DOI 10.1029/JC095iC12p22103; Johns WE, 2003, ELSEV OCEANOGR SERIE, V68, P411; JOHNS WE, 1993, DEEP-SEA RES PT I, V40, P293, DOI 10.1016/0967-0637(93)90005-N; Lee TN, 1996, J PHYS OCEANOGR, V26, P962, DOI 10.1175/1520-0485(1996)026<0962:MOOWBC>2.0.CO;2; Lozier MS, 1997, SCIENCE, V277, P361, DOI 10.1126/science.277.5324.361; Lumpkin R, 2003, J PHYS OCEANOGR, V33, P1902, DOI 10.1175/1520-0485(2003)033<1902:LVAHCI>2.0.CO;2; Lux M, 2001, DEEP-SEA RES PT I, V48, P605, DOI 10.1016/S0967-0637(00)00033-9; MCCARTNEY MS, 1992, PROG OCEANOGR, V29, P283, DOI 10.1016/0079-6611(92)90006-L; Muller TJ, 1998, J GEOPHYS RES-OCEANS, V103, P5429, DOI 10.1029/97JC03529; Richardson PL, 1999, DEEP-SEA RES PT II, V46, P305, DOI 10.1016/S0967-0645(98)00100-3; Schott FA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014786; Schott FA, 2004, J PHYS OCEANOGR, V34, P817, DOI 10.1175/1520-0485(2004)034<0817:CADEAT>2.0.CO;2; STOMMEL H, 1960, DEEP-SEA RES, V6, P140; Treguier AM, 2003, J PHYS OCEANOGR, V33, P580, DOI 10.1175/1520-0485(2003)033<0580:TOODZF>2.0.CO;2; Weatherly GL, 2000, J PHYS OCEANOGR, V30, P971, DOI 10.1175/1520-0485(2000)030<0971:EMOTNA>2.0.CO;2	21	77	80	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1018	1020		10.1038/nature03134	http://dx.doi.org/10.1038/nature03134			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616560				2022-12-28	WOS:000225887000039
J	Asch, SM; McGlynn, EA; Hogan, MM; Hayward, RA; Shekelle, P; Rubenstein, L; Keesey, J; Adams, J; Kerr, EA				Asch, SM; McGlynn, EA; Hogan, MM; Hayward, RA; Shekelle, P; Rubenstein, L; Keesey, J; Adams, J; Kerr, EA			Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; STANDARDIZED PATIENTS; UNITED-STATES; SYSTEM; AFFAIRS; VA; MANAGEMENT; HOSPITALS; UNDERUSE; SURGERY	Background: The Veterans Health Administration (VITA) has introduced an integrated electronic medical record, performance measurement, and other system changes directed at improving care. Recent comparisons with other delivery systems have been limited to a small set of indicators. Objective: To compare the quality of VITA care with that of care in a national sample by using a comprehensive quality-of-care measure. Design: Cross-sectional comparison. Setting: 12 VITA health care systems and 12 communities. Patients: 596 VITA patients and 992 patients identified through random-digit dialing. All were men older than 35 years of age. Measurements: Between 1997 and 2000, quality was measured by using a chart-based quality instrument consisting of 348 indicators targeting 26 conditions. Results were adjusted for clustering, age, number of visits, and medical conditions. Results: Patients from the VITA scored significantly higher for adjusted overall quality (67% vs. 51%; difference, 16 percentage points [95% CI, 14 to 18 percentage points]), chronic disease care (72% vs. 59%; difference, 13 percentage points [CI, 10 to 17 percentage points]), and preventive care (64% vs. 44%; difference, 20 percentage points [CI, 12 to 28 percentage points]), but not for acute care. The VITA advantage was most prominent in processes targeted by VITA performance measurement (66% vs. 43%; difference, 23 percentage points [CI, 21 to 26 percentage points]) and least prominent in areas unrelated to VITA performance measurement (55% vs. 50%; difference, 5 percentage points [CI, 0 to 10 percentage points]). Limitations: Unmeasured residual differences in patient characteristics, a lower response rate in the national sample, and differences in documentation practices could have contributed to some of the observed differences. Conclusions: Patients from the VITA received higher-quality care according to a broad measure. Differences were greatest in areas where the VITA has established performance measures and actively monitors performance.	Univ Calif Los Angeles, Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA; RAND Hlth, Santa Monica, CA USA; Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Univ Michigan, Ann Arbor, MI 48109 USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Asch, SM (corresponding author), W Los Angeles Vet Affairs Med Ctr, 11301 Wilshire Blvd,Mail Code 111G, Los Angeles, CA 90073 USA.	Steven.Asch@med.va.gov	Young, Alexander/A-1523-2009; Wilkins, Thad/G-2541-2010	Young, Alexander/0000-0002-9367-9213; 	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS009463] Funding Source: NIH RePORTER; AHRQ HHS [5U18HS09463-03] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Adams K., 2003, PRIORITY AREAS NATL; Asch SM, 2000, QUALITY CARE ONCOLOG; Brook RH, 1994, CLIN PRACTICE GUIDEL; Corrigan JM, 2002, LEADERSHIP EXAMPLE C; Dedier J, 2001, ARCH INTERN MED, V161, P2099, DOI 10.1001/archinte.161.17.2099; Demakis JG, 2000, MED CARE, V38, pS17; Efron B., 1994, MONOGRAPHS STAT APPL; Every NR, 2000, MED CARE, V38, pS49; Fihn SD, 2000, NEW ENGL J MED, V343, P1963, DOI 10.1056/NEJM200012283432611; Halpern J, 1996, MED CARE, V34, pMS55; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Jones D, 2000, INT J QUAL HEALTH C, V12, P97, DOI 10.1093/intqhc/12.2.97; Kemper P, 1996, INQUIRY-J HEALTH CAR, V33, P195; Kerr EA, 2004, HEALTH AFFAIR, V23, P247, DOI 10.1377/hlthaff.23.3.247; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; Kerr EA, 2000, QUALITY CARE CARDIOP; KERR EA, 2000, QUALITY CARE GEN MED; Kizer KW, 1999, AM J MED QUAL, V14, P3, DOI 10.1177/106286069901400103; Kravitz RL, 1997, HEALTH POLICY, V42, P135, DOI 10.1016/S0168-8510(97)00064-X; LaBresh Kenneth A, 2003, Jt Comm J Qual Saf, V29, P539; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luck J, 2002, BMJ-BRIT MED J, V325, P679, DOI 10.1136/bmj.325.7366.679; Malin JL, 2000, CANCER-AM CANCER SOC, V88, P701, DOI 10.1002/(SICI)1097-0142(20000201)88:3<701::AID-CNCR29>3.0.CO;2-V; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; McGlynn EA, 1998, AM J PREV MED, V14, P14, DOI 10.1016/S0749-3797(97)00032-9; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McGlynn EA, 1999, WOMEN HEALTH ISS, V9, P184, DOI 10.1016/S1049-3867(99)00009-2; *NAT COMM QUAL ASS, 1999, HEDIS 2000, V2; *NAT PERF DAT FEED, 2004, 1999 NETW PERF REP; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Petersen LA, 2003, NEW ENGL J MED, V348, P2209, DOI 10.1056/NEJMsa021725; Petersen LA, 2001, CIRCULATION, V104, P2898, DOI 10.1161/hc4901.100524; PETERSON ED, 1994, JAMA-J AM MED ASSOC, V271, P1175, DOI 10.1001/jama.271.15.1175; Rogers WH, 1993, STATA TECHN B, V13, P19; Rosenthal GE, 2003, MED CARE, V41, P522, DOI 10.1097/00005650-200304000-00008; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Shekelle PG, 1998, NEW ENGL J MED, V338, P1888, DOI 10.1056/NEJM199806253382607; Steinberg EP, 2003, NEW ENGL J MED, V348, P2681, DOI 10.1056/NEJMe030085; *VET HLTH ADM OFF, 2004, SURV HEALTHC EXP PAT	40	385	386	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2004	141	12					938	945		10.7326/0003-4819-141-12-200412210-00010	http://dx.doi.org/10.7326/0003-4819-141-12-200412210-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882EY	15611491				2022-12-28	WOS:000225923000005
J	Berman, BM; Lao, LX; Langenberg, P; Lee, WL; Gilpin, AMK; Hochberg, MC				Berman, BM; Lao, LX; Langenberg, P; Lee, WL; Gilpin, AMK; Hochberg, MC			Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							CHINESE ACUPUNCTURE; RESEARCH-SOCIETY; CLINICAL-TRIALS; ORAL-SURGERY; TASK-FORCE; ARTHRITIS; COMPLEMENTARY; PAIN; EFFICACY; RECOMMENDATIONS	Background: Evidence on the efficacy of acupuncture for reducing the pain and dysfunction of osteoarthritis is equivocal. Objective: To determine whether acupuncture provides greater pain relief and improved function compared with sham acupuncture or education in patients with osteoarthritis of the knee. Design: Randomized, controlled trial. Setting: Two outpatient clinics (an integrative medicine facility and a rheumatology facility) located in academic teaching hospitals and 1 clinical trials facility. Patients: 570 patients with osteoarthritis of the knee (mean age [+/-SD], 65.5 +/- 8.4 years). Intervention: 23 true acupuncture sessions over 26 weeks. Controls received 6 two-hour sessions over 12 weeks or 23 sham acupuncture sessions over 26 weeks. Measurements: Primary outcomes were changes in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and function scores at 8 and 26 weeks. Secondary outcomes were patient global assessment, 6-minute walk distance, and physical health scores of the 36-Item Short-Form Health Survey (SF-36). Results: Participants in the true acupuncture group experienced greater improvement in WOMAC function scores than the sham acupuncture group at 8 weeks (mean difference, -2.9 [95% CI, -5.0 to -0.8]; P = 0.01) but not in WOMAC pain score (mean difference, -0.5 [CI, -1.2 to 0.2]; P = 0.18) or the patient global assessment (mean difference, 0.16 [CI, -0.02 to 0.34]; P > 0.2). At 26 weeks, the true acupuncture group experienced significantly greater improvement than the sham group in the WOMAC function score (mean difference, -2.5 [CI, -4.7 to -0.4]; P = 0.01), WOMAC pain score (mean difference, -0.87 [CI, -1.58 to -0.16]; P = 0.003), and patient global assessment (mean difference, 0.26 [CI, 0.07 to 0.45]; P = 0.02). Limitations: At 26 weeks, 43% of the participants in the education group and 25% in each of the true and sham acupuncture groups were not available for analysis. Conclusions: Acupuncture seems to provide improvement in function and pain relief as an adjunctive therapy for osteoarthritis of the knee when compared with credible sham acupuncture and education control groups.	Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Berman, BM (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.		Lao, Lixing/I-7979-2013	Lao, Lixing/0000-0003-0198-9714	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U01AT000171] Funding Source: NIH RePORTER; NCCIH NIH HHS [U01 AT-00171] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Altman RD, 2004, J RHEUMATOL, V31, P5; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Astin JA, 2000, J GERONTOL A-BIOL, V55, pM4; Bausell R.Barker., 2002, POWER ANAL EXPT RES; Bausell RB, 2001, MED CARE, V39, P190, DOI 10.1097/00005650-200102000-00009; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BERMAN BM, 1995, OSTEOARTHR CARTILAGE, V3, P139, DOI 10.1016/S1063-4584(05)80046-9; Berman BM, 2002, ARCH INTERN MED, V162, P766, DOI 10.1001/archinte.162.7.766; Berman BM, 1999, RHEUMATOLOGY, V38, P346, DOI 10.1093/rheumatology/38.4.346; Cheng X., 1999, CHINESE ACUPUNCTURE; Ezzo J, 2001, ARTHRITIS RHEUM, V44, P819, DOI 10.1002/1529-0131(200104)44:4<819::AID-ANR138>3.0.CO;2-P; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Felson DT, 2000, ANN INTERN MED, V133, P726, DOI 10.7326/0003-4819-133-9-200011070-00015; GAW AC, 1975, NEW ENGL J MED, V293, P375, DOI 10.1056/NEJM197508212930803; Hernandez-Diaz Sonia, 2001, American Journal of Medicine, V110, p20S; Hochberg MC, 2003, ANN INTERN MED, V139, P781, DOI 10.7326/0003-4819-139-9-200311040-00013; Hochberg MC, 2001, BEST PRACT RES CL RH, V15, P583, DOI 10.1053/berh.2001.0175; LAO LX, 1995, ORAL SURG ORAL MED O, V79, P423, DOI 10.1016/S1079-2104(05)80121-0; Lao LX, 1999, ARCH OTOLARYNGOL, V125, P567, DOI 10.1001/archotol.125.5.567; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lorig K, 1998, ARTHRIT CARE RES, V11, P448, DOI 10.1002/art.1790110604; MEENAN RF, 1992, ARTHRITIS RHEUM, V35, P1, DOI 10.1002/art.1780350102; OConnor J, 1981, ACUPUNCTURE COMPREHE; Pendleton A, 2000, ANN RHEUM DIS, V59, P936, DOI 10.1136/ard.59.12.936; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Rao JK, 1999, ANN INTERN MED, V131, P409, DOI 10.7326/0003-4819-131-6-199909210-00003; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Strand V, 2002, ARTHRIT RHEUM-ARTHR, V47, P349, DOI 10.1002/art.10560; Takeda W, 1994, Arthritis Care Res, V7, P118, DOI 10.1002/art.1790070304; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WONG TW, 1991, FAM PRACT, V8, P168, DOI 10.1093/fampra/8.2.168	32	378	404	1	83	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2004	141	12					901	910		10.7326/0003-4819-141-12-200412210-00006	http://dx.doi.org/10.7326/0003-4819-141-12-200412210-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882EY	15611487				2022-12-28	WOS:000225923000001
J	Fong, K				Fong, K			The next small step	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORTHOSTATIC HYPOTENSION; SPATIAL ORIENTATION; SPACE-FLIGHT; MICROGRAVITY; ADAPTATION; DURATION		Middlesex Hosp, Ctr Aviat Space & Extreme Environm, London W1T 3AA, England	University of London; University College London	Fong, K (corresponding author), Middlesex Hosp, Ctr Aviat Space & Extreme Environm, London W1T 3AA, England.	kfong@ucl.ac.uk						Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; Buckey JC, 1996, J APPL PHYSIOL, V81, P7, DOI 10.1152/jappl.1996.81.1.7; Carmeliet G, 1997, J BONE MINER RES, V12, P786, DOI 10.1359/jbmr.1997.12.5.786; Carmeliet G, 2001, CRIT REV EUKAR GENE, V11, P131; Clement G, 2004, EUR J APPL PHYSIOL, V92, P235, DOI 10.1007/s00421-004-1118-1; Crawford IA, 2004, ASTRON GEOPHYS, V45, P28, DOI 10.1046/j.1468-4004.2003.45228.x; D'Aunno DS, 2003, AM J CARDIOL, V91, P494, DOI 10.1016/S0002-9149(02)03259-9; DAVIS JR, 1988, AVIAT SPACE ENVIR MD, V59, P1185; Fitts RH, 2001, J EXP BIOL, V204, P3201; Fritsch-Yelle JM, 1998, AM J CARDIOL, V81, P1391, DOI 10.1016/S0002-9149(98)00179-9; HARM DL, 1994, J CLIN PHARMACOL, V34, P618, DOI 10.1002/j.1552-4604.1994.tb02015.x; Holstein G.R, 1999, J GRAVIT PHYSL, V6, P47; LACKNER JR, 1992, PERCEPTION, V21, P803, DOI 10.1068/p210803; Macho L, 2001, Endocr Regul, V35, P101; PARKER DE, 1985, AVIAT SPACE ENVIR MD, V56, P601; Reschke Millard F, 2002, J Gravit Physiol, V9, pP133; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Shi SJ, 2004, AVIAT SPACE ENVIR MD, V 75, P235; Smith SM, 2002, NUTRITION, V18, P864, DOI 10.1016/S0899-9007(02)00912-7; Sonnenfeld G, 2002, NUTRITION, V18, P899, DOI 10.1016/S0899-9007(02)00903-6; TSIOLKOVSKY KE, 1953, COLLECT WORKS, V2, P100; TURNER MJL, 2003, EXPEDITION MARS; Turner RT, 2000, J APPL PHYSIOL, V89, P840, DOI 10.1152/jappl.2000.89.2.840; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; Watenpaugh DE, 2001, J EXP BIOL, V204, P3209; Waters WW, 2002, J APPL PHYSIOL, V92, P586, DOI 10.1152/japplphysiol.00544.2001; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415	27	13	17	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1441	1444		10.1136/bmj.329.7480.1441	http://dx.doi.org/10.1136/bmj.329.7480.1441			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604178	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000225965800021
J	Hengstman, GJD; van Engelen, BGM				Hengstman, GJD; van Engelen, BGM			Polymyositis, invasion of-non-necrotic muscle fibres, and the art of repetition	BRITISH MEDICAL JOURNAL			English	Article							IDIOPATHIC INFLAMMATORY MYOPATHIES; INCLUSION-BODY MYOSITIS; OVERDIAGNOSED ENTITY; DIAGNOSTIC-CRITERIA; MONONUCLEAR-CELLS; DERMATOMYOSITIS; QUANTITATION; DISEASES; SUBSETS		Univ Nijmegen, Neuromuscular Ctr Nijmegen, Dept Neurol, Med Ctr, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hengstman, GJD (corresponding author), Univ Nijmegen, Neuromuscular Ctr Nijmegen, Dept Neurol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.		van Engelen, Baziel/H-8027-2014	van Engelen, Baziel/0000-0001-9867-9047				Amato AA, 1996, ANN NEUROL, V40, P581, DOI 10.1002/ana.410400407; Amato AA, 2003, NEUROLOGY, V61, P288, DOI 10.1212/WNL.61.3.288; ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206; BAROHN RJ, 1995, NEUROLOGY, V45, P1302, DOI 10.1212/WNL.45.7.1302; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Bradley WG, 2004, NEUROLOGY, V63, P402; Carpenter S, 1981, Pathol Annu, V16, P205; Carpenter S, 2001, PATHOLOGY SKELETAL M; DALAKAS M, 1990, CURR OPIN NEUROL NEU, V3, P689; Dalakas MC, 1998, ARCH NEUROL-CHICAGO, V55, P1509, DOI 10.1001/archneur.55.12.1509; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; Dalakas MC, 2002, RHEUM DIS CLIN N AM, V28, P779, DOI 10.1016/S0889-857X(02)00030-3; DALAKAS MC, 1991, NEW ENGL J MED, V325, P1487, DOI 10.1056/NEJM199111213252107; DALAKAS MC, 1992, NEUROPHARMACOLOGY, V5, P327; DALAKAS MC, 1988, POLYMYOSITIS DERMATO; DALAKAS MC, 1995, ANN NEUROL, V37, P74; DALAKAS MC, 2001, HARRISONS PRINCIPLES, P2524; DALAKAS MC, 2001, ADV NEUROL, V88, P253; EMSLIESMITH AM, 1989, HUM PATHOL, V20, P224, DOI 10.1016/0046-8177(89)90128-7; Engel A. G., 1994, MYOLOGY, P1335; ENGEL AG, 1986, HUM PATHOL, V17, P704, DOI 10.1016/S0046-8177(86)80180-0; ENGEL AG, 1989, CURR OPIN NEUROL NEU, V2, P695; ENGEL AG, 1990, J NEUROL SCI S, V98, P6; Hengstman GJD, 2004, NEUROLOGY, V63, P402; Hilton-Jones D, 2001, CURR OPIN NEUROL, V14, P591, DOI 10.1097/00019052-200110000-00007; HOHLFELD R, 1994, IMMUNOL TODAY, V15, P269, DOI 10.1016/0167-5699(94)90006-X; HOHLFELD R, 1993, BAILLIERE CLIN NEUR, V2, P617; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; KARPATI G, 1993, BAILLIERE CLIN NEUR, V2, P527; KARPATI G, 1988, CURR OPIN NEUROL NEU, V1, P806; Mastaglia FL, 2002, RHEUM DIS CLIN N AM, V28, P723, DOI 10.1016/S0889-857X(02)00021-2; Miller FW, 2004, NEUROLOGY, V63, P402, DOI 10.1212/WNL.63.2.402; Miller FW, 2003, LANCET, V362, P1762, DOI 10.1016/S0140-6736(03)14862-3; PLOTZ PH, 1989, ANN INTERN MED, V111, P143, DOI 10.7326/0003-4819-111-2-143; RINGEL SP, 1986, ARCH NEUROL-CHICAGO, V43, P1004, DOI 10.1001/archneur.1986.00520100026010; ROWLAND LP, 1995, MERRITTS TXB NEUROLO, P798; van der Meulen MFG, 2003, NEUROLOGY, V61, P316, DOI 10.1212/WNL.61.3.316; van der Meulen MFG, 1998, J NEUROL NEUROSUR PS, V64, P396, DOI 10.1136/jnnp.64.3.396; WALTON J, 1991, J NEUROL NEUROSUR PS, V54, P285, DOI 10.1136/jnnp.54.4.285; WHITAKER JN, 1982, MUSCLE NERVE, V5, P573, DOI 10.1002/mus.880050802	40	17	22	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1464	1467		10.1136/bmj.329.7480.1464	http://dx.doi.org/10.1136/bmj.329.7480.1464			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604185	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000225965800028
J	Kaira, K; Takise, A; Goto, T; Horie, T; Mori, M				Kaira, K; Takise, A; Goto, T; Horie, T; Mori, M			Barium sulphate aspiration	LANCET			English	Editorial Material									Maebashi Red Cross Hosp, Dept Resp Med, Gunma 3718511, Japan; Gunma Univ, Dept Internal Med 1, Gunma 3718511, Japan	Maebashi Red Cross Hospital; Gunma University	Kaira, K (corresponding author), Maebashi Red Cross Hosp, Dept Resp Med, 3-21-36 Asahi Cho, Gunma 3718511, Japan.	k-kaira@maebashi.jrc.or.jp							0	17	18	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2220	2220		10.1016/S0140-6736(04)17595-8	http://dx.doi.org/10.1016/S0140-6736(04)17595-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610809				2022-12-28	WOS:000225799700031
J	Knight, R				Knight, R			The Poohsticks phenomenon	BRITISH MEDICAL JOURNAL			English	Article											Knight, R (corresponding author), 1 Rutland Gate Mews, London SW7 1PH, England.							Milne A. A., 1992, HOUSE POOH CORNER	1	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1432	1433		10.1136/bmj.329.7480.1432	http://dx.doi.org/10.1136/bmj.329.7480.1432			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604173	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000225965800016
J	Martyn, C				Martyn, C			Commentary: Politics as a determinant of health	BRITISH MEDICAL JOURNAL			English	Editorial Material							EDUCATION; DEMOCRACY		BMJ, London WC1H 9JR, England		Martyn, C (corresponding author), BMJ, London WC1H 9JR, England.	cmartyn@bmj.com						Brown DS, 2004, COMP POLIT STUD, V37, P842, DOI 10.1177/0010414004266870; Brown DS, 2004, BRIT J POLIT SCI, V34, P137, DOI 10.1017/S0007123403210395; Franco A, 2004, BMJ-BRIT MED J, V329, P1421, DOI 10.1136/bmj.329.7480.1421; HUMAN DEV REPORT NOT	4	8	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1423	1424		10.1136/bmj.329.7480.1423	http://dx.doi.org/10.1136/bmj.329.7480.1423			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604166	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000225965800009
J	Breaker, RR				Breaker, RR			Natural and engineered nucleic acids as tools to explore biology	NATURE			English	Review							IN-VITRO SELECTION; PEPTIDYL TRANSFERASE CENTER; CONTROLS GENE-EXPRESSION; DIRECTED EVOLUTION; STRUCTURAL BASIS; RNA APTAMERS; AFFINITY-CHROMATOGRAPHY; ALLOSTERIC RIBOZYMES; PHOSPHORYLATING DNA; AUTOMATED SELECTION	RNA and DNA molecules can form complex, three-dimensional folded structures that have surprisingly sophisticated functions, including catalysing chemical reactions and controlling gene expression. Although natural nucleic acids make occasional use of these advanced functions, the true potential for sophisticated function by these biological polymers is far greater. An important challenge for biochemists is to take RNA and DNA beyond their proven use as polymers that form double-helical structures. Molecular engineers are beginning to harness the power of nucleic acids that form more complex three-dimensional structures, and apply them as tools for exploring biological systems and as therapeutics.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Breaker, Ronald/0000-0002-2165-536X				Bagheri S, 2004, CURR MOL MED, V4, P489, DOI 10.2174/1566524043360410; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Baskerville S, 2002, P NATL ACAD SCI USA, V99, P9154, DOI 10.1073/pnas.142153799; Beaudry A, 2000, CHEM BIOL, V7, P323, DOI 10.1016/S1074-5521(00)00110-1; Boncler MA, 2001, THROMB RES, V104, P215, DOI 10.1016/S0049-3848(01)00357-7; Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Brockstedt U, 2004, BIOCHEM BIOPH RES CO, V313, P1004, DOI 10.1016/j.bbrc.2003.12.030; Byun J, 2003, RNA, V9, P1254, DOI 10.1261/rna.5450203; Cox JC, 2001, BIOORGAN MED CHEM, V9, P2525, DOI 10.1016/S0968-0896(01)00028-1; Cox JC, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf107; Cox JC, 2002, COMB CHEM HIGH T SCR, V5, P289; Crooke ST, 2004, ANNU REV MED, V55, P61, DOI 10.1146/annurev.med.55.091902.104408; Csaky K, 2003, OPHTHALMOLOGY, V110, P879; Deng Q, 2001, ANAL CHEM, V73, P5415, DOI 10.1021/ac0105437; DYKXHOORN DM, 2003, NATURE REV MOL CELL, V23, P1961; EATON BE, 1995, ANNU REV BIOCHEM, V64, P837, DOI 10.1146/annurev.bi.64.070195.004201; Emilsson GM, 2002, CELL MOL LIFE SCI, V59, P596, DOI 10.1007/s00018-002-8452-4; Eulberg D, 2003, CHEMBIOCHEM, V4, P979, DOI 10.1002/cbic.200300663; Famulok M, 2002, TRENDS BIOTECHNOL, V20, P462, DOI 10.1016/S0167-7799(02)02063-2; Ferguson A, 2004, NUCLEIC ACIDS RES, V32, P1756, DOI 10.1093/nar/gkh336; Fernando FS, 2001, J MOL MED-JMM, V79, P695, DOI 10.1007/s001090100272; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Grate D, 2001, BIOORGAN MED CHEM, V9, P2565, DOI 10.1016/S0968-0896(01)00031-1; Gruenert DC, 2003, J CLIN INVEST, V112, P637, DOI 10.1172/JCI200319773; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Hamaguchi N, 2001, ANAL BIOCHEM, V294, P126, DOI 10.1006/abio.2001.5169; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Hanson S, 2003, MOL MICROBIOL, V49, P1627, DOI 10.1046/j.1365-2958.2003.03656.x; Hartig JS, 2002, NAT BIOTECHNOL, V20, P717, DOI 10.1038/nbt0702-717; Harvey I, 2002, RNA, V8, P452, DOI 10.1017/S135583820202633X; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Hesselberth JR, 2003, ANAL BIOCHEM, V312, P106, DOI 10.1016/S0003-2697(02)00441-4; Holmlund JT, 2003, ANN NY ACAD SCI, V1002, P244, DOI 10.1196/annals.1281.027; Homann M, 2001, BIOORGAN MED CHEM, V9, P2571, DOI 10.1016/S0968-0896(01)00032-3; Jarvis TC, 2000, J IMMUNOL, V165, P493, DOI 10.4049/jimmunol.165.1.493; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Jhaveri S, 2000, NAT BIOTECHNOL, V18, P1293, DOI 10.1038/82414; Jiang F, 1996, NATURE, V382, P183, DOI 10.1038/382183a0; Johansen LE, 2003, J BACTERIOL, V185, P5200, DOI 10.1128/JB.185.17.5200-5209.2003; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Kawa D, 1998, RNA, V4, P1397, DOI 10.1017/S1355838298980918; Kawasaki H, 2002, EMBO REP, V3, P443, DOI 10.1093/embo-reports/kvf098; Khudyakov Y.E., 2002, ARTIFICIAL DNA METHO; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Koizumi M, 1999, NAT STRUCT BIOL, V6, P1062; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Kossen K, 2004, CHEM BIOL, V11, P807, DOI 10.1016/j.chembiol.2004.03.029; Kuan Jean Y, 2004, Methods Mol Biol, V262, P173; Lazarev D, 2003, RNA, V9, P688, DOI 10.1261/rna.2600503; Li YF, 1999, P NATL ACAD SCI USA, V96, P2746, DOI 10.1073/pnas.96.6.2746; LIN Y, 1994, NUCLEIC ACIDS RES, V22, P5229, DOI 10.1093/nar/22.24.5229; Long MB, 2003, J CLIN INVEST, V112, P312, DOI 10.1172/JCI200319386; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; McCauley TG, 2003, ANAL BIOCHEM, V319, P244, DOI 10.1016/S0003-2697(03)00297-5; MCPHERSON MJ, 2000, PCR; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Muller S, 2004, CURR ORG SYNTH, V1, P293, DOI 10.2174/1570179043366675; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Najafi-Shoushtari SH, 2004, NUCLEIC ACIDS RES, V32, P3212, DOI 10.1093/nar/gkh643; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Osborne SE, 1997, CHEM REV, V97, P349, DOI 10.1021/cr960009c; Peracchi A, 2004, REV MED VIROL, V14, P47, DOI 10.1002/rmv.415; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; Rangarajan S, 2004, BIOCHEM J, V380, P611, DOI 10.1042/BJ20040442; Reese CB, 2002, J CHEM SOC PERK T 1, P2619, DOI 10.1039/b208802a; Rhoades K, 2003, MECH AGEING DEV, V124, P125, DOI 10.1016/S0047-6374(02)00175-6; Romig TS, 1999, J CHROMATOGR B, V731, P275, DOI 10.1016/S0378-4347(99)00243-1; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Santiago FS, 1999, NAT MED, V5, P1264, DOI 10.1038/15215; Santoro SW, 1998, BIOCHEMISTRY-US, V37, P13330, DOI 10.1021/bi9812221; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Sarafianos SG, 2004, INT J BIOCHEM CELL B, V36, P1706, DOI 10.1016/j.biocel.2004.02.027; Sayer NM, 2004, J BIOL CHEM, V279, P13102, DOI 10.1074/jbc.M310928200; Seetharaman S, 2001, NAT BIOTECHNOL, V19, P336, DOI 10.1038/86723; Silverman SK, 2003, RNA, V9, P377, DOI 10.1261/rna.2200903; Sooter LJ, 2001, BIOL CHEM, V382, P1327, DOI 10.1515/BC.2001.165; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Soukup GA, 2001, RNA, V7, P524, DOI 10.1017/S1355838201002175; Sreedhara A, 2004, J AM CHEM SOC, V126, P3454, DOI 10.1021/ja039713i; Srinivasan J, 2004, CHEM BIOL, V11, P499, DOI 10.1016/j.chembiol.2004.03.014; Stein C. A., 1998, APPL ANTISENSE OLIGO; Steitz TA, 2003, TRENDS BIOCHEM SCI, V28, P411, DOI 10.1016/S0968-0004(03)00169-5; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Suess B, 2003, NUCLEIC ACIDS RES, V31, P1853, DOI 10.1093/nar/gkg285; Suess B, 2004, NUCLEIC ACIDS RES, V32, P1610, DOI 10.1093/nar/gkh321; Sullenger BA, 2002, NATURE, V418, P252, DOI 10.1038/418252a; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; Toulme JJ, 2004, FEBS LETT, V567, P55, DOI 10.1016/j.febslet.2004.03.111; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; UHLENBECK OC, 1995, RNA, V1, P4; Unrau PJ, 1998, NATURE, V395, P260, DOI 10.1038/26193; Vaish NK, 2003, RNA, V9, P1058, DOI 10.1261/rna.5760703; Vater A, 2003, CURR OPIN DRUG DI DE, V6, P253; Walther W, 2000, DRUGS, V60, P249, DOI 10.2165/00003495-200060020-00002; Wang W, 2002, CHEM BIOL, V9, P507, DOI 10.1016/S1074-5521(02)00127-8; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Werstuck G, 1998, SCIENCE, V282, P296, DOI 10.1126/science.282.5387.296; WILSON C, 1995, NATURE, V374, P777, DOI 10.1038/374777a0; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Zhao HM, 2002, CURR OPIN BIOTECH, V13, P104, DOI 10.1016/S0958-1669(02)00291-4	114	273	304	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					838	845		10.1038/nature03195	http://dx.doi.org/10.1038/nature03195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602549				2022-12-28	WOS:000225733500040
J	Dobson, CM				Dobson, CM			Chemical space and biology	NATURE			English	Article							DRUG DISCOVERY; DIVERSITY; EVOLUTION; DESIGN	Chemical space - which encompasses all possible small organic molecules, including those present in biological systems - is vast. So vast, in fact, that so far only a tiny fraction of it has been explored. Nevertheless, these explorations have greatly enhanced our understanding of biology, and have led to the development of many of today's drugs. The discovery of new bioactive molecules, facilitated by a deeper understanding of the nature of the regions of chemical space that are relevant to biology, will advance our knowledge of biological processes and lead to new strategies to treat disease.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cmd44@cam.ac.uk						Agrafiotis DK, 2002, NAT REV DRUG DISCOV, V1, P337, DOI 10.1038/nrd791; [Anonymous], 2004, SCIENCE, V303, P1798, DOI 10.1126/science.303.5665.1796; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6; Buckingham S, 2003, NATURE, V425, P209, DOI 10.1038/425209a; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Dickson M, 2004, NAT REV DRUG DISCOV, V3, P417, DOI 10.1038/nrd1382; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DOBSON CM, 2001, FDN CHEM BIOL; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Goto S, 2002, NUCLEIC ACIDS RES, V30, P402, DOI 10.1093/nar/30.1.402; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Houghten RA, 2000, ANNU REV PHARMACOL, V40, P273, DOI 10.1146/annurev.pharmtox.40.1.273; KIANO H, 2001, NATURE, V420, P206; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Luria SE, 1981, VIEW LIFE; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Mullin R, 2004, CHEM ENG NEWS, V82, P23; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Schreiber SL, 1998, BIOORGAN MED CHEM, V6, P1127, DOI 10.1016/S0968-0896(98)00126-6; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Seeberger PH, 2003, CHEM COMMUN, P1115, DOI 10.1039/b210230g; Sills MA, 2002, J BIOMOL SCREEN, V7, P191, DOI 10.1177/108705710200700304; Skar J, 2003, PHILOS T ROY SOC A, V361, P1047, DOI 10.1098/rsta.2003.1183; Smith A, 2003, NATURE, V426, P883, DOI 10.1038/426883a; Steitz TA, 2003, TRENDS BIOCHEM SCI, V28, P411, DOI 10.1016/S0968-0004(03)00169-5; Townsend JA, 2004, ORG BIOMOL CHEM, V2, P3294, DOI 10.1039/b411033a; TSIEN RY, 2003, NAT REV MOL CELL BIO, V4, pSS16; Voet D., 1995, BIOCHEMISTRY; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; Williams R. J. P., 1997, NATURAL SELECTION CH; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987	44	701	756	4	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					824	828		10.1038/nature03192	http://dx.doi.org/10.1038/nature03192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602547	hybrid			2022-12-28	WOS:000225733500038
J	Eisebitt, S; Luning, J; Schlotter, WF; Lorgen, M; Hellwig, O; Eberhardt, W; Stohr, J				Eisebitt, S; Luning, J; Schlotter, WF; Lorgen, M; Hellwig, O; Eberhardt, W; Stohr, J			Lensless imaging of magnetic nanostructures by X-ray spectro-holography	NATURE			English	Article							MICROSCOPY; PHASE	Our knowledge of the structure of matter is largely based on X-ray diffraction studies of periodic structures and the successful transformation ( inversion) of the diffraction patterns into real-space atomic maps. But the determination of non-periodic nanoscale structures by X-rays is much more difficult. Inversion of the measured diffuse X-ray intensity patterns suffers from the intrinsic loss of phase information(1,2), and direct imaging methods are limited in resolution by the available X-ray optics(3). Here we demonstrate a versatile technique for imaging nanostructures, based on the use of resonantly tuned soft X-rays for scattering contrast and the direct Fourier inversion of a hololetters graphically formed interference pattern. Our implementation places the sample behind a lithographically manufactured mask with a micrometre-sized sample aperture and a nanometre-sized hole that defines a reference beam. As an example, we have used the resonant X-ray magnetic circular dichroism effect to image the random magnetic domain structure in a Co/Pt multilayer film with a spatial resolution of 50 nm. Our technique, which is a form of Fourier transformholography, is transferable to a wide variety of specimens, appears scalable to diffraction-limited resolution, and is well suited for ultrafast single-shot imaging with coherent X-ray free-electron laser sources(4).	Stanford Linear Accelerator Ctr, SSRL, Menlo Pk, CA 94025 USA; BESSY MbH, D-12489 Berlin, Germany; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Hitachi Global Storage Technol, San Jose Res Ctr, San Jose, CA 95120 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Stanford University	Eisebitt, S (corresponding author), Stanford Linear Accelerator Ctr, SSRL, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	eisebitt@bessy.de; luning@stanford.edu	Eberhardt, Wolfgang U/L-4406-2013	Eisebitt, Stefan/0000-0001-7608-5061				ADE H, 1993, SCIENCE, V262, P1427, DOI 10.1126/science.262.5138.1427; Bergemann C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.204801; Chao WL, 2003, OPT LETT, V28, P2019, DOI 10.1364/OL.28.002019; Cho A, 2002, SCIENCE, V296, P1008, DOI 10.1126/science.296.5570.1008; Eisebitt S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.104419; Emma P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074801; FIENUP JR, 1982, APPL OPTICS, V21, P2758, DOI 10.1364/AO.21.002758; FIENUP JR, 1987, J OPT SOC AM A, V4, P118, DOI 10.1364/JOSAA.4.000118; Fischer P, 1999, J MAGN MAGN MATER, V198-99, P624, DOI 10.1016/S0304-8853(98)01210-4; GABOR D, 1971, SCIENCE, V173, P11, DOI 10.1126/science.173.3991.11; GERCHBERG RW, 1972, OPTIK, V35, P237; HANNON JP, 1988, PHYS REV LETT, V61, P1245, DOI 10.1103/PhysRevLett.61.1245; Hellwig O, 2003, PHYSICA B, V336, P136, DOI 10.1016/S0921-4526(03)00282-5; Kilcoyne ALD, 2003, J SYNCHROTRON RADIAT, V10, P125, DOI 10.1107/S0909049502017739; Kortright JB, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.092401; Lindaas S, 1996, J OPT SOC AM A, V13, P1788, DOI 10.1364/JOSAA.13.001788; MCNULTY I, 1992, SCIENCE, V256, P1009, DOI 10.1126/science.256.5059.1009; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; SCHMAHL G, 2003, SYNCHROTRON RAD NEWS, V16, P2; STOHR J, 1993, SCIENCE, V259, P658, DOI 10.1126/science.259.5095.658; STROKE GW, 1965, APPL PHYS LETT, V6, P201, DOI 10.1063/1.1754131; TREBES JE, 1987, SCIENCE, V238, P517, DOI 10.1126/science.238.4826.517; WINTHROP JT, 1965, PHYS LETT, V15, P124, DOI 10.1016/0031-9163(65)91304-1; Xu WB, 2001, P NATL ACAD SCI USA, V98, P11301, DOI 10.1073/pnas.191361398; [No title captured]	26	493	504	1	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					885	888		10.1038/nature03139	http://dx.doi.org/10.1038/nature03139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602557	Green Published			2022-12-28	WOS:000225733500048
J	Matsuura, Y; Stewart, M				Matsuura, Y; Stewart, M			Structural basis for the assembly of a nuclear export complex	NATURE			English	Article							IMPORTIN-ALPHA; CRYSTALLOGRAPHIC ANALYSIS; LOCALIZATION SIGNAL; DOMAIN; BETA; RAN; TRANSPORT; RECOGNITION; CSE1P	The nuclear import and export of macromolecular cargoes through nuclear pore complexes is mediated primarily by carriers such as importin-beta. Importins carry cargoes into the nucleus, whereas exportins carry cargoes to the cytoplasm. Transport is orchestrated by nuclear RanGTP, which dissociates cargoes from importins, but conversely is required for cargo binding to exportins. Here we present the 2.0 Angstrom crystal structure of the nuclear export complex formed by exportin Cse1p complexed with its cargo ( Kap60p) and RanGTP, thereby providing a structural framework for understanding nuclear protein export and the different functions of RanGTP in export and import. In the complex, Cse1p coils around both RanGTP and Kap60p, stabilizing the RanGTP-state and clamping the Kap60p importin-beta-binding domain, ensuring that only cargo-free Kap60p is exported. Mutagenesis indicated that conformational changes in exportins couple cargo binding to high affinity for RanGTP, generating a spring-loaded molecule to facilitate disassembly of the export complex following GTP hydrolysis in the cytoplasm.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ms@mrc-lmb.cam.ac.uk						Askjaer P, 1999, MOL CELL BIOL, V19, P6276; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Behrens P, 2003, APOPTOSIS, V8, P39, DOI 10.1023/A:1021644918117; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Harreman MT, 2003, J BIOL CHEM, V278, P21361, DOI 10.1074/jbc.M301114200; Herold A, 1998, J CELL BIOL, V143, P309, DOI 10.1083/jcb.143.2.309; Hood JK, 1998, J BIOL CHEM, V273, P35142, DOI 10.1074/jbc.273.52.35142; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nilsson J, 2002, J MOL BIOL, V318, P583, DOI 10.1016/S0022-2836(02)00040-2; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Solsbacher J, 1998, MOL CELL BIOL, V18, P6805, DOI 10.1128/MCB.18.11.6805; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691, DOI 10.1128/MCB.13.8.4691	29	152	160	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					872	877		10.1038/nature03144	http://dx.doi.org/10.1038/nature03144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602554				2022-12-28	WOS:000225733500045
J	Gadagkar, R				Gadagkar, R			Sex ... only if really necessary in a feminine monarchy	SCIENCE			English	Editorial Material							HONEYBEE		Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Gadagkar, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	ragh@ces.iisc.ernet.in	Gadagkar, Raghavendra/E-3944-2012	Gadagkar, Raghavendra/0000-0002-0328-9378				[Anonymous], 1971, INSECT SOC; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Gadagkar R, 1997, CURR SCI INDIA, V72, P950; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; MAYNARD SMITH J., 1978, EVOLUTION SEX; PAGE RE, 1989, NATURE, V338, P576, DOI 10.1038/338576a0; Pearcy M, 2004, SCIENCE, V306, P1780, DOI 10.1126/science.1105453	8	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1694	1695		10.1126/science.1106673	http://dx.doi.org/10.1126/science.1106673			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576600	Green Accepted			2022-12-28	WOS:000225630800032
J	Imperiale, TF; Ransohoff, DF; Itzkowitz, SH; Turnbull, BA; Ross, ME				Imperiale, TF; Ransohoff, DF; Itzkowitz, SH; Turnbull, BA; Ross, ME		Colorectal Canc Study Grp	Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STOOL; NEOPLASIA; INSTABILITY; COLONOSCOPY; GUIDELINES; MUTATIONS; ADULTS; TESTS	BACKGROUND Although fecal occult-blood testing is the only available noninvasive screening method that reduces the risk of death from colorectal cancer, it has limited sensitivity. We compared an approach that identifies abnormal DNA in stool samples with the Hemoccult II fecal occult-blood test in average-risk, asymptomatic persons 50 years of age or older. METHODS Eligible subjects submitted one stool specimen for DNA analysis, underwent standard Hemoccult II testing, and then underwent colonoscopy. Of 5486 subjects enrolled, 4404 completed all aspects of the study. A subgroup of 2507 subjects was analyzed, including all those with a diagnosis of invasive adenocarcinoma or advanced adenoma plus randomly chosen subjects with no polyps or minor polyps. The fecal DNA panel consisted of 21 mutations. RESULTS The fecal DNA panel detected 16 of 31 invasive cancers, whereas Hemoccult II identified 4 of 31 (51.6 percent vs. 12.9 percent, P= 0.003). The DNA panel detected 29 of 71 invasive cancers plus adenomas with high-grade dysplasia, whereas Hemoccult II identified 10 of 71 (40.8 percent vs. 14.1 percent, P< 0.001). Among 418 subjects with advanced neoplasia ( defined as a tubular adenoma at least 1 cm in diameter, a polyp with a villous histologic appearance, a polyp with high-grade dysplasia, or cancer), the DNA panel was positive in 76 (18.2 percent), whereas Hemoccult II was positive in 45 (10.8 percent). Specificity in subjects with negative findings on colonoscopy was 94.4 percent for the fecal DNA panel and 95.2 percent for Hemoccult II. CONCLUSIONS Although the majority of neoplastic lesions identified by colonoscopy were not detected by either noninvasive test, the multitarget analysis of fecal DNA detected a greater proportion of important colorectal neoplasia than did Hemoccult II without compromising specificity.	Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA; Indiana Univ, Dept Med, Indianapolis, IN USA; Univ N Carolina, Dept Med, Chapel Hill, NC USA; Mt Sinai Sch Med, Dept Med, New York, NY USA; CareStat, Newton, MA USA; Exact Sci, Marlborough, MA USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University-Purdue University Indianapolis; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai	Imperiale, TF (corresponding author), Regenstrief Inst Hlth Care, 1050 Wishard Blvd, Indianapolis, IN 46202 USA.			Imperiale, Thomas/0000-0001-7586-1073				Ahlquist DA, 2000, HUM PATHOL, V31, P51, DOI 10.1016/S0046-8177(00)80198-7; Ahlquist DA, 2000, GASTROENTEROLOGY, V119, P1219, DOI 10.1053/gast.2000.19580; AHLQUIST DA, 1993, JAMA-J AM MED ASSOC, V269, P1262, DOI 10.1001/jama.269.10.1262; Ahlquist DA, 2002, CLIN CHIM ACTA, V315, P157, DOI 10.1016/S0009-8981(01)00712-4; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Calistri D, 2003, CLIN GASTROENTEROL H, V1, P377, DOI 10.1053/S1542-3565(03)00186-1; Charbonnel B, 2003, METABOLISM, V52, P1, DOI 10.1016/S0026-0495(03)00217-8; Dong SM, 2001, J NATL CANCER I, V93, P858, DOI 10.1093/jnci/93.11.858; Imperiale TF, 2003, ANN INTERN MED, V139, P959, DOI 10.7326/0003-4819-139-12-200312160-00005; Koornstra JJ, 2003, CRIT REV ONCOL HEMAT, V45, P37, DOI 10.1016/S1040-8428(01)00228-1; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MANDEL JS, 1993, NEW ENGL J MED, V329, P672; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; Pinsky PF, 2003, CLIN GASTROENTEROL H, V1, P103, DOI 10.1053/cgh.2003.50017; Ransohoff DF, 2004, JAMA-J AM MED ASSOC, V291, P1772, DOI 10.1001/jama.291.14.1772; Ransohoff DF, 1997, ANN INTERN MED, V126, P811, DOI 10.7326/0003-4819-126-10-199705150-00014; Ransohoff DF, 1997, ANN INTERN MED, V126, P808, DOI 10.7326/0003-4819-126-10-199705150-00014; Ransohoff DF, 2002, NEW ENGL J MED, V346, P40, DOI 10.1056/NEJMcp010886; Schoen RE, 2003, JAMA-J AM MED ASSOC, V290, P41, DOI 10.1001/jama.290.1.41; SIDRANSKY D, 1992, SCIENCE, V256, P102, DOI 10.1126/science.1566048; Smith RA, 2003, CA-CANCER J CLIN, V53, P27, DOI 10.3322/canjclin.53.1.27; Syngal S, 2003, GASTROENTEROLOGY, V124, pA5, DOI 10.1016/S0016-5085(03)80025-2; Tagore Kuldeep S, 2003, Clin Colorectal Cancer, V3, P47, DOI 10.3816/CCC.2003.n.011; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; Traverso G, 2002, LANCET, V359, P403, DOI 10.1016/S0140-6736(02)07591-8; Whitney D, 2004, J MOL DIAGN, V6, P386, DOI 10.1016/S1525-1578(10)60536-3; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044	37	573	624	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2704	2714		10.1056/NEJMoa033403	http://dx.doi.org/10.1056/NEJMoa033403			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616205	Bronze, Green Published			2022-12-28	WOS:000225877300006
J	Liao, SP; Seeman, NC				Liao, SP; Seeman, NC			Translation of DNA signals into polymer assembly instructions	SCIENCE			English	Article							DEVICE	We developed a DNA nanomechanical device that enables the positional synthesis of products whose sequences are determined by the state of the device. This machine emulates the translational capabilities of the ribosome. The device has been prototyped to make specific DNA sequences. The state of the device is established by the addition of DNA set strands. There is no transcriptional relationship between the set strands and the product strands. The device has potential applications that include designer polymer synthesis, encryption of information, and use as a variable-input device for DNA-based computation.	NYU, Dept Chem, New York, NY 10003 USA	New York University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	ned.seeman@nyu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029554] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM029554] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Feng LP, 2003, ANGEW CHEM INT EDIT, V42, P4342, DOI 10.1002/anie.200351818; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Jonoska N, 2004, LECT NOTES COMPUT SC, V2950, P219; LANDWEBER LF, 1997, P 3 DIMACS M DNA BAS, P161; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Shen ZY, 2004, J AM CHEM SOC, V126, P1666, DOI 10.1021/ja038381e; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Simmel FC, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041913; Simmel FC, 2002, APPL PHYS LETT, V80, P883, DOI 10.1063/1.1447008; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; YAN H, 2003, J SUPRAMOL CHEM, V1, P229; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhu L, 2003, J AM CHEM SOC, V125, P10178, DOI 10.1021/ja035186r	13	143	148	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2072	2074		10.1126/science.1104299	http://dx.doi.org/10.1126/science.1104299			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604403	Green Accepted			2022-12-28	WOS:000225841000056
J	Mills, CE; Robins, JM; Lipsitch, M				Mills, CE; Robins, JM; Lipsitch, M			Transmissibility of 1918 pandemic influenza	NATURE			English	Article							EPIDEMIC INFLUENZA; MORTALITY; DYNAMICS	The 1918 influenza pandemic killed 20 - 40 million people worldwide(1), and is seen as a worst-case scenario for pandemic planning. Like other pandemic influenza strains, the 1918 A/H1N1 strain spread extremely rapidly. A measure of transmissibility and of the stringency of control measures required to stop an epidemic is the reproductive number, which is the number of secondary cases produced by each primary case(2). Here we obtained an estimate of the reproductive number for 1918 influenza by fitting a deterministic SEIR (susceptible-exposed-infectious-recovered) model to pneumonia and influenza death epidemic curves from 45 US cities: the median value is less than three. The estimated proportion of the population with A/H1N1 immunity before September 1918 implies a median basic reproductive number of less than four. These results strongly suggest that the reproductive number for 1918 pandemic influenza is not large relative to many other infectious diseases(2). In theory, a similar novel influenza subtype could be controlled. But because influenza is frequently transmitted before a specific diagnosis is possible and there is a dearth of global antiviral and vaccine stores, aggressive transmission reducing measures will probably be required.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Mills, CE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	cmills@mit.edu		Lipsitch, Marc/0000-0003-1504-9213; /0000-0002-5063-8470				ANDERSON R M, 1991; *BUR CENS, 1998, POP 100 LARG URB PLA; *BUR CENS, 1923, MORB RAT 1910 1920 P; Collins SD, 1930, PUBLIC HEALTH REP, V45, P2277, DOI 10.2307/4579795; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Frost W.H., 1920, PUB HLTH REP, V35, P584, DOI DOI 10.2307/4575511; Frost WH, 1919, J AMER MED ASSOC, V73, P313, DOI 10.1001/jama.1919.02610310007003; Gog JR, 2003, P NATL ACAD SCI USA, V100, P11143, DOI 10.1073/pnas.1830296100; Hill AN, 2003, MATH BIOSCI, V181, P85, DOI 10.1016/S0025-5564(02)00129-3; Jordan EO., 1927, EPIDEMIC INFLUENZA S; KLOTZ O, 1919, STUDIES EPIDEMIC INF, P207; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; MACCALLUM WG, 1921, JOHNS HOPKINS HOSP R; Nicholson KG, 1998, TXB INFLUENZA, P219; OLSON DR, 2004, 4 INT C EM INF DIS; PATTERSON KD, 1991, B HIST MED, V65, P4; Pearl R., 1921, PUBLIC HLTH REPORTS, V36, P273, DOI [10.2307/4575894, DOI 10.2307/4575894]; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; SPICER CC, 1984, J HYG-CAMBRIDGE, V93, P105, DOI 10.1017/S0022172400060988; Stanley LL, 1919, PUBLIC HLTH REP, V34, P996, DOI [DOI 10.2307/4575142, 10.2307/4575142]; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wolbach SB, 1919, B JOHNS HOPKINS HOSP, V30, P104	27	536	555	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					904	906		10.1038/nature03063	http://dx.doi.org/10.1038/nature03063			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602562	Green Published			2022-12-28	WOS:000225733500053
J	Desai, AS; Fang, JC; Maisel, WH; Baughman, KL				Desai, AS; Fang, JC; Maisel, WH; Baughman, KL			Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy - A meta-analysis of randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							IDIOPATHIC DILATED CARDIOMYOPATHY; NONSUSTAINED VENTRICULAR-TACHYCARDIA; ANTIARRHYTHMIC-DRUG THERAPY; CARDIOVERTER-DEFIBRILLATOR; UNEXPLAINED SYNCOPE; EJECTION FRACTION; IMPROVED SURVIVAL; HEART-FAILURE; SUDDEN-DEATH; HIGH-RISK	Context Implantable cardioverter defibrillator (ICD) therapy is effective in primary and secondary prevention of sudden cardiac death among patients with prior myocardial infarction and depressed ejection fraction. However, conclusive evidence of survival benefit in patients with nonischemic cardiomyopathy (NICM) is still lacking. Objective To determine whether ICD therapy reduces all-cause mortality in patients with NICM. Data Sources MEDLINE (1966-2004), EMBASE (1991-2004), the Cochrane Central Register of Controlled Trials (through first quarter, 2004), reports presented at scientific meetings (2003-2004), and bibliographic review of secondary sources. Search terms included defibrillator, randomized controlled trials, clinical trials, and sudden death. Study Selection Eligible studies were prospective randomized controlled trials of ICD or combined cardiac resynchronization therapy and defibrillator (CRT-D) vs medical therapy enrolling at least some individuals with NICM and reporting all-cause mortality as an outcome. Of 675 potentially relevant articles screened initially, 8 reports of randomized trials enrolling a total of 2146 patients with NICM were included. Data Extraction Included studies were reviewed to determine the number of patients randomized, mean duration of follow-up, primary end point, mortality of ICD cohort, and mortality of control cohort. Data Synthesis Five primary prevention trials enrolling 1854 patients with NICM were identified; pooled analysis suggested a significant reduction in total mortality among patients randomized to ICD or CRT-D vs medical therapy (risk ratio [RR], 0.69; 95% confidence interval [CI], 0.55-0.87; P=.002). Mortality reduction remained significant even after elimination of CRT-D trials. Two of the 3 secondary prevention trials presented subgroup estimates for ICD efficacy in NICM. Pooled analysis of these secondary prevention trials (n=256 patients with NICM) indicated an equivalent but non-significant mortality reduction with ICD therapy (RR, 0.69; 95% Cl, 0.39-1.24; P=.22). Analysis of all 7 trials combined demonstrated a statistically significant 31% overall reduction in mortality with ICD therapy (RR, 0.69; 95% Cl, 0.56-0.86; P=.002). Conclusion ICD therapy appears to significantly reduce mortality in selected patients with NICM.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Cardiovasc Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Desai, AS (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	adesai@partners.org	Desai, Akshay/ABE-7250-2020					Bansch D, 2002, CIRCULATION, V105, P1453, DOI 10.1161/01.CIR.0000012350.99718.AD; BARDY GH, 2004, AM COLL CARD SCI SES; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; Fonarow GC, 2000, AM J CARDIOL, V85, P981, DOI 10.1016/S0002-9149(99)00914-5; Grimm W, 2003, CIRCULATION, V108, P2883, DOI 10.1161/01.CIR.0000100721.52503.85; Grimm W, 1998, J AM COLL CARDIOL, V32, P739, DOI 10.1016/S0735-1097(98)00306-4; Grimm W, 2002, J AM COLL CARDIOL, V39, P780, DOI 10.1016/S0735-1097(01)01822-8; HAYNES RB, 1994, J AM MED INFORM ASSN, V1, P447, DOI 10.1136/jamia.1994.95153434; Hsia HH, 2003, CIRCULATION, V108, P704, DOI 10.1161/01.CIR.0000083725.72693.EA; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Knight BP, 1999, J AM COLL CARDIOL, V33, P1964, DOI 10.1016/S0735-1097(99)00148-5; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; Levine JH, 1996, AM HEART J, V131, P59, DOI 10.1016/S0002-8703(96)90051-4; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Rankovic V, 2002, AM J CARDIOL, V89, P1072, DOI 10.1016/S0002-9149(02)02278-6; Russo AM, 2001, AM J CARDIOL, V88, P1444, DOI 10.1016/S0002-9149(01)02133-6; Steinberg JS, 2001, J CARDIOVASC ELECTR, V12, P996, DOI 10.1046/j.1540-8167.2001.00996.x; Strickberger SA, 2003, J AM COLL CARDIOL, V41, P1707, DOI 10.1016/S0735-1097(03)00297-3; TAMBURRO P, 1992, AM HEART J, V124, P1035, DOI 10.1016/0002-8703(92)90989-9	26	304	314	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2004	292	23					2874	2879		10.1001/jama.292.23.2874	http://dx.doi.org/10.1001/jama.292.23.2874			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879CR	15598919				2022-12-28	WOS:000225694500025
J	Langa, KM; Foster, NL; Larson, EB				Langa, KM; Foster, NL; Larson, EB			Mixed dementia - Emerging. concepts and therapeutic implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLACEBO-CONTROLLED TRIAL; VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; DOUBLE-BLIND; COGNITIVE FUNCTION; OCCAMS RAZOR; MEMANTINE; DIAGNOSIS; DONEPEZIL; EFFICACY	Context The prevalence of mixed dementia, defined as the coexistence of Alzheimer disease (AD) and vascular dementia (VaD), is likely to increase as the population ages. Objectives To provide an overview of the diagnosis, pathophysiology, and interaction of AD and VaD in mixed dementia, and to provide a systematic literature review of the current evidence for the pharmacologic therapy of mixed dementia. Data Sources, Study Selection, and Data Extraction The Cochrane Database of Systematic Reviews was searched using the keyword dementia. MEDLINE was searched for English-language articles published within the last 10 years using the keywords mixed dementia, the combination of keywords Alzheimer disease, cerebrovascular disorders, and drug therapy, and the combination of keywords vascular dementia and drug therapy. Evidence Synthesis Dementia is more likely to be present when vascular and AD lesions coexist, a situation that is especially common with increasing age. The measured benefits in clinical trials for the treatment of mixed dementia are best described as statistically significant differences in cognitive test scores and clinician and care-giver impressions of change. in these studies, the control groups' scores typically decline while the treatment groups improve slightly or decline to a lesser degree over the study period. Nevertheless, even the patients who experience treatment benefits eventually decline. Cholinesterase inhibitor (Chl) therapy for mixed dementia shows modest clinical benefits that are similar to those found for Chl treatment of AD. The N-methyl-D-aspartate (NMDA) antagonist memantine also shows modest clinical benefits for the treatment of moderate to severe AD and mild to moderate VaD, but it has not been studied specifically in mixed dementia. The treatment of cardiovascular risk factors, especially hypertension, may be a more effective way to protect brain function as primary, secondary, and tertiary prevention for mixed dementia. Conclusions Currently available medications provide only modest clinical benefits once a patient has developed mixed dementia. Cardiovascular risk factor control, especially for hypertension and hyperlipidemia, as well as other interventions to prevent recurrent stroke, likely represent important strategies for preventing or slowing the progression of mixed dementia. Additional research is needed to define better what individuals and families hope to achieve from dementia treatment and to determine the most appropriate use of medication to achieve these goals.	Univ Michigan, Sch Med, Dept Med, Div Gen Med, Ann Arbor, MI 48104 USA; Univ Michigan, Dept Vet Affairs, Ctr Practice Management & Outcomes Res, Ann Arbor, MI 48109 USA; Univ Michigan, SGIM Collaborat Ctr Res & Educ Care Older Adults, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Neurol, Ann Arbor, MI USA; Inst Social Res & Patient Safety Enhancement Prog, Ann Arbor, MI USA; Univ Washington, Div Gen Internal Med, Grp Hlth Cooperat Ctr Hlth Studies, Seattle, WA 98195 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Group Health Cooperative; University of Washington; University of Washington Seattle	Langa, KM (corresponding author), Univ Michigan Hlth Syst, Div Gen Med, 300 N Ingalls Bldg,Room 7E01,Box 0429, Ann Arbor, MI 48109 USA.	klanga@umich.edu		Langa, Kenneth/0000-0002-2798-1836	NATIONAL INSTITUTE ON AGING [U01AG006781, K08AG019180, P50AG008671] Funding Source: NIH RePORTER; NIA NIH HHS [U01 AG06781, K08 AG19180, P50 AG08671] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexander GC, 2003, JAMA-J AM MED ASSOC, V290, P953, DOI 10.1001/jama.290.7.953; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Bentham P, 2004, LANCET, V363, P2105; BIRKS J, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003120; Bugiani O, 2004, NEUROL SCI, V25, pS1, DOI 10.1007/s10072-004-0204-9; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Clark CM, 2003, ANN INTERN MED, V138, P400, DOI 10.7326/0003-4819-138-5-200303040-00010; Collins R, 2004, LANCET, V363, P757; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cummings JL, 2003, AM J GERIAT PSYCHIAT, V11, P131, DOI 10.1176/appi.ajgp.11.2.131; De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196; Doody RS, 2001, NEUROLOGY, V56, P1154, DOI 10.1212/WNL.56.9.1154; Drachman DA, 2000, ANN INTERN MED, V132, P403, DOI 10.7326/0003-4819-132-5-200003070-00010; Erkinjuntti T, 2002, LANCET, V359, P1283, DOI 10.1016/S0140-6736(02)08267-3; Esiri MM, 2001, LANCET, V357, P169; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; GEARING M, 1995, NEUROLOGY, V45, P461, DOI 10.1212/WNL.45.3.461; Glynn RJ, 1999, JAMA-J AM MED ASSOC, V281, P438, DOI 10.1001/jama.281.5.438; GRADY D, 2004, NY TIMES        0407, pA1; Grossberg GT, 2003, J GERONTOL A-BIOL, V58, P331; Haan MN, 2004, ANNU REV PUBL HEALTH, V25, P1, DOI 10.1146/annurev.publhealth.25.101802.122951; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; HACHINSKI V, 1992, LANCET, V340, P645; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hilliard AA, 2004, NEW ENGL J MED, V350, P599, DOI 10.1056/NEJMcps031794; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Karlawish JHT, 2003, J AM GERIATR SOC, V51, P1391, DOI 10.1046/j.1532-5415.2003.51456.x; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Konowski S, 2003, PHARMACOPSYCHIATRY, V36, P297, DOI 10.1055/s-2003-45117; Kumar V, 2000, EUR J NEUROL, V7, P159, DOI 10.1046/j.1468-1331.2000.00046.x; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; LeBars PL, 1997, JAMA-J AM MED ASSOC, V278, P1327, DOI 10.1001/jama.278.16.1327; Li G, 2004, NEUROLOGY, V63, P1624, DOI 10.1212/01.WNL.0000142963.90204.58; Lim A, 1999, J AM GERIATR SOC, V47, P564, DOI 10.1111/j.1532-5415.1999.tb02571.x; Malouf R, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004395.pub2, DOI 10.1002/14651858.CD004395.PUB2]; Massoud F, 1999, ARCH NEUROL-CHICAGO, V56, P1368, DOI 10.1001/archneur.56.11.1368; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; Murray MD, 2002, ARCH INTERN MED, V162, P2090, DOI 10.1001/archinte.162.18.2090; Nilsson SE, 2003, EUR J CLIN PHARMACOL, V59, P313, DOI 10.1007/s00228-003-0618-y; Orgogozo JM, 2002, STROKE, V33, P1834, DOI 10.1161/01.STR.0000020094.08790.49; Phelan EA, 2004, J AM GERIATR SOC, V52, P211, DOI 10.1111/j.1532-5415.2004.52056.x; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Riekse RG, 2004, J AM GERIATR SOC, V52, P1442, DOI 10.1111/j.1532-5415.2004.52405.x; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Roman GC, 2003, J AM GERIATR SOC, V51, pS296, DOI 10.1046/j.1532-5415.5155.x; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Sachs GA, 1998, J AM GERIATR SOC, V46, P782, DOI 10.1111/j.1532-5415.1998.tb03818.x; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Schneider LS, 2004, LANCET, V363, P2100, DOI 10.1016/S0140-6736(04)16533-1; Scott H.D., 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003160, 10.1002/14651858.CD003160]; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SKOOG I, 1993, NEW ENGL J MED, V328, P153, DOI 10.1056/NEJM199301213280301; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Tabet N, 2000, COCHRANE DB SYST REV; Tangarorang G, 2003, GERIATRIC MED, P149; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; van Dongen M, 2003, J CLIN EPIDEMIOL, V56, P367, DOI 10.1016/S0895-4356(03)00003-9; WHO, 1993, ICD 10 CLASS MENT BE; Wilkinson D, 2003, NEUROLOGY, V61, P479, DOI 10.1212/01.WNL.0000078943.50032.FC; Williams PS, 2000, COCHRANE DB SYST REV, pCD001296, DOI 10.1002/14651858.CD001296; Winblad B, 1999, INT J GERIATR PSYCH, V14, P135, DOI 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0; WOLFE N, 1994, ARCH NEUROL-CHICAGO, V51, P211, DOI 10.1001/archneur.1994.00540140129022; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Yaffe K, 2002, ARCH NEUROL-CHICAGO, V59, P378, DOI 10.1001/archneur.59.3.378; Zekry D, 2002, J AM GERIATR SOC, V50, P1431, DOI 10.1046/j.1532-5415.2002.50367.x	69	221	235	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2004	292	23					2901	2908		10.1001/jama.292.23.2901	http://dx.doi.org/10.1001/jama.292.23.2901			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879CR	15598922				2022-12-28	WOS:000225694500028
J	Steliarova-Foucher, E; Stiller, C; Kaatsch, P; Berrino, F; Coebergh, JW; Lacour, B; Parkin, M				Steliarova-Foucher, E; Stiller, C; Kaatsch, P; Berrino, F; Coebergh, JW; Lacour, B; Parkin, M			Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study	LANCET			English	Article							NON-HODGKINS-LYMPHOMA; INCREASING INCIDENCE; CHILDHOOD-CANCER; LEUKEMIA; BRITAIN; DISEASE	Background Cancer is rare before age 20 years. We aimed to use the European database of childhood and adolescent cancer cases, within the Automated Childhood Cancer Information System project, to estimate patterns and trends of incidence and survival within Europe. Methods Comparable, high-quality data from 63 European population-based cancer registries consisted of 113000 tumours in children and 18 243 in adolescents diagnosed in 1970-99. Incidence rates and survival were compared by region (east vs west), period, and malignant disease. Findings In the 1990s, age-standardised incidence rates were 140 per million for children (0-14 years) and 157 per million for ages 0-19 years. Over the three decades, overall incidence increased by 1.0% per year (p<0.0001) in children (increases for most tumour types), and by 1.5% (p<0.0001) in adolescents (15-19 years; notable increases were recorded for carcinomas, lymphomas, and germ-cell tumours). Overall 5-year survival for children in the 1990s was 64% in the east and 75% in the west, with differences between regions for virtually all tumour groups; 5-year survival was much the same in adolescents. Survival has improved dramatically since the 1970s in children and adolescents, more so in the west than in the east. Interpretation our results are clear evidence of an increase of cancer incidence in childhood and adolescence during the past decades, and of an acceleration of this trend. Geographical and temporal patterns suggest areas for further study into causes of these neoplasms, as well as providing an indicator of progress of public-health policy in Europe.	Int Agcy Res Canc, F-69372 Lyon, France; Univ Oxford, Childhood Canc Res Grp, Oxford, England; Johannes Gutenberg Univ Mainz, German Childhood Canc Registry, D-6500 Mainz, Germany; Natl Canc Inst, I-20133 Milan, Italy; Dutch Childhood Oncol Grp, The Hague, Netherlands; Erasmus Univ, Dept Publ Hlth, Rotterdam, Netherlands; Fac Med, French Natl Registry Childhood Solid Tumours, Vandoeuvre Les Nancy, France	World Health Organization; International Agency for Research on Cancer (IARC); University of Oxford; Johannes Gutenberg University of Mainz; Fondazione IRCCS Istituto Nazionale Tumori Milan; Dutch Childhood Oncology Group; Erasmus University Rotterdam; Universite de Lorraine	Steliarova-Foucher, E (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	steliarova@iarc.fr	Steliarova-Foucher, Eva/L-6508-2019; Berrino, Franco/AAC-2364-2020	Steliarova-Foucher, Eva/0000-0001-5777-9199; Berrino, Franco/0000-0002-4858-1866; Stiller, Charles/0000-0002-3006-7869; Coebergh, Jan Willem/0000-0002-2419-3930				ALEXANDER FE, 1995, EUR J CANCER, V31A, P863, DOI 10.1016/0959-8049(95)00023-2; [Anonymous], 2003, EUR J CANCER, V39, P2247, DOI 10.1016/j.ejca.2003.09.015; BERKSON J, 1950, P STAFF M MAYO CLIN, V25, P270; CARTWRIGHT R, 1994, LEUKEMIA LYMPHOMA, V14, P387, DOI 10.3109/10428199409049694; Coebergh JWW, 2001, EUR J CANCER, V37, P671, DOI 10.1016/S0959-8049(01)00005-3; CORREA P, 1971, INT J CANCER, V8, P192, DOI 10.1002/ijc.2910080203; COURTBROWN W, 1961, BMJ-BRIT MED J, V1, P981; Doll R., 1966, CANC INCIDENCE 5 CON, VI; Ferlay J, 2001, IARC CANCERBASE; FERLAY J, IARCTOOLS; Ferraris AM, 1997, ANN HEMATOL, V74, P131, DOI 10.1007/s002770050270; Gatta G, 2003, ANN ONCOL, V14, pV119, DOI 10.1093/annonc/mdg755; Glaser SL, 1997, INT J CANCER, V70, P375, DOI 10.1002/(SICI)1097-0215(19970207)70:4&lt;375::AID-IJC1&gt;3.0.CO;2-T; Greaves MF, 1997, LANCET, V349, P344, DOI 10.1016/S0140-6736(96)09412-3; Honjo S, 2003, INT J CANCER, V103, P538, DOI 10.1002/ijc.10859; Hrusak O, 2002, LEUKEMIA, V16, P720, DOI 10.1038/sj/leu/2402422; JENSEN OM, 1991, IARC SCI PUBL, V95, P159; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; KINLEN LJ, 1995, BRIT J CANCER, V71, P1, DOI 10.1038/bjc.1995.1; Kirkwood B., 1988, BR K ESSENTIALS MED; Kramarova E, 1996, INT J CANCER, V68, P759; KRAMAROVA E, 1996, 29 IARC; Magnani C, 2003, INT J CANCER, V105, P552, DOI 10.1002/ijc.11112; McNally RJQ, 2001, CANCER-AM CANCER SOC, V92, P1967, DOI 10.1002/1097-0142(20011001)92:7<1967::AID-CNCR1716>3.0.CO;2-#; Parkin D. M, 1988, IARC SCI PUBLICATION, V87; PARKIN DM, 2003, IARC TECHNICAL PUBLI, V40, P69; Parkin DM, 1994, 19 IARC; Parkin DM, 1998, IARC SCI PUBLICATION, V144; Percy C, 1992, INT CLASSIFICATION D; Shibata Y, 2001, LANCET, V358, P1965, DOI 10.1016/S0140-6736(01)06971-9; SMITH MA, 1999, NIH PUB; Stiller C A, 1990, Paediatr Perinat Epidemiol, V4, P303, DOI 10.1111/j.1365-3016.1990.tb00654.x; STILLER CA, 1991, BRIT J CANCER, V64, P543, DOI 10.1038/bjc.1991.347; Weidmann C, 1999, EUR J CANCER, V35, P1235, DOI 10.1016/S0959-8049(99)00108-2	34	397	410	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2004	364	9451					2097	2105		10.1016/S0140-6736(04)17550-8	http://dx.doi.org/10.1016/S0140-6736(04)17550-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589307				2022-12-28	WOS:000225742300022
J	Sawai, Y; Satake, K; Kamataki, T; Nasu, H; Shishikura, M; Atwater, BF; Horton, BP; Kelsey, HM; Nagumo, T; Yamaguchi, M				Sawai, Y; Satake, K; Kamataki, T; Nasu, H; Shishikura, M; Atwater, BF; Horton, BP; Kelsey, HM; Nagumo, T; Yamaguchi, M			Transient uplift after a 17th-century earthquake along the Kuril subduction zone	SCIENCE			English	Article							TOKACHI-OKI EARTHQUAKE; STRAIN ACCUMULATION; EASTERN HOKKAIDO; JAPAN; DEFORMATION; COAST	In eastern Hokkaido, 60 to 80 kilometers above a subducting oceanic plate, tidal mudflats changed into freshwater forests during the first decades after a 17th-century tsunami. The mudflats gradually rose by a meter, as judged from fossil diatom assemblages. Both the tsunami and the ensuing uplift exceeded any in the region's 200 years of written history, and both resulted from a shallow plate-boundary earthquake of unusually large size along the Kuril subduction zone. This earthquake probably induced more creep farther down the plate boundary than did any of the region's historical events.	Geol Survey Japan, Natl Inst Adv Ind Sci & Technol, Act Fault Res Ctr, Tsukuba, Ibaraki 3058567, Japan; Int Res Ctr Japan Studies, Nishikyo Ku, Kyoto 6101192, Japan; Univ Washington, US Geol Survey, Seattle, WA 98195 USA; Univ Penn, Dept Earth & Environm Sci, Sea Level Res Lab, Philadelphia, PA 19104 USA; Humboldt State Univ, Dept Geol, Arcata, CA 95521 USA; Nippon Dent Univ Tokyo, Dept Biol, Chiyoda Ku, Tokyo 1028159, Japan; Univ Tokyo, Grad Sch Frontier Sci, Bunkyo Ku, Tokyo 1130033, Japan	National Institute of Advanced Industrial Science & Technology (AIST); United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; University of Pennsylvania; California State University System; California State Polytechnic University, Humboldt; Nippon Dental University; University of Tokyo	Sawai, Y (corresponding author), Geol Survey Japan, Natl Inst Adv Ind Sci & Technol, Act Fault Res Ctr, Site C7 1-1-1 Higashi, Tsukuba, Ibaraki 3058567, Japan.	yuki.sawai@aist.go.jp	Satake, Kenji/GMX-4217-2022; Shishkura, Masanobu/N-2831-2018; Satake, Kenji/E-2312-2011; Sawai, Yuki/D-3216-2013	Satake, Kenji/0000-0002-3368-3085; Satake, Kenji/0000-0002-3368-3085; Sawai, Yuki/0000-0001-7015-4361; Horton, Benjamin/0000-0001-9245-3768; Atwater, Brian/0000-0003-1155-2815				Atwater BF, 2004, HOLOCENE, V14, P487, DOI 10.1191/0959683604hl726rp; BARRIENTOS SE, 1992, GEOPHYS RES LETT, V19, P701, DOI 10.1029/92GL00210; Cohen SC, 1997, J GEOPHYS RES-SOL EA, V102, P20479, DOI 10.1029/97JB01513; DEMETS C, 1992, J GEOPHYS RES-SOL EA, V97, P17615, DOI 10.1029/92JB01306; Furukawa R., 1997, B VOLCANOLOGICAL SOC, V42, P269; Guilbault JP, 1996, QUATERNARY SCI REV, V15, P913, DOI 10.1016/S0277-3791(96)00058-3; Heki K, 2004, EARTH PLANET SC LETT, V219, P13, DOI 10.1016/S0012-821X(03)00693-9; Heki K, 1997, NATURE, V386, P595, DOI 10.1038/386595a0; Hirata K, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001976; HU Y, IN PRESS J GEOPHYS R; KASAHARA K, 1975, PURE APPL GEOPHYS, V113, P127, DOI 10.1007/BF01592905; KASAHARA K, 1981, PURE APPL GEOPHYS, V119, P392, DOI 10.1007/BF00877774; Mazzotti S, 2000, J GEOPHYS RES-SOL EA, V105, P13159, DOI 10.1029/2000JB900060; Melbourne TI, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000555; Nakanishi A, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002574; Nanayama F, 2003, NATURE, V424, P660, DOI 10.1038/nature01864; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Okumura K, 1996, GEOGRAPHICAL REPORTS, V31, P19; Ozawa S, 2004, EARTH PLANETS SPACE, V56, P675, DOI 10.1186/BF03352530; Ozawa S., 1997, B GEOGRAPHICAL SURVE, V43, P1; SAVAGE JC, 1983, J GEOPHYS RES, V88, P4984, DOI 10.1029/JB088iB06p04984; Sawai Y, 2004, QUATERNARY SCI REV, V23, P2467, DOI 10.1016/j.quascirev.2004.05.006; Sawai Y, 2002, J QUATERNARY SCI, V17, P607, DOI 10.1002/jqs.708; Sawai Y, 2001, QUATERNARY RES, V56, P231, DOI 10.1006/qres.2001.2258; Shimazaki K., 1974, Physics of the Earth and Planetary Interiors, V8, P148, DOI 10.1016/0031-9201(74)90127-7; SHIMAZAKI K, 1975, PHYS EARTH PLANET IN, V9, P314, DOI 10.1016/0031-9201(74)90059-4; WANG K, IN PRESS SEISMOGENIC; Yamanaka Y, 2003, EARTH PLANETS SPACE, V55, pE21, DOI 10.1186/BF03352479; Zong Y, 2003, HOLOCENE, V13, P7, DOI 10.1191/0959683603hl590rp	29	96	100	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1918	1920		10.1126/science.1104895	http://dx.doi.org/10.1126/science.1104895			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591198				2022-12-28	WOS:000225695600039
J	Hoft, DF; Belshe, RB				Hoft, DF; Belshe, RB			The genetic archaeology of influenza	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS		St Louis Univ, Dept Internal Med & Mol Microbiol, Div Infect Dis & Immunol, St Louis, MO 63103 USA	Saint Louis University	Hoft, DF (corresponding author), St Louis Univ, Dept Internal Med & Mol Microbiol, Div Infect Dis & Immunol, St Louis, MO 63103 USA.							DAUER CC, 1961, AM REV RESPIR DIS, V83, P15; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793	3	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2004	351	24					2550	2551		10.1056/NEJMcibr043708	http://dx.doi.org/10.1056/NEJMcibr043708			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877TE	15590961				2022-12-28	WOS:000225593100015
J	Klingelhofer, G; Morris, RV; Bernhardt, B; Schroder, C; Rodionov, DS; de Souza, PA; Yen, A; Gellert, R; Evlanov, EN; Zubkov, B; Foh, J; Bonnes, U; Kankeleit, E; Gutlich, P; Ming, DW; Renz, F; Wdowiak, T; Squyres, SW; Arvidson, RE				Klingelhofer, G; Morris, RV; Bernhardt, B; Schroder, C; Rodionov, DS; de Souza, PA; Yen, A; Gellert, R; Evlanov, EN; Zubkov, B; Foh, J; Bonnes, U; Kankeleit, E; Gutlich, P; Ming, DW; Renz, F; Wdowiak, T; Squyres, SW; Arvidson, RE			Jarosite and hematite at Meridiani Planum from Opportunity's Mossbauer spectrometer	SCIENCE			English	Article							1ST SHERGOTTITE; BOUNCE ROCK; X-RAY; MARS; MINERALOGY; SOILS; CRATER; METEORITE; SULFATES; WATER	Mossbauer spectra measured by the Opportunity rover revealed four mineralogical components in Meridiani Planum at Eagle crater: jarosite- and hematite-rich outcrop, hematite-rich soil, olivine-bearing basaltic soil, and a pyroxene-bearing basaltic rock (Bounce rock). Spherutes, interpreted to be concretions, are hematite-rich and dispersed throughout the outcrop. Hematitic soils both within and outside Eagle crater are dominated by spherules and their fragments. Olivine-bearing basaltic soil is present throughout the region. Bounce rock is probably an impact erratic. Because jarosite is a hydroxide sulfate mineral, its presence at Meridiani Planum is mineralogical evidence for aqueous processes on Mars, probably under acid-sulfate conditions.	Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; IKI, Space Res Inst, Moscow 117997, Russia; Copanhia Vale Rio Doce Grp, Vitoria, Spain; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Max Planck Inst Chem, D-55128 Mainz, Germany; Tech Univ Darmstadt, D-64289 Darmstadt, Germany; Univ Alabama Birmingham, Birmingham, AL 35294 USA; Cornell Univ, Ithaca, NY 14853 USA; Washington Univ, St Louis, MO 63130 USA	Johannes Gutenberg University of Mainz; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; Technical University of Darmstadt; University of Alabama System; University of Alabama Birmingham; Cornell University; Washington University (WUSTL)	Klingelhofer, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, Staudinger Weg 9, D-55128 Mainz, Germany.	klingel@mail.uni-mainz.de	de Souza, Paulo/W-2993-2019; Schröder, Christian/B-3870-2009; de Souza, Paulo/P-7294-2019; de Souza, Paulo A/B-8961-2008	de Souza, Paulo/0000-0002-0091-8925; Schröder, Christian/0000-0002-7935-6039; de Souza, Paulo A/0000-0002-0091-8925; Renz, Franz/0000-0003-1494-1242				Bishop J.L., 1996, SPEC PUBL GEOCHEM SO, V5, P337; Bishop JL, 1998, J GEOPHYS RES-PLANET, V103, P31457, DOI 10.1029/1998JE900008; Burns R.G., 1988, LUNAR PLANET SCI, V18, P713; BURNS RG, 1989, ACS SYM SER, V415, P262; BURNS RG, 1993, GEOCHIM COSMOCHIM AC, V57, P4555, DOI 10.1016/0016-7037(93)90182-V; BURNS RG, 1987, J GEOPHYS RES-SOLID, V92, pE570, DOI 10.1029/JB092iB04p0E570; BURNS RG, 1986, NATURE, V320, P55, DOI 10.1038/320055a0; BURNS RG, 1990, J GEOPHYS RES-SOLID, V95, P14415, DOI 10.1029/JB095iB09p14415; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Dang MZ, 1998, HYPERFINE INTERACT, V117, P271, DOI 10.1023/A:1012655729417; de Souza PA, 1999, LAB ROBOTICS AUTOMAT, V11, P3, DOI 10.1002/(SICI)1098-2728(1999)11:1<3::AID-LRA2>3.0.CO;2-F; DEGRAVE E, 1990, PHYS CHEM MINER, V17, P344, DOI 10.1007/BF00200130; DEGRAVE E, 1991, PHYS CHEM MINER, V18, P337, DOI 10.1007/BF00200191; Dyar MD, 2003, METEORIT PLANET SCI, V38, P1733, DOI 10.1111/j.1945-5100.2003.tb00012.x; GOLOMBEK, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2003JE002074; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; HRYNKIEWICZ AZ, 1965, J INORG NUCL CHEM, V27, P2513, DOI 10.1016/0022-1902(65)80150-6; JOHNSTON JH, 1977, GEOCHIM COSMOCHIM AC, V41, P539, DOI 10.1016/0016-7037(77)90291-5; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; MCCAMMON C, 1995, AGU REFERENCE SHELF, V2, P332; MENZIES ON, 2001, LUNAR PLANET SCI, V32; MORRIS RV, 1995, J GEOPHYS RES-PLANET, V100, P5319, DOI 10.1029/94JE01500; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 1989, J GEOPHYS RES-SOLID, V94, P2760, DOI 10.1029/JB094iB03p02760; MORRIS RV, 1996, SPEC PUBL GEOCHEM SO, V5, P327; MURAD E, 1994, CLAY MINER, V29, P1, DOI 10.1180/claymin.1994.029.1.01; Murad E., 1987, MOSSBAUER SPECTRA AP, P507, DOI 10.1007/978-1-4899-0462-1.; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Rodionov D, 2004, METEORIT PLANET SCI, V39, pA91; SETTLE M, 1979, J GEOPHYS RES, V84, P8343, DOI 10.1029/JB084iB14p08343; SHERMAN DM, 1988, AM MINERAL, V73, P1346; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; STEVENS JG, 1998, MOSSBAUER MINERL HDB; VISTISEN L, 1992, PHYS SCRIPTA, V46, P94, DOI 10.1088/0031-8949/46/1/018; Zipfel J, 2004, METEORIT PLANET SCI, V39, pA118	40	606	618	3	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1740	1745		10.1126/science.1104653	http://dx.doi.org/10.1126/science.1104653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576610				2022-12-28	WOS:000225630800042
J	Sekikawa, T; Kosuge, A; Kanai, T; Watanabe, S				Sekikawa, T; Kosuge, A; Kanai, T; Watanabe, S			Nonlinear optics in the extreme ultraviolet	NATURE			English	Article							HARMONIC-GENERATION; ATTOSECOND PULSES; IONIZATION; SINGLE; KHZ; TI	Nonlinear responses to an optical field are universal in nature but have been difficult to observe in the extreme ultraviolet (XUV) and soft X-ray regions owing to a lack of coherent intense light sources. High harmonic generation is a well-known nonlinear optical phenomenon(1,2) and is now drawing much attention in attosecond pulse generation(3-6). For the application of high harmonics to nonlinear optics in the XUV and soft X-ray regime, optical pulses should have both large pulse energy and short pulse duration to achieve a high optical electric field. Here we show the generation of intense isolated pulses from a single harmonic (photon energy 27.9 eV) by using a sub-10-femtosecond blue laser pulse, producing a large dipole moment at the relatively low ( ninth) harmonic order nonadiabatically(7,8). The XUV pulses with pulse durations of 950 attoseconds and 1.3 femtoseconds were characterized by an autocorrelation technique, based on two-photon above-threshold ionization(9) of helium atoms. Because of the small cross-section for above-threshold ionization(10), such an autocorrelation measurement of XUV pulses with photon energy larger than the ionization energy of helium has not hitherto been demonstrated(6,11-13). The technique can be extended to the characterization of higher harmonics at shorter wavelengths.	Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	University of Tokyo	Watanabe, S (corresponding author), Univ Tokyo, Inst Solid State Phys, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778581, Japan.	watanabe@issp.u-tokyo.ac.jp	sekikawa, taro/A-5211-2012	sekikawa, taro/0000-0003-0537-5242				AGOSTINI P, 1979, PHYS REV LETT, V42, P1127, DOI 10.1103/PhysRevLett.42.1127; Ammosov M. V., 1986, Soviet Physics - JETP, V64, P1191; Antoine P, 1997, PHYS REV A, V56, P4960, DOI 10.1103/PhysRevA.56.4960; Barty CPJ, 1996, OPT LETT, V21, P219, DOI 10.1364/OL.21.000219; BECKER W, 1994, PHYS REV A, V50, P1540, DOI 10.1103/PhysRevA.50.1540; Christov IP, 1997, PHYS REV LETT, V78, P1251, DOI 10.1103/PhysRevLett.78.1251; Christov IP, 1998, PHYS REV A, V57, pR2285, DOI 10.1103/PhysRevA.57.R2285; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Diels J. C., 1996, ULTRASHORT LASER PUL; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Itatani J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173903; Kanai T, 2003, OPT LETT, V28, P1484, DOI 10.1364/OL.28.001484; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Kobayashi Y, 1998, OPT LETT, V23, P64, DOI 10.1364/OL.23.000064; KONDO K, 1994, PHYS REV A, V49, P3881, DOI 10.1103/PhysRevA.49.3881; MCPHERSON A, 1987, J OPT SOC AM B, V4, P595, DOI 10.1364/JOSAB.4.000595; Nabekawa Y, 1998, OPT LETT, V23, P1384, DOI 10.1364/OL.23.001384; Nikolopoulos LAA, 2001, J PHYS B-AT MOL OPT, V34, P545, DOI 10.1088/0953-4075/34/4/304; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Sekikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.103902; Sekikawa T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.193902; Sekikawa T, 1999, PHYS REV LETT, V83, P2564, DOI 10.1103/PhysRevLett.83.2564; Trebino R, 1997, REV SCI INSTRUM, V68, P3277, DOI 10.1063/1.1148286; Tzallas P, 2003, NATURE, V426, P267, DOI 10.1038/nature02091	24	274	275	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					605	608		10.1038/nature03108	http://dx.doi.org/10.1038/nature03108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577905				2022-12-28	WOS:000225433200041
J	Neukum, G; Jaumann, R; Hoffmann, H; Hauber, E; Head, JW; Basilevsky, AT; Ivanov, BA; Werner, SC; van Gasselt, S; Murray, JB; McCord, T				Neukum, G; Jaumann, R; Hoffmann, H; Hauber, E; Head, JW; Basilevsky, AT; Ivanov, BA; Werner, SC; van Gasselt, S; Murray, JB; McCord, T		HRSC Co-investigator Team	Recent and episodic volcanic and glacial activity on Mars revealed by the High Resolution Stereo Camera	NATURE			English	Article							WATER ICE; OLYMPUS MONS; EVOLUTION; ORIGIN	The large-area coverage at a resolution of 10 - 20 metres per pixel in colour and three dimensions with the High Resolution Stereo Camera Experiment on the European Space Agency Mars Express Mission has made it possible to study the time-stratigraphic relationships of volcanic and glacial structures in unprecedented detail and give insight into the geological evolution of Mars. Here we show that calderas on five major volcanoes on Mars have undergone repeated activation and resurfacing during the last 20 per cent of martian history, with phases of activity as young as two million years, suggesting that the volcanoes are potentially still active today. Glacial deposits at the base of the Olympus Mons escarpment show evidence for repeated phases of activity as recently as about four million years ago. Morphological evidence is found that snow and ice deposition on the Olympus construct at elevations of more than 7,000 metres led to episodes of glacial activity at this height. Even now, water ice protected by an insulating layer of dust may be present at high altitudes on Olympus Mons.	Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; DLR, Inst Plantenforsch, D-12489 Berlin, Germany; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; RAS, Vernadsky Inst Geochem & Analyt Chem, Moscow 119991, Russia; Inst Dynam Geospheres, Moscow 119334, Russia; Open Univ, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	Free University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); Brown University; Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry; Russian Academy of Sciences; Sadovsky Institute of Geosphere Dynamics of the Russian Academy of Sciences; Open University - UK; University of Hawaii System	Neukum, G (corresponding author), Free Univ Berlin, Inst Geol Wissensch, Malteserstr 74-100,Bldg D, D-12249 Berlin, Germany.	gneukum@zedat.fu-berlin.de	Basilevsky, Alexander T/A-6676-2017; Ivanov, Boris A/E-1413-2016; Hauber, Ernst/U-2521-2018; Jaumann, Ralf/N-1001-2018; van Gasselt, Stephan/L-9762-2013; Werner, Stephanie C/A-6438-2012	Ivanov, Boris A/0000-0002-9938-9428; Hauber, Ernst/0000-0002-1375-304X; Jaumann, Ralf/0000-0002-9759-6597; van Gasselt, Stephan/0000-0003-2130-6343; Werner, Stephanie C/0000-0001-5704-0909				Baker V.R., 1982, THE CHANNELS OF MARS, DOI [10.1029/EO063i045p00862, DOI 10.1029/EO063I045P00862]; BANIN A., 2000, MARS, P594; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, V1240, P37; Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Carr, 1996, WATER MARS, P229; Crumpler LS, 1996, GEOL SOC SP, P307, DOI 10.1144/GSL.SP.1996.110.01.24; CRUMPLER LS, 1978, ICARUS, V34, P496, DOI 10.1016/0019-1035(78)90041-6; GREELEY R, 1981, REV GEOPHYS, V19, P13, DOI 10.1029/RG019i001p00013; GULICK VC, 1990, J GEOPHYS RES-SOLID, V95, P14325, DOI 10.1029/JB095iB09p14325; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; HARRIS SA, 1977, J GEOPHYS RES, V82, P3099, DOI 10.1029/JB082i020p03099; Hartmann WK, 1999, NATURE, V397, P586, DOI 10.1038/17545; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; HAUBER E, 2004, EUR GEOPH UN 1 GEN A; HAUBER E, UNPUB NATURE; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; HEAD JW, IN PRESS NATURE; Ivanov BA, 2001, SPACE SCI REV, V96, P87, DOI 10.1023/A:1011941121102; Kossacki KJ, 1997, ICARUS, V128, P127, DOI 10.1006/icar.1997.5701; Kossacki KJ, 1999, PLANET SPACE SCI, V47, P1521, DOI 10.1016/S0032-0633(99)00037-9; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LOPES R, 1982, J GEOPHYS RES, V87, P9917, DOI 10.1029/JB087iB12p09917; LUCCHITTA BK, 1981, ICARUS, V45, P264, DOI 10.1016/0019-1035(81)90035-X; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MCCORD T, 2004, EUR GEOPH UN 1 GEN A; MILKOVICH SM, 2003, 6 INT MARS C, P3149; MOUGINISMARK PJ, 1982, J GEOPHYS RES, V87, P9890, DOI 10.1029/JB087iB12p09890; MURRAY JB, 2004, UNPUB NATURE; NEUKUM G, 1981, J GEOPHYS RES, V86, P3097, DOI 10.1029/JB086iB04p03097; Neukum G, 2001, SPACE SCI REV, V96, P55, DOI 10.1023/A:1011989004263; Neukum G., 2004, EUR SP AGENCY SPECIA, V1240, P17; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; Picardi G., 2004, EUROPEAN SPACE AGENC, P51; Richardson MI, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001536; Skorov YV, 2001, PLANET SPACE SCI, V49, P59, DOI 10.1016/S0032-0633(00)00121-5; Steinberger B, 2000, J GEOPHYS RES-SOL EA, V105, P11127, DOI 10.1029/1999JB900398; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; Wilson L, 2001, J GEOPHYS RES-PLANET, V106, P1423, DOI 10.1029/2000JE001280	38	308	312	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					971	979		10.1038/nature03231	http://dx.doi.org/10.1038/nature03231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616551				2022-12-28	WOS:000225887000030
J	Bashir, N; Ahmed, N; Singh, A; Tang, YZ; Young, M; Abba, A; Sampson, EL				Bashir, N; Ahmed, N; Singh, A; Tang, YZ; Young, M; Abba, A; Sampson, EL			A precious case from Middle Earth	BRITISH MEDICAL JOURNAL			English	Article									UCL Royal Free & Univ Coll, Sch Med, Dept Mental Hlth Sci, London NW3 2PF, England	University of London; University College London; UCL Medical School	Sampson, EL (corresponding author), UCL Royal Free & Univ Coll, Sch Med, Dept Mental Hlth Sci, London NW3 2PF, England.	e.sampson@rfc.ucl.ac.uk	Sampson, Elizabeth L/B-8647-2009	Sampson, Elizabeth L/0000-0001-8929-7362				Tolkien J.R.R., 1954, LORD RINGS; Tolkien J. R. R., 1937, HOBBIT; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	3	4	4	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1435	1436		10.1136/bmj.329.7480.1435	http://dx.doi.org/10.1136/bmj.329.7480.1435			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604176	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000225965800019
J	Breeze, ACG; Lees, CC				Breeze, ACG; Lees, CC			Managing shoulder dystocia	LANCET			English	Editorial Material							EPISIOTOMY; TRIAL		Addenbrookes Hosp, Div Maternal Fetal Med, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Lees, CC (corresponding author), Addenbrookes Hosp, Div Maternal Fetal Med, Hills Rd, Cambridge CB2 2QQ, England.	Christoph.lees@addenbrookes.nhs.uk	Breeze, Andrew/A-3801-2009	Breeze, Andrew/0000-0003-4836-1860				BASKETT TF, 1995, OBSTET GYNECOL, V86, P14, DOI 10.1016/0029-7844(95)00099-D; BELIZAN J, 1993, LANCET, V342, P1517; Bodner-Adler B, 2001, J REPROD MED, V46, P752; Gurewitsch ED, 2004, AM J OBSTET GYNECOL, V191, P911, DOI 10.1016/j.ajog.2004.06.041; James DK, 1999, HIGH RISK PREGNANCY; Lurie S, 1994, Asia Oceania J Obstet Gynaecol, V20, P195; *MAT CHILD HLTH RE, 1999, CONF ENQ STILLB DEAT; SLEEP J, 1984, BRIT MED J, V289, P587, DOI 10.1136/bmj.289.6445.587	8	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2004	364	9452					2160	2161		10.1016/S0140-6736(04)17607-1	http://dx.doi.org/10.1016/S0140-6736(04)17607-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610787				2022-12-28	WOS:000225799700007
J	Chworos, A; Severcan, I; Koyfman, AY; Weinkam, P; Oroudjev, E; Hansma, HG; Jaeger, L				Chworos, A; Severcan, I; Koyfman, AY; Weinkam, P; Oroudjev, E; Hansma, HG; Jaeger, L			Building programmable jigsaw puzzles with RNA	SCIENCE			English	Article							RIBOSOMAL-SUBUNIT; DNA; TECTORNA; CONSTRUCTION; DIMERIZATION; COMPLEXES; DESIGN	One challenge in supramolecular chemistry is the design of versatile, self-assembling building blocks to attain total control of arrangement of matter at a molecular level. We have achieved reliable prediction and design of the three-dimensional structure of artificial RNA building blocks to generate molecular jigsaw puzzle units called tectosquares. They can be programmed with control over their geometry, topology, directionatity, and addressability to algorithmically self-assemble into a variety of complex nanoscopic fabrics with predefined periodic and aperiodic patterns and finite dimensions. This work emphasizes the modular and hierarchical characteristics of RNA by showing that small RNA structural motifs can code the precise topology of large molecular architectures. It demonstrates that fully addressable materials based on RNA can be synthesized and provides insights into self-assembly processes involving large populations of RNA molecules.	Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California San Diego	Jaeger, L (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	jaeger@chem.ucsb.edu	Chworos, Arkadiusz/AAF-9169-2020	Chworos, Arkadiusz/0000-0001-9924-0503				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Batey RT, 1999, ANGEW CHEM INT EDIT, V38, P2327; Carbone A, 2002, P NATL ACAD SCI USA, V99, P12577, DOI 10.1073/pnas.202418299; Dirks RM, 2004, NUCLEIC ACIDS RES, V32, P1392, DOI 10.1093/nar/gkh291; Ennifar E, 2001, NAT STRUCT BIOL, V8, P1064, DOI 10.1038/nsb727; Hansma HG, 2003, J MICROSC-OXFORD, V212, P273, DOI 10.1111/j.1365-2818.2003.01276.x; Horiya S, 2003, CHEM BIOL, V10, P645, DOI 10.1016/S1074-5521(03)00146-7; Ikawa Y, 2002, STRUCTURE, V10, P527, DOI 10.1016/S0969-2126(02)00739-6; Jaeger L, 2000, ANGEW CHEM INT EDIT, V39, P2521, DOI 10.1002/1521-3773(20000717)39:14<2521::AID-ANIE2521>3.0.CO;2-P; Jaeger L, 2001, NUCLEIC ACIDS RES, V29, P455, DOI 10.1093/nar/29.2.455; Liu B, 2004, J AM CHEM SOC, V126, P4076, DOI 10.1021/ja031552v; Lodmell JS, 2001, J MOL BIOL, V311, P475, DOI 10.1006/jmbi.2001.4879; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Mao CD, 1997, NATURE, V386, P137, DOI 10.1038/386137b0; Michl J, 2002, P NATL ACAD SCI USA, V99, P4788, DOI 10.1073/pnas.052016299; Ringler P, 2003, SCIENCE, V302, P106, DOI 10.1126/science.1088074; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Seeman NC, 2002, P NATL ACAD SCI USA, V99, P6451, DOI 10.1073/pnas.221458298; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Szewczak AA, 1998, BIOCHEMISTRY-US, V37, P11162, DOI 10.1021/bi980633e; Westhof E, 1996, FOLD DES, V1, pR78, DOI 10.1016/S1359-0278(96)00037-5; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Winfree E, 2000, J BIOMOL STRUCT DYN, P263; Wolfram S., 2002, NEW KIND SCI; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yan H, 2003, P NATL ACAD SCI USA, V100, P8103, DOI 10.1073/pnas.1032954100; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	31	402	425	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2068	2072		10.1126/science.1104686	http://dx.doi.org/10.1126/science.1104686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604402				2022-12-28	WOS:000225841000055
J	Rupprecht, CE; Gibbons, RV				Rupprecht, CE; Gibbons, RV			Prophylaxis against rabies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PUBLIC VETERINARY-MEDICINE; GUILLAIN-BARRE-SYNDROME; DIPLOID CELL-CULTURE; UNITED-STATES; POSTEXPOSURE PROPHYLAXIS; ANTIRABIES VACCINE; HUMAN EXPOSURE; EPIDEMIOLOGY; HEALTH; HUMANS	A six-month- old girl presents for a "well-baby" appointment in New Jersey. The mother is concerned about a dead bat she found in the child's bedroom. A Virginia businessman relaxing on his patio after work pulls a toy from his puppy's mouth. He notices a dead raccoon within his fenced yard, where his puppy has been playing, and telephones you for advice. You receive e-mail from a South American colleague, who has been bitten by a stray dog while jogging. She solicits your medical opinion. How would you manage these situations?	Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand	Centers for Disease Control & Prevention - USA; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Rupprecht, CE (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,MS G33, Atlanta, GA 30333 USA.	cyr5@cdc.gov	Rupprecht, Charles/AAI-1544-2020					*ACIP, 2002, MMWR-MORBID MORTAL W, V51, P1; ANDERSON LJ, 1984, ANN INTERN MED, V100, P728, DOI 10.7326/0003-4819-100-5-728; ANDERSON LJ, 1980, JAMA-J AM MED ASSOC, V244, P781; BAHMANYAR M, 1976, JAMA-J AM MED ASSOC, V236, P2751, DOI 10.1001/jama.236.24.2751; BERNARD KW, 1982, JAMA-J AM MED ASSOC, V248, P3136, DOI 10.1001/jama.248.23.3136; BOE E, 1980, SCAND J INFECT DIS, V12, P231, DOI 10.3109/inf.1980.12.issue-3.12; Botvinkin AD, 2003, EMERG INFECT DIS, V9, P1623, DOI 10.3201/eid0912.030374; Briggs DJ, 2000, VACCINE, V19, P1055, DOI 10.1016/S0264-410X(00)00342-X; *CDCP, 2004, UPD INV RAB INF ORG; Chakravarty A, 2001, J Assoc Physicians India, V49, P927; Charlton K M, 1994, Curr Top Microbiol Immunol, V187, P95; Chhabra Mala, 2004, Indian Journal of Pediatrics, V71, P217, DOI 10.1007/BF02724273; Childs JE, 1997, J WILDLIFE DIS, V33, P20, DOI 10.7589/0090-3558-33.1.20; CHUTIVONGSE S, 1995, CLIN INFECT DIS, V20, P818, DOI 10.1093/clinids/20.4.818; Coleman PG, 2004, EMERG INFECT DIS, V10, P140, DOI 10.3201/eid1001.020744; DEAN DJ, 1963, NEW YORK STATE J MED, V63, P3507; DREESEN DW, 1986, VACCINE, V4, P45, DOI 10.1016/0264-410X(86)90096-4; DREESEN DW, 1989, VACCINE, V7, P397, DOI 10.1016/0264-410X(89)90152-7; FISHBEIN DB, 1993, VACCINE, V11, P1390, DOI 10.1016/0264-410X(93)90167-V; Fooks AR, 2003, EPIDEMIOL INFECT, V131, P1029, DOI 10.1017/S0950268803001481; Gibbons RV, 2002, EMERG INFECT DIS, V8, P532; Gibbons RV, 2002, ANN EMERG MED, V39, P528, DOI 10.1067/mem.2002.121521; GRIEGO RD, 1995, J AM ACAD DERMATOL, V33, P1019, DOI 10.1016/0190-9622(95)90296-1; Hanna JN, 2000, MED J AUSTRALIA, V172, P597, DOI 10.5694/j.1326-5377.2000.tb124126.x; HELD JR, 1967, PUBLIC HEALTH REP, V82, P1009, DOI 10.2307/4593183; HELMICK CG, 1983, JAMA-J AM MED ASSOC, V250, P1990, DOI 10.1001/jama.250.15.1990; Human death associated with bat rabies-California, 2003, MMWR MORB MORTAL WKL, V53, P33; *IMM PRACT ADV COM, 1999, MMWR RECOMM REP, V48, P1; Jackson AC, 2003, CLIN INFECT DIS, V36, P60, DOI 10.1086/344905; Jenkins SR, 2004, JAVMA-J AM VET MED A, V224, P216, DOI 10.2460/javma.2004.224.216; Jones RL, 2001, VACCINE, V19, P4635, DOI 10.1016/S0264-410X(01)00238-9; King A A, 1994, Curr Top Microbiol Immunol, V187, P267; KNITTEL T, 1989, LANCET, V1, P1334; Krebs J W, 1998, J Public Health Manag Pract, V4, P56; Krebs JW, 2004, JAVMA-J AM VET MED A, V224, P705; Krebs JW, 2003, J AM VET MED ASSOC, V223, P1736, DOI 10.2460/javma.2003.223.1736; LeGuerrier P, 1996, VACCINE, V14, P167, DOI 10.1016/0264-410X(95)00110-M; Messenger SL, 2002, CLIN INFECT DIS, V35, P738, DOI 10.1086/342387; Moran GJ, 2000, JAMA-J AM MED ASSOC, V284, P1001, DOI 10.1001/jama.284.8.1001; MOULIGNIER A, 1991, PRESSE MED, V20, P1121; Noah DL, 1998, ANN INTERN MED, V128, P922, DOI 10.7326/0003-4819-128-11-199806010-00012; Noah DL, 1996, AM J PUBLIC HEALTH, V86, P1149, DOI 10.2105/AJPH.86.8_Pt_1.1149; Parviz S, 1998, CLIN INFECT DIS, V27, P751, DOI 10.1086/514931; PICKERING LK, 2003, RED BOOK 2003 REPORT, P514; PLOTKIN SA, 1980, REV INFECT DIS, V2, P433; Rotz LD, 1998, J AM VET MED ASSOC, V212, P1198; SIBER GR, 1993, J PEDIATR-US, V122, P204, DOI 10.1016/S0022-3476(06)80114-9; SMITH JS, 1991, NEW ENGL J MED, V324, P205, DOI 10.1056/NEJM199101243240401; SWANSON MC, 1987, J INFECT DIS, V155, P909, DOI 10.1093/infdis/155.5.909; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Thraenhart O, 1994, Curr Top Microbiol Immunol, V187, P173; TORNATORE CS, 1990, LANCET, V335, P1346, DOI 10.1016/0140-6736(90)91231-X; *VAERS, 2003, MMWR SURVEILL SUMM, V52, P1; Warrell MJ, 2004, LANCET, V363, P959, DOI 10.1016/S0140-6736(04)15792-9; *WHO, 1997, WHO REC RAB POST EXP; *WHO, 2002, WORLD SURV RAB 35 YE; 1984, MMWR MORB MORTAL WKL, V33, P185	57	96	102	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2626	2635		10.1056/NEJMcp042140	http://dx.doi.org/10.1056/NEJMcp042140			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602023				2022-12-28	WOS:000225726100010
J	Goel, MS; McCarthy, EP; Phillips, RS; Wee, CC				Goel, MS; McCarthy, EP; Phillips, RS; Wee, CC			Obesity among US immigrant subgroups by duration of residence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-ACTIVITY; UNITED-STATES; HEALTH; MORTALITY; BEHAVIORS; ADULTS	Context The prevalence of obesity has increased substantially since the 1980s. While immigrants are the fastest growing segment of the US population, little is known about obesity or clinician counseling about diet and exercise in this group. Objectives To estimate the prevalence of obesity among immigrant subgroups and quantify the magnitude of the association with duration of US residence, and to describe reported diet and exercise counseling by birthplace, race, and ethnicity. Design, Setting, and Participants Cross-sectional study using data from the 2000 National Health Interview Survey. Main Outcome Measures Body mass index (BMI, measured as weight in kilograms divided by the square of height in meters) based on self-reported height and weight measurements, and self-reported rates of diet and exercise counseling. Results Of 32374 respondents, 14% were immigrants. The prevalence of obesity was 16% among immigrants and 22% among US-born individuals. The age- and sex-adjusted prevalence of obesity was 8% among immigrants living in the United States for less than 1 year, but 19% among those living in the United States for at least 15 years. After adjusting forage, sociodemographic, and lifestyle factors, living in the United States for 10 to 15 and at least 15 years was associated with BMI increases of 0.88 and 1.39, respectively. The association for 15 years or more was significant for all immigrant subgroups except foreign-born blacks. Additionally, immigrants were less likely than US-born individuals to report discussing diet and exercise with clinicians (18% vs 24%, P<.001; 19% vs 23%, P<.001, respectively). These differences were not accounted for by sociodemographic characteristics, illness burden, BMI, or access to care among some subgroups of immigrants. Conclusions Among different immigrant subgroups, number of years of residence in the United States is associated with higher BMI beginning after 10 years. The prevalence of obesity among immigrants living in the United States for at least 15 years approached that of US-born adults. Early intervention with diet and physical activity may represent an opportunity to prevent weight gain, obesity, and obesity-related chronic illnesses.	Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med, Chicago, IL 60611 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gen Med & Primary Care, Boston, MA USA	Northwestern University; Feinberg School of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Goel, MS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med, 676 N St Clair Ave,Suite 200, Chicago, IL 60611 USA.	mgoel@nmff.org			NCCIH NIH HHS [K24 AT00589-01A1] Funding Source: Medline; NCI NIH HHS [R29 CA79052] Funding Source: Medline; NIDDK NIH HHS [K23DK02962] Funding Source: Medline; BHP HRSA HHS [5T32PE11001] Funding Source: Medline; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE011001] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R29CA079052] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K24AT000589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK002962] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BHP HRSA HHS; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		American Association for Public Opinion Research, 2004, STAND DEF FIN DISP C; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Goel MS, 2003, J GEN INTERN MED, V18, P1028, DOI 10.1111/j.1525-1497.2003.20807.x; Gordon-Larsen P, 2003, SOC SCI MED, V57, P2023, DOI 10.1016/S0277-9536(03)00072-8; HARRIS SS, 1989, JAMA-J AM MED ASSOC, V261, P3588, DOI 10.1001/jama.261.24.3588; Johnson T, 1997, WILEY SER PROB STAT, P87; Kaplan MS, 2004, AM J PREV MED, V27, P323, DOI 10.1016/j.amepre.2004.07.005; Ku L, 2001, HEALTH AFFAIR, V20, P247, DOI 10.1377/hlthaff.20.1.247; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; McGee DL, 1999, AM J EPIDEMIOL, V149, P41; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; *NAT CTR HLTH STAT, 2002, NAT HLTH INT SURV 20; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; SCHMIDLEY AD, 2001, US BUREAU CENSUS CUR; Singh GK, 2002, HUM BIOL, V74, P83, DOI 10.1353/hub.2002.0011; *US PREV SERV TASK, 2003, SCREEN OB AD REC RAT; Wee CC, 1999, JAMA-J AM MED ASSOC, V282, P1583, DOI 10.1001/jama.282.16.1583; WHO, 2004, LANCET, V363, P902; World Health Organization, TURN TID MALN RESP C; World Health Organization, OB OV	25	452	455	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2004	292	23					2860	2867		10.1001/jama.292.23.2860	http://dx.doi.org/10.1001/jama.292.23.2860			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879CR	15598917	Bronze			2022-12-28	WOS:000225694500023
J	Lautze, S; Leaning, J; Raven-Roberts, A; Kent, R; Mazurana, D				Lautze, S; Leaning, J; Raven-Roberts, A; Kent, R; Mazurana, D			Assistance, protection, and governance networks in complex emergencies	LANCET			English	Review							LINKING RELIEF; CONFLICT; CHALLENGES	This article presents an introduction to the causes and characteristics of armed conflicts. It reviews some of the key humanitarian crises that broke new ground in terms of the technologies and practices that developed at the field level in response to each new complex emergency, with particular focus on the health sector. It introduces the concept of humanitarian governance as a framework for addressing the consequences and implications of the failure of worldwide governance for the protection of civilians in armed conflict. Here, we term humanitarian governance to include the use of international humanitarian law and human rights instruments to govern the behaviour of state and non-state organisations in conflict zones in a way that protects the lives and livelihoods of affected populations. We note, however, that terrorist concerns appear to be replacing humanitarian logic in the network of worldwide governance.	Univ Oxford Hertford Coll, Oxford OX1 3BW, England; Tufts Univ, Feinstein Int Famine Ctr, Medford, MA 02155 USA; Kings Coll London, Int Policy Res Inst, London WC2R 2LS, England; Tufts Univ, Feinstein Int Famine Ctr, Medford, MA 02155 USA	University of Oxford; Tufts University; University of London; King's College London; Tufts University	Lautze, S (corresponding author), Univ Oxford Hertford Coll, Oxford OX1 3BW, England.	sue.lautze@tufts.edu						ANDERSON M, 1999, DO NO HARM AID SUPPO; [Anonymous], 1989, WINDS DEATH IR US PO; Apter D., 1997, LEGITIMIZATION VIOLE; ATKINSON P, 1997, 22 OV DEV I HUM PRAC; AULAKIA J, 1996, TERROR TABOO FOLLIES; BOUTROUE J, 1998, R ROGERS WORKING PAP; BRADBURY M, NORMALISING CRISIS A; Brauman Rony, 1998, HARD CHOICES MORAL D, P177; Bruderlein C, 1999, BRIT MED J, V319, P430, DOI 10.1136/bmj.319.7207.430; BRYNE B, 1995, 34 MIN FOR AFF; BUCHANANSMITH M, 1994, IDS BULL-I DEV STUD, V25, P55, DOI 10.1111/j.1759-5436.1994.mp25004008.x; Chapman A. R., 1998, HUMAN RIGHTS HLTH LE; Collier P., 2001, GREED GRIEVANCE CIVI; Das V., 1997, VIOLENCE SUBJECTIVIT; de Waal A, 2002, IDS BULL-I DEV STUD, V33, P120; de Waal Alex, 1997, FAMINE CRIMES POLITI; de Waal Alexander, 1994, 5 AFR RIGHTS; Devereux S, 2002, IDS BULL-I DEV STUD, V33, P1, DOI 10.1111/j.1759-5436.2002.tb00038.x; DONINI A, 1996, 22 WATS I; DUFFIELD M, 1994, IDS BULL-I DEV STUD, V25, P37, DOI 10.1111/j.1759-5436.1994.mp25004006.x; DUFFIELD M, 1993, DEV CHANGE, V24, P131, DOI 10.1111/j.1467-7660.1993.tb00480.x; Duffield M., 1994, TROOPS TANKS HUMANIT; Duffield M., 2001, GLOBAL GOVERNANCE NE; Duffield Mark., 1998, CIVIL WARS, V1, P65, DOI DOI 10.1080/13698249808402367; ENLOE C, 1995, CULTURAL SURVIVAL, V19, P26; ENLOE C, 2000, MANUEVERS MILITARIAN; GHALI BB, 1992, SUMM M SEC COUNC JAN; GOETZ N, HUMANITARIAN ISSUES; Green Linda, 2002, GENOCIDE ANTHR READE, P307; Homer-Dixon Thomas, 2001, ENV SCARCITY VIOLENC; *HUM RIGHTS WATCH, 2000, HUM RIGHTS WATCH REP; HUMAN RIGHTS WATCH, 2001, HUM DEN SYST VIOL WO; *I STUD INT MIGR, 2003, M FEB 3 2003 WASH DC; IACOPINO V, 1998, TALIBANS WAR WOMEN H; KALDOR M, 1997, RESTRUCTURING GLOBAL, V1; Kaldor Mary., 1999, NEW OLD WARS ORG VIO; Keen D, 1994, BENEFITS FAMINE POLI; LAUTZE S, 1998, STRATEGIC HUMANITARI; LAUTZE S, 2002, CASH FAMINE FOOD INS; Lautze Sue, 1997, SAVING LIVES LIVELIH; LE BILLON PHILIPPE, 2000, 33 OV DEV I HUM PRAC; LEVINE I, 1997, 21 OV DEV I REL REH; Macrae J, 1997, DISASTERS, V21, P223, DOI 10.1111/1467-7717.00058; MACRAE J, 2000, 8 OV DEV I HUM POL G; Macrae J, 1994, WAR HUNGER; Macrae Joanna, 2001, AIDING RECOVERY CRIS; MARON M, 1997, ROAD HELL RAVAGING E; Maxwell D, 2002, IDS BULL-I DEV STUD, V33, P48, DOI 10.1111/j.1759-5436.2002.tb00043.x; Maxwell D, 1999, DISASTERS, V23, P373, DOI 10.1111/1467-7717.00126; MAZURANA D, IN PRESS GENDER CONF; MINEAR L, 1999, FRAMEWORK SURVIVAL H; Minear Larry, 2002, HUMANITARIAN ENTERPR; Minear Larry, 1991, HUMANITARIANISM SIEG; Minow M., 1998, VENGEANCE FORGIVENES; Moorehead C., 1998, DUNANTS DREAM WAR SW; NORDSTROM C, 1992, PATHS DOMINATION RES; *PHYS HUM RIGHTS, 1988, CAS CONFL MED CAR HU; *PHYS HUM RIGHTS, 1999, WAR CRIM KOS; *PHYS HUM RIGHTS, 2002, PHYS HUM RIGHTS CALL; *PHYS HUM RIGHTS, 1992, NO MERC MOG HUM COST; Pierre B., 2004, VIOLENCE WAR PEACE A, V5, P339; Prendergast J., 1996, FRONTLINE DIPLOMACY, V23, P84; RAVENROBERTS A, 2003, HDB APPL DEV SCI PRO, V3, P107; RESSLER R, 1988, UNACCOMPANIED CHILDR; Rieff David, 2002, BED NIGHT HUMANITARI; Robben Antonius C.G.M., 2000, CULTURES SIEGE COLLE; Sahnoun M., 1994, SOMALIA MISSED OPPOR; Shawcross William, 1984, QUALITY MERCY CAMBOD; SHULTZ RH, 1995, ANN AM ACAD POLIT SS, V541, P75, DOI 10.1177/0002716295541001005; Sivard R. L., 1996, WORLD MILITARY SOCIA; SLIM H, 1994, DEV STUD ASS C LANC; SMITH A, 2002, 38 OV DEV I HUM PRAC; SOMMERS M, 2000, 40 WATS I; Stewart F, 2002, BRIT MED J, V324, P342, DOI 10.1136/bmj.324.7333.342; Summerfield D., 1991, Development in Practice: An Oxfam Journal, V1, P159, DOI 10.1080/096145249100076351; The Sphere Project, 2004, HUM CHART MIN STAND; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TURPIN J, 1997, WEB VIOLENCE INTERPE; *UN, 2000, WOM PEAC SEC STUD SU; UVING P, 1998, AIDING VIOLENCE DEV; WALKER P, 1994, IDS BULL-I DEV STUD, V25, P107, DOI 10.1111/j.1759-5436.1994.mp25004016.x; Williams Michael C., 1998, CIVIL MILITARY RELAT; ZWI A, 1989, SOC SCI MED, V28, P633, DOI 10.1016/0277-9536(89)90210-4; [No title captured]	84	23	23	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2004	364	9451					2134	2141		10.1016/S0140-6736(04)17555-7	http://dx.doi.org/10.1016/S0140-6736(04)17555-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589312				2022-12-28	WOS:000225742300027
J	Bucksbaum, PH				Bucksbaum, PH			X-ray movies of wiggling crystals	SCIENCE			English	Editorial Material							DIFFRACTION; LASER		Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA	University of Michigan System; University of Michigan; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Bucksbaum, PH (corresponding author), Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA.	phb@umich.edu		Bucksbaum, Philip/0000-0003-1258-5571				Andruszkow J, 2000, PHYS REV LETT, V85, P3825, DOI 10.1103/PhysRevLett.85.3825; Bargheer M, 2004, SCIENCE, V306, P1771, DOI 10.1126/science.1104739; Bentson L, 2003, NUCL INSTRUM METH A, V507, P205, DOI 10.1016/S0168-9002(03)00875-1; Rischel C, 1997, NATURE, V390, P490, DOI 10.1038/37317; Siders CW, 1999, SCIENCE, V286, P1340, DOI 10.1126/science.286.5443.1340; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490	6	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1691	1692		10.1126/science.1106755	http://dx.doi.org/10.1126/science.1106755			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576597				2022-12-28	WOS:000225630800029
J	Herkenhoff, KE; Squyres, SW; Arvidson, R; Bass, DS; Bell, JF; Bertelsen, P; Ehlmann, BL; Farrand, W; Gaddis, L; Greeley, R; Grotzinger, J; Hayes, AG; Hviid, SF; Johnson, JR; Jolliff, B; Kinch, KM; Knoll, AH; Madsen, MB; Maki, JN; McLennan, SM; McSween, HY; Ming, DW; Rice, JW; Richter, L; Sims, M; Smith, PH; Soderblom, LA; Spanovich, N; Sullivan, R; Thompson, S; Wdowiak, T; Weitz, C; Whelley, P				Herkenhoff, KE; Squyres, SW; Arvidson, R; Bass, DS; Bell, JF; Bertelsen, P; Ehlmann, BL; Farrand, W; Gaddis, L; Greeley, R; Grotzinger, J; Hayes, AG; Hviid, SF; Johnson, JR; Jolliff, B; Kinch, KM; Knoll, AH; Madsen, MB; Maki, JN; McLennan, SM; McSween, HY; Ming, DW; Rice, JW; Richter, L; Sims, M; Smith, PH; Soderblom, LA; Spanovich, N; Sullivan, R; Thompson, S; Wdowiak, T; Weitz, C; Whelley, P			Evidence from Opportunity's microscopic imager for water on Meridiani Planum	SCIENCE			English	Article							SOILS; ROVER; MARS; CRATER; ROCKS	The Microscopic Imager on the Opportunity rover analyzed textures of soils and rocks at Meridiani Planum at a scale of 31 micrometers per pixel. The uppermost millimeter of some soils is weakly cemented, whereas other soils show little evidence of cohesion. Rock outcrops are laminated on a millimeter scale; image mosaics of cross-stratification suggest that some sediments were deposited by flowing water. Vugs in some outcrop faces are probably molds formed by dissolution of relatively soluble minerals during diagenesis. Microscopic images support the hypothesis that hematite-rich spherules observed in outcrops and soils also formed diagenetically as concretions.	US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Space Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Copenhagen, Ctr Planetary Sci, Danish Space Res Inst, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, DK-1168 Copenhagen, Denmark; Space Sci Inst, Boulder, CO 80301 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Max Planck Inst Aeron, D-37191 Katlenburg, Germany; Aarhus Univ, Inst Phys & Astron, Aarhus, Denmark; Harvard Univ, Dept Organism & Evolut Biol, Cambridge, MA 02138 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Off, Houston, TX 77058 USA; DLR Inst Raumsimulat, Cologne, Germany; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA; Planetary Sci Inst, Tucson, AZ 85719 USA	United States Department of the Interior; United States Geological Survey; Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Technical University of Denmark; University of Copenhagen; University of Copenhagen; Niels Bohr Institute; Arizona State University; Arizona State University-Tempe; Massachusetts Institute of Technology (MIT); Max Planck Society; Aarhus University; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Arizona; University of Alabama System; University of Alabama Birmingham	Herkenhoff, KE (corresponding author), US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA.	kherkenhoff@usgs.gov	Hayes, Alexander G/P-2024-2014; Sullivan, Robert/AAR-8193-2020; Madsen, Morten Bo/D-2082-2011; Kinch, Kjartan Bergeron/C-5742-2015; Johnson, Jeffrey R/F-3972-2015; Whelley, Patrick/B-9560-2012	Hayes, Alexander G/0000-0001-6397-2630; Madsen, Morten Bo/0000-0001-8909-5111; Kinch, Kjartan Bergeron/0000-0002-4629-8880; Johnson, Jeffrey R/0000-0002-5586-4901; Whelley, Patrick/0000-0003-3266-9772; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Dickinson WW, 2003, GEOLOGY, V31, P199, DOI 10.1130/0091-7613(2003)031<0199:APAAFW>2.0.CO;2; Dietz R.S., 1968, SHOCK METAMORPHISM N, P267; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Greeley R, 1999, J GEOPHYS RES-PLANET, V104, P8573, DOI 10.1029/98JE02553; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; IVERSEN JD, 1982, SEDIMENTOLOGY, V29, P111, DOI 10.1111/j.1365-3091.1982.tb01713.x; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; MARION GM, 1995, 9512 US ARM CORPS EN; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; SellesMartinez J, 1996, EARTH-SCI REV, V41, P177, DOI 10.1016/S0012-8252(96)00022-0; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910	20	123	124	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1727	1730		10.1126/science.1105286	http://dx.doi.org/10.1126/science.1105286			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576607	Green Published			2022-12-28	WOS:000225630800039
J	Squyres, SW; Grotzinger, JP; Arvidson, RE; Bell, JF; Calvin, W; Christensen, PR; Clark, BC; Crisp, JA; Farrand, WH; Herkenhoff, KE; Johnson, JR; Klingelhofer, G; Knoll, AH; McLennan, SM; McSween, HY; Morris, RV; Rice, JW; Rieder, R; Soderblom, LA				Squyres, SW; Grotzinger, JP; Arvidson, RE; Bell, JF; Calvin, W; Christensen, PR; Clark, BC; Crisp, JA; Farrand, WH; Herkenhoff, KE; Johnson, JR; Klingelhofer, G; Knoll, AH; McLennan, SM; McSween, HY; Morris, RV; Rice, JW; Rieder, R; Soderblom, LA			In situ evidence for an ancient aqueous environment at Meridiani Planum, Mars	SCIENCE			English	Article							OPPORTUNITY ROVER; NEAR-SURFACE; SOILS; CLASSIFICATION; CHEMISTRY; HEMATITE; CRATER; ROCKS	Sedimentary rocks at Eagle crater in Meridiani Planum are composed of fine-grained siliciclastic materials derived from weathering of basaltic rocks, sulfate minerals (including magnesium sulfate and jarosite) that constitute several tens of percent of the rock by weight, and hematite. Cross-stratification observed in rock outcrops indicates eolian and aqueous transport. Diagenetic features include hematite-rich concretions and crystal-mold vugs. We interpret the rocks to be a mixture of chemical and siliciciastic sediments with a complex diagenetic history. The environmental conditions that they record include episodic inundation by shallow surface water, evaporation, and desiccation. The geologic record at Meridiani Planum suggests that conditions were suitable for biological activity for a period of time in martian history.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; MIT, Dept Earth Atrmospher & Planetary Sci, Cambridge, MA 02139 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63031 USA; Univ Nevada, Dept Geol Sci, Reno, NV 89557 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Space Sci Inst, Boulder, CO 80301 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Johannes Gutenberg Univ Mainz, D-55128 Mainz, Germany; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Max Planck Inst Chem, D-55128 Mainz, Germany	Cornell University; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Nevada System of Higher Education (NSHE); University of Nevada Reno; Arizona State University; Arizona State University-Tempe; Lockheed Martin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; Johannes Gutenberg University of Mainz; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Max Planck Society	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	squyres@astrosun.tn.cornell.edu	Johnson, Jeffrey R/F-3972-2015; Crisp, Joy/H-8287-2016	Johnson, Jeffrey R/0000-0002-5586-4901; Crisp, Joy/0000-0002-3202-4416; McLennan, Scott/0000-0003-4259-7178				[Anonymous], 1982, STRUCTURES SEQUENCES; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002041; Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Billi D, 2002, RES MICROBIOL, V153, P7, DOI 10.1016/S0923-2508(01)01279-7; Bonny S, 2003, CAN J EARTH SCI, V40, P1483, DOI 10.1139/E03-060; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; CHOQUETTE PW, 1970, AM ASSOC PETR GEOL B, V54, P207; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Fernandez-Remolar DC, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001918; FERNANDEZREMOLA.D, 2002, P 33 LUN PLAN SCI C; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Hardie L.A., 1983, 6 INT S SALT I ALEX, V1, P11; HARDIE LA, 1991, ANNU REV EARTH PL SC, V19, P131, DOI 10.1146/annurev.earth.19.1.131; HARDIE LA, 1984, AM J SCI, V284, P193, DOI 10.2475/ajs.284.3.193; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Hunter R.E., 1983, EOLIAN SEDIMENTS PRO, V38, P429; Kinsman D.J., 1969, AAPG BULL, V53, P830, DOI DOI 10.1306/5D25C363-16C1-11D7-8645000102C1865D; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; LANE MD, 2003, GEOPHYS RES LETT, V30, DOI DOI 10.1029/2003GLO17183; Middleton G.V., 1984, SEPM SHORT COURSE 3, P401; Mountney NP, 2002, SEDIMENTOLOGY, V49, P805, DOI 10.1046/j.1365-3091.2002.00472.x; RENAULT RW, 1994, SEDIMENTOLOGY GEOCHE; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; RUBIN DM, 1982, SEDIMENTOLOGY, V29, P121, DOI 10.1111/j.1365-3091.1982.tb01714.x; Seilacher A, 2001, SEDIMENT GEOL, V143, P41, DOI 10.1016/S0037-0738(01)00092-6; SellesMartinez J, 1996, EARTH-SCI REV, V41, P177, DOI 10.1016/S0012-8252(96)00022-0; Smoot J.P., 1991, DEV SEDIMENTOL, V50, P189, DOI DOI 10.1016/S0070-4571(08)70261-9; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; SOUTHARD JB, 1990, J SEDIMENT PETROL, V60, P680, DOI 10.2110/jsr.60.680; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; WIBERG PL, 1987, WATER RESOUR RES, V23, P1471, DOI 10.1029/90WR02770; Zettler LAA, 2002, NATURE, V417, P137	35	734	752	4	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1709	1714		10.1126/science.1104559	http://dx.doi.org/10.1126/science.1104559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576604	Green Submitted			2022-12-28	WOS:000225630800036
J	Krause, O; Birkmann, SM; Rieke, GH; Lemke, D; Klaas, U; Hines, DC; Gordon, KD				Krause, O; Birkmann, SM; Rieke, GH; Lemke, D; Klaas, U; Hines, DC; Gordon, KD			No cold dust within the supernova remnant Cassiopeia A	NATURE			English	Article							OH	A large amount ( about three solar masses) of cold ( 18 K) dust in the prototypical type II supernova remnant Cassiopeia A was recently reported(1). It was concluded that dust production in type II supernovae can explain how the large quantities (similar to10(8) solar masses) of dust observed(2) in the most distant quasars could have been produced within only 700 million years after the Big Bang. Foreground clouds of interstellar material, however, complicate the interpretation of the earlier submillimetre observations of Cas A. Here we report far-infrared and molecular line observations that demonstrate that most of the detected submillimetre emission originates from interstellar dust in a molecular cloud complex located in the line of sight between the Earth and Cas A, and is therefore not associated with the remnant. The argument that type II supernovae produce copious amounts of dust is not supported by the case of Cas A, which previously appeared to provide the best evidence for this possibility.	Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; Max Planck Inst Astron, D-69117 Heidelberg, Germany; Space Sci Inst, Boulder, CO 80301 USA	University of Arizona; Max Planck Society	Krause, O (corresponding author), Univ Arizona, Steward Observ, 933 N Cherry Ave, Tucson, AZ 85721 USA.	krause@as.arizona.edu		Gordon, Karl/0000-0001-5340-6774				ARENDT RG, 1989, ASTROPHYS J SUPPL S, V70, P181, DOI 10.1086/191337; Bertoldi F, 2003, ASTRON ASTROPHYS, V406, pL55, DOI 10.1051/0004-6361:20030710; BIEGING JH, 1986, ASTROPHYS J, V310, P853, DOI 10.1086/164739; BLAIR WP, IN PRESS ASP C SER; Bogun S, 1996, ASTRON ASTROPHYS, V315, pL71; CRUTCHER RM, 1979, ASTROPHYS J, V234, P881, DOI 10.1086/157570; Dunne L, 2003, NATURE, V424, P285, DOI 10.1038/nature01792; Dwek E, 2004, ASTROPHYS J, V607, P848, DOI 10.1086/382653; DWEK E, 2004, ASTROPHYS J, V597, pL33; Harju J, 2000, ASTRON ASTROPHYS, V353, P1065; Hines DC, 2004, ASTROPHYS J SUPPL S, V154, P290, DOI 10.1086/422583; Holland WS, 1999, MON NOT R ASTRON SOC, V303, P659, DOI 10.1046/j.1365-8711.1999.02111.x; HUGHES DW, 1980, NATURE, V285, P132, DOI 10.1038/285132a0; Kinugasa K, 1999, PUBL ASTRON SOC JPN, V51, P239, DOI 10.1093/pasj/51.2.239; LEMKE D, 1996, ASTRON ASTROPHYS, V315, P64; Liszt H, 1999, ASTRON ASTROPHYS, V347, P258; LOINARD L, 2003, REV MEXICANA ASTRON, V15, P267; Morgan HL, 2003, ASTROPHYS J, V597, pL33, DOI 10.1086/379639; OSSENKOPF V, 1994, ASTRON ASTROPHYS, V291, P943; Reynoso EM, 2002, ASTROPHYS J, V575, P871, DOI 10.1086/341480; RIEKE GH, 2001, ASTROPHYS J SUPPL, V154, P25; ROTHENFLUG R, 1994, ASTRON ASTROPHYS, V291, P271; WEINREB S, 1963, NATURE, V200, P829, DOI 10.1038/200829a0; WILSON TL, 1993, ASTRON ASTROPHYS, V280, P221; Wright M, 1999, ASTROPHYS J, V518, P284, DOI 10.1086/307270	25	84	85	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2004	432	7017					596	598		10.1038/nature03110	http://dx.doi.org/10.1038/nature03110			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577902	Green Submitted			2022-12-28	WOS:000225433200038
J	Chen, JJ; Zhu, ZL; Gershon, AA; Gershon, MD				Chen, JJ; Zhu, ZL; Gershon, AA; Gershon, MD			Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster	CELL			English	Article							GLYCOPROTEIN-I; HERPES-ZOSTER; CELL; ENVELOPMENT; TRAFFICKING; GROWTH; ENTRY; LOCALIZATION; REPLICATION; LYMPHOCYTES	Varicella zoster virus (VZV) is a highly infectious human pathogen; nevertheless, infectious virions are not released in vitro where infection is cell associated. Four VZV envelope glycoproteins contain mannose 6-phosphate (Man 6-P), and Man 6-P blocks infection of cells by cell-free VZV. Expression of antisense cDNA or siRNA-like transcripts were used to generate five stable human cell lines deficient in cation-independent mannose 6-phosphate receptors (MPRci). All 5 MPRci-deficient lines resisted infection by cell-free, but not cell-associated, VZV, secreted lysosomal enzymes, and released infectious virions when infected by cell-associated VZV. Intracellular MPRci thus appear to divert newly enveloped VZV to late endosomes, and plasmalemmal MPRci are necessary for entry by cellfree VZV. Biopsies from VZV-infected human skin supported the idea that because MPRci expression is naturally lost in maturing superficial epidermal cells, these cells do not divert VZV to endosomes and constitutively secrete infectious VZV.	Columbia Univ, Dept Anat & Cell Biol, P&S, New York, NY 10032 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Columbia Univ, Dept Pediat, New York, NY 10032 USA	Columbia University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Columbia University	Gershon, MD (corresponding author), Columbia Univ, Dept Anat & Cell Biol, P&S, New York, NY 10032 USA.	mdg4@columbia.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027187, R01AI024021, R21AI027187, R21AI024021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012969] Funding Source: NIH RePORTER; NIAID NIH HHS [AI24021, AI27187] Funding Source: Medline; NINDS NIH HHS [NS12969] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], VARICELLA ZOSTER VIR; ARVIN AM, 1986, J INFECT DIS, V154, P422, DOI 10.1093/infdis/154.3.422; Arvin AM, 1996, ANNU REV MICROBIOL, V50, P59, DOI 10.1146/annurev.micro.50.1.59; ARVIN AM, 1995, VIROLOGY, P2547; BHAVSAR JH, 1994, ANAL BIOCHEM, V221, P234, DOI 10.1006/abio.1994.1407; BRUNETTI CR, 1994, J BIOL CHEM, V269, P17067; BRUNETTI CR, 1995, J VIROL, V69, P3517, DOI 10.1128/JVI.69.6.3517-3528.1995; Brunetti CR, 1998, J VIROL, V72, P3330, DOI 10.1128/JVI.72.4.3330-3339.1998; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; Chen Jason J., 2003, Journal of Medical Virology, V70, pS71, DOI 10.1002/jmv.10325; Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; COOK ML, 1970, J ULTRA MOL STRUCT R, V32, P334, DOI 10.1016/S0022-5320(70)80014-4; COOK ML, 1968, J VIROL, V2, P1458, DOI 10.1128/JVI.2.12.1458-1464.1968; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; DiRenzo J, 2002, CANCER RES, V62, P89; Duus KM, 1996, J VIROL, V70, P8961, DOI 10.1128/JVI.70.12.8961-8971.1996; GABEL CA, 1989, J VIROL, V63, P4264, DOI 10.1128/JVI.63.10.4264-4276.1989; GERSHON A, 1973, J GEN VIROL, V18, P21, DOI 10.1099/0022-1317-18-1-21; GERSHON AA, 1994, J VIROL, V68, P6372, DOI 10.1128/JVI.68.10.6372-6390.1994; GERSHON AA, 1999, VACCINES, P475; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; GROSE C, 1981, PEDIATRICS, V68, P735; HARDY I, 1991, NEW ENGL J MED, V325, P1545, DOI 10.1056/NEJM199111283252204; HARSON R, 1995, J VIROL, V69, P4994, DOI 10.1128/JVI.69.8.4994-5010.1995; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; JOHNSON KF, 1990, P NATL ACAD SCI USA, V87, P10010, DOI 10.1073/pnas.87.24.10010; JONES F, 1988, J VIROL, V62, P2701, DOI 10.1128/JVI.62.8.2701-2711.1988; Kinchington PR, 2000, J VIROL, V74, P2265, DOI 10.1128/JVI.74.5.2265-2277.2000; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KOROPCHAK CM, 1989, J VIROL, V63, P2392, DOI 10.1128/JVI.63.5.2392-2395.1989; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li ZS, 2004, J NEUROSCI, V24, P1330, DOI 10.1523/JNEUROSCI.3982-03.2004; Lungu O, 1998, P NATL ACAD SCI USA, V95, P7080, DOI 10.1073/pnas.95.12.7080; LUNGU O, 1995, P NATL ACAD SCI USA, V92, P10980, DOI 10.1073/pnas.92.24.10980; Mallory S, 1997, J VIROL, V71, P8279, DOI 10.1128/JVI.71.11.8279-8288.1997; Maresova L, 2001, J VIROL, V75, P9483, DOI 10.1128/JVI.75.19.9483-9492.2001; MOFFAT JF, 1995, J VIROL, V69, P5236, DOI 10.1128/JVI.69.9.5236-5242.1995; ROSS AH, 1962, NEW ENGL J MED, V267, P369, DOI 10.1056/NEJM196208232670801; SCHMIDT NJ, 1976, INFECT IMMUN, V14, P709, DOI 10.1128/IAI.14.3.709-715.1976; Silverstein S, 2000, VARICELLA ZOSTER VIR, P123; TSOLIA M, 1990, J PEDIATR-US, V116, P184, DOI 10.1016/S0022-3476(05)82872-0; Wang ZH, 2000, J VIROL, V74, P6600, DOI 10.1128/JVI.74.14.6600-6613.2000; Wang ZH, 2001, J VIROL, V75, P323, DOI 10.1128/JVI.75.1.323-340.2001; WELLER TH, 1983, NEW ENGL J MED, V309, P1362, DOI 10.1056/NEJM198312013092205; Weller TH, 1996, J INFECT DIS, V174, pS306, DOI 10.1093/infdis/174.Supplement_3.S306; Wertz PW, 2000, ACTA DERM-VENEREOL, P7; Zerboni L, 2000, VIROLOGY, V270, P278, DOI 10.1006/viro.2000.0304; Zhu Z, 1995, NEUROLOGY, V45, pS15, DOI 10.1212/WNL.45.12_Suppl_8.S15; ZHU ZL, 1995, J VIROL, V69, P7951, DOI 10.1128/JVI.69.12.7951-7959.1995; ZHU ZL, 1995, P NATL ACAD SCI USA, V92, P3546, DOI 10.1073/pnas.92.8.3546	51	103	109	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					915	926		10.1016/j.cell.2004.11.007	http://dx.doi.org/10.1016/j.cell.2004.11.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620351	Bronze			2022-12-28	WOS:000226109700005
J	Dorus, S; Vallender, EJ; Evans, PD; Anderson, JR; Gilbert, SL; Mahowald, M; Wyckoff, GJ; Malcom, CM; Lahn, BT				Dorus, S; Vallender, EJ; Evans, PD; Anderson, JR; Gilbert, SL; Mahowald, M; Wyckoff, GJ; Malcom, CM; Lahn, BT			Accelerated evolution of nervous system genes in the origin of Homo sapiens	CELL			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; CEREBRAL CORTICAL SIZE; DOPAMINE D2 RECEPTORS; HUMAN BRAIN SIZE; MICE LACKING; ADAPTIVE EVOLUTION; MAJOR DETERMINANT; SONIC HEDGEHOG; MOLECULAR EVOLUTION; MENTAL-RETARDATION	Human evolution is characterized by a dramatic increase in brain size and complexity. To probe its genetic basis, we examined the evolution of genes involved in diverse aspects of nervous system biology. We found that these genes display significantly higher rates of protein evolution in primates than in rodents. Importantly, this trend is most pronounced for the subset of genes implicated in nervous system development. Moreover, within primates, the acceleration of protein evolution is most prominent in the lineage leading from ancestral primates to humans. Thus, the remarkable phenotypic evolution of the human nervous system has a salient molecular correlate, i.e., accelerated evolution of the underlying genes, particularly those linked to nervous system development. In addition to uncovering broad evolutionary trends, our study also identified many candidate genes-most of which are implicated in regulating brain size and behavior-that might have played important roles in the evolution of the human brain.	Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Anthropol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago	Lahn, BT (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, 5841 S Maryland Ave, Chicago, IL 60637 USA.	blahn@bsd.uchicago.edu	Vallender, Eric/A-2450-2008	Vallender, Eric/0000-0003-3506-0540; Wyckoff, Gerald/0000-0003-2604-2666				Aiello L, 1990, INTRO HUMAN EVOLUTIO; ARMSTRONG E, 1982, PRIMATE BRAIN EVOLUT; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; BOULTER J, 1990, J BIOL CHEM, V265, P4472; Brodmann Karl, 1912, Anatomischer Anzeiger, V41; Burki F, 2004, NAT GENET, V36, P1061, DOI 10.1038/ng1431; Byrne R., 1988, MACHIAVELLIAN INTELL; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Chen FC, 2001, J HERED, V92, P481, DOI 10.1093/jhered/92.6.481; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; D'Adamo P, 2002, HUM MOL GENET, V11, P2567, DOI 10.1093/hmg/11.21.2567; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Darwin C., 1871, P475; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Elliott KJ, 1996, J MOL NEUROSCI, V7, P217, DOI 10.1007/BF02736842; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Evans PD, 2004, HUM MOL GENET, V13, P1139, DOI 10.1093/hmg/ddh126; Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jerison J. H, 1973, EVOLUTION BRAIN INTE; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Kouprina N, 2004, PLOS BIOL, V2, P653, DOI 10.1371/journal.pbio.0020126; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Li W. H, 1997, MOL EVOLUTION; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Matsuzawa T., 2001, PRIMATE ORIGINS HUMA; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; McConkey E, 2002, TRENDS GENET, V18, P446, DOI 10.1016/S0168-9525(02)02748-8; McConkey EH, 2000, MOL PHYLOGENET EVOL, V15, P1, DOI 10.1006/mpev.1999.0735; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; NOBACK CR, 1970, PRIMATE BRAIN; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; PAGEL MD, 1989, SCIENCE, V244, P1589, DOI 10.1126/science.2740904; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roseboom PH, 1998, MOL BRAIN RES, V63, P189, DOI 10.1016/S0169-328X(98)00273-3; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Shi JX, 2003, P NATL ACAD SCI USA, V100, P8331, DOI 10.1073/pnas.1332748100; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; SPUHLER JN, 1959, EVOLUTION MANS CAPAC; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; SZPIRER C, 1994, P NATL ACAD SCI USA, V91, P11849, DOI 10.1073/pnas.91.25.11849; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; WALKER A, 1983, NATURE, V305, P525, DOI 10.1038/305525a0; Wang YQ, 2004, HUM MOL GENET, V13, P1131, DOI 10.1093/hmg/ddh127; Williams MF, 2002, MED HYPOTHESES, V58, P284, DOI 10.1054/mehy.2001.1516; Yamada M, 2001, P NATL ACAD SCI USA, V98, P14096, DOI 10.1073/pnas.251542998; YANG ZH, 1995, GENETICS, V141, P1641; Yi SJ, 2002, MOL BIOL EVOL, V19, P2191, DOI 10.1093/oxfordjournals.molbev.a004043; Zhang JZ, 2003, GENETICS, V165, P2063; Zhou XH, 2001, MOL CELL BIOL, V21, P5970, DOI 10.1128/MCB.21.17.5970-5978.2001	81	330	394	0	58	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2004	119	7					1027	1040		10.1016/j.cell.2004.11.040	http://dx.doi.org/10.1016/j.cell.2004.11.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620360	Bronze			2022-12-28	WOS:000226109700014
J	Coburn, PS; Pillar, CM; Jett, BD; Haas, W; Gilmore, MS				Coburn, PS; Pillar, CM; Jett, BD; Haas, W; Gilmore, MS			Enterococcus faecalis senses target cells and in response expresses cytolysin	SCIENCE			English	Article							VIRULENCE; HEMOLYSIN; ENDOPHTHALMITIS; CONTRIBUTES; TOXIN; MODEL	Many virulent strains of Enterococcus faecalis. produce a two-subunit toxin, termed cytolysin. Cytolysin expression is regulated by one of the subunits (CylL(S)") through a quorum-sensing autoinduction mechanism. We found that when target cells are absent, the other subunit (CylL(L)") forms a complex with CylL(S)", blocking it from autoinducing the operon. When target cells are present, however, CylL(L)" binds preferentially to the target, allowing free CylL(S)" to accumulate above the induction threshold. Thus, enterococci use CylL(L)" to actively probe the environment for target cells, and when target cells are detected, allows the organism to express high levels of cytolysin in response.	Univ Oklahoma, Hlth Sci Ctr, Stanton L Young Biomed Res Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; Univ Oklahoma, Hlth Sci Ctr, Stanton L Young Biomed Res Ctr, Dept Ophthalmol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Gilmore, MS (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, 20 Staniford St, Boston, MA 02114 USA.	mgilmore@vision.eri.harvard.edu	Coburn, Phillip/V-6698-2019	Coburn, Phillip/0000-0003-3799-5251	NATIONAL EYE INSTITUTE [R01EY008289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041108] Funding Source: NIH RePORTER; NEI NIH HHS [EY08289] Funding Source: Medline; NIAID NIH HHS [AI041108] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Coburn PS, 2003, CELL MICROBIOL, V5, P661, DOI 10.1046/j.1462-5822.2003.00310.x; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; GILMORE MS, UNPUB; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; HUYCKE MM, 1991, ANTIMICROB AGENTS CH, V35, P1626, DOI 10.1128/AAC.35.8.1626; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; JETT BD, 1992, INFECT IMMUN, V60, P2445, DOI 10.1128/IAI.60.6.2445-2452.1992; Papo N, 2003, BIOCHEMISTRY-US, V42, P458, DOI 10.1021/bi0267846; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Singh KV, 1998, J INFECT DIS, V178, P1416, DOI 10.1086/314453; STEVENS SX, 1992, INVEST OPHTH VIS SCI, V33, P1650; Todd EW, 1934, J PATHOL BACTERIOL, V39, P299, DOI 10.1002/path.1700390207	13	74	80	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2270	2272		10.1126/science.1103996	http://dx.doi.org/10.1126/science.1103996			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618522				2022-12-28	WOS:000225950000051
J	Thursby-Pelham, F				Thursby-Pelham, F			A remarkable resilience	LANCET			English	Editorial Material									Royal Sussex Cty Hosp, Phys Intens Therapy Unit, Brighton BN2 5BE, E Sussex, England	University of Brighton	Thursby-Pelham, F (corresponding author), Royal Sussex Cty Hosp, Phys Intens Therapy Unit, Brighton BN2 5BE, E Sussex, England.								0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2229	2229		10.1016/S0140-6736(04)17599-5	http://dx.doi.org/10.1016/S0140-6736(04)17599-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610812				2022-12-28	WOS:000225799700035
J	Winkelmann, A; Guldner, FH				Winkelmann, A; Guldner, FH			Cadavers as teachers: the dissecting room experience in Thailand	BRITISH MEDICAL JOURNAL			English	Article							MEDICAL-EDUCATION; TEACHING ANATOMY; STUDENTS; DEAD		Univ Hosp, Inst Cell Biol & Neurobiol, Ctr Anat, Charite, D-10098 Berlin, Germany; Univ W Indies, Sect Anat, Dept Basic Med Sci, Fac Med, Kingston 7, Jamaica	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University West Indies Mona Jamaica	Winkelmann, A (corresponding author), Univ Hosp, Inst Cell Biol & Neurobiol, Ctr Anat, Charite, D-10098 Berlin, Germany.	andreas.winkelmann@charite.de		Winkelmann, Andreas/0000-0003-1047-2477				BERTMAN SL, 1985, MED EDUC, V19, P374, DOI 10.1111/j.1365-2923.1985.tb01340.x; Dyer GSM, 2000, ACAD MED, V75, P969, DOI 10.1097/00001888-200010000-00008; Furness P, 2003, BRIT MED J, V327, P759, DOI 10.1136/bmj.327.7418.759; Good B, 1994, MED RATIONALITY EXPE; Hafferty F.W., 1991, VALLEY DEATH SOCIALI; HAFFERTY FW, 1988, J HEALTH SOC BEHAV, V29, P344, DOI 10.2307/2136868; Hull S K, 1998, Acad Med, V73, P577, DOI 10.1097/00001888-199805000-00038; Lela J. W., 1988, BIOMEDICINE EXAMINED, P125; McLachlan JC, 2004, MED EDUC, V38, P418, DOI 10.1046/j.1365-2923.2004.01795.x; OLSON GA, 1992, ASIAN FOLKLORE STUD, V51, P279, DOI 10.2307/1178335; Ongcharit C, 1998, TRANSPLANT P, V30, P3385, DOI 10.1016/S0041-1345(98)01071-9; Popp Richard L., 1985, MISSIOLOGY, V13, P147; Rosenfield PJ, 2004, MED EDUC, V38, P927, DOI 10.1111/j.1365-2929.2004.01931.x; SCHOTZINGER KA, 1987, OMEGA-J DEATH DYING, V18, P217, DOI 10.2190/UH6B-TYMB-65UU-3PK0; SEGAL DA, 1988, ANTHROPOL QUART, V61, P17, DOI 10.2307/3317868; Shaffer K, 2004, NEW ENGL J MED, V351, P1279, DOI 10.1056/NEJMp048100; SUKOL RB, 1995, HUM PATHOL, V26, P700, DOI 10.1016/0046-8177(95)90216-3; Suwanwela C, 1996, MED EDUC, V30, P401, DOI 10.1111/j.1365-2923.1996.tb00858.x; Tuffs Annette, 2003, BMJ, V327, P1068, DOI 10.1136/bmj.327.7423.1068-c	19	89	90	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1455	1457		10.1136/bmj.329.7480.1455	http://dx.doi.org/10.1136/bmj.329.7480.1455			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	882VB	15604182	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000225965800025
J	Mervis, J				Mervis, J			Department of energy - Nominee scores cabinet hat trick	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2004	306	5704					2018	2018						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604373				2022-12-28	WOS:000225841000017
J	Shimizu, KK; Cork, JM; Caicedo, AL; Mays, CA; Moore, RC; Olsen, KM; Ruzsa, S; Coop, G; Bustamante, CD; Awadalla, P; Purugganan, MD				Shimizu, KK; Cork, JM; Caicedo, AL; Mays, CA; Moore, RC; Olsen, KM; Ruzsa, S; Coop, G; Bustamante, CD; Awadalla, P; Purugganan, MD			RETRACTED: Darwinian selection on a selfing locus (Retracted Article. See vol 320, pg 176, 2008)	SCIENCE			English	Article; Retracted Publication							ARABIDOPSIS-THALIANA; S-LOCUS; INCOMPATIBILITY; GENES; DIVERSITY; EVOLUTION; DISTANCE	The shift to self-pollination is one of the most prevalent evolutionary transitions in flowering plants. In the selfing plant Arabidopsis thaliana, pseudogenes at the SCR and SRK self-incompatibility loci are believed to underlie the evolution of self-fertilization. Positive directional selection has driven the evolutionary fixation of pseudogene alleles of SCR, leading to substantially reduced nucleotide variation. Coalescent simulations indicate that this adaptive event may have occurred very recently and is possibly associated with the post-Pleistocene expansion of A. thaliana from glacial refugia. This suggests that ancillary morphological innovations associated with self-pollination can evolve rapidly after the inactivation of the self-incompatibility response.	N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA	University of North Carolina; North Carolina State University; Kyoto University; University of Oxford; Cornell University	Purugganan, MD (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	michaelp@unity.ncsu.edu	Awadalla, Philip/AAC-4896-2021	Olsen, Kenneth/0000-0002-8338-3638; Coop, Graham/0000-0001-8431-0302				ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Bergelson J, 1998, GENETICS, V148, P1311; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Charles R, 2003, J DENT RES, V82, P101; Charlesworth D, 1998, HEREDITY, V81, P1, DOI 10.1038/sj.hdy.6884000; Charlesworth D, 2003, GENETICS, V164, P1519; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Chookajorn T, 2004, P NATL ACAD SCI USA, V101, P911, DOI 10.1073/pnas.2637116100; Coop G, 2004, THEOR POPUL BIOL, V66, P219, DOI 10.1016/j.tpb.2004.06.006; Darwin CR, 1876, EFFECTS CROSS SELF F; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HUDSON RR, 1994, GENETICS, V136, P1329; JAIN SK, 1976, ANNU REV ECOL SYST, V7, P469, DOI 10.1146/annurev.es.07.110176.002345; Kachroo A, 2001, SCIENCE, V293, P1824, DOI 10.1126/science.1062509; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; McVean G, 2002, GENETICS, V160, P1231; Nasrallah ME, 2002, SCIENCE, V297, P247, DOI 10.1126/science.1072205; OKane SL, 1997, NOVON, V7, P323, DOI 10.2307/3391949; Olsen KM, 2002, GENETICS, V160, P1641; Runions CJ, 2000, AM J BOT, V87, P1439, DOI 10.2307/2656870; Sato K, 2002, GENETICS, V162, P931; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; STEBBINS GL, 1950, VARIATION EVOLUTION; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Yoshida K, 2003, GENES GENET SYST, V78, P11, DOI 10.1266/ggs.78.11	28	84	93	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2081	2084		10.1126/science.1103776	http://dx.doi.org/10.1126/science.1103776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604405				2022-12-28	WOS:000225841000059
J	Harding, A				Harding, A			Sir John Robert Vane - Obituary	LANCET			English	Biographical-Item												anne_harding@yahoo.com						McCook A, 2004, LANCET, V364, P930, DOI 10.1016/S0140-6736(04)17009-8	1	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	2004	364	9451					2090	2090		10.1016/S0140-6736(04)17571-5	http://dx.doi.org/10.1016/S0140-6736(04)17571-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15595196				2022-12-28	WOS:000225742300011
J	Prasad, SK; Assomull, RG; Pennell, D				Prasad, SK; Assomull, RG; Pennell, D			Recent developments in non-invasive cardiology	BRITISH MEDICAL JOURNAL			English	Review							BEAM COMPUTED-TOMOGRAPHY; CARDIOVASCULAR MAGNETIC-RESONANCE; ACUTE MYOCARDIAL-INFARCTION; BRAIN NATRIURETIC PEPTIDE; CORONARY-ARTERY-DISEASE; VENTRICULAR EJECTION FRACTION; HEART-FAILURE; AMERICAN-COLLEGE; PERFUSION; RISK		Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, London SW3 6NP, England	Royal Brompton Hospital	Prasad, SK (corresponding author), Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, London SW3 6NP, England.	s.prasad@rbh.ntharnes.nhs.uk		Pennell, Dudley/0000-0001-5523-1314				Beek AM, 2003, J AM COLL CARDIOL, V42, P895, DOI 10.1016/S0735-1097(03)00835-0; Bellenger NG, 2000, EUR HEART J, V21, P1387, DOI 10.1053/euhj.2000.2011; Chen H H, 2000, Curr Cardiol Rep, V2, P198, DOI 10.1007/s11886-000-0069-3; Detrano RC, 1999, CIRCULATION, V99, P2633, DOI 10.1161/01.CIR.99.20.2633; Gerber BL, 2002, CIRCULATION, V106, P1083, DOI 10.1161/01.CIR.0000027818.15792.1E; Harrison A, 2002, ANN EMERG MED, V39, P131, DOI 10.1067/mem.2002.121483; Heidenreich PA, 2004, J AM COLL CARDIOL, V43, P1019, DOI 10.1016/j.jacc.2003.10.043; Hobbs FDR, 2002, BMJ-BRIT MED J, V324, P1498, DOI 10.1136/bmj.324.7352.1498; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; Klein C, 2002, CIRCULATION, V105, P162, DOI 10.1161/hc0202.102123; Klocke FJ, 2003, J AM COLL CARDIOL, V42, P1318, DOI 10.1016/j.jacc.2003.08.011; Krishnaswamy P, 2001, AM J MED, V111, P274, DOI 10.1016/S0002-9343(01)00841-5; Maisel A, 2002, CIRCULATION, V105, P2328, DOI 10.1161/01.CIR.0000019121.91548.C2; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Moon JCC, 2004, HEART, V90, P645, DOI 10.1136/hrt.2003.014969; Nagel E, 2003, CIRCULATION, V108, P432, DOI 10.1161/01.CIR.0000080915.35024.A9; O'Rourke RA, 2000, CIRCULATION, V102, P126, DOI 10.1161/01.CIR.102.1.126; Panting JR, 2002, NEW ENGL J MED, V346, P1948, DOI 10.1056/NEJMoa012369; Raggi P, 2000, CIRCULATION, V101, P850, DOI 10.1161/01.CIR.101.8.850; Rich S, 2002, PREV MED, V34, P1, DOI 10.1006/pmed.2000.0813; Richards AM, 2001, J AM COLL CARDIOL, V37, P1781, DOI 10.1016/S0735-1097(01)01269-4; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Shaw LJ, 2001, J NUCL MED, V42, P1424; Taillefer R, 1999, J NUCL CARDIOL, V6, P169, DOI 10.1016/S1071-3581(99)90077-6; Taylor AM, 2000, CIRCULATION, V101, P1670; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Underwood SR, 1999, EUR HEART J, V20, P157, DOI 10.1053/euhj.1998.1196; Yuan C, 2002, CIRCULATION, V105, P181, DOI 10.1161/hc0202.102121	29	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 11	2004	329	7479					1386	1389		10.1136/bmj.329.7479.1386	http://dx.doi.org/10.1136/bmj.329.7479.1386			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880JB	15591565	Green Published			2022-12-28	WOS:000225785000024
J	Erdelyi, Z; Sladecek, M; Stadler, LM; Zizak, I; Langer, GA; Kis-Varga, M; Beke, DL; Sepiol, B				Erdelyi, Z; Sladecek, M; Stadler, LM; Zizak, I; Langer, GA; Kis-Varga, M; Beke, DL; Sepiol, B			Transient interface sharpening in miscible alloys	SCIENCE			English	Article							MULTILAYERS; SEGREGATION	We observed that diffuse interfaces sharpen rather than broaden in completely miscible ideal binary systems. This is shown in situ during heat treatments at gradually increasing temperatures by scattering of synchrotron radiation in coherent Mo/V multilayers containing initially diffuse interfaces. This effect provides a useful tool for the improvement of interfaces and offers a way to fabricate better x-ray or neutron mirrors, microelectronic devices, or multilayers with giant magnetic resistance.	Univ Debrecen, Dept Solid State Phys, H-4010 Debrecen, Hungary; Hungarian Acad Sci, Nucl Res Inst, H-4100 Debrecen, Hungary; Univ Vienna, Inst Mat Phys, A-1090 Vienna, Austria; Hahn Meitner Inst Berlin GmbH, D-14109 Berlin, Germany	University of Debrecen; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Nuclear Research; University of Vienna; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Erdelyi, Z (corresponding author), Univ Debrecen, Dept Solid State Phys, POB 2, H-4010 Debrecen, Hungary.	zerdelyi@dragon.unideb.hu	Zizak, Ivo/A-4661-2010; Erdélyi, Zoltán/E-4035-2010	Zizak, Ivo/0000-0002-5959-0995; Erdélyi, Zoltán/0000-0003-0364-7996				Dudas A, 1999, J APPL PHYS, V86, P2008, DOI 10.1063/1.371001; Erdelyi Z, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.165901; Erdelyi Z, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.092102; Erdelyi Z, 2002, SURF SCI, V496, P129, DOI 10.1016/S0039-6028(01)01571-0; FULLERTON EE, 1992, PHYS REV B, V45, P9292, DOI 10.1103/PhysRevB.45.9292; JESSON DE, 1997, HDB THIN FILM PROCES, VF; KANO H, 1993, APPL PHYS LETT, V63, P2839, DOI 10.1063/1.110791; Labat S, 1999, APPL PHYS LETT, V75, P914, DOI 10.1063/1.124552; STEARNS MB, 1988, PHYS REV B, V38, P8109, DOI 10.1103/PhysRevB.38.8109; Walther T, 1997, DEFECT DIFFUS FORUM, V143, P1135, DOI 10.4028/www.scientific.net/DDF.143-147.1135; Xu M, 2000, J CRYST GROWTH, V212, P291, DOI 10.1016/S0022-0248(00)00007-5	11	64	65	4	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2004	306	5703					1913	1915		10.1126/science.1104400	http://dx.doi.org/10.1126/science.1104400			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591196				2022-12-28	WOS:000225695600037
J	Lizarralde, D; Gaherty, JB; Collins, JA; Hirth, G; Kim, SD				Lizarralde, D; Gaherty, JB; Collins, JA; Hirth, G; Kim, SD			Spreading-rate dependence of melt extraction at mid-ocean ridges from mantle seismic refraction data	NATURE			English	Article							ANISOTROPY; VELOCITY; ROCKS; CRUST	A variety of observations indicate that mid-ocean ridges produce less crust at spreading rates below 20 mm yr(-1) (refs 1-3), reflecting changes in fundamental ridge processes with decreasing spreading rate. The nature of these changes, however, remains uncertain, with end-member explanations being decreasing shallow melting(3) or incomplete melt extraction(2), each due to the influence of a thicker thermal lid. Here we present results of a seismic refraction experiment designed to study mid-ocean ridge processes by imaging residual mantle structure. Our results reveal an abrupt lateral change in bulk mantle seismic properties associated with a change from slow to ultraslow palaeo-spreading rate. Changes in mantle velocity gradient, basement topography and crustal thickness all correlate with this spreading-rate change. These observations can be explained by variations in melt extraction at the ridge, with a gabbroic phase preferentially retained in the mantle at slower spreading rates. The estimated volume of retained melt balances the similar to1.5-km difference in crustal thickness, suggesting that changes in spreading rate affect melt-extraction processes rather than total melting.	Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Woods Hole Oceanog Inst, Dept Marine Geol & Geophys, Woods Hole, MA 02543 USA	University System of Georgia; Georgia Institute of Technology; Columbia University; Woods Hole Oceanographic Institution	Lizarralde, D (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	danl@eas.gatech.edu		Lizarralde, Daniel/0000-0001-6152-6039				[Anonymous], 1983, GEOPHYS J ROY ASTR S, V75, P23, DOI 10.1111/j.1365-246X.1983.tb01877.x; ASADA T, 1979, TECTONOPHYSICS, V56, P67, DOI 10.1016/0040-1951(79)90009-X; Ben Ismail W, 1998, TECTONOPHYSICS, V296, P145; Blackman DK, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000247; Cannat M, 1996, J GEOPHYS RES-SOL EA, V101, P2847, DOI 10.1029/95JB03116; CHEN YJ, 1992, GEOPHYS RES LETT, V19, P753, DOI 10.1029/92GL00161; Chian DP, 1996, GEOPHYS RES LETT, V23, P2077, DOI 10.1029/96GL02070; CHRISTENSEN NI, 1974, J GEOPHYS RES, V79, P407, DOI 10.1029/JB079i002p00407; Detrick RS, 1998, J GEOPHYS RES-SOL EA, V103, P30485, DOI 10.1029/98JB02409; Dick H.B.J, 1989, GEOL SOC LOND SPEC P, V42, P71, DOI DOI 10.1144/GSL.SP.1989.042.01.06; GAHERTY JB, IN PRESS EARTH PLANE; Goes S, 2000, J GEOPHYS RES-SOL EA, V105, P11153, DOI 10.1029/1999JB900300; GOODMAN D, 1991, GEOPHYS J INT, V106, P667, DOI 10.1111/j.1365-246X.1991.tb06338.x; GREEN DH, 1967, GEOCHIM COSMOCHIM AC, V31, P767, DOI 10.1016/S0016-7037(67)80031-0; Greenfield RJ, 1996, J GEOPHYS RES-SOL EA, V101, P5643, DOI 10.1029/95JB03462; GROVE TL, 1992, GEOPH MONOG SERIES, V71, P281; GROW JA, 1977, GEOLOGY, V5, P625, DOI 10.1130/0091-7613(1977)5<625:IMSRPF>2.0.CO;2; Jokat W, 2003, NATURE, V423, P962, DOI 10.1038/nature01706; Jordan T. H., 1979, MANTLE SAMPLE INCLUS, P1, DOI DOI 10.1029/SP016P0001; Kelemen P.B., 2004, JOIDES J P ODP 209 I, V30, P14; LANGMUIR CH, 1992, GEOPH MONOG SERIES, V71, P183; Lizarralde D, 1997, J GEOPHYS RES-SOL EA, V102, P22855, DOI 10.1029/96JB03805; Muller RD, 1997, J GEOPHYS RES-SOL EA, V102, P3211, DOI 10.1029/96JB01781; NAKAMURA Y, 1987, GEOPHYSICS, V52, P1601, DOI 10.1190/1.1442277; PURDY GM, 1983, GEOPHYS J ROY ASTR S, V72, P115, DOI 10.1111/j.1365-246X.1983.tb02808.x; Spiegelman M, 1999, NATURE, V402, P282, DOI 10.1038/46260; STEPHEN RA, 1985, J GEOPHYS RES-SOLID, V90, P1383, DOI 10.1029/JB090iB13p11383; White RS, 2001, J PETROL, V42, P1171, DOI 10.1093/petrology/42.6.1171; ZELT CA, 1992, GEOPHYS J INT, V108, P16, DOI 10.1111/j.1365-246X.1992.tb00836.x; ZVEREV SM, 1987, GEODYN SER AM GEOPHY, V16, P273	30	82	83	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					744	747		10.1038/nature03140	http://dx.doi.org/10.1038/nature03140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592410				2022-12-28	WOS:000225597200045
J	Elsayed, EA; Mousa, N; Dabbagh, A; El-Bushra, H; Mahoney, F; Haithami, S; El-Sakka, H; Sabitenelli, G; Agbo, S; Nandy, R; Cairns, L				Elsayed, EA; Mousa, N; Dabbagh, A; El-Bushra, H; Mahoney, F; Haithami, S; El-Sakka, H; Sabitenelli, G; Agbo, S; Nandy, R; Cairns, L		CDC	Emergency measles control activities - Darfur, Sudan, 2004 (Reprinted from MMWR, vol 53, pg 897-899, 2004)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint									Fed Minst Hlth Sudan, Khartoum, Sudan; WHO, CH-1211 Geneva, Switzerland; WHO, Eastern Mediterranean Reg Off, Cairo, Egypt; UNICEF, Khartoum, Sudan; CDC, Global Immunizat Div, Natl Immunizat Program, Atlanta, GA 30333 USA	World Health Organization; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Centers for Disease Control & Prevention - USA	Elsayed, EA (corresponding author), Fed Minst Hlth Sudan, Khartoum, Sudan.							Elsayed E. A., 2004, Morbidity and Mortality Weekly Report, V53, P897	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2004	292	22					2716	2718						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877CY	15585723				2022-12-28	WOS:000225546600009
J	Eckart, RE; Scoville, SL; Campbell, CL; Shry, EA; Stajduhar, KC; Potter, RN; Pearse, LA; Virmani, R				Eckart, RE; Scoville, SL; Campbell, CL; Shry, EA; Stajduhar, KC; Potter, RN; Pearse, LA; Virmani, R			Sudden death in young adults: A 25-year review of autopsies in military recruits	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY ANOMALIES; SICKLE-CELL TRAIT; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC DEATH; CARDIOVASCULAR-DISEASE; WATER-INTOXICATION; POPULATION; ECHOCARDIOGRAPHY; ATHLETE; CLASSIFICATION	Background: Sudden death among military recruits is a rare but devastating occurrence. Because extensive medical data are available on this cross-sectional and diverse population, identification of the underlying causes of sudden death may promote health care policy to reduce the incidence of sudden death. Objective: To determine the causes of nontraumatic sudden death among a cohort of military recruits. Design: Retrospective cohort study using demographic and autopsy data from the Department of Defense Recruit Mortality Registry. Setting: Basic military training. Patients: All nontraumatic sudden deaths from a monitored 6.3 million men and women age 18 to 35 years. Measurements: Descriptive analysis, crude mortality rates of causes of sudden death, and frequency of events as a function of cause of death. Results: Of 126 nontraumatic sudden deaths (rate, 13.0/100 000 recruit-years), 108 (86%) were related to exercise. The most common cause of sudden death was an identifiable cardiac abnormality (64 of 126 recruits [51%]); however, a substantial number of deaths remained unexplained (44 of 126 recruits [35%]). The predominant structural cardiac abnormalities were coronary artery abnormalities (39 of 64 recruits [61%]), myocarditis (13 of 64 recruits [20%]), and hypertrophic cardiomyopathy (8 of 64 recruits [13%]). An anomalous coronary artery accounted for one third (21 of 64 recruits) of the cases in this cohort, and, in each, the left coronary artery arose from the right (anterior) sinus of Valsalva, coursing between the pulmonary artery and aorta. Limitations: This cohort underwent a preenlistment screening program that included history and physical examination; this may have altered outcomes. Conclusions: cardiac abnormalities are the leading identifiable cause of sudden death among military recruits; however, more than one third of sudden deaths remain unexplained after detailed medical investigation.	Brooke Army Med Ctr, San Antonio, TX USA; Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD USA; Wilford Hall USAF Med Ctr, Lackland AFB, TX 78236 USA; Armed Forces Inst Pathol, Washington, DC 20306 USA	San Antonio Military Medical Center; United States Department of Defense; United States Army; United States Department of Defense; United States Air Force; United States Department of Defense	Eckart, RE (corresponding author), Brigham & Womens Hosp, USA, Cardiac Arrhythmia Serv, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	Robert.Eckart@us.army.mil						ANDERSON TM, 1983, PEDIATRICIAN, V13, P165; ANGELINI P, 1989, AM HEART J, V117, P418, DOI 10.1016/0002-8703(89)90789-8; Angelini P, 2002, TEX HEART I J, V29, P271; Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0; Basso C, 2001, Cardiol Rev, V9, P312, DOI 10.1097/00045415-200111000-00005; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Cupp MJ, 1999, AM FAM PHYSICIAN, V59, P1239; Davis JA, 2001, J AM COLL CARDIOL, V37, P593, DOI 10.1016/S0735-1097(00)01136-0; Dodge-Khatami A, 2000, Ann Thorac Surg, V69, pS270; EPSTEIN SE, 1986, J AM COLL CARDIOL, V7, P220, DOI 10.1016/S0735-1097(86)80285-6; Felmeden D, 2000, INT J CLIN PRACT, V54, P390; Franklin BA, 1997, SPORTS MED, V24, P97, DOI 10.2165/00007256-199724020-00003; Gardner JW, 2002, MIL MED, V167, P964; Gardner JW, 2002, MIL MED, V167, P432; Garigan TP, 1999, MIL MED, V164, P234, DOI 10.1093/milmed/164.3.234; KARK JA, 1987, NEW ENGL J MED, V317, P781, DOI 10.1056/NEJM198709243171301; Kollef M H, 1990, Mil Med, V155, pA7; LEWIS JF, 1989, AM J CARDIOL, V64, P1029, DOI 10.1016/0002-9149(89)90802-3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Maron BJ, 2000, CIRCULATION, V102, P858; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 1998, ANN INTERN MED, V129, P379, DOI 10.7326/0003-4819-129-5-199809010-00006; Maron BJ, 2003, AM J CARDIOL, V91, P1195, DOI 10.1016/S0002-9149(03)00266-2; MARON BJ, 1993, NEW ENGL J MED, V329, P55, DOI 10.1056/NEJM199307013290113; MARON BJ, 1986, J AM COLL CARDIOL, V7, P204, DOI 10.1016/S0735-1097(86)80283-2; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; Maron BJ, 1998, CURR PROB CARDIOLOGY, V23, P482, DOI 10.1016/S0146-2806(98)80008-X; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; McNeill KM, 2000, EMERG INFECT DIS, V6, P415, DOI 10.3201/eid0604.000419; Murray MJ, 1996, MIL MED, V161, P303, DOI 10.1093/milmed/161.5.303; MURRY PM, 1995, AM J CARDIOL, V76, P849, DOI 10.1016/S0002-9149(99)80244-6; Neuhauser KM, 1999, MIL MED, V164, P841, DOI 10.1093/milmed/164.12.841; Phelps SE, 2000, MIL MED, V165, P157, DOI 10.1093/milmed/165.2.157; PHILLIPS M, 1986, JAMA-J AM MED ASSOC, V256, P2696, DOI 10.1001/jama.256.19.2696; ROTHMAN KJ, 1975, INT J BIOMED COMPUT, V6, P33, DOI 10.1016/0020-7101(75)90022-7; Samenuk D, 2002, MAYO CLIN PROC, V77, P12, DOI 10.4065/77.1.12; SCOVILLE S, 2002, THESIS U HLTH SCI; Scoville SL, 2004, AM J PREV MED, V26, P205, DOI 10.1016/j.amepre.2003.12.003; Scoville SL, 2004, AM J PREV MED, V26, P194, DOI 10.1016/j.amepre.2003.11.001; Shry EA, 2001, AM J CARDIOL, V87, P1428, DOI 10.1016/S0002-9149(01)01572-7; TAYLOR AJ, 1992, J AM COLL CARDIOL, V20, P640, DOI 10.1016/0735-1097(92)90019-J; Villa RB, 2001, REV ESP CARDIOL, V54, P269; Virmani Renu, 1997, Cardiology Clinics, V15, P439, DOI 10.1016/S0733-8651(05)70351-9; Waller B F, 1985, Cardiovasc Clin, V15, P9; WEIDENBENER EJ, 1995, CLIN J SPORT MED, V5, P86, DOI 10.1097/00042752-199504000-00003	45	585	615	2	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2004	141	11					829	834		10.7326/0003-4819-141-11-200412070-00005	http://dx.doi.org/10.7326/0003-4819-141-11-200412070-00005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876WZ	15583223				2022-12-28	WOS:000225530700001
J	Carrell, RW				Carrell, RW			Prion dormancy and disease	SCIENCE			English	Editorial Material							BLOOD-TRANSFUSION; TRANSMISSION; BSE		Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England	University of Cambridge	Carrell, RW (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England.	rwc1000@cam.ac.uk						Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; ANDREWS NJ, UK CREUTZFELDTJAKOB; Collins SJ, 2004, LANCET, V363, P51, DOI 10.1016/S0140-6736(03)15171-9; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Lee HS, 2001, J INFECT DIS, V183, P192, DOI 10.1086/317935; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932	10	7	8	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1692	1693		10.1126/science.1106679	http://dx.doi.org/10.1126/science.1106679			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576598				2022-12-28	WOS:000225630800030
J	Iriarte, J; Holst, I; Marozzi, O; Listopad, C; Alonso, E; Rinderknecht, A; Montana, J				Iriarte, J; Holst, I; Marozzi, O; Listopad, C; Alonso, E; Rinderknecht, A; Montana, J			Evidence for cultivar adoption and emerging complexity during the mid-Holocene in the La Plata basin	NATURE			English	Article							IDENTIFYING MAIZE	Multidisciplinary investigations at the Los Ajos archaeological mound complex in the wetlands of southeastern Uruguay challenge the traditional view that the La Plata basin was inhabited by simple groups of hunters and gatherers for much of the pre-Hispanic era(1-4). Here we report new archaeological, palaeoecological and botanical data indicating that during an increasingly drier mid-Holocene, at around 4,190 radiocarbon (C-14) years before present (BP), Los Ajos became a permanent circular plaza village, and its inhabitants adopted the earliest cultivars known in southern South America. The architectural plan of Los Ajos during the following Ceramic Mound Period ( around 3,000-500 C-14 yr B P) is similar to, but earlier than, settlement patterns demonstrated in Amazonia(5-10), revealing a new and independent architectural tradition for South America.	Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archaeol, Balboa, Panama; Fac Humanidades & Ciencias Educ, Dept Antropol, Montevideo 1200, Uruguay; Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; Univ Republica, Fac Quim, Dept Bot, Montevideo, Uruguay; Museo Nacl Hist Nat, Montevideo, Uruguay; Museo Nacl Antropol, Montevideo, Uruguay; Univ Republica, Fac Agron, Montevideo 12900, Uruguay	Smithsonian Institution; Smithsonian Tropical Research Institute; Florida Institute of Technology; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Iriarte, J (corresponding author), Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archaeol, Box 2072, Balboa, Panama.	iriartej@ancon.si.edu	Iriarte, Jose/A-1141-2010	Iriarte, Jose/0000-0002-8155-5360				BARCCO R, 1993, PROYECTO ARQUEOLOGIA; Bracco R., 1999, ARQUEOLOGIA BIOANTRO, P13; Bracco Roberto., 2000, ARQUEOLOG A TIERRAS, P13; DEBLASIS P, 1998, J AM ARCHAEOL, V15, P75; DILLEHAY TD, 1989, AM ANTIQUITY, V54, P733, DOI 10.2307/280679; Erickson CL, 1995, ARCHAEOLOGY LOWLAND, P66; Heckenberger MJ, 2003, SCIENCE, V301, P1710, DOI 10.1126/science.1086112; Iriarte J, 2003, J ARCHAEOL SCI, V30, P1085, DOI 10.1016/S0305-4403(02)00164-4; Iriarte J., 2001, ENDURING RECORDS ENV, P61; Iriarte J., 2003, THESIS U KENTUCKY; LATHRAP DW, 1977, ARCHAEOLOGY, V30, P2; LEHMANN J, 2003, AMAZONIAN DARK EARTH; Lopez Mazz JM, 2001, LAT AM ANTIQ, V12, P231; Meggers B. J., 1978, ANCIENT NATIVE AM, P543; Moseley M. E., 1974, MARITIME FDN ANDEAN; Pearsall DM, 2003, J ARCHAEOL SCI, V30, P611, DOI 10.1016/S0305-4403(02)00237-6; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; Piperno DR, 2000, NATURE, V407, P894, DOI 10.1038/35038055; Piperno DR, 2003, SCIENCE, V299, P1054, DOI 10.1126/science.1080365; Roosevelt Anna, 1991, MOUNDBUILDERS AMAZON; Sandweiss DH, 1999, SCIENCE, V283, P499, DOI 10.1126/science.283.5401.499; SCHMITZ PI, 1987, J WORLD PREHIST, V1, P53, DOI 10.1007/BF00974817; SCMITZ PI, 1998, ATERROS INDIGENAS PA; Solis RS, 2001, SCIENCE, V292, P723, DOI 10.1126/science.1059519; Spencer CS, 1998, LAT AM ANTIQ, V9, P95, DOI 10.2307/971989; Steward Julian H., 1959, NATIVE PEOPLES S AM; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Willey Gordon R., 1971, INTRO AM ARCHAEOLOGY, V2; Wust I, 1999, LAT AM ANTIQ, V10, P3, DOI 10.2307/972208	30	111	116	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					614	617		10.1038/nature02983	http://dx.doi.org/10.1038/nature02983			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577908				2022-12-28	WOS:000225433200044
J	Phan, RT; Dalla-Favera, R				Phan, RT; Dalla-Favera, R			The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells	NATURE			English	Article							CLASS-SWITCH RECOMBINATION; DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; TRANSCRIPTIONAL REPRESSOR; TUMOR SUPPRESSION; LYMPHOMA; INFLAMMATION; MUTATIONS; DIFFERENTIATION	The human proto-oncogene BCL6 encodes a BTB/POZ-zinc-finger transcriptional repressor that is necessary for germinal-centre formation and is implicated in the pathogenesis of B-cell lymphoma(1-3). The precise function of BCL6 in germinal-centre development and lymphomagenesis is unclear because very few direct BCL6 target genes have been identified(4-7). Here we report that BCL6 suppresses the expression of the p53 ( also known as TP53) tumour suppressor gene and modulates DNA damage-induced apoptotic responses in germinal-centre B cells. BCL6 represses p53 transcription by binding two specific DNA sites within the p53 promoter region and, accordingly, p53 expression is absent in germinal-centre B cells where BCL6 is highly expressed. Suppression of BCL6 expression via specific short interfering RNA leads to increased levels of p53 messenger RNA and protein both under basal conditions and in response to DNA damage. Most notably, constitutive expression of BCL6 protects B cell lines from apoptosis induced by DNA damage. These results suggest that an important function of BCL6 is to allow germinal-centre B cells to tolerate the physiological DNA breaks required for immunoglobulin class switch recombination and somatic hypermutation without inducing a p53-dependent apoptotic response. These findings also imply that deregulated BCL6 expression contributes to lymphomagenesis in part by functional inactivation of p53.	Columbia Univ, Inst Canc Res, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Res, New York, NY 10032 USA.	rd10@columbia.edu						Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Kurosu T, 2003, ONCOGENE, V22, P4459, DOI 10.1038/sj.onc.1206755; LO CF, 1994, BLOOD, V83, P1757; LOCOCO F, 1993, BLOOD, V82, P2289; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Niu HF, 2003, J EXP MED, V198, P211, DOI 10.1084/jem.20021395; Offit K, 1995, LEUKEMIA LYMPHOMA, V20, P85, DOI 10.3109/10428199509054757; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Storb U, 1996, CURR OPIN IMMUNOL, V8, P206, DOI 10.1016/S0952-7915(96)80059-8; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Ye BH, 1995, EMBO J, V14, P6209, DOI 10.1002/j.1460-2075.1995.tb00311.x; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	29	482	506	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					635	639		10.1038/nature03147	http://dx.doi.org/10.1038/nature03147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577913				2022-12-28	WOS:000225433200049
J	Imaizumi-Anraku, H; Takeda, N; Charpentier, M; Perry, J; Miwa, H; Umehara, Y; Kouchi, H; Murakami, Y; Mulder, L; Vickers, K; Pike, J; Downie, JA; Wang, T; Sato, S; Asamizu, E; Tabata, S; Yoshikawa, M; Murooka, Y; Wu, GJ; Kawaguchi, M; Kawasaki, S; Parniske, M; Hayashi, M				Imaizumi-Anraku, H; Takeda, N; Charpentier, M; Perry, J; Miwa, H; Umehara, Y; Kouchi, H; Murakami, Y; Mulder, L; Vickers, K; Pike, J; Downie, JA; Wang, T; Sato, S; Asamizu, E; Tabata, S; Yoshikawa, M; Murooka, Y; Wu, GJ; Kawaguchi, M; Kawasaki, S; Parniske, M; Hayashi, M			Plastid proteins crucial for symbiotic fungal and bacterial entry into plant roots	NATURE			English	Article							LEGUME LOTUS-JAPONICUS; NODULE ORGANOGENESIS; SIGNAL-TRANSDUCTION; CALCIUM SPIKING; LJSYM4 GENE; MUTANTS; NODULATION; RECOGNITION; CHANNEL; GENOME	The roots of most higher plants form arbuscular mycorrhiza, an ancient, phosphate-acquiring symbiosis with fungi, whereas only four related plant orders are able to engage in the evolutionary younger nitrogen-fixing root-nodule symbiosis with bacteria(1). Plant symbioses with bacteria and fungi require a set of common signal transduction components that redirect root cell development(2,3). Here we present two highly homologous genes from Lotus japonicus, CASTOR and POLLUX, that are indispensable for microbial admission into plant cells and act upstream of intracellular calcium spiking(4), one of the earliest plant responses to symbiotic stimulation. Surprisingly, both twin proteins are localized in the plastids of root cells, indicating a previously unrecognized role of this ancient endosymbiont in controlling intracellular symbioses that evolved more recently.	Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; Biooriented Technol Res Advancement Inst, Tokyo Off, Minato Ku, Tokyo 1050001, Japan; Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320112, Japan; Kazusa DNA Res Inst, Chiba 2920818, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	National Institute of Agrobiological Sciences - Japan; Osaka University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Japan Science & Technology Agency (JST); Kazusa DNA Research Institute; University of Tokyo	Kawasaki, S (corresponding author), Natl Inst Agrobiol Sci, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	kawasa@nias.affrc.go.jp	Sato, Shusei/A-3616-2015; Parniske, Martin/F-2202-2011; Hayashi, Makoto/N-5379-2015; Downie, Allan/I-3487-2012; Parniske, Martin/M-3781-2019	Sato, Shusei/0000-0002-0293-5366; Parniske, Martin/0000-0001-8561-747X; Hayashi, Makoto/0000-0001-6389-4265; Parniske, Martin/0000-0001-8561-747X; Downie, Allan/0000-0003-1011-4960; Kawaguchi, Masayoshi/0000-0002-1032-6261				Ane JM, 2004, SCIENCE, V303, P1364, DOI 10.1126/science.1092986; Bonfante P, 2000, MOL PLANT MICROBE IN, V13, P1109, DOI 10.1094/MPMI.2000.13.10.1109; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Cardenas L, 2000, PLANT PHYSIOL, V123, P443, DOI 10.1104/pp.123.2.443; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; FIRMIN JL, 1993, MOL MICROBIOL, V10, P351, DOI 10.1111/j.1365-2958.1993.tb01961.x; Harris JM, 2003, MOL PLANT MICROBE IN, V16, P335, DOI 10.1094/MPMI.2003.16.4.335; Hayashi M, 2001, DNA RES, V8, P301, DOI 10.1093/dnares/8.6.301; Isono K, 1997, P NATL ACAD SCI USA, V94, P14948, DOI 10.1073/pnas.94.26.14948; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Kawaguchi M, 2002, MOL PLANT MICROBE IN, V15, P17, DOI 10.1094/MPMI.2002.15.1.17; Kawaguchi M, 2001, MOL GENET GENOMICS, V266, P157, DOI 10.1007/s004380100540; Kawasaki S, 2000, J PLANT RES, V113, P497, DOI 10.1007/PL00013960; Kistner C, 2002, TRENDS PLANT SCI, V7, P511, DOI 10.1016/S1360-1385(02)02356-7; Kohler RH, 1997, SCIENCE, V276, P2039, DOI 10.1126/science.276.5321.2039; Kwok EY, 2004, PLANT CELL REP, V23, P188, DOI 10.1007/s00299-004-0824-9; Nakamura Y, 2002, DNA RES, V9, P63, DOI 10.1093/dnares/9.2.63; Niwa S, 2001, MOL PLANT MICROBE IN, V14, P848, DOI 10.1094/MPMI.2001.14.7.848; Novero M, 2002, NEW PHYTOL, V154, P741, DOI 10.1046/j.1469-8137.2002.00424.x; Oldroyd GED, 2001, ANN BOT-LONDON, V87, P709, DOI 10.1006/anbo.2001.1410; Perry JA, 2003, PLANT PHYSIOL, V131, P866, DOI 10.1104/pp.102.017384; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Schauser L, 1998, MOL GEN GENET, V259, P414, DOI 10.1007/s004380050831; Senoo K, 2000, PLANT CELL PHYSIOL, V41, P726, DOI 10.1093/pcp/41.6.726; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Szczyglowski K, 1998, MOL PLANT MICROBE IN, V11, P684, DOI 10.1094/MPMI.1998.11.7.684; TRUCHET G, 1991, NATURE, V351, P670, DOI 10.1038/351670a0	30	278	307	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					527	531		10.1038/nature03237	http://dx.doi.org/10.1038/nature03237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15616514				2022-12-28	WOS:000226727200050
J	Nadeau, RM; Dolenc, D				Nadeau, RM; Dolenc, D			Nonvolcanic tremors deep beneath the San Andreas Fault	SCIENCE			English	Article							SUBDUCTION		Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Nadeau, RM (corresponding author), Univ Calif Berkeley, Berkeley Seismol Lab, 211 McCone Hall, Berkeley, CA 94720 USA.	nadeau@seismo.berkeley.edu	Nadeau, Robert/G-1884-2017	Nadeau, Robert/0000-0003-1255-0643				JACKSON DD, 1995, B SEISMOL SOC AM, V85, P379; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Wallace R. E., 1990, 1515 US GEOL SURV	4	212	223	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2005	307	5708					389	389		10.1126/science.1107142	http://dx.doi.org/10.1126/science.1107142			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15591163				2022-12-28	WOS:000226492300035
J	Takato, N; Bus, SJ; Terada, H; Pyo, TS; Kobayashi, N				Takato, N; Bus, SJ; Terada, H; Pyo, TS; Kobayashi, N			Detection of a deep 3-mu m absorption feature in the spectrum of Amalthea (JV)	SCIENCE			English	Article							GALILEAN SATELLITES; SURFACE-COMPOSITION; OPTICAL-PROPERTIES; ICE; SPECTROGRAPH; CONSTANTS	Near-infrared spectra of Jupiter's small inner satellites Amalthea and Thebe are similar to those of D-type asteroids in the 0.8- to 2.5-micrometer wavelength range; A deep absorption feature is detected at 3 micrometers in the spectra of the. trailing side of Amalthea, which is similar to that of the non-ice components of Callisto and can be attributed to hydrous minerals. These surface materials cannot be explained if the satellite formed at its present orbit by accreting from a circumjovian nebula. Amalthea and Thebe may be the remnants of Jupiter's inflowing building blocks that formed in the outer part or outside of the circumjovian nebula.	Natl Astron Observ, Subaru Telescope, Hilo, HI 96720 USA; Univ Hawaii, Inst Astron, Hilo, HI 96720 USA; Univ Tokyo, Grad Sch Sci, Inst Astron, Tokyo 1810015, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Hawaii System; University Hawaii Hilo; University of Tokyo	Takato, N (corresponding author), Natl Astron Observ, Subaru Telescope, 650 N Aohoku Pl, Hilo, HI 96720 USA.	takato@naoj.org						ANDERSON JD, 2002, AM GEOPH UN M SAN FR, P3; Astakhov SA, 2003, NATURE, V423, P264, DOI 10.1038/nature01622; Canup RM, 2002, ASTRON J, V124, P3404, DOI 10.1086/344684; CLARK RN, 1984, J GEOPHYS RES, V89, P6341, DOI 10.1029/JB089iB07p06341; DRAINE BT, 1985, ASTROPHYS J SUPPL S, V57, P587, DOI 10.1086/191016; Emery JP, 2003, ICARUS, V164, P104, DOI 10.1016/S0019-1035(03)00143-X; Fuller K. A., 1998, HDB OPTICAL CONSTANT, V3, P899; GRADIE J, 1982, SCIENCE, V216, P1405, DOI 10.1126/science.216.4553.1405; GRADIE J, 1980, ICARUS, V44, P373, DOI 10.1016/0019-1035(80)90032-9; Hapke B., 1993, THEORY REFLECTANCE E; Hiroi T, 2001, SCIENCE, V293, P2234, DOI 10.1126/science.1063734; KHARE BN, 1994, CAN J CHEM, V72, P678, DOI 10.1139/v94-093; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; Kobayashi N, 2000, PROC SPIE, V4008, P1056, DOI 10.1117/12.395423; LEBOFSKY LA, 1989, ORIGIN EVOLUTION PLA, P192; McCord TB, 1998, J GEOPHYS RES-PLANET, V103, P8603, DOI 10.1029/98JE00788; Nakano H, 2003, ASTROPHYS J, V592, P1252, DOI 10.1086/375856; Peale SJ, 1999, ANNU REV ASTRON ASTR, V37, P533, DOI 10.1146/annurev.astro.37.1.533; POLLACK JB, 1982, SATELLITES JUPITER, P872; Prinn R.G.P., 1989, ORIGIN EVOLUTION PLA, P78; PRINN RG, 1981, ASTROPHYS J, V249, P308, DOI 10.1086/159289; Rayner JT, 2003, PUBL ASTRON SOC PAC, V115, P362, DOI 10.1086/367745; Rivkin A.S., 2002, ASTEROIDS, VIII, P235, DOI DOI 10.1038/NATURE09028; Simonelli DP, 2000, ICARUS, V147, P353, DOI 10.1006/icar.2000.6474; STOOKE PJ, 1992, EARTH MOON PLANETS, V56, P123, DOI 10.1007/BF00056353; Thomas PC, 1998, ICARUS, V135, P360, DOI 10.1006/icar.1998.5976; VEVERKA J, 1981, J GEOPHYS RES-SPACE, V86, P8675, DOI 10.1029/JA086iA10p08675; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206	28	16	16	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2224	2227		10.1126/science.1105427	http://dx.doi.org/10.1126/science.1105427			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618511				2022-12-28	WOS:000225950000036
J	White, P; Lewith, G; Prescott, P; Conway, J				White, P; Lewith, G; Prescott, P; Conway, J			Acupuncture versus placebo for the treatment of chronic mechanical neck pain - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							CERVICAL SPONDYLOSIS; LONGITUDINAL DATA; DISABILITY INDEX; CLINICAL-TRIALS; OSTEOARTHRITIS; INTERVENTIONS; STIMULATION; RELIABILITY; DISORDERS; MEDICINE	Background: Despite substantial increases in its popularity and use, the efficacy of acupuncture for chronic mechanical neck pain remains unproved. Objective: To compare acupuncture and placebo for neck pain. Design: A randomized, single-blind, placebo-controlled, parallel-arm trial with 1-year follow-up. Setting: The outpatient departments of 2 major hospitals in the United Kingdom, 1999 to 2001. Patients: 135 patients 18 to 80 years of age who had chronic mechanical neck pain. Eleven patients withdrew from treatment, and 124 completed the primary end point. Measurements: The primary outcome was pain 1 week after treatment, according to a visual analogue scale. Secondary outcomes were pain at other time points, score on the Neck Disability Index and the Short Form-36, and use of analgesic medications. Interventions: Patients were randomly assigned to receive, over 4 weeks, 8 treatments with acupuncture or with mock transcutaneous electrical stimulation of acupuncture points using a decommissioned electroacupuncture stimulation unit. Results: Both groups improved statistically from baseline, and acupuncture and placebo had similar credibility. For the primary outcome (weeks 1 to 5), a statistically significant difference in visual analogue scale score in favor of acupuncture (6.3 mm [95% CI, 1.4 to 11.3 mm]; P = 0.01) was observed between the 2 study groups, after adjustment for baseline pain and other covariates. However, this difference was not clinically significant because it demonstrated only a 12% (CI, 3% to 21%) difference between acupuncture and placebo. Secondary outcomes showed a similar pattern. Limitations: All treatments were provided by 1 practitioner. Although the control was credible, it did not mimic the process of needling. A nonintervention group was not present to control for regression to the mean. Conclusions: Acupuncture reduced neck pain and produced a statistically, but not clinically, significant effect compared with placebo. The beneficial effects of acupuncture for pain may be due to both nonspecific and specific effects.	Univ Southampton, Southampton, Hants, England	University of Southampton	White, P (corresponding author), Univ Southampton, Southampton, Hants, England.	pjw1@soton.ac.uk		Lewith, George/0000-0002-2364-3960; Conway, Joy/0000-0001-6464-1526				Aker PD, 1996, BMJ-BRIT MED J, V313, P1291; Andresen EM, 1998, EVAL HEALTH PROF, V21, P244, DOI 10.1177/016327879802100206; BARLAS P, 1997, PHYS THERAPY REV, V2, P239; Beaton DE, 1997, J CLIN EPIDEMIOL, V50, P79, DOI 10.1016/S0895-4356(96)00296-X; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Berman BM, 1997, PRIMARY CARE, V24, P743, DOI 10.1016/S0095-4543(05)70308-0; BOGDUK N, 1982, SPINE, V7, P319, DOI 10.1097/00007632-198207000-00001; Bogduk Nikolai, 1998, Current Opinion in Rheumatology, V10, P110, DOI 10.1097/00002281-199803000-00004; DELATORRE CS, 1993, FRONTIER PERSPECTIVE, V3, P33; Dincer F, 2003, COMPLEMENT THER MED, V11, P235, DOI 10.1016/S0965-2299(03)00124-9; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; ELLIS N, 1999, ACUPUNCTURE CLIN PRA; Ernst E, 1997, SCAND J RHEUMATOL, V26, P444, DOI 10.3109/03009749709065717; Hains F, 1998, J MANIP PHYSIOL THER, V21, P75; Hemingway H, 1997, BMJ-BRIT MED J, V315, P1273, DOI 10.1136/bmj.315.7118.1273; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kjellman GV, 1999, SCAND J REHABIL MED, V31, P139; LAITINEN J, 1975, SCAND J REHABIL MED, V7, P114; LEWITH GT, 1983, PAIN, V16, P111, DOI 10.1016/0304-3959(83)90202-6; LIANGYUE D, 1990, CHINESE ACUPUNCTURE; McCormack BM, 1996, WESTERN J MED, V165, P43; MELZACK R, 1975, PAIN, V1, P357, DOI 10.1016/0304-3959(75)90073-1; MILLARD RW, 1997, CRITICAL REV PHYS RE, V9, P35; Paramore LC, 1997, J PAIN SYMPTOM MANAG, V13, P83, DOI 10.1016/S0885-3924(96)00299-0; PETRIE J, 1985, CLIN EXP RHEUMATOL, V3, P151; PETRIE JP, 1986, BRIT J RHEUMATOL, V25, P271; PETRIE JP, 1983, CLIN EXP RHEUMATOL, V1, P333; Riddle DL, 1998, PHYS THER, V78, P951, DOI 10.1093/ptj/78.9.951; Sari-Kouzel H, 1999, PRACTITIONER, V243, P334; Shapiro ET, 1996, AM J SPORT MED, V24, P196, DOI 10.1177/036354659602400214; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; THOMAS M, 1991, AM J CHINESE MED, V19, P95, DOI 10.1142/S0192415X91000156; Twisk JWR, 2003, APPL LONGITUDINAL DA; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vernon H., 1996, J MUSCULOSKELET PAIN, V4, P95, DOI [10.1300/J094v04n04_09, DOI 10.1300/J094V04N04_09, DOI 10.1300/J094V04N04_]; VINCENT C, 1995, J ROY SOC MED, V88, P199; Vincent C, 1990, COMPLEMENT MED RES, V4, P8; Westaway MD, 1998, J ORTHOP SPORT PHYS, V27, P331, DOI 10.2519/jospt.1998.27.5.331; White AR, 1999, RHEUMATOLOGY, V38, P143, DOI 10.1093/rheumatology/38.2.143; White P, 2002, RHEUMATOLOGY, V41, P1224, DOI 10.1093/rheumatology/41.11.1224; WOOD R, 1998, COMPLEMENT THER MED, V6, P79; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	43	114	121	1	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2004	141	12					911	919		10.7326/0003-4819-141-12-200412210-00007	http://dx.doi.org/10.7326/0003-4819-141-12-200412210-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882EY	15611488				2022-12-28	WOS:000225923000002
J	Berger, VW; Ioannidis, JPA				Berger, VW; Ioannidis, JPA			The Decameron of poor research	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; NCI, Biometry Res Grp, NIH, Bethesda, MD 20892 USA	University of Ioannina; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011						0	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1436	1440		10.1136/bmj.329.7480.1436	http://dx.doi.org/10.1136/bmj.329.7480.1436			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604177	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000225965800020
J	Bishop, JP; Stenger, VJ				Bishop, JP; Stenger, VJ			Retroactive prayer: lots of history, not much mystery, and no science	BRITISH MEDICAL JOURNAL			English	Article							RELIGIOUS INVOLVEMENT; INTERCESSORY PRAYER; CONTROLLED-TRIAL; OUTCOMES; MEDICINE; REMOTE		Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Boulder	Bishop, JP (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jeffrey.bishop@utsouthwestern.edu						Bishop JP, 2003, ARCH INTERN MED, V163, P1405, DOI 10.1001/archinte.163.12.1405; BRONSON P, 2002, WIRED, V10; DEBEAUREGARD OC, 1953, CR HEBD ACAD SCI, V236, P1632; Dossey L., 1999, REINVENTING MED MIND; DRUCKMAN D, 1987, ENHANCING HUMAN PERF; George LK, 2002, PSYCHOL INQ, V13, P190, DOI 10.1207/S15327965PLI1303_04; Harris WS, 2000, ARCH INTERN MED, V160, P1878; Harris WS, 1999, ARCH INTERN MED, V159, P2273, DOI 10.1001/archinte.159.19.2273; Koenig H. G., 2003, HDB RELIG HLTH; Krucoff MW, 2001, AM HEART J, V142, P760, DOI 10.1067/mhj.2001.119138; Leibovici L, 2001, BRIT MED J, V323, P1450, DOI 10.1136/bmj.323.7327.1450; LEIBOVICI L, 2001, BMJ; Mueller PS, 2001, MAYO CLIN PROC, V76, P1225, DOI 10.4065/76.12.1225; Olshansky B, 2003, BMJ-BRIT MED J, V327, P1465, DOI 10.1136/bmj.327.7429.1465; PETRE J, 2003, DAILY TELEGRAPH 1015; Price H., 1996, TIMES ARROW ARCHIMED; SCHMIDT H, 1982, FOUND PHYS, V12, P565, DOI 10.1007/BF00731929; Sicher F, 1998, WESTERN J MED, V169, P356; Stenger V. J., 2000, TIMELESS REALITY SYM; STENGER VJ, 1990, PHYS PSYCHICS SEARCH	20	8	8	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1444	1446		10.1136/bmj.329.7480.1444	http://dx.doi.org/10.1136/bmj.329.7480.1444			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604179	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000225965800022
J	Klumpen, HJ; Westermann, AM				Klumpen, HJ; Westermann, AM			Diagnostic dilemma in a man with seminoma	LANCET			English	Editorial Material							HEREDITARY PERSISTENCE; ALPHA-FETOPROTEIN; MARKERS; HPAFP		Acad Ctr, Dept Med Oncol, NL-1100 DD Amsterdam, Netherlands		Klumpen, HJ (corresponding author), Acad Ctr, Dept Med Oncol, F4-224,Postbus 22660, NL-1100 DD Amsterdam, Netherlands.	h.Klumpen@amc.uva.nl						Doherty AP, 1997, BRIT J UROL, V79, P247, DOI 10.1046/j.1464-410X.1997.27517.x; FERGUSONSMITH MA, 1984, CYTOGENET CELL GENET, V37, P469; FERGUSONSMITH MA, 1983, J MED GENET, V20, P458; MCVEY JH, 1993, HUM MOL GENET, V2, P379, DOI 10.1093/hmg/2.4.379; STAPLES J, 1986, LANCET, V2, P1277	5	7	7	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2230	2230		10.1016/S0140-6736(04)17600-9	http://dx.doi.org/10.1016/S0140-6736(04)17600-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610813				2022-12-28	WOS:000225799700036
J	Dixit, NM; Layden-Almer, JE; Layden, TJ; Perelson, AS				Dixit, NM; Layden-Almer, JE; Layden, TJ; Perelson, AS			Modelling how ribavirin improves interferon response rates in hepatitis C virus infection	NATURE			English	Article							VIRAL DYNAMICS; PLUS RIBAVIRIN; COMBINATION THERAPY; INITIAL TREATMENT; CONTROLLED TRIAL; PLACEBO; ALPHA; REPLICATION; MONOTHERAPY; KINETICS	Nearly 200 million individuals worldwide are currently infected with hepatitis C virus (HCV)(1). Combination therapy with pegylated interferon and ribavirin, the latest treatment for HCV infection, elicits long-term responses in only about 50% of patients treated(2-4). No effective alternative treatments exist for non-responders(5). Consequently, significant efforts are continuing to maximize response to combination therapy(6,7). However, rational therapy optimization is precluded by the poor understanding of the mechanism(s) of ribavirin action against HCV8. Ribavirin alone induces either a transient early decline or no decrease in HCV viral load(9-12), but in combination with interferon it significantly improves long-term response rates(2-4,13-15). Here we present a model of HCV dynamics in which, on the basis of growing evidence(16-21), we assume that ribavirin decreases HCV infectivity in an infected individual in a dose-dependent manner. The model quantitatively predicts long-term response rates to interferon monotherapy and combination therapy, fits observed patterns of HCV RNA decline in patients undergoing therapy, reconciles conflicting observations of the influence of ribavirin on HCV RNA decline, provides key insights into the mechanism of ribavirin action against HCV, and establishes a framework for rational therapy optimization.	Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; Univ Illinois, Dept Med, Chicago, IL 60612 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Perelson, AS (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	asp@lanl.gov	Perelson, Alan S/Z-1959-2019	Perelson, Alan S/0000-0002-2455-0002				[Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Bodenheimer HC, 1997, HEPATOLOGY, V26, P473, DOI 10.1002/hep.510260231; Contreras AM, 2002, J VIROL, V76, P8505, DOI 10.1128/JVI.76.17.8505-8517.2002; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Dusheiko G, 1996, J HEPATOL, V25, P591, DOI 10.1016/S0168-8278(96)80225-X; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Glue P, 1999, SEMIN LIVER DIS, V19, P17; Herrmann E, 2003, HEPATOLOGY, V37, P1351, DOI 10.1053/jhep.2003.50218; Hong Z, 2003, HEPATOLOGY, V38, P807, DOI 10.1053/jhep.2003.50464; Hoofnagle JH, 2003, HEPATOLOGY, V38, P66, DOI 10.1053/jhep.2003.50258; Lanford RE, 2003, J VIROL, V77, P1092, DOI 10.1128/JVI.77.2.1092-1104.2003; Lanford RE, 2001, J VIROL, V75, P8074, DOI 10.1128/JVI.75.17.8074-8081.2001; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Layden-Almer JE, 2003, HEPATOLOGY, V37, P1343, DOI 10.1053/jhep.2003.50217; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2000, GASTROENTEROLOGY, V119, P1317, DOI 10.1053/gast.2000.19289; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Neumann AU, 2000, J INFECT DIS, V182, P28, DOI 10.1086/315661; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Pawlotsky JM, 2004, GASTROENTEROLOGY, V126, P703, DOI 10.1053/j.gastro.2003.12.002; Powers KA, 2003, SEMIN LIVER DIS, V23, P13; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Reichard O, 1998, LANCET, V351, P83, DOI 10.1016/S0140-6736(97)06088-1; Shiffman ML, 2001, J INFECT DIS, V184, P405, DOI 10.1086/322778; STEINDLMUNDA P, 2003, 11 INT S VIR HEP LIV, P75; Tan SL, 2002, NAT REV DRUG DISCOV, V1, P867, DOI 10.1038/nrd937; Tsubota A, 2002, INTERVIROLOGY, V45, P33, DOI 10.1159/000050085; *WHO, 2000, WKLY EPIDEMIOL REC, V75, P18; Young KC, 2003, HEPATOLOGY, V38, P869, DOI 10.1053/jhep.2003.50445; Zoulim F, 1998, J VIRAL HEPATITIS, V5, P193, DOI 10.1046/j.1365-2893.1998.00099.x	30	263	278	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					922	924		10.1038/nature03153	http://dx.doi.org/10.1038/nature03153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602565				2022-12-28	WOS:000225733500058
J	Narasimha, R				Narasimha, R			Divide, conquer and unify - Fluid dynamics: Ludwig Prandtl's ideas brought hydraulics and hydrodynamics together to found a new field.	NATURE			English	Editorial Material									Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Narasimha, R (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Jakkur PO, Bangalore 560064, Karnataka, India.							Birkhoff G, 1960, HYDRODYNAMICS STUDY; VANDYKE MD, 1964, PERTURBATION METHODS; VOGELPRANDTL J, 1993, LUDWIG PRANDTL MITT, V107	3	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2004	432	7019					807	807		10.1038/432807a	http://dx.doi.org/10.1038/432807a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602532	Bronze			2022-12-28	WOS:000225733500025
J	Sharp, D				Sharp, D			Labelling salt in food: if yes, how?	LANCET			English	Editorial Material							DASH-SODIUM TRIAL; INFORMATION PROGRAM; BLOOD-PRESSURE; RESTRICTION; REDUCTION; IMPACT		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Beard TC, 2003, LANCET, V362, P403, DOI 10.1016/S0140-6736(03)14032-9; Bray GA, 2004, AM J CARDIOL, V94, P222, DOI 10.1016/j.amjcard.2004.03.070; *CONS ACT SALT HLT, SALT SOD LAB FOOD; *FED BAK, BAK IND SALT; Food and Nutrition Board Institute of Medicine, 2004, DIET REF INT DRIS RE; *FOOD STAND AG, 2004, AG LAUCH SALT CAMP; *FOOD STAND AG, 2004, UPD IND SALT RED ACT; Geleijnse JM, 1997, HYPERTENSION, V29, P913, DOI 10.1161/01.HYP.29.4.913; Girgis S, 2003, EUR J CLIN NUTR, V57, P616, DOI 10.1038/sj.ejcn.1601583; HANNEMAN RL, 2004, COMMUNICATION   0406; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; He FJ, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004937, DOI 10.1002/14651858.CD004937]; HM Government/Department of Health, 2004, CM6374; Hooper L, 2002, BMJ-BRIT MED J, V325, P628, DOI 10.1136/bmj.325.7365.628; Hooper L., 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003656.PUB2; *I FOOD SCI TECHN, 2003, CURR HOT TOP SALT JU; JURGENS G, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004022.PUB2; McCarron DA, 2003, AM J HYPERTENS, V16, P92, DOI 10.1016/S0895-7061(02)03200-4; Neily JB, 2002, AM HEART J, V143, P29, DOI 10.1067/mhj.2002.119380; O'Shaughnessy KM, 2004, J CLIN INVEST, V113, P1075, DOI 10.1172/JCI200421560; *SALT MAN ASS, 2002, RESP SALT MAN ASS SA; Williams P, 2003, HEALTH PROMOT INT, V18, P51, DOI 10.1093/heapro/18.1.51; Young L, 2002, HEALTH PROMOT INT, V17, P13, DOI 10.1093/heapro/17.1.13	23	18	18	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	2004	364	9451					2079	2081		10.1016/S0140-6736(04)17564-8	http://dx.doi.org/10.1016/S0140-6736(04)17564-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589296				2022-12-28	WOS:000225742300007
J	Bauer, GEW				Bauer, GEW			Applied physics - Mesmerizing semiconductors	SCIENCE			English	Editorial Material									Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands	Delft University of Technology	Bauer, GEW (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands.	g.e.w.bauer@tnw.tudelft.nl	Bauer, Gerrit Ernst-Wilhelm/F-8273-2010	Bauer, Gerrit Ernst-Wilhelm/0000-0002-3615-8673				BERNEVIG BA, CONDMAT0408442; Buranelli V., 1975, WIZARD VIENNA; DYAKONOV MI, 1971, JETP LETT-USSR, V13, P467; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Inoue J, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.041303; Inoue J, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.033104; Kato Y, 2004, NATURE, V427, P50, DOI 10.1038/nature02202; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Kato YK, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.176601; Levitov L. S., 1985, Soviet Physics - JETP, V61, P133; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Murakami S, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.241202; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; WUNDERLICH J, CONDMAT0410295; Zhang SF, 2000, PHYS REV LETT, V85, P393, DOI 10.1103/PhysRevLett.85.393	16	7	7	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1898	1899		10.1126/science.1106931	http://dx.doi.org/10.1126/science.1106931			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591190				2022-12-28	WOS:000225695600030
J	Marti, M; Good, RT; Rug, M; Knuepfer, E; Cowman, AF				Marti, M; Good, RT; Rug, M; Knuepfer, E; Cowman, AF			Targeting malaria virulence and remodeling proteins to the host erythrocyte	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; ANTIGENIC VARIATION; GENOME SEQUENCE; EXPRESSION; TRAFFICKING; SURFACE; GENES	To establish infection in the host, malaria parasites export remodeling and virulence proteins into the erythrocyte. These proteins can traverse a series of membranes, including the parasite membrane, the parasitophorous vacuole membrane, and the erythrocyte membrane. We show that a conserved pentameric sequence plays a central role in protein export into the host cell and predict the exported proteome in Plasmodium falciparum. We identified 400 putative erythrocyte-targeted proteins corresponding to similar to8% of all predicted genes, with 225 virulence proteins and a further 160 proteins likely to be involved in remodeling of the host erythrocyte. The conservation of this signal across Plasmodium species has implications for the development of new antimalarials.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	cowman@wehi.edu.au	Cowman, Alan F/C-7642-2013; Rug, Melanie/B-5417-2015; Rug, Melanie/A-9504-2011	Cowman, Alan F/0000-0001-5145-9004; Knuepfer, Ellen/0000-0002-6090-1877	PHS HHS [R01-A144008-04A1] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baldi DL, 2000, EMBO J, V19, P2435, DOI 10.1093/emboj/19.11.2435; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Foley M, 1998, INT J PARASITOL, V28, P1671, DOI 10.1016/S0020-7519(98)00132-5; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Haldar K, 2002, CELL MICROBIOL, V4, P383, DOI 10.1046/j.1462-5822.2002.00204.x; KNUEPFER E, UNPUB; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100; POLOGE LG, 1987, P NATL ACAD SCI USA, V84, P7139, DOI 10.1073/pnas.84.20.7139; SCHERF A, 1992, EMBO J, V11, P2293, DOI 10.1002/j.1460-2075.1992.tb05288.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	20	668	690	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1930	1933		10.1126/science.1102452	http://dx.doi.org/10.1126/science.1102452			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591202				2022-12-28	WOS:000225695600043
J	Emre, M; Aarsland, D; Albanese, A; Byrne, EJ; Deuschl, G; De Deyn, PP; Durif, F; Kulisevsky, J; van Laar, T; Lees, A; Poewe, W; Robillard, A; Rosa, MM; Wolters, E; Quarg, P; Tekin, S; Lane, R				Emre, M; Aarsland, D; Albanese, A; Byrne, EJ; Deuschl, G; De Deyn, PP; Durif, F; Kulisevsky, J; van Laar, T; Lees, A; Poewe, W; Robillard, A; Rosa, MM; Wolters, E; Quarg, P; Tekin, S; Lane, R			Rivastigmine for dementia associated with Parkinson's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; LEWY BODIES; INVENTORY; SYMPTOMS	Background: Cholinergic deficits are prominent in patients who have dementia associated with Parkinson's disease. We investigated the effects of the dual cholinesterase inhibitor rivastigmine in such patients. Methods: Patients in whom mild-to-moderate dementia developed at least 2 years after they received a clinical diagnosis of Parkinson's disease were randomly assigned to receive placebo or 3 to 12 mg of rivastigmine per day for 24 weeks. Primary efficacy variables were the scores for the cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog) and Alzheimer's Disease Cooperative Study-Clinician's Global Impression of Change (ADCS-CGIC). Secondary clinical outcomes were the scores for the Alzheimer's Disease Cooperative Study-Activities of Daily Living, the 10-item Neuropsychiatric Inventory, the Mini-Mental State Examination, Cognitive Drug Research power of attention tests, the Verbal Fluency test, and the Ten Point Clock-Drawing test. Results: A total of 541 patients were enrolled, and 410 completed the study. The outcomes were better among patients treated with rivastigmine than among those who received placebo; however, the differences between these two groups were moderate and similar to those reported in trials of rivastigmine for Alzheimer's disease. Rivastigmine-treated patients had a mean improvement of 2.1 points in the score for the 70-point ADAS-cog, from a baseline score of 23.8, as compared with a 0.7-point worsening in the placebo group, from a baseline score of 24.3 (P<0.001). Clinically meaningful improvements in the scores for the ADCS-CGIC were observed in 19.8 percent of patients in the rivastigmine group and 14.5 percent of those in the placebo group, and clinically meaningful worsening was observed in 13.0 percent and 23.1 percent, respectively (mean score at 24 weeks, 3.8 and 4.3, respectively; P=0.007). Significantly better outcomes were seen with rivastigmine with respect to all secondary efficacy variables. The most frequent adverse events were nausea (affecting 29.0 percent of patients in the rivastigmine group and 11.2 percent of those in the placebo group, P<0.001), vomiting (16.6 and 1.7 percent, P<0.001), and tremor (10.2 and 3.9 percent, P=0.01). Conclusions: In this placebo-controlled study, rivastigmine was associated with moderate improvements in dementia associated with Parkinson's disease but also with higher rates of nausea, vomiting, and tremor.	Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey; Cent Hosp Rogaland, Stavanger, Norway; Univ Bergen, Sch Med, Bergen, Norway; Ist Nazl Neurol Carlo Besta, Milan, Italy; Univ Cattolica Sacro Cuore, I-20123 Milan, Italy; Univ Manchester, Manchester M13 9PL, Lancs, England; Univ Kiel, Kiel, Germany; Middelheim Hosp, Zeikenhuis Netwerk Antwerpen, Antwerp, Belgium; Univ Antwerp, Born Bunge Fdn, Antwerp, Belgium; Ctr Hosp Univ Clermont Ferrand, Clermont Ferrand, France; Sant Pau Hosp, Barcelona, Spain; Univ Groningen Hosp, Groningen, Netherlands; UCL, Reta Lila Weston Inst Neurol Studies, London, England; Innsbruck Med Univ, Innsbruck, Austria; Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; Hosp Santa Maria, Lisbon, Portugal; Vrije Univ Amsterdam, Med Ctr, Neurosci Res Inst, Amsterdam, Netherlands; Novartis Pharmaceut, Basel, Switzerland; Novartis Pharmaceut, E Hanover, NJ USA	Istanbul University; University of Bergen; IRCCS Istituto Neurologico Besta; Catholic University of the Sacred Heart; University of Manchester; University of Kiel; ZNA Middelheim Hospital; University of Antwerp; CHU Clermont Ferrand; University of Groningen; University of London; University College London; Medical University of Innsbruck; Universite de Montreal; Universidade de Lisboa; Hospital Santa Maria; Vrije Universiteit Amsterdam; Novartis; Novartis	Emre, M (corresponding author), Istanbul Tip Fak, Noroloji Anabilim Dali, TR-34390 Istanbul, Turkey.	muratemre@superonline.com	Lees, Andrew J/A-6605-2009; Deuschl, Gunther/A-7986-2010; Durif, Franck/CAA-1077-2022; van Laar, Teus/AAO-3906-2021; Albanese, Alberto/K-7396-2016; Tekin, Sibel/F-3382-2018	Lees, Andrew J/0000-0002-2476-4385; Deuschl, Gunther/0000-0002-4176-9196; Albanese, Alberto/0000-0002-5864-0006; Aarsland, Dag/0000-0001-6314-216X; van Laar, Teus/0000-0001-5088-480X; Tekin, Sibel/0000-0003-4985-7593				Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Aarsland D, 2002, J NEUROL NEUROSUR PS, V73, P354; Aarsland D, 2002, J NEUROL NEUROSUR PS, V72, P708, DOI 10.1136/jnnp.72.6.708; Aarsland D, 1999, INT J GERIATR PSYCH, V14, P866, DOI 10.1002/(SICI)1099-1166(199910)14:10<866::AID-GPS38>3.3.CO;2-Q; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Apaydin H, 2002, ARCH NEUROL-CHICAGO, V59, P102, DOI 10.1001/archneur.59.1.102; Bohnen NI, 2003, ARCH NEUROL-CHICAGO, V60, P1745, DOI 10.1001/archneur.60.12.1745; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Clegg A, 2001, Health Technol Assess, V5, P1; Cummings J L, 1988, J Geriatr Psychiatry Neurol, V1, P24, DOI 10.1177/089198878800100106; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Delis DC, 2001, DELIS KAPLAN EXECUTI; Doody RS, 2001, NEUROLOGY, V56, P1154, DOI 10.1212/WNL.56.9.1154; Emre M, 2003, LANCET NEUROL, V2, P229, DOI 10.1016/S1474-4422(03)00351-X; Fahn S., 1987, RECENT DEV PARKINSON, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Giladi N, 2003, ACTA NEUROL SCAND, V108, P368, DOI 10.1034/j.1600-0404.2003.00211.x; HUBER SJ, 1988, J NEUROL NEUROSUR PS, V51, P855, DOI 10.1136/jnnp.51.6.855; Leech R W, 2001, J Okla State Med Assoc, V94, P507; MANOS PJ, 1994, INT J PSYCHIAT MED, V24, P229, DOI 10.2190/5A0F-936P-VG8N-0F5R; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; PERRY EK, 1985, J NEUROL NEUROSUR PS, V48, P413, DOI 10.1136/jnnp.48.5.413; Reading PJ, 2001, MOVEMENT DISORD, V16, P1171, DOI 10.1002/mds.1204; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Schneider LS, 1997, ALZ DIS ASSOC DIS, V11, pS22; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; SIMPSON PM, 1991, INT J GERIATR PSYCH, V6, P95, DOI 10.1002/gps.930060208; STERN RG, 1994, AM J PSYCHIAT, V151, P390; Tiraboschi P, 2000, NEUROLOGY, V54, P407, DOI 10.1212/WNL.54.2.407	32	781	817	1	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2004	351	24					2509	2518		10.1056/NEJMoa041470	http://dx.doi.org/10.1056/NEJMoa041470			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877TE	15590953	Green Published			2022-12-28	WOS:000225593100006
J	Gawande, A				Gawande, A			Casualties of war -- Military care for the wounded from Iraq and Afghanistan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Gawande, A (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.			Gawande, Atul/0000-0002-1824-9176				[Anonymous], 2004, PRINC WARS WHICH US; *DEP DEF, 2004, US CAS STAT; Harris A. R., 2002, HOMICIDE STUDIES, V6, P128, DOI DOI 10.1177/108876790200600203; Pear R., 2004, NY TIMES, pA22; Whelan T J Jr, 1975, Surg Annu, V7, P1	5	384	404	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2004	351	24					2471	2475		10.1056/NEJMp048317	http://dx.doi.org/10.1056/NEJMp048317			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877TE	15590948				2022-12-28	WOS:000225593100001
J	Mao, JH; Perez-Iosada, J; Wu, D; DelRosario, R; Tsunematsu, R; Nakayama, KI; Brown, K; Bryson, S; Balmain, A				Mao, JH; Perez-Iosada, J; Wu, D; DelRosario, R; Tsunematsu, R; Nakayama, KI; Brown, K; Bryson, S; Balmain, A			Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene	NATURE			English	Article							F-BOX PROTEIN; CYCLIN-E; CENTROSOME AMPLIFICATION; CHROMOSOMAL INSTABILITY; UBIQUITIN LIGASE; P53; CANCER; MICE; NOTCH; EXPRESSION	The FBXW7/hCDC4 gene encodes a ubiquitin ligase implicated in the control of chromosome stability(1). Here we identify the mouse Fbxw7 gene as a p53-dependent tumour suppressor gene by using a mammalian genetic screen for p53-dependent genes involved in tumorigenesis. Radiation-induced lymphomas from p53(+/-) mice, but not those from p53(-/-) mice, show frequent loss of heterozygosity and a 10% mutation rate of the Fbxw7 gene. Fbxw7(+/-) mice have greater susceptibility to radiation-induced tumorigenesis, but most tumours retain and express the wildtype allele, indicating that Fbxw7 is a haploinsufficient tumour suppressor gene. Loss of Fbxw7 alters the spectrum of tumours that develop in p53 deficient mice to include a range of tumours in epithelial tissues such as the lung, liver and ovary. Mouse embryo fibroblasts from Fbxw7-deficient mice, or wild-type mouse cells expressing Fbxw7 small interfering RNA, have higher levels of Aurora-A kinase, c-Jun and Notch4, but not of cyclin E. We propose that p53-dependent loss of Fbxw7 leads to genetic instability by mechanisms that might involve the activation of Aurora-A, providing a rationale for the early occurrence of these mutations in human cancers.	Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; Univ Glasgow, CRC Dept Med Oncol, Glasgow G61 1BD, Lanark, Scotland	University of California System; University of California San Francisco; Kyushu University; University of Glasgow	Balmain, A (corresponding author), Univ Calif San Francisco, Canc Res Inst, 2340 Sutter St, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu	Mao, Jian-Hua/EIZ-8595-2022; Pérez-Losada, Jesús/A-5883-2019	Mao, Jian-Hua/0000-0001-9320-6021; Pérez-Losada, Jesús/0000-0003-2400-624X				Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Browes C, 2001, FEBS LETT, V497, P20, DOI 10.1016/S0014-5793(01)02429-2; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calhoun ES, 2003, AM J PATHOL, V163, P1255, DOI 10.1016/S0002-9440(10)63485-2; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Frenkel J, 1999, ONCOGENE, V18, P2901, DOI 10.1038/sj.onc.1202518; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; LINARDOPOULOS S, 1995, CANCER RES, V55, P5168; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Ye Q, 2004, LEUKEMIA, V18, P777, DOI 10.1038/sj.leu.2403291; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	30	308	320	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					775	779		10.1038/nature03155	http://dx.doi.org/10.1038/nature03155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592418				2022-12-28	WOS:000225597200053
J	Gillespie, D				Gillespie, D			Buying health in Honduras	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Bill & Melinda Gates Inst Reprod Hlth & Populat, Baltimore, MD 21205 USA	Bill & Melinda Gates Foundation; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gillespie, D (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Bill & Melinda Gates Inst Reprod Hlth & Populat, Baltimore, MD 21205 USA.	dgillesp@jhsph.edu						[Anonymous], 1978, INT C PRIM HLTH CAR; Buekens P, 2004, JAMA-J AM MED ASSOC, V291, P2639, DOI 10.1001/jama.291.21.2639; *INT DEV BANK, 2004, HOND COMPR SOC SAF N; *INT DEV BANK RES, 2003, ID DEV AM, V1; *INT FOOD POL RES, SEARCH TARG INT RED; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Rawlings L., 2004, NEW APPROACH SOCIAL; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; United Nations, 2000, MILL DECL; Wagstaff A, 2004, AM J PUBLIC HEALTH, V94, P726, DOI 10.2105/AJPH.94.5.726; *WORLD BANK GROUP, 2004, HIGH LEV FOR HLTH MI	12	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2004	364	9450					1996	1997		10.1016/S0140-6736(04)17524-7	http://dx.doi.org/10.1016/S0140-6736(04)17524-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582042				2022-12-28	WOS:000225495700004
J	Gallavotti, A; Zhao, Q; Kyozuka, J; Meeley, RB; Ritter, M; Doebley, JF; Pe, ME; Schmidt, RJ				Gallavotti, A; Zhao, Q; Kyozuka, J; Meeley, RB; Ritter, M; Doebley, JF; Pe, ME; Schmidt, RJ			The role of barren stalk1 in the architecture of maize	NATURE			English	Article							AXILLARY MERISTEM DEVELOPMENT; ZEA-MAYS; EVOLUTION; GENE; DOMESTICATION; DIVERSITY; TRANSCRIPTION; POLYMORPHISM; ARABIDOPSIS; REGULATORS	The architecture of higher plants is established through the activity of lateral meristems-small groups of stem cells formed during vegetative and reproductive development. Lateral meristems generate branches and inflorescence structures, which define the overall form of a plant(1-3), and are largely responsible for the evolution of different plant architectures(3). Here, we report the isolation of the barren stalk1 gene, which encodes a non-canonical basic helix-loop-helix protein required for the initiation of all aerial lateral meristems in maize. barren stalk1 represents one of the earliest genes involved in the patterning of maize inflorescences, and, together with the teosinte branched1 gene(4), it regulates vegetative lateral meristem development. The architecture of maize has been a major target of selection for early agriculturalists and modern farmers, because it influences harvesting, breeding strategies and mechanization. By sampling nucleotide diversity in the barren stalk1 region, we show that two haplotypes entered the maize gene pool from its wild progenitor, teosinte, and that only one was incorporated throughout modern inbreds, suggesting that barren stalk1 was selected for agronomic purposes.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; Pioneer HiBred Int Inc, Crop Genet Res, Johnston, IA 50131 USA	University of California System; University of California San Diego; University of Milan; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; DuPont	Schmidt, RJ (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	rschmidt@ucsd.edu	Kyozuka, Junko/E-7844-2012					Ambrose BA, 2000, MOL CELL, V5, P569, DOI 10.1016/S1097-2765(00)80450-5; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1995, GENETICS, V141, P333; HOFMEYER JDJ, 1931, THESIS CORNELL U ITH; Hubbard L, 2002, GENETICS, V162, P1927; HUDSON RR, 1987, GENETICS, V116, P153; Irish EE, 1997, AM J BOT, V84, P1502, DOI 10.2307/2446611; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; Lukens LN, 1999, GENET RES, V74, P291, DOI 10.1017/S0016672399004073; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McSteen P, 2001, DEVELOPMENT, V128, P2881; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Ritter MK, 2002, AM J BOT, V89, P203, DOI 10.3732/ajb.89.2.203; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sussex IM, 2001, CURR OPIN PLANT BIOL, V4, P33, DOI 10.1016/S1369-5266(00)00132-1; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; TAJIMA F, 1989, GENETICS, V123, P585; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999	30	226	255	4	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					630	635		10.1038/nature03148	http://dx.doi.org/10.1038/nature03148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577912				2022-12-28	WOS:000225433200048
J	Ogawa, M; Yoshimori, T; Suzuki, T; Sagara, H; Mizushima, N; Sasakawa, C				Ogawa, M; Yoshimori, T; Suzuki, T; Sagara, H; Mizushima, N; Sasakawa, C			Escape of intracellular Shigella from autophagy	SCIENCE			English	Article							BACTERIAL; INVASION; PROTEIN; SPREAD; ICSA	The degradation of undesirable cellular components or organelles, including invading microbes, by autophagy is crucial for cell survival. Here, Shigella, an invasive bacteria, was found to be able to escape autophagy by secreting IcsB by means of the type III secretion system. Mutant bacteria lacking IcsB were trapped by autophagy during multiplication within the host cells. IcsB did not directly inhibit autophagy. Rather, Shigella VirG, a protein required for intracellular actin-based motility, induced autophagy by binding to the autophagy protein, Atg5. In nonmutant Shigella, this binding is competitively inhibited by IcsB binding to VirG.	Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Dept Fine Morphol, Minato Ku, Tokyo 1088639, Japan; Natl Inst Genet, Dept Cell Genet, Shizuoka 4118540, Japan; Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Bunkyo Ku, Tokyo 1138613, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi 3320012, Japan	University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Sasakawa, C (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444				BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dorn BR, 2002, CELL MICROBIOL, V4, P1, DOI 10.1046/j.1462-5822.2002.00164.x; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Marino G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Ogawa M, 2003, MOL MICROBIOL, V48, P913, DOI 10.1046/j.1365-2958.2003.03489.x; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Robbins JR, 2001, MOL MICROBIOL, V41, P861, DOI 10.1046/j.1365-2958.2001.02552.x; Suzuki T, 1996, J BIOL CHEM, V271, P21878, DOI 10.1074/jbc.271.36.21878; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023	17	685	707	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					727	731		10.1126/science.1106036	http://dx.doi.org/10.1126/science.1106036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15576571				2022-12-28	WOS:000226814900044
J	Chen, W; Ren, XR; Nelson, CD; Barak, LS; Chen, JK; Beachy, PA; de Sauvage, F; Lefkowitz, RJ				Chen, W; Ren, XR; Nelson, CD; Barak, LS; Chen, JK; Beachy, PA; de Sauvage, F; Lefkowitz, RJ			Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2	SCIENCE			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; ACTIVATION; ZEBRAFISH; MUTATIONS; IDENTIFICATION; ASSOCIATION; COSTAL2; KINASES; KINESIN; COMPLEX	Binding of Sonic Hedgehog (Shh) to Patched (Ptc) relieves the latter's tonic inhibition of Smoothened (Smo), a receptor that spans the cell membrane seven times. This initiates signaling which, by unknown mechanisms, regulates vertebrate developmental processes. We find that two molecules interact with mammalian Smo in an activation-dependent manner: G protein-coupled receptor kinase 2 (GRK2) leads to phosphorylation of Smo, and beta-arrestin 2 fused to green fluorescent protein interacts with Smo. These two processes promote endocytosis of Smo in clathrin-coated pits. Ptc inhibits association of beta-arrestin 2 with Smo, and this inhibition is relieved in cells treated with Shh. A Smo agonist stimulated and a Smo antagonist (cyclopamine) inhibited both phosphorylation of Smo by GRK2 and interaction of beta-arrestin 2 with Smo. beta-Arrestin 2 and GRK2 are thus potential mediators of signaling by activated Smo.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; Johns Hopkins University; Roche Holding; Genentech	Chen, W (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	w.chen@duke.edu; lefko001@receptor-biol.duke.edu	Chen, James/G-9972-2011; Lefkowitz, Robert/AAW-2649-2021	Chen, James/0000-0002-9220-8436; Chen, Wei/0000-0002-9934-4000				Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen WB, 2001, DEVELOPMENT, V128, P2385; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Hynes M, 2000, NAT NEUROSCI, V3, P41, DOI 10.1038/71114; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Ogden SK, 2003, CURR BIOL, V13, P1998, DOI 10.1016/j.cub.2003.10.004; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	28	232	247	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2257	2260		10.1126/science.1104135	http://dx.doi.org/10.1126/science.1104135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618519				2022-12-28	WOS:000225950000047
J	Cairns, BR				Cairns, BR			Around the world of DNA damage INO80 days	CELL			English	Editorial Material							CHROMATIN REMODELING COMPLEX; RECOMBINATION	DNA damage is detected and repaired in the context of chromatin. In this issue of Cell, van Attikum et al. (2004) and Morrison et al. (2004) demonstrate that double-stranded break repair involves the recruitment of a specialized chromatin remodeling complex, INO80, through an interaction with phosphorylated histone H2A.	Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Cairns, BR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.				Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		DOWNS JA, 2004, IN PRESS MOL CELL, V16; Fritsch O, 2004, MOL CELL, V16, P479, DOI 10.1016/j.molcel.2004.09.034; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; KUSCH T, 2004, IN PRESS SCIENCE; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033	11	16	16	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 17	2004	119	6					733	735		10.1016/j.cell.2004.12.005	http://dx.doi.org/10.1016/j.cell.2004.12.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607967	Bronze, Green Accepted			2022-12-28	WOS:000225907200001
J	Pai, JK; Pischon, T; Ma, J; Manson, JE; Hankinson, SE; Joshipura, K; Curhan, GC; Rifai, N; Cannuscio, CC; Stampfer, MJ; Rimm, EB				Pai, JK; Pischon, T; Ma, J; Manson, JE; Hankinson, SE; Joshipura, K; Curhan, GC; Rifai, N; Cannuscio, CC; Stampfer, MJ; Rimm, EB			Inflammatory markers and the risk of coronary heart disease in men and women.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; TUMOR-NECROSIS-FACTOR; APPARENTLY HEALTHY-MEN; MIDDLE-AGED MEN; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PHOSPHOLIPASE A(2); PREDICTION; ATHEROSCLEROSIS; EVENTS	BACKGROUND: Few studies have simultaneously investigated the role of soluble tumor necrosis factor alpha (TNF-alpha) receptors types 1 and 2 (sTNF-R1 and sTNF-R2), C-reactive protein, and interleukin-6 as predictors of cardiovascular events. The value of these inflammatory markers as independent predictors remains controversial. METHODS: We examined plasma levels of sTNF-R1, sTNF-R2, interleukin-6, and C-reactive protein as markers of risk for coronary heart disease among women participating in the Nurses' Health Study and men participating in the Health Professionals Follow-up Study in nested case-control analyses. Among participants who provided a blood sample and who were free of cardiovascular disease at baseline, 239 women and 265 men had a nonfatal myocardial infarction or fatal coronary heart disease during eight years and six years of follow-up, respectively. Using risk-set sampling, we selected controls in a 2:1 ratio with matching for age, smoking status, and date of blood sampling. RESULTS: After adjustment for matching factors, high levels of interleukin-6 and C-reactive protein were significantly related to an increased risk of coronary heart disease in both sexes, whereas high levels of soluble TNF-alpha receptors were significant only among women. Further adjustment for lipid and nonlipid factors attenuated all associations; only C-reactive protein levels remained significant. The relative risk among all participants was 1.79 for those with C-reactive protein levels of at least 3.0 mg per liter, as compared with those with levels of less than 1.0 mg per liter (95 percent confidence interval, 1.27 to 2.51; P for trend <0.001). Additional adjustment for the presence or absence of diabetes and hypertension moderately attenuated the relative risk to 1.68 (95 percent confidence interval, 1.18 to 2.38; P for trend = 0.008). CONCLUSIONS: Elevated levels of inflammatory markers, particularly C-reactive protein, indicate an increased risk of coronary heart disease. Although plasma lipid levels were more strongly associated with an increased risk than were inflammatory markers, the level of C-reactive protein remained a significant contributor to the prediction of coronary heart disease.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA; Harvard Univ, Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, Boston, MA USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; Merck Res Labs, W Point, PA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Harvard University; Boston Children's Hospital; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Merck & Company	Rimm, EB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	erimm@hsph.harvard.edu	Cannuscio, Carolyn/A-1123-2007; Pischon, Tobias/HGE-8577-2022; Joshipura, Kaumudi J/AAA-3852-2020	Pischon, Tobias/0000-0003-1568-767X; Joshipura, Kaumudi/0000-0003-1964-7579	NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464, HL07575, HL34594] Funding Source: Medline; NIAAA NIH HHS [AA11181] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464, R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Aderka Dan, 1996, Cytokine and Growth Factor Reviews, V7, P231, DOI 10.1016/S1359-6101(96)00026-3; Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Benjafield AV, 2001, J MOL MED, V79, P109, DOI 10.1007/s001090000168; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; DIEZRUIZ A, 1995, EUR J HAEMATOL, V54, P1, DOI 10.1111/j.1600-0609.1995.tb01618.x; Hackam DG, 2003, JAMA-J AM MED ASSOC, V290, P932, DOI 10.1001/jama.290.7.932; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Pai JK, 2002, CLIN CHEM, V48, P1781; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pischon T, 2003, OBES RES, V11, P1055, DOI 10.1038/oby.2003.145; Pischon T, 2003, CIRCULATION, V108, P155, DOI 10.1161/01.CIR.0000079224.46084.C2; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Pradhan AD, 2002, EUR HEART J, V23, P831, DOI 10.1053/euhj.2001.3052; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; PRENTICE RL, 1978, BIOMETRIKA, V65, P153, DOI 10.2307/2335290; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Sharrett AR, 2004, ATHEROSCLEROSIS, V172, P143, DOI 10.1016/j.atherosclerosis.2003.09.015; Takkouche B, 1999, AM J EPIDEMIOL, V150, P206; van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323; Willett WC, 1998, NUTR EPIDEMIOLOGY, P101, DOI DOI 10.1093/ACPROF:OSO/9780195122978.003.06; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3	41	861	895	1	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2599	2610		10.1056/NEJMoa040967	http://dx.doi.org/10.1056/NEJMoa040967			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602020				2022-12-28	WOS:000225726100007
J	Sanudo-Wilhelmy, SA; Tovar-Sanchez, A; Fu, FX; Capone, DG; Carpenter, EJ; Hutchins, DA				Sanudo-Wilhelmy, SA; Tovar-Sanchez, A; Fu, FX; Capone, DG; Carpenter, EJ; Hutchins, DA			The impact of surface-adsorbed phosphorus on phytoplankton Redfield stoichiometry	NATURE			English	Article							NORTH-ATLANTIC OCEAN; MARINE-PHYTOPLANKTON; NUTRIENT LIMITATION; NITROGEN-FIXATION; SOUTHERN-OCEAN; IRON; TRICHODESMIUM; PRODUCTIVITY; VARIABILITY; RATIOS	The Redfield ratio of 106 carbon: 16 nitrogen: 1 phosphorus in marine phytoplankton(1) is one of the foundations of ocean biogeochemistry, with applications in algal physiology(2), palaeoclimatology(3) and global climate change(4). However, this ratio varies substantially in response to changes in algal nutrient status(5) and taxonomic affiliation(6,7). Here we report that Redfield ratios are also strongly affected by partitioning into surface-adsorbed and intracellular phosphorus pools. The C: N: surface-adsorbed P (80 - 105 C: 15 - 18 N: 1 P) and total (71 - 80 C: 13 - 14 N: 1 P) ratios in natural populations and cultures of Trichodesmium were close to Redfield values and not significantly different from each other. In contrast, intracellular ratios consistently exceeded the Redfield ratio ( 316 - 434 C: 59 - 83 N: 1 intracellular P). These high intracellular ratios were associated with reduced N-2 fixation rates, suggestive of phosphorus deficiency. Other algal species also have substantial surface-adsorbed phosphorus pools, suggesting that our Trichodesmium results are generally applicable to all phytoplankton. Measurements of the distinct phytoplankton phosphorus pools may be required to assess nutrient limitation accurately from elemental composition. Deviations from Redfield stoichiometry may be attributable to surface adsorption of phosphorus rather than to biological processes, and this scavenging could affect the interpretation of marine nutrient inventories and ecosystem models.	SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA; IMEDEA, CSIC, UIB, Inst Mediterraneo Estudios Avanzados, Mallorca 07190, Islas Baleares, Spain; Univ So Calif, Wrigley Inst Environm Studies, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA 94920 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Southern California; University of Southern California; California State University System; San Francisco State University	Sanudo-Wilhelmy, SA (corresponding author), SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA.	ssanudo@notes.cc.sunysb.edu	Tovar-Sánchez, Antonio/B-8003-2010; Hutchins, David A/D-3301-2013	Tovar-Sánchez, Antonio/0000-0003-4375-1982; Hutchins, David A/0000-0002-6637-756X				Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Bury SJ, 2001, DEEP-SEA RES PT I, V48, P689, DOI 10.1016/S0967-0637(00)00066-2; FANNING KA, 1989, NATURE, V339, P460, DOI 10.1038/339460a0; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Guildford SJ, 2000, LIMNOL OCEANOGR, V45, P1213, DOI 10.4319/lo.2000.45.6.1213; HUDSON RJM, 1993, DEEP-SEA RES PT I, V40, P129, DOI 10.1016/0967-0637(93)90057-A; Hutchins DA, 1999, AQUAT MICROB ECOL, V19, P129, DOI 10.3354/ame019129; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1529, DOI 10.1016/S0967-0645(00)00152-1; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Kuss J, 1999, MAR CHEM, V68, P71, DOI 10.1016/S0304-4203(99)00066-3; LAWS EA, 1983, J THEOR BIOL, V105, P469, DOI 10.1016/0022-5193(83)90188-1; Lenton TM, 2000, GLOBAL BIOGEOCHEM CY, V14, P225, DOI 10.1029/1999GB900065; MCCARTHY JJ, 1979, J PHYCOL, V15, P75, DOI 10.1111/j.0022-3646.1979.00075.x; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Pahlow M, 2000, SCIENCE, V287, P831, DOI 10.1126/science.287.5454.831; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; REDFIELD AC, 1958, AM SCI, V46, P205; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Schneider B, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001871; SIGG L, 1981, COLLOID SURFACE, V2, P101, DOI 10.1016/0166-6622(81)80001-7; Tovar-Sanchez A, 2003, MAR CHEM, V82, P91, DOI 10.1016/S0304-4203(03)00054-9; VanCappellen P, 1996, SCIENCE, V271, P493, DOI 10.1126/science.271.5248.493; Wang XJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001938	25	159	170	8	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					897	901		10.1038/nature03125	http://dx.doi.org/10.1038/nature03125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602560				2022-12-28	WOS:000225733500051
J	Arici, A; Bukulmez, O				Arici, A; Bukulmez, O			Phyto-oestrogens and the endometrium	LANCET			English	Editorial Material							POSTMENOPAUSAL WOMEN; SOY PHYTOESTROGENS; BREAST-CANCER; HOT FLASHES; LONG-TERM; TRIAL; HYPERPLASIA; ISOFLAVONES		Yale Univ, Sch Med, Dept Obstet & Gynecol & Reprod Sci, Div Reprod Endocrinol & Infertil, New Haven, CT 06510 USA; Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Dallas, TX 75235 USA	Yale University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Arici, A (corresponding author), Yale Univ, Sch Med, Dept Obstet & Gynecol & Reprod Sci, Div Reprod Endocrinol & Infertil, 333 Cedar St, New Haven, CT 06510 USA.	aydin.arici@yale.edu						BAIRD DD, 1995, J CLIN ENDOCR METAB, V80, P1685, DOI 10.1210/jc.80.5.1685; Clark TJ, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-18; Han KK, 2002, OBSTET GYNECOL, V99, P389, DOI 10.1016/S0029-7844(01)01744-6; Johnson EB, 2001, OBSTET GYNECOL, V98, P947, DOI 10.1016/S0029-7844(01)01542-3; Judd HL, 1996, JAMA-J AM MED ASSOC, V275, P370, DOI 10.1001/jama.1996.03530290040035; Kayisli UA, 2002, J CLIN ENDOCR METAB, V87, P5539, DOI 10.1210/jc.2002-020716; Knight D C, 1999, Climacteric, V2, P79, DOI 10.3109/13697139909025570; KURMAN RJ, 1985, CANCER, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X; Lethaby A., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000402, DOI 10.1002/14651858.CD000402, 10.1002/14651858.CD000402.pub2]; Montgomery BE, 2004, OBSTET GYNECOL SURV, V59, P368, DOI 10.1097/00006254-200405000-00025; Murray MJ, 2003, MENOPAUSE, V10, P456, DOI 10.1097/01.GME.0000063567.84134.D1; Penotti M, 2003, FERTIL STERIL, V79, P1112, DOI 10.1016/S0015-0282(03)00158-4; Quella SK, 2000, J CLIN ONCOL, V18, P1068, DOI 10.1200/JCO.2000.18.5.1068; Somekawa Y, 2001, J CLIN ENDOCR METAB, V86, P3202, DOI 10.1210/jc.86.7.3202; St Clair RW, 1998, CURR OPIN LIPIDOL, V9, P457, DOI 10.1097/00041433-199810000-00010; Terakawa N, 1997, J Obstet Gynaecol Res, V23, P223; Unfer V, 2004, J SOC GYNECOL INVEST, V11, P323, DOI 10.1016/j.jsgi.2003.12.007; Unfer V, 2004, FERTIL STERIL, V82, P145, DOI 10.1016/j.fertnstert.2003.11.041; Van Patten CL, 2002, J CLIN ONCOL, V20, P1449, DOI 10.1200/JCO.20.6.1449	19	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	2004	364	9451					2081	2082		10.1016/S0140-6736(04)17565-X	http://dx.doi.org/10.1016/S0140-6736(04)17565-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589297				2022-12-28	WOS:000225742300008
J	Lennon, VA; Wingerchuk, DM; Kryzer, TJ; Pittock, SJ; Lucchinetti, CF; Fujihara, K; Nakashima, I; Weinshenker, BG				Lennon, VA; Wingerchuk, DM; Kryzer, TJ; Pittock, SJ; Lucchinetti, CF; Fujihara, K; Nakashima, I; Weinshenker, BG			A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis	LANCET			English	Article							DISEASE; GUIDELINES	Background Neuromyelitis optica is an inflammatory demyelinating disease with generally poor prognosis that selectively targets optic nerves and spinal cord. It is commonly misdiagnosed as multiple sclerosis. Neither disease has a distinguishing biomarker, but optimum treatments differ. The relation of neuromyelitis optica to optic-spinal multiple sclerosis in Asia is uncertain. We assessed the capacity of a putative marker for neuromyelitis optica (NMO-IgG) to distinguish neuromyelitis optica and related disorders from multiple sclerosis. Methods Indirect immunofluorescence with a composite substrate of mouse tissues identified a distinctive NMO-IgG staining pattern, which we characterised further by dual immunostaining. We tested masked serum samples from 102 North American patients with neuromyelitis optica or with syndromes that suggest high risk of the disorder, and 12 Japanese patients. with optic-spinal multiple sclerosis. Control patients had multiple sclerosis, other myelopathies, optic neuropathies, and miscellaneous disorders. We also established clinical diagnoses for 14 patients incidentally shown to have NMO-IgG among 85 000 tested for suspected paraneoplastic autoimmunity. Findings NMO-IgG outlines CNS microvessels, pia, subpia, and Virchow-Robin space. It partly colocalises with laminin. Sensitivity and specificity were 73% (95% CI 60-86) and 91% (79-100) for neuromyelitis optica and 58% (30-86) and 100% (66-100) for optic-spinal multiple sclerosis. NMO-IgG was detected in half of patients with high-risk syndromes. Of 14 seropositive cases identified incidentally, 12 had neuromyelitis optica or a high-risk syndrome for the disease. Interpretation NMO-IgG is a specific marker autoantibody of neuromyelitis optica and binds at or near the blood-brain barrier. it distinguishes neuromyelitis optica from multiple sclerosis. Asian optic-spinal multiple sclerosis seems to be the same as neuromyelitis optica.	Mayo Clin & Mayo Fdn, Neuroimmunol Lab, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin Scottsdale, Dept Neurol, Scottsdale, AZ USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 9808574, Japan	Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Tohoku University	Lennon, VA (corresponding author), Mayo Clin & Mayo Fdn, Neuroimmunol Lab, Dept Neurol, Guggenheim Bldg,Room 828, Rochester, MN 55905 USA.	lennon.vanda@mayo.edu	Nakashima, Ichiro/AAC-3073-2019; Weinshenker, Brian G/ABH-6146-2020	Nakashima, Ichiro/0000-0002-2612-8948; Weinshenker, Brian G/0000-0001-5806-6203				Cree BAC, 2002, SEMIN NEUROL, V22, P105, DOI 10.1055/s-2002-36534; de Seze J, 2003, MULT SCLER J, V9, P521, DOI 10.1191/1352458503ms947oa; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Keegan M, 2002, NEUROLOGY, V58, P143, DOI 10.1212/WNL.58.1.143; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; LEE KH, 1991, NEUROLOGY, V41, P657, DOI 10.1212/WNL.41.5.657; Lennon VA, 2003, J CLIN INVEST, V111, P907, DOI 10.1172/JCI200317429; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Mandler RN, 1998, NEUROLOGY, V51, P1219, DOI 10.1212/WNL.51.4.1219; MANDLER RN, 1993, ANN NEUROL, V34, P162, DOI 10.1002/ana.410340211; Misu T, 2002, BRAIN, V125, P2460, DOI 10.1093/brain/awf260; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; ORiordan JI, 1996, J NEUROL NEUROSUR PS, V60, P382, DOI 10.1136/jnnp.60.4.382; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Weinshenker BG, 2003, LANCET, V361, P889, DOI 10.1016/S0140-6736(03)12784-5; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Yu ZY, 2001, ANN NEUROL, V49, P146	18	2188	2412	5	112	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	2004	364	9451					2106	2112		10.1016/S0140-6736(04)17551-X	http://dx.doi.org/10.1016/S0140-6736(04)17551-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589308				2022-12-28	WOS:000225742300023
J	Xia, QY; Zhou, ZY; Lu, C; Cheng, DJ; Dai, FY; Li, B; Zhao, P; Zha, XF; Cheng, TC; Chai, CL; Pan, GQ; Xu, JS; Liu, C; Lin, Y; Qian, JF; Hou, Y; Wu, ZL; Li, GR; Pan, MH; Li, CF; Shen, YH; Lan, XQ; Yuan, LW; Li, T; Xu, HF; Yang, GW; Wan, YJ; Zhu, Y; Yu, MD; Shen, WD; Wu, DY; Xiang, ZH; Yu, J; Wang, J; Li, RQ; Shi, JP; Li, H; Li, GY; Su, JN; Wang, XL; Li, GQ; Zhang, ZJ; Wu, QF; Li, J; Zhang, QP; Wei, N; Xu, JZ; Sun, HB; Dong, L; Liu, DY; Zhao, SL; Zhao, XL; Meng, QS; Lan, FD; Huang, XG; Li, YZ; Fang, L; Li, CF; Li, DW; Sun, YQ; Zhang, ZP; Yang, Z; Huang, YQ; Xi, Y; Qi, QH; He, DD; Huang, HY; Zhang, XW; Wang, ZQ; Li, WJ; Cao, YZ; Yu, YP; Yu, H; Li, JH; Ye, JH; Chen, H; Zhou, Y; Liu, B; Wang, J; Ye, J; Ji, H; Li, ST; Ni, PX; Zhang, JG; Zhang, Y; Zheng, HK; Mao, BY; Wang, W; Ye, C; Li, SG; Wang, J; Wong, GKS; Yang, HM				Xia, QY; Zhou, ZY; Lu, C; Cheng, DJ; Dai, FY; Li, B; Zhao, P; Zha, XF; Cheng, TC; Chai, CL; Pan, GQ; Xu, JS; Liu, C; Lin, Y; Qian, JF; Hou, Y; Wu, ZL; Li, GR; Pan, MH; Li, CF; Shen, YH; Lan, XQ; Yuan, LW; Li, T; Xu, HF; Yang, GW; Wan, YJ; Zhu, Y; Yu, MD; Shen, WD; Wu, DY; Xiang, ZH; Yu, J; Wang, J; Li, RQ; Shi, JP; Li, H; Li, GY; Su, JN; Wang, XL; Li, GQ; Zhang, ZJ; Wu, QF; Li, J; Zhang, QP; Wei, N; Xu, JZ; Sun, HB; Dong, L; Liu, DY; Zhao, SL; Zhao, XL; Meng, QS; Lan, FD; Huang, XG; Li, YZ; Fang, L; Li, CF; Li, DW; Sun, YQ; Zhang, ZP; Yang, Z; Huang, YQ; Xi, Y; Qi, QH; He, DD; Huang, HY; Zhang, XW; Wang, ZQ; Li, WJ; Cao, YZ; Yu, YP; Yu, H; Li, JH; Ye, JH; Chen, H; Zhou, Y; Liu, B; Wang, J; Ye, J; Ji, H; Li, ST; Ni, PX; Zhang, JG; Zhang, Y; Zheng, HK; Mao, BY; Wang, W; Ye, C; Li, SG; Wang, J; Wong, GKS; Yang, HM			A draft sequence for the genome of the domesticated silkworm (Bombyx mori)	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; ANOPHELES-GAMBIAE; PATTERN-FORMATION; DISTAL-LESS; PROTEIN; INSECT; GENE; CHROMOSOME; CONSTRUCTION; POSTERIOR	We report a draft sequence for the genome of the domesticated silkworm (Bombyx mori), covering 90.9% of all known silkworm genes. Our estimated gene count is 18,510, which exceeds the 13,379 genes reported for Drosophila melanogaster. Comparative analyses to fruitfly, mosquito, spider, and butterfly reveal both similarities and differences in gene content.	SW Agr Univ, Chongqing Beibei 400716, Peoples R China; Chinese Acad Sci, Beijing Genom Inst, Beijing Proteom Inst, Beijing 101300, Peoples R China; Zhejiang Univ, Hangzhou Genom Inst, Key Lab Genom Bioinformat Zhejiang Prov, James D Watson Inst Genome Sci, Hangzhou 310008, Peoples R China; Univ Washington, Dept Med, Genome Ctr, Seattle, WA 98195 USA	Southwest University - China; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Zhejiang University; University of Washington; University of Washington Seattle	Xia, QY (corresponding author), SW Agr Univ, Chongqing Beibei 400716, Peoples R China.	xiaqy@swau.cq.cn; xzh@swau.cq.cn; junyu@genomics.org.cn; gksw@genomics.org.cn; yanghm@genomics.org.cn	WONG, Gane Ka-Shu/G-5784-2013; Chen, Huan/CAH-8180-2022; 郑, 征/C-8514-2011; Li, Heng/D-9344-2011; Mao, Bingyu/L-9955-2014; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	WONG, Gane Ka-Shu/0000-0001-6108-5560; Li, Heng/0000-0003-4874-2874; Wang, Jun/0000-0002-8540-8931; Zha, Xingfu/0000-0003-2085-5260; Li, Jun/0000-0001-7218-429X; Xia, Qingyou/0000-0002-9263-2886; Wang, Jun/0000-0002-2113-5874; Zhang, Jianguo/0000-0003-0723-1701; cheng, tingcai/0000-0002-3862-0817	NHGRI NIH HHS [1 P50 HG02351] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002351] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abe H, 2000, MOL GEN GENET, V263, P916, DOI 10.1007/s004380000270; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Beldade P, 2002, NATURE, V415, P315, DOI 10.1038/415315a; Brody T, 1999, TRENDS GENET, V15, P333, DOI 10.1016/S0168-9525(99)01775-8; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; DOIRA H, 1992, GENETIC STOCKS MUTAT; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Goldsmith Marian R., 1995, P21, DOI 10.1017/CBO9780511529931.003; GOLDSMITH MR, 2004, ANN REV ENTOMOL; GRZELAK K, 1995, COMP BIOCHEM PHYS B, V110, P671, DOI 10.1016/0305-0491(94)00215-G; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Koch PB, 2003, DEV GENES EVOL, V212, P571, DOI 10.1007/s00427-002-0277-5; Li W. H, 1997, MOL EVOLUTION; Luque T, 2002, INSECT BIOCHEM MOLEC, V32, P1597, DOI 10.1016/S0965-1748(02)00080-2; McMillan WO, 2002, TRENDS ECOL EVOL, V17, P125, DOI 10.1016/S0169-5347(01)02427-2; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Mulnix Amy B., 1995, P369, DOI 10.1017/CBO9780511529931.015; Pouchkina NN, 2003, INSECT BIOCHEM MOLEC, V33, P229, DOI 10.1016/S0965-1748(02)00207-2; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schutt C, 2000, DEVELOPMENT, V127, P667; Stear JH, 2002, GENE DEV, V16, P1498, DOI 10.1101/gad.989102; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Suzuki MG, 2001, INSECT BIOCHEM MOLEC, V31, P1201, DOI 10.1016/S0965-1748(01)00067-4; Suzuki MG, 1998, HEREDITY, V81, P275, DOI 10.1046/j.1365-2540.1998.00356.x; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; Vanzo NF, 2002, DEVELOPMENT, V129, P3705; WANG J, IN PRESS NUCL ACIDS; Wu C, 1999, MOL GEN GENET, V261, P698, DOI 10.1007/s004380050013; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; ZHOU Y, 1958, GEN ENTOMOLOGY	33	875	1139	14	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1937	1940		10.1126/science.1102210	http://dx.doi.org/10.1126/science.1102210			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591204				2022-12-28	WOS:000225695600045
J	Cannistra, SA				Cannistra, SA			Cancer of the ovary	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GYNECOLOGIC-ONCOLOGY-GROUP; RANDOMIZED PHASE-III; HORMONE-RELATED PROTEIN; PROPHYLACTIC OOPHORECTOMY; STAGE-III; CA 125; INTRAVENOUS CYCLOPHOSPHAMIDE; CLINICOPATHOLOGICAL ANALYSIS; INTRAPERITONEAL CISPLATIN; ORAL-CONTRACEPTIVES		Beth Israel Deaconess Med Ctr, Program Gynecol Med Oncol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Cannistra, SA (corresponding author), Beth Israel Deaconess Med Ctr, Program Gynecol Med Oncol, 330 Brookline Ave, Boston, MA 02215 USA.	scannist@bidmc.harvard.edu						AbuJawdeh GM, 1996, LAB INVEST, V74, P1105; Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603; Alper O, 2001, J NATL CANCER I, V93, P1375, DOI 10.1093/jnci/93.18.1375; [Anonymous], 1995, JAMA, V273, P491; ARMSTRONG DK, 2002, P AN M AM SOC CLIN, V21, pA201; Armstrong K, 2000, NEW ENGL J MED, V342, P564, DOI 10.1056/NEJM200002243420807; Bandera CA, 1998, OBSTET GYNECOL, V92, P596, DOI 10.1016/S0029-7844(98)00223-3; BAST RC, 1985, GYNECOL ONCOL, V22, P115, DOI 10.1016/0090-8258(85)90015-0; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; BAST RC, 1985, EUR J OBSTET GYN R B, V19, P354, DOI 10.1016/0028-2243(85)90130-3; Bell J, 2003, GYNECOL ONCOL, V88, P156; Ben David Y, 2002, J CLIN ONCOL, V20, P463, DOI 10.1200/JCO.20.2.463; Berkenblit A, 2003, GYNECOL ONCOL, V89, P486, DOI 10.1016/S0090-8258(03)00138-0; Berkenblit A, 2001, WOMENS ONCOL REV, V1, P1; Bookman MA, 1998, J CLIN ONCOL, V16, P3345, DOI 10.1200/JCO.1998.16.10.3345; Bookman MA, 2003, J CLIN ONCOL, V21, P283, DOI 10.1200/JCO.2003.10.104; Bowman A, 2002, CLIN CANCER RES, V8, P2233; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Burger RA, 1999, GYNECOL ONCOL, V72, P148, DOI 10.1006/gyno.1998.5243; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Cannistra SA, 2004, J CLIN ONCOL, V22, P1542, DOI 10.1200/JCO.2004.02.150; Cannistra SA, 2002, J CLIN ONCOL, V20, P1158, DOI 10.1200/JCO.2002.20.5.1158; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; COLOMBO N, 1994, GYNECOL ONCOL, V55, pS47, DOI 10.1006/gyno.1994.1341; CRAWFORD SM, 2004, PROG P AM SOC CLIN O, V23, P448; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Eltabbakh GH, 1997, J REPROD MED, V42, P617; Evans TRJ, 1996, CANCER, V77, P2544, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2544::AID-CNCR18>3.0.CO;2-S; Fang XJ, 2002, BBA-MOL CELL BIOL L, V1582, P257, DOI 10.1016/S1388-1981(02)00179-8; Ford JM, 1992, PERFORMANCE IMPROVEM, V5, P2, DOI [10.1111/j.1937-8327.1992.tb00531.x, DOI 10.1111/J.1937-8327.1992.TB00531.X]; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; FURNEAUX HM, 1990, NEW ENGL J MED, V322, P1844, DOI 10.1056/NEJM199006283222604; Garber JE, 2004, J CLIN ONCOL, V22, P978, DOI 10.1200/JCO.2004.01.926; Gordon AN, 2001, J CLIN ONCOL, V19, P3312, DOI 10.1200/JCO.2001.19.14.3312; GRANBERG S, 1989, GYNECOL ONCOL, V35, P139, DOI 10.1016/0090-8258(89)90031-0; HANKINSON SE, 1993, JAMA-J AM MED ASSOC, V270, P2813, DOI 10.1001/jama.270.23.2813; HOLGUIN T, 1986, GYNECOL ONCOL, V25, P128, DOI 10.1016/0090-8258(86)90074-0; HOLTZ F, 1982, CANCER, V50, P2438, DOI 10.1002/1097-0142(19821201)50:11<2438::AID-CNCR2820501132>3.0.CO;2-X; Homesley HD, 2001, GYNECOL ONCOL, V83, P394, DOI 10.1006/gyno.2001.6435; HOSKINS WJ, 1989, GYNECOL ONCOL, V34, P365, DOI 10.1016/0090-8258(89)90175-3; International Collaborative Ovarian Neoplasm Group, 2003, LANCET, V361, P706; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kitazawa R, 1997, HUM PATHOL, V28, P379, DOI 10.1016/S0046-8177(97)90139-8; LAVIN PT, 1987, OBSTET GYNECOL, V69, P223; Levine DA, 2003, J CLIN ONCOL, V21, P4222, DOI 10.1200/JCO.2003.04.131; Liotta LA, 2001, JAMA-J AM MED ASSOC, V286, P2211, DOI 10.1001/jama.286.18.2211; Markman M, 1999, J CLIN ONCOL, V17, P1141, DOI 10.1200/JCO.1999.17.4.1141; MARKMAN M, 1993, CANCER, V71, P634; Markman M, 2001, J CLIN ONCOL, V19, P1001, DOI 10.1200/JCO.2001.19.4.1001; MARKMAN M, 1991, J CLIN ONCOL, V9, P389, DOI 10.1200/JCO.1991.9.3.389; Markman M, 2003, CANCER, V98, P885, DOI 10.1002/cncr.11607; Markman M, 2002, J CLIN ONCOL, V20, P2365, DOI 10.1200/JCO.2002.09.130; Markman M, 2003, J CLIN ONCOL, V21, P2460, DOI 10.1200/JCO.2003.07.013; Markman M, 1998, GYNECOL ONCOL, V69, P91, DOI 10.1006/gyno.1998.4997; Markman M, 1996, GYNECOL ONCOL, V62, P4, DOI 10.1006/gyno.1996.0181; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; MEDSGER TA, 1982, ANN INTERN MED, V96, P424, DOI 10.7326/0003-4819-96-4-424; Mendelsohn J, 2002, J CLIN ONCOL, V20, p1S, DOI 10.1200/JCO.2002.07.121; Menon U, 2001, INT J GYNECOL CANCER, V11, P3, DOI 10.1046/j.1525-1438.2001.11(suppl.1)sup1003.x; Meyer T, 2000, BRIT J CANCER, V82, P1535; Modan B, 2001, NEW ENGL J MED, V345, P235, DOI 10.1056/NEJM200107263450401; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; Muto MG, 1996, CANCER RES, V56, P1250; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; Ness RB, 2002, AM J EPIDEMIOL, V155, P217, DOI 10.1093/aje/155.3.217; NILOFF JM, 1986, AM J OBSTET GYNECOL, V155, P56, DOI 10.1016/0002-9378(86)90077-3; OMURA GA, 1991, J CLIN ONCOL, V9, P1138, DOI 10.1200/JCO.1991.9.7.1138; Ozols RF, 2003, J CLIN ONCOL, V21, P2451, DOI 10.1200/JCO.2003.03.039; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Ozols RF, 2002, LANCET, V360, P2086, DOI 10.1016/S0140-6736(02)11984-2; Ozols RF, 2002, J CLIN ONCOL, V20, P1161, DOI 10.1200/JCO.2002.20.5.1161; Ozols RF, 2001, SEMIN ONCOL, V28, P18, DOI 10.1016/S0093-7754(01)90274-X; Paley PJ, 2001, GYNECOL ONCOL, V80, P176, DOI 10.1006/gyno.2000.6071; Parmar MKB, 2003, LANCET, V361, P2099; Parmar MKB, 2002, LANCET, V360, P505; PETRU E, 1992, GYNECOL ONCOL, V44, P83, DOI 10.1016/0090-8258(92)90017-D; PFISTERER J, 2004, P AN M AM SOC CLIN, V23, P449; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P2751, DOI 10.1002/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J; Raffel GD, 2001, J CLIN ONCOL, V19, P4341, DOI 10.1200/JCO.2001.19.23.4341; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Rose PG, 2002, P AN M AM SOC CLIN, V21, p201a; ROSSING MA, 1994, NEW ENGL J MED, V331, P771, DOI 10.1056/NEJM199409223311204; ROWINSKY EK, 1995, NEW ENGL J MED, V333, P75; Rubin SC, 1996, NEW ENGL J MED, V335, P1413, DOI 10.1056/NEJM199611073351901; SCHILDKRAUT JM, 1988, AM J EPIDEMIOL, V128, P456, DOI 10.1093/oxfordjournals.aje.a114994; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Scully R, 1996, SCIENCE, V272, P123, DOI 10.1126/science.272.5258.123; Skates SJ, 2003, J CLIN ONCOL S, V21, P206, DOI DOI 10.1200/JC0.2003.02.955; SPENTZOS D, IN PRESS J CLIN ONCO; Strobel T, 1996, P NATL ACAD SCI USA, V93, P14094, DOI 10.1073/pnas.93.24.14094; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P105; Tsunematsu R, 2000, GYNECOL ONCOL, V76, P218, DOI 10.1006/gyno.1999.5619; van Nagell JR, 1999, CURR OPIN OBSTET GYN, V11, P45, DOI 10.1097/00001703-199901000-00009; VANDERBURG MEL, 1995, NEW ENGL J MED, V332, P629, DOI 10.1056/NEJM199503093321002; Vasey P.A., 2002, P AN M AM SOC CLIN, V21, p202a; Vasey PA, 2002, J CLIN ONCOL, V20, P1562, DOI 10.1200/JCO.20.6.1562; VENN A, 1995, LANCET, V346, P995, DOI 10.1016/S0140-6736(95)91687-3; WENZEL LB, 2004, PROG PROC AM SOC CLI, V23, pA454; WHITTEMORE AS, 1994, GYNECOL ONCOL, V55, pS15, DOI 10.1006/gyno.1994.1334; YOUNG RC, 1983, JAMA-J AM MED ASSOC, V250, P3072, DOI 10.1001/jama.250.22.3072; Young RC, 2003, J CLIN ONCOL, V21, P4350, DOI 10.1200/JCO.2003.02.154; Young RC, 2003, JNCI-J NATL CANCER I, V95, P94, DOI 10.1093/jnci/95.2.94; YOUNG RC, 1990, NEW ENGL J MED, V322, P1021, DOI 10.1056/NEJM199004123221501; YOUNG RH, 1991, AM J SURG PATHOL, V15, P415, DOI 10.1097/00000478-199105000-00001; ZAINO RJ, 1984, GYNECOL ONCOL, V19, P329, DOI 10.1016/0090-8258(84)90200-2	110	1400	1475	1	91	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2004	351	24					2519	2529		10.1056/NEJMra041842	http://dx.doi.org/10.1056/NEJMra041842			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877TE	15590954				2022-12-28	WOS:000225593100007
J	Bluemke, DA; Gatsonis, CA; Chen, MH; DeAngelis, GA; DeBruhl, N; Harms, S; Heywang-Kobrunner, SH; Hylton, N; Kuhl, CK; Lehman, C; Pisano, ED; Causer, P; Schnitt, SJ; Smazal, SF; Stelling, CB; Weatherall, PT; Schnall, MD				Bluemke, DA; Gatsonis, CA; Chen, MH; DeAngelis, GA; DeBruhl, N; Harms, S; Heywang-Kobrunner, SH; Hylton, N; Kuhl, CK; Lehman, C; Pisano, ED; Causer, P; Schnitt, SJ; Smazal, SF; Stelling, CB; Weatherall, PT; Schnall, MD			Magnetic resonance imaging of the breast prior to biopsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GD-DTPA; LESIONS; MAMMOGRAPHY; CANCER; DIAGNOSIS; CARCINOMA; MRI; ENHANCEMENT; EXPERIENCE; SONOGRAPHY	Context Breast magnetic resonance imaging (MRI) has been shown to have high sensitivity for cancer detection and is increasingly used following mammography to evaluate suspicious breast lesions. Objective To determine the accuracy of breast MRI in conjunction with mammography for the detection of breast cancer in patients with suspicious mammographic or clinical findings. Design, Setting, and Patients Prospective multicenter investigation of the International Breast MR Consortium conducted at 14 university hospitals in North America and Europe from June 2, 1998, through October 31, 2001, of 821 patients referred for breast biopsy for American College of Radiology category 4 or 5 mammographic assessment or suspicious clinical or ultrasound finding. Interventions MRI examinations performed prior to breast biopsy; MRI results were interpreted at each site, which were blinded to pathological results. Main Outcome Measures Area under the receiver operating characteristic curve (AUC), sensitivity, and specificity of breast MRI. Results Among the 821 patients, there were 404 malignant index lesions, of which 63 were ductal carcinoma in situ (DCIS) and 341 were invasive carcinoma. Of the 417 nonmalignant index lesions, 366 were benign, 47 showed atypical histology, and 4 were lobular carcinoma in situ. The AUC pooled over all institutions was 0.88 (95% confidence interval [CI], 0.86-0.91). MRI correctly detected cancer in 356 of 404 cancer cases (DCIS or invasive cancer), resulting in a sensitivity of 88.1% (95% CI, 84.6%-91.1%), and correctly identified as negative for cancer 281 of 417 cases without cancer, resulting in a specificity of 67.7% (95% CI, 62.7%-71.9%). MRI performance was not significantly affected by mammographic breast density, tumor histology, or menopausal status. The positive predictive values for 356 of 492 patients was 72.4% (95% CI, 68.2%-76.3%) and of mammography for 367 of 695 patients was 52.8% (95% CI, 49.0%-56.6%) (P<.005). Dynamic MRI did not improve the AUC compared with 3-dimensional MRI alone, but the specificity of a washout pattern for 123 of 136 patients without cancer was 90.4% (95% CI, 84%-95%). Conclusions Breast MRI has high sensitivity but only moderate specificity independent of breast density, tumor type, and menopausal status. Although the positive predictive value of MRI is greater than mammography, MRI does not obviate the need for subsequent tissue sampling in this setting.	Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Radiol Sci, Baltimore, MD 21205 USA; Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA; Univ Virginia Hlth Syst, Dept Radiol, Charlottesville, VA USA; Univ Calif Los Angeles, Sch Med, Dept Radiol Sci, Los Angeles, CA 90024 USA; Univ Arkansas Med Sci, Dept Radiol, Little Rock, AR 72205 USA; Tech Univ, Dept Breast Imaging, Munich, Germany; Univ Calif San Francisco, Magnet Resonance Sci Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; Univ Bonn, Dept Radiol, D-5300 Bonn, Germany; Univ Washington, Canc Care Alliance, Seattle, WA 98195 USA; Univ Washington, Dept Radiol, Seattle, WA 98195 USA; Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; Univ Toronto, Dept Radiol, Toronto, ON M5S 1A1, Canada; Sunnybrook Canc Care Ctr, Toronto, ON, Canada; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Radiol Imaging Associates, Littleton, CO USA; Porter Adventist Hosp, Littleton, CO USA; Univ Texas, MD Anderson Canc Ctr, Div Diagnost Imaging, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, Dept Radiol, Dallas, TX 75235 USA; Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Brown University; University of Virginia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Arkansas System; University of Arkansas Medical Sciences; Technical University of Munich; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Bonn; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania	Bluemke, DA (corresponding author), Johns Hopkins Univ Hosp, Dept Radiol, 600 N Wolfe St, Baltimore, MD 21287 USA.	dbluemke@jhmi.edu	Hylton, Nola/AAF-7861-2019; Kuhl, Christiane K/H-3301-2013; Bluemke, David/GYU-8169-2022	Kuhl, Christiane K/0000-0001-8696-2363; Bluemke, David/0000-0002-8323-8086; Chen, Mei-Hsiu/0000-0003-0566-073X	NATIONAL CANCER INSTITUTE [U01CA074680, U01CA074696] Funding Source: NIH RePORTER; NCI NIH HHS [UO1-CA74680, UO1-CA74696] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIRD RE, 1992, RADIOLOGY, V184, P613, DOI 10.1148/radiology.184.3.1509041; Bone B, 2003, ACTA RADIOL, V44, P28; Bone B, 1997, ACTA RADIOL, V38, P489; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Brinck U, 1997, AM J ROENTGENOL, V168, P1331, DOI 10.2214/ajr.168.5.9129437; Cron GO, 2004, MAGNET RESON MED, V51, P1066, DOI 10.1002/mrm.20042; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Drew PJ, 1999, ANN SURG, V230, P680, DOI 10.1097/00000658-199911000-00010; Fischer U, 1999, RADIOLOGY, V213, P881, DOI 10.1148/radiology.213.3.r99dc01881; GILLES R, 1995, RADIOLOGY, V196, P415, DOI 10.1148/radiology.196.2.7617854; HALL FM, 1988, RADIOLOGY, V167, P353, DOI 10.1148/radiology.167.2.3282256; HANLEY JA, 1989, CRIT REV DIAGN IMAG, V29, P307; HARMS SE, 1993, RADIOLOGY, V187, P493, DOI 10.1148/radiology.187.2.8475297; HEYWANG SH, 1989, RADIOLOGY, V171, P95, DOI 10.1148/radiology.171.1.2648479; Heywang-Korunner SH, 2001, EUR RADIOL, V11, P531, DOI 10.1007/s003300000745; HEYWANGKOBRUNNER SH, 1994, INVEST RADIOL, V29, P94, DOI 10.1097/00004424-199401000-00019; Ishwaran H, 2000, CAN J STAT, V28, P731, DOI 10.2307/3315913; Jacobs MA, 2003, RADIOLOGY, V229, P225, DOI 10.1148/radiol.2291020333; Kacl GM, 1998, EUR RADIOL, V8, P194, DOI 10.1007/s003300050362; KAISER WA, 1989, RADIOLOGY, V170, P681, DOI 10.1148/radiology.170.3.2916021; KELCZ F, 1995, CRIT REV DIAGN IMAG, V36, P287; KOPANS DB, 1989, BREAST IMAGING, P320; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 1997, RADIOLOGY, V203, P137, DOI 10.1148/radiology.203.1.9122382; Kuhl CK, 1999, RADIOLOGY, V211, P101, DOI 10.1148/radiology.211.1.r99ap38101; Leconte I, 2003, AM J ROENTGENOL, V180, P1675, DOI 10.2214/ajr.180.6.1801675; Leisenring W, 2000, BIOMETRICS, V56, P345, DOI 10.1111/j.0006-341X.2000.00345.x; Liberman L, 2003, AM J ROENTGENOL, V180, P901, DOI 10.2214/ajr.180.4.1800901; Majid AS, 2003, RADIOGRAPHICS, V23, P881, DOI 10.1148/rg.234025083; Malur S, 2001, BREAST CANCER RES, V3, P55, DOI 10.1186/bcr271; METZ C, 1998, ROCKFIT MANUAL; Morakkabati N, 2003, RADIOLOGY, V229, P893, DOI 10.1148/radiol.2293020167; MullerSchimpfle M, 1997, JMRI-J MAGN RESON IM, V7, P236, DOI 10.1002/jmri.1880070137; *NIH, MULT COOP AGR CLIN E; Nunes LW, 2001, RADIOLOGY, V219, P484, DOI 10.1148/radiology.219.2.r01ma44484; Orel SG, 2001, RADIOLOGY, V220, P13, DOI 10.1148/radiology.220.1.r01jl3113; OREL SG, 1994, RADIOLOGY, V193, P97, DOI 10.1148/radiology.193.1.8090928; Shahar KH, 2002, J COMPUT ASSIST TOMO, V26, P1047, DOI 10.1097/00004728-200211000-00034; Sherif H, 1997, RADIOLOGY, V205, P209, DOI 10.1148/radiology.205.1.9314987; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; STOMPER PC, 1995, RADIOLOGY, V197, P387, DOI 10.1148/radiology.197.2.7480682; Teifke A, 2002, RADIOLOGY, V224, P881, DOI 10.1148/radiol.2243010547; Wiberg MK, 2002, ACTA RADIOL, V43, P275, DOI 10.1034/j.1600-0455.2002.430308.x	43	370	385	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2004	292	22					2735	2742		10.1001/jama.292.22.2735	http://dx.doi.org/10.1001/jama.292.22.2735			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877CY	15585733				2022-12-28	WOS:000225546600022
J	Oreskes, N				Oreskes, N			Beyond the ivory tower - The scientific consensus on climate change	SCIENCE			English	Editorial Material									Univ Calif San Diego, Dept Hist, La Jolla, CA 92093 USA; Univ Calif San Diego, Sci Studies Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Oreskes, N (corresponding author), Univ Calif San Diego, Dept Hist, La Jolla, CA 92093 USA.	noreskes@ucsd.edu						*AM GEOPH UN, 2003, EOS, V84, P574; American Meteorological Society, 2003, B AM METEOROL SOC, V84, P508; McCarthy J.J., 2001, CLIMATE CHANGE 2001; National Academy of Sciences Committee on the Science of Climate Change, 2001, CLIM CHANG SCI AN SO; REVKIN AC, 2003, NY TIMES        0619, pA1; van den Hove S, 2002, CLIM POLICY, V2, P3, DOI 10.1016/S1469-3062(02)00008-6	6	889	983	10	238	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1686	1686		10.1126/science.1103618	http://dx.doi.org/10.1126/science.1103618			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576594				2022-12-28	WOS:000225630800026
J	Schultz, T; Samoylova, E; Radloff, W; Hertel, IV; Sobolewski, AL; Domcke, W				Schultz, T; Samoylova, E; Radloff, W; Hertel, IV; Sobolewski, AL; Domcke, W			Efficient deactivation of a model base pair via excited-state hydrogen transfer	SCIENCE			English	Article							AB-INITIO; ELECTRONIC-SPECTRA; CYTOSINE; GUANINE; 2-AMINOPYRIDINE; DYNAMICS; DECAY	We present experimental and theoretical evidence for an excited-state deactivation mechanism specific to hydrogen-bonded aromatic dimers, which may account, in part, for the photostability of the Watson-Crick base pairs in DNA. Femtosecond time-resolved mass spectroscopy of 2-aminopyridine clusters reveals an excited-state lifetime of 65+/-10 picoseconds for the near-planar hydrogen-bonded dimer, which is significantly shorter than the lifetime of either the monomer or the 3- and 4-membered nonplanar clusters. Ab initio calculations of reaction pathways and potential-energy profiles identify the mechanism of the enhanced excited-state decay of the dimer: Conical intersections connect the locally excited (1)pipi* state and the electronic ground state with a (1)pipi* charge-transfer state that is strongly stabilized by the transfer of a proton.	Max Born Inst, D-10247 Berlin, Germany; Polish Acad Sci, Inst Phys, PL-02668 Warsaw, Poland; Tech Univ Munich, Dept Chem, D-85747 Garching, Germany	Max Born Institute for Nonlinear Optics & Short Term Spectroscopy; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; Technical University of Munich	Schultz, T (corresponding author), Max Born Inst, Max Born Str 2A, D-10247 Berlin, Germany.	schultz@mbi-berlin.de	Samoylova, Elena/A-3016-2011; Schultz, Thomas/C-2749-2009; Domcke, Wolfgang/C-1179-2010; Sobolewski, Andrzej L/K-8868-2016	Schultz, Thomas/0000-0001-6901-1814; Sobolewski, Andrzej L./0000-0001-5718-489X				Borst DR, 2002, J PHYS CHEM A, V106, P4022, DOI 10.1021/jp0140769; Crespo-Hernandez CE, 2004, CHEM REV, V104, P1977, DOI 10.1021/cr0206770; de Vries M., COMMUNICATION; Domcke W., 2004, CONICAL INTERSECTION, VVol. 15; DOUHAL A, 1995, NATURE, V378, P260, DOI 10.1038/378260a0; HAGER JW, 1987, J PHYS CHEM-US, V91, P1375, DOI 10.1021/j100290a021; Ismail N, 2002, J AM CHEM SOC, V124, P6818, DOI 10.1021/ja0258273; Jurecka P, 2003, J AM CHEM SOC, V125, P15608, DOI 10.1021/ja036611j; Merchan M, 2003, J AM CHEM SOC, V125, P8108, DOI 10.1021/ja0351600; Nir E, 2002, PHYS CHEM CHEM PHYS, V4, P732, DOI 10.1039/b107429f; Sobolewski AL, 2004, PHYS CHEM CHEM PHYS, V6, P2763, DOI 10.1039/b314419d; Sobolewski AL, 2002, PHYS CHEM CHEM PHYS, V4, P1093, DOI 10.1039/b110941n; Sobolewski AL, 2003, CHEM PHYS, V294, P73, DOI 10.1016/S0301-0104(03)00388-4	13	288	290	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1765	1768		10.1126/science.1104038	http://dx.doi.org/10.1126/science.1104038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576616				2022-12-28	WOS:000225630800049
J	[Anonymous]				[Anonymous]			Opportunity at Meridiani Planum: Plates	SCIENCE			English	Article																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1715	1722						8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576605				2022-12-28	WOS:000225630800037
J	Paludan, C; Schmid, D; Landthaler, M; Vockerodt, M; Kube, D; Tuschl, T; Munz, C				Paludan, C; Schmid, D; Landthaler, M; Vockerodt, M; Kube, D; Tuschl, T; Munz, C			Endogenous MHC class II processing of a viral nuclear antigen after autophagy	SCIENCE			English	Article							CYTOSOLIC ANTIGEN; RESTRICTED PRESENTATION; PROTEIN-DEGRADATION; T-CELLS; COMPLEX; CD4(+); MOLECULES; PROTEASOMES; INHIBITION; EXPRESSION	CD4(+) T cells classically recognize antigens that are endocytosed and processed in lysosomes for presentation on major histocompatibility complex (MHC) class II molecules. Here, endogenous Epstein-Barr virus nuclear antigen 1 (EBNA1) was found to gain access to this pathway by autophagy. On inhibition of lysosomal acidification, EBNA1, the dominant CD4(+) T cell antigen of latent Epstein-Barr virus infection, slowly accumulated in cytosolic autophagosomes. In addition, inhibition of autophagy decreased recognition by EBNA1-specific CD4(+) T cell clones. Thus, lysosomal processing after autophagy may contribute to MHC class II-restricted surveillance of long-lived endogenous antigens including nuclear proteins relevant to disease.	Rockefeller Univ, Lab Viral Immunobiol, New York, NY 10021 USA; Rockefeller Univ, Christopher H Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA; Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10021 USA; Univ Gottingen, Ctr Internal Med Hematol & Oncol, D-37099 Gottingen, Germany	Rockefeller University; Rockefeller University; Rockefeller University; University of Gottingen	Munz, C (corresponding author), Rockefeller Univ, Lab Viral Immunobiol, 1230 York Ave, New York, NY 10021 USA.	munzc@mail.rockefeller.edu	Landthaler, Markus/A-1427-2010; Vockerodt, Martina/L-4465-2014; Münz, Christian/W-4881-2017	Landthaler, Markus/0000-0002-1075-8734; Vockerodt, Martina/0000-0001-7761-5829; Dormann, Dorothee/0000-0002-9260-2775; Munz, Christian/0000-0001-6419-1940				Aichinger G, 1997, J BIOL CHEM, V272, P29127, DOI 10.1074/jbc.272.46.29127; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Bonifaz LC, 1999, EUR J IMMUNOL, V29, P119, DOI 10.1002/(SICI)1521-4141(199901)29:01<119::AID-IMMU119>3.0.CO;2-O; Brazil MI, 1997, EUR J IMMUNOL, V27, P1506, DOI 10.1002/eji.1830270629; Busch R, 2000, CURR OPIN IMMUNOL, V12, P99, DOI 10.1016/S0952-7915(99)00057-6; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Gueguen M, 1996, P NATL ACAD SCI USA, V93, P14692, DOI 10.1073/pnas.93.25.14692; HENDIL KB, 1988, BIOCHEM INT, V17, P471; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Lee SP, 2004, J EXP MED, V199, P1409, DOI 10.1084/jem.20040121; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; MALNATI MS, 1992, NATURE, V357, P702, DOI 10.1038/357702a0; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Muller S, 1998, AM J PATHOL, V152, P261; Munz C, 2000, J EXP MED, V191, P1649, DOI 10.1084/jem.191.10.1649; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Paludan C, 2002, J IMMUNOL, V169, P1593, DOI 10.4049/jimmunol.169.3.1593; PALUDAN C, UNPUB; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x; TANAKA K, 1989, BIOCHEM BIOPH RES CO, V159, P1309, DOI 10.1016/0006-291X(89)92253-5; Tellam J, 2004, J EXP MED, V199, P1421, DOI 10.1084/jem.20040191; Voo KS, 2004, J EXP MED, V199, P459, DOI 10.1084/jem.20031219; Voo KS, 2002, CANCER RES, V62, P7195; WEISS S, 1991, CELL, V64, P767, DOI 10.1016/0092-8674(91)90506-T; WU Z, 1994, CLIN EXP IMMUNOL, V98, P470; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yawalkar N, 2001, AM J PATHOL, V158, P803, DOI 10.1016/S0002-9440(10)64027-8; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902	36	668	708	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					593	596		10.1126/science.1104904	http://dx.doi.org/10.1126/science.1104904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15591165				2022-12-28	WOS:000226694000051
J	Miners, AH; Garau, M; Fidan, D; Fischer, AJ				Miners, AH; Garau, M; Fidan, D; Fischer, AJ			Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To assess the association between different types of organisation and the results front economic evaluations. Design Retrospective pairwise comparison of evidence submitted to the technology appraisal programme of the National Institute for Clinical Excellence (NICE) by manufacturers of the relevant healtltcare technologies and by contracted university based assessment groups. Data sources Data front the first 62 appraisals. Main outcome measure Incremental cost effectiveness ratios. Results Data from 27 of the 62 appraisals could be compared. The analysis of 54 pairwise comparisons showed that manufacturer's estimates of incremental cost effectiveness ratios were lower (suggesting a snore cost effective use of resources) than those produced by the assessment groups (25 were lower, 29 were the wine, none were higher, P < 0.01). Restriction of this dataset to include only one pairwise comparison per appraisal (27 pairs) produced a similar result (21 were lower, two were the same, four were higher, P < 0.001). Conclusions The estimated incremental cost effectiveness ratios submitted by manufacturers were on average significantly lower than those submitted by the assessment groups. These results show that an important role of NICE's appraisal committee, and of decision makers in general, is to determine which economic evaluations, or parts of evaluations, should be given more credence.	Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England; Univ York, Dept Econ, York YO1 5DD, N Yorkshire, England; Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England; Univ London St Georges Hosp, Sch Med, Dept Community Hlth Sci, London SW17 0RE, England	Brunel University; University of York - UK; University of London; London School of Hygiene & Tropical Medicine; St Georges University London	Miners, AH (corresponding author), Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England.	Alec.Miners@nice.nhs.uk	Garau, Martina/P-5582-2014					Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Azimi NA, 1998, J GEN INTERN MED, V13, P664, DOI 10.1046/j.1525-1497.1998.00201.x; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Drummond MF, 2015, METHODS EC EVALUATIO; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Garrison LP, 2003, VALUE HEALTH, V6, P6, DOI 10.1046/j.1524-4733.2003.00003.x; Gold MR, 1996, COST EFFECTIVENESS H; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; *NICE, GUID MAN SPONS; Raftery J, 2001, BRIT MED J, V323, P1300, DOI 10.1136/bmj.323.7324.1300; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505	13	61	62	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2005	330	7482					65	68		10.1136/bmj.38285.482350.82	http://dx.doi.org/10.1136/bmj.38285.482350.82			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887GR	15601681	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000226294300011
J	Graf, ER; Zhang, XZ; Jin, SX; Linhoff, MW; Craig, AM				Graf, ER; Zhang, XZ; Jin, SX; Linhoff, MW; Craig, AM			Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins	CELL			English	Article							HIPPOCAMPAL-NEURONS; GABAERGIC SYNAPSES; ADHESION MOLECULE; RECEPTOR; BINDING; DYSTROGLYCAN; LIGAND; HETEROGENEITY; PLASTICITY; EVOLUTION	Formation of synaptic connections requires alignment of neurotransmitter receptors on postsynaptic dendrites opposite matching transmitter release sites on presynaptic axons. beta-neurexins and neuroligins form a trans-synaptic link at glutamate synapses. We show here that neurexin alone is sufficient to induce glutamate postsynaptic differentiation in contacting dendrites. Surprisingly, neurexin also induces GABA postsynaptic differentiation. Conversely, neuroligins induce presynaptic differentiation in both glutamate and GABA axons. Whereas neuroligins-1, -3, and -4 localize to glutamate postsynaptic sites, neuroligin-2 localizes primarily to GABA synapses. Direct aggregation of neuroligins reveals a linkage of neuroligin-2 to GABA and glutamate postsynaptic proteins, but the other neuroligins only to glutamate postsynaptic proteins. Furthermore, mislocalized expression of neuroligin-2 disperses postsynaptic proteins and disrupts synaptic transmission. Our findings indicate that the neurexin-neuroligin link is a core component mediating both GABAergic and glutamatergic synaptogenesis, and differences in isoform localization and binding affinities may contribute to appropriate differentiation and specificity.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Craig, AM (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	acraig@pcg.wustl.edu	Craig, Ann Marie/M-2054-2014		NINDS NIH HHS [P01 NS034448, R01 NS033184-10, NS34448, NS33184, P01 NS034448-070005, R01 NS033184-11, R01 NS033184, P01 NS034448-080005] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033184, P01NS034448] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Goslin K., 1998, CULTURING NERVE CELL, P339; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Knuesel I, 1999, EUR J NEUROSCI, V11, P4457, DOI 10.1046/j.1460-9568.1999.00887.x; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Petrenko AG, 1996, J NEUROSCI, V16, P4360; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8	42	696	730	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					1013	1026		10.1016/j.cell.2004.11.035	http://dx.doi.org/10.1016/j.cell.2004.11.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620359	Green Accepted, Bronze			2022-12-28	WOS:000226109700013
J	Shi, YJ; Lan, F; Matson, C; Mulligan, P; Whetstine, JR; Cole, PA; Casero, RA; Shi, Y				Shi, YJ; Lan, F; Matson, C; Mulligan, P; Whetstine, JR; Cole, PA; Casero, RA; Shi, Y			Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1	CELL			English	Article							METHYLTRANSFERASE ACTIVITY; LYSINE-9 METHYLATION; H3 METHYLATION; EPSILON-ALKYLLYSINASE; TRANSCRIPTION; ACETYLATION; CHROMATIN; COMPLEX; DOMAIN; PURIFICATION	Posttranslational modifications of histone N-terminal tails impact chromatin structure and gene transcription. While the extent of histone acetylation is determined by both acetyltransferases and deacetylases, it has been unclear whether histone methylation is also regulated by enzymes with opposing activities. Here, we provide evidence that LSD1 (KIAA0601), a nuclear homolog of amine oxidases, functions as a histone demethylase and transcriptional corepressor. LSD1 specifically demethylates histone H3 lysine 4, which is linked to active transcription. Lysine demethylation occurs via an oxidation reaction that generates formaldehyde. Importantly, RNAi inhibition of LSD1 causes an increase in H3 lysine 4 methylation and concomitant derepression of target genes, suggesting that LSD1 represses transcription via histone demethylation. The results thus identify a histone demethylase conserved from S. pombe to human and reveal dynamic regulation of histone methylation by both histone methylases and demethylases.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu		Casero, Robert/0000-0001-5653-3306; Mulligan, Peter/0000-0003-0737-2328	NIGMS NIH HHS [GM071004, GM70095-02, F32GM070690] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070690, R01GM071004, F32GM070095] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLIS CD, 1980, CELL, V20, P55; Aravind L., 2002, GENOME BIOL, V3, DOI [DOI 10.1186/GB-2002-3-8-RESEARCH0039, 10.1186/gb-2002-3-8-research0039]; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Binda C, 2002, J BIOL CHEM, V277, P23973, DOI 10.1074/jbc.R200005200; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chinenov Y, 2002, TRENDS BIOCHEM SCI, V27, P115, DOI 10.1016/S0968-0004(02)02058-3; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Eimer S, 2002, EMBO J, V21, P5787, DOI 10.1093/emboj/cdf561; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jarriault S, 2002, GENE DEV, V16, P2713, DOI 10.1101/gad.1022402; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Joseph B, 2003, P NATL ACAD SCI USA, V100, P15619, DOI 10.1073/pnas.2635658100; KIM S, 1964, J BIOL CHEM, V239, P3790; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Landry J, 2003, BIOCHEM BIOPH RES CO, V303, P771, DOI 10.1016/S0006-291X(03)00416-9; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Lizcano JM, 2000, ANAL BIOCHEM, V286, P75, DOI 10.1006/abio.2000.4782; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; PAIK WK, 1974, ARCH BIOCHEM BIOPHYS, V165, P369, DOI 10.1016/0003-9861(74)90175-1; PAIK WK, 1973, BIOCHEM BIOPH RES CO, V51, P781, DOI 10.1016/0006-291X(73)91383-1; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rozylo TK, 2000, BIOMED CHROMATOGR, V14, P173, DOI 10.1002/1099-0801(200005)14:3<173::AID-BMC957>3.0.CO;2-O; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shi YJ, 2004, TRENDS GENET, V20, P445, DOI 10.1016/j.tig.2004.07.004; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	64	2957	3209	13	349	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					941	953		10.1016/j.cell.2004.12.012	http://dx.doi.org/10.1016/j.cell.2004.12.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620353	Bronze			2022-12-28	WOS:000226109700007
J	Hill, GE				Hill, GE			A head start for some redstarts	SCIENCE			English	Editorial Material									Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Auburn University System; Auburn University	Hill, GE (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	ghill@acesag.auburn.edu	Hill, Geoffrey E./R-7354-2019	Hill, Geoffrey E./0000-0001-8864-6495				Hill G. E., 2002, RED BIRD BROWN BAG F; Hobson KA, 1999, OECOLOGIA, V120, P312, DOI 10.1007/s004420050864; Loria DE, 1990, BEHAV ECOL, V1, P24, DOI 10.1093/beheco/1.1.24; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Norris DR, 2004, SCIENCE, V306, P2249, DOI 10.1126/science.1103542; Terborgh John, 1989, HAVE ALL BIRDS GONE	6	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2201	2202		10.1126/science.1107749	http://dx.doi.org/10.1126/science.1107749			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15619587				2022-12-28	WOS:000225950000029
J	Jia, JH; Tong, C; Wang, B; Luo, LP; Jiang, J				Jia, JH; Tong, C; Wang, B; Luo, LP; Jiang, J			Hedgehog signalling activity of Smoothened requires phosphorylation by protein kinase A and casein kinase I	NATURE			English	Article							CUBITUS INTERRUPTUS; DROSOPHILA; TRANSDUCTION; TRANSCRIPTION; LOCALIZATION; RECOGNITION; PROTEOLYSIS; EXPRESSION; INHIBITOR; ACTIVATOR	The Hedgehog (Hh) family of secreted proteins governs cell growth and patterning in animal development(1). The Hh signal is transduced by the seven-transmembrane protein Smoothened (Smo); however, the mechanism by which Smo is regulated remains largely unknown. Here we show that protein kinase A (PKA) and casein kinase I (CKI) regulate Smo cell-surface accumulation and activity in response to Hh. Blocking PKA or CKI activity in the Drosophila wing disc prevents Hh-induced Smo accumulation and attenuates pathway activity, whereas increasing PKA activity promotes Smo accumulation and pathway activation. We show that PKA and CKI phosphorylate Smo at several sites, and that phosphorylation-deficient forms of Smo fail to accumulate on the cell surface and are unable to transduce the Hh signal. Conversely, phosphorylation-mimicking Smo variants show constitutive cell-surface expression and signalling activity. Furthermore, we find that the levels of Smo cell-surface expression and activity correlate with its levels of phosphorylation. Our data indicate that Hh induces progressive Smo phosphorylation by PKA and CKI, leading to elevation of Smo cell-surface levels and signalling activity.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Jiang, J (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA.	jin.jiang@utsouthwestern.edu		Tong, Chao/0000-0001-6521-5465; Jia, Jianhang/0000-0002-9313-3843	NIGMS NIH HHS [R01 GM061269, R01 GM067045] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067045, R01GM061269] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jiang J, 2002, GENE DEV, V16, P2315, DOI 10.1101/gad.1027902; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; KALDERON D, 1988, GENE DEV, V2, P1539, DOI 10.1101/gad.2.12a.1539; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; LEPAGE T, 1995, NATURE, V373, P711, DOI 10.1038/373711a0; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Ohlmeyer JT, 1997, GENE DEV, V11, P2250, DOI 10.1101/gad.11.17.2250; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; Price MA, 1999, DEVELOPMENT, V126, P4331; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Strigini M, 1997, DEVELOPMENT, V124, P4697; UMPHRESS JL, 1992, EUR J BIOCHEM, V203, P239, DOI 10.1111/j.1432-1033.1992.tb19852.x; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; Wang GL, 1999, GENE DEV, V13, P2828, DOI 10.1101/gad.13.21.2828; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	30	251	263	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1045	1050		10.1038/nature03179	http://dx.doi.org/10.1038/nature03179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616566				2022-12-28	WOS:000225887000046
J	Oxman, AD; Chalmers, L; Liberati, A				Oxman, AD; Chalmers, L; Liberati, A		World Artifexology Grp	A field guide to experts	BRITISH MEDICAL JOURNAL			English	Article									Norwegian Hlth Serv Res Ctr, Informed Choice Res Dept, N-0130 Oslo, Norway; James Lind Lib, Oxford, England; Univ Modena & Reggio Emilia, Agcy Sanitaria Reg, Bologna, Italy	Universita di Modena e Reggio Emilia	Oxman, AD (corresponding author), Norwegian Hlth Serv Res Ctr, Informed Choice Res Dept, N-0130 Oslo, Norway.	oxman@online.no	Oxman, Andrew/Y-3004-2019	Oxman, Andrew/0000-0002-5608-5061					0	11	11	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1460	1463		10.1136/bmj.329.7480.1460	http://dx.doi.org/10.1136/bmj.329.7480.1460			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604184	Green Submitted, Green Published			2022-12-28	WOS:000225965800027
J	Park, MP; Park, RHR				Park, MP; Park, RHR			The fine art of patient-doctor relationships	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VANGOGH,VINCENT ILLNESS		Univ Glasgow, Dept Adult & Continuing Educ, Glasgow G3 6NH, Lanark, Scotland; So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow; University of Glasgow	Park, MP (corresponding author), Univ Glasgow, Dept Adult & Continuing Educ, Glasgow G3 6NH, Lanark, Scotland.	mpark@educ.gla.ac.uk						ALLDERIDGE P, 1974, LATE R DADD; Allderidge P H, 1970, Med Hist, V14, P308; CAWTHORNE T, 1962, P ROY SOC MED, V55, P213, DOI 10.1177/003591576205500308; FOY JL, 1971, CONSCIOUS UNCONSCIOU, V3; Frith William, 1888, MY AUTOBIOGRAPHY REM; GROVES T, 1989, BRIT MED J, V299, P1576, DOI 10.1136/bmj.299.6715.1576; Heller R., 1984, MUNCH HIS LIFE WORK; HERRERA H, 1989, FRIDA BIOGRAPHY F KA; JAMISON KR, 1992, BRIT MED J, V304, P577, DOI 10.1136/bmj.304.6826.577-c; KETTENMANN A, 1993, F KAHLO PAIN PASSION; Licht Fred, 1983, GOYA ORIGINS MODERN; LOFTUS LS, 1991, BRIT MED J, V303, P1589, DOI 10.1136/bmj.303.6817.1589; LOMAS D, 1989, BMJ-BRIT MED J, V299, P1584, DOI 10.1136/bmj.299.6715.1584; MCEWAN J, 1994, J BELLANY; Pickvance Ronald, 1986, VANGOGH SAINTREMY AU; STAINBROOK E, 1948, Bull Hist Med, V22, P156; STANG N, 1972, E MUNCH; STENERSEN R, 1969, E MUNCH CLOSE UP GEN; TRALBAUT ME, 1974, V VANGOGH; Viederman M, 1994, J Am Acad Psychoanal, V22, P73; 1978, COMPLETE LETT V VANG	21	7	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1475	1480		10.1136/bmj.329.7480.1475	http://dx.doi.org/10.1136/bmj.329.7480.1475			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604190	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000225965800033
J	Richardson, PG; Kassarjian, A; Jing, W				Richardson, PG; Kassarjian, A; Jing, W			A 40-year-old man with a large tumor of the skull - Plasma-cell myeloma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROTEASOME INHIBITOR PS-341; UNTREATED MULTIPLE-MYELOMA; OVERCOMES DRUG-RESISTANCE; HIGH-DOSE CHEMOTHERAPY; STAGING SYSTEM; THALIDOMIDE; DEXAMETHASONE; TRANSPLANTATION; THERAPY; PHASE-2		Brigham & Womens Hosp, Jerome Lipper Multiple Myeloma Ctr, Div Hematol Oncol, Dept Med, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Richardson, PG (corresponding author), Brigham & Womens Hosp, Jerome Lipper Multiple Myeloma Ctr, Div Hematol Oncol, Dept Med, Boston, MA 02115 USA.			Kassarjian, Ara/0000-0002-9969-3227				Alexanian R, 2002, ANN ONCOL, V13, P1116, DOI 10.1093/annonc/mdf188; Arana E, 1999, AM J ROENTGENOL, V172, P1683, DOI 10.2214/ajr.172.6.10350315; Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Attal M, 2004, NEW ENGL J MED, V350, P2628; ATTAL M, 2004, P MULT MYEL 2004 C T, P111; BARLOGIE B, 1984, NEW ENGL J MED, V310, P1353, DOI 10.1056/NEJM198405243102104; BERENSON JR, 1996, NEW ENGL J MED, V334, P448; CAVENAGH JD, 2004, PROG P AM SOC CLIN O, V23, P570; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Greipp PR, 2003, BLOOD, V102, p190A; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2000, BLOOD, V96, P2943, DOI 10.1182/blood.V96.9.2943; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; HOLLAND J, 1992, CANCER, V69, P1513, DOI 10.1002/1097-0142(19920315)69:6<1513::AID-CNCR2820690633>3.0.CO;2-X; Ibrahim A, 2003, CLIN CANCER RES, V9, P2394; Jaffe ES, 2001, PATHOLOGY GENETICS T, V3; Jagannath S, 2003, BLOOD, V102, p236A; LeBlanc R, 2002, CANCER RES, V62, P4996; LOHRMANN HP, 1984, ONCOLOGY, V41, P180, DOI 10.1159/000225819; Maloney DG, 2003, BLOOD, V102, P3447, DOI 10.1182/blood-2002-09-2955; Miller FR, 1998, OTOLARYNG HEAD NECK, V119, P614, DOI 10.1016/S0194-5998(98)70021-X; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Rajkumar SV, 2002, J CLIN ONCOL, V20, P4319, DOI 10.1200/JCO.2002.02.116; RAJKUMAR SV, 2004, PROG P AM SOC CLIN O, V23, P560; RESNICK D, 1995, DIAGNOSIS BONE JOINT, P2150; Richardson P, 2004, MAYO CLIN PROC, V79, P875, DOI 10.4065/79.7.875; Richardson P, 2002, ANNU REV MED, V53, P629, DOI 10.1146/annurev.med.53.082901.104043; RICHARDSON P, 2004, P AN M AM SOC CLIN, V23, P558; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Richardson PG, 2002, BLOOD, V100, P3063, DOI 10.1182/blood-2002-03-0996; Segeren CM, 1999, BRIT J HAEMATOL, V105, P127, DOI 10.1111/j.1365-2141.1999.01279.x; SHEPORAITIS LA, 1992, AM J NEURORADIOL, V13, P29; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Singhal S, 2000, NEW ENGL J MED, V342, P364; Weber D, 2003, J CLIN ONCOL, V21, P16, DOI 10.1200/JCO.2003.03.139; Weber Donna, 2003, Cancer Control, V10, P375; Zangari M, 2001, BLOOD, V98, P1614, DOI 10.1182/blood.V98.5.1614	40	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2637	2645		10.1056/NEJMcpc049029	http://dx.doi.org/10.1056/NEJMcpc049029			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602025				2022-12-28	WOS:000225726100013
J	Penson, RT; Sahani, D; Bell, DA				Penson, RT; Sahani, D; Bell, DA			Case 37-2004: A 52-year-old woman with postmenopausal bleeding and a cystic ovarian mass - Right ovary: papillary serous cystadenocarcinoma, grade 2 to 3 of 3, arising as a polypoid intracystic mass in a serous tumor containing benign, typical borderline, and micropapillary borderline areas. Left ovary: serous borderline tumor, typical type, small. Uterus, omentum, and lymph nodes: no evidence of cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADJUVANT CHEMOTHERAPY; NEOPLASM TRIAL; STAGE-I; CRIBRIFORM PATTERNS; CARCINOMA; CISPLATIN; PACLITAXEL; WOMEN; CYCLOPHOSPHAMIDE		Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Ctr Canc, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Penson, RT (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Ctr Canc, Boston, MA 02114 USA.							BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L; BELL DA, IN PRESS HUM PATHOL; Bell KA, 2001, AM J SURG PATHOL, V25, P419, DOI 10.1097/00000478-200104000-00001; Bolis G, 1995, ANN ONCOL, V6, P887, DOI 10.1093/oxfordjournals.annonc.a059355; Burks RT, 1996, AM J SURG PATHOL, V20, P1319, DOI 10.1097/00000478-199611000-00003; Cannistra SA, 1999, J CLIN ONCOL, V17, P741, DOI 10.1200/JCO.1999.17.3.741; Colombo N, 2003, J NATL CANCER I, V95, P125; Deavers MT, 2002, AM J SURG PATHOL, V26, P1129, DOI 10.1097/00000478-200209000-00003; Eichhorn JH, 1999, AM J SURG PATHOL, V23, P397, DOI 10.1097/00000478-199904000-00004; Gilks CB, 2003, INT J GYNECOL PATHOL, V22, P29, DOI 10.1097/00004347-200301000-00008; LEDERMANN JA, 2003, P AN M AM SOC CLIN, V22, P446; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Mink PJ, 2002, CANCER, V95, P2380, DOI 10.1002/cncr.10935; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Ozols RF, 1999, SEMIN ONCOL, V26, P34; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Pothuri Bhavana, 2001, Gynecologic Oncology, V80, P277; Prat J, 2002, AM J SURG PATHOL, V26, P1111, DOI 10.1097/00000478-200209000-00002; Rose PG, 2004, NEW ENGL J MED, V351, P2489, DOI 10.1056/NEJMoa041125; Rosenthal AN, 1998, INT J BIOL MARKER, V13, P216, DOI 10.1177/172460089801300408; Scully RE, 1999, HISTOLOGICAL TYPING; Sehdev AES, 2003, AM J SURG PATHOL, V27, P725, DOI 10.1097/00000478-200306000-00003; Seidman JD, 1996, AM J SURG PATHOL, V20, P1331, DOI 10.1097/00000478-199611000-00004; SILVERBERG SX, IN PRESS HUM PATHOL; Singer G, 2002, AM J PATHOL, V160, P1223, DOI 10.1016/S0002-9440(10)62549-7; Singer G, 2003, INT J GYNECOL PATHOL, V22, P37, DOI 10.1097/00004347-200301000-00009; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Slomovitz BM, 2002, AM J SURG PATHOL, V26, P592, DOI 10.1097/00000478-200205000-00005; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P105; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P113, DOI 10.1093/jnci/95.2.113; Trope C, 2000, ANN ONCOL, V11, P281, DOI 10.1023/A:1008399414923; van der Burg M E, 2001, Curr Treat Options Oncol, V2, P109; VANDERBURG MEL, 1995, NEW ENGL J MED, V332, P629, DOI 10.1056/NEJM199503093321002; VASEY P, 2001, PROG PROC AM SOC CLI, V20, P202; Vergote I, 2001, LANCET, V357, P176, DOI 10.1016/S0140-6736(00)03590-X; YOUNG R, 2003, GYNECOL ONCOL, V88, P156; YOUNG RC, 1990, NEW ENGL J MED, V322, P1021, DOI 10.1056/NEJM199004123221501; YOUNG RC, 1999, PROG PROC AM SOC CLI, V18, P357	39	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2004	351	24					2531	2538		10.1056/NEJMcpc049022	http://dx.doi.org/10.1056/NEJMcpc049022			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877TE	15590956				2022-12-28	WOS:000225593100010
J	Miller, NR; Newman, NJ				Miller, NR; Newman, NJ			The eye in neurological disease	LANCET			English	Review							HERPES-ZOSTER OPHTHALMICUS; GIANT-CELL ARTERITIS; MULTIPLE-SCLEROSIS; OPTIC NEURITIS; RETINAL PERIPHLEBITIS; CLINICAL SPECTRUM; PRESENTING SIGN; NEUROFIBROMATOSIS; MANIFESTATIONS; OCCLUSION	Neurological disease can involve the eye in many ways. Every structure the conjunctiva, cornea, anterior chamber, iris, lens, vitreous humour, retina, choroid, and optic nerve-can be affected. In many cases, ocular involvement is the first manifestation of the underlying disease. In such cases, the ability of the physician to recognise the nature and significance of the ocular abnormality can lead to early diagnosis and successful treatment of the underlying condition. In other cases, recognition of the ocular abnormality can prevent permanent visual dysfunction.	Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD 21287 USA; Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurol Surg, Atlanta, GA 30322 USA	Johns Hopkins University; Johns Hopkins Medicine; Emory University; Emory University; Emory University	Miller, NR (corresponding author), Johns Hopkins Univ Hosp, Wilmer Eye Inst, B-109,600 N Wolfe St, Baltimore, MD 21287 USA.	nrmiller@jhmi.edu	Newman, Nancy/AAB-2532-2021					Abu El-Asrar AM, 2003, EUR J OPHTHALMOL, V13, P474, DOI 10.1177/112067210301300509; Amitava AK, 2001, J PEDIAT OPHTH STRAB, V38, P229; Arigon V, 2002, EUR J OPHTHALMOL, V12, P413, DOI 10.1177/112067210201200512; ARNOLD AC, 1984, OPHTHALMOLOGY, V91, P255; Arnold AC, 2003, J NEURO-OPHTHALMOL, V23, P157, DOI 10.1097/00041327-200306000-00012; ASHWORTH B, 1987, NEURO-OPHTHALMOLOGY, V7, P75, DOI 10.3109/01658108709007433; Barquet N, 1997, JAMA-J AM MED ASSOC, V278, P491, DOI 10.1001/jama.278.6.491; Bataller L, 2004, CURR OPIN NEUROL, V17, P3, DOI 10.1097/00019052-200402000-00003; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; Beck RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P944; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Biousse V, 1999, NEUROLOGY, V52, P179, DOI 10.1212/WNL.52.1.179; Birch MK, 1996, ARCH OPHTHALMOL-CHIC, V114, P34, DOI 10.1001/archopht.1996.01100130032005; Biswas J, 2002, OCUL IMMUNOL INFLAMM, V10, P293, DOI 10.1076/ocii.10.4.293.15590; Buhmann C, 2002, ACTA NEUROL SCAND, V106, P236, DOI 10.1034/j.1600-0404.2002.01323.x; Carbone J, 2001, J RHEUMATOL, V28, P2437; Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2; CARROLL WM, 1980, BRAIN, V103, P413, DOI 10.1093/brain/103.2.413; CARTER JE, 1984, ANN OPHTHALMOL, V16, P572; Caruso JM, 2000, J PEDIAT OPHTH STRAB, V37, P119; Celebi S, 2000, EUR J OPHTHALMOL, V10, P239, DOI 10.1177/112067210001000308; Chan CCK, 2001, CLIN EXP OPHTHALMOL, V29, P411, DOI 10.1046/j.1442-9071.2001.00456.x; Chan JW, 2002, OCUL IMMUNOL INFLAMM, V10, P161, DOI 10.1076/ocii.10.3.161.15603; Chan RY, 2001, OPHTHALMOLOGY, V108, P2225, DOI 10.1016/S0161-6420(01)00818-1; Chang CH, 2003, GRAEF ARCH CLIN EXP, V241, P554, DOI 10.1007/s00417-003-0680-2; Chang JHM, 2002, OCUL IMMUNOL INFLAMM, V10, P263, DOI 10.1076/ocii.10.4.263.15592; COTLIER E, 1977, ARCH OPHTHALMOL-CHIC, V95, P1990; Deguti Marta M., 2002, Journal of Hepatology, V37, P700, DOI 10.1016/S0168-8278(02)00179-4; Desai UR, 2001, RETINA-J RET VIT DIS, V21, P40, DOI 10.1097/00006982-200102000-00007; DICKERSIN K, 1995, JAMA-J AM MED ASSOC, V273, P625, DOI 10.1001/jama.1995.03520320035038; ENGELL T, 1986, ACTA NEUROL SCAND, V73, P168; Farr AK, 2002, AM J OPHTHALMOL, V134, P891, DOI 10.1016/S0002-9394(02)01796-8; Foroozan R, 2003, OPHTHALMOLOGY, V110, P539, DOI 10.1016/S0161-6420(02)01775-X; Friedman JM, 2002, J CHILD NEUROL, V17, P548, DOI 10.1177/088307380201700802; GANLEY JP, 1984, UVEITIS UPDATE, P345; Giordano M, 1996, OPHTHALMIC RES, V28, P224, DOI 10.1159/000267907; Gonzalez-Gay MA, 2000, MEDICINE, V79, P283, DOI 10.1097/00005792-200009000-00001; Goyal V, 2000, J NEUROL NEUROSUR PS, V69, P133, DOI 10.1136/jnnp.69.1.133; Hayreh SS, 2002, ACTA OPHTHALMOL SCAN, V80, P355, DOI 10.1034/j.1600-0420.2002.800403.x; INSLER MS, 1985, AM J OPHTHALMOL, V99, P731, DOI 10.1016/S0002-9394(14)76056-8; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobson DM, 2003, NEUROLOGY, V60, P881, DOI 10.1212/01.WNL.0000049475.94171.8C; JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206; Kattah JC, 2002, ARCH OPHTHALMOL-CHIC, V120, P1234; Katz JM, 2003, ARCH NEUROL-CHICAGO, V60, P426, DOI 10.1001/archneur.60.3.426; Kelman S., 1998, WALSH HOYTS CLIN NEU, V1, P549; Knox D L, 1969, Surv Ophthalmol, V13, P245; Lawrence Peter F, 2002, Vasc Endovascular Surg, V36, P415, DOI 10.1177/153857440203600602; Lee AG, 2002, SURV OPHTHALMOL, V47, P137, DOI 10.1016/S0039-6257(01)00303-4; Liu MM, 2002, AM J OPHTHALMOL, V133, P832, DOI 10.1016/S0002-9394(02)01408-3; LUCCHESE NJ, 1981, J PEDIAT OPHTH STRAB, V18, P45; Miller N R, 1998, WALSH HOYTS CLIN NEU, P487; MILLER NR, 1998, WALSH HOYTS CLIN NEU, V3, P3263; Miller NR., 1998, WALSH HOYTS CLIN NEU, V5; MORRISSEY SP, 1995, J NEUROL NEUROSUR PS, V58, P70, DOI 10.1136/jnnp.58.1.70; Muci-Mendoza R, 2002, BRIT J OPHTHALMOL, V86, P282, DOI 10.1136/bjo.86.3.282; Mustonen E, 1997, NEURO-OPHTHALMOLOGY, V17, P117, DOI 10.3109/01658109709044655; NEWMAN NJ, 1998, WALSH HOYTS CLIN NEU, V5, P5539; O'Halloran HS, 1998, OPHTHALMOLOGY, V105, P1038, DOI 10.1016/S0161-6420(98)96005-5; Onder F, 2002, J PEDIAT OPHTH STRAB, V39, P49, DOI 10.3928/0191-3913-20020101-12; Ong TJ, 2002, CLIN EXP OPHTHALMOL, V30, P284, DOI 10.1046/j.1442-9071.2002.00543.x; Ormerod L D, 1999, Curr Opin Ophthalmol, V10, P209, DOI 10.1097/00055735-199906000-00010; Papo T, 1998, MEDICINE, V77, P3, DOI 10.1097/00005792-199801000-00002; Park DW, 1997, AM J OPHTHALMOL, V123, P533, DOI 10.1016/S0002-9394(14)70179-5; Ragge NK, 1997, EYE, V11, P12, DOI 10.1038/eye.1997.3; Rattray KM, 2000, EYE, V14, P706, DOI 10.1038/eye.2000.188; REPKA MX, 1998, WALSH HOYTS CLIN NEU, V2, P2811; Riono WP, 1999, OPHTHALMOLOGY, V106, P1328, DOI 10.1016/S0161-6420(99)00719-8; Rowley SA, 2001, BRIT J OPHTHALMOL, V85, P420, DOI 10.1136/bjo.85.4.420; Sadda SR, 2001, AM J OPHTHALMOL, V132, P743, DOI 10.1016/S0002-9394(01)01199-0; SADUN AA, 1990, OPHTHALMOLOGY, V97, P9; Schmidt DP, 2002, AM J NEURORADIOL, V23, P1301; Severson EA, 2003, ARCH OPHTHALMOL-CHIC, V121, P386, DOI 10.1001/archopht.121.3.386; SHIBUYA M, 1990, ACTA NEUROCHIR, V103, P71, DOI 10.1007/BF01420195; Sumer MM, 2000, ANN OPHTHALMOL, V32, P30, DOI 10.1007/s12009-000-0009-2; SUSAC JO, 1974, ARCH OPHTHALMOL-CHIC, V92, P69; Tabery HM, 2000, ACTA OPHTHALMOL SCAN, V78, P651, DOI 10.1034/j.1600-0420.2000.078006651.x; Thean JHJ, 2001, CLIN EXP OPHTHALMOL, V29, P406, DOI 10.1046/j.1442-9071.2001.d01-29.x; Thompson HS, 1998, WALSH HOYTS CLIN NEU, Vone, P961; Thorne JE, 1998, ARCH NEUROL-CHICAGO, V55, P862, DOI 10.1001/archneur.55.6.862; TOLA MR, 1993, EUR NEUROL, V33, P93, DOI 10.1159/000116912; TREFT RL, 1984, OPHTHALMOLOGY, V91, P908; Tsai Tony, 2002, International Ophthalmology Clinics, V42, P115; VINE AK, 1992, AM J OPHTHALMOL, V113, P28, DOI 10.1016/S0002-9394(14)75748-4; Wakakura M, 1999, JPN J OPHTHALMOL, V43, P133, DOI 10.1016/S0021-5155(98)00071-9; Yasunari T, 2000, LANCET, V356, P988, DOI 10.1016/S0140-6736(00)02716-1; ZIERHUT M, 1992, DEV OPHTHALMOL, V23, P41	87	10	11	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2004	364	9450					2045	2054		10.1016/S0140-6736(04)17517-X	http://dx.doi.org/10.1016/S0140-6736(04)17517-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582062				2022-12-28	WOS:000225495700028
J	Christensen, PR; Wyatt, MB; Glotch, TD; Rogers, AD; Anwar, S; Arvidson, RE; Bandfield, JL; Blaney, DL; Budney, C; Calvin, WM; Faracaro, A; Fergason, RL; Gorelick, N; Graff, TG; Hamilton, VE; Hayes, AG; Johnson, JR; Knudson, AT; McSween, HY; Mehall, GL; Mehall, LK; Moersch, JE; Morris, RV; Smith, MD; Squyres, SW; Ruff, SW; Wolff, MJ				Christensen, PR; Wyatt, MB; Glotch, TD; Rogers, AD; Anwar, S; Arvidson, RE; Bandfield, JL; Blaney, DL; Budney, C; Calvin, WM; Faracaro, A; Fergason, RL; Gorelick, N; Graff, TG; Hamilton, VE; Hayes, AG; Johnson, JR; Knudson, AT; McSween, HY; Mehall, GL; Mehall, LK; Moersch, JE; Morris, RV; Smith, MD; Squyres, SW; Ruff, SW; Wolff, MJ			Mineralogy at Meridiani Planum from the Mini-TES experiment on the Opportunity Rover	SCIENCE			English	Article							THERMAL EMISSION-SPECTROSCOPY; MARTIAN SURFACE; CRYSTALLINE HEMATITE; TERRA-MERIDIANI; SPIRIT ROVER; GUSEV CRATER; MGS-TES; MARS; ROCKS; SPECTROMETER	The Miniature Thermal Emission Spectrometer (Mini-TES) on Opportunity investigated the mineral abundances and compositions of outcrops, rocks, and soils at Meridiani Planum. Coarse crystalline hematite and olivine-rich basaltic sands were observed as predicted from orbital TES spectroscopy. Outcrops of aqueous origin are composed of 15 to 35% by volume magnesium and calcium sulfates [a high-silica component modeled as a combination of glass, feldspar, and sheet silicates (similar to20 to 30%)], and hematite; only minor jarosite is identified in Mini-TES spectra. Mini-TES spectra show only a hematite signature in the millimeter-sized spherules. Basaltic materials have more plagioclase than pyroxene, contain olivine, and are similar in inferred mineral composition to basalt mapped from orbit. Bounce rock is dominated by clinopyroxene and is close in inferred mineral composition to the basaltic martian meteorites. Bright wind streak material matches global dust. Waterlain rocks covered by unaltered basaltic sands suggest a change from an aqueous environment to one dominated by physical weathering.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Dept Geol Sci, Reno, NV 89557 USA; Univ Hawaii, Inst Geophys & Planetol, Honolulu, HI 96822 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Space Sci Inst, Martinez, GA 30907 USA	Arizona State University; Arizona State University-Tempe; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Hawaii System; Cornell University; United States Department of the Interior; United States Geological Survey; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Christensen, PR (corresponding author), Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA.	phil.christensen@asu.edu	Smith, Michael/C-8875-2012; Rogers, Deanne/I-9737-2016; Glotch, Timothy/B-6829-2008; Hayes, Alexander G/P-2024-2014; Moersch, Jeffrey E/F-7189-2010; Johnson, Jeffrey R/F-3972-2015; Rogers, A. Deanne/ABE-8469-2021	Rogers, Deanne/0000-0002-4671-2551; Hayes, Alexander G/0000-0001-6397-2630; Moersch, Jeffrey E/0000-0003-3433-9419; Johnson, Jeffrey R/0000-0002-5586-4901; Rogers, A. Deanne/0000-0002-4671-2551; Bandfield, Joshua/0000-0003-3571-3716; Gorelick, Noel/0000-0002-5548-2436				ADAMS JB, 1986, J GEOPHYS RES-SOLID, V91, P8098, DOI 10.1029/JB091iB08p08098; Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002290; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; BISHOP JL, 2001, 64 ANN MET SOC M, V36, P21; Catling DC, 2003, ICARUS, V165, P277, DOI 10.1016/S0019-1035(03)00173-8; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9609, DOI 10.1029/1999JE001127; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002233; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; CHRISTENSEN PR, 1993, J GEOPHYS RES-SOL EA, V98, P19819, DOI 10.1029/93JB00135; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Feely KC, 1999, J GEOPHYS RES-PLANET, V104, P24195, DOI 10.1029/1999JE001034; Glotch TD, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002224; Graff T.G., 2003, THESIS ARIZONA STATE; GREELEY R, 2001, LUNAR PLANET SCI, V32; Hamilton VE, 2000, J GEOPHYS RES-PLANET, V105, P9717, DOI 10.1029/1999JE001113; Hamilton VE, 2003, METEORIT PLANET SCI, V38, P871, DOI 10.1111/j.1945-5100.2003.tb00284.x; Hamilton VE, 1997, J GEOPHYS RES-PLANET, V102, P25593, DOI 10.1029/97JE01874; Hamilton VE, 2001, J GEOPHYS RES-PLANET, V106, P14733, DOI 10.1029/2000JE001353; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Johnson JR, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001405; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Lane MD, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001832; Lane MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017183; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; MCSWEEN HY, 1983, GEOCHIM COSMOCHIM AC, V47, P1501, DOI 10.1016/0016-7037(83)90309-5; ONDRUSEK J, 1993, J GEOPHYS RES-SOL EA, V98, P15903, DOI 10.1029/93JB01559; Ramsey MS, 1998, J GEOPHYS RES-SOL EA, V103, P577, DOI 10.1029/97JB02784; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Rogers D, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001913; Smith MD, 2004, SCIENCE, V306, P1750, DOI 10.1126/science.1104257; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; VEVERKA J, 1981, ICARUS, V45, P154, DOI 10.1016/0019-1035(81)90011-7; Wyatt MB, 2004, GEOLOGY, V32, P645, DOI 10.1130/G20527.1; Wyatt MB, 2001, J GEOPHYS RES-PLANET, V106, P14711, DOI 10.1029/2000JE001356	47	305	312	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1733	1739		10.1126/science.1104909	http://dx.doi.org/10.1126/science.1104909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576609				2022-12-28	WOS:000225630800041
J	Minelli, A				Minelli, A			Bits and pieces	SCIENCE			English	Editorial Material							SEGMENTATION; EXPRESSION		Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Padua	Minelli, A (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.	alessandro.minelli@unipd.it		Minelli, Alessandro/0000-0003-3387-1489				Ansenne A., 1990, P125; Braun V, 2003, BIOINFORMATICS, V19, P851, DOI 10.1093/bioinformatics/btg087; Budd GE, 2001, EVOL DEV, V3, P332, DOI 10.1046/j.1525-142X.2001.01041.x; Chertenko L.P., 2003, THESIS, P190, DOI [10.13140/RG.2.2.14771.37925, DOI 10.13140/RG.2.2.14771.37925]; Holland P.W.H., 1990, Seminars in Developmental Biology, V1, P135; Jacobs DK, 2000, EVOL DEV, V2, P340, DOI 10.1046/j.1525-142x.2000.00077.x; Janssen R, 2004, DEV BIOL, V268, P89, DOI 10.1016/j.ydbio.2003.12.021; LAWRENCE PA, 1993, MAKING FLY; Minelli A, 2004, TRENDS ECOL EVOL, V19, P423, DOI 10.1016/j.tree.2004.06.007; Negrisolo E, 2004, MOL BIOL EVOL, V21, P770, DOI 10.1093/molbev/msh078; Pisani D, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-1; Sierwald P, 2003, J ZOOL SYST EVOL RES, V41, P87, DOI 10.1046/j.1439-0469.2003.00202.x	12	6	7	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2004	306	5702					1693	1694		10.1126/science.1098138	http://dx.doi.org/10.1126/science.1098138			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576599				2022-12-28	WOS:000225630800031
J	Chiappe, LM; Codorniu, L; Grellet-Tinner, G; Rivarola, D				Chiappe, LM; Codorniu, L; Grellet-Tinner, G; Rivarola, D			Argentinian unhatched pterosaur fossil	NATURE			English	Editorial Material							ONTOGENY		Nat Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA; Univ Nacl San Luis, Dept Geol, RA-5700 San Luis, Argentina; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	Universidad Nacional de San Luis; University of Southern California	Chiappe, LM (corresponding author), Nat Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA.	chiappe@nhm.org		Chiappe, Luis/0000-0001-9661-0601				BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; BOARD GB, 1995, EGG INCUBATION ITS E, P71; Chiappe Luis M., 2000, Contributions in Science (Los Angeles), V483, P1; Codorniu L, 2004, CAN J EARTH SCI, V41, P9, DOI 10.1139/E03-080; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Mikhailov Konstantin E., 1992, Natural History Museum of Los Angeles County Science Series, V36, P361; Schleich H.H., 1988, REPTILE EGG SHELLS S; SERENO PC, 1991, SOC VERTEBRATE PALEO, V2, P1, DOI DOI 10.2307/3889336; Starck J.M., 1993, Current Ornithology, V10, P275; UNWIN DM, 2003, GEOL SOC SP PUBL, V217; Wang XL, 2004, NATURE, V429, P621, DOI 10.1038/429621a; Wellnhofer P., 1970, ABH BAYER AKAD WISS, V141, P1	13	44	49	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2004	432	7017					571	572		10.1038/432571a	http://dx.doi.org/10.1038/432571a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577899	Green Published			2022-12-28	WOS:000225433200030
J	Glazener, CMA; Herbison, GP; MacArthur, C; Grant, A; Wilson, PD				Glazener, CMA; Herbison, GP; MacArthur, C; Grant, A; Wilson, PD			Randomised controlled trial of conservative management of postnatal urinary and faecal incontinence: six year follow up	BRITISH MEDICAL JOURNAL			English	Article							DELIVERY	Objective To determine die long term effects of a conservative nurse-led intervention for postnatal urinary incontinence. Design Randomised controlled trial. Setting Community based intervention in three centres in the United Kingdom and New Zealand. Participants 747 women with urinary incontinence at three months after childbirth, of whom 516 were followed up again at six years (69%). Intervention Active conservative treatment (pelvic floor muscle training and bladder training) at five, seven, and nine months after delivery or standard care. Main outcome measures Urinary and faecal incontinence, performance of pelvic floor muscle training. Results Of 2632 women with urinary incontinence, 747 participated in the original trial. The significant improvements relative to controls in urinary (60% v 69%) and faecal (4% v 11%) incontinence at one year were not found at six year follow up (76% v 79% (95% confidence interval for difference in means -10.2% to 4.1%) for urinary incontinence, 12% v 13% (- 6.4% to 5.1%) for faecal incontinence) irrespective of subsequent obstetric events. In the short term the intervention had motivated more women to perform pelvic floor muscle training (83% v 55%) but this fell to 50% in both groups in the long term. Both urinary and faecal incontinence increased in prevalence in both groups during the study period. Conclusions The moderate short term benefits of a brief nurse-led conservative treatment of postnatal urinary incontinence may not persist, even among women with no further deliveries. About three quarters of women with urinary incontinence three months after childbirth still have this six years later.	Univ Aberdeen, Sch Med, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; Univ Otago, Dunedin Sch Med, Dept Womens & Childrens Hlth, Dunedin, New Zealand; Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England	University of Aberdeen; University of Otago; University of Otago; University of Birmingham	Glazener, CMA (corresponding author), Univ Aberdeen, Sch Med, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland.	c.glazener@abdn.ac.uk	MacArthur, Christine/ABA-8601-2021	MacArthur, Christine/0000-0003-0434-2158; Herbison, Graham Peter/0000-0002-5684-024X				Chiarelli P, 2002, BMJ-BRIT MED J, V324, P1241, DOI 10.1136/bmj.324.7348.1241; Glazener CMA, 2001, BRIT MED J, V323, P593, DOI 10.1136/bmj.323.7313.593; Hay-Smith EJ, 2001, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001407; HAYSMITH EJC, 2002, COCHRANE DATABASE SY, DOI UNSP CD003191; Hughes P., 2001, Neurourology and Urodynamics, V20, P447; MacArthur C, 1997, BRIT J OBSTET GYNAEC, V104, P46, DOI 10.1111/j.1471-0528.1997.tb10648.x; NORTON C, 2000, COCHRANE DB SYST REV; Salvesen KA, 2004, BMJ-BRIT MED J, V329, P378, DOI 10.1136/bmj.38163.724306.3A; Sleep J, 1987, Midwifery, V3, P158, DOI 10.1016/S0266-6138(87)80035-9; SNOOKS SJ, 1985, BRIT J UROL, V57, P422, DOI 10.1111/j.1464-410X.1985.tb06302.x; Wallace SA, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001308.PUB2; Wilson P D, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P257, DOI 10.1007/BF01901501; Wilson PD, 1996, BRIT J OBSTET GYNAEC, V103, P154, DOI 10.1111/j.1471-0528.1996.tb09668.x	13	72	73	0	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 12	2005	330	7487					337	339		10.1136/bmj.38320.613461.82	http://dx.doi.org/10.1136/bmj.38320.613461.82			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897OZ	15615766	Green Published, Bronze			2022-12-28	WOS:000227015800017
J	Livesey, A				Livesey, A			A multiagency protocol for responding to sudden unexpected death in infancy: descriptive study	BRITISH MEDICAL JOURNAL			English	Article									Royal Alexandra Hosp Sick Children, S Downs Hlth NHS Trust, Dept Community Child Hlth, Brighton BN1 3JN, E Sussex, England		Livesey, A (corresponding author), Royal Alexandra Hosp Sick Children, S Downs Hlth NHS Trust, Dept Community Child Hlth, Brighton BN1 3JN, E Sussex, England.	anne.livesey@southdowns.nhs.uk						*ROYAL COLL PATH R, 2004, SUDD UN DEATH INF; Sadler DW, 1998, J CLIN PATHOL, V51, P689, DOI 10.1136/jcp.51.9.689	2	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 29	2005	330	7485					227	228		10.1136/bmj.38323.652523.F7	http://dx.doi.org/10.1136/bmj.38323.652523.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894GR	15596417	Green Published, Bronze			2022-12-28	WOS:000226779400019
J	Iavarone, A; King, ER; Dai, XM; Leone, G; Stanley, ER; Lasorella, A				Iavarone, A; King, ER; Dai, XM; Leone, G; Stanley, ER; Lasorella, A			Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages	NATURE			English	Article							BONE-MARROW; COMPLEX-FORMATION; CHIMERIC MICE; IN-VITRO; MOUSE; RB; CELLS; DIFFERENTIATION; PROTEIN; GENE	tiation(1,2). Targeted disruption of the retinoblastoma (Rb) tumour suppressor gene in the mouse leads to embryonic death caused by failure of erythroblasts to enucleate(3-5). The erythroid defect has been attributed to loss of Rb in cells that support erythropoiesis, but the identity of these cells is unknown(6). Here we show that Rb-deficient embryos carry profound abnormalities of fetal liver macrophages that prevent physical interactions with erythroblasts. In contrast, wild-type macrophages bind Rb-deficient erythroblasts and lead them to terminal differentiation and enucleation. Loss of Id2, a helix - loop - helix protein that mediates the lethality of Rb-deficient embryos(7), rescues the defects of Rb-deficient fetal liver macrophages. Rb promotes differentiation of macrophages by opposing the inhibitory functions of Id2 on the transcription factor PU.1, a master regulator of macrophage differentiation. Thus, Rb has a cell autonomous function in fetal liver macrophages, and restrains Id2 in these cells in order to implement definitive erythropoiesis.In mammals, the fetal liver is the first site of definitive erythropoiesis - the generation of mature, enucleated red cells. The functional unit for definitive erythropoiesis is the erythroblastic island, a multicellular structure composed of a central macrophage surrounded by erythroblasts at various stages of differen	Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Columbia University; Columbia University; Columbia University; Columbia University; University System of Ohio; Ohio State University; Yeshiva University; Albert Einstein College of Medicine	Iavarone, A (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	ai2102@columbia.edu	Stanley, Evan R/J-9154-2013	Stanley, Evan R/0000-0002-2910-2065; Iavarone, Antonio/0000-0002-0683-4634; Dai, Xuming/0000-0003-3092-9323				Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Bergh G, 1999, BLOOD, V94, P1971; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Clark AJ, 2004, BLOOD, V104, P1324, DOI 10.1182/blood-2004-02-0618; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Himes SR, 2001, J LEUKOCYTE BIOL, V70, P812; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; MORIOKA Y, 1994, J LEUKOCYTE BIOL, V55, P642, DOI 10.1002/jlb.55.5.642; Naito M, 1997, MICROSC RES TECHNIQ, V39, P350, DOI 10.1002/(SICI)1097-0029(19971115)39:4<350::AID-JEMT5>3.0.CO;2-L; Nakajima H, 1996, LEUKEMIA RES, V20, P665, DOI 10.1016/0145-2126(96)00020-3; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Sasaki K, 1997, MICROSC RES TECHNIQ, V39, P398, DOI 10.1002/(SICI)1097-0029(19971201)39:5<398::AID-JEMT2>3.0.CO;2-D; Stanley E R, 1997, Methods Mol Biol, V75, P301; Tagoh H, 2002, GENE DEV, V16, P1721, DOI 10.1101/gad.222002; Toma JG, 2000, J NEUROSCI, V20, P7648; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Vooijs M, 1999, ONCOGENE, V18, P5293, DOI 10.1038/sj.onc.1202999; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Yates PR, 1999, EMBO J, V18, P968, DOI 10.1093/emboj/18.4.968; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	30	112	116	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1040	1045		10.1038/nature03068	http://dx.doi.org/10.1038/nature03068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616565				2022-12-28	WOS:000225887000045
J	Tolman, KG; Fonseca, V; Tan, MH; Dalpiaz, A				Tolman, KG; Fonseca, V; Tan, MH; Dalpiaz, A			Narrative review: Hepatobiliary disease in type 2 diabetes mellitus	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC HEPATITIS-C; HUMAN HEPATOCELLULAR-CARCINOMA; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS NASH; REAL-TIME ULTRASONOGRAPHY; INSULIN-RESISTANCE; VIRUS-INFECTION; AUTONOMIC NEUROPATHY; URSODEOXYCHOLIC ACID; GLUCOSE-TOLERANCE	Diabetes mellitus is the fifth leading cause of death in the United States; 17 million people are affected. Liver disease is one of the leading causes of death in persons with type 2 diabetes. The standardized mortality rate for death from liver disease is greater than that for cardiovascular disease. The spectrum of liver disease in type 2 diabetes ranges from nonalcoholic fatty liver disease to cirrhosis and hepatocellular carcinoma. The incidence of hepatitis C and acute liver failure is also increased. Nonalcoholic fatty liver disease is now considered part of the metabolic syndrome, and, with alcohol and hepatitis C, is the most common cause of chronic liver disease in the United States. Weight reduction and exercise are the mainstays of treatment for nonalcoholic fatty liver disease, but there are promising results with the new thiazolidinediones (pioglitazone and rosiglitazone) as well as metformin and 3-hydroxy-3-methylglutaryl coenzyme A inhibitors.	Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA; Univ Hosp & Clin, Salt Lake City, UT USA; Tulane Univ, New Orleans, LA 70118 USA; Eli Lilly & Co, Indianapolis, IN 46285 USA	Utah System of Higher Education; University of Utah; Tulane University; Eli Lilly	Tolman, KG (corresponding author), Univ Utah, Sch Med, Dept Internal Med, 30 N 1900 E, Salt Lake City, UT 84132 USA.	keith.tolman@hsc.utah.edu						Abdelmalek MF, 2001, AM J GASTROENTEROL, V96, P2711; Acosta RC, 2001, GASTROENTEROLOGY, V120, pA546, DOI 10.1016/S0016-5085(01)82715-3; Adami HO, 1996, J NATL CANCER I, V88, P1472, DOI 10.1093/jnci/88.20.1472; ADLER M, 1979, AM J MED, V67, P811, DOI 10.1016/0002-9343(79)90740-X; Al-Salman J, 2000, ANN INTERN MED, V132, P121, DOI 10.7326/0003-4819-132-2-200001180-00006; ALLISON MED, 1994, J HEPATOL, V21, P1135, DOI 10.1016/S0168-8278(05)80631-2; ANDERSEN T, 1991, J HEPATOL, V12, P224, DOI 10.1016/0168-8278(91)90942-5; Andrade RJ, 1996, ANN INTERN MED, V124, P931, DOI 10.7326/0003-4819-124-10-199605150-00030; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Angulo P, 2003, EXPERT OPIN PHARMACO, V4, P611, DOI 10.1517/eoph.4.5.611.22207; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Attili AF, 1997, HEPATOLOGY, V26, P809, DOI 10.1002/hep.510260401; BACON BR, 1994, GASTROENTEROLOGY, V107, P1103, DOI 10.1016/0016-5085(94)90235-6; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P200, DOI 10.1210/jc.2003-031315; Bajaj M, 2003, DIABETES, V52, P1364, DOI 10.2337/diabetes.52.6.1364; Basaranoglu M, 1999, J HEPATOL, V31, P384, DOI 10.1016/S0168-8278(99)80243-8; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boige V, 1997, CANCER RES, V57, P1986; Bonkovsky HL, 2002, DIGEST DIS SCI, V47, P1632, DOI 10.1023/A:1015895925374; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Burge MR, 1999, DIABETES CARE, V22, P2037, DOI 10.2337/diacare.22.12.2037; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Carrascosa M, 1997, LANCET, V349, P698, DOI 10.1016/S0140-6736(05)60134-1; Cassader M, 2001, LIPIDS, V36, P1117, DOI 10.1007/s11745-001-0822-5; Castera L, 2004, GUT, V53, P420, DOI 10.1136/gut.2002.009936; CATNACH SM, 1993, GUT, V34, P1123, DOI 10.1136/gut.34.8.1123; Chan KA, 2003, ARCH INTERN MED, V163, P728, DOI 10.1001/archinte.163.6.728; Chapman BA, 1998, DIGEST DIS SCI, V43, P344, DOI 10.1023/A:1018810523399; Chapman BA, 1996, DIGEST DIS SCI, V41, P2222, DOI 10.1007/BF02071404; Chase AP, 2002, AM J GASTROENTEROL, V97, P502; Clementsen P, 1986, Ugeskr Laeger, V148, P771; CUMMINGS MH, 1995, DIABETOLOGIA, V38, P959, DOI 10.1007/s001250050378; CURZIO M, 1985, INT J TISSUE REACT, V7, P137; DAVIS T W, 1959, Can Med Assoc J, V81, P101; de Marco R, 1999, DIABETES CARE, V22, P756, DOI 10.2337/diacare.22.5.756; DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313; DeSantis A, 1997, HEPATOLOGY, V25, P787, DOI 10.1002/hep.510250401; Diaz-Gutierrez FL, 1998, AM J GASTROENTEROL, V93, P481, DOI 10.1111/j.1572-0241.1998.481_1.x; DIEHL AM, 1988, GASTROENTEROLOGY, V95, P1056, DOI 10.1016/0016-5085(88)90183-7; DRENICK EJ, 1970, NEW ENGL J MED, V282, P829, DOI 10.1056/NEJM197004092821502; El-Serag HB, 2002, GASTROENTEROLOGY, V122, P1822, DOI 10.1053/gast.2002.33650; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; ERIKSSON S, 1986, ACTA MED SCAND, V220, P83; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FIORUCCI S, 1992, DIGEST DIS SCI, V37, P1671, DOI 10.1007/BF01299857; FIORUCCI S, 1990, DIGEST DIS SCI, V35, P1089, DOI 10.1007/BF01537580; Forman LM, 2000, ANN INTERN MED, V132, P118, DOI 10.7326/0003-4819-132-2-200001180-00005; Freedman R, 2003, DIABETES, V52, pA76; FRIEDMAN LS, 1988, ANN INTERN MED, V109, P913, DOI 10.7326/0003-4819-109-11-913; FRIER BM, 1977, CLIN TOXICOL, V11, P13, DOI 10.3109/15563657708989814; Fujino Y, 2001, DIABETES-METAB RES, V17, P374, DOI 10.1002/dmrr.214; George DK, 1998, GASTROENTEROLOGY, V114, P311, DOI 10.1016/S0016-5085(98)70482-2; GOODMAN RC, 1987, ANN INTERN MED, V106, P837, DOI 10.7326/0003-4819-106-6-837; Gouda HE, 2001, AM J MED, V111, P584, DOI 10.1016/S0002-9343(01)00926-3; GRAY H, 1995, DIABETIC MED, V12, P244, DOI 10.1111/j.1464-5491.1995.tb00466.x; GUPTA R, 1985, AM J GASTROENTEROL, V80, P381; HABER GB, 1979, GUT, V20, P518, DOI 10.1136/gut.20.6.518; HAFFNER SM, 1990, AM J EPIDEMIOL, V132, P327, DOI 10.1093/oxfordjournals.aje.a115662; Hahm JS, 1996, AM J GASTROENTEROL, V91, P2391; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; HJORTRUP A, 1985, BRIT J SURG, V72, P783, DOI 10.1002/bjs.1800721005; Holoman J, 2000, J HEPATOL, V32, P210, DOI 10.1016/S0168-8278(00)81130-7; Horlander JC, 2001, GASTROENTEROLOGY, V120, pA544; Hui JM, 2002, J GASTROEN HEPATOL, V17, P873, DOI 10.1046/j.1440-1746.2002.02813.x; Isokawa O, 1999, HEPATOLOGY, V30, P408, DOI 10.1002/hep.510300211; Ito T, 1996, MOL CELL BIOL, V16, P943; JENG CY, 1994, DIABETES, V43, P1440, DOI 10.2337/diabetes.43.12.1440; JENKINS DJA, 1989, AM J GASTROENTEROL, V84, P732; JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2; KAO CH, 1993, NUCL MED COMMUN, V14, P868, DOI 10.1097/00006231-199310000-00006; Kaserer K, 1998, HISTOPATHOLOGY, V32, P454; Kazachkov Y, 1998, LIVER, V18, P156; KESHAVARZIAN A, 1987, DIGEST DIS SCI, V32, P824, DOI 10.1007/BF01296703; Kim SO, 1996, CANCER RES, V56, P3831; KINGSTON ME, 1984, GASTROENTEROLOGY, V87, P688; Kishimoto Y, 1996, J CANCER RES CLIN, V122, P585, DOI 10.1007/BF01221189; Kiyici M, 2003, CAN J GASTROENTEROL, V17, P713, DOI 10.1155/2003/857869; Knobler H, 1998, J CLIN GASTROENTEROL, V26, P30, DOI 10.1097/00004836-199801000-00009; Kojima H, 1997, GASTROENTEROLOGY, V112, P493, DOI 10.1053/gast.1997.v112.pm9024303; Konrad T, 2000, EUR J CLIN INVEST, V30, P111; KRONERT K, 1989, ULTRASOUND MED BIOL, V15, P535, DOI 10.1016/0301-5629(89)90185-3; Laurin J, 1996, HEPATOLOGY, V23, P1464; Lavine JE, 2000, J PEDIATR-US, V136, P734, DOI 10.1016/S0022-3476(00)05040-X; LAWSON DH, 1986, Q J MED, V61, P945; Lebovitz HE, 2002, DIABETES CARE, V25, P815, DOI 10.2337/diacare.25.5.815; LEE RG, 1989, HUM PATHOL, V20, P594, DOI 10.1016/0046-8177(89)90249-9; Leonarduzzi G, 1997, FASEB J, V11, P851, DOI 10.1096/fasebj.11.11.9285483; Lewis GF, 1999, DIABETES, V48, P570, DOI 10.2337/diabetes.48.3.570; LIEBER MM, 1952, ANN SURG, V135, P394, DOI 10.1097/00000658-195203000-00011; Lindor KD, 2004, HEPATOLOGY, V39, P770, DOI 10.1002/hep.20092; Lonardo A, 2004, GASTROENTEROLOGY, V126, P586, DOI 10.1053/j.gastro.2003.11.020; LONGO R, 1995, JMRI-J MAGN RESON IM, V5, P281, DOI 10.1002/jmri.1880050311; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Luyckx FH, 1998, INT J OBESITY, V22, P222, DOI 10.1038/sj.ijo.0800571; Macdonald GA, 1998, HEPATOLOGY, V28, P90, DOI 10.1002/hep.510280114; Maeda K, 2001, ANN INTERN MED, V135, P306, DOI 10.7326/0003-4819-135-4-200108210-00029; Malmstrom R, 1997, DIABETOLOGIA, V40, P454, DOI 10.1007/s001250050700; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Marchesini G, 2001, LANCET, V358, P893, DOI 10.1016/S0140-6736(01)06042-1; Marks V, 1999, ENDOCRIN METAB CLIN, V28, P555, DOI 10.1016/S0889-8529(05)70088-8; Mason AL, 1999, HEPATOLOGY, V29, P328, DOI 10.1002/hep.510290235; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; May LD, 2002, ANN INTERN MED, V136, P449, DOI 10.7326/0003-4819-136-6-200203190-00008; MCMAHON T F, 1963, Med Ann Dist Columbia, V32, P509; Meguro T, 1997, J GASTROENTEROL, V32, P628, DOI 10.1007/BF02934112; MEINDERS AE, 1981, DIGEST DIS SCI, V26, P402, DOI 10.1007/BF01313581; MITCHELL DG, 1992, RADIOLOGY, V185, P1; MORGAN DO, 1987, NATURE, V329, P301, DOI 10.1038/329301a0; Nagai H, 1997, ONCOGENE, V14, P2927, DOI 10.1038/sj.onc.1201136; NAIR S, 2002, GASTROENTEROLOGY, V122, P4; Neuschwander-Tetri BA, 2003, J HEPATOL, V38, P434, DOI 10.1016/S0168-8278(03)00027-8; Ozyilkan E, 1996, AM J GASTROENTEROL, V91, P1480; Pacchioni M, 2000, DIGEST DIS SCI, V45, P2002, DOI 10.1023/A:1005544009372; PALMER M, 1990, GASTROENTEROLOGY, V99, P1408, DOI 10.1016/0016-5085(90)91169-7; Pazzi P, 2000, ALIMENT PHARM THERAP, V14, P62, DOI 10.1046/j.1365-2036.2000.014s2062.x; Petersen M, 2003, DIABETES CARE, V26, P917; PETRIDES AS, 1994, HEPATOLOGY, V19, P616, DOI 10.1002/hep.1840190312; PETRIDES AS, 1994, DIABETES REV, V2, P2; Pinto HC, 1996, DIGEST DIS SCI, V41, P172, DOI 10.1007/BF02208601; Poonawala A, 2000, HEPATOLOGY, V32, P689, DOI 10.1053/jhep.2000.17894; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Promrat K, 2004, HEPATOLOGY, V39, P188, DOI 10.1002/hep.20012; RANSOHOFF DF, 1987, ANN INTERN MED, V106, P829, DOI 10.7326/0003-4819-106-6-829; REICHEL J, 1960, AM J MED, V28, P654, DOI 10.1016/0002-9343(60)90161-3; ROZENTAL P, 1967, AM J DIG DIS, V12, P198, DOI 10.1007/BF02233443; Rubbia-Brandt L, 2001, HISTOPATHOLOGY, V39, P119, DOI 10.1046/j.1365-2559.2001.01208.x; SANDLER RS, 1986, GASTROENTEROLOGY, V91, P157, DOI 10.1016/0016-5085(86)90452-X; Sanyal A, 2002, HEPATOLOGY, V36, p382A; Saw D, 1996, DIGEST DIS SCI, V41, P322, DOI 10.1007/BF02093822; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; SHREINER DP, 1986, J NUCL MED, V27, P357; SILVERMAN JF, 1990, AM J GASTROENTEROL, V85, P1349; SILVERMAN JF, 1989, PATHOL ANNU, V24, P275; Simo R, 1996, DIABETES CARE, V19, P998, DOI 10.2337/diacare.19.9.998; SPARKS CE, 1986, METABOLISM, V35, P1128, DOI 10.1016/0026-0495(86)90026-0; STONE BG, 1988, GASTROENTEROLOGY, V95, P170, DOI 10.1016/0016-5085(88)90307-1; Tanaka H, 1997, J MED, V28, P335; Tanaka S, 1996, J BIOL CHEM, V271, P14610, DOI 10.1074/jbc.271.24.14610; Tanaka S, 1996, J CLIN INVEST, V98, P2100, DOI 10.1172/JCI119016; Tanaka S, 1996, CANCER RES, V56, P3391; TASKINEN MR, 1986, DIABETES, V35, P1268, DOI 10.2337/diabetes.35.11.1268; Ueno T, 1997, J HEPATOL, V27, P103, DOI 10.1016/S0168-8278(97)80287-5; Walsh MJ, 2004, HEPATOLOGY, V39, P1230, DOI 10.1002/hep.20179; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; Weltman MD, 1998, HEPATOLOGY, V27, P128, DOI 10.1002/hep.510270121; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; WONGPAITOON V, 1981, POSTGRAD MED J, V57, P244, DOI 10.1136/pgmj.57.666.244; ZATLOUKAL K, 1991, LAB INVEST, V64, P200; Zawadski J, TROGLITAZONE ASS 15	150	83	100	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2004	141	12					946	956		10.7326/0003-4819-141-12-200412210-00011	http://dx.doi.org/10.7326/0003-4819-141-12-200412210-00011			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882EY	15611492				2022-12-28	WOS:000225923000006
J	Morris, J				Morris, J			Commentary: A Fee-Nom-in-Hum and an Expotition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Wythenshawe Hosp, S Manchester NHS Trust, Manchester M23 9LT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Morris, J (corresponding author), Wythenshawe Hosp, S Manchester NHS Trust, Manchester M23 9LT, Lancs, England.	julie_m@fs1.with.man.ac.uk						Knight R, 2004, BRIT MED J, V329, P1432, DOI 10.1136/bmj.329.7480.1432	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1434	1434		10.1136/bmj.329.7480.1434	http://dx.doi.org/10.1136/bmj.329.7480.1434			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604175	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000225965800018
J	Ncayiyana, DJ				Ncayiyana, DJ			Is democracy good for people's health? A South African perspective	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Durban Inst Technol, Durban, South Africa	Durban University of Technology	Ncayiyana, DJ (corresponding author), Durban Inst Technol, POB 1334, Durban, South Africa.	vice-chancellor@dit.ac.za						De Gruchy Jeanelle, 1999, AMBULANCE WRONG COLO; Ijumba P, 2004, S AFRICAN HLTH REV 2; *INT COMM POV IN O, 1998, POV IN S AFR	3	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1425	1426		10.1136/bmj.329.7480.1425	http://dx.doi.org/10.1136/bmj.329.7480.1425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604168	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000225965800011
J	Morrison, AJ; Highland, J; Krogan, NJ; Arbel-Eden, A; Greenblatt, JF; Haber, JE; Shen, XT				Morrison, AJ; Highland, J; Krogan, NJ; Arbel-Eden, A; Greenblatt, JF; Haber, JE; Shen, XT			INO80 and gamma-H2AX interaction links ATP-dependent chromatin remodeling to DNA damage repair	CELL			English	Article							DOUBLE-STRAND BREAK; SACCHAROMYCES-CEREVISIAE; HISTONE H2AX; RECRUITMENT; PROTEINS; PHOSPHORYLATION; SUPPRESSOR; PATHWAYS; COMPLEX	While the role of ATP-dependent chromatin remodeling in transcription is well established, a link between chromatin remodeling and DNA repair has remained elusive. We have found that the evolutionarily conserved INO80 chromatin remodeling complex directly participates in the repair of a double-strand break (DSB) in yeast. The INO80 complex is recruited to a HO endonuclease-induced DSB through a specific interaction with the DNA damage-induced phosphorylated histone H2A (gamma-H2AX). This interaction requires Nhp10, an HMG-like subunit of the INO80 complex. The loss of Nhp10 or gamma-H2AX results in reduced INO80 recruitment to the DSB. Finally, components of the INO80 complex show synthetic genetic interactions with the RAD52 DNA repair pathway, the main pathway for DSB repair in yeast. Our findings reveal a new role of ATP-dependent chromatin remodeling in nuclear processes and suggest that an ATP-dependent chromatin remodeling complex can read a DNA repair histone code.	MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX 78957 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	University of Texas System; UTMD Anderson Cancer Center; University of Toronto; Brandeis University; Brandeis University	Shen, XT (corresponding author), MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX 78957 USA.	snowshen@mac.com	Morrison, Ashby/AHE-2820-2022	Haber, James/0000-0002-1878-0610; Shen, Xuetong/0000-0002-4267-5298; Morrison, Ashby/0000-0003-1228-5093	NCI NIH HHS [1K22CA100017] Funding Source: Medline; NIEHS NIH HHS [ES07784] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA100017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Brachmann CB, 1998, YEAST, V14, P115; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Fernandez-Capetillo O, 2004, P NATL ACAD SCI USA, V101, P1427, DOI 10.1073/pnas.0307342101; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Haber JE, 2000, MUTAT RES-FUND MOL M, V451, P53, DOI 10.1016/S0027-5107(00)00040-3; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2004, METHOD ENZYMOL, V377, P401; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	33	431	444	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					767	775		10.1016/j.cell.2004.11.037	http://dx.doi.org/10.1016/j.cell.2004.11.037			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607974	Bronze			2022-12-28	WOS:000225907200008
J	Mombaerts, P				Mombaerts, P			Love at first smell - The 2004 Nobel Prize in Physiology or Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Mombaerts, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.							BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck Linda B., 2004, Cell, VS116, pS117, DOI 10.1016/S0092-8674(04)00051-0	2	13	13	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2579	2580		10.1056/NEJMp048325	http://dx.doi.org/10.1056/NEJMp048325			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602018				2022-12-28	WOS:000225726100004
J	Kuhne, M; Soler, M; Ludwig, C; Peters, T				Kuhne, M; Soler, M; Ludwig, C; Peters, T			A stroke of luck in a 90-year-old	LANCET			English	Editorial Material									St Clara Hosp, Dept Internal Med & Endocrinol, Basel, Switzerland		Peters, T (corresponding author), St Clara Hosp, Dept Internal Med & Endocrinol, Basel, Switzerland.	thomas.peters@claraspital.ch	Kühne, Michael/AAB-5202-2022	Kühne, Michael/0000-0002-2937-3711				Craig CEH, 2002, POSTGRAD MED J, V78, P623, DOI 10.1136/pmj.78.924.623; CRYER PE, 2003, WILLIAMS TXB ENDOCRI, P1599; DAGGETT P, 1984, POSTGRAD MED J, V60, P577, DOI 10.1136/pgmj.60.707.577; Hoegerle S, 2001, RADIOLOGY, V220, P373, DOI 10.1148/radiology.220.2.r01au25373; SERVICE FJ, 1995, NEW ENGL J MED, V332, P1444	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2004	364	9451					2152	2152		10.1016/S0140-6736(04)17557-0	http://dx.doi.org/10.1016/S0140-6736(04)17557-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589314				2022-12-28	WOS:000225742300029
J	Jewitt, DC; Luu, J				Jewitt, DC; Luu, J			Crystalline water ice on the Kuiper belt object (50000) Quaoar	NATURE			English	Article							SURFACE; SPECTROSCOPY; IRRADIATION; SATELLITES; SPECTRUM; CENTAUR	The Kuiper belt is a disk-like structure consisting of solid bodies orbiting the Sun beyond Neptune(1). It is the source of the short-period comets and the likely repository of the Solar System's most primitive materials(2). Surface temperatures in the belt are low (similar to50 K), suggesting that ices trapped at formation should have been preserved over the age of the Solar System. Unfortunately, most Kuiper belt objects are too faint for meaningful compositional study, even with the largest available telescopes. Water ice has been reported in a handful of objects(3-5), but most appear spectrally featureless(5,6). Here we report near-infrared observations of the large Kuiper belt object (50000) Quaoar, which reveal the presence of crystalline water ice and ammonia hydrate. Crystallinity indicates that the ice has been heated to at least 110 K. Both ammonia hydrate and crystalline water ice should be destroyed by energetic particle irradiation on a timescale of about 10(7) yr. We conclude that Quaoar has been recently resurfaced, either by impact exposure of previously buried ( shielded) ices or by cryovolcanic outgassing, or by a combination of these processes.	Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; MIT, Lincoln Lab, Lexington, MA 02420 USA	University of Hawaii System; Lincoln Laboratory; Massachusetts Institute of Technology (MIT)	Jewitt, DC (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	jewitt@hawaii.edu						Bauer JM, 2002, ICARUS, V158, P178, DOI 10.1006/icar.2002.6876; Brown ME, 2000, SCIENCE, V287, P107, DOI 10.1126/science.287.5450.107; Brown ME, 2004, ASTRON J, V127, P2413, DOI 10.1086/382513; Brown RH, 1999, ASTROPHYS J, V519, pL101, DOI 10.1086/312098; Choi YJ, 2002, ICARUS, V160, P300, DOI 10.1006/icar.2002.6976; Churchin J. M, 2001, LUN PLAN I C ABSTR, V32, P1496; Cooper JF, 2003, EARTH MOON PLANETS, V92, P261, DOI 10.1023/B:MOON.0000031944.41883.80; Cruikshank DP, 1998, ICARUS, V135, P389, DOI 10.1006/icar.1998.5997; Czechowski L, 2003, CELEST MECH DYN ASTR, V87, P157, DOI 10.1023/A:1026136025400; DAVIES J, 2004, 1 DECADAL REV EDGEWO; Dumas C, 2001, ASTRON J, V121, P1163, DOI 10.1086/318747; Fornasier S, 2004, ASTRON ASTROPHYS, V422, pL43, DOI 10.1051/0004-6361:20048004; Grundy WM, 1998, J GEOPHYS RES-PLANET, V103, P25809, DOI 10.1029/98JE00738; Hansen GB, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002149; Jenniskens P, 1998, ASTROPHYS SPACE SC L, V227, P139, DOI 10.1007/978-94-011-5252-5_7; JEWITT D, 1993, NATURE, V362, P730, DOI 10.1038/362730a0; Jewitt DC, 2001, ASTRON J, V122, P2099, DOI 10.1086/323304; Kawakita H, 2002, ASTROPHYS J, V572, pL177, DOI 10.1086/341746; LANZEROTTI LJ, 1984, NATURE, V312, P139, DOI 10.1038/312139a0; Licandro J, 2002, ASTRON ASTROPHYS, V388, pL9, DOI 10.1051/0004-6361:20020533; Marcopulos BA, 2003, CLIN NEUROPSYCHOL, V17, P19, DOI 10.1076/clin.17.1.19.15630; Motohara K, 2002, PUBL ASTRON SOC JPN, V54, P315, DOI 10.1093/pasj/54.2.315; OWEN TC, 1993, SCIENCE, V261, P745, DOI 10.1126/science.261.5122.745; Schmitt B, 1998, ASTROPHYS SPACE SC L, V227, P199, DOI 10.1007/978-94-011-5252-5_9; STEVENSON DJ, 1982, NATURE, V298, P142, DOI 10.1038/298142a0; STRAZZULLA G, 1991, J GEOPHYS RES-PLANET, V96, P17547, DOI 10.1029/91JE01688	26	186	187	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					731	733		10.1038/nature03111	http://dx.doi.org/10.1038/nature03111			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592406				2022-12-28	WOS:000225597200041
J	Kiepiela, P; Leslie, AJ; Honeyborne, I; Ramduth, D; Thobakgale, C; Chetty, S; Rathnavalu, P; Moore, C; Pfafferott, KJ; Hilton, L; Zimbwa, P; Moore, S; Allen, T; Brander, C; Addo, MM; Altfeld, M; James, I; Mallal, S; Bunce, M; Barber, LD; Szinger, J; Day, C; Klenerman, P; Mullins, J; Korber, B; Coovadia, HM; Walker, BD; Goulder, PJR				Kiepiela, P; Leslie, AJ; Honeyborne, I; Ramduth, D; Thobakgale, C; Chetty, S; Rathnavalu, P; Moore, C; Pfafferott, KJ; Hilton, L; Zimbwa, P; Moore, S; Allen, T; Brander, C; Addo, MM; Altfeld, M; James, I; Mallal, S; Bunce, M; Barber, LD; Szinger, J; Day, C; Klenerman, P; Mullins, J; Korber, B; Coovadia, HM; Walker, BD; Goulder, PJR			Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA	NATURE			English	Article							CLASS-I MOLECULES; IMMUNE-RESPONSES; VIRUS; AIDS; TRANSMISSION; PROGRESSION; INFECTION; ALLELES; ADVANTAGE; EVOLUTION	The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8(+) T cells(1-3). HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8(+) T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8(+) T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8(+) T-cell activity(4,5). In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8(+) T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles(6-8). The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design.	Univ KwaZuluNatal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4015 Durban, South Africa; Nuffield Dept Med, Dept Paediat, Oxford OX1 3SY, England; Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; Murdoch Univ, Royal Perth Hosp, Perth, WA 6000, Australia; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Massachusetts Gen Hosp, Partners AIDS Res Ctr, Charlestown, MA 02129 USA; Dynal Biotech Ltd, Wirral CH62 3QL, Merseyside, England; Royal Free Hosp, Anthony Nolan Res Inst, London NW3 2QG, England; Santa Fe Inst, Santa Fe, NM 87501 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Kwazulu Natal; University of Oxford; Royal Perth Hospital; University of Western Australia; Murdoch University; Royal Perth Hospital; University of Western Australia; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; The Santa Fe Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; Howard Hughes Medical Institute	Goulder, PJR (corresponding author), Univ KwaZuluNatal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, 719 Umbilo Rd, ZA-4015 Durban, South Africa.	philip.goulder@ndm.ox.ac.uk	Mallal, Simon Alexander/HDM-9561-2022; Addo, Marylyn M./GNP-2548-2022; Day, Cheryl L/J-9844-2012; Allen, Todd/F-5473-2011; Day, Cheryl/GQQ-9720-2022; Altfeld, Marcus/AAE-7306-2019	Mallal, Simon Alexander/0000-0002-7036-1309; Day, Cheryl L/0000-0002-6497-4846; Allen, Todd/0000-0002-6609-1318; Altfeld, Marcus/0000-0001-5972-2997; leslie, alasdair/0000-0003-2538-6467; Korber, Bette/0000-0002-2026-5757; Thobakgale-Tshabalala, Christina/0000-0001-5619-8894; Szinger, James/0000-0002-6605-9940; Brander, Christian/0000-0002-0548-5778; klenerman, paul/0000-0003-4307-9161; Addo, Marylyn/0000-0003-2836-9224				Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; BELICH MP, 1992, NATURE, V357, P326, DOI 10.1038/357326a0; Bunce Mike, 2003, Methods Mol Biol, V210, P143; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Marsh SG, 2000, HLA FACTS BOOK; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; MCADAM SN, 1994, P NATL ACAD SCI USA, V91, P5893, DOI 10.1073/pnas.91.13.5893; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Ramos M, 2002, TISSUE ANTIGENS, V60, P191, DOI 10.1034/j.1399-0039.2002.600301.x; SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816; Thio CL, 2003, J VIROL, V77, P12083, DOI 10.1128/JVI.77.22.12083-12087.2003; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; WATKINS DI, 1992, NATURE, V357, P329, DOI 10.1038/357329a0	28	618	643	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					769	774		10.1038/nature03113	http://dx.doi.org/10.1038/nature03113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592417				2022-12-28	WOS:000225597200052
J	Schwender, J; Goffman, F; Ohlrogge, JB; Shachar-Hill, Y				Schwender, J; Goffman, F; Ohlrogge, JB; Shachar-Hill, Y			Rubisco without the Calvin cycle improves the carbon efficiency of developing green seeds	NATURE			English	Article							BRASSICA-NAPUS EMBRYOS; METABOLIC NETWORKS; FLUX; OILSEEDS; PATHWAY	Efficient storage of carbon in seeds is crucial to plant fitness and to agricultural productivity. Oil is a major reserve material in most seeds(1), and these oils provide the largest source of renewable reduced carbon chains available from nature. However, the conversion of carbohydrate to oil through glycolysis results in the loss of one-third of the carbon as CO2. Here we show that, in developing embryos of Brassica napus L. (oilseed rape), Rubisco ( ribulose 1,5-bisphosphate carboxylase/oxygenase) acts without the Calvin cycle(2) and in a previously undescribed metabolic context to increase the efficiency of carbon use during the formation of oil. In comparison with glycolysis, the metabolic conversion we describe provides 20% more acetyl-CoA for fatty-acid synthesis and results in 40% less loss of carbon as CO2. Our conclusions are based on measurements of mass balance, enzyme activity and stable isotope labelling, as well as an analysis of elementary flux modes.	Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University	Schwender, J (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	schwend2@msu.edu	Shachar-Hill, Yair/B-6165-2013; Schwender, Jorg/P-2282-2014	Shachar-Hill, Yair/0000-0001-8793-5084; Schwender, Jorg/0000-0003-1350-4171				BASSHAM JA, 1954, J AM CHEM SOC, V76, P1760, DOI 10.1021/ja01636a012; Goffman FD, 2004, PLANT PHYSIOL BIOCH, V42, P703, DOI 10.1016/j.plaphy.2004.07.003; King SP, 1998, AUST J PLANT PHYSIOL, V25, P377, DOI 10.1071/PP97157; LEVIN DA, 1974, AM NAT, V108, P193, DOI 10.1086/282899; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Ruuska SA, 2004, PLANT PHYSIOL, V136, P2700, DOI 10.1104/pp.104.047977; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Schwender J, 2003, J BIOL CHEM, V278, P29442, DOI 10.1074/jbc.M303432200; Schwender J, 2002, PLANT PHYSIOL, V130, P347, DOI 10.1104/pp.004275	11	343	356	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					779	782		10.1038/nature03145	http://dx.doi.org/10.1038/nature03145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592419				2022-12-28	WOS:000225597200054
J	Zhurov, V; Terzin, T; Grbic, M				Zhurov, V; Terzin, T; Grbic, M			Early blastomere determines embryo proliferation and caste fate in a polyembryonic wasp	NATURE			English	Article							SEQUENCE ALIGNMENT; EVOLUTION; SPECIFICATION; INSECTS; EXPRESSION; PATTERN	Polyembryonic development is a unique mode of metazoan development in which a single zygote generates multiple embryos by clonal proliferation(1). The polyembryonic parasitic insect Copidosoma floridanum shows one of the most extreme cases of polyembryony, producing up to 2,000 embryos from a single egg. In addition, this wasp exhibits an unusual polyphenism, producing two morphologically distinct larval castes, termed precocious and reproductive, that develop clonally from the same zygote(2). This form of development seems incompatible with a model of insect development in which maternal prepatterning of the egg specifies embryonic axial polarity(3). Here we show that maternal pre-patterning in the form of germ plasm creates cellular asymmetry at the four-cell stage embryo of Copidosoma that is perpetuated throughout development. Laser ablations of cells show that the cell inheriting the germ plasm regulates both the fate and proliferation of the reproductive caste. Thus, we have uncovered a new mechanism of caste specification, mediated by the regulatory capacity of a single cell. This study shows that the evolution of mammalian-like regulative development of an insect embryo relies on a novel cellular context that might ultimately enhance developmental plasticity.	Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada	Western University (University of Western Ontario)	Grbic, M (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.	mgrbic@uwo.ca	Grbic, Miodrag/AID-4825-2022; Terzin, Tomislav/C-7592-2015	Terzin, Tomislav/0000-0001-5100-0623; Zhurov, Vladimir/0000-0002-7120-4655				Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; BAEHRECKE EH, 1993, DEV BIOL, V158, P275, DOI 10.1006/dbio.1993.1188; Craig SF, 1997, EVOL ECOL, V11, P127, DOI 10.1023/A:1018443714917; CRUZ YP, 1981, NATURE, V294, P446, DOI 10.1038/294446a0; Dearden PK, 2001, DEVELOPMENT, V128, P3435; Evans JD, 2001, BIOESSAYS, V23, P62, DOI 10.1002/1521-1878(200101)23:1&lt;62::AID-BIES1008&gt;3.0.CO;2-7; Gardner RL, 2001, DEVELOPMENT, V128, P839; GEBERDING M, 2002, DEVELOPMENT, V129, P5789; Goldstein B, 1997, BIOESSAYS, V19, P105, DOI 10.1002/bies.950190205; Grbic M, 2000, BIOESSAYS, V22, P920, DOI 10.1002/1521-1878(200010)22:10&lt;920::AID-BIES7&gt;3.0.CO;2-Q; Grbic M, 1997, J INSECT PHYSIOL, V43, P553, DOI 10.1016/S0022-1910(97)00004-8; GRBIC M, 1992, NATURE, V360, P254, DOI 10.1038/360254a0; Grbic M, 1998, DEV GENES EVOL, V208, P69, DOI 10.1007/s004270050156; Grbic M, 1996, DEVELOPMENT, V122, P795; Johnson AD, 2003, PHILOS T ROY SOC B, V358, P1371, DOI 10.1098/rstb.2003.1331; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; Meinhardt H, 2001, INT J DEV BIOL, V45, P177; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; PEDERSEN RA, 1986, EXPT APPROACHES MAMM, P3; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Schwalm F, 1988, INSECT MORPHOGENESIS; Silvestri F., 1906, ANN R SCUOLA SUP AGR, V6, P3; STJOHNSTON D, 1992, CELL, V68, P201; Strand MR, 1997, CURR TOP DEV BIOL, V35, P121, DOI 10.1016/S0070-2153(08)60258-6; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UNDERWOOD EM, 1980, DEV BIOL, V77, P303, DOI 10.1016/0012-1606(80)90476-5; WOODRING J, 1994, J INSECT PHYSIOL, V40, P685, DOI 10.1016/0022-1910(94)90095-7	30	39	40	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					764	769		10.1038/nature03171	http://dx.doi.org/10.1038/nature03171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592416				2022-12-28	WOS:000225597200051
J	Conway, S; Harvey, I				Conway, S; Harvey, I			Use and offering of chaperones by general practitioners: postal questionnaire survey in Norfolk	BRITISH MEDICAL JOURNAL			English	Article									The Surgery, Hingham NR9 4JG, Norfolk, England; Univ E Anglia, Sch Med Hlth Policy & Practice, Populat Hlth Grp, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Conway, S (corresponding author), The Surgery, Hingham NR9 4JG, Norfolk, England.	Shaun.Conway@nhs.net						*GEN MED COUNC, 2002, DUT DOCT 2002; Royal College of Obstetricians and Gynaecologists, 2002, GYN EX GUID SPEC PRA; SPEELMAN A, 1993, BRIT MED J, V307, P986, DOI 10.1136/bmj.307.6910.986; Stern V, 2001, LANCET, V358, P1896, DOI 10.1016/S0140-6736(01)06892-1; Whitford DL, 2001, BRIT J GEN PRACT, V51, P381	5	14	14	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 29	2005	330	7485					235	236		10.1136/bmj.38320.472986.8F	http://dx.doi.org/10.1136/bmj.38320.472986.8F			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894GR	15604154	Green Published, Bronze			2022-12-28	WOS:000226779400023
J	Hall, AJ				Hall, AJ			Vaccination and child mortality	LANCET			English	Editorial Material							ROUTINE VACCINATIONS; WEST-AFRICA; SURVIVAL		Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Hall, AJ (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Andy.hall@lshtm.ac.uk						Aaby P, 2004, INT J EPIDEMIOL, V33, P367, DOI 10.1093/ije/dyh004; Aaby P, 2003, INT J EPIDEMIOL, V32, P106, DOI 10.1093/ije/dyg005; Aaby Peter, 2003, Semin Pediatr Infect Dis, V14, P220, DOI 10.1016/S1045-1870(03)00037-2; Garly ML, 2003, VACCINE, V21, P2782, DOI 10.1016/S0264-410X(03)00181-6; Global Advisory Committee on Vaccine Safety, 2004, WKLY EPIDEMIOL REC, V79, P269; HALL AJ, 1990, INT J EPIDEMIOL, V19, P777, DOI 10.1093/ije/19.4.777; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435	7	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2156	2157		10.1016/S0140-6736(04)17604-6	http://dx.doi.org/10.1016/S0140-6736(04)17604-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610784				2022-12-28	WOS:000225799700004
J	Gutierrez, MG; Master, SS; Singh, SB; Taylor, GA; Colombo, MI; Deretic, V				Gutierrez, MG; Master, SS; Singh, SB; Taylor, GA; Colombo, MI; Deretic, V			Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages	CELL			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; PHAGOSOME MATURATION; CELL-DEATH; YEAST; KINASE; AVIUM; MACROAUTOPHAGY; ACIDIFICATION; BIOGENESIS; LYSOSOMES	Mycobacterium tuberculosis is an intracellular pathogen persisting within phagosomes through interference with phagolysosome biogenesis. Here we show that stimulation of autophagic pathways in macrophages causes mycobacterial phagosomes to mature into phagolysosomes. Physiological induction of autophagy or its pharmacological stimulation by rapamycin resulted in mycobacterial phagosome colocalization with the autophagy effector LC3, an elongation factor in autophagosome formation. Autophagy stimulation increased phagosomal colocalization with Beclin-1, a subunit of the phosphatidylinositol 3-kinase hVPS34, necessary for autophagy and a target for mycobacterial phagosome maturation arrest. Induction of autophagy suppressed intracellular survival of mycobacteria. IFN-gamma induced autophagy in macrophages, and so did transfection with LRG-47, an effector of IFN-gamma required for antimycobacterial action. These findings demonstrate that autophagic pathways can overcome the trafficking block imposed by M. tuberculosis. Autophagy, which is a hormonally, developmentally, and, as shown here, immunologically regulated process, represents an underappreciated innate defense mechanism for control of intracellular pathogens.	Univ Nacl Cuyo, CONICET, Fac Ciencias Med, Inst Histol & Embriol, RA-5500 Mendoza, Argentina; Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; Duke Univ, Ctr Med, Dept Med, Durham, NC 27710 USA; Duke Univ, Ctr Med, Dept Immunol, Durham, NC 27710 USA; Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University of New Mexico; Duke University; Duke University; University of New Mexico	Colombo, MI (corresponding author), Univ Nacl Cuyo, CONICET, Fac Ciencias Med, Inst Histol & Embriol, RA-5500 Mendoza, Argentina.	mcolombo@fcm.uncu.edu.ar; vderetic@salud.unm.edu		Deretic, Vojo/0000-0002-3624-5208; Gutierrez, Maximiliano/0000-0003-3199-0337	FIC NIH HHS [TW06982] Funding Source: Medline; NIAID NIH HHS [AI42999, R01 AI057831, AI45148] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW006982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057831, R01AI042999, R01AI045148] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Chua J, 2004, J BIOL CHEM, V279, P36982, DOI 10.1074/jbc.M405082200; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; CROWLE AJ, 1991, INFECT IMMUN, V59, P1823, DOI 10.1128/IAI.59.5.1823-1831.1991; Dardalhon V, 2002, CELL BIOL INT, V26, P669, DOI 10.1006/cbir.2002.0917; DETER RL, 1967, J CELL BIOL, V33, P437, DOI 10.1083/jcb.33.2.437; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Oh YK, 1996, INFECT IMMUN, V64, P319, DOI 10.1128/IAI.64.1.319-325.1996; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Saeki K, 2003, J LEUKOCYTE BIOL, V74, P1108, DOI 10.1189/jlb.0503211; Schaible UE, 1998, J IMMUNOL, V160, P1290; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; *SURV MON PROJ, JAMA, V282, P677; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527; Via LE, 1998, J CELL SCI, V111, P897; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; YAIKO DM, 1995, J CLIN MICROBIOL, V33, P2324; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; J BIOL CHEM, V275, P992	53	1671	1751	5	162	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					753	766		10.1016/j.cell.2004.11.038	http://dx.doi.org/10.1016/j.cell.2004.11.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607973	Bronze			2022-12-28	WOS:000225907200007
J	Olive, KP; Tuveson, DA; Ruhe, ZC; Yin, B; Willis, NA; Bronson, RT; Crowley, D; Jacks, T				Olive, KP; Tuveson, DA; Ruhe, ZC; Yin, B; Willis, NA; Bronson, RT; Crowley, D; Jacks, T			Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome	CELL			English	Article							WILD-TYPE; TUMOR-ANTIGEN; SV40-TRANSFORMED CELLS; FUNCTION MUTATIONS; TRANSFORMED-CELLS; OF-FUNCTION; MICE; GENE; EXPRESSION; P73	The p53 tumor suppressor gene is commonly altered in human tumors, predominantly through missense mutations that result in accumulation of mutant p53 protein. These mutations may confer dominant-negative or gain-of-function properties to p53. To ascertain the physiological effects of p53 point mutation, the structural mutant p53(R172H) and the contact mutant p53(R270H) (codons 175 and 273 in humans) were engineered into the endogenous p53 locus in mice. p53(R270H/+) and p53(R172H/-) mice are models of Li-Fraumeni Syndrome; they developed allele-specific tumor spectra distinct from p53(+/-) mice. In addition, p53(R270H/-) and p53(R172H/-) mice developed novel tumors compared to p53(-/-) mice, including a variety of carcinomas and more frequent endothelial tumors. Dominant effects that varied by allele and function were observed in primary cells derived from p53(R270H/+) and p53(R172H/+), mice. These results demonstrate that point mutant p53 alleles expressed under physiological control have enhanced oncogenic potential beyond the simple loss of p53 function.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Tufts Univ, Sch Vet, Dept Biomed Sci, North Grafton, MA 01536 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); University of Pennsylvania; Pennsylvania Medicine; Tufts University; Howard Hughes Medical Institute	Jacks, T (corresponding author), MIT, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu		Olive, Kenneth/0000-0002-3392-8994				Aurelio ON, 2000, MOL CELL BIOL, V20, P770, DOI 10.1128/MCB.20.3.770-778.2000; BAKER SJ, 1990, CANCER RES, V50, P7717; Birch JM, 1998, ONCOGENE, V17, P1061, DOI 10.1038/sj.onc.1202033; Cadwell C, 2001, GENE, V277, P15, DOI 10.1016/S0378-1119(01)00696-5; Casciano I, 2002, CELL DEATH DIFFER, V9, P246, DOI 10.1038/sj.cdd.4400993; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CORDONCARDO C, 1994, CANCER RES, V54, P794; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eid H, 1999, ANTICANCER RES, V19, P3485; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FORRESTER K, 1995, ONCOGENE, V10, P2103; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; HALEVY O, 1990, SCIENCE, V250, P113, DOI 10.1126/science.2218501; HARVEY M, 1995, NAT GENET, V9, P305, DOI 10.1038/ng0395-305; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HSIAO M, 1994, AM J PATHOL, V145, P702; Hwang SJ, 2003, AM J HUM GENET, V72, P975, DOI 10.1086/374567; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kleihues P, 1997, AM J PATHOL, V150, P1; Kuperwasser C, 2000, AM J PATHOL, V157, P2151, DOI 10.1016/S0002-9440(10)64853-5; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; Peller S, 1998, SEMIN CANCER BIOL, V8, P379, DOI 10.1006/scbi.1998.0100; PURDIE CA, 1994, ONCOGENE, V9, P603; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; SHAULSKY G, 1991, CANCER RES, V51, P5232; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang XJ, 1998, ONCOGENE, V17, P35, DOI 10.1038/sj.onc.1201890; Webley KM, 2000, J PATHOL, V191, P361; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; YEWDELL JW, 1986, J VIROL, V59, P444, DOI 10.1128/JVI.59.2.444-452.1986; ZHOU MX, 1995, BLOOD, V85, P1608, DOI 10.1182/blood.V85.6.1608.bloodjournal8561608	56	914	931	3	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					847	860		10.1016/j.cell.2004.11.004	http://dx.doi.org/10.1016/j.cell.2004.11.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607980	Bronze			2022-12-28	WOS:000225907200014
J	Stivers, JT				Stivers, JT			Comment on "uracil DNA glycosylase activity is dispensable for immunoglobutin class switch"	SCIENCE			English	Editorial Material							SINGLE-STRANDED-DNA; BASE-EXCISION-REPAIR; SOMATIC HYPERMUTATION; STRUCTURAL BASIS; CATALYSIS; SPECIFICITY; DEAMINATION		Johns Hopkins Med Sch, Dept Pharmacol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Stivers, JT (corresponding author), Johns Hopkins Med Sch, Dept Pharmacol, 725 N Wolfe St, Baltimore, MD 21205 USA.	jstivers@jhmi.edu			NIGMS NIH HHS [GM56834-09, R01 GM056834] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; BENNETT SE, 1993, J BIOL CHEM, V268, P26879; Cappelli E, 2001, CARCINOGENESIS, V22, P387, DOI 10.1093/carcin/22.3.387; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11876, DOI 10.1021/bi9910880; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Jiang YL, 2002, J BIOL CHEM, V277, P15385, DOI 10.1074/jbc.M200634200; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Scaramozzino N, 2003, NUCLEIC ACIDS RES, V31, P4950, DOI 10.1093/nar/gkg672; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Unniraman S, 2004, SCIENCE, V305, P1113, DOI 10.1126/science.1102692	16	14	14	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2004	306	5704					2042A	2042A		10.1126/science.1104396	http://dx.doi.org/10.1126/science.1104396			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604391				2022-12-28	WOS:000225841000041
J	Gao, S; Rudnick, RL; Yuan, HL; Liu, XM; Liu, YS; Xu, WL; Ling, WL; Ayers, J; Wang, XC; Wang, QH				Gao, S; Rudnick, RL; Yuan, HL; Liu, XM; Liu, YS; Xu, WL; Ling, WL; Ayers, J; Wang, XC; Wang, QH			Recycling lower continental crust in the North China craton	NATURE			English	Article							ZIRCON; CONSTRAINTS; BENEATH; MELTS; TEMPERATURE; PERIDOTITE; XENOLITHS; MAGMAS	Foundering of mafic lower continental crust into underlying convecting mantle has been proposed as one means to explain the unusually evolved chemical composition of Earth's continental crust(1,2), yet direct evidence of this process has been scarce. Here we report that Late Jurassic high-magnesium andesites, dacites and adakites ( siliceous lavas with high strontium and low heavy-rare-earth element and yttrium contents) from the North China craton have chemical and petrographic features consistent with their origin as partial melts of eclogite that subsequently interacted with mantle peridotite. Similar features observed in adakites and some Archaean sodium-rich granitoids of the tonalite-trondhjemite-granodiorite series have been interpreted to result from interaction of slab melts with the mantle wedge. Unlike their arc-related counterparts, however, the Chinese magmas carry inherited Archaean zircons and have neodymium and strontium isotopic compositions overlapping those of eclogite xenoliths derived from the lower crust of the North China craton. Such features cannot be produced by crustal assimilation of slab melts, given the high Mg#, nickel and chromium contents of the lavas. We infer that the Chinese lavas derive from ancient mafic lower crust that foundered into the convecting mantle and subsequently melted and interacted with peridotite. We suggest that lower crustal foundering occurred within the North China craton during the Late Jurassic, and thus provides constraints on the timing of lithosphere removal beneath the North China craton.	Univ Maryland, Dept Geol, Geochem Lab, College Pk, MD 20742 USA; NW Univ Xian, Dept Geol, Key Lab Continental Dynam, Xian 710069, Peoples R China; China Univ Geosci, Fac Earth Sci, Wuhan 430074, Peoples R China; Jilin Univ, Sch Earth Sci, Changchun 130061, Peoples R China; Vanderbilt Univ, Dept Geol, Nashville, TN 37235 USA	University System of Maryland; University of Maryland College Park; Northwest University Xi'an; China University of Geosciences; Jilin University; Vanderbilt University	Gao, S (corresponding author), Univ Maryland, Dept Geol, Geochem Lab, College Pk, MD 20742 USA.	sgao@263.net.cn; rudnick@geol.umd.edu	Liu, Yongsheng/D-4440-2011; Liu, Yong/GWQ-6163-2022; Wang, Xuan-Ce/F-1516-2010; Wang, Xuan-Ce/K-9270-2019; Ayers, John C./B-4871-2010; Rudnick, Roberta Lyn/J-2398-2013	Liu, Yongsheng/0000-0002-9340-9205; Wang, Xuan-Ce/0000-0001-7276-6273; Wang, Xuan-Ce/0000-0001-7276-6273; Ayers, John C./0000-0003-2737-4718; Rudnick, Roberta Lyn/0000-0003-1559-7463				ATHERTON MP, 1993, NATURE, V362, P144, DOI 10.1038/362144a0; Ayers JC, 2002, CHEM GEOL, V186, P315, DOI 10.1016/S0009-2541(02)00008-6; Black LP, 2003, CHEM GEOL, V200, P155, DOI 10.1016/S0009-2541(03)00165-7; Davis GA, 2001, GEOL SOC AM MEM, V194, P171; Gao S, 1998, EARTH PLANET SC LETT, V161, P101, DOI 10.1016/S0012-821X(98)00140-X; Gao S, 2002, EARTH PLANET SC LETT, V198, P307, DOI 10.1016/S0012-821X(02)00489-2; Griffin WL, 1998, GEODYNAMICS, V27, P107; HARRISON TM, 1983, CONTRIB MINERAL PETR, V84, P66, DOI 10.1007/BF01132331; Huang ZX, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001696; Jull M, 2001, J GEOPHYS RES-SOL EA, V106, P6423, DOI 10.1029/2000JB900357; KAY RW, 1978, J VOLCANOL GEOTH RES, V4, P117, DOI 10.1016/0377-0273(78)90032-X; KAY RW, 1991, GEOL RUNDSCH, V80, P259, DOI 10.1007/BF01829365; KAY RW, 1993, TECTONOPHYSICS, V219, P177, DOI 10.1016/0040-1951(93)90295-U; LIU DY, 1992, GEOLOGY, V20, P339, DOI 10.1130/0091-7613(1992)020<0339:ROMCIT>2.3.CO;2; Ludwig K.R., 2003, ISOPLOT, V4; Martin H, 1999, LITHOS, V46, P411, DOI 10.1016/S0024-4937(98)00076-0; Menzies M.A., 1993, GEOL SOC SPEC PUBL, V76, P71, DOI 10.1144/GSL.SP.1993.076.01.04; Qiu YM, 2002, MINER DEPOSITA, V37, P283, DOI 10.1007/s00126-001-0238-3; Rapp RP, 1999, CHEM GEOL, V160, P335, DOI 10.1016/S0009-2541(99)00106-0; RUDNICK RL, 1995, NATURE, V378, P571, DOI 10.1038/378571a0; Rudnick RL, 2004, LITHOS, V77, P609, DOI 10.1016/j.lithos.2004.03.033; RUDNICK RL, 1995, REV GEOPHYS, V33, P267, DOI 10.1029/95RG01302; STERN RA, 1991, J PETROL, V32, P201, DOI 10.1093/petrology/32.1.201; WATSON EB, 1983, EARTH PLANET SC LETT, V64, P295, DOI 10.1016/0012-821X(83)90211-X; Wilde SA, 2003, GEOLOGY, V31, P817, DOI 10.1130/G19489.1; Williams I.S., 1998, REV EC GEOLOGY, V7, P1, DOI DOI 10.1080/07474938808800138; WOLF MB, 1994, CONTRIB MINERAL PETR, V115, P369, DOI 10.1007/BF00320972; Xu JF, 2002, GEOLOGY, V30, P1111, DOI 10.1130/0091-7613(2002)030<1111:OOMAIR>2.0.CO;2; Xu WL, 2002, CHINESE SCI BULL, V47, P1212, DOI 10.1360/02tb9271; YUAN HL, IN PRESS GEOSTAND NE; Zhao GC, 2001, PRECAMBRIAN RES, V107, P45, DOI 10.1016/S0301-9268(00)00154-6; Zheng JP, 2004, GEOLOGY, V32, P229, DOI 10.1130/G20133.1; Zheng JP, 2003, TECTONOPHYSICS, V361, P37, DOI 10.1016/S0040-1951(02)00537-1	33	1492	1909	25	536	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					892	897		10.1038/nature03162	http://dx.doi.org/10.1038/nature03162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602559				2022-12-28	WOS:000225733500050
J	Saper, RB; Kales, SN; Paquin, J; Burns, MJ; Eisenberg, DM; Davis, RB; Phillips, RS				Saper, RB; Kales, SN; Paquin, J; Burns, MJ; Eisenberg, DM; Davis, RB; Phillips, RS			Heavy metal content of Ayurvedic herbal medicine products	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD LEAD; EXPOSURE	Context Lead, mercury, and arsenic intoxication have been associated with the use of Ayurvedic herbal medicine product (HMPs). Objectives To determine the prevalence and concentration of heavy metals in Ayurvedic HMPs manufactured in South Asia and sold in Boston-area stores and to compare estimated daily metal ingestion with regulatory standards. Design and Setting Systematic search strategy to identify all stores 20 miles or less from Boston City Hall that sold Ayurvedic HMPs from South Asia by searching online Yellow Pages using the categories markets, supermarkets, and convenience stores, and business names containing the word India, Indian cities, and Indian words. An online national directory of Indian grocery stores, a South Asian community business directory, and a newspaper were also searched. We visited each store and purchased all unique Ayurvedic HMPs between April 25 and October 24, 2003. Main Outcome Measures Concentrations (mug/g) of lead, mercury, and arsenic in each HMP as measured by x-ray fluorescence spectroscopy. Estimates of daily metal ingestion for adults and children estimated using manufacturers' dosage recommendations with comparisons to US Pharmacopeia and US Environmental Protection Agency regulatory standards. Results A total of 14 (20%) of 70 HMPs (95% confidence interval, 11%-31%) contained heavy metals: lead (n=13; median concentration, 40 mug/g; range, 5-37000), mercury (n=6; median concentration, 20225 mug/g; range, 28-104000), and/or arsenic (n=6; median concentration, 430 mug/g; range, 37-8130). If taken as recommended by the manufacturers, each of these 14 could result in heavy metal intakes above published regulatory standards. Conclusions One of 5 Ayurvedic HMPs produced in South Asia and available in Boston South Asian grocery stores contains potentially harmful levels of lead, mercury, and/or arsenic. Users of Ayurvedic medicine may be at risk for heavy metal toxicity, and testing of Ayurvedic HMPs for toxic heavy metals should be mandatory.	Harvard Univ, Sch Med, Osher Inst, Div Res & Educ Complementary & Integrat Med Thera, Boston, MA USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Emergency Med, Div Toxicol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Cambridge Hosp, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; US EPA, New England Reg Lab, N Chelmsford, MA USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard University; Harvard T.H. Chan School of Public Health; United States Environmental Protection Agency	Saper, RB (corresponding author), Boston Univ, Sch Med, Dept Family Med, 1 Boston Med Ctr Pl,Dowling 5 S, Boston, MA 02118 USA.	robert.saper@bmc.org	Saper, Robert B/Y-4598-2018	Saper, Robert B/0000-0002-0992-6198	NCCIH NIH HHS [T32 AT00051, K24 AT00589] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K24AT000589] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [T32AT000051] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ACHARYA VJT, 1998, RASAMRITAM; AlKhayat S, 1997, ANN TROP PAEDIATR, V17, P39; Ang HH, 2003, HUM EXP TOXICOL, V22, P445, DOI 10.1191/0960327103ht382oa; [Anonymous], 2011, NAT I STAND TECHN ST; ASLAM M, 1979, PUBLIC HEALTH, V93, P274, DOI 10.1016/S0033-3506(79)80078-5; Baer RD, 1998, SOC SCI MED, V47, P1263, DOI 10.1016/S0277-9536(98)00183-X; Barnes PM., 2004, COMPLEMENTARY ALTERN; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; *CDCP, 1984, MMWR-MORBID MORTAL W, V33, P638; *CDCP, 1984, MMWR-MORBID MORTAL W, V33, P643; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P582; CHONGHAI T, 1975, MED J AUSTRALIA, V2, P424, DOI 10.5694/j.1326-5377.1975.tb105939.x; Chopra A, 2002, MED CLIN N AM, V86, P75, DOI 10.1016/S0025-7125(03)00073-7; Dwivedi SK, 2002, ARCH ENVIRON HEALTH, V57, P229, DOI 10.1080/00039890209602941; Ernst E, 2002, EUR J CLIN PHARMACOL, V57, P891, DOI 10.1007/s00228-001-0400-y; Gogtay NJ, 2002, DRUG SAFETY, V25, P1005, DOI 10.2165/00002018-200225140-00003; GUNN VL, 2002, H LANE HDB, P722; HONTZ J, 2004, LOS ANGELES TIM 0126, P1; Ibrahim AS, 2002, SAUDI MED J, V23, P591; KLAASSEN CD, 2001, GOODMAN GILMANS PHAR, P1851; Ko RJ, 1998, NEW ENGL J MED, V339, P847, DOI 10.1056/NEJM199809173391214; Lecours S, 1989, Can Dis Wkly Rep, V15, P177; Lekouch N, 2001, SCI TOTAL ENVIRON, V280, P39, DOI 10.1016/S0048-9697(01)00801-4; Lin JL, 2003, NEW ENGL J MED, V348, P277, DOI 10.1056/NEJMoa021672; Marcus DM, 2002, NEW ENGL J MED, V347, P2073, DOI 10.1056/NEJMsb022858; MCELVAINE MD, 1990, JAMA-J AM MED ASSOC, V264, P2212; Moore C, 2000, PEDIATRICS, V106, P600, DOI 10.1542/peds.106.3.600; Nash D, 2003, JAMA-J AM MED ASSOC, V289, P1523, DOI 10.1001/jama.289.12.1523; PrpicMajic D, 1996, J TOXICOL-CLIN TOXIC, V34, P417, DOI 10.3109/15563659609013812; Spriewald BM, 1999, OCCUP ENVIRON MED, V56, P282, DOI 10.1136/oem.56.4.282; Tait PA, 2002, MED J AUSTRALIA, V177, P193, DOI 10.5694/j.1326-5377.2002.tb04731.x; Tertian R., 1982, PRINCIPLES QUANTITAT; Traub SJ, 2002, J TOXICOL-CLIN TOXIC, V40, P781, DOI 10.1081/CLT-120015839; *US EPA, 2004, INT RISK INF SYST; *US PHARM CONV INC, 2003, 2004 USP, V27; Weide R, 2003, DEUT MED WOCHENSCHR, V128, P2418, DOI 10.1055/s-2003-43590; 2003, INDIA NEW ENGLA 0501, P27; INDIAN GROCERIES US	38	405	412	3	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2004	292	23					2868	2873		10.1001/jama.292.23.2868	http://dx.doi.org/10.1001/jama.292.23.2868			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879CR	15598918				2022-12-28	WOS:000225694500024
J	Cole, C				Cole, C			Registering childhood cancers	LANCET			English	Editorial Material							CHILDREN; PROGRAM; TRIALS; TUMORS		Princess Margaret Hosp Children, Dept Paediat Haematol Oncol, Perth, WA 6001, Australia	University of Western Australia	Cole, C (corresponding author), Princess Margaret Hosp Children, Dept Paediat Haematol Oncol, Perth, WA 6001, Australia.	Catherine.Cole@health.wa.gov.au						Birch JM, 2003, EUR J CANCER, V39, P2622, DOI 10.1016/j.ejca.2003.08.006; Bleyer WA, 1997, J ADOLESCENT HEALTH, V21, P366, DOI 10.1016/S1054-139X(97)00110-9; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Masera G, 2004, PEDIATR BLOOD CANCER, V43, P103, DOI 10.1002/pbc.20135; Masera G, 1998, LANCET, V352, P1923, DOI 10.1016/S0140-6736(98)07077-9; Michalkiewicz E, 2004, J CLIN ONCOL, V22, P838, DOI 10.1200/JCO.2004.08.085; MURPHY SB, 1995, MED PEDIATR ONCOL, V24, P279, DOI 10.1002/mpo.2950240502; PARKIN DM, 1999, INT INCIDENCE CHILDH, V2; Ribeiro RC, 1996, LEUKEMIA, V10, P570; Smith MA, 1998, J NATL CANCER I, V90, P1269, DOI 10.1093/jnci/90.17.1269	11	7	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	2004	364	9451					2074	2076		10.1016/S0140-6736(04)17561-2	http://dx.doi.org/10.1016/S0140-6736(04)17561-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589293				2022-12-28	WOS:000225742300004
J	Spender, Q				Spender, Q			Commentary: abandoning the diagnosis will endanger severely depressed children	BRITISH MEDICAL JOURNAL			English	Article							ADOLESCENTS; TRIAL		Chichester Child & Adolescent Mental Hlth Serv, Chichester PO19 6PQ, England		Spender, Q (corresponding author), Chichester Child & Adolescent Mental Hlth Serv, Chichester PO19 6PQ, England.	spender@sghms.ac.uk						March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Mufson L, 2004, ARCH GEN PSYCHIAT, V61, P577, DOI 10.1001/archpsyc.61.6.577; Timimi S, 2004, BRIT MED J, V329, P1394, DOI 10.1136/bmj.329.7479.1394; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 11	2004	329	7479					1396	1396		10.1136/bmj.329.7479.1396	http://dx.doi.org/10.1136/bmj.329.7479.1396			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880JB	15591568	Green Published			2022-12-28	WOS:000225785000027
J	Zerhouni, EA				Zerhouni, EA			Information access - NIH public access policy	SCIENCE			English	Editorial Material									NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Zerhouni, EA (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.							*INT HLTH RES, 2003, PEW INT AM LIF PROJ; *MANH RES, 2003, CYB HLTH 3 0 SURV; *NIH, 2004, NOTOD04064 NIH; 2004, FED REG, V69, P56074	4	16	16	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2004	306	5703					1895	1895		10.1126/science.1106929	http://dx.doi.org/10.1126/science.1106929			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591188	Green Published			2022-12-28	WOS:000225695600028
J	Green, JL; Holmes, AJ; Westoby, M; Oliver, I; Briscoe, D; Dangerfield, M; Gillings, M; Beattie, AJ				Green, JL; Holmes, AJ; Westoby, M; Oliver, I; Briscoe, D; Dangerfield, M; Gillings, M; Beattie, AJ			Spatial scaling of microbial eukaryote diversity	NATURE			English	Article							SPECIES-AREA RELATIONSHIPS; BIODIVERSITY; SOIL; COMMUNITIES; ECOLOGY; SIMILARITY; BACTERIAL; DISTANCE; SYSTEMS; DECAY	Patterns in the spatial distribution of organisms provide important information about mechanisms that regulate the diversity of life and the complexity of ecosystems(1,2). Although microorganisms may comprise much of the Earth's biodiversity(3,4) and have critical roles in biogeochemistry and ecosystem functioning(5-7), little is known about their spatial diversification. Here we present quantitative estimates of microbial community turnover at local and regional scales using the largest spatially explicit microbial diversity data set available (> 10(6) sample pairs). Turnover rates were small across large geographical distances, of similar magnitude when measured within distinct habitats, and did not increase going from one vegetation type to another. The taxa - area relationship of these terrestrial microbial eukaryotes was relatively flat (slope z = 0.074) and consistent with those reported in aquatic habitats(8,9). This suggests that despite high local diversity, microorganisms may have only moderate regional diversity. We show how turnover patterns can be used to project taxa - area relationships up to whole continents. Taxa dissimilarities across continents and between them would strengthen these projections. Such data do not yet exist, but would be feasible to collect.	Macquarie Univ, Dept Biol Sci, Key Ctr Biodivers & Bioresources, N Ryde, NSW 2109, Australia; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; Univ New England, New S Wales Dept Infrastruct Planning & Nat Resou, Armidale, NSW 2351, Australia	Macquarie University; University of Sydney; University of New England	Green, JL (corresponding author), Univ Calif, Sch Nat Sci, POB 2039, Merced, CA 95344 USA.	jgreen@ucmerced.edu	Green, Jessica/C-4828-2009; Gillings, Michael/AAF-5772-2020; Holmes, Andrew/A-4618-2009; Carneiro, Fernanda/E-9513-2013; Holmes, Andrew/AAI-2845-2020; Gillings, Michael R/C-6553-2008	Gillings, Michael/0000-0002-4043-4351; Carneiro, Fernanda/0000-0001-6389-4564; Gillings, Michael R/0000-0002-4043-4351; Westoby, Mark/0000-0001-7690-4530				Azovsky AI, 2002, ECOGRAPHY, V25, P273, DOI 10.1034/j.1600-0587.2002.250303.x; Balser TC, 2001, MONOGRAPHS POPULATIO, P265; Brown JH, 2002, PHILOS T R SOC B, V357, P619, DOI 10.1098/rstb.2001.0993; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Finlay BJ, 1998, PROTIST, V149, P29, DOI 10.1016/S1434-4610(98)70007-0; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Harrison S, 1997, ECOLOGY, V78, P1898, DOI 10.1890/0012-9658(1997)078[1898:HNHPAT]2.0.CO;2; Harte J, 1999, OIKOS, V86, P45, DOI 10.2307/3546568; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Kent AD, 2002, ANNU REV MICROBIOL, V56, P211, DOI 10.1146/annurev.micro.56.012302.161120; Legendre P, 2000, J STAT COMPUT SIM, V67, P37, DOI 10.1080/00949650008812035; Legendre P., 2012, NUMERICAL ECOLOGY; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Manly BFJ, 1997, RANDOMIZATION BOOTST; Morin PJ, 2004, OIKOS, V104, P458, DOI 10.1111/j.0030-1299.2004.13256.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; ODEN NL, 1992, J CLASSIF, V9, P275, DOI 10.1007/BF02621410; Oliver I, 2004, ECOL APPL, V14, P485, DOI 10.1890/02-5181; Ovreas L, 2000, ECOL LETT, V3, P236, DOI 10.1046/j.1461-0248.2000.00148.x; Poulin R, 2003, J BIOGEOGR, V30, P1609, DOI 10.1046/j.1365-2699.2003.00949.x; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; Schluter Dolph, 1993, P1; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Wardle D., 2002, COMMUNITIES ECOSYSTE; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Yeates C, 1998, LETT APPL MICROBIOL, V27, P49, DOI 10.1046/j.1472-765X.1998.00383.x	30	427	464	15	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					747	750		10.1038/nature03034	http://dx.doi.org/10.1038/nature03034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592411				2022-12-28	WOS:000225597200046
J	Bardenheier, BH; Euler, G				Bardenheier, BH; Euler, G		CDC	Influenza and pneumococcal vaccination coverage among persons aged >= 65 years and persons aged 18-64 years with diabetes or asthma - United States, 2003 (Reprinted from MMWR, vol 53, pg 1007-1012, 2004)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint									Immunizat Svcs Div, Atlanta, GA 30333 USA; CDC, Eidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Bardenheier, BH (corresponding author), Immunizat Svcs Div, Atlanta, GA 30333 USA.							Centers of Disease Control and Prevention, 2004, MMWR-MORBID MORTAL W, V53, P1007	1	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2004	292	22					2715	2716						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877CY	15585722	Bronze			2022-12-28	WOS:000225546600008
J	Bal, R; Bijker, WE; Hendriks, R				Bal, R; Bijker, WE; Hendriks, R			Democratisation of scientific advice	BRITISH MEDICAL JOURNAL			English	Article									Erasmus Univ, Med Ctr, Dept Hlth Policy & Management, NL-3000 DR Rotterdam, Netherlands; Univ Maastricht, Fac Arts & Culture, NL-6200 MD Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Maastricht University	Bal, R (corresponding author), Erasmus Univ, Med Ctr, Dept Hlth Policy & Management, POB 1738, NL-3000 DR Rotterdam, Netherlands.	r.bal@bmg.eur.nl		Hendriks, Ruud/0000-0002-4381-6689; Bal, Roland/0000-0001-7202-5053; Bijker, Wiebe/0000-0002-7307-8330				BAL R, 2002, PARADOX WETENSCHAPPE; Collins HM, 2002, SOC STUD SCI, V32, P235, DOI 10.1177/0306312702032002003; *EUR COMM, 2000, 19150 EUR EN EUR COM; FIORINO DJ, 1990, SCI TECHNOL HUM VAL, V15, P226, DOI 10.1177/016224399001500204; FORTUYN WSP, 1990, ORDENING DOOR ONTVLE; *GEZ, 1995, 199515 GEZ; Goffman E., 1959, BODIES MATTER; Gulick L., 1937, PAPERS SCI ADM, P3; Hilgartner S., 2000, SCI STAGE EXPERT ADV; Hindmarsh J, 2002, SOCIOL QUART, V43, P139, DOI 10.1525/tsq.2002.43.2.139; House of Lords Select Committee on Science and Technology, 2000, SCI SOC; Jasanoff S., 1998, POLITICS CHEM RISK S, P173; Weingart P., 1999, SCI PUBL POLICY, V26, P151, DOI [10.3152/147154399781782437, DOI 10.3152/147154399781782437]; WOODHOUSE EJ, 2001, KNOWLEDGE POWER PART, P73	14	19	19	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 4	2004	329	7478					1339	1341		10.1136/bmj.329.7478.1339	http://dx.doi.org/10.1136/bmj.329.7478.1339			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	878PC	15576747	Green Published, Green Submitted			2022-12-28	WOS:000225657800025
J	Hamdy, FC; Catto, JWF				Hamdy, FC; Catto, JWF			Less is more: artificial intelligence and gene-expression arrays	LANCET			English	Editorial Material							NEURAL-NETWORKS; CANCER; PREDICTION		Univ Sheffield, Royal Hallamshire Hosp, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Hamdy, FC (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England.	f.c.hamdy@sheffield.ac.uk		Hamdy, Freddie/0000-0003-2627-2154; catto, james/0000-0003-2787-8828				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Burke HB, 1997, CANCER, V79, P857, DOI 10.1002/(SICI)1097-0142(19970215)79:4<857::AID-CNCR24>3.0.CO;2-Y; Catto JWF, 2003, CLIN CANCER RES, V9, P4172; CROSS SS, 1995, LANCET, V346, P1075, DOI 10.1016/S0140-6736(95)91746-2; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; SHIMADA H, 1995, J NATL CANCER I, V87, P1470, DOI 10.1093/jnci/87.19.1470; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695	9	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					2003	2004		10.1016/S0140-6736(04)17528-4	http://dx.doi.org/10.1016/S0140-6736(04)17528-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582046				2022-12-28	WOS:000225495700008
J	Musher, DM; Musher, BL				Musher, DM; Musher, BL			Medical progress - Contagious acute gastrointestinal infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEMOLYTIC-UREMIC-SYNDROME; ESCHERICHIA-COLI O157-H7; DAY-CARE-CENTERS; ASTROVIRUS-ASSOCIATED GASTROENTERITIS; ROUND-STRUCTURED VIRUS; NORWALK-LIKE VIRUS; TYPHOID-FEVER; VIRAL GASTROENTERITIS; CAMPYLOBACTER-JEJUNI; UNITED-STATES		Michael E DeBakey VA Med Ctr, Infect Dis Sect, Med Serv, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Pennsylvania	Musher, DM (corresponding author), Michael E DeBakey VA Med Ctr, Infect Dis Sect, Med Serv, Houston, TX 77030 USA.	daniel.musher@med.va.gov						Abad FX, 1997, FEMS MICROBIOL LETT, V156, P107, DOI 10.1016/S0378-1097(97)00410-2; ADDISS DG, 1991, PEDIATR INFECT DIS J, V10, P907, DOI 10.1097/00006454-199112000-00005; ADLER JL, 1969, J INFECT DIS, V119, P668, DOI 10.1093/infdis/119.6.668; AGER EA, 1972, COMMUNICABLE INFECT, P567; Allos BM, 2004, CLIN INFECT DIS, V38, pS115, DOI 10.1086/381577; [Anonymous], 1971, Am J Epidemiol, V93, P33; ANSARI SA, 1989, APPL ENVIRON MICROB, V55, P3113, DOI 10.1128/AEM.55.12.3113-3118.1989; ASHLEY CR, 1978, J CLIN PATHOL, V31, P939, DOI 10.1136/jcp.31.10.939; BARTLETT AV, 1988, J PEDIATR-US, V113, P435, DOI 10.1016/S0022-3476(88)80624-3; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Becker KM, 2000, NEW ENGL J MED, V343, P1223, DOI 10.1056/NEJM200010263431704; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Belliot G, 1997, J MED VIROL, V51, P101, DOI 10.1002/(SICI)1096-9071(199702)51:2&lt;101::AID-JMV3&gt;3.0.CO;2-B; BELONGIA EA, 1993, JAMA-J AM MED ASSOC, V269, P883, DOI 10.1001/jama.269.7.883; BLACK RE, 1981, AM J EPIDEMIOL, V113, P445, DOI 10.1093/oxfordjournals.aje.a113112; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BLASER MJ, 1983, ANN INTERN MED, V98, P360, DOI 10.7326/0003-4819-98-3-360; BLASER MJ, 1981, J PEDIATR-US, V98, P254, DOI 10.1016/S0022-3476(81)80652-X; BRANDT CD, 1985, J INFECT DIS, V151, P437, DOI 10.1093/infdis/151.3.437; Bresee JS, 2002, CLIN INFECT DIS, V35, P748, DOI 10.1086/342386; BUCHWALD DS, 1984, REV INFECT DIS, V6, P345; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P41; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P477; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1112; Charlett A, 2003, EPIDEMIOL INFECT, V130, P367; CHIBA S, 1983, LANCET, V2, P954; Davis BD, 1967, MICROBIOLOGY; Davison WC, 1922, MEDICINE, V1, P389, DOI 10.1097/00005792-192211000-00001; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; DEWIT JC, 1982, ZBL BAKT MIK HYG B, V176, P553; Dingle JH., 1964, STUDY 25000 ILLNESSE; DUPONT HL, 1972, J INFECT DIS, V125, P12, DOI 10.1093/infdis/125.1.12; DUPONT HL, 1995, NEW ENGL J MED, V332, P855, DOI 10.1056/NEJM199503303321304; DUPUIS P, 1995, PRESSE MED, V24, P356; Esfandiari A, 1997, CELL MOL BIOL, V43, P1077; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; GATTI S, 1995, T ROY SOC TROP MED H, V89, P403, DOI 10.1016/0035-9203(95)90029-2; GATTI S, 1995, T ROY SOC TROP MED H, V89, P537; Gaudreau C, 2003, CLIN INFECT DIS, V37, P131, DOI 10.1086/375221; GELLERT GA, 1990, INFECT CONT HOSP EP, V11, P459; Gibson LL, 2002, J APPL MICROBIOL, V92, p136S, DOI 10.1046/j.1365-2672.92.5s1.17.x; Glass RI, 2000, J INFECT DIS, V181, pS254, DOI 10.1086/315588; GLYNN JR, 1995, EPIDEMIOL INFECT, V115, P23, DOI 10.1017/S0950268800058088; Gotz H, 2001, CLIN INFECT DIS, V33, P622, DOI 10.1086/322608; GRAHAM DY, 1987, ARCH VIROL, V92, P261, DOI 10.1007/BF01317483; GRAY JJ, 1987, J MED VIROL, V23, P377, DOI 10.1002/jmv.1890230410; Gulati BR, 2001, J FOOD PROTECT, V64, P1430, DOI 10.4315/0362-028X-64.9.1430; HARTER L, 1984, AM J PUBLIC HEALTH, V74, P155, DOI 10.2105/AJPH.74.2.155; Hedlund KO, 2000, J INFECT DIS, V181, pS275, DOI 10.1086/315585; HEIJBEL H, 1987, PEDIATR INFECT DIS J, V6, P532, DOI 10.1097/00006454-198706000-00009; HERRMANN JE, 1991, NEW ENGL J MED, V324, P1757, DOI 10.1056/NEJM199106203242501; HO MS, 1989, LANCET, V2, P961; HORNICK RB, 1970, NEW ENGL J MED, V283, P686, DOI 10.1056/NEJM197009242831306; Imhoff B, 2004, CLIN INFECT DIS, V38, pS219, DOI 10.1086/381590; JOHNSON S, 1989, J INFECT DIS, V159, P340, DOI 10.1093/infdis/159.2.340; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; KAPPERUD G, 1990, J CLIN MICROBIOL, V28, P2597, DOI 10.1128/JCM.28.12.2597-2601.1990; KESWICK BH, 1983, APPL ENVIRON MICROB, V46, P813, DOI 10.1128/AEM.46.4.813-816.1983; Kilgore PE, 1996, J INFECT DIS, V173, P787, DOI 10.1093/infdis/173.4.787; KIM K, 1983, J PEDIATR-US, V102, P376, DOI 10.1016/S0022-3476(83)80652-0; KONNO T, 1982, J MED VIROL, V9, P11, DOI 10.1002/jmv.1890090103; KOOPMAN JS, 1989, AM J EPIDEMIOL, V130, P760, DOI 10.1093/oxfordjournals.aje.a115397; KURTZ JB, 1977, J CLIN PATHOL, V30, P948, DOI 10.1136/jcp.30.10.948; KURTZ JB, 1979, J MED VIROL, V3, P221, DOI 10.1002/jmv.1890030308; Kuusi M, 2002, EPIDEMIOL INFECT, V129, P133, DOI 10.1017/S0950268802007276; Larson EL, 2004, ANN INTERN MED, V140, P321, DOI 10.7326/0003-4819-140-5-200403020-00007; Larson EL, 2003, AM J INFECT CONTROL, V31, P72, DOI 10.1067/mic.2003.33; LEAVITT JW, 1996, TYPHOID MARY CAPTIVE; LENGERICH EJ, 1994, CLIN INFECT DIS, V18, P760, DOI 10.1093/clinids/18.5.760; LESSER CF, 2001, HARRISONS PRINCIPLES, P970; LEVINE MM, 1972, AM J EPIDEMIOL, V96, P40, DOI 10.1093/oxfordjournals.aje.a121431; LEWIS DC, 1989, J HOSP INFECT, V14, P9, DOI 10.1016/0195-6701(89)90128-X; LEWIS JN, 1972, COMMUNICABLE INFECT, P585; Lin CM, 2003, J FOOD PROTECT, V66, P2296, DOI 10.4315/0362-028X-66.12.2296; LIN CM, 2004, J FOOD PROT, V67; Litwin CM, 1997, J INFECT DIS, V175, P864, DOI 10.1086/513983; MACKENZIE WR, 1995, CLIN INFECT DIS, V21, P57, DOI 10.1093/clinids/21.1.57; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P1035; Marks PJ, 2000, EPIDEMIOL INFECT, V124, P481, DOI 10.1017/S0950268899003805; Marshall MM, 1998, CLIN MICROBIOL REV, V11, P404, DOI 10.1128/CMR.11.2.404; Marshall MM, 1997, CLIN MICROBIOL REV, V10, P67, DOI 10.1128/CMR.10.1.67; MATHIEU JJ, 1994, ARCH INTERN MED, V154, P1713, DOI 10.1001/archinte.154.15.1713; McCrae T., 1914, PRINCIPLES PRACTICE; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mermin JH, 1999, J INFECT DIS, V179, P1416, DOI 10.1086/314766; MISTCHENKO AS, 1992, EPIDEMIOL INFECT, V109, P539, DOI 10.1017/S0950268800050524; MITCHELL DK, 1995, J INFECT DIS, V172, P1437, DOI 10.1093/infdis/172.6.1437; MOHLEBOETANI JC, 1995, AM J PUBLIC HEALTH, V85, P812, DOI 10.2105/AJPH.85.6.812; MUSHER DM, 1973, ARCH INTERN MED, V132, P869, DOI 10.1001/archinte.132.6.869; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; Naficy AB, 2000, J INFECT DIS, V182, P685, DOI 10.1086/315763; Newcomb S, 1997, MIL MED, V162, P783, DOI 10.1093/milmed/162.12.783; OISHI I, 1994, J INFECT DIS, V170, P439, DOI 10.1093/infdis/170.2.439; OJEH CK, 1995, MOL CELL PROBE, V9, P341, DOI 10.1016/S0890-8508(95)91652-0; Okhuysen PC, 2001, CLIN INFECT DIS, V33, P110, DOI 10.1086/320894; OOSTEROM J, 1984, J HYG-CAMBRIDGE, V93, P325, DOI 10.1017/S002217240006486X; Oppermann H, 2001, INT J HYG ENVIR HEAL, V203, P369, DOI 10.1078/1438-4639-4410044; OVERTURF GD, 1994, CLIN INFECT DIS, V18, P764, DOI 10.1093/clinids/18.5.764; Owen R. L., 1984, Giardiaand giardiasis - biology, pathogenesis, and epidemiology., P329; PARRINO TA, 1977, NEW ENGL J MED, V297, P86, DOI 10.1056/NEJM197707142970204; PAVIA AT, 1990, J PEDIATR-US, V116, P544, DOI 10.1016/S0022-3476(05)81600-2; PICKERING LK, 1981, J PEDIATR-US, V99, P51, DOI 10.1016/S0022-3476(81)80956-0; PICKERING LK, 1986, REV INFECT DIS, V8, P539; Quiroz ES, 2000, J INFECT DIS, V181, P695, DOI 10.1086/315279; Reller ME, 2003, CLIN INFECT DIS, V37, P141, DOI 10.1086/375590; RICHMOND SJ, 1979, LANCET, V1, P1178; RODRIGUEZ WJ, 1985, J PEDIATR-US, V107, P514, DOI 10.1016/S0022-3476(85)80007-X; RODRIGUEZ WJ, 1987, PEDIATR INFECT DIS J, V6, P170, DOI 10.1097/00006454-198702000-00006; Rowe PC, 1998, J PEDIATR-US, V132, P777, DOI 10.1016/S0022-3476(98)70303-8; ROY SK, 1985, J INFECT DIS, V151, P1138, DOI 10.1093/infdis/151.6.1138; SAWYER LA, 1988, AM J EPIDEMIOL, V127, P1261, DOI 10.1093/oxfordjournals.aje.a114918; SCHREIBER DS, 1973, NEW ENGL J MED, V288, P1318, DOI 10.1056/NEJM197306212882503; SKIRROW MB, 1990, LANCET, V336, P921, DOI 10.1016/0140-6736(90)92282-M; Slutsker L, 1997, ANN INTERN MED, V126, P505, DOI 10.7326/0003-4819-126-7-199704010-00002; SMITH D. T., 1960, ZINSSER MICROBIOLOGY; SPIKA JS, 1986, J PEDIATR-US, V109, P287, DOI 10.1016/S0022-3476(86)80386-9; STEERE AC, 1975, ANN INTERN MED, V83, P683, DOI 10.7326/0003-4819-83-5-683; STEKETEE RW, 1989, AM J PUBLIC HEALTH, V79, P485, DOI 10.2105/AJPH.79.4.485; Thurston-Enriquez JA, 2003, APPL ENVIRON MICROB, V69, P3979, DOI 10.1128/AEM.69.7.3979-3985.2003; VAN R, 1992, J PEDIATR-US, V120, P516, DOI 10.1016/S0022-3476(05)82477-1; VESIKARI T, 1985, PEDIATR INFECT DIS J, V4, P622, DOI 10.1097/00006454-198511000-00005; Vizzi E, 1996, RES VIROLOGY, V147, P333, DOI 10.1016/S0923-2516(97)85125-4; Vreden SGS, 2000, CLIN INFECT DIS, V31, P1101, DOI 10.1086/318153; Waters V, 2000, PEDIATR INFECT DIS J, V19, P843, DOI 10.1097/00006454-200009000-00007; WENMAN WM, 1979, NEW ENGL J MED, V301, P303, DOI 10.1056/NEJM197908093010604; WHARTON M, 1990, J INFECT DIS, V162, P1324, DOI 10.1093/infdis/162.6.1324; Wolfs TFW, 2001, CLIN INFECT DIS, V32, pE97, DOI 10.1086/319224; 1972, MMWR MORB MORTAL WKL, V21, P290; 2001, MMWR MORB MORTAL WKL, V50, P922; 2003, MMWR MORB MORTAL WKL, V52, P113	131	109	114	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2004	351	23					2417	2427		10.1056/NEJMra041837	http://dx.doi.org/10.1056/NEJMra041837			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875OC	15575058				2022-12-28	WOS:000225429000011
J	Darby, S; Hill, D; Auvinen, A; Barrios-Dios, JM; Baysson, H; Bochicchio, F; Deo, H; Falk, R; Forastiere, F; Hakama, M; Heid, I; Kreienbrock, L; Kreuzer, M; Lagarde, F; Makelainen, I; Muirhead, C; Oberaigner, W; Pershagen, G; Ruano-Ravina, A; Ruosteenoja, E; Rosario, AS; Tirmarche, M; Tomasek, L; Whitley, E; Wichmann, HE; Doll, R				Darby, S; Hill, D; Auvinen, A; Barrios-Dios, JM; Baysson, H; Bochicchio, F; Deo, H; Falk, R; Forastiere, F; Hakama, M; Heid, I; Kreienbrock, L; Kreuzer, M; Lagarde, F; Makelainen, I; Muirhead, C; Oberaigner, W; Pershagen, G; Ruano-Ravina, A; Ruosteenoja, E; Rosario, AS; Tirmarche, M; Tomasek, L; Whitley, E; Wichmann, HE; Doll, R			Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESIDENTIAL RADON; INDOOR RADON; EXPOSURE; MORTALITY	Objective To determine the risk of lung cancer associated with exposure at home to the radioactive disintegration products of naturally Occurring radon gas. Design Collaborative analysis of individual data from 13 case-control studies of residential radon and lung cancer. Setting Nine European countries. Subjects 7148 cases Of lung cancer and 14 208 controls. Main outcome measures Relative risks of lung cancer and radon gas concentrations in homes inhabited during the previous 5-34 years measured in becquerels (radon disintegrations per second) per cubic incite (Bq/m(3)) Of household air. Results The mean measured radon concentration in homes of people in tire control group was 97 Bq/m(3), with 11% measuring > 200 and 4% measuring > 400 Bq/m(3). For cases of lung cancer the mean concentration was 104 Bq/m(3). The risk of lung cancer increased by 8.4% (95% confidence interval 3.0% to 15.8%) per 100 Bq/m(3) increase in measured radon (P = 0.0007). This corresponds to an increase of 16% (5% to 31%) per 100 Bq/m(3) increase in usual radon-that is, after correction for the dilution caused by random uncertainties in measuring radon concentrations. The dose-response relation seemed to be linear with no threshold and remained significant (P=0.04) in analyses limited to individuals from homes with measured radon < 200 Bq/m(3). The proportionate excess risk did not differ significantly with study, age, sex, or smoking. In the absence of other causes of death, the absolute risks of lung cancer by age 75 years at usual radon concentrations of 0, 100, and 400 Bq/m(3) would be about 0.4%, 0.5%, and 0.7%, respectively, for lifelong non-smokers, and about 25 times greater (10%, 12%, and 16%) for cigarette smokers. Conclusions Collectively, though not separately, these studies show appreciable hazards from residential radon, particularly for smokers and recent ex-smokers, and indicate that it is responsible for about 2% of all deaths from cancer in Europe.	Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England; Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland; Univ Santiago de Compostela, Area Prevent Med & Publ Hlth, Santiago De Compostela, Spain; Inst Radioprotect & Surete Nucl, Direct Radioprotect Homme, Serv Radiobiol & Epidemiol, Fontenay Aux Roses, France; Italian Natl Inst Hlth, Dept Technol & Hlth, Unit Radioact & Hlth Effects, Rome, Italy; Univ Reading, Dept Appl Stat, Reading RG6 2AL, Berks, England; Swedish Radiat Protect Author, SE-17116 Stockholm, Sweden; Rome E Hlth Author, Dept Epidemiol, Rome, Italy; Finnish Canc Registry, FIN-00170 Helsinki, Finland; GSF, Res Ctr Environm & Hlth, Inst Epidemiol, Neuherberg, Germany; Univ Vet Med, Inst Biometry Epidemiol & Informat Proc, Hannover, Germany; Fed Off Radiat Protect, Dept Radiat Protect & Hlth, Neuherberg, Germany; Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; STUK Radiat & Nucl Safety Author, Helsinki, Finland; Natl Radiol Protect Board, Didcot OX11 0RQ, Oxon, England; Tumorregister Tirol, Innsbruck, Austria; Natl Radiat Protect Inst, Epidemiol Unit, Prague, Czech Republic; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; Tampere University; Universidade de Santiago de Compostela; Istituto Superiore di Sanita (ISS); University of Reading; Finnish Cancer Registry; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Veterinary Medicine Hannover, Foundation; Karolinska Institutet; Radiation & Nuclear Safety Authority (STUK); National Radiation Protection Institute; State Office for Nuclear Safety - Czech Republic; University of Bristol	Darby, S (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.	sarah.darby@ctsu.ox.ac.uk	Ruano-Ravina, Alberto/M-5705-2018; Wichmann, Heinz Erich/AAA-5695-2022; Auvinen, Anssi/AAL-2111-2020; Auvinen, Anssi/AAD-9311-2020; BOCHICCHIO, FRANCESCO/E-2134-2015; Genetic Epidemiology, Innsbruck Med.Univ./C-2095-2008; Forastiere, Francesco/J-9067-2016	Ruano-Ravina, Alberto/0000-0001-9927-7453; Auvinen, Anssi/0000-0003-1125-4818; Forastiere, Francesco/0000-0002-9162-5684; Muirhead, Colin/0000-0001-5394-1267; BARROS-DIOS, JUAN MIGUEL/0000-0002-8632-6540; Pershagen, Goran/0000-0002-9701-1130; Baysson, Helene/0000-0003-4676-4500				Auvinen A, 1996, J NATL CANCER I, V88, P966, DOI 10.1093/jnci/88.14.966; Auvinen A, 1998, JNCI-J NATL CANCER I, V90, P401; Barros-Dios JM, 2002, AM J EPIDEMIOL, V156, P548, DOI 10.1093/aje/kwf070; Baysson H, 2004, EPIDEMIOLOGY, V15, P709, DOI 10.1097/01.ede.0000142150.60556.b8; BOCHICCHIO F, IN PRESS INT J CANC; Darby S, 1998, BRIT J CANCER, V78, P394, DOI 10.1038/bjc.1998.506; DARBY S, IN PRESS SCAND J WOR; HEID IM, IN PRESS J TOXICOL E; *INT AG RES CANC, 2000, IARC MON EV CARC R 2, V78; International Agency for Research on Cancer, 2001, IARC MON EV CARC R 2, V78; KREWSKI D, IN PRESS EPIDEMIOLOG; Lagarde F, 1997, HEALTH PHYS, V72, P269, DOI 10.1097/00004032-199702000-00010; Lagarde F, 2001, EPIDEMIOLOGY, V12, P396, DOI 10.1097/00001648-200107000-00009; Lubin JH, 2004, INT J CANCER, V109, P132, DOI 10.1002/ijc.11683; Lubin JH, 1997, RADIAT RES, V147, P126, DOI 10.2307/3579412; National Research Council (US), 1999, COMM HLTH RISKS EXP; Oberaigner W., 2002, RADON LUNGENKREBS BE; Pavia M, 2003, B WORLD HEALTH ORGAN, V81, P732; PERSHAGEN G, 1992, HEALTH PHYS, V63, P179, DOI 10.1097/00004032-199208000-00004; PERSHAGEN G, 1994, NEW ENGL J MED, V330, P159, DOI 10.1056/NEJM199401203300302; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Puskin JS, 2003, HEALTH PHYS, V84, P526, DOI 10.1097/00004032-200304000-00012; Ruosteenoja E, 1996, HEALTH PHYS, V71, P185, DOI 10.1097/00004032-199608000-00009; Tomasek L, 2001, Cent Eur J Public Health, V9, P150; *UN SCI COMM EFF A, 2000, SOURC EFF ION RAD UN, V1; Wichmann HE, 2005, HEALTH PHYS, V88, P71, DOI 10.1097/01.HP.0000142497.31627.86; WICHMANN HE, IN PRESS HLTH PHYS	27	1008	1062	6	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2005	330	7485					223	226		10.1136/bmj.38308.477650.63	http://dx.doi.org/10.1136/bmj.38308.477650.63			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894GR	15613366	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000226779400017
J	Hug, C; Lodish, HF				Hug, C; Lodish, HF			Visfatin: A new adipokine	SCIENCE			English	Editorial Material							ADIPOSE-TISSUE; ENDOCRINE		Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Childrens Hosp, Div Resp Dis, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital	Hug, C (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.							Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; MOLLER DE, IN PRESS ANN REV MED; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Strowski MZ, 2004, ENDOCRINOLOGY, V145, P5259, DOI 10.1210/en.2004-0610; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974	10	151	182	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					366	367		10.1126/science.1106933	http://dx.doi.org/10.1126/science.1106933			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15604359				2022-12-28	WOS:000226492300028
J	Powers, T				Powers, T			Ribosome biogenesis: Giant steps for a giant problem	CELL			English	Editorial Material							TOR-SIGNALING PATHWAY; YEAST; GROWTH	In this issue of Cell, the Hall group describes how the rapamycin-sensitive TOR signaling network controls ribosomal protein (RP) gene expression via the Forkhead-like transcription factor FHL1 in budding yeast (Martin et al., 2004). These findings represent a crucial advance in our understanding of the mechanism by which TOR regulates ribosome biogenesis in response to environmental cues.	Univ Calif Davis, Sect Mol & Cellular Biol, Div Biol Sci, Davis, CA 95616 USA; Univ Calif Davis, Ctr Genet & Dev, Div Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Powers, T (corresponding author), Univ Calif Davis, Sect Mol & Cellular Biol, Div Biol Sci, Davis, CA 95616 USA.							Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463	10	11	11	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2004	119	7					901	902		10.1016/j.cell.2004.12.011	http://dx.doi.org/10.1016/j.cell.2004.12.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620347	Bronze			2022-12-28	WOS:000226109700001
J	Norris, DR; Marra, PP; Montgomerie, R; Kyser, TK; Ratcliffe, LM				Norris, DR; Marra, PP; Montgomerie, R; Kyser, TK; Ratcliffe, LM			Reproductive effort molting latitude, and feather color in a migratory songbird	SCIENCE			English	Article							ISOTOPES; GROUNDS; WINTER; BIRD	Toward the end of the breeding season, migratory songbirds face crucial tradeoffs between the timing of reproduction, molt, and migration. Using stable hydrogen isotopes, we show that male American redstarts investing in high levels of reproduction late in the season adopt a unique strategy of combining molt and migration. Tail feathers molted during migration also reflect less orange-red light, indicating reduced carotenoid concentration. Thus, we show how reproduction in a migratory animal can influence both life history strategies (location of molt) and social signals (feather color) during subsequent periods of the annual cycle.	Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Geol Sci & Engn, Kingston, ON K7L 3N6, Canada; Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; Univ British Columbia, Ctr Appl Conservat Res, Forest Sci Ctr, Vancouver, BC V6T 1Z4, Canada	Queens University - Canada; Queens University - Canada; Smithsonian Institution; Smithsonian Environmental Research Center; University of British Columbia	Norris, DR (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	ryann@biology.queensu.ca	Bond, Alexander L/A-3786-2010; Norris, Ryan/F-4720-2011; Montgomerie, Robert D/C-6516-2008	Norris, Ryan/0000-0003-4874-1425; Montgomerie, Robert D/0000-0003-4701-4525; Kyser, Kurt/0000-0001-9667-4103; Marra, Peter/0000-0002-0508-7577				Graves GR, 2002, P NATL ACAD SCI USA, V99, P8096, DOI 10.1073/pnas.082240899; Hill G. E., 2002, RED BIRD BROWN BAG F; Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; HOLMES RT, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P563; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Saks L, 2003, FUNCT ECOL, V17, P555, DOI 10.1046/j.1365-2435.2003.00765.x; Sherry Thomas W., 1997, Birds of North America, V277, P1; Wassenaar LI, 2001, ENVIRON SCI TECHNOL, V35, P1845, DOI 10.1021/es0010204; [No title captured]	13	99	102	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2249	2250		10.1126/science.1103542	http://dx.doi.org/10.1126/science.1103542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618516				2022-12-28	WOS:000225950000044
J	Haas, J; Creamer, W; Ruiz, A				Haas, J; Creamer, W; Ruiz, A			Dating the Late Archaic occupation of the Norte Chico region in Peru	NATURE			English	Article							AGE CALIBRATION	The Norte Chico region on the coast of Peru north of Lima consists of four adjacent river valleys - Huaura, Supe, Pativilca and Fortaleza - in which archaeologists have been aware of a number work in 2002 and 2003 to determine the dates of occupation of sites in the Fortaleza and Pativilca valleys. Here we present 95 new radiocarbon dates from a sample of 13 of more than 20 large, early sites. These sites share certain basic characteristics, including large-scale monumental architecture, extensive residential architecture and a lack of ceramics. The 95 new dates confirm the emergence and development of a major cultural complex in this region during the Late Archaic period between 3000 and 1800 calibrated calendar years BC. The results help to redefine a broader understanding of the respective roles of agricultural and fishing economies in the beginnings of civilization in South America.	Field Museum, Dept Anthropol, Chicago, IL 60605 USA; No Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA	Field Museum of Natural History (Chicago); Northern Illinois University	Haas, J (corresponding author), Field Museum, Dept Anthropol, Chicago, IL 60605 USA.	jhaas@fieldmuseum.org						BURGER R, 1995, CHAVIN ORIGINS ANDEA, P27; CENTENO RV, 1998, B ARQUEOL, V2, P219; Feldman R. A., 1983, CIVILIZATIONS ANCIEN, P289; Feldman Robert, 1980, THESIS HARVARD U; Haas J, 2001, SCIENCE, V294, P1652; Hass Jonathan., 2004, ANDEAN ARCHAEOLOGY, P35; KOSOK P, 1985, LIFE LAND WATER ANCI, P216; MOSELEY M, 2001, INCAS THEIR ANCESTOR, P99; Moseley M.E., 1975, MARITIME FDN ANDEAN; MOSELEY ME, 1973, AM ANTIQUITY, V38, P452, DOI 10.2307/279151; Shady R. S., 2003, CIUDAD SAGRADA CARAL; Solis RS, 2001, SCIENCE, V292, P723, DOI 10.1126/science.1059519; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; WILLIAMS C, 1972, APUNTES, V1, P1; WILLIAMS C, 1985, EARLY CEREMONIAL ARC, P227; ZECHENTER E, 1988, THESIS UCLA	17	35	37	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1020	1023		10.1038/nature03146	http://dx.doi.org/10.1038/nature03146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616561				2022-12-28	WOS:000225887000040
J	Ran, MS; Chen, EYH				Ran, MS; Chen, EYH			Cognitive enhancement therapy for schizophrenia	LANCET			English	Editorial Material							FAMILY; INTERVENTION; RELAPSE; TRIALS		Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Ran, MS (corresponding author), Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Pokfulam, Hong Kong, Peoples R China.	ranmaosh@yahoo.com	Ran, Maosheng/B-9847-2017	Ran, Maosheng/0000-0001-7343-3729; Chen, Eric/0000-0002-5247-3593				Bell M, 2001, ARCH GEN PSYCHIAT, V58, P763, DOI 10.1001/archpsyc.58.8.763; BILDER RM, 1992, PSYCHOPHARMACOL BULL, V28, P353; Green MF, 1999, SCHIZOPHRENIA BULL, V25, P309, DOI 10.1093/oxfordjournals.schbul.a033380; Hogarty GE, 2004, ARCH GEN PSYCHIAT, V61, P866, DOI 10.1001/archpsyc.61.9.866; Hogarty GE, 1997, AM J PSYCHIAT, V154, P1514, DOI 10.1176/ajp.154.11.1514; Hogarty GE, 1999, SCHIZOPHRENIA BULL, V25, P693, DOI 10.1093/oxfordjournals.schbul.a033411; Leucht S, 2003, AM J PSYCHIAT, V160, P1209, DOI 10.1176/appi.ajp.160.7.1209; Mohamed S, 1999, ARCH GEN PSYCHIAT, V56, P749, DOI 10.1001/archpsyc.56.8.749; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Ran MS, 2003, SOC PSYCH PSYCH EPID, V38, P69, DOI 10.1007/s00127-003-0601-z; Rattok J., 1992, NEUROPSYCHOLOGIA, V6, P395, DOI DOI 10.1037/0894-4105.6.4.395; Rund BR, 1998, SCHIZOPHRENIA BULL, V24, P425, DOI 10.1093/oxfordjournals.schbul.a033337; Schooler NR, 1997, ARCH GEN PSYCHIAT, V54, P453; Spaulding WD, 1999, SCHIZOPHRENIA BULL, V25, P657, DOI 10.1093/oxfordjournals.schbul.a033409; XIANG MG, 1994, BRIT J PSYCHIAT, V165, P544, DOI 10.1192/bjp.165.4.544	15	2	2	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2163	2165		10.1016/S0140-6736(04)17609-5	http://dx.doi.org/10.1016/S0140-6736(04)17609-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610789				2022-12-28	WOS:000225799700009
J	Hoshi, T; Lahiri, S				Hoshi, T; Lahiri, S			Oxygen sensing: It's a gas!	SCIENCE			English	Editorial Material							K-CA CHANNELS; LARGE-CONDUCTANCE; CAROTID-BODY; CELLULAR MECHANISMS; SIGNALING COMPLEX; CARBON-MONOXIDE; BETA-1 SUBUNIT; HYPOXIA; SENSOR; CELLS		Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Hoshi, T (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	hoshi@hoshi.org; lahiri@mail.med.upenn.edu						Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; Lewis A, 2002, J PHYSIOL-LONDON, V540, P771, DOI 10.1113/jphysiol.2001.013888; Liu GX, 2004, EMBO J, V23, P2196, DOI 10.1038/sj.emboj.7600228; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Marshall C, 1996, AM J RESP CELL MOL, V15, P633, DOI 10.1165/ajrcmb.15.5.8918370; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Patel AJ, 2001, EUR RESPIR J, V18, P221, DOI 10.1183/09031936.01.00204001; Perez-Garcia MT, 2001, BIOPHYS J, V80, p206A; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Prabhakar NR, 2000, RESP PHYSIOL, V122, P209, DOI 10.1016/S0034-5687(00)00160-2; Prabhakar NR, 2000, J APPL PHYSIOL, V88, P2287, DOI 10.1152/jappl.2000.88.6.2287; Riesco-Fagundo AM, 2001, CIRC RES, V89, P430, DOI 10.1161/hh1701.095632; ROTHBERG BS, 2004, SCI STKE, pPE16; Roy A, 2004, RESP PHYSIOL NEUROBI, V141, P115, DOI 10.1016/j.resp.2004.03.010; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Soto MA, 2002, AM J PHYSIOL-CELL PH, V282, pC461, DOI 10.1152/ajpcell.00167.2001; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Tang XD, 2004, NAT STRUCT MOL BIOL, V11, P171, DOI 10.1038/nsmb725; Wang R, 1997, J BIOL CHEM, V272, P8222, DOI 10.1074/jbc.272.13.8222; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Xi Q, 2004, AM J PHYSIOL-HEART C, V286, pH610, DOI 10.1152/ajpheart.00782.2003; Xia XM, 2004, J NEUROSCI, V24, P5585, DOI 10.1523/JNEUROSCI.1296-04.2004	28	28	31	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2050	2051		10.1126/science.1107069	http://dx.doi.org/10.1126/science.1107069			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604396				2022-12-28	WOS:000225841000048
J	Itatani, J; Levesque, J; Zeidler, D; Niikura, H; Pepin, H; Kieffer, JC; Corkum, PB; Villeneuve, DM				Itatani, J; Levesque, J; Zeidler, D; Niikura, H; Pepin, H; Kieffer, JC; Corkum, PB; Villeneuve, DM			Tomographic imaging of molecular orbitals	NATURE			English	Article							HIGH-HARMONIC-GENERATION; LASER-PULSES; NEUTRAL MOLECULES; IONIZATION; ALIGNMENT; FIELDS; DYNAMICS; CYCLE	Single-electron wavefunctions, or orbitals, are the mathematical constructs used to describe the multi-electron wavefunction of molecules. Because the highest-lying orbitals are responsible for chemical properties, they are of particular interest. To observe these orbitals change as bonds are formed and broken is to observe the essence of chemistry. Yet single orbitals are difficult to observe experimentally, and until now, this has been impossible on the timescale of chemical reactions. Here we demonstrate that the full three-dimensional structure of a single orbital can be imaged by a seemingly unlikely technique, using high harmonics generated from intense femtosecond laser pulses focused on aligned molecules. Applying this approach to a series of molecular alignments, we accomplish a tomographic reconstruction of the highest occupied molecular orbital of N-2. The method also allows us to follow the attosecond dynamics of an electron wave packet.	Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada; Univ Ottawa, Ottawa, ON K1N 6N5, Canada; INRS Energie & Mat, Varennes, PQ J3X 1S2, Canada; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	National Research Council Canada; University of Ottawa; University of Quebec; Institut national de la recherche scientifique (INRS); Japan Science & Technology Agency (JST)	Villeneuve, DM (corresponding author), Natl Res Council Canada, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	david.villeneuve@nrc.ca	Itatani, Jiro/A-3105-2008; NIIKURA, HIROMICHI/C-3838-2012; Villeneuve, David M/I-4140-2012	Itatani, Jiro/0000-0002-4023-7489; Villeneuve, David M/0000-0002-2810-3648; Corkum, Paul/0000-0003-3394-5572				BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Brion CE, 2001, CHEM PHYS, V270, P13, DOI 10.1016/S0301-0104(01)00385-8; BURNETT K, 1992, PHYS REV A, V45, P3347, DOI 10.1103/PhysRevA.45.3347; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; de Nalda R, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.031804; Delone N. B., 2000, MULTIPHOTON PROCESSE; DIETRICH P, 1994, PHYS REV A, V50, pR3585, DOI 10.1103/PhysRevA.50.R3585; Dooley PW, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.023406; DUNN TJ, 1995, PHYS REV LETT, V74, P884, DOI 10.1103/PhysRevLett.74.884; Hankin SM, 2000, PHYS REV LETT, V84, P5082, DOI 10.1103/PhysRevLett.84.5082; Hay N, 2003, J MOD OPTIC, V50, P561, DOI 10.1080/09500340210152666; Hay N, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.053805; Kak A. C., 2001, PRINCIPLES COMPUTERI; Larsen JJ, 2000, PHYS REV LETT, V85, P2470, DOI 10.1103/PhysRevLett.85.2470; Lee KF, 2004, J PHYS B-AT MOL OPT, V37, pL43, DOI 10.1088/0953-4075/37/3/L02; Lein M, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.023819; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; LIANG Y, 1994, J PHYS B-AT MOL OPT, V27, P5119, DOI 10.1088/0953-4075/27/20/024; LINUS CP, 1960, NATURE CHEM BOND STR; Litvinyuk IV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.233003; Mairesse Y, 2003, SCIENCE, V302, P1540, DOI 10.1126/science.1090277; Mulliken RS, 1932, PHYS REV, V41, P49, DOI 10.1103/PhysRev.41.49; Niikura H, 2002, NATURE, V417, P917, DOI 10.1038/nature00787; Otobe T, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.053404; Parr R. G., 1989, DENSITY FUNCTIONAL T; Rosca-Pruna F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.153902; Sakai H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.083001; Sakai H, 1999, J CHEM PHYS, V110, P10235, DOI 10.1063/1.478039; SAKAI H, 1995, APPL PHYS B-LASERS O, V61, P493, DOI 10.1007/BF01081279; Sanpera A, 1998, J PHYS B-AT MOL OPT, V31, pL841, DOI 10.1088/0953-4075/31/19/012; Skovsen E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090406; Spanner M, 2004, J PHYS B-AT MOL OPT, V37, pL243, DOI 10.1088/0953-4075/37/12/L02; Stapelfeldt H, 1997, PHYS REV LETT, V79, P2787, DOI 10.1103/PhysRevLett.79.2787; Stapelfeldt H, 2003, REV MOD PHYS, V75, P543, DOI 10.1103/RevModPhys.75.543; Tong XM, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.033402; Velotta R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.183901; Yudin GL, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.013409	37	1836	1861	10	342	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2004	432	7019					867	871		10.1038/nature03183	http://dx.doi.org/10.1038/nature03183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602553				2022-12-28	WOS:000225733500044
J	Allen, RL; Bittner-Eddy, PD; Grenvitte-Briggs, LJ; Meitz, JC; Rehmany, AP; Rose, LE; Beynon, JL				Allen, RL; Bittner-Eddy, PD; Grenvitte-Briggs, LJ; Meitz, JC; Rehmany, AP; Rose, LE; Beynon, JL			Host-parasite coevolutionary conflict between Arabidopsis and downy mildew	SCIENCE			English	Article							RICE BLAST RESISTANCE; AVIRULENCE GENE; CLADOSPORIUM-FULVUM; DISEASE RESISTANCE; PERONOSPORA-PARASITICA; PROTEIN; THALIANA; ELICITOR; POLYMORPHISM; INFECTION	Plants are constantly exposed to attack by an array of diverse pathogens but lack a somatically adaptive immune system. In spite of this, natural plant populations do not often suffer destructive disease epidemics. Elucidating how allelic diversity within plant genes that function to detect pathogens (resistance genes) counteracts changing structures of pathogen genes required for host invasion (pathogenicity effectors) is critical to our understanding of the dynamics of natural plant populations. The RPP13 resistance gene is the most polymorphic gene analyzed to date in the model plant Arabidopsis thaliana. Here we report the cloning of the avirulence gene, ATR13, that triggers RPP13-mediated resistance, and we show that it too exhibits extreme levels of amino acid polymorphism. Evidence of diversifying selection visible in both components suggests that the host and pathogen may be locked in a coevolutionary conflict at these loci, where attempts to evade host resistance by the pathogen are matched by the development of new detection capabilities by the host.	HRI Univ Warwick, Warwick CV35 9EF, England; Univ Munich, Dept Evolutionary Biol, D-82152 Planegg Martinsried, Germany	University of Warwick; University of Munich	Beynon, JL (corresponding author), HRI Univ Warwick, Warwick CV35 9EF, England.	jim.beynon@warwick.ac.uk	Grenville-Briggs, Laura J/C-3419-2014; Meitz-Hopkins, Julia/M-3938-2016; Grenville-Briggs, Laura/B-3386-2013	Grenville-Briggs, Laura J/0000-0001-5910-3651; Meitz-Hopkins, Julia/0000-0002-8127-6978; 	Biotechnology and Biological Sciences Research Council [P20029] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ALLEN R, UNPUB; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bittner-Eddy PD, 2003, MOL PLANT PATHOL, V4, P501, DOI 10.1046/J.1364-3703.2003.00194.X; Bittner-Eddy PD, 2000, PLANT J, V21, P177, DOI 10.1046/j.1365-313x.2000.00664.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hahn M, 2001, CURR OPIN PLANT BIOL, V4, P322, DOI 10.1016/S1369-5266(00)00180-1; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jin QL, 2003, MICROBES INFECT, V5, P301, DOI 10.1016/S1286-4579(03)00032-7; Jones DA, 1997, ADV BOT RES, V24, P90, DOI DOI 10.1016/S0065-2296(08)60072-5; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; KEEN NT, 1990, MOL PLANT MICROBE IN, V3, P112, DOI 10.1094/MPMI-3-112; Luderer R, 2002, MOL MICROBIOL, V45, P875, DOI 10.1046/j.1365-2958.2002.03060.x; MAY RM, 1983, COEVOLUTION, P189; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Rose LE, 2004, GENETICS, V166, P1517, DOI 10.1534/genetics.166.3.1517; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; VANKAN JAL, 1991, MOL PLANT MICROBE IN, V4, P52, DOI 10.1094/MPMI-4-052; Westerink N, 2002, MOL PLANT MICROBE IN, V15, P1219, DOI 10.1094/MPMI.2002.15.12.1219	26	324	343	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1957	1960		10.1126/science.1104022	http://dx.doi.org/10.1126/science.1104022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591208				2022-12-28	WOS:000225695600051
J	Mollica, RF; Cardozo, BL; Osofsky, HJ; Raphael, B; Ager, A; Salama, P				Mollica, RF; Cardozo, BL; Osofsky, HJ; Raphael, B; Ager, A; Salama, P			Mental health in complex emergencies	LANCET			English	Review							POSTTRAUMATIC-STRESS-DISORDER; EYE-MOVEMENT DESENSITIZATION; NATIONAL COMORBIDITY SURVEY; PUBLIC-HEALTH; POLITICAL VIOLENCE; FUNCTIONAL HEALTH; BEHAVIOR PROBLEMS; BOSNIAN REFUGEES; BORDER CAMPS; PRIMARY-CARE	Mental health is becoming a central issue for public health complex emergencies. In this review we present a culturally valid mental health action plan based on scientific evidence that is capable of addressing the mental health effects of complex emergencies. A mental health system of primary care providers, traditional healers, and relief workers, if properly trained and supported, can provide cost-effective, good mental health care. This plan emphasises the need for standardised approaches to the assessment, monitoring, and outcome of all related activities. Crucial to the improvement of outcomes during crises and the availability to future emergencies of lessons learned from earlier crises is the regular dissemination of the results achieved with the action plan. A research agenda is included that should, in time, fill knowledge gaps and reduce the negative mental health effects of complex emergencies.	Massachusetts Gen Hosp, Harvard Program Refugee Trauma, Cambridge, MA USA; Ctr Dis Control & Prevent, Int Emergency & Reguee Hlth Branch, Atlanta, GA USA; Louisiana State Univ, Hlth Sci Ctr, Baton Rouge, LA 70803 USA; New S Wales Hlth Dept, Ctr Mental Hlth, Sydney, NSW, Australia; Ctr Int Hlth Studies, Edinburgh, Midlothian, Scotland; UNICEF, Kabul, Afghanistan	Harvard University; Massachusetts General Hospital; Centers for Disease Control & Prevention - USA; Louisiana State University System; Louisiana State University; Louisiana State University Health Sciences Center at Shreveport; Queen Margaret University	Mollica, RF (corresponding author), Harvard Program Refugee Trauma, 22 Putnam Ave 2nd Floor, Cambridge, MA 02139 USA.	rmollica@partners.org		Ager, Alastair/0000-0002-9474-3563				ACIERNO R, 1994, CLIN PSYCHOL REV, V14, P287, DOI 10.1016/0272-7358(94)90026-4; Ager A, 2002, LANCET, V360, pS43, DOI 10.1016/S0140-6736(02)11817-4; Ager A, 2000, PSYCHOSOCIAL WELLNES, P24; AGER A, 2000, CULTIVATING HLTH APP; Ager A., 1997, DEV PRACTICE, V7, P402, DOI DOI 10.1080/09614529754198; Agger I., 1996, PSYCHO SOCIAL ASSIST; ALEISSA YA, 1995, SOC SCI MED, V41, P1033, DOI 10.1016/0277-9536(94)00414-O; [Anonymous], 1996, GLOBAL BURDEN DIS CO; *ANT FDN, 2002, 2 C STRESS HUM WORK; ARMFIELD F, 1994, MIL MED, V159, P739, DOI 10.1093/milmed/159.12.739; ARROYO W, 1985, POSTTRAUMATIC STRESS, P103; Baker A, 1999, CLIN PSYCHOL REV, V19, P935, DOI 10.1016/S0272-7358(99)00004-5; Banatvala N, 2000, BMJ-BRIT MED J, V321, P101, DOI 10.1136/bmj.321.7253.101; BATZION N, 1993, PSYCHOLOGICAL EFFECTS OF WAR AND VIOLENCE ON CHILDREN, P143; Berry J.W., 1992, CROSS CULTURAL PSYCH; BISSON J, 2002, CLIN EVID, V8, P1010; Bramsen I, 1999, ACTA PSYCHIAT SCAND, V100, P350; Bryant RA, 1999, AM J PSYCHIAT, V156, P1780; Bryant RA, 1998, J CONSULT CLIN PSYCH, V66, P862, DOI 10.1037/0022-006X.66.5.862; BURKLE FM, 1999, BMJ-BRIT MED J, V322, P1; *CA PAN ETHN HLTH, 2001, DIV PAT DISP EXP US; Cairns E, 1996, CHILD DEV, V67, P129, DOI 10.2307/1131691; Cairns E., 1996, CHILDREN POLITICAL V; CAMPBELL EJM, 1979, BMJ-BRIT MED J, V2, P757, DOI 10.1136/bmj.2.6193.757; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Cardozo BL, 2004, SOC SCI MED, V58, P2637, DOI 10.1016/j.socscimed.2003.09.024; Cardozo BL, 2003, J TRAUMA STRESS, V16, P351, DOI 10.1023/A:1024413918346; CARDOZO BL, 2002, SHARING FRONT LINE B, P242; *CCSDPT, 1988, ANN C P BANGK THAIL; CHIMIENTI G, 1989, SOC PSYCH PSYCH EPID, V24, P282, DOI 10.1007/BF01788030; CICCHETTI D, 1997, ROCHESTER S DEV PSYC, V8; Cohen A, 2001, EFF MENT HLTH SERV P; Colletta NJ., 2000, VIOLENT CONFLICT TRA; CROSS T, 1991, CULTURALLY COMPETENT; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Dybdahl R, 2001, CHILD DEV, V72, P1214, DOI 10.1111/1467-8624.00343; ENGELHARDT HT, 1976, J MED PHILOS, V1, P256, DOI 10.1093/jmp/1.3.256; FLAHERTY JA, 1988, J NERV MENT DIS, V176, P257; Flynn Brian W, 1999, HUMANITARIAN CRISES, P97; Foa EB, 2000, J TRAUMA STRESS, V13, P539, DOI 10.1023/A:1007802031411; FORTIER JP, 1999, CULTURAL LINGUISTICS; Garbarino J, 1996, CHILD DEV, V67, P33, DOI 10.1111/j.1467-8624.1996.tb01717.x; GEDDES J, 2002, CLIN EVID, V8, P951; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; HENDERSON DC, IN PRESS J NERV MENT; HIEGEL JP, 1994, AMIDST PERIL PAIN ME; HJERN A, 1991, CHILD ABUSE NEGLECT, V15, P239, DOI 10.1016/0145-2134(91)90068-O; Hollifield M, 2002, JAMA-J AM MED ASSOC, V288, P611, DOI 10.1001/jama.288.5.611; HOLZMAN SE, 1998, ROLE WORLD BANK POST; HUBBARD J, 1995, J AM ACAD CHILD PSY, V34, P1167, DOI 10.1097/00004583-199509000-00014; Iacopino V, 2001, AM J PUBLIC HEALTH, V91, P2013, DOI 10.2105/AJPH.91.12.2013; *INT FED RED CROSS, 1996, COD COND INT RED CRO; JONES L, 1995, BRIT MED J, V310, P1052, DOI 10.1136/bmj.310.6986.1052; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kleinman A., 1981, PATIENTS HEALERS CON; Kulka RA., 1988, NATL VIETNAM VETERAN; KUTEROVAC G, 1994, BRIT J MED PSYCHOL, V67, P363, DOI 10.1111/j.2044-8341.1994.tb01804.x; Laor N, 1996, ARCH GEN PSYCHIAT, V53, P416, DOI 10.1001/archpsyc.1996.01830050052008; Last M, 2000, Med Confl Surviv, V16, P370, DOI 10.1080/13623690008409537; LAVELLE J, 1996, HARVARD GUIDE KHMER; Leaning J, 2001, LANCET, V357, P1432, DOI 10.1016/S0140-6736(00)04572-4; Loga S, 1999, Med Arh, V53, P139; MCCLOSKEY LA, 1995, J COMMUNITY PSYCHOL, V23, P95, DOI 10.1002/1520-6629(199504)23:2<95::AID-JCOP2290230202>3.0.CO;2-A; MCDONALD L, 2002, 7 TUFTS U FEINST INT; MILGRAM RM, 1976, J PSYCHOL, V94, P107, DOI 10.1080/00223980.1976.9921403; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Mollica RF, 1997, J AM ACAD CHILD PSY, V36, P1098, DOI 10.1097/00004583-199708000-00017; Mollica RF, 2000, SCI AM, V282, P54, DOI 10.1038/scientificamerican0600-54; Mollica RF, 1996, MED J AUSTRALIA, V165, P594, DOI 10.5694/j.1326-5377.1996.tb138657.x; Mollica RF, 2002, J NERV MENT DIS, V190, P158, DOI 10.1097/00005053-200203000-00004; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; Mollica RF, 2001, JAMA-J AM MED ASSOC, V285, P1213, DOI 10.1001/jama.285.9.1213; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; MOLLICA RF, 2001, OXFORD TXB PSYCHIAT, P1591; MOLLICA RF, 1999, HUMANITARIAN EMERGEN, P125; MOLLICA RF, 1998, PATHWAY HEALING; MOLLICA RF, 1989, COMMUNITY CONFINEMEN; MOLLICA RF, 1989, TURNING POINT KHMER; Mollica RH, 2001, JAMA-J AM MED ASSOC, V286, P546, DOI 10.1001/jama.286.5.546; Mollica Richard F, 1988, POSTTRAUMATIC THERAP; MOOREN GTM, 2003, J CLIN PSYCHOL, V59, P1; NADER K, 1993, PSYCHOLOGICAL EFFECTS OF WAR AND VIOLENCE ON CHILDREN, P181; National Institute of Mental Health, 2002, NIH PUBL, V025138; Neugebauer R, 1997, AM J PUBLIC HEALTH, V87, P726, DOI 10.2105/AJPH.87.5.726; *NSW HLTH NSW I PS, 2000, DIS MENT HLTH RESP H; Office of the Surgeon General, 2019, SURG GEN ADV MAR US; *OMB PROJ WORK GRO, 1998, OMB HUM ASS; OSWALT R, 1993, PSYCHOL REP, V73, P99, DOI 10.2466/pr0.1993.73.1.99; OSWEI T, 1961, SCI CHANGE, P629; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Paardekooper B, 1999, J CHILD PSYCHOL PSYC, V40, P529, DOI 10.1017/S002196309900390X; Pinderhughes, 1989, UNDERSTANDING RACE E; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; PUTNAM RD, 1993, AM PROSPECT, V13, P36; Roberts LW, 2002, AM J PSYCHIAT, V159, P705, DOI 10.1176/appi.ajp.159.5.705; Robertson DW, 2002, LANCET, V360, P330, DOI 10.1016/S0140-6736(02)09558-2; Robins L.N., 1991, PSYCHIAT DISORDERS A; Rookers P., 2000, PERCEPTION THEORY DE; Rosen GM, 1999, J ANXIETY DISORD, V13, P173, DOI 10.1016/S0887-6185(98)00046-2; Rost K, 2002, BMJ-BRIT MED J, V325, P934, DOI 10.1136/bmj.325.7370.934; Sack WH, 1996, CHILD DEV, V67, P107, DOI 10.2307/1131689; SACK WH, 1993, J AM ACAD CHILD PSY, V32, P431, DOI 10.1097/00004583-199303000-00027; SACK WH, 1995, J AM ACAD CHILD PSY, V34, P1160, DOI 10.1097/00004583-199509000-00013; SAIGH PA, 1989, J ABNORM PSYCHOL, V98, P189, DOI 10.1037/0021-843X.98.2.189; Savin Dan, 1996, Journal of the American Academy of Child and Adolescent Psychiatry, V35, P384; SCHWARZWALD J, 1993, J ABNORM PSYCHOL, V102, P404, DOI 10.1037/0021-843X.102.3.404; Shaffer D, 1996, J AM ACAD CHILD PSY, V35, P865, DOI 10.1097/00004583-199607000-00012; Silove D, 2000, LANCET, V355, P1548, DOI 10.1016/S0140-6736(00)02177-2; Silove D, 1999, J NERV MENT DIS, V187, P200, DOI 10.1097/00005053-199904000-00002; Silove D, 2000, CURR OPIN PSYCHIATR, V13, P231, DOI 10.1097/00001504-200003000-00016; Stein B, 1999, SOC PSYCH PSYCH EPID, V34, P464, DOI 10.1007/s001270050221; Sue S, 1998, AM PSYCHOL, V53, P440, DOI 10.1037/0003-066X.53.4.440; Summerfield D, 1999, SOC SCI MED, V48, P1449, DOI 10.1016/S0277-9536(98)00450-X; SWISS S, 1993, JAMA-J AM MED ASSOC, V270, P612, DOI 10.1001/jama.270.5.612; Thabet AZ, 2000, CHILD ABUSE NEGLECT, V24, P291, DOI 10.1016/S0145-2134(99)00127-1; The Sphere Project, 2000, HUM CHART MIN STAND; Toole M, 2002, LANCET, V360, P869, DOI 10.1016/S0140-6736(02)09959-2; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; *UNESCO, 2001, THEM STUD WORLD ED F; *UNHCR, 2001, EV POL AN UN HLTH CO; *UNHCR, 1996, COMM SERV INTR; United Nations, 1948, UN DECL HUM RIGHTS; US Department of Health and Human Services, 2001, MENT HLTH CULT RAC E; van Pietersom T., 2002, SHARING FRONT LINE B, P194; Waldman RJ, 2001, LANCET, V357, P1427, DOI 10.1016/S0140-6736(00)04568-2; Watters C, 2001, SOC SCI MED, V52, P1709, DOI 10.1016/S0277-9536(00)00284-7; WEINBERG J, 1995, SOC SCI MED, V40, P1663, DOI 10.1016/0277-9536(95)00022-Y; WEINE S, 1995, J AM ACAD CHILD PSY, V34, P1153, DOI 10.1097/00004583-199509000-00012; *WHO, 2003, MENT HLTH EM MENT SO; WHO, 2001, WORLD HLTH REPORT 20; *WHO, 1978, ALM AT 1978 PRIM HLT; *WHO UNHCR, 1996, MENT HLTH REF; Willis GB, 1998, J NERV MENT DIS, V186, P283, DOI 10.1097/00005053-199805000-00004; World Health Organization, 2001, TRAD MED TRAD MED; World Health Organization, 1990, INTR MENT HLTH COMP; World Health Organization (WHO), 2001, INT CLASS FUNCT DIS; Yehuda R, 1998, AM J PSYCHIAT, V155, P1163, DOI 10.1176/ajp.155.9.1163; ZIVCIC I, 1993, J AM ACAD CHILD PSY, V32, P709, DOI 10.1097/00004583-199307000-00002; 1997, C P NAIR; 1995, LANCET, V345, P529	145	193	197	1	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2004	364	9450					2058	2067		10.1016/S0140-6736(04)17519-3	http://dx.doi.org/10.1016/S0140-6736(04)17519-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	876KM	15582064				2022-12-28	WOS:000225495700030
J	Mees, A; Klar, T; Gnau, P; Hennecke, U; Eker, APM; Carell, T; Essen, LO				Mees, A; Klar, T; Gnau, P; Hennecke, U; Eker, APM; Carell, T; Essen, LO			Crystal structure of a photolyase bound to a CPD-like DNA lesion after in situ repair	SCIENCE			English	Article							CATALYTIC COFACTOR FADH(-); ELECTRON-TRANSFER; THYMINE DIMERS; MECHANISM; ENZYME; MODEL; RECOGNITION; SUBSTRATE; DAMAGE	DNA photolyases use light energy to repair DNA that comprises ultrarviolet-induced lesions such as the cis-syn cyclobutane pyrimidine dimers (CPDs). Here we report the crystal structure of a DNA photolyase bound to duplex DNA that is bent by 50degrees and comprises a synthetic CPD lesion. This CPD lesion is flipped into the active site and split there into two thymines by synchrotron radiation at 100 K. Although photolyases catalyze blue light-driven CPD cleavage only above 200 K, this structure apparently mimics a structural substate during light-driven DNA repair in which back-flipping of the thymines into duplex DNA has not yet taken place.	Univ Marburg, Dept Chem, D-35032 Marburg, Germany; Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany; Erasmus Univ, Dept Cell Biol & Genet, Med Genet Centrum, Med Ctr, NL-3000 DR Rotterdam, Netherlands	Philipps University Marburg; University of Munich; Erasmus University Rotterdam; Erasmus MC	Carell, T (corresponding author), Univ Marburg, Dept Chem, Hans Meerwin Str, D-35032 Marburg, Germany.	thomas.carell@cup.uni-muenchen.de; essen@chemie.uni-marburg.de	Carell, Thomas/G-4799-2012; Essen, Lars-Oliver/L-3862-2016; Hennecke, Ulrich/A-7723-2010	Carell, Thomas/0000-0001-7898-2831; Essen, Lars-Oliver/0000-0003-4272-4026; Hennecke, Ulrich/0000-0002-4904-6793				Antony J, 2000, J AM CHEM SOC, V122, P1057, DOI 10.1021/ja993784t; Butenandt J, 2000, CHEM-EUR J, V6, P62, DOI 10.1002/(SICI)1521-3765(20000103)6:1<62::AID-CHEM62>3.3.CO;2-Z; Carell T, 2001, CURR OPIN CHEM BIOL, V5, P491, DOI 10.1016/S1367-5931(00)00239-8; Christine KS, 2002, J BIOL CHEM, V277, P38339, DOI 10.1074/jbc.M206531200; Hahn J, 1999, J PHYS CHEM B, V103, P2001, DOI 10.1021/jp984197h; HUSAIN I, 1987, J BIOL CHEM, V262, P13188; HUSAIN I, 1988, P NATL ACAD SCI USA, V85, P2558, DOI 10.1073/pnas.85.8.2558; KIENER A, 1989, J BIOL CHEM, V264, P13880; Komori H, 2001, P NATL ACAD SCI USA, V98, P13560, DOI 10.1073/pnas.241371398; Kort R, 2004, ACTA CRYSTALLOGR D, V60, P1205, DOI 10.1107/S0907444904009321; Langenbacher T, 1997, J AM CHEM SOC, V119, P10532, DOI 10.1021/ja9721024; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Medvedev D, 2001, J THEOR BIOL, V210, P237, DOI 10.1006/jtbi.2001.2291; MIKI K, 1993, J MOL BIOL, V233, P167, DOI 10.1006/jmbi.1993.1492; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Pezeshk A, 1996, J PHYS CHEM-US, V100, P19714, DOI 10.1021/jp962196o; Rak J, 1999, J PHYS CHEM A, V103, P3569, DOI 10.1021/jp9901545; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sanders DB, 1999, J AM CHEM SOC, V121, P5127, DOI 10.1021/ja982660y; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Tamada T, 1997, NAT STRUCT BIOL, V4, P887, DOI 10.1038/nsb1197-887; Torizawa T, 2004, J BIOL CHEM, V279, P32950, DOI 10.1074/jbc.M404536200; Vande Berg BJ, 1998, J BIOL CHEM, V273, P20276, DOI 10.1074/jbc.273.32.20276; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Weber S, 2001, J AM CHEM SOC, V123, P3790, DOI 10.1021/ja003426m	26	296	301	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1789	1793		10.1126/science.1101598	http://dx.doi.org/10.1126/science.1101598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576622				2022-12-28	WOS:000225630800057
J	Flasar, FM; Achterberg, RK; Conrath, BJ; Pearl, JC; Bjoraker, GL; Jennings, DE; Romani, PN; Simon-Miller, AA; Kunde, VG; Nixon, CA; Bezard, B; Orton, GS; Spilker, LJ; Spencer, JR; Irwin, PGJ; Teanby, NA; Owen, TC; Brasunas, J; Segura, ME; Carlson, RC; Mamoutkine, A; Gierasch, PJ; Schinder, PJ; Showaiter, MR; Ferrari, C; Barucci, A; Courtin, R; Coustenis, A; Fouchet, T; Gautier, D; Lellouch, E; Marten, A; Prange, R; Strobel, DF; Calcutt, SB; Read, PL; Taylor, FW; Bowles, N; Samuelson, RE; Abbas, MM; Raulin, F; Ade, P; Edgington, S; Pilorz, S; Wallis, B; Wishnow, EH				Flasar, FM; Achterberg, RK; Conrath, BJ; Pearl, JC; Bjoraker, GL; Jennings, DE; Romani, PN; Simon-Miller, AA; Kunde, VG; Nixon, CA; Bezard, B; Orton, GS; Spilker, LJ; Spencer, JR; Irwin, PGJ; Teanby, NA; Owen, TC; Brasunas, J; Segura, ME; Carlson, RC; Mamoutkine, A; Gierasch, PJ; Schinder, PJ; Showaiter, MR; Ferrari, C; Barucci, A; Courtin, R; Coustenis, A; Fouchet, T; Gautier, D; Lellouch, E; Marten, A; Prange, R; Strobel, DF; Calcutt, SB; Read, PL; Taylor, FW; Bowles, N; Samuelson, RE; Abbas, MM; Raulin, F; Ade, P; Edgington, S; Pilorz, S; Wallis, B; Wishnow, EH			Temperatures, winds, and composition in the saturnian system	SCIENCE			English	Article							GALILEO PHOTOPOLARIMETER-RADIOMETER; 1990 EQUATORIAL DISTURBANCE; GIANT PLANETS; INFRARED OBSERVATIONS; ZONAL WINDS; RINGS; ABUNDANCES; ATMOSPHERE; ELEMENTS; MODEL	Stratospheric temperatures on Saturn imply a strong decay of the equatorial winds with attitude. If the decrease in winds reported from recent Hubble Space Telescope images is not a temporal change, then the features tracked must have been at least 130 kilometers higher than in earlier studies. Saturn's south polar stratosphere is warmer than predicted from simple radiative models. The C/H ratio on Saturn is seven times solar, twice Jupiter's. Saturn's ring, temperatures have radial variations down to the smallest scale resolved (100 kilometers). Diurnal surface temperature variations on Phoebe suggest a more porous regolith than on the jovian satellites.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Sci Syst & Applicat Inc, Lanham, MD 20706 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Observ Paris, CNRS, UMR 8109, LESIA, F-91925 Meudon, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; QSS Grp Inc, Lanham, MD 20706 USA; NASA, Ames Res Ctr, Stanford Univ, Moffett Field, CA 94035 USA; CEA Saclay, Serv Astrophys, F-91191 Gif Sur Yvette, France; Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; NASA, George C Marshall Space Flight Ctr, Natl Space Sci & Technol Ctr SD50, Huntsville, AL 35812 USA; Univ Paris 07, LISA, F-94010 Creteil, France; Univ Paris 12, CNRS, UMR 7583, F-94010 Creteil, France; Univ Cardiff, Dept Phys & Astron, Cardiff CF24 3YB, S Glam, Wales; Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; Univ Calif Berkeley, Space Sci Lab, Livermore, CA 94551 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Science Systems and Applications Inc; Cornell University; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Oxford; University of Hawaii System; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Stanford University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Cardiff University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley	Flasar, FM (corresponding author), NASA, Goddard Space Flight Ctr, Code 693, Greenbelt, MD 20771 USA.	f.m.flasar@nasa.gov	Bjoraker, Gordon L/D-5032-2012; brasunas, john/I-2798-2013; Simon, Amy/C-8020-2012; Nixon, Conor A/A-8531-2009; Romani, Paul N/D-2729-2012; Flasar, F Michael/C-8509-2012; Fouchet, Thierry/C-6374-2017; Ferrari, Cécile/P-9735-2016; Jennings, Donald/D-7978-2012; Orton, Glenn/AAD-9862-2020; Strobel, Darrell5/AAO-6643-2021	Simon, Amy/0000-0003-4641-6186; Nixon, Conor A/0000-0001-9540-9121; Fouchet, Thierry/0000-0001-9040-8285; Ferrari, Cécile/0000-0001-5962-7439; Strobel, Darrell5/0000-0002-0944-8675; Achterberg, Richard/0000-0002-7643-7626; Bezard, Bruno/0000-0002-5433-5661; Taylor, Fred/0000-0002-0675-9769; Calcutt, Simon/0000-0002-0102-3170; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; Teanby, Nicholas/0000-0003-3108-5775; Ade, Peter/0000-0002-5127-0401				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ANDREWS DG, 1987, MIDDLE ATMOSPHERE DY, P126; BARNET CD, 1992, ICARUS, V100, P499, DOI 10.1016/0019-1035(92)90113-L; BEEBE RF, 1992, ICARUS, V95, P163, DOI 10.1016/0019-1035(92)90035-6; BEZARD B, 1984, ICARUS, V60, P274, DOI 10.1016/0019-1035(84)90189-1; BEZARD B, 1985, ICARUS, V61, P296, DOI 10.1016/0019-1035(85)90110-1; CONRATH BJ, 1990, ICARUS, V83, P255, DOI 10.1016/0019-1035(90)90068-K; ESPOSITO LW, 1983, ICARUS, V56, P439, DOI 10.1016/0019-1035(83)90165-3; Flasar FM, 2004, SPACE SCI REV, V115, P169, DOI 10.1007/s11214-004-1454-9; FROIDEVAUX L, 1980, J GEOPHYS RES-SPACE, V85, P5929, DOI 10.1029/JA085iA11p05929; HANEL R, 1981, SCIENCE, V212, P192, DOI 10.1126/science.212.4491.192; HANEL R, 1982, SCIENCE, V215, P544, DOI 10.1126/science.215.4532.544; INGERSOLL AP, 1984, SATURN, P195; Kunde V, 1996, P SOC PHOTO-OPT INS, V2803, P162, DOI 10.1117/12.253416; MIZUNO H, 1980, PROG THEOR PHYS, V64, P544, DOI 10.1143/PTP.64.544; Owen T, 2003, SPACE SCI REV, V106, P121, DOI 10.1023/A:1024633603624; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Rathbun JA, 2004, ICARUS, V169, P127, DOI 10.1016/j.icarus.2003.10.021; Sanchez-Lavega A, 2000, ICARUS, V147, P405, DOI 10.1006/icar.2000.6449; Sanchez-Lavega A, 2003, NATURE, V423, P623, DOI 10.1038/nature01653; SanchezLavega A, 1996, SCIENCE, V271, P631, DOI 10.1126/science.271.5249.631; SANCHEZLAVEGA A, 1991, NATURE, V353, P397, DOI 10.1038/353397a0; Seidelmann PK, 2002, CELEST MECH DYN ASTR, V82, P83, DOI 10.1023/A:1013939327465; Simonelli DP, 1999, ICARUS, V138, P249, DOI 10.1006/icar.1999.6077; Spencer JR, 1999, SCIENCE, V284, P1514, DOI 10.1126/science.284.5419.1514; SPENCER JR, 1987, THESIS U ARIZONA TUS; Spilker L, 2003, PLANET SPACE SCI, V51, P929, DOI 10.1016/j.pss.2003.05.004	29	138	138	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1247	1251		10.1126/science.1105806	http://dx.doi.org/10.1126/science.1105806			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15618486				2022-12-28	WOS:000227313200041
J	Sorensen, HT; Pedersen, L; Skriver, MV; Norgaard, M; Norgard, B; Hatch, EE				Sorensen, HT; Pedersen, L; Skriver, MV; Norgaard, M; Norgard, B; Hatch, EE			Use of clomifene during early pregnancy and risk of hypospadias: population based case-control study	BRITISH MEDICAL JOURNAL			English	Article							IN-UTERO; DIETHYLSTILBESTROL	Clomifene is widely used for inducing ovulation.(1) It is structurally related to diethylstilbestrol, which has been linked to vaginal and cervical clear cell adenocarcinoma in women exposed in utero. The adverse effect is less severe in sons, although links to testicular cancer and urogenital anomalies, such as epididymal cysts, have been reported.(2,3) A recent study also found an increased risk of hypospadias in the sons of women exposed to diethylstilbestrol in utero.(4) Clomifene has a half life of about five days, but its metabolites have been found in blood samples on day 22 of the menstrual cycle and in faeces up to six weeks after administration.(5) The occurrence of hypospadias may be increasing. Little is known about the risk of hypospadias in boys born to women who have used clomifene to induce ovulation.	Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Aarhus University; Boston University	Sorensen, HT (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark.	hts@soci.au.dk	Sorensen, Henrik Toft/Z-6181-2019; Nørgård, Bente M/F-9563-2013	Sorensen, Henrik Toft/0000-0003-4299-7040; Nørgård, Bente M/0000-0002-9514-3033; Skriver, Mette/0000-0002-7017-8221; Norgaard, Mette/0000-0001-6110-5891; Hatch, Elizabeth/0000-0001-7901-3928				FURR BJA, 1988, J ENDOCRINOL INVEST, V11, P535, DOI 10.1007/BF03350179; GEIER A, 1987, FERTIL STERIL, V47, P778; Klip H, 2002, LANCET, V359, P1102, DOI 10.1016/S0140-6736(02)08152-7; Strohsnitter WC, 2001, J NATL CANCER I, V93, P545, DOI 10.1093/jnci/93.7.545; WILCOX AJ, 1995, NEW ENGL J MED, V332, P1411, DOI 10.1056/NEJM199505253322104	5	31	31	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 15	2005	330	7483					126	127		10.1136/bmj.38326.606979.79	http://dx.doi.org/10.1136/bmj.38326.606979.79			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889PM	15613365	Bronze, Green Published			2022-12-28	WOS:000226454900018
J	Hayase, A; Takagi, M; Miyazaki, T; Oshiumi, H; Shinohara, M; Shinohara, A				Hayase, A; Takagi, M; Miyazaki, T; Oshiumi, H; Shinohara, M; Shinohara, A			A protein complex containing Mei5 and Sae3 promotes the assembly of the meiosis-specific RecA homolog Dmc1	CELL			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; RAD51; DNA; REPAIR; GENES; TRANSITION; PACHYTENE; DISTINCT	Meiotic recombination requires the meiosis-specific RecA homolog Dmc1 as well as the mitotic RecA homolog Rad51. Here, we show that the two meiosisspecific proteins Mei5 and Sae3 are necessary for the assembly of Dmc1, but not for Rad51, on chromosomes including the association of Dmc1 with a recombination hot spot. Mei5, Sae3, and Dmc1 form a ternary and evolutionary conserved complex that requires Rad51 for recruitment to chromosomes. Mei5, Sae3, and Dmc1 are mutually dependent for their chromosome association, and their absence prevents the disassembly of Rad51 filaments. Our results suggest that Mei5 and Sae3 are loading factors for the Dmc1 recombinase and that the Dmc1-Mei5-Sae3 complex is integrated onto Rad51 ensembles and, together with Rad51, plays both catalytic and structural roles in interhomolog recombination during meiosis.	Osaka Univ, Grad Sch Sci, Inst Prot Res, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Sci, Dept Biol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Shinohara, A (corresponding author), Osaka Univ, Grad Sch Sci, Inst Prot Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ashino@protein.osaka-u.ac.jp	Oshiumi, Hiroyuki/G-1645-2012; Shinohara, Miki/E-7151-2013	Oshiumi, Hiroyuki/0000-0003-1567-8722; Shinohara, Miki/0000-0002-7413-8235				Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P15770, DOI 10.1073/pnas.2632890100; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Anderson LK, 1997, P NATL ACAD SCI USA, V94, P6868, DOI 10.1073/pnas.94.13.6868; Bishop DK, 1999, GENES CELLS, V4, P425, DOI 10.1046/j.1365-2443.1999.00273.x; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Dresser ME, 1997, GENETICS, V147, P533; Enyenihi AH, 2003, GENETICS, V163, P47; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Masson JY, 1999, EMBO J, V18, P6552, DOI 10.1093/emboj/18.22.6552; McKee AHZ, 1997, GENETICS, V146, P817; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Passy SI, 1999, P NATL ACAD SCI USA, V96, P10684, DOI 10.1073/pnas.96.19.10684; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 2003, GENETICS, V164, P855; Shinohara M, 2003, GENETICS, V163, P1273; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Tsubouchi H, 2003, DEV CELL, V5, P915, DOI 10.1016/S1534-5807(03)00357-5; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zierhut C, 2004, CURR BIOL, V14, P752, DOI 10.1016/j.cub.2004.04.030	44	94	102	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					927	940		10.1016/j.cell.2004.10.031	http://dx.doi.org/10.1016/j.cell.2004.10.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620352	Bronze			2022-12-28	WOS:000226109700006
J	Martin, DE; Soulard, A; Hall, MN				Martin, DE; Soulard, A; Hall, MN			TOR regulates ribosomal protein gene expression via PKA and the forkhead transcription factor FHL1	CELL			English	Article							RNA-POLYMERASE-I; SACCHAROMYCES-CEREVISIAE; SIGNALING PATHWAY; HEAD PROTEIN; FHA DOMAIN; YEAST; RAPAMYCIN; RECRUITMENT; PHOSPHORYLATION; LOCALIZATION	The regulation of ribosome biogenesis in response to environmental conditions is a key aspect of cell growth control. Ribosomal protein (RP) genes are regulated by the nutrient-sensitive, conserved target of rapamycin (TOR) signaling pathway. TOR controls the subcellular localization of protein kinase A (PKA) and the PKA-regulated kinase YAK1. However, the target transcription factor(s) of the TOR-PKA pathway are unknown. We show that regulation of RP gene transcription via TOR and PKA in yeast involves the Forkhead-like transcription factor FHL1 and the two cofactors IFH1 (a coactivator) and CRF1 (a corepressor). TOR, via PKA, negatively regulates YAK1 and maintains CRF1 in the cytoplasm. Upon TOR inactivation, activated YAK1 phosphorylates and activates CRF1. Phosphorylated CRF1 accumulates in the nucleus and competes with IFH1 for binding to FHL1 at RP gene promoters, and thereby inhibits transcription of RP genes. Thus, we describe a signaling mechanism linking an environmental sensor to ribosome biogenesis.	Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland	University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.	m.hall@unibas.ch		Soulard, Alexandre/0000-0003-3556-1994; Hall, Michael N/0000-0002-2998-0757				Ausubel FM, 1998, CURRENT PROTOCOLS MO; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; CHEREL I, 1995, YEAST, V11, P261, DOI 10.1002/yea.320110308; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Darieva Z, 2003, CURR BIOL, V13, P1740, DOI 10.1016/j.cub.2003.08.053; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Griffioen G, 2001, MOL CELL BIOL, V21, P511, DOI 10.1128/MCB.21.2.511-523.2001; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; HERMANNLEDENMAT S, 1994, MOL CELL BIOL, V14, P2905, DOI 10.1128/MCB.14.5.2905; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Humphrey EL, 2004, CHEM BIOL, V11, P295, DOI 10.1016/j.chembiol.2004.03.001; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; James P, 1996, GENETICS, V144, P1425; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen Paul, 2004, VVolume 42, P329; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Nomura M, 2001, COLD SPRING HARB SYM, V66, P555, DOI 10.1101/sqb.2001.66.555; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; SHERMAN F, 1991, METHOD ENZYMOL, V194, P12; Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zappacosta F, 2002, ANAL CHEM, V74, P3221, DOI 10.1021/ac025538x; Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463	49	350	363	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					969	979		10.1016/j.cell.2004.11.047	http://dx.doi.org/10.1016/j.cell.2004.11.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620355	Bronze			2022-12-28	WOS:000226109700009
J	D'Hondt, S; Jorgensen, BB; Miller, DJ; Batzke, A; Blake, R; Cragg, BA; Cypionka, H; Dickens, GR; Ferdelman, T; Hinrichs, KU; Holm, NG; Mitterer, R; Spivack, A; Wang, GZ; Bekins, B; Engelen, B; Ford, K; Gettemy, G; Rutherford, SD; Sass, H; Skilbeck, CG; Aiello, IW; Guerin, G; House, CH; Inagaki, F; Meister, P; Naehr, T; Niitsuma, S; Parkes, RJ; Schippers, A; Smith, DC; Teske, A; Wiegel, J; Padilla, CN; Acosta, JLS				D'Hondt, S; Jorgensen, BB; Miller, DJ; Batzke, A; Blake, R; Cragg, BA; Cypionka, H; Dickens, GR; Ferdelman, T; Hinrichs, KU; Holm, NG; Mitterer, R; Spivack, A; Wang, GZ; Bekins, B; Engelen, B; Ford, K; Gettemy, G; Rutherford, SD; Sass, H; Skilbeck, CG; Aiello, IW; Guerin, G; House, CH; Inagaki, F; Meister, P; Naehr, T; Niitsuma, S; Parkes, RJ; Schippers, A; Smith, DC; Teske, A; Wiegel, J; Padilla, CN; Acosta, JLS			Distributions of microbial activities in deep subseafloor sediments	SCIENCE			English	Article							PROKARYOTES; OXIDATION; CRUST; LIFE	Diverse microbial communities and numerous energy-yielding activities occur in deeply buried sediments of the eastern Pacific Ocean. Distributions of metabolic activities often deviate from the standard model. Rates of activities, cell concentrations, and populations of cultured bacteria vary consistently from one subseafloor environment to another. Net rates of major activities principally rely on electron acceptors and electron donors from the photosynthetic surface world. At open-ocean sites, nitrate and oxygen are supplied to the deepest sedimentary communities through the underlying basaltic aquifer. In turn, these sedimentary communities may supply dissolved electron donors and nutrients to the underlying crustal biosphere.	Univ Rhode Isl, Grad Sch Oceanog, NASA Astrobiol Inst, Narragansett, RI 02882 USA; Univ Oldenburg, Inst Chem & Biol Meeres, D-26111 Oldenburg, Germany; Univ Oldenburg, Ocean Drilling Program Leg Shipboard Sci Party 20, D-26111 Oldenburg, Germany; Roger Williams Univ, Dept Environm Sci, Bristol, RI 02809 USA	National Aeronautics & Space Administration (NASA); University of Rhode Island; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	D'Hondt, S (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, NASA Astrobiol Inst, S Ferry Rd, Narragansett, RI 02882 USA.	dhondt@gso.uri.edu	Sass, Henrik/B-8817-2009; Holm, Nils/H-3726-2012; Jorgensen, Bo B/C-2214-2013; Engelen, Bert/ABB-7315-2021; Cragg, Barry/D-2690-2009; Schippers, Axel/AAB-3919-2021; Teske, Andreas/AAQ-9577-2021; Smith, David/A-8309-2013; Ferdelman, Timothy G/A-3758-2013; Skilbeck, Charles/M-6872-2013; Dickens, Gerald R/G-1222-2011; Parkes, Ronald/B-1731-2010; Inagaki, Fumio/AAI-1156-2019; chen, qi/C-8585-2011; Naehr, Thomas/C-2958-2008; Hinrichs, Kai-Uwe/C-7675-2009	Sass, Henrik/0000-0001-8740-4224; Holm, Nils/0000-0001-8904-6053; Jorgensen, Bo B/0000-0001-9398-8027; Engelen, Bert/0000-0002-8117-0460; Schippers, Axel/0000-0002-4469-9883; Smith, David/0000-0003-0627-5788; Ferdelman, Timothy G/0000-0002-9701-3793; Parkes, Ronald/0000-0001-9402-5943; Inagaki, Fumio/0000-0003-2887-6525; Hinrichs, Kai-Uwe/0000-0002-0739-9291; Dickens, Gerald/0000-0003-2869-4860; Ford, Kathryn H./0000-0002-5515-8521; Skilbeck, Greg/0000-0003-1634-963X; Wiegel, Juergen/0000-0002-6343-6464; Nicolaus, Anja/0000-0002-2026-3540; Meister, Patrick/0000-0003-3623-6456				Bach W, 2003, GEOCHIM COSMOCHIM AC, V67, P3871, DOI 10.1016/S0016-7037(03)00304-1; BAKER PA, 1991, EARTH PLANET SC LETT, V105, P522, DOI 10.1016/0012-821X(91)90189-O; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; DHONDT S, 2003, P ODP IN REP 201 CD; Fisk MR, 1998, SCIENCE, V281, P978, DOI 10.1126/science.281.5379.978; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; GOLD T, 1992, P NATL ACAD SCI USA, V89, P6045, DOI 10.1073/pnas.89.13.6045; Jahnke RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P71, DOI 10.1029/95GB03525; Jorgensen B.B., 2006, MARINE GEOCHEMISTRY, P169, DOI DOI 10.1007/3-540-32144-6_5; LAUER A, 2004, INT J ASTROBIOL, V3, P63; Nealson KH, 1997, ANNU REV EARTH PL SC, V25, P403, DOI 10.1146/annurev.earth.25.1.403; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Schulz H.D., 2000, MARINE GEOCHEMISTRY, P85; SORENSEN KB, IN PRESS GEOBIOLOGY; Sturt HF, 2004, RAPID COMMUN MASS SP, V18, P617, DOI 10.1002/rcm.1378; Suess E., 1988, P ODP IN REP, V112; SUSS J, IN PRESS FEMS MICROB; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zink KG, 2003, ORG GEOCHEM, V34, P755, DOI 10.1016/S0146-6380(03)00041-X	19	537	554	5	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2216	2221		10.1126/science.1101155	http://dx.doi.org/10.1126/science.1101155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618510				2022-12-28	WOS:000225950000034
J	Kodama, R; Sentoku, Y; Chen, ZL; Kumar, GR; Hatchett, SP; Toyama, Y; Cowan, TE; Freeman, RR; Fuchs, J; Izawa, Y; Key, MH; Kitagawa, Y; Kondo, K; Matsuoka, T; Nakamura, H; Nakatsutsumi, M; Norreys, PA; Norimatsu, T; Snavely, RA; Stephens, RB; Tampo, M; Tanaka, KA; Yabuuchi, T				Kodama, R; Sentoku, Y; Chen, ZL; Kumar, GR; Hatchett, SP; Toyama, Y; Cowan, TE; Freeman, RR; Fuchs, J; Izawa, Y; Key, MH; Kitagawa, Y; Kondo, K; Matsuoka, T; Nakamura, H; Nakatsutsumi, M; Norreys, PA; Norimatsu, T; Snavely, RA; Stephens, RB; Tampo, M; Tanaka, KA; Yabuuchi, T			Plasma devices to guide and collimate a high density of MeV electrons	NATURE			English	Article							FAST IGNITER RESEARCH; INTENSE LASERS; HOT-ELECTRONS; FUSION	The development of ultra-intense lasers(1) has facilitated new studies in laboratory astrophysics(2) and high-density nuclear science(3), including laser fusion(4-7). Such research relies on the efficient generation of enormous numbers of high-energy charged particles. For example, laser - matter interactions at petawatt (10(15) W) power levels can create pulses of MeV electrons(8-10) with current densities as large as 10(12) A cm(-2). However, the divergence of these particle beams(5) usually reduces the current density to a few times 10(6) A cm(-2) at distances of the order of centimetres from the source. The invention of devices that can direct such intense, pulsed energetic beams will revolutionize their applications. Here we report high-conductivity devices consisting of transient plasmas that increase the energy density of MeV electrons generated in laser - matter interactions by more than one order of magnitude. A plasma fibre created on a hollow-cone target guides and collimates electrons in a manner akin to the control of light by an optical fibre and collimator. Such plasma devices hold promise for applications using high energy-density particles and should trigger growth in charged particle optics.	Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; Univ Nevada, Dept Phys, Reno, NV 89557 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Ohio State Univ, Columbus, OH 43210 USA; Univ Calif Davis, Dept Appl Sci, Livermore, CA 94550 USA; Osaka Univ, Fac Engn, Suita, Osaka 5650871, Japan; Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; Gen Atom Co, San Diego, CA 92186 USA; Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India; Univ Paris 06, Ecole Polytech, CEA, CNRS,UMR 7605,Lab Utilisat Lasers Intenses, F-91128 Palaiseau, France	Osaka University; Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University System of Ohio; Ohio State University; University of California System; University of California Davis; Osaka University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; General Atomics & Affiliated Companies; Tata Institute of Fundamental Research (TIFR); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; CEA; Institut Polytechnique de Paris	Kodama, R (corresponding author), Osaka Univ, Inst Laser Engn, 2-6 Yamada Oka, Suita, Osaka 5650871, Japan.	ryo@ile.osaka-u.ac.jp	Toyama, Yusuke/H-8023-2012; Cowan, Thomas E/A-8713-2011; Yabuuchi, Toshinori/S-8560-2018; Norimatsu, Takayoshi/I-5710-2015; Sentoku, Yasuhiko/P-5419-2014; Tampo, Motonobu/I-2897-2012; Fuchs, Julien/D-3450-2016; Tanaka, Kazuo A/AAL-2115-2020; Kodama, Ryosuke/G-2627-2016; Stephens, Richard/D-3840-2017	Toyama, Yusuke/0000-0003-3230-1062; Cowan, Thomas E/0000-0002-5845-000X; Yabuuchi, Toshinori/0000-0003-0638-7640; Fuchs, Julien/0000-0001-9765-0787; Stephens, Richard/0000-0002-7034-6141; Sentoku, Yasuhiko/0000-0003-2093-7100				Fill E, 1999, INST PHYS CONF SER, V159, P301; Key MH, 2001, NATURE, V412, P775, DOI 10.1038/35090666; Key MH, 1998, PHYS PLASMAS, V5, P1966, DOI 10.1063/1.872867; Kitagawa Y, 2004, IEEE J QUANTUM ELECT, V40, P281, DOI 10.1109/JQE.2003.823043; Kodama R, 2002, NATURE, V418, P933, DOI 10.1038/418933a; Kodama R, 2001, PHYS PLASMAS, V8, P2268, DOI 10.1063/1.1352598; Kodama R, 1999, REV SCI INSTRUM, V70, P625, DOI 10.1063/1.1149383; Kodama R, 2001, NATURE, V412, P798, DOI 10.1038/35090525; KODAMA R, 2004, INERTIAL FUSION SCI, P333; Ledingham KWD, 2003, SCIENCE, V300, P1107, DOI 10.1126/science.1080552; PERRY MD, 1994, SCIENCE, V264, P917, DOI 10.1126/science.264.5161.917; Remington BA, 1999, SCIENCE, V284, P1488, DOI 10.1126/science.284.5419.1488; Sentoku Y, 2004, PHYS PLASMAS, V11, P3083, DOI 10.1063/1.1735734; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; TANAKA K, IN PRESS REV SCI INS; Wharton KB, 1998, PHYS REV LETT, V81, P822, DOI 10.1103/PhysRevLett.81.822; Zimmerman G. B., 1975, Comments on Plasma Physics and Controlled Fusion, V2, P51	17	153	155	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1005	1008		10.1038/nature03133	http://dx.doi.org/10.1038/nature03133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616556				2022-12-28	WOS:000225887000035
J	Martin, J; Han, C; Gordon, LA; Terry, A; Prabhakar, S; She, XW; Xie, G; Hellsten, U; Chan, YM; Altherr, M; Couronne, O; Aerts, A; Bajorek, E; Black, S; Blumer, H; Branscomb, E; Brown, NC; Bruno, WJ; Buckingham, JM; Callen, DF; Campbell, CS; Campbell, ML; Campbell, EW; Caoile, C; Challacombe, JF; Chasteen, LA; Chertkov, O; Chi, HC; Christensen, M; Clark, LM; Cohn, JD; Denys, M; Detter, JC; Dickson, M; Dimitrijevic-Bussod, M; Escobar, J; Fawcett, JJ; Flowers, D; Fotopulos, D; Glavina, T; Gomez, M; Gonzales, E; Goodstein, D; Goodwin, LA; Grady, DL; Grigoriev, I; Groza, M; Hammon, N; Hawkins, T; Haydu, L; Hildebrand, CE; Huang, W; Israni, S; Jett, J; Jewett, PB; Kadner, K; Kimball, H; Kobayashi, A; Krawczyk, MC; Leyba, T; Longmire, JL; Lopez, F; Lou, YN; Lowry, S; Ludeman, T; Manohar, CF; Mark, GA; McMurray, KL; Meincke, LJ; Morgan, J; Moyzis, RK; Mundt, MO; Munk, AC; Nandkeshwar, RD; Pitluck, S; Pollard, M; Predki, P; Parson-Quintana, B; Ramirez, L; Rash, S; Retterer, J; Ricke, DO; Robinson, DL; Rodriguez, A; Salamov, A; Saunders, EH; Scott, D; Shough, T; Stallings, RL; Stalvey, M; Sutherland, RD; Tapia, R; Tesmer, JG; Thayer, N; Thompson, LS; Tice, H; Torney, DC; Tran-Gyamfi, M; Tsai, M; Ulanovsky, LE; Ustaszewska, A; Vo, N; White, PS; Williams, AL; Wills, PL; Wu, JR; Wu, K; Yang, J; DeJong, P; Bruce, D; Doggett, NA; Deaven, L; Schmutz, J; Grimwood, J; Richardson, P; Rokhsar, DS; Eichler, EE; Gilna, P; Lucas, SM; Myers, RM; Rubin, EM; Pennacchio, LA				Martin, J; Han, C; Gordon, LA; Terry, A; Prabhakar, S; She, XW; Xie, G; Hellsten, U; Chan, YM; Altherr, M; Couronne, O; Aerts, A; Bajorek, E; Black, S; Blumer, H; Branscomb, E; Brown, NC; Bruno, WJ; Buckingham, JM; Callen, DF; Campbell, CS; Campbell, ML; Campbell, EW; Caoile, C; Challacombe, JF; Chasteen, LA; Chertkov, O; Chi, HC; Christensen, M; Clark, LM; Cohn, JD; Denys, M; Detter, JC; Dickson, M; Dimitrijevic-Bussod, M; Escobar, J; Fawcett, JJ; Flowers, D; Fotopulos, D; Glavina, T; Gomez, M; Gonzales, E; Goodstein, D; Goodwin, LA; Grady, DL; Grigoriev, I; Groza, M; Hammon, N; Hawkins, T; Haydu, L; Hildebrand, CE; Huang, W; Israni, S; Jett, J; Jewett, PB; Kadner, K; Kimball, H; Kobayashi, A; Krawczyk, MC; Leyba, T; Longmire, JL; Lopez, F; Lou, YN; Lowry, S; Ludeman, T; Manohar, CF; Mark, GA; McMurray, KL; Meincke, LJ; Morgan, J; Moyzis, RK; Mundt, MO; Munk, AC; Nandkeshwar, RD; Pitluck, S; Pollard, M; Predki, P; Parson-Quintana, B; Ramirez, L; Rash, S; Retterer, J; Ricke, DO; Robinson, DL; Rodriguez, A; Salamov, A; Saunders, EH; Scott, D; Shough, T; Stallings, RL; Stalvey, M; Sutherland, RD; Tapia, R; Tesmer, JG; Thayer, N; Thompson, LS; Tice, H; Torney, DC; Tran-Gyamfi, M; Tsai, M; Ulanovsky, LE; Ustaszewska, A; Vo, N; White, PS; Williams, AL; Wills, PL; Wu, JR; Wu, K; Yang, J; DeJong, P; Bruce, D; Doggett, NA; Deaven, L; Schmutz, J; Grimwood, J; Richardson, P; Rokhsar, DS; Eichler, EE; Gilna, P; Lucas, SM; Myers, RM; Rubin, EM; Pennacchio, LA			The sequence and analysis of duplication-rich human chromosome 16	NATURE			English	Article							BAC CONTIG MAP; HUMAN-GENOME; DNA-SEQUENCE; SEGMENTAL DUPLICATIONS; HUMAN CHROMOSOME-16; EVOLUTIONARY RATES; PHYSICAL MAP; RECOMBINATION; CONSTRUCTION; ELEMENTS	Human chromosome 16 features one of the highest levels of segmentally duplicated sequence among the human autosomes. We report here the 78,884,754 base pairs of finished chromosome 16 sequence, representing over 99.9% of its euchromatin. Manual annotation revealed 880 protein-coding genes confirmed by 1,670 aligned transcripts, 19 transfer RNA genes, 341 pseudogenes and three RNA pseudogenes. These genes include metallothionein, cadherin and iroquois gene families, as well as the disease genes for polycystic kidney disease and acute myelomonocytic leukaemia. Several large-scale structural polymorphisms spanning hundreds of kilobase pairs were identified and result in gene content differences among humans. Whereas the segmental duplications of chromosome 16 are enriched in the relatively gene-poor pericentromere of the p arm, some are involved in recent gene duplication and conversion events that are likely to have had an impact on the evolution of primates and human disease susceptibility.	DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Stanford Univ, Sch Med, Dept Genet, Stanford Human Genome Ctr, Palo Alto, CA 94304 USA; Childrens Hosp Oakland, Oakland, CA 94609 USA	United States Department of Energy (DOE); United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; Stanford University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Rubin, EM (corresponding author), DOE Joint Genome Inst, 2800 Mitchell Ave, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov; LAPennacchio@lbl.gov	Callen, David F/G-1975-2012; Gilna, Paul/I-3608-2016; Grimwood, Jane/ABD-5737-2021; Couronne, Olivier Couronne/G-1244-2012; Terry, Astrid Y/A-2538-2011; Stallings, Raymond/A-7213-2008; Schmutz, Jeremy/N-3173-2013	Gilna, Paul/0000-0002-6542-0191; Terry, Astrid Y/0000-0002-5234-1224; Schmutz, Jeremy/0000-0001-8062-9172; Han, Cliff/0000-0003-1972-0692; Grigoriev, Igor/0000-0002-3136-8903; Pennacchio, Len/0000-0002-8748-3732; Rokhsar, Daniel/0000-0002-8704-2224; Ricke, Darrell/0000-0002-2842-2809; Cohn, Judith/0000-0002-1333-3395; Callen, David/0000-0002-6189-9991; Martin, Joel/0000-0001-9511-6441				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; CALLEN DF, 1992, GENOMICS, V13, P1178, DOI 10.1016/0888-7543(92)90035-Q; Cao YC, 1999, GENOME RES, V9, P763; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; DEAVEN LL, 1986, COLD SPRING HARB SYM, V51, P159, DOI 10.1101/SQB.1986.051.01.019; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOGGETT NA, 1995, NATURE, V377, P335; Eichler EE, 2001, J HERED, V92, P462, DOI 10.1093/jhered/92.6.462; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Guy J, 2003, GENOME RES, V13, P159, DOI 10.1101/gr.644503; Han CS, 2000, GENOME RES, V10, P714, DOI 10.1101/gr.10.5.714; HILDEBRAND CE, 1980, BIOCHEMISTRY-US, V19, P5850, DOI 10.1021/bi00566a029; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; KARLIN S, 1992, ADV APPL PROBAB, V24, P113, DOI 10.2307/1427732; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kouprina N, 1998, GENOMICS, V53, P21, DOI 10.1006/geno.1998.5469; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; SICILIANO MJ, 1987, ISOZYMES-CURR T BIOL, V15, P217; STALLINGS RL, 1984, MOL CELL BIOL, V4, P2932, DOI 10.1128/MCB.4.12.2932; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	48	119	641	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					988	994		10.1038/nature03187	http://dx.doi.org/10.1038/nature03187			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616553	Green Submitted, Bronze			2022-12-28	WOS:000225887000032
J	Schawalder, SB; Kabani, M; Howald, I; Choudhury, U; Werner, M; Shore, D				Schawalder, SB; Kabani, M; Howald, I; Choudhury, U; Werner, M; Shore, D			Growth-regulated recruitment of the essential yeast ribosomal protein gene activator Ifh1	NATURE			English	Article							GENOME-WIDE LOCATION; FORK HEAD PROTEIN; SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-CHANGES; EXPRESSION; PATHWAY; RAP1; BINDING; FHL1	Regulation of ribosome biogenesis is central to the control of cell growth(1). In rapidly growing yeast cells, ribosomal protein (RP) genes account for approximately one-half of all polymerase II transcription-initiation events(1), yet these genes are markedly and coordinately downregulated in response to a number of environmental stress conditions(2-4), or during the transition from fermentation to respiration(5). Although several conserved signalling pathways (TOR, RAS/protein kinase A and protein kinase C) impinge upon RP gene transcription(1), little is known about how initiation at these genes is controlled. Rap1 (refs 6, 7) and more recently Fhl1 (ref. 8) were shown to bind upstream of many RP genes. Here we show that the essential protein Ifh1 binds to and activates many RP gene promoters under optimal growth conditions in Saccharomyces cerevisiae. Ifh1 is recruited to RP gene promoters through the forkhead-associated domain of Fhl1. Ifh1 binding decreases when RP genes are downregulated either by TOR inhibition or nutrient depletion, and is restored after release from starvation or upon regulated induction of IFH1 expression. These findings indicate a central role for Ifh1 and Fhl1 in RP gene regulation.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, NCCR Program Frontiers Genet, CH-1211 Geneva 4, Switzerland; CEA Saclay, Serv Biochim & Genet Mol, F-91191 Gif Sur Yvette, France	University of Geneva; University of Geneva; CEA; UDICE-French Research Universities; Universite Paris Saclay	Shore, D (corresponding author), Univ Geneva, Dept Mol Biol, Sci 3,30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	David.Shore@molbio.unige.ch	Kabani, Mehdi/G-7456-2012; Werner, Michel/B-7316-2009; Shore, David/F-6240-2015	Kabani, Mehdi/0000-0001-7440-6394; Werner, Michel/0000-0002-2965-5858; Shore, David/0000-0002-9859-143X				Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CHEREL I, 1995, YEAST, V11, P261, DOI 10.1002/yea.320110308; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466; HERMANNLEDENMAT S, 1994, MOL CELL BIOL, V14, P2905, DOI 10.1128/MCB.14.5.2905; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Jorgensen P, 2000, GENOME BIOL, V1; JU QD, 1994, YEAST, V10, P151, DOI 10.1002/yea.320100203; Kim M, 2002, J BIOL CHEM, V277, P38781, DOI 10.1074/jbc.M201559200; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7	28	171	173	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1058	1061		10.1038/nature03200	http://dx.doi.org/10.1038/nature03200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616569	Green Published			2022-12-28	WOS:000225887000049
J	Wolfrum, C; Asilmaz, E; Luca, E; Friedman, JM; Stoffel, M				Wolfrum, C; Asilmaz, E; Luca, E; Friedman, JM; Stoffel, M			Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes	NATURE			English	Article							INSULIN-RESISTANCE; HEPATIC GLUCONEOGENESIS; COACTIVATOR PGC-1; GENE-EXPRESSION; MICE; SENSITIVITY; ACID; HEPATOCYTES; INHIBITION; MECHANISM	The regulation of fat and glucose metabolism in the liver is controlled primarily by insulin and glucagon. Changes in the circulating concentrations of these hormones signal fed or starvation states and elicit counter-regulatory responses that maintain normoglycaemia. Here we show that in normal mice, plasma insulin inhibits the forkhead transcription factor Foxa2 by nuclear exclusion and that in the fasted ( low insulin) state Foxa2 activates transcriptional programmes of lipid metabolism and ketogenesis. In insulin-resistant or hyperinsulinaemic mice, Foxa2 is inactive and permanently located in the cytoplasm of hepatocytes. In these mice, adenoviral expression of Foxa2T156A, a nuclear, constitutively active Foxa2 that cannot be inhibited by insulin(1), decreases hepatic triglyceride content, increases hepatic insulin sensitivity, reduces glucose production, normalizes plasma glucose and significantly lowers plasma insulin. These changes are associated with increased expression of genes encoding enzymes of fatty acid oxidation, ketogenesis and glycolysis. Chronic hyperinsulinaemia in insulin-resistant syndromes results in the cytoplasmic localization and inactivation of Foxa2, thereby promoting lipid accumulation and insulin resistance in the liver. Pharmacological intervention to inhibit phosphorylation of Foxa2 may be an effective treatment for type 2 diabetes.	Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Stoffel, M (corresponding author), Rockefeller Univ, Lab Metab Dis, 1230 York Ave, New York, NY 10021 USA.	stoffel@rockefeller.edu	Adiels, Martin/C-9278-2011	Stoffel, Markus/0000-0003-1304-5817; Wolfrum, Christian/0000-0002-3862-6805				Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Casteels K, 2003, REV ENDOCR METAB DIS, V4, P159, DOI 10.1023/A:1022942120000; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; FRENEAUX E, 1988, HEPATOLOGY, V8, P1056, DOI 10.1002/hep.1840080513; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Kim H, 2004, DIABETES, V53, pS60, DOI 10.2337/diabetes.53.2007.S60; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lang C, 2001, J LIPID RES, V42, P22; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Louet JF, 2002, J BIOL CHEM, V277, P37991, DOI 10.1074/jbc.M205087200; MATSUDA T, 1990, J BIOCHEM-TOKYO, V108, P778, DOI 10.1093/oxfordjournals.jbchem.a123280; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Stuempfle KJ, 1996, BIOTECHNIQUES, V21, P48; TOBEY TA, 1982, METABOLISM, V31, P608, DOI 10.1016/0026-0495(82)90100-7; UNTERMAN TG, 1994, BIOCHEM BIOPH RES CO, V203, P1835, DOI 10.1006/bbrc.1994.2401; VAULONT S, 1994, FASEB J, V8, P28, DOI 10.1096/fasebj.8.1.8299888; Voshol PJ, 2003, ENDOCRINOLOGY, V144, P3456, DOI 10.1210/en.2002-0036; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	30	299	319	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1027	1032		10.1038/nature03047	http://dx.doi.org/10.1038/nature03047			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616563				2022-12-28	WOS:000225887000042
J	Begaud, B; Verdoux, H				Begaud, B; Verdoux, H			Did the US boycott of French products spread to include scientific output?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Bordeaux 2, IFR99 Publ Hlth, F-33076 Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux	Verdoux, H (corresponding author), Univ Bordeaux 2, IFR99 Publ Hlth, Batiment Presidence,EA 3676, F-33076 Bordeaux, France.	bernard.begaud@phannaco.u-bordeaux2.fr	Verdoux, Helene/T-1996-2019	Verdoux, Helene/0000-0003-2948-3782				Link AM, 1998, JAMA-J AM MED ASSOC, V280, P246, DOI 10.1001/jama.280.3.246; Ray JG, 2002, QJM-INT J MED, V95, P769, DOI 10.1093/qjmed/95.12.769; *WORLD ASS MED ED, WAME POL STAT GEOP I	3	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1430	1431		10.1136/bmj.329.7480.1430	http://dx.doi.org/10.1136/bmj.329.7480.1430			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604172	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000225965800015
J	Harlow, T; Greaves, C; White, A; Brown, L; Hart, A; Ernst, E				Harlow, T; Greaves, C; White, A; Brown, L; Hart, A; Ernst, E			Randomised controlled trial of magnetic bracelets for relieving pain in osteoarthritis of the hip and knee	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WOMAC OSTEOARTHRITIS; STATIC MAGNETS; RESPONSIVENESS; VALIDATION; THERAPY; INDEX	Objective To determine the effectiveness of commercially available magnetic bracelets for pain control in osteoarthritis of the hip and knee. Design Randomised, placebo controlled trial with three parallel groups. Setting Five rural general practices. Participants 194 men and women aged 45-80 years with osteoarthritis of the hip or knee. Intervention Wearing a standard strength static bipolar magnetic bracelet, a weak magnetic bracelet, or a non-magnetic (dummy) bracelet for 12 weeks. Main outcome measures Change in the Western Ontario and McMaster Universities osteoarthritis lower limb pain scale (WOMAC A) after 12 weeks, with the primary comparison between the standard and dummy groups. Secondary outcomes included changes in WOMAC B and C scales and a visual analogue scale for pain. Results Mean pain scores were reduced more in the standard magnet group than in the dummy group (mean difference 1.3 points, 95% confidence interval 0.05 to 2.55). Self reported blinding status did not affect the results. The scores for secondary outcome measures were consistent with the WOMAC A scores. Conclusion Pain from osteoarthritis of the hip and knee decreases when wearing magnetic bracelets. It is uncertain whether this response is due to specific or non-specific (placebo) effects.	Univ Cent Lancashire, Lancashire Sch Hlth & Postgrad Med, Preston PR1 2HE, Lancs, England; Coll Surg, Cullompton EX15 1TG, Devon, England; Peninsula Med Sch, Plymouth PL6 8BX, Devon, England; Peninsula Med Sch Complementary Med, Exeter EX2 4NT, Devon, England	University of Central Lancashire; University of Plymouth; University of Exeter	Harlow, T (corresponding author), Hospiscare, Dryden Rd, Exeter EX2 5JJ, Devon, England.	timharlow@ectipse.co.uk	Greaves, Colin/AAY-1555-2020	Greaves, Colin/0000-0003-4425-2691				Alfano AP, 2001, J ALTERN COMPLEM MED, V7, P53, DOI 10.1089/107555301300004538; Angst F, 2001, ANN RHEUM DIS, V60, P834; *ARTHR RES CAMP, 2002, ARTHR BIG PICT; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bookman AAM, 2004, CAN MED ASSOC J, V171, P333, DOI 10.1503/cmaj.1031793; *BRIT MED ASS, 2004, BRIT NAT FORM; Brown CS, 2002, AM J OBSTET GYNECOL, V187, P1581, DOI 10.1067/mob.2002.128026; Caselli MA, 1997, J AM PODIAT MED ASSN, V87, P11, DOI 10.7547/87507315-87-1-11; Collacott EA, 2000, JAMA-J AM MED ASSOC, V283, P1322, DOI 10.1001/jama.283.10.1322; *EC, SINGL MOD MAGN BRAC; Hinman MR, 2002, ALTERN THER HEALTH M, V8, P50; Langman MJS, 2003, FUND CLIN PHARMACOL, V17, P393, DOI 10.1046/j.1472-8206.2003.00179.x; Man D, 1999, PLAST RECONSTR SURG, V104, P2261, DOI 10.1097/00006534-199912000-00051; O'Reilly SC, 1999, ANN RHEUM DIS, V58, P15, DOI 10.1136/ard.58.1.15; Pham T, 2003, J RHEUMATOL, V30, P1648; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Roos EM, 1999, SCAND J RHEUMATOL, V28, P210; Schulz KF, 2002, LANCET, V359, P696, DOI 10.1016/S0140-6736(02)07816-9; Vallbona C, 1999, Phys Med Rehabil Clin N Am, V10, P729; Weintraub MI, 2003, ARCH PHYS MED REHAB, V84, P736, DOI 10.1016/S0003-9993(03)00106-0; Weintraub MI, 1999, AM J PAIN MANAGE, V9, P8; WINEMILLER MH, 2003, JAMA-J AM MED ASSOC, V290, P45; Wolsko PM, 2004, ALTERN THER HEALTH M, V10, P36; Zhao SZ, 1999, PHARMACOTHERAPY, V19, P1269, DOI 10.1592/phco.19.16.1269.30879	24	49	51	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2004	329	7480					1450	1454		10.1136/bmj.329.7480.1450	http://dx.doi.org/10.1136/bmj.329.7480.1450			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604181	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000225965800024
J	Shaughnessy, AF; Slawson, DC				Shaughnessy, AF; Slawson, DC			Easy ways to resist change in medicine	BRITISH MEDICAL JOURNAL			English	Article									Univ Virginia, Hlth Sci Ctr, Dept Family Med, Charlottesville, VA 22908 USA; Tufts Univ, Dept Family Med & Community Hlth, Sch Med, Malden, MA 02148 USA	University of Virginia; Tufts University	Slawson, DC (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Family Med, Box 800729, Charlottesville, VA 22908 USA.	dslawson@virginia.edu						Bleck TP, 2000, BRIT MED J, V321, P239; Covey S., 1990, 7 HABITS HIGHLY EFFE	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 18	2004	329	7480					1473	1474		10.1136/bmj.329.7480.1473	http://dx.doi.org/10.1136/bmj.329.7480.1473			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882VB	15604189	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000225965800032
J	Ju, BG; Solum, D; Song, EJ; Lee, KJ; Rose, DW; Glass, CK; Rosenfeld, MG				Ju, BG; Solum, D; Song, EJ; Lee, KJ; Rose, DW; Glass, CK; Rosenfeld, MG			Activating the PARP-1 sensor component of the Groucho/TLE1 corepressor complex mediates a CaMKinase II delta-dependent neurogenic gene activation pathway	CELL			English	Article							POLY(ADP-RIBOSE) POLYMERASE BINDS; NUCLEAR RECEPTOR COREPRESSOR; ALPHA-GLUCOSIDASE GENE; CENTRAL-NERVOUS-SYSTEM; DNA TOPOISOMERASE-II; LOOP-HELIX FACTORS; PROTEIN-KINASE-II; NEURONAL DIFFERENTIATION; STEM-CELLS; TRANSCRIPTIONAL REPRESSION	Switching specific patterns of gene repression and activation in response to precise temporal/spatial signals is critical for normal development. Here we report a pathway in which induction of CaMKIIdelta triggers an unexpected switch in the function of the HES1 transcription factor from a TLE-dependent repressor to an activator required for neuronal differentiation. These events are based on activation of the poly(ADPribose) polymerase1 (PARP-1) sensor component of the groucho/TLE-corepressor complex mediating dismissal of the corepressor complex from HES1-regulated promoters. In parallel, CaMKIIdelta mediates a required phosphorylation of HES1 to permit neurogenic gene activation, revealing the ability of a specific signaling pathway to modulate both the derepression and the subsequent coactivator recruitment events required for transcriptional activation of a neurogenic program. The identification of PARP-1 as a regulated promoter-specific exchange factor required for activation of specific neurogenic gene programs is likely to be prototypic of similar molecular mechanisms.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Div Endocrinol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Ewha Womans Univ, Ctr Cell Signaling Res, Div Mol Life Sci, Seoul 120750, South Korea; Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Ewha Womans University; Ewha Womans University	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Lee, Kong-Joo/0000-0001-7972-6020; Song, Eun Joo/0000-0002-2420-6666				ACKERMAN P, 1988, J BIOL CHEM, V263, P12653; ADACHIY, 1991, CELL, V54, P137; Akiyama T, 2001, P NATL ACAD SCI USA, V98, P48, DOI 10.1073/pnas.240458597; Aoufouchi S, 1997, BIOCHEM J, V325, P543, DOI 10.1042/bj3250543; Bally-Cuif L, 2003, CURR OPIN NEUROBIOL, V13, P16, DOI 10.1016/S0959-4388(03)00015-1; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BROU C, 1993, NUCLEIC ACIDS RES, V21, P4011, DOI 10.1093/nar/21.17.4011; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Carey MB, 1999, DEV BIOL, V215, P298, DOI 10.1006/dbio.1999.9433; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Ciccolini F, 2003, J NEUROSCI, V23, P103; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dasen JS, 2001, GENE DEV, V15, P3193, DOI 10.1101/gad.932601; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Enarsson M, 2002, MOL CANCER RES, V1, P147; FERRO AM, 1982, J BIOL CHEM, V257, P7808; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; Gilchrist JSC, 2002, J CELL BIOCHEM, V85, P268, DOI 10.1002/jcb.10121; Glass CK, 2000, GENE DEV, V14, P121; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; HERRERA JE, 1995, NUCLEIC ACIDS RES, V23, P3974, DOI 10.1093/nar/23.19.3974; Hoch B, 1998, J CELL BIOCHEM, V68, P259, DOI 10.1002/(SICI)1097-4644(19980201)68:2<259::AID-JCB12>3.0.CO;2-A; Homburg S, 2000, J CELL BIOL, V150, P293, DOI 10.1083/jcb.150.2.293; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; INOUYE CJ, 1994, J BIOL CHEM, V269, P6506; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2002, J CELL SCI, V115, P689; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kun E, 2004, BIOCHEMISTRY-US, V43, P210, DOI 10.1021/bi0301791; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Plaza S, 1999, ONCOGENE, V18, P1041, DOI 10.1038/sj.onc.1202406; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Roger B, 2002, J BIOL CHEM, V277, P10209, DOI 10.1074/jbc.M106412200; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Sewer MB, 2002, ENDOCR RES, V28, P551, DOI 10.1081/ERC-120016840; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Strom A, 1997, GENE DEV, V11, P3168, DOI 10.1101/gad.11.23.3168; SUGIURA H, 1992, BRAIN RES, V593, P97, DOI 10.1016/0006-8993(92)91269-K; Tsai SC, 2000, NAT GENET, V26, P349, DOI 10.1038/81671; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; VANDOREN M, 1994, GENE DEV, V8, P2729, DOI 10.1101/gad.8.22.2729; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Wang HY, 1997, J BIOL CHEM, V272, P1817, DOI 10.1074/jbc.272.3.1817; Yan B, 2002, BIOCHEM BIOPH RES CO, V291, P582, DOI 10.1006/bbrc.2002.6483; Yan B, 2001, J BIOL CHEM, V276, P1789, DOI 10.1074/jbc.M005959200; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120	67	240	247	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 17	2004	119	6					815	829		10.1016/j.cell.2004.11.017	http://dx.doi.org/10.1016/j.cell.2004.11.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607978	Bronze			2022-12-28	WOS:000225907200012
J	Katz, IT; Wright, AA				Katz, IT; Wright, AA			International medical aid - Collateral damage - Medecins sans Frontieres leaves Afghanistan and Iraq	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Katz, IT (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.		Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X				Fox RC, 1995, SOC SCI MED, V41, P1607, DOI 10.1016/0277-9536(95)00144-V; MACASKILL E, 2004, GUARDIAN        0506; *OFF MIN HLTH, 2004, POS PAP SEC ACC HLTH; Powell C, 2001, REM NAT FOR POL C LE	4	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2571	2573		10.1056/NEJMp048296	http://dx.doi.org/10.1056/NEJMp048296			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602015				2022-12-28	WOS:000225726100001
J	Landon, MB; Hauth, JC; Leveno, KJ; Spong, CY; Leindecker, S; Varner, MW; Moawad, AH; Caritis, SN; Harper, M; Wapner, RJ; Sorokin, Y; Miodovnik, M; Carpenter, M; Peaceman, AM; O'Sullivan, MJ; Sibai, B; Langer, O; Thorp, JM; Ramin, SM; Mercer, BM; Gabbe, SG; Iams, J; Johnson, F; Meadows, S; Walker, H; Rouse, D; Northen, A; Tate, S; Bloom, S; McCampbell, J; Bradford, D; Belfort, M; Porter, F; Oshiro, B; Anderson, K; Guzman, A; Hibbard, J; Jones, P; Ramos-Brinson, M; Moran, M; Scott, D; Lain, K; Cotroneo, M; Fischer, D; Luce, M; Meis, P; Swain, M; Moorefield, C; Lanier, K; Steele, L; Sciscione, A; DiVito, M; Talucci, M; Pollock, M; Dombrowski, M; Norman, G; Millinder, A; Sudz, C; Steffy, B; Siddiqi, T; How, H; Elder, N; Malone, F; D'Alton, M; Pemberton, V; Carmona, V; Husami, H; Silver, H; Tillinghast, J; Catlow, D; Allard, D; Socol, M; Gradishar, D; Mallett, G; Burkett, G; Gilles, J; Potter, J; Doyle, F; Chandler, S; Mabie, W; Ramsey, R; Conway, D; Barker, S; Rodriguez, M; Moise, K; Dorman, K; Brody, S; Mitchell, J; Gilstrap, L; Day, M; Kerr, M; Gildersleeve, E; Catalano, P; Milluzzi, C; Slivers, B; Santori, C; Thom, E; Julienson-Stevenson, H; Fischer, M; Weiner, S; McNellis, D; Howell, K; Pagliaro, S				Landon, MB; Hauth, JC; Leveno, KJ; Spong, CY; Leindecker, S; Varner, MW; Moawad, AH; Caritis, SN; Harper, M; Wapner, RJ; Sorokin, Y; Miodovnik, M; Carpenter, M; Peaceman, AM; O'Sullivan, MJ; Sibai, B; Langer, O; Thorp, JM; Ramin, SM; Mercer, BM; Gabbe, SG; Iams, J; Johnson, F; Meadows, S; Walker, H; Rouse, D; Northen, A; Tate, S; Bloom, S; McCampbell, J; Bradford, D; Belfort, M; Porter, F; Oshiro, B; Anderson, K; Guzman, A; Hibbard, J; Jones, P; Ramos-Brinson, M; Moran, M; Scott, D; Lain, K; Cotroneo, M; Fischer, D; Luce, M; Meis, P; Swain, M; Moorefield, C; Lanier, K; Steele, L; Sciscione, A; DiVito, M; Talucci, M; Pollock, M; Dombrowski, M; Norman, G; Millinder, A; Sudz, C; Steffy, B; Siddiqi, T; How, H; Elder, N; Malone, F; D'Alton, M; Pemberton, V; Carmona, V; Husami, H; Silver, H; Tillinghast, J; Catlow, D; Allard, D; Socol, M; Gradishar, D; Mallett, G; Burkett, G; Gilles, J; Potter, J; Doyle, F; Chandler, S; Mabie, W; Ramsey, R; Conway, D; Barker, S; Rodriguez, M; Moise, K; Dorman, K; Brody, S; Mitchell, J; Gilstrap, L; Day, M; Kerr, M; Gildersleeve, E; Catalano, P; Milluzzi, C; Slivers, B; Santori, C; Thom, E; Julienson-Stevenson, H; Fischer, M; Weiner, S; McNellis, D; Howell, K; Pagliaro, S		Natl Inst Child Hlth Human Dev Mat	Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UTERINE RUPTURE; RISK; WOMEN	BACKGROUND: The proportion of women who attempt vaginal delivery after prior cesarean delivery has decreased largely because of concern about safety. The absolute and relative risks associated with a trial of labor in women with a history of cesarean delivery, as compared with elective repeated cesarean delivery without labor, are uncertain. METHODS: We conducted a prospective four-year observational study of all women with a singleton gestation and a prior cesarean delivery at 19 academic medical centers. Maternal and perinatal outcomes were compared between women who underwent a trial of labor and women who had an elective repeated cesarean delivery without labor. RESULTS: Vaginal delivery was attempted by 17,898 women, and 15,801 women underwent elective repeated cesarean delivery without labor. Symptomatic uterine rupture occurred in 124 women who underwent a trial of labor (0.7 percent). Hypoxic-ischemic encephalopathy occurred in no infants whose mothers underwent elective repeated cesarean delivery and in 12 infants born at term whose mothers underwent a trial of labor (P<0.001). Seven of these cases of hypoxic-ischemic encephalopathy followed uterine rupture (absolute risk, 0.46 per 1000 women at term undergoing a trial of labor), including two neonatal deaths. The rate of endometritis was higher in women undergoing a trial of labor than in women undergoing repeated elective cesarean delivery (2.9 percent vs. 1.8 percent), as was the rate of blood transfusion (1.7 percent vs. 1.0 percent). The frequency of hysterectomy and of maternal death did not differ significantly between groups (0.2 percent vs. 0.3 percent, and 0.02 percent vs. 0.04 percent, respectively). CONCLUSIONS: A trial of labor after prior cesarean delivery is associated with a greater perinatal risk than is elective repeated cesarean delivery without labor, although absolute risks are low. This information is relevant for counseling women about their choices after a cesarean section.	Ohio State Univ, Coll Med & Publ Hlth, Dept Obstet & Gynecol, Columbus, OH 43210 USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ Texas San Antonio SW, Dallas, TX USA; NICHHD, Bethesda, MD 20892 USA; George Washington Univ, Ctr Biostat, Washington, DC USA; Univ Utah, Salt Lake City, UT USA; Univ Chicago, Chicago, IL 60637 USA; Univ Pittsburgh, Pittsburgh, PA USA; Magee Womens Hosp, Pittsburgh, PA USA; Wake Forest Univ, Winston Salem, NC 27109 USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Wayne State Univ, Detroit, MI USA; Univ Cincinnati, Cincinnati, OH USA; Columbia Univ, New York, NY USA; Brown Univ, Providence, RI 02912 USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Miami, Miami, FL 33152 USA; Univ Tennessee, Memphis, TN USA; Univ Texas San Antonio, San Antonio, TX 78285 USA; Univ N Carolina, Chapel Hill, NC USA; Univ Texas San Antonio, Houston, TX USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Vanderbilt Univ, Nashville, TN USA	University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); George Washington University; Utah System of Higher Education; University of Utah; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Jefferson University; Wayne State University; University System of Ohio; University of Cincinnati; Columbia University; Brown University; Northwestern University; University of Miami; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas at San Antonio (UTSA); University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas at San Antonio (UTSA); Case Western Reserve University; Vanderbilt University	Landon, MB (corresponding author), Ohio State Univ, Coll Med & Publ Hlth, Dept Obstet & Gynecol, 1654 Upham Dr,Means Hall,5th Fl, Columbus, OH 43210 USA.	landon.1@osu.edu	/AAO-2076-2020; Varner, Michael/K-9890-2013	Peaceman, Alan/0000-0002-4515-4850; Varner, Michael/0000-0001-9455-3973; caritis, steve/0000-0002-2169-0712	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD034208, UG1HD040500, UG1HD040545, U10HD040485, U10HD034116, UG1HD027915, UG1HD034116, U10HD027869, U10HD027917, U10HD027915, UG1HD040512, U10HD021410, U10HD040560, U10HD036801, U10HD040544, U10HD034208, U10HD040500, UG1HD040544, UG1HD027869, UG1HD040485, U10HD040545, U10HD040512, UG1HD040560] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD021410, U01HD036801, U01HD021414, U10HD027860, U10HD034210, U10HD027861, U10HD034122, U10HD034136, U10HD021414, U10HD027905] Funding Source: NIH RePORTER; NICHD NIH HHS [HD40560, HD27905, HD27915, HD27869, HD40545, HD27917, HD40544, HD40512, HD40500, HD34116, HD34122, HD40485, HD34136, HD36801, HD27861, HD34210, HD27860, HD21414, HD21410, HD34208] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		*AM COLL OBST GYN, 1999, ACOG PRACT B, V5; Badawi N, 1998, BMJ-BRIT MED J, V317, P1554, DOI 10.1136/bmj.317.7172.1554; Chauhan SP, 2003, AM J OBSTET GYNECOL, V189, P408, DOI 10.1067/S0002-9378(03)00675-6; *DEP HOUS URB DEV, 2000, HOUS TOD         WIN, P1; Hamilton Brady E, 2003, Natl Vital Stat Rep, V51, P1; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; McMahon MJ, 1996, NEW ENGL J MED, V335, P689, DOI 10.1056/NEJM199609053351001; Menacker F, 2001, Natl Vital Stat Rep, V49, P1; Mozurkewich EL, 2000, AM J OBSTET GYNECOL, V183, P1187, DOI 10.1067/mob.2000.108890; *PUBL HLTH SERV, 1990, DHHS PUBL, P378; Rageth JC, 1999, OBSTET GYNECOL, V93, P332, DOI 10.1016/S0029-7844(98)00446-3; Sachs BP, 1999, NEW ENGL J MED, V340, P54, DOI 10.1056/NEJM199901073400112; *VBAC, 2003, AHRQ PUBL; Zelop CM, 1999, AM J OBSTET GYNECOL, V181, P882, DOI 10.1016/S0002-9378(99)70319-4	14	813	857	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2581	2589		10.1056/NEJMoa040405	http://dx.doi.org/10.1056/NEJMoa040405			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15598960				2022-12-28	WOS:000225726100005
J	Charles, D; Ness, AR; Campbell, D; Smith, GD; Hall, MH				Charles, D; Ness, AR; Campbell, D; Smith, GD; Hall, MH			Taking folate in pregnancy and risk of maternal breast cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLIC-ACID; DEFICIENCY; PREVENTION		Div Child Hlth, Unit Paediat & Perinatal Epidemiol, Bristol BS8 1TQ, Avon, England; Aberdeen Matern Hosp, Dept Obstet & Gynaecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZL, Scotland; Univ Bristol, Dept Social Med, Bristol B58 2PR, Avon, England	University of Aberdeen; University of Bristol	Ness, AR (corresponding author), Div Child Hlth, Unit Paediat & Perinatal Epidemiol, Bristol BS8 1TQ, Avon, England.	Andy.Ness@bris.ac.uk	Ness, Andy R/M-7612-2013; Davey Smith, George/A-7407-2013; Hall, Mei-Hua/GLR-9172-2022	Ness, Andy R/0000-0003-3548-9523; Davey Smith, George/0000-0002-1407-8314; Hall, Mei-Hua/0000-0002-4558-7023				CHARLES DHM, 2005, IN PRESS PAEDIAT PER, V19; HALL MH, 1972, J OBSTET GYN BR COMM, V79, P159; Kotsopoulos J, 2003, CARCINOGENESIS, V24, P937, DOI 10.1093/carcin/bgg036; Lucock M, 2004, BMJ-BRIT MED J, V328, P211, DOI 10.1136/bmj.328.7433.211; WALD N, 1991, LANCET, V338, P131	5	86	87	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2004	329	7479					1375	1376		10.1136/bmj.329.7479.1375	http://dx.doi.org/10.1136/bmj.329.7479.1375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880JB	15591563	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000225785000018
J	Horton, R				Horton, R			UNICEF leadership 2005-2015: a call for strategic change	LANCET			English	Editorial Material							HEALTH; TRIAL		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.	richard.horton@lancet.com						[Anonymous], 2004, LANCET, V364, P1911; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; Lee JW, 2003, LANCET, V362, P2083, DOI 10.1016/S0140-6736(03)15107-0; Lee JW, 2003, LANCET, V362, P262, DOI 10.1016/S0140-6736(03)14006-8; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; World Bank, 2004, RIS CHALL MILL DEV G	11	30	30	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2004	364	9451					2071	2074		10.1016/S0140-6736(04)17560-0	http://dx.doi.org/10.1016/S0140-6736(04)17560-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589292				2022-12-28	WOS:000225742300003
J	Timimi, S				Timimi, S			Rethinking childhood depression	BRITISH MEDICAL JOURNAL			English	Article							ADOLESCENTS; CHILDREN		Lincolnshire Partnership NHS Trust, Sleaford NG34 8QA, Lincolnshire, England		Timimi, S (corresponding author), Lincolnshire Partnership NHS Trust, Sleaford NG34 8QA, Lincolnshire, England.	stimimi@talk21.com						[Anonymous], 1995, PSYCHOSOCIAL DISORDE; Boseley S, 2003, GUARDIAN        0421, P1; Fombonne E, 2001, BRIT J PSYCHIAT, V179, P210, DOI 10.1192/bjp.179.3.210; Gelder M, 1989, OXFORD TXB PSYCHIAT, V2nd; HARRINGTON RC, 1993, BRIT J PSYCHIAT, V162, P627, DOI 10.1192/bjp.162.5.627; Harrington Richard, 1994, CLIN HDB CHILD ADOLE, P110; HILL P, 1997, ESSENTIALS POSTGRADU, P97; Jenhs C., 1996, CHILDHOOD; Jenkins H., 1998, CHILDRENS CULTURE RE, P1; Jenkins H., 1998, CHILDRENS CULTURE RE, P159; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Pampel FC, 2001, SOC FORCES, V80, P251, DOI 10.1353/sof.2001.0083; Pickles A, 2001, BRIT J PSYCHIAT, V179, P230, DOI 10.1192/bjp.179.3.230; Ramchandani P, 2004, BRIT MED J, V328, P3, DOI 10.1136/bmj.328.7430.3; Reynolds W. M., 1994, HDB DEPRESSION CHILD; Timimi S., 2002, PATHOLOGICAL CHILD P; Weinman-Lear M., 1963, CHILD WORSHIPERS; WICKESNELSON R, 2002, BEHAV DISORDERS CHIL; Wolfenstein M., 1955, CHILDHOOD CONT CULTU, P168; Zuckerman Michael, 1975, FAMILY HIST, P179	20	23	26	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 11	2004	329	7479					1394	1396		10.1136/bmj.329.7479.1394	http://dx.doi.org/10.1136/bmj.329.7479.1394			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	880JB	15591567	Green Published			2022-12-28	WOS:000225785000026
J	Gargett, A; Wells, J; Tejada-Martinez, AE; Grosch, CE				Gargett, A; Wells, J; Tejada-Martinez, AE; Grosch, CE			Langmuir supercells: A mechanism for sediment resuspension and transport in shallow seas	SCIENCE			English	Article							MIXED-LAYER; BUBBLE CLOUDS; CIRCULATION; OCEAN; TURBULENCE	Recent measurements at a cabled sea-floor node in 15 meters of water off the coast of New Jersey suggest that Langmuir supercells, Langmuir circulations that achieve vertical scales equal to the water depth under extended storms, are an important mechanism for major sediment resuspension events on the extensive shallow shelves off the eastern U.S. coast. Because sediment resuspension is a prelude to transport, supercell events are a necessary condition for major sediment transport. Such events may also contribute to shelf-sea exchange and to offshore gradation of benthic community structure in shallow seas.	Old Dominion Univ, Dept Ocean Earth & Atmospher Sci, Norfolk, VA 23529 USA	Old Dominion University	Gargett, A (corresponding author), Old Dominion Univ, Dept Ocean Earth & Atmospher Sci, Norfolk, VA 23529 USA.	gargett@ccpo.odu.edu		Gargett, Ann/0000-0002-7324-0668				BURDIGE D, COMMUNICATION; CRAIK ADD, 1976, J FLUID MECH, V73, P401, DOI 10.1017/S0022112076001420; DONELAN MA, 1985, PHILOS T R SOC LON A, V315; GLENN S, 2004, OCEANOGRAPHY, V17, P86; Gnanadesikan A, 1996, J FLUID MECH, V322, P81, DOI 10.1017/S0022112096002716; GRANT WD, 1986, ANNU REV FLUID MECH, V18, P265, DOI 10.1146/annurev.fl.18.010186.001405; Langmuir I, 1938, SCIENCE, V87, P119, DOI 10.1126/science.87.2250.119; Li M, 1997, J PHYS OCEANOGR, V27, P121, DOI 10.1175/1520-0485(1997)027<0121:MLDDTL>2.0.CO;2; LI M, 1993, J MAR RES, V51, P737, DOI 10.1357/0022240933223945; LONGUETHIGGINS MS, 1952, J MAR RES, V11, P245; Lumley J.L., 1979, ADV APPL MECH, V18, P123, DOI 10.1016/S0065-2156(08)70266-7; McWilliams JC, 1997, J FLUID MECH, V334, P1, DOI 10.1017/S0022112096004375; Papavassiliou DV, 1997, INT J HEAT FLUID FL, V18, P55, DOI 10.1016/S0142-727X(96)00138-5; POPE SB, 2000, TURBULENT FLOWS, P393; SKYLLINGSTAD ED, 1995, J GEOPHYS RES-OCEANS, V100, P8501, DOI 10.1029/94JC03202; SMITH J, 1987, J PHYS OCEANOGR, V17, P425, DOI 10.1175/1520-0485(1987)017<0425:VSITML>2.0.CO;2; Teixeira MAC, 2002, J FLUID MECH, V458, P229, DOI 10.1017/S0022112002007838; THORPE SA, 1983, CONT SHELF RES, V1, P353, DOI 10.1016/0278-4343(83)90003-1; WELLER RA, 1988, DEEP-SEA RES, V35, P711, DOI 10.1016/0198-0149(88)90027-1; ZEDEL L, 1991, J GEOPHYS RES-OCEANS, V96, P8889, DOI 10.1029/91JC00189	20	123	124	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2004	306	5703					1925	1928		10.1126/science.1100849	http://dx.doi.org/10.1126/science.1100849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591200				2022-12-28	WOS:000225695600041
J	Chang, P; Jacobson, MK; Mitchison, TJ				Chang, P; Jacobson, MK; Mitchison, TJ			Poly(ADP-ribose) is required for spindle assembly and structure	NATURE			English	Article							POLYMERASE; TANKYRASE; PROTEIN; DYNAMICS; NUMA; TUBULIN; IRAP; PARP	The mitotic spindle is typically thought of as an array of microtubules, microtubule-associated proteins and motors that self-organizes to align and segregate chromosomes(1). The major spindle components consist of proteins and DNA, the primary structural elements of the spindle(1). Other macromolecules including RNA and lipids also associate with spindles, but their spindle function, if any, is unknown. Poly(ADP-ribose) ( PAR) is a large, branched, negatively charged polymeric macromolecule whose polymerization onto acceptor proteins is catalysed by a family of poly(ADP-ribose) polymerases (PARPs)(2). Several PARPs localize to the spindle in vertebrate cells, suggesting that PARPs and/or PAR have a role in spindle function(2). Here we show that PAR is enriched in the spindle and is required for spindle function-PAR hydrolysis or perturbation leads to rapid disruption of spindle structure, and hydrolysis during spindle assembly blocks the formation of bipolar spindles. PAR exhibits localization dynamics that differ from known spindle proteins and are consistent with a low rate of turnover in the spindle. Thus, PAR is a non-proteinaceous, non-chromosomal component of the spindle required for bipolar spindle assembly and function.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA	Harvard University; Harvard Medical School; University of Arizona; Arizona Center Cancer Care; University of Arizona	Chang, P (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	paul_chang2@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070090] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM070090] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoufouchi S, 1997, BIOCHEM J, V325, P543, DOI 10.1042/bj3250543; Bakondi E, 2002, J HISTOCHEM CYTOCHEM, V50, P91, DOI 10.1177/002215540205000110; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; Dionne MA, 1999, CELL MOTIL CYTOSKEL, V42, P189, DOI 10.1002/(SICI)1097-0169(1999)42:3<189::AID-CM3>3.0.CO;2-X; Earle E, 2000, HUM MOL GENET, V9, P187, DOI 10.1093/hmg/9.2.187; HAAKEYAMA K, 1986, J BIOL CHEM, V261, P14902; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; OLMSTED JB, 1989, J CELL BIOL, V109, P211, DOI 10.1083/jcb.109.1.211; PickettHeaps JD, 1997, CELL MOTIL CYTOSKEL, V37, P1, DOI 10.1002/(SICI)1097-0169(1997)37:1<1::AID-CM1>3.0.CO;2-D; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; SLAMA JT, 1995, J MED CHEM, V38, P389, DOI 10.1021/jm00002a021; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Smith S, 1999, J CELL SCI, V112, P3649; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; TROLL W, 1990, BASIC LIFE SCI, V52, P225; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405	29	183	192	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					645	649		10.1038/nature03061	http://dx.doi.org/10.1038/nature03061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577915				2022-12-28	WOS:000225433200051
J	Boyle, P; Exeter, D; Feng, ZQ; Flowerdew, R				Boyle, P; Exeter, D; Feng, ZQ; Flowerdew, R			Suicide gap among young adults in Scotland: population study	BRITISH MEDICAL JOURNAL			English	Article							DEPRIVATION		Univ St Andrews, Sch Geog & Geosci, St Andrews KY16 9ST, Fife, Scotland	University of St Andrews	Boyle, P (corresponding author), Univ St Andrews, Sch Geog & Geosci, St Andrews KY16 9ST, Fife, Scotland.	P.Boyle@st-andrews.ac.uk		Exeter, Daniel/0000-0003-1061-5925				EXETER D, 1981, IN PRESS POPULATION; GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227; McLoone P, 1996, BRIT MED J, V312, P543, DOI 10.1136/bmj.312.7030.543; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Scottish Executive, 2002, CHOOS LIF NAT STRAT	5	28	28	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 22	2005	330	7484					175	176		10.1136/bmj.38328.559572.55	http://dx.doi.org/10.1136/bmj.38328.559572.55			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891OQ	15615765	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000226590800017
J	Stulemeijer, M; de Jong, LWAM; Fiselier, TJW; Hoogveld, SWB; Bleijenberg, G				Stulemeijer, M; de Jong, LWAM; Fiselier, TJW; Hoogveld, SWB; Bleijenberg, G			Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; CHILDREN	Objective To evaluate the efficacy of cognitive behaviour therapy for adolescents aged 10-17 years with chronic fatigue syndrome. Design Randomised controlled trial. Setting Department of child psychology. Participants 71 consecutively referred patients with chronic fatigue syndrome; 36 were randomly assigned to immediate cognitive behaviour therapy and 35 to the waiting list for therapy Intervention 10 sessions of therapy over five months. Treatment protocols depended on the type of activity pattern (relatively active or passive). All participants were assessed again after five months. Main outcome measures Fatigue severity (checklist individual strength), functional impairment (SF-36 physical functioning), and school attendance. Results 62 patients had complete data at five months (29 in the immediate therapy group and 33 on the waiting list). Patients in the therapy group reported significantly greater decrease in fatigue severity (difference in decrease on checklist individual strength was 14.5, 95% confidence interval 7.4 to 21.6) and functional impairment (difference in increase on SF-36 physical functioning was 17.3, 6.2 to 28.4) and their attendance at school increased significantly (difference in increase in percentage school attendance was 18.2, 0.8 to 35.5). They Also reported a significant reduction in several accompanying symptoms. Self reported improvement was largest in the therapy group. Conclusion Cognitive behaviour therapy is an effective treatment for chronic fatigue syndrome in adolescents.	Univ Med Ctr Nijmegen, Expert Ctr Chron Fatigue, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Med Psychol, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Paediat, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Bleijenberg, G (corresponding author), Univ Med Ctr Nijmegen, Expert Ctr Chron Fatigue, POB 9101, NL-6500 HB Nijmegen, Netherlands.	G.Bleijenberg@nkcv.umcn.nl	Bleijenberg, Gijs/E-6984-2010					Bell DS, 2001, PEDIATRICS, V107, P994; Beurskens AJHM, 2000, OCCUP ENVIRON MED, V57, P353, DOI 10.1136/oem.57.5.353; BLEIJENBREG C, 2003, HDB CHRONIC FATIGUE; CARTER BD, 1995, PEDIATRICS, V95, P179; Chalder T, 2003, BRIT MED J, V327, P654, DOI 10.1136/bmj.327.7416.654; Chalder T, 2002, ARCH DIS CHILD, V86, P95, DOI 10.1136/adc.86.2.95; Faul F., 1992, GPOWER PRIORI POSTHO; FRITZ U, 2000, HDB DEV PSYCHOPATHOL; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; FUKUSHIMA M, 1991, ADHESIVE DENT, V9, P9; Garralda ME, 2002, J CHILD PSYCHOL PSYC, V43, P169, DOI 10.1111/1469-7610.00010; Gill AC, 2004, ARCH PEDIAT ADOL MED, V158, P225, DOI 10.1001/archpedi.158.3.225; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Powell P, 2001, BMJ-BRIT MED J, V322, P387, DOI 10.1136/bmj.322.7283.387; Prins JB, 2001, LANCET, V357, P841, DOI 10.1016/S0140-6736(00)04198-2; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Taylor RR, 2003, HDB CHRONIC FATIGUE; van der Werf SP, 2000, J PSYCHOSOM RES, V49, P373, DOI 10.1016/S0022-3999(00)00197-5; Vercoulen JHMM, 1997, J PSYCHIAT RES, V31, P661, DOI 10.1016/S0022-3956(97)00039-3; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Whiting P, 2001, JAMA-J AM MED ASSOC, V286, P1360, DOI 10.1001/jama.286.11.1360	22	157	158	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 1	2005	330	7481					14	17		10.1136/bmj.38301.587106.63	http://dx.doi.org/10.1136/bmj.38301.587106.63			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885SH	15585538	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000226176700010
J	Maragakis, LL; Cosgrove, SE; Song, XY; Kim, D; Rosenbaum, P; Ciesla, N; Srinivasan, A; Ross, T; Carroll, K; Perl, TM				Maragakis, LL; Cosgrove, SE; Song, XY; Kim, D; Rosenbaum, P; Ciesla, N; Srinivasan, A; Ross, T; Carroll, K; Perl, TM			An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-STREAM INFECTIONS; RISK-FACTORS; PATTERNS; FEATURES; BROOKLYN; UNIT	Context Pulsatile lavage is a high-pressure irrigation treatment used increasingly in a variety of health care settings to debride wounds. Infection control precautions are not routinely used during the procedure and are not included in pulsatile lavage equipment package labeling. Objectives To investigate an outbreak of multidrug-resistant Acinetobacter baumannii and to test the hypothesis that pulsatile lavage wound treatment was the mode of transmission for the organism. Design Outbreak case-control investigation including case identification, review of medical records, environmental cultures, and pulsed-field gel electrophoresis. Setting A 1000-bed tertiary care hospital in Baltimore, Md, during September and October 2003. Patients The investigation included 11 patients infected or colonized with multidrug-resistant A baumannii. Seven of these patients met the case definition for the case-control study and were compared with 28 controls randomly selected from a list of inpatients without multidrug-resistant A baumannii who had a wound care consultation. Main Outcome Measure Infection or colonization with multidrug-resistant A baumannii. Results Eleven patients had cultures that grew multidrug-resistant A baumannii during the outbreak period. Of the 10 health care-associated cases, 8 had received pulsatile lavage treatment. One strain of multidrug-resistant A baumannii was recovered from all 6 pulsatile lavage patients who had isolates available for pulsed-field gel electrophoresis analysis and from multiple surfaces in the wound care area. Six of 7 cases (86%) were treated with pulsatile lavage vs 4 of 28 controls (14%) (odds ratio, 36; 95% confidence interval, 2.8-1721; P<.001). These results confirm that pulsatile lavage was a significant risk factor for acquisition of multidrug-resistant A baumannii. Conclusions Transmission was apparently caused by dissemination of multidrug-resistant A baumannii during the pulsatile lavage procedure, resulting in environmental contamination. Appropriate infection control precautions should be used during pulsatile lavage therapy and should be included in pulsatile lavage equipment labeling.	Johns Hopkins Univ Hosp, Dept Hosp Epidemiol & Infect Control, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ Hosp, Dept Phys Med & Rehabil, Baltimore, MD 21287 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Prevent Med, Baltimore, MD USA; Ctr Dis Control & Prevent, Div Healthcare Qual & Promot, Atlanta, GA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA	Maragakis, LL (corresponding author), Johns Hopkins Univ Hosp, Dept Hosp Epidemiol & Infect Control, 600 N Wolfe St,Osler 425, Baltimore, MD 21287 USA.	lmaraga1@jhmi.edu	Maragakis, Lisa/AAW-9806-2020		NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [K01CI000300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007291] Funding Source: NIH RePORTER; NIAID NIH HHS [5-T32/AI07291] Funding Source: Medline; ODCDC CDC HHS [UR8/CCU315092] Funding Source: Medline; NCPDCID CDC HHS [1 K01 CI000300-01] Funding Source: Medline	NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ODCDC CDC HHS; NCPDCID CDC HHS		CEFAI C, 1990, J HOSP INFECT, V15, P177, DOI 10.1016/0195-6701(90)90128-B; Das I, 2002, J HOSP INFECT, V50, P110, DOI 10.1053/jhin.2001.1127; Gales AC, 2001, CLIN INFECT DIS, V32, pS104, DOI 10.1086/320183; Greene DL, 2004, J ORTHOP TRAUMA, V18, P41, DOI 10.1097/00005131-200401000-00008; Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996; Landman D, 2002, ARCH INTERN MED, V162, P1515, DOI 10.1001/archinte.162.13.1515; Loeb MB, 2003, AM J EPIDEMIOL, V157, P40, DOI 10.1093/aje/kwf173; LOEHNE HB, 2002, S ADV WOUND CAR MED; LOEHNE HB, 2001, WOUND CARE COLLABORA; Mah MW, 2001, AM J INFECT CONTROL, V29, P284, DOI 10.1067/mic.2001.114232; Manikal VM, 2000, CLIN INFECT DIS, V31, P101, DOI 10.1086/313902; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Simor AE, 2002, INFECT CONT HOSP EP, V23, P261, DOI 10.1086/502046; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tobias AM, 2002, ANN PLAS SURG, V48, P443, DOI 10.1097/00000637-200204000-00019; Urban C, 2003, CLIN INFECT DIS, V36, P1268, DOI 10.1086/374847; Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205; Wisplinghoff H, 1999, CLIN INFECT DIS, V28, P59, DOI 10.1086/515067; Wisplinghoff H, 2000, CLIN INFECT DIS, V31, P690, DOI 10.1086/314040	19	86	95	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					3006	3011		10.1001/jama.292.24.3006	http://dx.doi.org/10.1001/jama.292.24.3006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613669				2022-12-28	WOS:000225841900035
J	Breiman, RF; Streatfield, PK; Phelan, M; Shifa, N; Rashid, M; Yunus, M				Breiman, RF; Streatfield, PK; Phelan, M; Shifa, N; Rashid, M; Yunus, M			Effect of infant immunisation on childhood mortality in rural Bangladesh: analysis of health and demographic surveillance data	LANCET			English	Article							MEASLES VACCINATION	Background In developing countries, immunisation programmes must compete with other strategies to improve public health and quality of life. Studies of long-term effects of immunisation programmes are rare. We assessed associations between vaccinations and mortality over 15 years after the introduction of routine infant immunisation programmes in Matlab, Bangladesh. Methods We analysed data recorded in a comprehensive health and demographic surveillance system from 1986 to 2001. We did univariate analyses and assessed vaccinations as independent factors with other variables in Cox models with time dependent covariates. Findings Diphtheria-tetanus-pertussis (DTP) and oral polio vaccination were independently associated with decreased risk of death before age 9 months, as were amount of maternal education, maternal age, and birth order of the child. DTP vaccination was associated with increased survival (hazard ratio=0.76, 95% CI 0.67-0.88; p=0.001) in a model evaluating mortality between 6 weeks and 9 months of age. Measles vaccination was also associated with increased survival when data after late immunisation with DTP and Bacille Calmette-Guerin (BCG) were excluded. BCG vaccination was associated with reduced survival; however, children vaccinated with BCG during the first 6 months of life had significantly lower risk of death than those vaccinated later (hazard ratio=0.59; 95% CI 0.47-0.73; p=0.0001). Interpretation By contrast with previous findings, we noted substantially reduced mortality among children who received DTP vaccine. This effect could be due to actual protection against pertussis disease and secondary illnesses or to a non-specific benefit, although we cannot rule out epidemiological artifact. Our findings show the value of population-based health surveillance systems.	Ctr Hlth & Populat Res, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; Ctr Dis Control & Prevent, Atlanta, GA USA	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA	Breiman, RF (corresponding author), CDC Kenya, Int Emerging Infect Program, Nairobi, Kenya.	rbreiman@cdc.gov						Allison P. D, 1995, SURVIVAL ANAL USING; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; CDC, 1999, MMWR MORB MORTAL WKL, V48, P243; Chen RT, 2001, INFECT DIS CLIN N AM, V15, P21, DOI 10.1016/S0891-5520(05)70266-X; CLAYTON D, 1996, STAT MODELS EPIDEMIO, P307; CLEMENS JD, 1988, AM J EPIDEMIOL, V128, P1330, DOI 10.1093/oxfordjournals.aje.a115086; COLLETT D, 1994, MODELLING SURVIVAL D, P223; Fine P, 2000, BRIT MED J, V321, P1439; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; HENDERSON RH, 1990, SCAND J INFECT DIS, P7; *ICDDRB CTR HLTH P, 2001, 88 ICDDRB CTR HLTH P; KOENIG MA, 1990, B WORLD HEALTH ORGAN, V68, P441; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Melgaard B, 2001, ACTA TROP, V80, P119, DOI 10.1016/S0001-706X(01)00165-6; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; PARMAR M, 1995, SURVIVAL ANAL PRACTI; PARMAR MKB, 2001, SAS SYSTEM WINDOWS R; Shann F, 2000, BMJ-BRIT MED J, V321, P1423, DOI 10.1136/bmj.321.7274.1423; STREATFIELD K, 1990, DEMOGRAPHY, V27, P447, DOI 10.2307/2061378; USA National Vaccine Advisory Committee, 1999, JAMA, Journal of the American Medical Association, V282, P363, DOI 10.1001/jama.282.4.363; Ward BJ, 2000, B WORLD HEALTH ORGAN, V78, P205	21	116	116	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2004	364	9452					2204	2211		10.1016/S0140-6736(04)17593-4	http://dx.doi.org/10.1016/S0140-6736(04)17593-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610807				2022-12-28	WOS:000225799700029
J	Kahn-Kirby, AH; Dantzker, JLM; Apicella, AJ; Schafer, WR; Browse, J; Bargmann, CI; Watts, JL				Kahn-Kirby, AH; Dantzker, JLM; Apicella, AJ; Schafer, WR; Browse, J; Bargmann, CI; Watts, JL			Specific polyunsaturated fatty acids drive TRPV-dependent sensory signaling in vivo	CELL			English	Article							NUCLEOTIDE-GATED CHANNEL; MECHANOSENSORY NEURONS; CAPSAICIN RECEPTOR; CATION CHANNEL; PROTEIN; RESPONSES; ENCODES; MUTANT; TOUCH; CHEMOSENSATION	A variety of lipid and lipid-derived molecules can modulate TRP cation channel activity, but the identity of the lipids that affect TRP channel function in vivo is unknown. Here, we use genetic and behavioral analysis in the nematode C. elegans to implicate a subset of 20-carbon polyunsaturated fatty acids (PUFAs) in TRPV channel-dependent olfactory and nociceptive behaviors. Olfactory and nociceptive TRPV signaling are sustained by overlapping but nonidentical sets of 20-carbon PUFAs including eicosapentaenoic acid (EPA) and arachidonic acid (AA). PUFAs act upstream of TRPV family channels in sensory transduction. Shortterm dietary supplementation with PUFAs can rescue PUFA biosynthetic mutants, and exogenous PUFAs elicit rapid TRPV-dependent calcium transients in sensory neurons, bypassing the normal requirement for PUFA synthesis. These results suggest that a subset of PUFAs with omega-3 and omega-6 acyl groups act as endogenous modulators of TRPV signal transduction.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, HHMI, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	Washington State University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego	Watts, JL (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	jwatts@mail.wsu.edu	Watts, Jennifer/AAC-7425-2020	Watts, Jennifer/0000-0003-4349-0639; Browse, John/0000-0002-2554-2821; Bargmann, Cornelia/0000-0002-8484-0618; Schafer, William/0000-0002-6676-8034	NIDA NIH HHS [DA016445] Funding Source: Medline; NIDCD NIH HHS [DC04089] Funding Source: Medline; NIGMS NIH HHS [R01 GM62521] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016445] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; Grimaldi M, 2003, J NEUROSCI, V23, P4737; Hardie RC, 2003, J BIOL CHEM, V278, P18851, DOI 10.1074/jbc.M300310200; Hardie RC, 2001, J EXP BIOL, V204, P3403; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HILGEMANN DW, SCI STKE 2001, pRE19; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; HILLIARD MA, 2004, IN PRESS EMBO J; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kniazeva M, 2003, GENETICS, V163, P159; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lesa GM, 2003, J CELL SCI, V116, P4965, DOI 10.1242/jcs.00918; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lopez PM, 2003, EUR J CLIN NUTR, V57, pS22, DOI 10.1038/sj.ejcn.1601805; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Montell C, 2003, CELL CALCIUM, V33, P409, DOI 10.1016/S0143-4160(03)00053-8; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Nonet ML, 1997, J NEUROSCI, V17, P8061; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; von Schacky C, 2004, CURR OPIN CLIN NUTR, V7, P131, DOI 10.1097/00075197-200403000-00005; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watts JL, 2003, GENETICS, V163, P581; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; West RJ, 2001, GENE, V266, P103, DOI 10.1016/S0378-1119(01)00373-0; Xu XZS, 2003, CELL, V114, P285, DOI 10.1016/S0092-8674(03)00565-8; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	57	125	136	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					889	900		10.1016/j.cell.2004.11.005	http://dx.doi.org/10.1016/j.cell.2004.11.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607983	Bronze			2022-12-28	WOS:000225907200017
J	Wang, ZF; Rolish, ME; Yeo, G; Tung, V; Mawson, M; Burge, CB				Wang, ZF; Rolish, ME; Yeo, G; Tung, V; Mawson, M; Burge, CB			Systematic identification and analysis of exonic splicing silencers	CELL			English	Article							MESSENGER-RNA; HNRNP A1; REGULATORY ELEMENTS; NONSENSE MUTATION; SEQUENCE MOTIFS; A/B PROTEINS; TAT EXON-2; BINDING; SITE; INHIBITION	Exonic splicing silencers (ESSs) are cis-regulatory elements that inhibit the use of adjacent splice sites, often contributing to alternative splicing (AS). To systematically identify ESSs, an in vivo splicing reporter system was developed to screen a library of random decanucleotides. The screen yielded 141 ESS decamers, 133 of which were unique. The silencer activity of over a dozen of these sequences was also confirmed in a heterologous exon/intron context and in a second cell type. Of the unique ESS decamers, most could be clustered into groups to yield seven putative ESS motifs, some resembling known motifs bound by hnRNPs H and A1. Potential roles of ESSs in constitutive splicing were explored using an algorithm, ExonScan, which simulates splicing based on known or putative splicing-related motifs. ExonScan and related bioinformatic analyses suggest that these ESS motifs play important roles in suppression of pseudoexons, in splice site definition, and in AS.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cburge@mit.edu	Burge, Christopher B./AAH-2177-2020; Yeo, Gene/AAE-7676-2019	Yeo, Gene/0000-0002-0799-6037; Wang, Zefeng/0000-0002-6605-3637				AMENDT BA, 1995, MOL CELL BIOL, V15, P4606; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Buratti E, 2004, MOL CELL BIOL, V24, P1387, DOI 10.1128/MCB.24.3.1387-1400.2004; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Caputi M, 2002, GENE DEV, V16, P1754, DOI 10.1101/gad.997502; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chen CD, 1999, GENE DEV, V13, P593, DOI 10.1101/gad.13.5.593; Cote J, 2001, P NATL ACAD SCI USA, V98, P938, DOI 10.1073/pnas.031564098; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; Domsic JK, 2003, MOL CELL BIOL, V23, P8762, DOI 10.1128/MCB.23.23.8762-8772.2003; Fairbrother WG, 2000, MOL CELL BIOL, V20, P6816, DOI 10.1128/MCB.20.18.6816-6825.2000; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Ladd AN, 2002, GENOME BIOL, V3; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; Si ZH, 1997, NUCLEIC ACIDS RES, V25, P861, DOI 10.1093/nar/25.4.861; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Sironi M, 2004, NUCLEIC ACIDS RES, V32, P1783, DOI 10.1093/nar/gkh341; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; Sterner DA, 1996, P NATL ACAD SCI USA, V93, P15081, DOI 10.1073/pnas.93.26.15081; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Tu M, 2000, MUTAT RES-GENOMICS, V432, P15, DOI 10.1016/S1383-5726(99)00011-4; Valentine CR, 1997, RNA, V3, P660; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wilkinson MF, 2002, NAT CELL BIOL, V4, pE144, DOI 10.1038/ncb0602-e144; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096; Zheng ZM, 1998, P NATL ACAD SCI USA, V95, P14088, DOI 10.1073/pnas.95.24.14088; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	48	506	528	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					831	845		10.1016/j.cell.2004.11.010	http://dx.doi.org/10.1016/j.cell.2004.11.010			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607979	Bronze			2022-12-28	WOS:000225907200013
J	Brookmeyer, R; Johnson, E; Bollinger, R				Brookmeyer, R; Johnson, E; Bollinger, R			Public health vaccination policies for containing an anthrax outbreak	NATURE			English	Article							POSTEXPOSURE PROPHYLAXIS; EMERGENCY RESPONSE; BIOLOGICAL WEAPON; PREVENTION; ATTACK; RISK	Concern about biological weapons has raised questions about the most effective public health policies to contain an anthrax outbreak(1-3). We developed a probability model to predict the impact of different anthrax antibiotic and vaccination policies. An anthrax outbreak can be significantly contained by minimizing the delay until initiation of antibiotic prophylaxis. However, even if mass distribution of antibiotics is completed within six days of the initial exposure, then at most about 70% of cases can be prevented. Post-exposure vaccination will not significantly increase that prevention rate if adherence to antibiotic regimens is similar or higher than that attained in the 2001 US outbreak(4). However, post-exposure vaccination can be useful either in shortening the duration of a prolonged antibiotic regimen, in the event of an antibiotic-resistant strain, or if antibiotic adherence rates are very low. Here we show that a mass pre-exposure vaccination programme for the general population would require very high population coverage rates to significantly increase prevention rates from that achieved with targeted and rapid post-exposure prophylaxis programmes.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Bollinger, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, 615 N Wolfe St, Baltimore, MD 21205 USA.	rbrook@jhsph.edu		Bollinger, Robert/0000-0002-6798-6834				Bozzette SA, 2003, NEW ENGL J MED, V348, P416, DOI 10.1056/NEJMsa025075; Brachman P S, 1980, Ann N Y Acad Sci, V353, P83, DOI 10.1111/j.1749-6632.1980.tb18910.x; Brookmeyer R, 2003, P NATL ACAD SCI USA, V100, P10129, DOI 10.1073/pnas.1631983100; Brookmeyer R, 2002, SCIENCE, V295, P1861, DOI 10.1126/science.1068474; Centers for Disease Control and Prevention, 2004, MASS ANT DISP PRIM; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1024; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P1008; CIESLAK TJ, 1999, INFECT DIS, V5, P51; *COMM RES DEV NEED, 1999, CHEM BIOL TERR; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Friedlander AM, 2000, CURR CLIN TOPICS INF, V20, P335; FRIEDLANDER AM, 1993, J INFECT DIS, V167, P1239, DOI 10.1093/infdis/167.5.1239; Haas CN, 2002, RISK ANAL, V22, P189, DOI 10.1111/0272-4332.00028; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; HENDERSON D. W., 1956, JOUR HYG, V54, P28; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Joellenbeck LM, 2002, ANTHRAX VACCINE IS I; Kaplan EH, 2002, P NATL ACAD SCI USA, V99, P10935, DOI 10.1073/pnas.162282799; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; *NAT I ALL INF DIS, 2002, DIS BIOD RES AG CDC; ROSS JM, 1957, J PATHOL BACTERIOL, V73, P485, DOI 10.1002/path.1700730219; Shepard CW, 2002, EMERG INFECT DIS, V8, P1124, DOI 10.3201/eid0810.020349; WATSON A, 1994, EPIDEMIOL INFECT, V113, P479, DOI 10.1017/S0950268800068497; Wein LM, 2003, P NATL ACAD SCI USA, V100, P4346, DOI 10.1073/pnas.0636861100	28	47	48	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					901	904		10.1038/nature03087	http://dx.doi.org/10.1038/nature03087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602561				2022-12-28	WOS:000225733500052
J	Fowler, J				Fowler, J			Limits of medical assistance - Beyond humanitarian bandages - Confronting genocide in Sudan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US Holocaust Mem Museum, Comm Conscience, Washington, DC 20024 USA		Fowler, J (corresponding author), US Holocaust Mem Museum, Comm Conscience, Washington, DC 20024 USA.							Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; NEWS BBC, 2004, AIDING DARFUR NURSES; *WHO, 2004, RETR MORT SURV INT D	3	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2574	2576		10.1056/NEJMp048297	http://dx.doi.org/10.1056/NEJMp048297			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602016				2022-12-28	WOS:000225726100002
J	Maria, SF; Russell, LM; Gilles, MK; Myneni, SCB				Maria, SF; Russell, LM; Gilles, MK; Myneni, SCB			Organic aerosol growth mechanisms and their climate-forcing implications	SCIENCE			English	Article							CHEMISTRY	Surface- and volume-limited chemical reactions on and in atmospheric aerosol particles cause growth while changing organic composition by 13 to 24% per day. Many of these particles contain carbonaceous components from mineral dust and combustion emissions in Africa, Asia, and North America and reveal reaction rates that are three times slower than those typically used in climate models. These slower rates for converting from volatile or hydrophobic to condensed and hygroscopic organic compounds increase carbonaceous particle burdens in climate models by 70%, producing organic aerosol climate forcings of as much as -0.8 watt per square meter cooling and +03 watt per square meter warming.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Princeton University; Princeton University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Russell, LM (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	lmrussell@ucsd.edu		Russell, Lynn/0000-0002-6108-2375				Charlson RJ, 2001, SCIENCE, V292, P2025, DOI 10.1126/science.1060096; Chung SH, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001397; Cooke WF, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001274; Cooke WF, 1999, J GEOPHYS RES-ATMOS, V104, P22137, DOI 10.1029/1999JD900187; Crahan KK, 2004, ATMOS ENVIRON, V38, P3757, DOI 10.1016/j.atmosenv.2004.04.009; Gard EE, 1998, SCIENCE, V279, P1184, DOI 10.1126/science.279.5354.1184; Garrett TJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002228; Grassian VH, 2001, INT REV PHYS CHEM, V20, P467, DOI 10.1080/01442350120722; Kanakidou M, 2000, J GEOPHYS RES-ATMOS, V105, P9243, DOI 10.1029/1999JD901148; Koch D, 2001, J GEOPHYS RES-ATMOS, V106, P20311, DOI 10.1029/2001JD900038; Maria SF, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003703; NOVAKOV T, 1993, NATURE, V365, P823, DOI 10.1038/365823a0; RAMASWAMY V, 2001, CLIMATE CHANGE 2001, P289; Ravishankara AR, 1997, SCIENCE, V276, P1058, DOI 10.1126/science.276.5315.1058; Russell LM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014874; Worsnop DR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015542	16	199	210	2	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2004	306	5703					1921	1924		10.1126/science.1103491	http://dx.doi.org/10.1126/science.1103491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591199				2022-12-28	WOS:000225695600040
J	Daviglus, ML; Liu, K; Yan, LJL; Pirzada, A; Manheim, L; Manning, W; Garside, DB; Wang, RW; Dyer, AR; Greenland, P; Stamler, J				Daviglus, ML; Liu, K; Yan, LJL; Pirzada, A; Manheim, L; Manning, W; Garside, DB; Wang, RW; Dyer, AR; Greenland, P; Stamler, J			Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; ASSOCIATION DETECTION PROJECT; HEALTH-CARE COSTS; CARDIOVASCULAR-DISEASE; UNITED-STATES; RISK-FACTOR; US ADULTS; FOLLOW-UP; OBESITY; OVERWEIGHT	Context Increasing prevalence of overweight/obesity and rapid aging of the US population have raised concerns of increasing health care costs, with important implications for Medicare. However, little is known about the impact of body mass index (BMI) earlier in life on Medicare expenditures (cardiovascular disease [CVD]-related, diabetes-related, and total) in older age. Objective To examine relationships of BMI in young adulthood and middle age to subsequent health care expenditures at ages 65 years and older. Design, Setting, and Participants Medicare data (1984-2002) were linked with baseline data from the Chicago Heart Association Detection Project in Industry (CHA) (1967-1973) for 9978 men (mean age, 46.0 years) and 7623 women (mean age, 48.4 years) (baseline overall age range, 33 to 64 years) who were free of coronary heart disease, diabetes, and major electrocardiographic abnormalities, were not underweight (BMI <18.5), and were Medicare-eligible (&GE;65 years) for at least 2 years during 1984-2002. Participants were classified by their baseline BMI as nonoverweight (BMI, 18.5-24.9), overweight (25.0-29.9), obese (30.0-34.9), and severely obese (&GE;35.0). Main Outcome Measures Cardiovascular disease-related, diabetes-related, and total average annual Medicare charges, and cumulative Medicare charges from age 65 years to death or to age 83 years. Results In multivariate analyses, average annual and cumulative Medicare charges (CVD-related, diabetes-related, and total) were significantly higher by higher baseline BMI for both men and women. Thus, with adjustment for baseline age, race, education, and smoking, total average annual charges for nonoverweight, overweight, obese, and severely obese women were, respectively, $6224, $7653, $9612, and $12342 (P<.001 for trend); corresponding total cumulative,Charges were $76866, $100959, $125470, and $174752 (P<.001 for trend). For nonoverweight, overweight, obese, and severely obese men, total average annual charges were, respectively, $7205, $8390, $10128, and $13674 (P<001 for trend). Corresponding total cumulative charges were $100431, $109098, $119318, and $176947 (P<.001 for trend). Conclusion Overweight/obesity in young adulthood and middle age has long-term adverse consequences for health care costs in older age.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Geriatr, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Hlth Serv Res & Policy Studies, Chicago, IL 60611 USA; Univ Chicago, Harris Sch Publ Policy Studies, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Chicago	Daviglus, ML (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	daviglus@northwestern.edu	Pirzada, Amber/ABG-6028-2021; Greenland, Philip/ABD-5528-2021	Pirzada, Amber/0000-0003-0526-3611; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021010, R01HL062684] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL21010, R01 HL62684] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; *AM HEART ASS, 2003, HEART STROK STAT 200; Bungum T, 2003, AM J HEALTH BEHAV, V27, P456, DOI 10.5993/AJHB.27.4.17; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cooper R, 2000, CIRCULATION, V102, P3137; Cornier MA, 2002, OBES RES, V10, P1167, DOI 10.1038/oby.2002.158; Daviglus ML, 2003, ARCH INTERN MED, V163, P2448, DOI 10.1001/archinte.163.20.2448; Daviglus ML, 1998, NEW ENGL J MED, V339, P1122, DOI 10.1056/NEJM199810153391606; Dorn JM, 1997, AM J EPIDEMIOL, V146, P919, DOI 10.1093/oxfordjournals.aje.a009218; Dyer AR, 2004, ANN EPIDEMIOL, V14, P101, DOI 10.1016/S1047-2797(03)00121-2; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Finkelstein EA, 2004, OBES RES, V12, P18, DOI 10.1038/oby.2004.4; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Foot DK, 2000, J AM COLL CARDIOL, V35, P1067, DOI 10.1016/S0735-1097(00)00561-1; FRIED VM, 2003, CHARTBOOK TRENDS HLT; *GLOB PREV SEC TRE, 1999, OB PREV MAN GLOB EP, P16; Gorsky RD, 1996, AM J PREV MED, V12, P388, DOI 10.1016/S0749-3797(18)30296-4; HLATKY MA, 1990, CIRCULATION, V82, P208; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kuriyama S, 2002, INT J OBESITY, V26, P1069, DOI 10.1038/sj.ijo.0802021; LEVINE JB, 1964, CLIN CHIM ACTA, V10, P381, DOI 10.1016/0009-8981(64)90073-7; *MED PAYM ADV COMM, 2004, REP C MED PAYM POL H; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; *NHLBI OB ED IN EX, 1998, NIH PUBL; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; PRINEAS RJ, 1983, HYPERTENSION, V5, P160; PRIYANATH A, 2001, JPN J CARDIOVASC D S, V36, P131; Pronk NP, 1999, JAMA-J AM MED ASSOC, V282, P2235, DOI 10.1001/jama.282.23.2235; Quesenberry CP, 1998, ARCH INTERN MED, V158, P466, DOI 10.1001/archinte.158.5.466; Shaper AG, 1997, BRIT MED J, V314, P1311, DOI 10.1136/bmj.314.7090.1311; STAMLER J, 1975, J CHRON DIS, V28, P527, DOI 10.1016/0021-9681(75)90060-0; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; Thompson D, 2001, OBES RES, V9, P210, DOI 10.1038/oby.2001.23; *US BUR CENS, 2002, STAT ABSTR US 2002, P453; *US DEP HHS, 1980, DHHS PUBL; Wang GJ, 2002, AM J PREV MED, V23, P1, DOI 10.1016/S0749-3797(02)00448-8; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461	39	168	172	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2004	292	22					2743	2749		10.1001/jama.292.22.2743	http://dx.doi.org/10.1001/jama.292.22.2743			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877CY	15585734	Bronze			2022-12-28	WOS:000225546600023
J	Campbell, S; Warner, M; Esiri, M; Lanzon-Miller, S; Butterworth, R				Campbell, S; Warner, M; Esiri, M; Lanzon-Miller, S; Butterworth, R			CJD - a case of mistaken identity	LANCET			English	Editorial Material							CREUTZFELDT-JAKOB-DISEASE; DIAGNOSIS		John Radcliffe Hosp, Oxford OX3 9DU, England; Queen Elizabeth II Hosp, Welwyn Garden City AL7 4HQ, Herts, England; Radcliffe Infirm, Dept Neuropathol, Oxford OX2 6HG, England; Milton Keynes Dist Gen Hosp, Milton Keynes MK6 5LD, Bucks, England	University of Oxford; Radcliffe Infirmary	Campbell, S (corresponding author), John Radcliffe Hosp, Headley Way, Oxford OX3 9DU, England.	simoncampbell@hotmail.com						Brandel JP, 1999, BIOMED PHARMACOTHER, V53, P14, DOI 10.1016/S0753-3322(99)80055-9; Chapman T, 2000, NEUROLOGY, V55, P1396, DOI 10.1212/WNL.55.9.1396; Giraud P, 2002, EUR NEUROL, V48, P218, DOI 10.1159/000066174; Green AJE, 2002, BIOCHEM SOC T, V30, P382, DOI 10.1042/bst0300382; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	5	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					2068	2068		10.1016/S0140-6736(04)17520-X	http://dx.doi.org/10.1016/S0140-6736(04)17520-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582065				2022-12-28	WOS:000225495700031
J	Lemmon, MT; Wolff, MJ; Smith, MD; Clancy, RT; Banfield, D; Landis, GA; Ghosh, A; Smith, PH; Spanovich, N; Whitney, B; Whelley, P; Greeley, R; Thompson, S; Bell, JF; Squyres, SW				Lemmon, MT; Wolff, MJ; Smith, MD; Clancy, RT; Banfield, D; Landis, GA; Ghosh, A; Smith, PH; Spanovich, N; Whitney, B; Whelley, P; Greeley, R; Thompson, S; Bell, JF; Squyres, SW			Atmospheric imaging results from the Mars exploration rovers: Spirit and Opportunity	SCIENCE			English	Article							GUSEV CRATER; MARTIAN ATMOSPHERE; MERIDIANI-PLANUM; PATHFINDER; DUST; IMAGER; TES; LOCALIZATION; AEROSOLS	A visible atmospheric optical depth of 0.9 was measured by the Spirit rover at Gusev crater and by the Opportunity rover at Meridiani Planum. Optical depth decreased by about 0.6 to 0.7% per sol through both 90-sol primary missions. The vertical distribution of atmospheric dust at Gusev crater was consistent with uniform mixing, with a measured scale height of 11.56+/-0.62 kilometers. The dust's cross section weighted mean radius was 1.47+/-0.21 micrometers (mum) at Gusev and 1.52+/-0.18 pm at Meridiani. Comparison of visible optical depths with 9-mum optical depths shows a visible-to-infrared optical depth ratio of 2.0+/-0.2 for comparison with previous monitoring of infrared optical depths.	Texas A&M Univ, College Stn, TX 77843 USA; Space Sci Inst, Boulder, CO 80301 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Cornell Univ, Ithaca, NY 14853 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Univ Arizona, Tucson, AZ 85721 USA; Arizona State Univ, Tempe, AZ 85287 USA	Texas A&M University System; Texas A&M University College Station; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Cornell University; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; University of Arizona; Arizona State University; Arizona State University-Tempe	Lemmon, MT (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	lemmon@tamu.edu	Lemmon, Mark/X-2333-2019; Smith, Michael/C-8875-2012; Whelley, Patrick/B-9560-2012; Lemmon, Mark T/E-9983-2010; Banfield, Don J/I-3523-2018	Lemmon, Mark/0000-0002-4504-5136; Whelley, Patrick/0000-0003-3266-9772; Lemmon, Mark T/0000-0002-4504-5136; Banfield, Don J/0000-0003-2664-0164				Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Balme MR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002096; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Clancy RT, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002058; COLBURN DS, 1989, ICARUS, V79, P159, DOI 10.1016/0019-1035(89)90114-0; Ferri F, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2000JE001421; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Greeley R, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002006; Johnson JR, 2003, ICARUS, V163, P330, DOI 10.1016/S0019-1035(03)00084-8; Kahn R. A., 1992, MARS, P1017; LIVINGSTON WC, 2000, ALLENS ASTROPHYSICAL; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; Markiewicz WJ, 1999, J GEOPHYS RES-PLANET, V104, P9009, DOI 10.1029/1998JE900033; POLLACK JB, 1995, J GEOPHYS RES-PLANET, V100, P5235, DOI 10.1029/94JE02640; POLLACK JB, 1980, J ATMOS SCI, V37, P868, DOI 10.1175/1520-0469(1980)037<0868:SBNPOS>2.0.CO;2; POLLACK JB, 1977, J GEOPHYS RES, V82, P8064; Smith MD, 2004, SCIENCE, V306, P1750, DOI 10.1126/science.1104257; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Smith PH, 1999, J GEOPHYS RES-PLANET, V104, P8975, DOI 10.1029/1998JE900017; Tomasko MG, 1999, J GEOPHYS RES-PLANET, V104, P8987, DOI 10.1029/1998JE900016; Wolff MJ, 1999, J GEOPHYS RES-PLANET, V104, P9027, DOI 10.1029/98JE01967	25	182	184	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1753	1756		10.1126/science.1104474	http://dx.doi.org/10.1126/science.1104474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576613				2022-12-28	WOS:000225630800045
J	Allen, MR; Lord, R				Allen, MR; Lord, R			The blame game	NATURE			English	Editorial Material									Univ Oxford, Dept Phys, Oxford OX1 3PU, England; Brick Court Chambers, London WC2R 3LD, England	University of Oxford	Allen, MR (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 3PU, England.		Allen, Myles R/A-5172-2012		Natural Environment Research Council [NER/T/S/2001/00968, NER/A/S/2002/00881] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allen M, 2003, NATURE, V421, P891, DOI 10.1038/421891a; Black E, 2004, WEATHER, V59, P217, DOI [10.1256/wea.74.04, DOI 10.1256/WEA.74.04]; CAMPBELL P, 2004, NATURE, V421, P1; COGAN D, 2003, CORPORATE GOVERNANCE; *EUR, 2004, ICRC WORLD DIS REP, pCH2; Grossman David A., 2003, COLUM J ENV L, V28, P1; Schar C, 2004, NATURE, V432, P559, DOI 10.1038/432559a; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089	9	44	44	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2004	432	7017					551	552		10.1038/432551a	http://dx.doi.org/10.1038/432551a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577882				2022-12-28	WOS:000225433200016
J	Joughin, I; Abdalati, W; Fahnestock, M				Joughin, I; Abdalati, W; Fahnestock, M			Large fluctuations in speed on Greenland's Jakobshavn Isbrae glacier	NATURE			English	Article							ICE-SHEET; WEST GREENLAND; RADAR INTERFEROMETRY; SURFICIAL GLACIOLOGY; OUTLET GLACIER; VELOCITIES; ACCELERATION; ANTARCTICA; COLLAPSE; SHELF	It is important to understand recent changes in the velocity of Greenland glaciers because the mass balance of the Greenland Ice Sheet is partly determined by the flow rates of these outlets. Jakobshavn Isbrae is Greenland's largest outlet glacier(1), draining about 6.5 per cent of the ice-sheet area, and it has been surveyed repeatedly since 1991 (ref. 2). Here we use remote sensing data to measure the velocity of Jakobshavn Isbr between 1992 and 2003. We detect large variability of the velocity over time, including a slowing down from 6,700 m yr(-1) in 1985 to 5,700 m yr(-1) in 1992, and a subsequent speeding up to 9,400 m yr(-1) by 2000 and 12,600 m yr(-1) in 2003. These changes are consistent with earlier evidence for thickening of the glacier in the early 1990s and rapid thinning thereafter(3). Our observations indicate that fast-flowing glaciers can significantly alter ice discharge at sub-decadal time-scales, with at least a potential to respond rapidly to a changing climate.	CALTECH, Jet Prop Lab, Pasadena, CA 91125 USA; NASA, Goddard Space Flight Ctr, Oceans & Ice Branch, Greenbelt, MD 20771 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Complex Syst Res Ctr, Durham, NH 03824 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System Of New Hampshire; University of New Hampshire	Joughin, I (corresponding author), Univ Washington, Appl Phys Lab, Polar Sci Ctr, 1013 NE 40th St, Seattle, WA 98105 USA.	ian@apl.washington.edu	Joughin, Ian R/A-2998-2008; Fahnestock, Mark/N-2678-2013; Joughin, Ian/AAR-7778-2021	Joughin, Ian R/0000-0001-6229-679X; Joughin, Ian/0000-0001-6229-679X				Abdalati W, 2001, J GEOPHYS RES-ATMOS, V106, P33729, DOI 10.1029/2001JD900192; Abdalati W, 2001, J GEOPHYS RES-ATMOS, V106, P33983, DOI 10.1029/2001JD900181; Abdalati W, 1999, REMOTE SENS ENVIRON, V67, P194, DOI 10.1016/S0034-4257(98)00086-8; De Angelis H, 2003, SCIENCE, V299, P1560, DOI 10.1126/science.1077987; ECHELMEYER K, 1990, J GLACIOL, V36, P82, DOI 10.3189/S0022143000005591; ECHELMEYER K, 1992, J GLACIOL, V38, P169, DOI 10.3189/S0022143000009709; ECHELMEYER K, 1991, J GLACIOL, V37, P368, DOI 10.3189/S0022143000005803; FASTOOK JL, 1995, J GLACIOL, V41, P161, DOI 10.3189/S0022143000017858; HOUGHTON JT, CLIMATE CHANGE 2001, pCH11; HUGHES T, 1986, GEOPHYS RES LETT, V13, P46, DOI 10.1029/GL013i001p00046; Joughin I, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001029; Joughin I, 2002, ANN GLACIOL-SER, V34, P195, DOI 10.3189/172756402781817978; Joughin I, 1996, SCIENCE, V274, P228, DOI 10.1126/science.274.5285.228; Krabill W, 2000, SCIENCE, V289, P428, DOI 10.1126/science.289.5478.428; Mohr JJ, 1998, NATURE, V391, P273, DOI 10.1038/34635; Paterson W.S.B., 1994, PHYS GLACIERS, Vthird; Rignot E, 2002, ANN GLACIOL, V34, P189, DOI 10.3189/172756402781817950; Rott H, 2002, ANN GLACIOL-SER, V34, P277, DOI 10.3189/172756402781817716; Scambos TA, 2000, J GLACIOL, V46, P516, DOI 10.3189/172756500781833043; SCAMBOS TA, 1992, REMOTE SENS ENVIRON, V42, P177, DOI 10.1016/0034-4257(92)90101-O; Sohn HG, 1998, GEOPHYS RES LETT, V25, P2699, DOI 10.1029/98GL01973; Thomas RH, 2003, J GLACIOL, V49, P231, DOI 10.3189/172756503781830764; Thomas RH, 2000, GEOPHYS RES LETT, V27, P1291, DOI 10.1029/1999GL008473; van der Veen CJ, 1998, COLD REG SCI TECHNOL, V27, P31, DOI 10.1016/S0165-232X(97)00022-0; Weidick A., 1995, 1386C USGS; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	26	358	362	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					608	610		10.1038/nature03130	http://dx.doi.org/10.1038/nature03130			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577906				2022-12-28	WOS:000225433200042
J	Stott, PA; Stone, DA; Allen, MR				Stott, PA; Stone, DA; Allen, MR			Human contribution to the European heatwave of 2003	NATURE			English	Article							20TH-CENTURY TEMPERATURE-CHANGE; CLIMATE-CHANGE; PART I; VARIABILITY; TRENDS; MODEL	The summer of 2003 was probably the hottest in Europe since at latest AD 1500(1-4), and unusually large numbers of heat-related deaths were reported in France, Germany and Italy(5). It is an ill-posed question whether the 2003 heatwave was caused, in a simple deterministic sense, by a modification of the external influences on climate-for example, increasing concentrations of greenhouse gases in the atmosphere-because almost any such weather event might have occurred by chance in an unmodified climate. However, it is possible to estimate by how much human activities may have increased the risk of the occurrence of such a heatwave(6-8). Here we use this conceptual framework to estimate the contribution of human-induced increases in atmospheric concentrations of greenhouse gases and other pollutants to the risk of the occurrence of unusually high mean summer temperatures throughout a large region of continental Europe. Using a threshold for mean summer temperature that was exceeded in 2003, but in no other year since the start of the instrumental record in 1851, we estimate it is very likely (confidence level > 90%)(9) that human influence has at least doubled the risk of a heatwave exceeding this threshold-magnitude.	Univ Reading, Hadley Ctr Climate Predict & Res, Reading Unit, Met Off, Reading RG6 6BB, Berks, England; Univ Oxford, Dept Phys, Oxford OX1 3PU, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Met Office - UK; Hadley Centre; University of Reading; University of Oxford; University of Oxford	Stott, PA (corresponding author), Univ Reading, Hadley Ctr Climate Predict & Res, Reading Unit, Met Off, Meteorol Bldg, Reading RG6 6BB, Berks, England.	peter.stott@metoffice.gov.uk	Allen, Myles R/A-5172-2012; Stott, Peter/N-1228-2016; Scott, Peter/GYA-5335-2022	Stott, Peter/0000-0003-4853-7686; Stone, Daithi/0000-0002-2518-100X	Natural Environment Research Council [NER/A/S/2002/00881, NER/T/S/2001/00968] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allen M, 2003, NATURE, V421, P891, DOI 10.1038/421891a; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Allen MR, 2003, CLIM DYNAM, V21, P477, DOI 10.1007/s00382-003-0313-9; Allen MR, 1999, CLIM DYNAM, V15, P419, DOI 10.1007/s003820050291; Beniston M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018857; Black E, 2004, WEATHER, V59, P217, DOI [10.1256/wea.74.04, DOI 10.1256/WEA.74.04]; Coles S., 2001, INTRO STAT MODELING; Colman A, 1999, INT J CLIMATOL, V19, P513, DOI 10.1002/(SICI)1097-0088(199904)19:5<513::AID-JOC370>3.0.CO;2-D; Giorgi F, 2002, CLIM DYNAM, V18, P675, DOI 10.1007/s00382-001-0204-x; Grossman David A., 2003, COLUM J ENV L, V28, P1; Houghton J.T., 2001, IPCC CLIMATE CHANGE; *I VEILL SAN, 2003, IMP SAN VAG CHAL AOU; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Jones PD, 2003, J CLIMATE, V16, P206, DOI 10.1175/1520-0442(2003)016<0206:HALSSA>2.0.CO;2; Karoly DJ, 2003, SCIENCE, V302, P1200, DOI 10.1126/science.1089159; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; NAKICEOVIC N, 2000, SPECIAL REPORT EMISS; Palmer TN, 2002, NATURE, V415, P512, DOI 10.1038/415512a; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; STONE DA, IN PRESS CLIM CHANGE; Stott PA, 2003, J CLIMATE, V16, P4079, DOI 10.1175/1520-0442(2003)016<4079:DMUTSC>2.0.CO;2; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Stott PA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017324; Stott PA, 2001, CLIM DYNAM, V17, P1, DOI 10.1007/PL00007924; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; TETT SFB, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029/2000JD00028; Zwiers FW, 2003, J CLIMATE, V16, P793, DOI 10.1175/1520-0442(2003)016<0793:TRSCCD>2.0.CO;2	28	1048	1075	10	251	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					610	614		10.1038/nature03089	http://dx.doi.org/10.1038/nature03089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577907				2022-12-28	WOS:000225433200043
J	Olesen, C; Sorensen, TLM; Nielsen, RC; Moller, JV; Nissen, P				Olesen, C; Sorensen, TLM; Nielsen, RC; Moller, JV; Nissen, P			Dephosphorylation of the calcium pump coupled to counterion occlusion	SCIENCE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; P-TYPE ATPASES; RECONSTITUTED PROTEOLIPOSOMES; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; DOMAIN-A; TRANSPORT; COUNTERTRANSPORT; CA-2+-ATPASE; TRANSDUCTION	P-type ATPases extract energy by hydrolysis of adenosine triphosphate (ATP) in two steps, formation and breakdown of a covalent phosphoenzyme intermediate. This process drives active. transport and countertransport of the cation pumps. We have determined the crystal structure of rabbit sarcoplasmic reticulum Ca2+ adenosine triphosphatase in complex with aluminum fluoride, which mimics the transition state of hydrolysis of the counterion-bound (protonated) phosphoenzyme. On the basis of structural analysis and biochemical data, we find this form to represent an occluded state of the proton counterions. Hydrolysis is catalyzed by the conserved Thr-Gly-Glu-Ser motif, and it exploits an associative nucleophilic reaction mechanism of the same type as phosphoryl transfer from ATP. On this basis, we propose a general mechanism of occluded transition states of Ca2+ transport and H+ countertransport coupled to phosphorylation and dephosphorylation, respectively.	Aarhus Univ, Dept Mol Biol, Ctr Struct Biol, DK-8000 Aarhus C, Denmark; Aarhus Univ, Inst Physiol & Biophys, Dept Biophys, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Moller, JV (corresponding author), Aarhus Univ, Dept Mol Biol, Ctr Struct Biol, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	jvm@biophys.au.dk; pn@mb.au.dk	Nissen, Poul/D-5774-2014; Sørensen, Thomas Lykke-Møller/AAA-7052-2020	Olesen, Claus/0000-0002-0462-1686; Nissen, Poul/0000-0003-0948-6628; Sorensen, Thomas Lykke-Moller/0000-0003-3873-3499				Barth A, 1997, J BIOL CHEM, V272, P25507, DOI 10.1074/jbc.272.41.25507; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; CORNELIUS F, 1991, FEBS LETT, V284, P46, DOI 10.1016/0014-5793(91)80758-U; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; DeLano W.L, PYMOL MOL GRAPHICS S; FORBUSH B, 1991, SOC GEN PHY, V46, P211; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; JENCKS WP, 1989, J BIOL CHEM, V264, P18855; Lancaster CRD, 2004, NATURE, V432, P286, DOI 10.1038/432286a; LEVY D, 1990, J BIOL CHEM, V265, P19524; Moller JV, 2003, ANN NY ACAD SCI, V986, P82, DOI 10.1111/j.1749-6632.2003.tb07142.x; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Seekoe T, 2001, J BIOL CHEM, V276, P46737, DOI 10.1074/jbc.M106320200; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6947; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Toustrup-Jensen M, 2003, J BIOL CHEM, V278, P11402, DOI 10.1074/jbc.M212136200; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9; YU X, 1994, J BIOL CHEM, V269, P16656; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	27	229	232	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2251	2255		10.1126/science.1106289	http://dx.doi.org/10.1126/science.1106289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618517				2022-12-28	WOS:000225950000045
J	Tzedakis, PC; Roucoux, KH; de Abreu, L; Shackleton, NJ				Tzedakis, PC; Roucoux, KH; de Abreu, L; Shackleton, NJ			The duration of forest stages in southern Europe and interglacial climate variability	SCIENCE			English	Article							SEA-LEVEL; MARINE; LONG; TERRESTRIAL; RECORDS; TEMPERATURE; VEGETATION; CYCLES; PHASE	Foraminiferal oxygen isotope and pollen analyses from a deep-sea sequence off southwest Portugal show that the duration of temperate stages on land over the past 350,000 years varied considerably. The record shows forest contractions during intervals of low ice volume, coeval with declines in atmospheric methane, after which tree populations did not always recover. What emerges is that, although the broad timing of interglacials is consistent with orbital theory, their specific duration may be dictated by millennial. variability. This complicates the prediction of the natural duration of interglacials, at least until the origin of this climate variability is understood.	Univ Leeds, Sch Geog, Earth & Biosphere Inst, Leeds LS2 9JT, W Yorkshire, England; Univ Cambridge, Dept Earth Sci, Godwin Lab, Cambridge CB2 3SA, England	University of Leeds; University of Cambridge	Tzedakis, PC (corresponding author), Univ Leeds, Sch Geog, Earth & Biosphere Inst, Leeds LS2 9JT, W Yorkshire, England.	P.C.Tzedakis@teeds.ac.uk	Tzedakis, Polychronis/J-1894-2012	Roucoux, Katherine/0000-0001-6757-7267; Tzedakis, Polychronis/0000-0001-6072-1166				Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Bard E, 2002, EARTH PLANET SC LETT, V196, P135, DOI 10.1016/S0012-821X(01)00600-8; Brook EJ, 1999, GEOPH MONOG SERIES, V112, P165; de Beaulieu JL, 2001, QUATERNARY SCI REV, V20, P1593, DOI 10.1016/S0277-3791(01)00027-0; Delmotte M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004417; FOLLIERI M, 1988, Pollen et Spores, V30, P329; Goni MFS, 1999, EARTH PLANET SC LETT, V171, P123; Kukla G, 1997, QUATERNARY SCI REV, V16, P605, DOI 10.1016/S0277-3791(96)00114-X; Parrenin F, 2003, EARTH PLANET SC LETT, V214, P243, DOI 10.1016/S0012-821X(03)00363-7; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Reille M, 1998, QUATERNARY SCI REV, V17, P1107, DOI 10.1016/S0277-3791(97)00093-0; REILLE M, 1995, QUATERNARY RES, V44, P205, DOI 10.1006/qres.1995.1065; Rohling EJ, 2003, CLIM DYNAM, V20, P257, DOI 10.1007/s00382-002-0266-4; Roucoux KH, 2001, QUATERNARY RES, V56, P128, DOI 10.1006/qres.2001.2218; SHACKLETON NJ, 1969, PROC R SOC SER B-BIO, V174, P135, DOI 10.1098/rspb.1969.0085; Shackleton NJ, 2003, GLOBAL PLANET CHANGE, V36, P151, DOI 10.1016/S0921-8181(02)00181-9; Shackleton NJ, 2002, QUATERNARY RES, V58, P14, DOI 10.1006/qres.2001.2312; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Turner C, 1998, QUATERN INT, V47-8, P41, DOI 10.1016/S1040-6182(97)00069-4; Tzedakis PC, 1997, EARTH PLANET SC LETT, V150, P171, DOI 10.1016/S0012-821X(97)00078-2; Tzedakis PC, 2003, EARTH PLANET SC LETT, V212, P197, DOI 10.1016/S0012-821X(03)00233-4; Tzedakis PC, 2002, QUATERNARY RES, V58, P53, DOI 10.1006/qres.2002.2328; Tzedakis PC, 2001, QUATERNARY SCI REV, V20, P1583, DOI 10.1016/S0277-3791(01)00025-7; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Watanabe O, 2003, NATURE, V422, P509, DOI 10.1038/nature01525; WIJMSTRA TA, 1976, ACTA BOT NEERL, V25, P297, DOI 10.1111/j.1438-8677.1976.tb00241.x	26	134	135	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2231	2235		10.1126/science.1102398	http://dx.doi.org/10.1126/science.1102398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15576573				2022-12-28	WOS:000225950000039
J	Ackerman, AS; Kirkpatrick, MP; Stevens, DE; Toon, OB				Ackerman, AS; Kirkpatrick, MP; Stevens, DE; Toon, OB			The impact of humidity above stratiform clouds on indirect aerosol climate forcing	NATURE			English	Article							MARINE BOUNDARY-LAYER; STRATOCUMULUS; MICROPHYSICS; PARAMETERIZATION; SUSCEPTIBILITY; INSTABILITY; SIMULATION; DYNAMICS; SHALLOW; ALBEDO	Some of the global warming from anthropogenic greenhouse gases is offset by increased reflection of solar radiation by clouds with smaller droplets that form in air polluted with aerosol particles that serve as cloud condensation nuclei(1). The resulting cooling tendency, termed the indirect aerosol forcing, is thought to be comparable in magnitude to the forcing by anthropogenic CO2, but it is difficult to estimate because the physical processes that determine global aerosol and cloud populations are poorly understood(2). Smaller cloud droplets not only reflect sunlight more effectively, but also inhibit precipitation, which is expected to result in increased cloud water(3,4). Such an increase in cloud water would result in even more reflective clouds, further increasing the indirect forcing. Marine boundary-layer clouds polluted by aerosol particles, however, are not generally observed to hold more water(5-7). Here we simulate stratocumulus clouds with a fluid dynamics model that includes detailed treatments of cloud microphysics and radiative transfer. Our simulations show that the response of cloud water to suppression of precipitation from increased droplet concentrations is determined by a competition between moistening from decreased surface precipitation and drying from increased entrainment of overlying air. Only when the overlying air is humid or droplet concentrations are very low does sufficient precipitation reach the surface to allow cloud water to increase with droplet concentrations. Otherwise, the response of cloud water to aerosol-induced suppression of precipitation is dominated by enhanced entrainment of overlying dry air. In this scenario, cloud water is reduced as droplet concentrations increase, which diminishes the indirect climate forcing.	NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Tasmania, Hobart, Tas 7001, Australia; Lawrence Livermore Natl Lab, Livermore, CA 94552 USA; Univ Colorado, Boulder, CO 80309 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Tasmania; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Colorado System; University of Colorado Boulder	Ackerman, AS (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	andrew.ackerman@nasa.gov	Kirkpatrick, Michael/AAB-9398-2019; Ackerman, Andrew S/D-4433-2012	Ackerman, Andrew S/0000-0003-0254-6253; Kirkpatrick, Michael/0000-0002-7157-6440				ACKERMAN AS, 1995, J GEOPHYS RES-ATMOS, V100, P7121, DOI 10.1029/95JD00026; Ackerman AS, 2000, J ATMOS SCI, V57, P2684, DOI 10.1175/1520-0469(2000)057<2684:EOAOCA>2.0.CO;2; Ackerman AS, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016634; ACKERMAN AS, 1995, J ATMOS SCI, V52, P1204, DOI 10.1175/1520-0469(1995)052<1204:AMFPMT>2.0.CO;2; ALBRECHT BA, 1989, SCIENCE, V245, P1227, DOI 10.1126/science.245.4923.1227; Brenguier JL, 2000, J ATMOS SCI, V57, P803, DOI 10.1175/1520-0469(2000)057<0803:RPOBLC>2.0.CO;2; BRETHERTON CS, 1995, J ATMOS SCI, V52, P2724, DOI 10.1175/1520-0469(1995)052<2724:CAMBLD>2.0.CO;2; Brown AR, 2001, BOUND-LAY METEOROL, V98, P411, DOI 10.1023/A:1018703209408; Coakley JA, 2002, J ATMOS SCI, V59, P668, DOI 10.1175/1520-0469(2002)059<0668:LTTAIR>2.0.CO;2; DEARDORFF JW, 1980, J ATMOS SCI, V37, P131, DOI 10.1175/1520-0469(1980)037<0131:CTEI>2.0.CO;2; DUYNKERKE PG, 1995, J ATMOS SCI, V52, P2763, DOI 10.1175/1520-0469(1995)052<2763:MATSON>2.0.CO;2; DUYNKERKE PG, IN PRESS Q JR METEOR; GERMANO M, 1991, PHYS FLUIDS A-FLUID, V3, P1760, DOI 10.1063/1.857955; Haywood J, 2000, REV GEOPHYS, V38, P513, DOI 10.1029/1999RG000078; HOUGHTON JT, 2001, CLIMATE CHANGE 2001, pCH5; Jiang HL, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001502; Knutti R, 2002, NATURE, V416, P719, DOI 10.1038/416719a; MACVEAN MK, 1990, J ATMOS SCI, V47, P1012, DOI 10.1175/1520-0469(1990)047<1012:CTEITS>2.0.CO;2; McFarlane SA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001011; Nakajima T, 2001, GEOPHYS RES LETT, V28, P1171, DOI 10.1029/2000GL012186; PINCUS R, 1994, NATURE, V372, P250, DOI 10.1038/372250a0; Platnick S, 2000, J ATMOS SCI, V57, P2607, DOI 10.1175/1520-0469(2000)057<2607:TROBCM>2.0.CO;2; RADKE LF, 1989, SCIENCE, V246, P1146, DOI 10.1126/science.246.4934.1146; RANDALL DA, 1980, J ATMOS SCI, V37, P125, DOI 10.1175/1520-0469(1980)037<0125:CIOTFK>2.0.CO;2; Stevens B, 1998, J ATMOS SCI, V55, P3616, DOI 10.1175/1520-0469(1998)055<3616:LESOSP>2.0.CO;2; Stevens B, 2003, Q J ROY METEOR SOC, V129, P3469, DOI 10.1256/qj.02.202; Stevens B, 2003, B AM METEOROL SOC, V84, P579, DOI 10.1175/BAMS-84-5-579; STEVENS B, 2003, 8 GCSS BOUND LAY CLO; STEVENS B, IN PRESS MON WEATH R; TOON OB, 1989, J GEOPHYS RES-ATMOS, V94, P16287, DOI 10.1029/JD094iD13p16287; TWOMEY S, 1974, ATMOS ENVIRON, V8, P1251, DOI 10.1016/0004-6981(74)90004-3; 1996, 4 GLOB EN WAT EXP GE	33	461	469	4	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1014	1017		10.1038/nature03174	http://dx.doi.org/10.1038/nature03174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616559	Green Submitted			2022-12-28	WOS:000225887000038
J	Dorman, SE; Picard, C; Lammas, D; Heyne, K; van Dissel, JT; Baretto, R; Rosenzweig, SD; Newport, M; Levin, M; Roesler, J; Kumararatne, D; Casanova, JL; Holland, SM				Dorman, SE; Picard, C; Lammas, D; Heyne, K; van Dissel, JT; Baretto, R; Rosenzweig, SD; Newport, M; Levin, M; Roesler, J; Kumararatne, D; Casanova, JL; Holland, SM		IFNgammaR1 Deficiency Study Grp	Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies	LANCET			English	Article							INTERFERON-GAMMA-RECEPTOR; BACILLE CALMETTE-GUERIN; INHERITED INTERLEUKIN-12 DEFICIENCY; SMALL DELETION HOTSPOT; IFN-GAMMA; MYCOBACTERIAL; INFECTION; CHILD; SUSCEPTIBILITY; IMMUNITY	Background Interferon gamma receptor 1 (IFNgammaR1) deficiency is a primary immunodeficiency with allelic dominant and recessive mutations characterised clinically by severe infections with mycobacteria. We aimed to compare the clinical features of recessive and dominant IFNgammaR1 deficiencies. Methods We obtained data from a large cohort of patients worldwide. We assessed these people by medical histories, records, and genetic and immunological studies. Data were abstracted onto a standard form. Findings We identified 22 patients with recessive complete IFNgammaR1 deficiency and 38 with dominant partial deficiency. BCG and environmental mycobacteria were the most frequent pathogens. In recessive patients, 17 (77%) had environmental mycobacterial disease and all nine BCG-vaccinated patients had, BCG disease. In dominant patients, 30 (79%) had environmental mycobacterial disease and 11 (73%) of 15 BCG-vaccinated patients had BCG disease. Compared with dominant patients, those with recessive deficiency were younger at onset of first environmental mycobacterial disease (mean 3.1 years [SD 2.5] vs 13.4 years [14.3], p=0.001), had more mycobacterial disease episodes (19 vs 8 per 100 person-years of observation, p=0.0001), had more severe mycobacterial disease (mean number of organs infected by Mycobacterium avium complex 4.1 [SD 0.8] vs 2.0 [1.1], p=0.004), had shorter mean disease-free intervals (1.6 years [SD 1.4] vs 7.2 years [7.6], p<0.0001), and lower Kaplan-Meier survival probability (p<0.0001). M avium complex osteomyelitis was more frequent in dominant than in recessive patients (22/28 [79%] vs 1/8 [13%], p=0.002), and this disorder without other organ involvement arose only in dominant patients (9/28 [32%]). Disease caused by rapidly growing mycobacteria was present in more recessive than dominant patients (7/22 [32%] vs 1/38 [3%], p=0.002). Interpretation Recessive complete and dominant partial IFNgammaR1 deficiencies have related clinical phenotypes, but are distinguishable by age at onset, dissemination, and clinical course of mycobacterial diseases. A strong correlation exists between IFNGR1 genotype, cellular responsiveness to interferon gamma, and clinical disease features.	NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; Univ Paris 05, Lab Human Genet Infect Dis, INSERM, U550,Necker Med Sch, Paris, France; Hop Necker Enfants Malad, Dept Paediat, Paediat Immunol Haematol Unit, Paris, France; Univ Birmingham, Div Immun & Infect, Birmingham, W Midlands, England; Illerweg, Kiel, Germany; Leiden Univ, Med Ctr, Leiden, Netherlands; Hosp Garrahan, Buenos Aires, DF, Argentina; Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Paediat, London, England; Univ Dresden, Dresden, Germany; Addenbrookes Hosp, Dept Clin Biochem & Immunol, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Birmingham; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London; Technische Universitat Dresden; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Casanova, JL (corresponding author), NIAID, Lab Clin Infect Dis, NIH, Bldg 10,CRC B3-419,10 Ctr Dr,MSC 1684, Bethesda, MD 20892 USA.	casanova@necker.fr; smh@nih.gov	Casanova, Jean-Laurent/I-3418-2017; Picard, Capucine/H-3914-2017; Uekama, Kaneto/G-9890-2011	Picard, Capucine/0000-0001-8788-5056; Levin, Michael/0000-0003-2767-6919; Newport, Melanie/0000-0002-8946-7525	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000647, Z01AI000647] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allende LM, 2001, CLIN DIAGN LAB IMMUN, V8, P133, DOI 10.1128/CDLI.8.1.133-137.2001; Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Altare F, 1998, AM J HUM GENET, V62, P723, DOI 10.1086/301750; [Anonymous], 1999, PRIMARY IMMUNODEFICI; Arend SM, 2001, NETH J MED, V59, P140, DOI 10.1016/S0300-2977(01)00152-8; Camcioglu Y, 2004, J PEDIATR-US, V144, P519, DOI 10.1016/j.jpeds.2003.11.012; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Cunningham JA, 2000, INT J TUBERC LUNG D, V4, P791; Doffinger R, 2000, J INFECT DIS, V181, P379, DOI 10.1086/315197; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Dorman SE, 1999, J PEDIATR-US, V135, P640, DOI 10.1016/S0022-3476(99)70064-8; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Dupuis S, 2000, IMMUNOL REV, V178, P129, DOI 10.1034/j.1600-065X.2000.17810.x; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Edgar JDM, 2001, J PEDIATR-US, V139, P600, DOI 10.1067/mpd.2001.117068; Fieschi C, 2003, EUR J IMMUNOL, V33, P1461, DOI 10.1002/eji.200324038; Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; Holland SM, 1998, J INFECT DIS, V178, P1095, DOI 10.1086/515670; Holland SM, 2000, MICROBES INFECT, V2, P1579, DOI 10.1016/S1286-4579(00)01314-9; Jouanguy E, 2000, J CLIN INVEST, V105, P1429, DOI 10.1172/JCI9166; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; Koscielniak E, 2003, PEDIATR INFECT DIS J, V22, P378; LEVIN M, 1995, LANCET, V345, P79, DOI 10.1016/S0140-6736(95)90059-4; LINCOLN EM, 1972, AM REV RESPIR DIS, V105, P683; Lotte A, 1984, Adv Tuberc Res, V21, P107; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; MCKUSICK V, 1998, CATALOGS HUMAN GENES; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; RASZKA WV, 1994, CLIN PEDIATR, V33, P611, DOI 10.1177/000992289403301007; Roesler J, 2004, J PEDIATR-US, V145, P806, DOI 10.1016/j.jpeds.2004.08.021; Roesler J, 1999, EXP HEMATOL, V27, P1368, DOI 10.1016/S0301-472X(99)00077-6; Rosenzweig S, 2002, CLIN IMMUNOL, V102, P25, DOI 10.1006/clim.2001.5135; SHEEHAN KCF, 1988, J IMMUNOL, V140, P4231; Vesterhus P, 1998, CLIN INFECT DIS, V27, P822, DOI 10.1086/514939; Villella A, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e47; Waibel KH, 2002, ANN ALLERG ASTHMA IM, V89, P239, DOI 10.1016/S1081-1206(10)61949-7	41	303	319	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2004	364	9451					2113	2121		10.1016/S0140-6736(04)17552-1	http://dx.doi.org/10.1016/S0140-6736(04)17552-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589309				2022-12-28	WOS:000225742300024
J	Lohse, D; Rauhe, R; Bergmann, R; van der Meer, D				Lohse, D; Rauhe, R; Bergmann, R; van der Meer, D			Creating a dry variety of quicksand	NATURE			English	Editorial Material									Univ Twente, Fac Sci, NL-7500 AE Enschede, Netherlands; Univ Twente, JM Burgers Ctr Fluid Dynam, NL-7500 AE Enschede, Netherlands	University of Twente; University of Twente	Lohse, D (corresponding author), Univ Twente, Fac Sci, POB 217, NL-7500 AE Enschede, Netherlands.	d.lohse@utwente.nl	Lohse, Detlef/B-4915-2013; van der Meer, Devaraj/B-6552-2013	Lohse, Detlef/0000-0003-4138-2255; van der Meer, Devaraj/0000-0003-4420-9714				Bagnold R., 1941, PHYS BLOWN SAND DESE; Jaeger HM, 1996, PHYS TODAY, V49, P32, DOI 10.1063/1.881494; Lawrence T. E., 1926, 7 PILLARS WISDOM; LIU CH, 1995, SCIENCE, V269, P513, DOI 10.1126/science.269.5223.513; Lohse D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.198003; Snoeijer JH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.054302; Stone MB, 2004, NATURE, V427, P503, DOI 10.1038/427503a; Thoroddsen ST, 2001, PHYS FLUIDS, V13, P4, DOI 10.1063/1.1328359	8	117	117	3	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					689	690		10.1038/432689a	http://dx.doi.org/10.1038/432689a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592401				2022-12-28	WOS:000225597200035
J	Lorber, B				Lorber, B			Update in infectious diseases	ANNALS OF INTERNAL MEDICINE			English	Review							PLACEBO-CONTROLLED TRIAL; WEST-NILE-VIRUS; SMALLPOX VACCINATION; DOUBLE-BLIND; TRANSMISSION; ANTIBIOTICS; ENFUVIRTIDE; OUTBREAK; HIV-1		Temple Univ, Dept Med, Sch Med, Philadelphia, PA 19140 USA; Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Lorber, B (corresponding author), Temple Univ, Dept Med, Sch Med, Broad St, Philadelphia, PA 19140 USA.	lorberb@tuhs.temple.edu						Barringer TA, 2003, ANN INTERN MED, V138, P365, DOI 10.7326/0003-4819-138-5-200303040-00005; Cool CD, 2003, NEW ENGL J MED, V349, P1113, DOI 10.1056/NEJMoa035115; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Martin M, 2003, NEW ENGL J MED, V348, P1112, DOI 10.1056/NEJMoa022521; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Steinman MA, 2003, ANN INTERN MED, V138, P525, DOI 10.7326/0003-4819-138-7-200304010-00008; Stohr K, 2003, LANCET, V361, P1730, DOI 10.1016/S0140-6736(03)13376-4; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534; 2003, MMWR MORB MORTAL WKL, V52, P360; 2003, MMWR MORB MORTAL WKL, V52, P362	17	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2004	141	11					875	881		10.7326/0003-4819-141-11-200412070-00012	http://dx.doi.org/10.7326/0003-4819-141-11-200412070-00012			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876WZ	15583230				2022-12-28	WOS:000225530700008
J	Rathbun, SW; Whitsett, TL; Raskob, GE				Rathbun, SW; Whitsett, TL; Raskob, GE			Negative D-dimer result to exclude recurrent deep venous thrombosis: A management trial	ANNALS OF INTERNAL MEDICINE			English	Article							PROXIMAL-VEIN THROMBOSIS; PULMONARY-EMBOLISM; INITIAL TREATMENT; DIAGNOSIS; THROMBOEMBOLISM; HEPARIN; ULTRASONOGRAPHY; OUTPATIENTS; EXCLUSION; UTILITY	Background: All of the available diagnostic tests for deep venous thrombosis (DVT) have limitations for excluding acute recurrent DVT. Measurement of plasma D-dimer by using an automated quantitative assay may be useful as a rapid exclusion test in patients with suspected recurrent DVT. Objective: To test the safety of withholding additional diagnostic testing and heparin treatment in patients who have a negative D-dimer result at presentation (using the automated quantitative assay STA-Liatest D-di), regardless of their symptoms. Design: Prospective cohort study. Setting: Academic medical center in the United States. Patients: 300 consecutive patients with suspected recurrent DVT. Intervention: Patients underwent D-dimer testing at presentation. In patients with negative D-dimer results, heparin therapy was withheld, and no further diagnostic testing for DVT was done as part of the initial evaluation. Patients with positive D-dimer results underwent compression ultrasonography. Measurements: The primary outcome measure was a diagnosis of new symptomatic venous thromboembolism confirmed by diagnostic testing during the 3-month follow-up period. Results: Of the 300 study patients, the D-dimer result was negative at presentation in 134 patients (45%; negative cohort) and positive at presentation in 166 patients. Of the 166 patients, compression ultrasonography documented new DVT in 54 patients. Compression ultrasonography findings were normal in 79 patients and were inconclusive in 33 patients. After 3 months of follow-up, 1 of 134 patients in the negative cohort had confirmed venous thromboembolism (0.75% [95% Cl, 0.02% to 4.09%]). Venous thromboembolism on follow-up could not be definitively excluded in 5 patients with recurrent leg symptoms and in 1 patient who died. If these patients are considered to have venous thromboembolism, the incidence during the 3-month follow-up period would be 6.0% (Cl, 2.6% to 11.4%) (8 of 134 patients). Limitations: There is no accepted diagnostic reference standard for recurrent DVT. The precision of the estimate of the incidence of venous thromboembolism on follow-up and the generalizability to settings other than an academic health center should be evaluated. Conclusions: Measurement of plasma D-dimer by using the automated quantitative assay STA-Liatest D-di seems to provide a simple method for excluding acute recurrent DVT in symptomatic patients.	Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Rathbun, SW (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, WP 3120,920 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	suman-rathbun@ouhsc.edu			NHLBI NIH HHS [K23 HL004200-04, K23 HL04200-03, K23 HL004200-03, K23 HL004200] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL004200] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Bates SM, 2003, ARCH INTERN MED, V163, P452, DOI 10.1001/archinte.163.4.452; Bernardi E, 1998, BRIT MED J, V317, P1037; BRANDJES DPM, 1992, NEW ENGL J MED, V327, P1485, DOI 10.1056/NEJM199211193272103; HEIJBOER H, 1992, ACTA RADIOL, V33, P297; HUISMAN MV, 1988, ARCH INTERN MED, V148, P681, DOI 10.1001/archinte.148.3.681; HUISMAN MV, 1996, VENOUS THROMBOEMBOLI; HULL R, 1981, CIRCULATION, V64, P622, DOI 10.1161/01.CIR.64.3.622; HULL R, 1979, NEW ENGL J MED, V301, P855, DOI 10.1056/NEJM197910183011602; HULL RD, 1986, NEW ENGL J MED, V315, P1109, DOI 10.1056/NEJM198610303151801; HULL RD, 1983, CIRCULATION, V67, P901, DOI 10.1161/01.CIR.67.4.901; KOOPMAN MMW, 1995, HAEMOSTASIS, V25, P49; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; MURPHY TP, 1990, RADIOLOGY, V177, P543, DOI 10.1148/radiology.177.2.2217798; Oger E, 1998, AM J RESP CRIT CARE, V158, P65, DOI 10.1164/ajrccm.158.1.9710058; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; PRANDONI P, 1993, CIRCULATION, V88, P1730, DOI 10.1161/01.CIR.88.4.1730; Prandoni P, 2002, ANN INTERN MED, V137, P955, DOI 10.7326/0003-4819-137-12-200212170-00008; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; van der Graaf F, 2000, THROMB HAEMOSTASIS, V83, P191; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; 1990, JAMA, V263, P2753	27	63	66	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2004	141	11					839	845		10.7326/0003-4819-141-11-200412070-00007	http://dx.doi.org/10.7326/0003-4819-141-11-200412070-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876WZ	15583225	Green Accepted			2022-12-28	WOS:000225530700003
J	Spiegel, K; Tasali, E; Penev, P; Van Cauter, E				Spiegel, K; Tasali, E; Penev, P; Van Cauter, E			Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite	ANNALS OF INTERNAL MEDICINE			English	Article							OBESITY; NEUROENDOCRINE; DEPRIVATION; DURATION; SYSTEMS; HUMANS; ADULTS	Background: Total sleep deprivation in rodents and in humans has been associated with hyperphagia. Over the past 40 years, self-reported sleep duration in the United States has decreased by almost 2 hours. Objective: To determine whether partial sleep curtailment, an increasingly prevalent behavior, alters appetite regulation. Design: Randomized, 2-period, 2-condition crossover clinical study. Setting: Clinical Research Center, University of Chicago, Chicago, Illinois. Patients: 12 healthy men (mean age [+/-SD, 22 +/- 2 years; mean body mass index [+/-SD], 23.6 +/- 2.0 kg/M-2). Measurements: Daytime profiles of plasma leptin and ghrelin levels and subjective ratings of hunger and appetite. Intervention: 2 days of sleep restriction and 2 days of sleep extension under controlled conditions of caloric intake and physical activity. Results: sleep restriction was associated with average reductions in the anorexigenic hormone leptin (decrease, 18%; P= 0.04), elevations in the orexigenic factor ghrelin (increase, 28%; P < 0.04), and increased hunger (increase, 24%; P < 0.01) and appetite (increase, 23%; P = 0.01), especially for calorie-dense foods with high carbohydrate content (increase, 33% to 45%; P= 0.02). Limitations: The study included only 12 young men and did not measure energy expenditure. Conclusions: Short sleep duration in young, healthy men is associated with decreased leptin levels, increased ghrelin levels, and increased hunger and appetite.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Free Univ Brussels, Brussels, Belgium	University of Chicago; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Van Cauter, E (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA.		Spiegel, Karine/H-4456-2017		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000055] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, R01DK041814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR-00055, P41 RR013642] Funding Source: Medline; NHLBI NIH HHS [HL-72694] Funding Source: Medline; NIA NIH HHS [AG-11412] Funding Source: Medline; NIDDK NIH HHS [DK-41814, DK-20595] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Chin-Chance C, 2000, J CLIN ENDOCR METAB, V85, P2685, DOI 10.1210/jc.85.8.2685; DANGUIR J, 1979, PHYSIOL BEHAV, V22, P735, DOI 10.1016/0031-9384(79)90240-3; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; FERNSTROM MH, 1987, BIOL PSYCHIAT, V22, P529, DOI 10.1016/0006-3223(87)90180-6; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Heath RB, 2004, J ENDOCRINOL, V180, P273, DOI 10.1677/joe.0.1800273; Irwin M, 1999, J CLIN ENDOCR METAB, V84, P1979, DOI 10.1210/jc.84.6.1979; KRIPKE DF, 1979, ARCH GEN PSYCHIAT, V36, P103; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Muccioli G, 2002, EUR J PHARMACOL, V440, P235, DOI 10.1016/S0014-2999(02)01432-2; *NAT SLEEP FND, 2000, 2000 SLEEP AM POLL; *NAT SLEEP FND, 2001, 2002 SLEEP AM POLL; *NAT SLEEP FND, 2001, 2001 SLEEP AM POLL; Rayner DV, 2001, J MOL MED, V79, P8, DOI 10.1007/s001090100198; Seale JL, 1999, EUR J CLIN NUTR, V53, P107, DOI 10.1038/sj.ejcn.1600685; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Stubbs RJ, 2000, BRIT J NUTR, V84, P405, DOI 10.1017/S0007114500001719; Sugino T, 2003, BIOCHEM BIOPH RES CO, V304, P308, DOI 10.1016/S0006-291X(03)00593-X; Taheri S, 2004, SLEEP, V27, P146; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Vioque J, 2000, INT J OBESITY, V24, P1683, DOI 10.1038/sj.ijo.0801434; Zhang K, 2002, INT J OBESITY, V26, P376, DOI 10.1038/sj.ijo.0801922	23	1562	1613	1	181	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2004	141	11					846	850		10.7326/0003-4819-141-11-200412070-00008	http://dx.doi.org/10.7326/0003-4819-141-11-200412070-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876WZ	15583226				2022-12-28	WOS:000225530700004
J	Kahneman, D; Krueger, AB; Schkade, DA; Schwarz, N; Stone, AA				Kahneman, D; Krueger, AB; Schkade, DA; Schwarz, N; Stone, AA			A survey method for characterizing daily life experience: The day reconstruction method	SCIENCE			English	Article							QUALITY	The Day Reconstruction Method (DRM) assesses how people spend their time and how they experience the various activities and settings of their lives, combining features of time-budget measurement and experience sampling. Participants systematically reconstruct their activities and experiences of the preceding day with procedures designed to reduce recall biases. The DRM's utility is shown by documenting close correspondences between the DRM reports of 909 employed women and established results from experience sampling. An analysis of the hedonic treadmill shows the DRM's potential for well-being research.	Univ Calif San Diego, Rady Sch Management, La Jolla, CA 92093 USA; Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08540 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; Princeton Univ, Dept Econ, Princeton, NJ 08540 USA; Univ Michigan, Inst Social Res, Ann Arbor, MI 48106 USA; Univ Michigan, Dept Psychol, Ann Arbor, MI 48106 USA; SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA	University of California System; University of California San Diego; Princeton University; Princeton University; Princeton University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Schkade, DA (corresponding author), Univ Calif San Diego, Rady Sch Management, La Jolla, CA 92093 USA.	schkade@ucsd.edu	Stone, Arthur A./AAC-3610-2019; Schwarz, Norbert/B-3591-2008	Schwarz, Norbert/0000-0002-8868-7067				Andrews F. M., 1976, SOCIAL INDICATORS WE; Axarloglou K, 2003, J EUR ECON ASSOC, V1, P1402, DOI 10.1162/154247603322752584; BECKER GS, 1965, ECON J, V75, P493, DOI 10.2307/2228949; Belli RF, 1998, MEMORY, V6, P383, DOI 10.1080/741942610; BERGNER M, 1987, ANNU REV PUBL HEALTH, V8, P191, DOI 10.1146/annurev.publhealth.8.1.191; Brickman P., 1971, ADAPTATION LEVEL THE, P215; Campbell A, 1981, SENSE WELL BEING AM; Cohen S, 2003, PSYCHOL SCI, V14, P389, DOI 10.1111/1467-9280.01452; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Diener E, 2009, SOC INDIC RES SER, V37, P201, DOI [10.1111/j.0963-7214.2004.00501001.x, 10.1007/978-90-481-2350-6_9]; Dow G. K., 1985, TIME GOODS WELL BEIN, P397; EASTERLIN RA, 1995, J ECON BEHAV ORGAN, V27, P35, DOI 10.1016/0167-2681(95)00003-B; Edgeworth F.Y., 1881, MATH PSYCHICS ESSAY; Flood L, 1997, HOUSEHOLD MARKET NON, VVI; FORTSON KN, 2004, MON LABOR REV, V127, P18, DOI DOI 10.2307/41888141; Juster FT, 1985, TIME GOODS WELL BEIN, P397; Kahneman D, 1997, Q J ECON, V112, P375, DOI 10.1162/003355397555235; Kahneman D, 2004, AM ECON REV, V94, P429, DOI 10.1257/0002828041301713; KAHNEMAN D, 2000, CHOICES VALUES FRAME, pCH38; LYUBOMIRSKY S, IN PRESS REV GEN PSY; Marmot M, 2004, STATUS SYNDROME; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; Schkade DA, 1998, PSYCHOL SCI, V9, P340, DOI 10.1111/1467-9280.00066; Semmer NK, 2004, R OCC ST W, V3, P205; Stone AA, 1998, J PERS SOC PSYCHOL, V74, P1670, DOI 10.1037/0022-3514.74.6.1670; Stone AA., 1999, WELL BEING FDN HEDON, P26; VANDEVEN P, 1999, MEASURING WELL BEING	27	1739	1778	12	315	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1776	1780		10.1126/science.1103572	http://dx.doi.org/10.1126/science.1103572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	878FA	15576620				2022-12-28	WOS:000225630800053
J	Chiaverini, J; Leibfried, D; Schaetz, T; Barrett, MD; Blakestad, RB; Britton, J; Itano, WM; Jost, JD; Knill, E; Langer, C; Ozeri, R; Wineland, DJ				Chiaverini, J; Leibfried, D; Schaetz, T; Barrett, MD; Blakestad, RB; Britton, J; Itano, WM; Jost, JD; Knill, E; Langer, C; Ozeri, R; Wineland, DJ			Realization of quantum error correction	NATURE			English	Article							TRAPPED IONS; TELEPORTATION; COMPUTERS; STATES; CODE	Scalable quantum computation(1) and communication require error control to protect quantum information against unavoidable noise. Quantum error correction(2,3) protects information stored in two-level quantum systems (qubits) by rectifying errors with operations conditioned on the measurement outcomes. Error-correction protocols have been implemented in nuclear magnetic resonance experiments(4-6), but the inherent limitations of this technique(7) prevent its application to quantum information processing. Here we experimentally demonstrate quantum error correction using three beryllium atomic-ion qubits confined to a linear, multi-zone trap. An encoded one-qubit state is protected against spin-flip errors by means of a three-qubit quantum error-correcting code. A primary ion qubit is prepared in an initial state, which is then encoded into an entangled state of three physical qubits (the primary and two ancilla qubits). Errors are induced simultaneously in all qubits at various rates. The encoded state is decoded back to the primary ion one-qubit state, making error information available on the ancilla ions, which are separated from the primary ion and measured. Finally, the primary qubit state is corrected on the basis of the ancillae measurement outcome. We verify error correction by comparing the corrected final state to the uncorrected state and to the initial state. In principle, the approach enables a quantum state to be maintained by means of repeated error correction, an important step towards scalable fault-tolerant quantum computation using trapped ions.	NIST, Div Time & Frequency, Boulder, CO 80305 USA; NIST, Math & Computat Sci Div, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA	Chiaverini, J (corresponding author), NIST, Div Time & Frequency, Boulder, CO 80305 USA.	john.chiaverini@boulder.nist.gov	Itano, Wayne/AAV-8781-2020; Jost, John D/F-4701-2010; Barrett, Murray D/G-2732-2012	Barrett, Murray D/0000-0002-1483-8029; Britton, Joe/0000-0001-8103-7347; jost, john/0000-0002-1698-8602				Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Calderbank AR, 1996, PHYS REV A, V54, P1098, DOI 10.1103/PhysRevA.54.1098; Cory DG, 1998, PHYS REV LETT, V81, P2152, DOI 10.1103/PhysRevLett.81.2152; Cory DG, 2000, FORTSCHR PHYS, V48, P875, DOI 10.1002/1521-3978(200009)48:9/11<875::AID-PROP875>3.0.CO;2-V; King BE, 1998, PHYS REV LETT, V81, P1525, DOI 10.1103/PhysRevLett.81.1525; Knill E, 2001, PHYS REV LETT, V86, P5811, DOI 10.1103/PhysRevLett.86.5811; Leibfried D, 2004, SCIENCE, V304, P1476, DOI 10.1126/science.1097576; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Leung D, 1999, PHYS REV A, V60, P1924, DOI 10.1103/PhysRevA.60.1924; Lo HK, 1999, SCIENCE, V283, P2050, DOI 10.1126/science.283.5410.2050; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Preskill J, 1998, P ROY SOC A-MATH PHY, V454, P385, DOI 10.1098/rspa.1998.0167; Rowe MA, 2002, QUANTUM INF COMPUT, V2, P257; Schaetz T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040505; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; Steane A, 1996, P ROY SOC A-MATH PHY, V452, P2551, DOI 10.1098/rspa.1996.0136; Wineland DJ, 2003, PHILOS T R SOC A, V361, P1349, DOI 10.1098/rsta.2003.1205	20	336	343	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2004	432	7017					602	605		10.1038/nature03074	http://dx.doi.org/10.1038/nature03074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577904				2022-12-28	WOS:000225433200040
J	Huber, TL; Kouskoff, V; Fehling, HJ; Palis, J; Keller, G				Huber, TL; Kouskoff, V; Fehling, HJ; Palis, J; Keller, G			Haemangioblast commitment is initiated in the primitive streak of the mouse embryo	NATURE			English	Article							DEFINITIVE HEMATOPOIESIS; CELL-DIFFERENTIATION; EXPRESSION PATTERN; COMMON PRECURSOR; MESODERMAL CELLS; SMOOTH-MUSCLE; YOLK-SAC; GENE; FLK-1; ERYTHROPOIESIS	Haematopoietic and vascular cells are thought to arise from a common progenitor called the haemangioblast. Support for this concept has been provided by embryonic stem (ES) cell differentiation studies that identified the blast colony-forming cell (BL-CFC), a progenitor with both haematopoietic and vascular potential(1,2). Using conditions that support the growth of BL-CFCs, we identify comparable progenitors that can form blast cell colonies (displaying haematopoietic and vascular potential) in gastrulating mouse embryos. Cell mixing and limiting dilution analyses provide evidence that these colonies are clonal, indicating that they develop from a progenitor with haemangioblast potential. Embryo-derived haemangioblasts are first detected at the mid-streak stage of gastrulation and peak in number during the neural plate stage. Analysis of embryos carrying complementary DNA of the green fluorescent protein targeted to the brachyury locus demonstrates that the haemangioblast is a subpopulation of mesoderm that co-expresses brachyury ( also known as T) and Flk-1 (also known as Kdr). Detailed mapping studies reveal that haemangioblasts are found at highest frequency in the posterior region of the primitive streak, indicating that initial stages of haematopoietic and vascular commitment occur before blood island development in the yolk sac.	CUNY Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; Univ Clin, Fac Med, Dept Immunol, D-89081 Ulm, Germany; Univ Rochester, Med Ctr, Dept Pediat, Ctr Canc, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Human Genet & Mol Pediat Dis, Rochester, NY 14642 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Paterson Institute for Cancer Research; Ulm University; University of Rochester; University of Rochester	Keller, G (corresponding author), CUNY Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA.	james_palis@urmc.rochester.edu; gordon.keller@mssm.edu		Keller, Gordon/0000-0001-9309-9297; Palis, James/0000-0001-7324-1049				Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Biben C, 1998, DEV BIOL, V194, P135, DOI 10.1006/dbio.1997.8812; BRADY G, 1993, METHOD ENZYMOL, V225, P611; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Choi K, 1998, DEVELOPMENT, V125, P725; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; DUBAND JL, 1993, DIFFERENTIATION, V55, P1, DOI 10.1111/j.1432-0436.1993.tb00027.x; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; Kabrun N, 1997, DEVELOPMENT, V124, P2039; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; ORKIN SH, 1992, BLOOD, V80, P575; Palis J, 1999, DEVELOPMENT, V126, P5073; Robertson SM, 2000, DEVELOPMENT, V127, P2447; Saga Y, 1996, DEVELOPMENT, V122, P2769; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Silver L, 1997, BLOOD, V89, P1154, DOI 10.1182/blood.V89.4.1154; Sitzmann J, 1995, ONCOGENE, V11, P2273; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001	28	480	505	4	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					625	630		10.1038/nature03122	http://dx.doi.org/10.1038/nature03122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577911				2022-12-28	WOS:000225433200047
J	Watts, G				Watts, G			Science commentary: Radon blues	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Watts, G (corresponding author), 28 New End Sq, London NW3 1LS, England.	geoff@scileg.freeserve.co.uk						Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; HOWARTH C, 2004, ENV RADON NEWSLETTER, V39, P4; Naismith SP, 1998, HEALTH PHYS, V75, P410, DOI 10.1097/00004032-199810000-00008; *PARL OFF SCI TECH, RED RAD RISKS HOM	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2005	330	7485					226	227		10.1136/bmj.38315.668009.63	http://dx.doi.org/10.1136/bmj.38315.668009.63			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894GR	15613367	Bronze, Green Published			2022-12-28	WOS:000226779400018
J	Wilbanks, AM; Fralish, GB; Kirby, ML; Barak, LS; Li, YX; Caron, MG				Wilbanks, AM; Fralish, GB; Kirby, ML; Barak, LS; Li, YX; Caron, MG			beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway	SCIENCE			English	Article							PROTEIN-KINASE-A; SONIC-HEDGEHOG; NEGATIVE REGULATOR; BETA-ARRESTIN; EXPRESSION; RECEPTOR; MUTATIONS; TRANSDUCTION; SUPPRESSOR; HOMOLOG	beta-arrestins are multifunctional proteins that act as scaffolds and transducers of intracellular signals from heptahelical transmembrane-spanning receptors (7TMR). Hedgehog (Hh) signaling, which uses the putative 7TMR, Smoothened, is established as a fundamental pathway in development, and unregulated Hh signaling is associated with certain malignancies. Here, we show that the functional knockdown of beta-arrestin 2 in zebrafish embryos recapitulates the many phenotypes of Hh pathway mutants. Expression of wild-type beta-arrestin 2, or constitutive activation of the Hh pathway downstream of Smoothened, rescues the phenotypes caused by beta-arrestin 2 deficiency. These results suggest that a functional interaction between beta-arrestin 2 and Smoothened may be critical to regulate Hh signaling in zebrafish development.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Ctr Models Human Dis,Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Li, YX (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	lyx@duke.edu; caron002@mc.duke.edu		Li, Yinxiong/0000-0002-8802-7720	NHLBI NIH HHS [HL36059, HL61365] Funding Source: Medline; NIGMS NIH HHS [GM069086-01] Funding Source: Medline; NINDS NIH HHS [NS19576] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036059, R01HL061365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM069086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barresi MJF, 2000, DEVELOPMENT, V127, P2189; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen WB, 2001, DEVELOPMENT, V128, P2385; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Concordet JP, 1996, DEVELOPMENT, V122, P2835; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; EKKER M, 1992, DEVELOPMENT, V116, P1001; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; HATTA K, 1991, DEVELOPMENT, V112, P821; HOPKINS N, UNPUB; Luttrell LM, 2002, J CELL SCI, V115, P455; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; NYAKKEN K, 2002, CURR OPIN GENE DEV, V12, P503; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Stickney HL, 2000, DEV DYNAM, V219, P287; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; WILBANKS A, UNPUB	27	102	104	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2264	2267		10.1126/science.1104193	http://dx.doi.org/10.1126/science.1104193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618520				2022-12-28	WOS:000225950000049
J	Wade, JT; Hall, DB; Struhl, K				Wade, JT; Hall, DB; Struhl, K			The transcription factor Ifh1 is a key regulator of yeast ribosomal protein genes	NATURE			English	Article							FORK HEAD PROTEIN; SACCHAROMYCES-CEREVISIAE; BINDING-SITES; EXPRESSION; RAP1; PROMOTER; SEQUENCE; ASSOCIATION; RECRUITMENT; ACTIVATOR	Ribosomal protein (RP) genes in eukaryotes are coordinately regulated in response to growth stimuli and environmental stress, thereby permitting cells to adjust ribosome number and overall protein synthetic capacity to physiological conditions(1-5). Approximately 50% of RNA polymerase II transcription is devoted to RP genes(5). The transcriptional regulator Rap1 binds most yeast RP promoters(6), and Rap1 sites are important for coordinate regulation of RP genes(7-10). However, Rap1 is not the specific regulator that controls RP transcription because it also functions as a repressor, and many Rap1-activated promoters are not coordinately regulated with RP promoters(11,12). Here we show that the transcription factors Fhl1 and Ifh1 associate almost exclusively with RP promoters; association depends on Rap1 and ( to a lesser extent) a DNA element at many RP promoters. Ifh1 is recruited to promoters via the forkhead-associated (FHA) domain of Fhl1; the level of Ifh1 associated with RP promoters determines the level of transcription; and environmental stress causes a marked reduction in the association of Ifh1, but not Fhl1 or Rap1. Thus, Ifh1 association with promoters is the key regulatory step for coordinate expression of RP genes.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu		Wade, Joseph/0000-0002-9779-3160; Hall, Daniel B/0000-0002-5085-8334				APARICIO O, 2004, CURRENT PROTOCOLS MO; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Brachmann CB, 1998, YEAST, V14, P115; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CHEREL I, 1995, YEAST, V11, P261, DOI 10.1002/yea.320110308; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GONCALVES PM, 1995, NUCLEIC ACIDS RES, V23, P1475, DOI 10.1093/nar/23.9.1475; HERMANNLEDENMAT S, 1994, MOL CELL BIOL, V14, P2905, DOI 10.1128/MCB.14.5.2905; Kim M, 2002, J BIOL CHEM, V277, P38781, DOI 10.1074/jbc.M201559200; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; Lascaris RF, 1999, BIOINFORMATICS, V15, P267, DOI 10.1093/bioinformatics/15.4.267; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li BJ, 1999, MOL CELL BIOL, V19, P5393; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; MAGER WH, 1988, BIOCHIM BIOPHYS ACTA, V949, P1, DOI 10.1016/0167-4781(88)90048-6; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; NEUMANSILBERBERG FS, 1995, MOL CELL BIOL, V15, P3187; PIERANDREIAMALDI P, 1994, GENETICA, V94, P181, DOI 10.1007/BF01443432; POGUEGEILE K, 1991, MOL CELL BIOL, V11, P3842, DOI 10.1128/MCB.11.8.3842; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SESHADRI T, 1993, J BIOL CHEM, V268, P18474; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7	30	160	164	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2004	432	7020					1054	1058		10.1038/nature03175	http://dx.doi.org/10.1038/nature03175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881RL	15616568				2022-12-28	WOS:000225887000048
J	Gaspar, HB; Parsley, KL; Howe, S; King, D; Gilmour, KC; Sinclair, J; Brouns, G; Schmidt, M; Von Kalle, C; Barington, T; Jakobsen, MA; Christensen, HO; Al Ghonaium, A; White, HN; Smith, JL; Levinsky, RJ; Ali, RR; Kinnon, C; Thrasher, AJ				Gaspar, HB; Parsley, KL; Howe, S; King, D; Gilmour, KC; Sinclair, J; Brouns, G; Schmidt, M; Von Kalle, C; Barington, T; Jakobsen, MA; Christensen, HO; Al Ghonaium, A; White, HN; Smith, JL; Levinsky, RJ; Ali, RR; Kinnon, C; Thrasher, AJ			Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector	LANCET			English	Article							STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; LONG-TERM; GAMMA-CHAIN; BONE-MARROW; VIVO	Background X-linked severe combined immunodeficiency (SCID-X1) is caused by mutations in the common cytokine-receptor gamma chain (gammac), resulting in disruption of development of T lymphocytes and natural-killer cells. B-lymphocyte function is also intrinsically compromised. Allogeneic bone-marrow transplantation is successful if HLA-matched family donors are available, but HLA-mismatched procedures are associated with substantial morbidity and mortality. We investigated the application of somatic gene therapy by use of a gibbon-ape-leukaemia-virus pseudotyped gammaretroviral vector. Methods Four children with SCID-X1 were enrolled. Autologouls CD34-positive haemopoietic bone-marrow stem cells were transduced ex vivo and returned to the patients without preceding cytoreductive chemotherapy. The patients were monitored for integration and expression of the gammac vector and for functional immunological recovery. Findings All patients have shown substantial improvements in clinical and immunological features, and prophylactic medication could be withdrawn in two. No serious adverse events have been recorded. T cells responded normally to mitogenic and antigenic stimuli, and the T-cell-receptor (TCR) repertoire was highly diverse. Where assessable, humoral immunity, in terms of antibody production, was also restored and associated with increasing rates of somatic mutation in immunoglobuilin genes. Interpretation Gene therapy for SCID-X1 is a highly effective strategy for restoration of functional cellular and Immoral immunity.	UCL, Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England; Great Ormond St Hosp Sick Children, Dept Clin Immunol, London WC1N 3JH, England; Univ Freiburg, Dept Internal Med, D-7800 Freiburg, Germany; Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany; Cincinnati Childrens Res Fdn, Div Expt Hematol, Cincinnati, OH USA; Odense Univ Hosp, Dept Clin Immunol, DK-5000 Odense, Denmark; Odense Univ Hosp, Dept Paediat, DK-5000 Odense, Denmark; King Faisal Specialist Hosp & Res Ctr, Dept Paediat Allergy Immunol, Riyadh 11211, Saudi Arabia; Southampton Gen Hosp, Dept Immunol, Southampton SO9 4XY, Hants, England; UCL, Inst Ophthalmol, Dept Mol Genet, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Freiburg; University of Freiburg; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; King Faisal Specialist Hospital & Research Center; University of Southampton; University of London; University College London	Thrasher, AJ (corresponding author), UCL, Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England.	a.thrasher@ich.ucl.ac.uk	Barington, Torben/C-3922-2009; Kinnon, Christine/A-1585-2010; Howe, Steven J/C-4801-2008; Barington, Torben/R-6841-2019	Barington, Torben/0000-0001-6968-148X; Howe, Steven J/0000-0003-2940-2874; Thrasher, Adrian/0000-0002-6097-6115; Gilmour, Kimberly/0000-0003-0285-3958; white, harry/0000-0001-8186-7789; Ali, Robin/0000-0003-3126-6517; Jakobsen, Marianne Antonius/0000-0003-2352-9276	Wellcome Trust [062578] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Haddad E, 1998, BLOOD, V91, P3646; Hess AD, 1997, IMMUNOL REV, V157, P111, DOI 10.1111/j.1600-065X.1997.tb00977.x; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Patel DD, 2000, NEW ENGL J MED, V342, P1325, DOI 10.1056/NEJM200005043421804; Schmidt M, 2001, ANN NY ACAD SCI, V938, P146; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Teshima T, 2002, SEMIN HEMATOL, V39, P15, DOI 10.1053/shem.2002.29246; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; White H, 2000, EUR J IMMUNOL, V30, P732; Whitwam T, 1998, BLOOD, V92, P1565, DOI 10.1182/blood.V92.5.1565.417k12_1565_1575	19	495	533	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2181	2187		10.1016/S0140-6736(04)17590-9	http://dx.doi.org/10.1016/S0140-6736(04)17590-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610804				2022-12-28	WOS:000225799700026
J	Oransky, I				Oransky, I			Ancel Keys - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com							0	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2174	2174		10.1016/S0140-6736(04)17578-8	http://dx.doi.org/10.1016/S0140-6736(04)17578-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15614938				2022-12-28	WOS:000225799700015
J	Meyron-Holtz, EG; Ghosh, MC; Rouault, TA				Meyron-Holtz, EG; Ghosh, MC; Rouault, TA			Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo	SCIENCE			English	Article							SULFUR CLUSTER; DEGRADATION; METABOLISM; CELLS; IRP2; HOMEOSTASIS; ACONITASE; TENSION; MUTANT; HEME	The iron-regulatory proteins (IRPs) posttranscriptionally regulate expression of transferrin receptor, ferritin, and other iron metabolism proteins. Although both IRPs can regulate expression of the same target genes, IRP2(-/-) mice significantly misregulate iron metabolism and develop neurodegeneration, whereas IRP1(-/-) mice are spared. We found that IRP2(-/-) cells misregulated iron metabolism when cultured in 3 to 6% oxygen, which is comparable to physiological tissue concentrations, but not in 21% oxygen, a concentration that activated IRP1 and allowed it to substitute for IRP2. Thus, IRP2 dominates regulation of mammalian iron homeostasis because it alone registers iron concentrations and modulates its RNA-binding activity at physiological oxygen tensions.	NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rouault, TA (corresponding author), NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA.	trou@helix.nih.gov	Meyron-Holtz, Esther/B-5991-2013		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001602] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001602] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bourdon E, 2003, BLOOD CELL MOL DIS, V31, P247, DOI 10.1016/S1079-9796(03)00161-X; BOUTON C, 2003, SCI STKE; Cairo G, 2002, BIOCHEMISTRY-US, V41, P7435, DOI 10.1021/bi025756k; Carlsson PO, 2001, DIABETES, V50, P489, DOI 10.2337/diabetes.50.3.489; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; DERUSSO PA, 1995, J BIOL CHEM, V270, P15451, DOI 10.1074/jbc.270.26.15451; DEXTER DT, 1992, ANN NEUROL, V32, P94; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Goessling LS, 1998, J BIOL CHEM, V273, P12555, DOI 10.1074/jbc.273.20.12555; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Hanson ES, 1999, GENE EXPRESSION, V7, P367; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Schneider B D, 2000, Curr Opin Clin Nutr Metab Care, V3, P267, DOI 10.1097/00075197-200007000-00005; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Smith SR, 2004, ANN NY ACAD SCI, V1012, P65, DOI 10.1196/annals.1306.006; SMITH SS, UNPUB; Studer L, 2000, J NEUROSCI, V20, P7377; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang J, 2002, MOL CELL BIOL, V22, P4638, DOI 10.1128/MCB.22.13.4638-4651.2002; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952	29	185	196	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2087	2090		10.1126/science.1103786	http://dx.doi.org/10.1126/science.1103786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604406				2022-12-28	WOS:000225841000061
J	York, JD; Hunter, T				York, JD; Hunter, T			Unexpected mediators of protein phosphorylation	SCIENCE			English	Editorial Material							INOSITOL PYROPHOSPHATES; POLYPHOSPHATES; DICTYOSTELIUM; KINASES		Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Salk Inst Biol Studies, Mol & Cellular Biol Lab, La Jolla, CA 92037 USA	Duke University; Howard Hughes Medical Institute; Salk Institute	York, JD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	yorkj@duke.edu						AGRANOFF BW, 1978, TRENDS BIOCHEM SCI, V3, pN283; EUROPEFINNER GN, 1991, BIOCHEM BIOPH RES CO, V181, P191, DOI 10.1016/S0006-291X(05)81400-7; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Pesesse X, 2004, J BIOL CHEM, V279, P43378, DOI 10.1074/jbc.C400286200; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; SNYDER S, COMMUNICATION; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; YORK JD, 2003, HDB CELL SIGNALING, P229; YORK SJ, 2004, J BIOL CHEM     1123	16	18	19	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2004	306	5704					2053	2055		10.1126/science.1107225	http://dx.doi.org/10.1126/science.1107225			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604398				2022-12-28	WOS:000225841000050
J	Clardy, J; Walsh, C				Clardy, J; Walsh, C			Lessons from natural molecules	NATURE			English	Article							CYANOBACTERIUM LYNGBYA-MAJUSCULA; ANTIBODY-TARGETED CHEMOTHERAPY; TAXOL BIOSYNTHESIS; ANTITUMOR AGENTS; GENE-CLUSTER; VANCOMYCIN BIOSYNTHESIS; SUBSTRATE-SPECIFICITY; BIOLOGICAL-PROPERTIES; CYTOTOXIC PEPTIDES; COUPLING REACTION	Natural products have inspired chemists and physicians for millennia. Their rich structural diversity and complexity has prompted synthetic chemists to produce them in the laboratory, often with therapeutic applications in mind, and many drugs used today are natural products or natural-product derivatives. Recent years have seen considerable advances in our understanding of natural-product biosynthesis. Coupled with improvements in approaches for natural-product isolation, characterization and synthesis, these could be opening the door to a new era in the investigation of natural products in academia and industry.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Clardy, J (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	jon_clardy@hms.harvard.edu						Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Altmann KH, 2001, CURR OPIN CHEM BIOL, V5, P424, DOI 10.1016/S1367-5931(00)00225-8; Anderson HJ, 1997, CANCER CHEMOTH PHARM, V39, P223; Aune GJ, 2002, ANTI-CANCER DRUG, V13, P545, DOI 10.1097/00001813-200207000-00001; Boghaert ER, 2004, CLIN CANCER RES, V10, P4538, DOI 10.1158/1078-0432.CCR-04-0037; Boldi AM, 2004, CURR OPIN CHEM BIOL, V8, P281, DOI 10.1016/j.cbpa.2004.04.010; Brady SF, 2002, J AM CHEM SOC, V124, P9968, DOI 10.1021/ja0268985; Brady SF, 2001, J AM CHEM SOC, V123, P9900, DOI 10.1021/ja016176y; Brohm D, 2002, ANGEW CHEM INT EDIT, V41, P307, DOI 10.1002/1521-3773(20020118)41:2<307::AID-ANIE307>3.0.CO;2-1; Burke MD, 2003, SCIENCE, V302, P613, DOI 10.1126/science.1089946; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Carson Culley C 3rd, 2003, Curr Urol Rep, V4, P488; Chau M, 2004, CHEM BIOL, V11, P663, DOI 10.1016/j.chembiol.2004.02.025; Choi Jai-Pil, 1996, EUROPEAN J POLITICAL, V12, P273, DOI DOI 10.1016/0176-2680(95)00017-8; DiJoseph JF, 2004, BLOOD, V103, P1807, DOI 10.1182/blood-2003-07-2466; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; Eppelmann K, 2002, BIOCHEMISTRY-US, V41, P9718, DOI 10.1021/bi0259406; Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FULLER RW, 1992, J MED CHEM, V35, P3007, DOI 10.1021/jm00094a012; FURUSAKI A, 1978, J CHEM SOC CHEM COMM, P800, DOI 10.1039/c39780000800; Gerth K, 1996, J ANTIBIOT, V49, P560, DOI 10.7164/antibiotics.49.560; GUNASEKERA SP, 1990, J ORG CHEM, V55, P4912, DOI 10.1021/jo00303a029; Gunasekera SP, 1996, J AM CHEM SOC, V118, P8759, DOI 10.1021/ja961961+; Huang QL, 2001, BIOORGAN MED CHEM, V9, P2237, DOI 10.1016/S0968-0896(01)00072-4; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; Jennewein S, 2004, P NATL ACAD SCI USA, V101, P9149, DOI 10.1073/pnas.0403009101; Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kim MY, 2003, CANCER RES, V63, P3247; Kohli RM, 2003, CHEM COMMUN, P297, DOI 10.1039/b208333g; KONISHI M, 1990, J AM CHEM SOC, V112, P3715, DOI 10.1021/ja00165a097; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; LEE MD, 1987, J AM CHEM SOC, V109, P3464, DOI 10.1021/ja00245a050; Liu SP, 1998, SCIENCE, V282, P1324, DOI 10.1126/science.282.5392.1324; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; Losey HC, 2002, CHEM BIOL, V9, P1305, DOI 10.1016/S1074-5521(02)00270-3; Lu W, 2004, BIOCHEMISTRY-US, V43, P4548, DOI 10.1021/bi035945i; Luesch H, 2001, J AM CHEM SOC, V123, P5418, DOI 10.1021/ja010453j; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; McDaniel R, 1999, P NATL ACAD SCI USA, V96, P1846, DOI 10.1073/pnas.96.5.1846; Mendez C, 2001, TRENDS BIOTECHNOL, V19, P449, DOI 10.1016/S0167-7799(01)01765-6; Meng LH, 1999, CANCER RES, V59, P2798; Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P92, DOI 10.1021/op034130e; Newman DJ, 2002, CURR CANCER DRUG TAR, V2, P279, DOI 10.2174/1568009023333791; Newman DJ, 2000, NAT PROD REP, V17, P215, DOI 10.1039/a902202c; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Ondeyka JG, 2003, J NAT PROD, V66, P121, DOI 10.1021/np020339u; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Pindur U, 1999, CURR MED CHEM, V6, P29; Pylypenko O, 2003, J BIOL CHEM, V278, P46727, DOI 10.1074/jbc.M306486200; Rawlings BJ, 2001, NAT PROD REP, V18, P231, DOI 10.1039/b100191o; RINEHART KL, 1990, J ORG CHEM, V55, P4512, DOI 10.1021/jo00302a007; Roth BD, 2002, PROGR MED CHEM, V40, P1, DOI 10.1016/S0079-6468(08)70080-8; Sasse F, 2000, J ANTIBIOT, V53, P879, DOI 10.7164/antibiotics.53.879; SCHANTZ EJ, 1975, J AM CHEM SOC, V93, P7344; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; Scotto KW, 2002, ANTI-CANCER DRUG, V13, pS3; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; SHELDRICK GM, 1978, NATURE, V271, P223, DOI 10.1038/271223a0; Shen B, 2003, CURR MED CHEM, V10, P2317, DOI 10.2174/0929867033456701; TALPIR R, 1994, TETRAHEDRON LETT, V35, P4453, DOI 10.1016/S0040-4039(00)73382-X; Tang L, 2001, CHEM BIOL, V8, P547, DOI 10.1016/S1074-5521(01)00032-1; Thorson JS, 2000, CURR PHARM DESIGN, V6, P1841, DOI 10.2174/1381612003398564; Walker K, 2001, PHYTOCHEMISTRY, V58, P1, DOI 10.1016/S0031-9422(01)00160-1; Walsh C, 2003, J MED CHEM, V46, P3425, DOI 10.1021/jm030257i; Walsh C., 2003, ANTIBIOTICS ACTIONS; Wang GYS, 2000, ORG LETT, V2, P2401, DOI 10.1021/ol005860z; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.0.CO;2-#; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099; WILLIAMSON MP, 1981, J AM CHEM SOC, V103, P6580, DOI 10.1021/ja00412a008; Wohlleben W, 2002, CHEM BIOL, V9, P1163, DOI 10.1016/S1074-5521(02)00267-3; WONG DT, 1995, ADV EXP MED BIOL, V363, P77; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Yotsu-Yamashita M, 2004, P NATL ACAD SCI USA, V101, P4346, DOI 10.1073/pnas.0400368101; Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784; Zerbe K, 2002, J BIOL CHEM, V277, P47476, DOI 10.1074/jbc.M206342200	81	824	865	7	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					829	837		10.1038/nature03194	http://dx.doi.org/10.1038/nature03194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602548				2022-12-28	WOS:000225733500039
J	Carrat, F; Bani-Sadr, F; Pol, S; Rosenthal, E; Lunel-Fabiani, F; Benzekri, A; Morand, P; Goujard, C; Pialoux, G; Piroth, L; Salmon-Ceron, D; Degott, C; Cacoub, P; Perronne, C				Carrat, F; Bani-Sadr, F; Pol, S; Rosenthal, E; Lunel-Fabiani, F; Benzekri, A; Morand, P; Goujard, C; Pialoux, G; Piroth, L; Salmon-Ceron, D; Degott, C; Cacoub, P; Perronne, C		ANRS HCO2 RIBAVIC Study Team	Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PEGINTERFERON ALPHA-2A; COMBINATION THERAPY; HIV/HCV COINFECTION; INITIAL TREATMENT; NATURAL-HISTORY; LIVER-DISEASE; UNITED-STATES; CIRRHOSIS; MORTALITY	Context Treatment of chronic hepatitis C virus (HCV) infection in human immunodeficiency virus (HIV)-infected patients is a growing concern. Most data on the virologic efficacy and safety of the combination of peginterferon alfa-2b and ribavirin in coinfected patients come from uncontrolled studies. Objective To study the safety and efficacy of peginterferon alfa-2b plus ribavirin vs standard interferon alfa-2b plus ribavirin in HIV-HCV coinfected patients. Design and Settings A multicenter, randomized, parallel-group, open-label trial. Patients were enrolled from February 2000 to February 2002 and followed up for 72 weeks. Patients Four hundred twelve HIV-HCV coinfected patients with detectable serum HCV-RNA, abnormal liver histology, a CD4 cell count of at least 200 x 10(6)/L, and stable plasma HIV-RNA. Intervention Treatment with ribavirin 400 mg twice a day, orally, plus either peginterferon alfa-2b (1.5 mug/kg subcutaneous injection once a week) or standard interferon alfa-2b (3 million units of subcutaneous injection 3 times a week) for 48 weeks. Main Outcome Measures Sustained virologic response, defined by undetectable serum HCV-RNA at week 72. Results More patients had sustained virologic responses in the peginterferon group than in the standard interferon group (27% vs 20%, P=.047). This difference between the treatments was found in patients with HCV genotype 1 or 4 infection (17% for peginterferon vs 6% for standard interferon, P = .006) but was not found in patients with HCV genotype 2, 3, or 5 (44% for peginterferon vs 43% for standard interferon, P =.88). Together, a decline in HCV-RNA of less than 2 log(10) from baseline and detectable serum HCV-RNA at week 12 predicted 99% of treatment failures. Histologic activity diminished and fibrosis stabilized in virologic responders. The 2 regimens showed similar tolerability although dose modifications for clinical and biological events were more frequent with peginterferon. Eleven cases of pancreatitis or symptomatic hyperlactatemia were observed, all in patients receiving didanosine-containing antiretroviral regimens. Conclusion In combination with ribavirin, treatment with peginterferon alfa-2b is more effective than standard interferon alfa-2b for HCV infection in HIV-infected patients.	Univ Paris 06, Grp Hosp Univ Est, INSERM, U444, Paris, France; Univ Paris 05, INSERM, U370, Grp Hosp Univ Ouest, Paris, France; Hop Archet, Fac Med, Nice, France; Fac Med, Grp Hosp, Angers, France; Univ Paris 07, Grp Hosp Univ Nord, F-75221 Paris 05, France; CHU Grenoble, F-38043 Grenoble, France; Univ Paris 11, Grp Hosp Univ Sud, Paris, France; CHU, Dijon, France; Univ Versailles, CHU Raymond Poincare, Garches, France	Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Nice; Universite d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Saclay; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Carrat, F (corresponding author), Univ Paris 06, Grp Hosp Univ Est, INSERM, U444, Paris, France.		Carrat, Fabrice/AAU-8480-2020; françoise, lunel/B-7273-2015	Carrat, Fabrice/0000-0002-8672-7918; françoise, lunel/0000-0002-1856-0300; Cacoub, Patrice/0000-0002-6727-4992				Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bailon P, 2001, BIOCONJUGATE CHEM, V12, P195, DOI 10.1021/bc000082g; Ballesteros AL, 2004, AIDS, V18, P59, DOI 10.1097/00002030-200401020-00007; Becquemont L, 2002, CLIN PHARMACOL THER, V71, P488, DOI 10.1067/mcp.2002.124468; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Brau N, 2002, AM J GASTROENTEROL, V97, P2071, DOI 10.1111/j.1572-0241.2002.05924.x; Cacoub P, 2001, CLIN INFECT DIS, V32, P1207, DOI 10.1086/319747; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; *FDA CDER, SUMM SAF REL DRUG LA; Fontaine H, 2001, HUM PATHOL, V32, P904, DOI 10.1053/hupa.2001.28228; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Glue P, 2000, CLIN PHARMACOL THER, V68, P556, DOI 10.1067/mcp.2000.110973; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; John M, 1998, AIDS, V12, P2289, DOI 10.1097/00002030-199817000-00010; Lafeuillade A, 2001, LANCET, V357, P280, DOI 10.1016/S0140-6736(00)03618-7; Laguno M, 2004, AIDS, V18, pF27, DOI 10.1097/00002030-200409030-00003; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mauss S, 2004, AIDS, V18, pF21, DOI 10.1097/00002030-200409030-00002; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Molina JM, 2000, J INFECT DIS, V182, P599, DOI 10.1086/315711; Moreno L, 2004, AIDS, V18, P67, DOI 10.1097/00002030-200401020-00008; Myers RP, 2004, AIDS, V18, P75, DOI 10.1097/00002030-200401020-00009; Perez-Olmeda M, 2003, AIDS, V17, P1023, DOI 10.1097/00002030-200305020-00011; Rockstroh EK, 2003, JAIDS-J ACQ IMM DEF, V34, pS59, DOI 10.1097/00126334-200309011-00009; Rosenthal E, 2003, AIDS, V17, P1803, DOI 10.1097/00002030-200308150-00009; Salmon-Ceron D, 2003, CLIN INFECT DIS, V36, P1295, DOI 10.1086/374837; Salmon-Ceron D, 2001, LANCET, V357, P1803, DOI 10.1016/S0140-6736(00)04921-7; Schaefer M, 2003, HEPATOLOGY, V37, P443, DOI 10.1053/jhep.2003.50031; Soriano V, 2004, AIDS, V18, P1, DOI 10.1097/00002030-200401020-00001; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Vento S, 1998, AIDS, V12, P116; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	38	643	670	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2004	292	23					2839	2848		10.1001/jama.292.23.2839	http://dx.doi.org/10.1001/jama.292.23.2839			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879CR	15598915	Bronze			2022-12-28	WOS:000225694500021
J	McCluskey, P; Powell, RJ				McCluskey, P; Powell, RJ			The eye in systemic inflammatory diseases	LANCET			English	Review							GIANT-CELL ARTERITIS; INCLUDING TEMPORAL ARTERITIS; LONG-TERM SURVIVAL; POLYMYALGIA RHEUMATICA; CLASSIFICATION; EPIDEMIOLOGY; INFLIXIMAB; THERAPY; BIOPSY	Systemic inflammatory diseases commonly affect the sclera, cornea, retina, and orbit, and can pose a serious threat to sight. They encompass both primary and secondary vasculitic disorders and specific granulomatous inflammatory conditions. As well as direct eye involvement from the systemic inflammatory process, there can be signs of ocular ischaemia, due to carotid or ophthalmic arteritis, hypertensive retinopathy, and ocular complications such as chloroquine maculopathy related to anti-inflammatory drug treatment. Additionally, systemic infection relating to the eye, either as the result of primary infective disease processes or infection secondary to immunosuppression, might be mistaken as endogenous intraocular inflammation. Infection can closely mimic the ocular signs of endogenous inflammation, and in selected patients (such as those who have been immunosuppressed to treat vasculitis and who additionally have had invasive surgery, indwelling intravenous catheters, or systemic sepsis), it might be necessary to specifically exclude infection by the sampling and culturing of intraocular fluids and tissue.	St Vincents Hosp, Dept Ophthalmol, Sydney, NSW 2050, Australia; Royal Prince Alfred Hosp, Sydney, NSW, Australia; Univ Hosp, Queens Med Ctr, Clin Immunol Unit, Nottingham, England	St Vincents Hospital Sydney; University of Sydney; Nottingham University Hospital NHS Trust; University of Nottingham	McCluskey, P (corresponding author), St Vincents Hosp, Dept Ophthalmol, Sydney, NSW 2050, Australia.	iritis@ozemail.com.au	McCluskey, Peter J/H-7607-2013	McCluskey, Peter J/0000-0002-8177-1637				ALLISON MC, 1984, ANN RHEUM DIS, V43, P416, DOI 10.1136/ard.43.3.416; ANDERSSON R, 1986, ACTA MED SCAND, V220, P361; BENGTSSON BA, 1981, ARTHRITIS RHEUM, V24, P899, DOI 10.1002/art.1780240706; Cantini F, 2001, ARTHRITIS RHEUM, V44, P2933, DOI 10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y; CHAVIS PS, 1995, INT OPHTHALMOL CLIN, V35, P43, DOI 10.1097/00004397-199503520-00006; DIAZLLOPIS M, 1990, CURR EYE RES, V9, P17, DOI 10.3109/02713689008999414; Edelsten C, 1999, EYE, V13, P748, DOI 10.1038/eye.1999.221; FONG LP, 1991, OPHTHALMOLOGY, V98, P472; Foroozan R, 2003, OPHTHALMOLOGY, V110, P539, DOI 10.1016/S0161-6420(02)01775-X; FOSTER CS, 1984, OPHTHALMOLOGY, V91, P1253; FOSTER CS, 1994, SCLERA, P209; Gonzalez-Gay MA, 1998, ARTHRITIS RHEUM, V41, P1497, DOI 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z; HALL S, 1985, MEDICINE, V64, P89, DOI 10.1097/00005792-198503000-00002; Harman LE, 1998, SURV OPHTHALMOL, V42, P458, DOI 10.1016/S0039-6257(97)00133-1; Humuryudan V., 1997, ARTHRITIS RHEUMATISM, V40, P760; ISHIKAWA K, 1978, CIRCULATION, V57, P27, DOI 10.1161/01.CIR.57.1.27; JABS DA, 1994, RETINA, P1437; Jones Nicholas P, 2002, Ophthalmol Clin North Am, V15, P319, DOI 10.1016/S0896-1549(02)00021-4; Jover JA, 2001, ANN INTERN MED, V134, P106, DOI 10.7326/0003-4819-134-2-200101160-00010; Marmor MF, 2002, OPHTHALMOLOGY, V109, P1377, DOI 10.1016/S0161-6420(02)01168-5; Matteson EL, 1996, AM J MED, V100, P193, DOI 10.1016/S0002-9343(97)89458-2; Messmer EM, 1999, SURV OPHTHALMOL, V43, P379, DOI 10.1016/S0039-6257(98)00051-4; MOORTHY RS, 1995, SURV OPHTHALMOL, V39, P265, DOI 10.1016/S0039-6257(05)80105-5; Morton SJ, 2001, CLIN EXP ALLERGY, V31, P686, DOI 10.1046/j.1365-2222.2001.01123.x; Muhaya M, 2000, OCUL IMMUNOL INFLAMM, V8, P141, DOI 10.1076/0927-3948(200009)8:3;1-K;FT141; Okhravi N, 1999, OPHTHALMOLOGY, V106, P710, DOI 10.1016/S0161-6420(99)90155-0; Read RW, 2001, AM J OPHTHALMOL, V131, P599, DOI 10.1016/S0002-9394(01)00937-0; Rothova A, 2000, BRIT J OPHTHALMOL, V84, P110, DOI 10.1136/bjo.84.1.110; Sfikakis PP, 2001, LANCET, V358, P295, DOI 10.1016/S0140-6736(01)05497-6; SHELHAMER JH, 1985, ANN INTERN MED, V103, P121, DOI 10.7326/0003-4819-103-1-121; Shingadia D, 2002, LANCET INFECT DIS, V2, P310, DOI 10.1016/S1473-3099(02)00265-7; SHULMAN ST, 1995, PEDIATR CLIN N AM, V42, P1205; SILMAN AJ, 1990, LANCET, V335, P1078; Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002; TAKAHASHI M, 1987, CIRCULATION, V75, P387, DOI 10.1161/01.CIR.75.2.387; Taylor PC, 2003, INTERNAL MED, V42, P15, DOI 10.2169/internalmedicine.42.15; Valsakumar AK, 2003, J RHEUMATOL, V30, P1793; WATSON PG, 1982, T OPHTHAL SOC UK, V102, P257; WATSON PG, 2001, SCLERITIS, P24; Watts RA, 1997, BAILLIERE CLIN RHEUM, V11, P191, DOI 10.1016/S0950-3579(97)80043-X; WEINER J, 1982, OTOLARYNG CLIN N AM, V15, P519; Williams R V, 2001, Paediatr Drugs, V3, P649, DOI 10.2165/00128072-200103090-00003; YAZICI H, 1990, NEW ENGL J MED, V322, P281, DOI 10.1056/NEJM199002013220501; Zeuner M, 1997, J RHEUMATOL, V24, P96	44	53	54	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2004	364	9451					2125	2133		10.1016/S0140-6736(04)17554-5	http://dx.doi.org/10.1016/S0140-6736(04)17554-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589311				2022-12-28	WOS:000225742300026
J	Bico, J; Roman, B; Moulin, L; Boudaoud, A				Bico, J; Roman, B; Moulin, L; Boudaoud, A			Elastocapillary coalescence in wet hair	NATURE			English	Editorial Material									Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7636, F-75231 Paris 5, France; Ecole Normale Super, Phys Stat Lab, CNRS, UMR 8550, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite	Bico, J (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7636, 10 Rue Vauquelin, F-75231 Paris 5, France.	jbico@pmmh.espci.fr	Bico, José/Q-1614-2015; Roman, Benoit/C-6273-2014; Boudaoud, Arezki/Q-7436-2016	Bico, José/0000-0002-3872-1239; Roman, Benoit/0000-0002-1473-2734; Boudaoud, Arezki/0000-0002-2780-4717				Chakrapani N, 2004, P NATL ACAD SCI USA, V101, P4009, DOI 10.1073/pnas.0400734101; Cohen AE, 2003, P NATL ACAD SCI USA, V100, P12141, DOI 10.1073/pnas.1534600100; Eisner T, 2000, P NATL ACAD SCI USA, V97, P6568, DOI 10.1073/pnas.97.12.6568; Freund LB, 1990, DYNAMIC FRACTURE MEC, DOI [10.1017/oretCBO9780511546761-en, DOI 10.1017/ORETCBO9780511546761-EN]; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Hui CY, 2002, LANGMUIR, V18, P1394, DOI 10.1021/la0113567; Lau KKS, 2003, NANO LETT, V3, P1701, DOI 10.1021/nl034704t; Leyvraz F, 2003, PHYS REP, V383, P95, DOI 10.1016/S0370-1573(03)00241-2; Mastrangelo C. H., 1993, Journal of Microelectromechanical Systems, V2, P33, DOI 10.1109/84.232593; Raccurt O, 2004, J MICROMECH MICROENG, V14, P1083, DOI 10.1088/0960-1317/14/7/031; TANAKA T, 1993, JPN J APPL PHYS 1, V32, P6059, DOI 10.1143/JJAP.32.6059	11	341	348	6	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					690	690		10.1038/432690a	http://dx.doi.org/10.1038/432690a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592402	Bronze			2022-12-28	WOS:000225597200036
J	Ardissino, D; Cavallini, C; Bramucci, E; Indolfi, C; Marzocchi, A; Manari, A; Angeloni, G; Carosio, G; Bonizzoni, E; Colusso, S; Repetto, M; Merlini, PA				Ardissino, D; Cavallini, C; Bramucci, E; Indolfi, C; Marzocchi, A; Manari, A; Angeloni, G; Carosio, G; Bonizzoni, E; Colusso, S; Repetto, M; Merlini, PA		SES-SMART Investigators	Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BALLOON ANGIOPLASTY; SMALL VESSELS; PLACEMENT; DISEASE; REVASCULARIZATION; IMPLANTATION; DIAMETER; LESIONS; SIZE	Context Percutaneous coronary revascularization of small vessels is associated with a high restenosis rate. Sirolimus-eluting stents reduce restenosis in simple and previously untreated lesions of large coronary arteries, but their outcomes in small vessels have not been adequately investigated. Objective To determine whether sirolimus-eluting stents are associated with a reduced 8-month rate of angiographic restenosis in comparison with an uncoated stent. Design, Setting, and Patients This was a randomized, multicenter, single-blind, prospective trial performed with 257 patients undergoing percutaneous coronary revascularization for ischemic heart disease, and who had a previously untreated atherosclerotic lesion located in a small segment with a diameter of 2.75 mm or less, in 20 Italian centers between August 2002 and December 2003. Intervention Patients were randomly assigned to receive a sirolimus-eluting stent (129 patients) or an uncoated stent having an identical architecture and radiographic appearance (128 patients). Main Outcome Measures The primary end point was the 8-month binary in-segment restenosis rate; secondary end points included procedural success and the 8-month rate of major adverse cardiac and cerebrovascular events. Results The mean (SD) reference diameter of the treated segment was 2.2 (0.28) mm; the lesion length, 11.84(6.15) mm. After 8 months, the binary in-segment restenosis rate was 53.1% (60/113) in the patients receiving an uncoated stent and 9.8% (12/123) in those receiving a sirolimus-eluting stent (relative risk [RR], 0.18; 95% confidence interval [CI], 0.10-0.32; P<.001). Fewer patients randomized to sirolimus-eluting stents experienced major adverse cardiac events (12/129 [9.3%] vs 40/128 [31.3%]; RR, 0.30; 95% CI, 0.15-0.55; P<.001) mainly because of a reduction in target lesion revascularization (9/129 [7%] vs 27/128 [21.1%]; RR, 0.33; 95% CI, 0.14-0.70; P=.002) and myocardial infarction (2/129 [1.6%] vs 10/129 [7.8%]; RR, 0.20; 95% CI, 0.01-0.93; P=.04). Conclusion The use of sirolimus-eluting stents to treat atherosclerotic lesions in small coronary arteries reduces restenosis and may also reduce major adverse cardiac events.	Univ Parma, Osped Maggiore, Div Cardiol, Dipartimento Cuore, I-43100 Parma, Italy; Osped Ca Foncello, Div Cardiol, Treviso, Italy; Univ Pavia, Ist Ricovero & Cura Carattere Sci, Policlin San Matteo, Div Cardiol, I-27100 Pavia, Italy; Univ Magna Grecia, Div Cardiol, Catanzaro, Italy; Univ Bologna, Osped Sant Orsola, Div Cardiol, I-40126 Bologna, Italy; Osped Santa Maria Nuova, Div Cardiol, Reggio Emilia, Italy; Univ Cattolica Sacro Cuore, Policlin A Gemelli, Div Cardiol, Rome, Italy; Osped SS Antonio & Biagio & Cesare Arrigo, Div Cardiol, Alessandria, Italy; Univ Milan, Inst Med Stat & Biometry, I-20122 Milan, Italy; Osped Niguarda Ca Granda, Div Cardiol, Milan, Italy	University of Parma; University Hospital of Parma; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; IRCCS Fondazione San Matteo; University of Pavia; Magna Graecia University of Catanzaro; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Arcispedale S. Maria Nuova; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Azienda Ospedaliera SS Antonio Biagio Cesare Arrigo; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Ardissino, D (corresponding author), Univ Parma, Osped Maggiore, Div Cardiol, Dipartimento Cuore, Via Gramsci 14, I-43100 Parma, Italy.	cardiologia.parma@ao.pr.it	Ardissino, Diego/AAC-4041-2022	INDOLFI, Ciro/0000-0003-1241-6487; solinas, emilia/0000-0003-3532-1317				Akiyama T, 1998, J AM COLL CARDIOL, V32, P1610, DOI 10.1016/S0735-1097(98)00444-6; Al Suwaidi J, 2000, JAMA-J AM MED ASSOC, V284, P1828, DOI 10.1001/jama.284.14.1828; ARDISSINO D, 1991, NEW ENGL J MED, V325, P1053, DOI 10.1056/NEJM199110103251501; Briguori C, 2000, CATHETER CARDIO INTE, V50, P390, DOI 10.1002/1522-726X(200008)50:4<390::AID-CCD4>3.0.CO;2-S; CROSBY IK, 1981, ANN SURG, V193, P743, DOI 10.1097/00000658-198106000-00009; Doucet S, 2001, CIRCULATION, V104, P2029, DOI 10.1161/circ.104.17.2029; Elezi S, 1998, CIRCULATION, V98, P1875, DOI 10.1161/01.CIR.98.18.1875; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; FOLEY DP, 1994, CIRCULATION, V90, P1239, DOI 10.1161/01.CIR.90.3.1239; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; HIRSHFELD JW, 1991, J AM COLL CARDIOL, V18, P647, DOI 10.1016/0735-1097(91)90783-6; Kastrati A, 2000, CIRCULATION, V102, P2593; Koning R, 2001, CIRCULATION, V104, P1604, DOI 10.1161/hc3901.096695; Mehilli J, 2000, JAMA-J AM MED ASSOC, V284, P1799, DOI 10.1001/jama.284.14.1799; Moer R, 2001, J AM COLL CARDIOL, V38, P1598, DOI 10.1016/S0735-1097(01)01602-3; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; OConnor NJ, 1996, CIRCULATION, V93, P652, DOI 10.1161/01.CIR.93.4.652; Savage MP, 1998, J AM COLL CARDIOL, V31, P307, DOI 10.1016/S0735-1097(97)00511-1; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Schunkert H, 1999, J AM COLL CARDIOL, V34, P40, DOI 10.1016/S0735-1097(99)00181-3; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Sousa JE, 2001, CIRCULATION, V103, P192; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441	24	239	259	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2004	292	22					2727	2734		10.1001/jama.292.22.2727	http://dx.doi.org/10.1001/jama.292.22.2727			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877CY	15585732	Bronze			2022-12-28	WOS:000225546600021
J	Newnham, JP; Doherty, DA; Kendall, GE; Zubrick, SR; Landau, LL; Stanley, FJ				Newnham, JP; Doherty, DA; Kendall, GE; Zubrick, SR; Landau, LL; Stanley, FJ			Effects of repeated prenatal ultrasound examinations on childhood outcome up to 8 years of age: follow-up of a randomised controlled trial	LANCET			English	Article							NEUROLOGICAL DEVELOPMENT; SUBSEQUENT HANDEDNESS; DIAGNOSTIC ULTRASOUND; BIRTH-WEIGHT; PREGNANCY; EXPOSURE; GROWTH	Backgound Despite the widespread use of prenatal ultrasound studies, there are no published data from randomised controlled trials describing childhood outcomes that might be influenced by repeated ultrasound exposures. We previously undertook a randomised controlled trial to assess the effects of multiple studies on pregnancy and childhood outcomes and reported that those pregnancies allocated to receive multiple examinations had an unexplained and significant increase in the proportion of growth restricted newborns. Our aim was to investigate the possible effects of multiple prenatal ultrasound scans on growth and development in childhood. Here, we provide follow-up data of the childrens' development. Methods Physical and developmental assessments were done on children whose pregnant mothers had been allocated at random to a protocol of five studies of ultrasound imaging and umbilical artery Doppler flow velocity waveform between 18 and 38 weeks' gestation (intensive group n=1490) or a single imaging study at 18 weeks' gestation (regular group n=1477). We used generalised logistic and linear regression models to assess the group differences in developmental and growth outcomes over time. Primary data analysis was done by intention-to-treat. Findings Examinations were done at 1, 2, 3, 5, and 8 years of age on children born without congenital abnormalities and from singleton pregnancies (intensive group n=1362, regular group n=1352). The follow-up rate at 1 year was 85% (2310/2714) and at 8 years was 75% (2042/2714). By 1 year of age and thereafter, physical sizes were similar in the two groups. There were no significant differences indicating deleterious effects of multiple ultrasound studies at any age as measured by standard tests of childhood speech, language, behaviour, and neurological development. Interpretation Exposure to multiple prenatal ultrasound examinations from 18 weeks' gestation onwards might be associated with a small effect on fetal growth but is followed in childhood by growth and measures of developmental outcome similar to those in children who had received a single prenatal scan.	Univ Western Australia, King Edward Mem Hosp, Sch Womens & Infants Hlth, Subiaco, WA 6008, Australia; TVW Telethon Inst Child Hlth Res, Perth, WA, Australia; Curtin Ctr Dev Hlth, Inst Child Hlth Res, Perth, WA, Australia; Univ Western Australia, Fac Med & Dent, Perth, WA 6009, Australia	King Edward Memorial Hospital; University of Western Australia; Telethon Kids Institute; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia	Newnham, JP (corresponding author), Univ Western Australia, King Edward Mem Hosp, Sch Womens & Infants Hlth, 374 Bagot Rd, Subiaco, WA 6008, Australia.	jnewnham@obsgyn.uwa.edu.au	Zubrick, Stephen R/H-1997-2013; Zubrick, Stephen R/CAI-1970-2022; Study, Raine/K-4517-2013	Zubrick, Stephen R/0000-0002-6369-1713; Newnham, John/0000-0001-9983-7457				[Anonymous], 1991, MANUAL CHILD BEHAV C; Barnett SB, 2000, ULTRASOUND MED BIOL, V26, P355, DOI 10.1016/S0301-5629(00)00204-0; BRICKER D, 1989, TOP EARLY CHILD SPEC, V9, P67, DOI 10.1177/027112148900900306; Coplan J., 1993, EARLY LANGUAGE MILES; Dunn L.M., 2007, PEABODY PICTURE VOCA; Evans S, 1996, EARLY HUM DEV, V45, P203, DOI 10.1016/0378-3782(96)01728-8; Frankenburg W.K., 1992, DENVER 2 TRAINING MA, V2nd ed.; GESCHWIND N, 1985, ARCH NEUROL-CHICAGO, V42, P428, DOI 10.1001/archneur.1985.04060050026008; Harding K, 1996, J MATERN-FETAL INVES, V6, P77; HENDERSON J, 1995, ULTRASOUND MED BIOL, V21, P699, DOI 10.1016/0301-5629(94)00158-A; Kieler H, 1997, BRIT J OBSTET GYNAEC, V104, P1267, DOI 10.1111/j.1471-0528.1997.tb10973.x; Kieler H, 2001, EPIDEMIOLOGY, V12, P618, DOI 10.1097/00001648-200111000-00007; Kieler H, 1998, EARLY HUM DEV, V50, P233, DOI 10.1016/S0378-3782(97)00097-2; MCDONALD W, 1996, LANCET, V348, P482; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; OBERKLAID F, 1990, PEDIATRICS, V85, P559; OBRIEN WD, 1983, J ULTRAS MED, V2, P1; RESCORLA L, 1989, J SPEECH HEAR DISORD, V54, P587, DOI 10.1044/jshd.5404.587; SALVESEN KA, 1993, ULTRASOUND OBST GYN, V3, P6, DOI 10.1046/j.1469-0705.1993.03010006.x; SALVESEN KA, 1993, BRIT MED J, V307, P159, DOI 10.1136/bmj.307.6897.159; SALVESEN KA, 1995, ULTRASOUND OBST GYN, V6, P293, DOI 10.1046/j.1469-0705.1995.06040293.x; Salvesen KA, 1999, ULTRASOUND OBST GYN, V13, P241, DOI 10.1046/j.1469-0705.1999.13040241.x; Salvesen KA, 1999, ULTRASOUND MED BIOL, V25, P1025, DOI 10.1016/S0301-5629(99)00051-4; TARANTAL AF, 1989, TERATOLOGY, V39, P137, DOI 10.1002/tera.1420390206	24	71	72	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 4	2004	364	9450					2038	2044		10.1016/S0140-6736(04)17516-8	http://dx.doi.org/10.1016/S0140-6736(04)17516-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876KM	15582061				2022-12-28	WOS:000225495700027
J	Lan, Q; Zhang, LP; Li, GL; Vermeulen, R; Weinberg, RS; Dosemeci, M; Rappaport, SM; Shen, M; Alter, BP; Wu, YJ; Kopp, W; Waidyanatha, S; Rabkin, C; Guo, WH; Chanock, S; Hayes, RB; Linet, M; Kim, S; Yin, SN; Rothman, N; Smith, MT				Lan, Q; Zhang, LP; Li, GL; Vermeulen, R; Weinberg, RS; Dosemeci, M; Rappaport, SM; Shen, M; Alter, BP; Wu, YJ; Kopp, W; Waidyanatha, S; Rabkin, C; Guo, WH; Chanock, S; Hayes, RB; Linet, M; Kim, S; Yin, SN; Rothman, N; Smith, MT			Hematotoxicity in workers exposed to low levels of benzene	SCIENCE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; TOXICITY; BLOOD; RISK; NQ01	Benzene is known to have toxic effects on the blood and bone marrow, but its impact at levels below the U.S. occupational standard of 1 part per million (ppm) remains uncertain. in a study of 250 workers exposed to benzene, white blood cell and platelet counts were significantly lower than in 140 controls, even for exposure below 1 ppm in air. Progenitor cell colony formation significantly declined with increasing benzene exposure and was more sensitive to the effects of benzene than was the number of mature blood cells. Two genetic variants in key metabolizing enzymes, myeloperoxidase and NAD(P)H:quinone oxidoreductase, influenced susceptibility to benzene hematotoxicity. Thus, hematotoxicity from exposure to benzene occurred at air levels of 1 ppm or less and may be particularly evident among genetically susceptible subpopulations.	Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA; Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; New York Blood Ctr, Clin Serv, White Plains, NY 10605 USA; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27599 USA; Peking Union Med Coll, Beijing, Peoples R China; SAIC Frederick Inc, Frederick, MD 21702 USA; NCI, Ctr Canc Res, NIH, US Dept HHS, Bethesda, MD 20892 USA	University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Center for Disease Control & Prevention; New York Blood Center; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Smith, MT (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	martynts@berkeley.edu	Weinberg, Rona/M-8637-2019; Vermeulen, Roel/F-8037-2011	Vermeulen, Roel/0000-0003-4082-8163; Kim, Sungkyoon/0000-0002-1378-8795; Hayes, Richard/0000-0002-0918-661X	NATIONAL CANCER INSTITUTE [Z01CP010121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006721, P42ES004705, P42ES005948, P30ES010126, P30ES001896] Funding Source: NIH RePORTER; NIEHS NIH HHS [P42ES05948, P30ES10126, P30ES01896, P42ES04705, P42 ES004705, R01ES06721] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abernethy DJ, 2004, TOXICOL SCI, V79, P82, DOI 10.1093/toxsci/kfh095; AKSOY M, 1989, ENVIRON HEALTH PERSP, V82, P193, DOI 10.2307/3430775; Bauer AK, 2003, CANCER RES, V63, P929; COLLINS JJ, 1991, J OCCUP ENVIRON MED, V33, P619; Collins JJ, 1997, J OCCUP ENVIRON MED, V39, P232, DOI 10.1097/00043764-199703000-00013; Gist GL, 1997, TOXICOL IND HEALTH, V13, P661, DOI 10.1177/074823379701300601; Kreja L, 1999, INT J RADIAT BIOL, V75, P1241, DOI 10.1080/095530099139395; Qu QS, 2002, AM J IND MED, V42, P275, DOI 10.1002/ajim.10121; Ross D, 1996, EUR J HAEMATOL, V57, P111; Rothman N, 1997, CANCER RES, V57, P2839; Simon V, 2004, SCI TOTAL ENVIRON, V334, P177, DOI 10.1016/j.scitotenv.2004.04.065; Smith MT, 2000, CARCINOGENESIS, V21, P1485, DOI 10.1093/carcin/21.8.1485; Tsai SP, 2004, REGUL TOXICOL PHARM, V40, P67, DOI 10.1016/j.yrtph.2004.05.010; Vermeulen R, 2004, ANN OCCUP HYG, V48, P105, DOI 10.1093/annhyg/meh005; Wan JX, 2002, ENVIRON HEALTH PERSP, V110, P1213, DOI 10.1289/ehp.021101213; Ward E, 1996, AM J IND MED, V29, P247, DOI 10.1002/(SICI)1097-0274(199603)29:3<247::AID-AJIM4>3.0.CO;2-N; Winterbourn CC, 2000, CURR OPIN HEMATOL, V7, P53, DOI 10.1097/00062752-200001000-00010; Xu Jian-ning, 2003, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V21, P86; Yoon BI, 2001, EXP HEMATOL, V29, P278, DOI 10.1016/S0301-472X(00)00671-8; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang Ben, 1996, Zhonghua Yufang Yixue Zazhi, V30, P164	21	461	507	5	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1774	1776		10.1126/science.1102443	http://dx.doi.org/10.1126/science.1102443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576619	Green Submitted, Green Accepted			2022-12-28	WOS:000225630800052
J	Green, RE; Cornell, SJ; Scharlemann, JPW; Balmford, A				Green, RE; Cornell, SJ; Scharlemann, JPW; Balmford, A			Farming and the fate of wild nature	SCIENCE			English	Article							10 BILLION PEOPLE; LOS-TUXTLAS; POPULATION; WORLD; LAND; BIODIVERSITY; ENVIRONMENT; COUNTRYSIDE; DIVERSITY; HABITATS	World food demand is expected to more than double by 2050. Decisions about how to meet this challenge will have profound effects on wild species and habitats. We show that farming is already the greatest extinction threat to birds (the best known taxon), and its adverse impacts took set to increase, especially in developing countries. Two competing solutions have been proposed: wildlife-friendly farming (which boosts densities of wild populations on farmland but may decrease agricultural yields) and land sparing (which minimizes demand for farmland by increasing yield). We present a model that identifies how to resolve the trade-off between these approaches. This shows that the best type of farming for species persistence depends on the demand for agricultural products and on how the population densities of different species on farmland change with agricultural yield. Empirical data on such density-yield functions are sparse, but evidence from a range of taxa in developing countries suggests that high-yield farming may allow more species to persist.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, ZA-7701 Rondebosch, South Africa	University of Cambridge; Royal Society for Protection of Birds; University of Leeds; University of Cape Town	Green, RE (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	reg29@hermes.cam.ac.uk	Cornell, Stephen J/D-3955-2009; Scharlemann, Jorn/A-4737-2008	Scharlemann, Jorn/0000-0002-2834-6367; Balmford, Andrew/0000-0002-0144-3589				Angelsen A., 2001, Tradeoffs or synergies? Agricultural intensification, economic development and the environment, P89, DOI 10.1079/9780851994352.0089; [Anonymous], 2003, WORLD POP PROSP 2002; Avery DT, 1997, ISSUES SCI TECHNOL, V14, P59; AVERY M., 2001, ECOS, V22, P3; Barbier EB, 1997, LAND ECON, V73, P174, DOI 10.2307/3147281; Barrett Christopher B., 2001, TRADEOFFS SYNERGIES; Bongaarts J, 1996, POPUL DEV REV, V22, P483, DOI 10.2307/2137717; Borlaug NE, 2002, IN VITRO CELL DEV-PL, V38, P221, DOI 10.1079/IVP2001279; Daily GC, 2001, NATURE, V411, P245, DOI 10.1038/35077178; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Estrada A, 1998, J TROP ECOL, V14, P577, DOI 10.1017/S0266467498000418; Estrada A, 1997, BIODIVERS CONSERV, V6, P19, DOI 10.1023/A:1018328930981; *EUR ENV AG, 2002, 9 EUR ENV AG; FAO, 2001, GLOBAL FOREST RESOUR; FAOSTAT, 2001, FAO STAT DAT; Freudenberger MS, 2002, NATURAL RESOURCES MANAGEMENT IN AFRICAN AGRICULTURE: UNDERSTANDING AND IMPROVING CURRENT PRACTICES, P181, DOI 10.1079/9780851995847.0181; Goklany I. M., 1992, SUSTAINING DEV BIODI; Groombridge B, 2002, WORLD ATLAS BIODIVER; Hughes JB, 2002, ECOL LETT, V5, P121, DOI 10.1046/j.1461-0248.2002.00294.x; IUCN, 2001, IUCN RED LIST CAT CR; Jenkins M, 2003, CONSERV BIOL, V17, P20, DOI 10.1046/j.1523-1739.2003.01719.x; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; LOH J, 2002, LIVING PLANET REPORT; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; McNeely J.A., 2002, ECOAGRICULTURE STRAT; Myers N, 2003, P NATL ACAD SCI USA, V100, P4963, DOI 10.1073/pnas.0438061100; Pain D.J, 1997, FARMING BIRDS EUROPE; Pretty J., 2002, AGR RECONNECTING PEO; Richards J.F., 1990, EARTH TRANSFORMED HU, P163; ROBINSON JG, 1994, INT WILDL, V24, P30; Rosenzweig M. L., 2003, WIN WIN ECOLOGY EART; Rosenzweig ML, 2003, ORYX, V37, P194, DOI 10.1017/S0030605303000371; RSPB, 2001, FUT LARG SCAL HAB RE; Southgate D., 1994, CAUSES TROPICAL DEFO, P134; Sutherland WJ, 2002, TRENDS ECOL EVOL, V17, P148, DOI 10.1016/S0169-5347(01)02421-1; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Waggoner PE, 1996, POPUL DEV REV, V22, P531, DOI 10.2307/2137720; WAGGONER PE, 1995, TECHNOL SOC, V17, P17, DOI 10.1016/0160-791X(94)00024-8	42	1302	1365	18	845	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2005	307	5709					550	555		10.1126/science.1106049	http://dx.doi.org/10.1126/science.1106049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15618485				2022-12-28	WOS:000226694000039
J	Gunnell, D; Magnusson, PKE; Rasmussen, F				Gunnell, D; Magnusson, PKE; Rasmussen, F			Low intelligence test scores in 18 year old men and risk of suicide: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACCIDENTAL DEATH; CHILDHOOD IQ; PREDICTORS	Objective To examine the association between intelligence test scores in men, measured at age 18, and subsequent suicide. Design Record linkage study of the Swedish military service conscription register (1968-94) with the multi-generation register, cause of death register, and census data. Four tests were performed. at conscription covering logic, language, spatial, and technical skills. Setting Sweden. Participants 987 308 Swedish men followed up for 5-26 years. Main outcome measure Suicide. Results 2811 Suicides occurred during follow up. The risk of suicide was two to three times higher in those with lowest compared with the highest test scores. The strongest associations were seen with the logic test: for each unit increase in test score the risk of suicide decreased by 12% (95% confidence interval 10% to 14%). Associations were only slightly attenuated when we controlled for parents' socioeconomic position. Greatest risks were seen among poorly performing offspring of well educated parents. Conclusions Performance in intelligence tests is strongly related to subsequent risk of suicide in men. This may be due to the importance of cognitive ability in either the aetiology of serious mental disorder or an individual's capacity to solve problems while going through an acute life crisis or suffering from mental illness.	Karolinska Inst, Dept Publ Hlth Sci, Child & Adolescent Publ Hlth Epidemiol Grp, SE-17176 Stockholm, Sweden; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75105 Uppsala, Sweden	Karolinska Institutet; University of Bristol; Uppsala University	Rasmussen, F (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Child & Adolescent Publ Hlth Epidemiol Grp, SE-17176 Stockholm, Sweden.	finn.rasmussen@phs.ki.se	Magnusson, Patrik KE/C-4458-2017; Gunnell, David/ABE-6653-2020	Magnusson, Patrik KE/0000-0002-7315-7899; Gunnell, David/0000-0002-0829-6470; Rasmussen, Finn/0000-0001-7915-7809				ALLEBECK P, 1988, BRIT MED J, V297, P176, DOI 10.1136/bmj.297.6642.176; APTER A, 1993, ARCH GEN PSYCHIAT, V50, P138; Carlstedt B., 2000, THESIS U GOTHENBURG; David AS, 1997, PSYCHOL MED, V27, P1311, DOI 10.1017/S0033291797005680; Gunnell D, 2002, BRIT J PSYCHIAT, V181, P298, DOI 10.1192/bjp.181.4.298; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; Jiang GX, 1999, ACTA PSYCHIAT SCAND, V100, P433, DOI 10.1111/j.1600-0447.1999.tb10893.x; Neeleman J, 1998, LANCET, V351, P93, DOI 10.1016/S0140-6736(97)06364-2; OTOOLE BI, 1992, PERS INDIV DIFFER, V13, P699, DOI 10.1016/0191-8869(92)90241-G; OToole BI, 1995, SUICIDE LIFE-THREAT, V25, P475; OTTO U, 1976, ACTA PSYCHIAT SCAND, P5; PAFFENBA.RS, 1969, AM J PUBLIC HEALTH N, V59, P900, DOI 10.2105/AJPH.59.6.900; Sacker A, 2002, SOC SCI MED, V55, P863, DOI 10.1016/S0277-9536(01)00228-3; vanOs J, 1997, ARCH GEN PSYCHIAT, V54, P625; Whalley LJ, 2001, BRIT MED J, V322, P819, DOI 10.1136/bmj.322.7290.819	15	119	119	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2005	330	7484					167	170A		10.1136/bmj.38310.473565.8F	http://dx.doi.org/10.1136/bmj.38310.473565.8F			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	891OQ	15615767	Bronze, Green Published			2022-12-28	WOS:000226590800015
J	Willer, CJ; Dyment, DA; Sadovnick, AD; Rothwell, PM; Murray, TJ; Ebers, GC				Willer, CJ; Dyment, DA; Sadovnick, AD; Rothwell, PM; Murray, TJ; Ebers, GC		Canadian Collaborative Study Grp	Timing of birth and risk of multiple sclerosis: population based study.	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; SEASON; SKIN; EPIDEMIOLOGY; IMMIGRANTS; BORN; MS	Objectives To determine if risk of multiple sclerosis (MS) is associated with month of birth in countries in the northern hemisphere and if factors related to month of birth interact with genetic risk. Design Population based study with population and family based controls and a retrospective cohort identified from death certificates. A post hoc pooled analysis was carried out for large northern datasets including Sweden and Denmark. Setting 19 MS clinics in major cities across Canada (Canadian collaborative project on the genetic susceptibility to multiple sclerosis); incident cases of MS from a population based study in the Lothian and Border regions of Scotland; and death records from the UK Registrar General. Populations 17 874 Canadian patients mid 11 502 British patients with multiple sclerosis. Main outcome measure Diagnosis of multiple sclerosis. Results In Canada (n = 17 874) significantly fewer patients with MS Were born in November compared with controls from the population census and unaffected siblings. These observations were confirmed in a dataset of British patients (n = 11502), in which there was also an increase in the number of births in May. A pooled analysis of datasets from Canada, Great Britain, Denmark, and Sweden (n = 42 045) showed that significantly fewer (805%) people with MS were born in November mid significantly more (9.1%) were born in May. For recent incident data, the effect of month of birth was most evident in Scotland, where MS prevalence is the highest. Conclusions Month of birth and risk of MS are associated, more so in familial cases, implying interactions between genes and environment that are related to climate. Such interactions may act during gestation or shortly after birth in individuals born in the northern countries studied.	Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Fac Med, Div Neurol, Vancouver, BC V6T 2B5, Canada; Dalhousie Univ, Halifax, NS B3H 4R2, Canada	Radcliffe Infirmary; University of Oxford; University of Michigan System; University of Michigan; University of Oxford; Wellcome Centre for Human Genetics; University of British Columbia; University of British Columbia; Dalhousie University	Ebers, GC (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England.	george.ebers@cineuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211; Sadovnick, Dessa/0000-0003-2987-2008; Ebers, George/0000-0003-4771-4177; Willer, Cristen/0000-0001-5645-4966				ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x; BRANDA RF, 1978, SCIENCE, V201, P625, DOI 10.1126/science.675247; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; DEAN G, 1967, BRIT MED J, V2, P724, DOI 10.1136/bmj.2.5554.724; Ebers GC, 2000, ANN NEUROL, V48, P927, DOI 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.3.CO;2-6; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; ELIAN M, 1987, J NEUROL NEUROSUR PS, V50, P327, DOI 10.1136/jnnp.50.3.327; FAWCETT J, 1988, NEUROLOGY, V38, P416, DOI 10.1212/WNL.38.3.416; Hammond SR, 2000, BRAIN, V123, P968, DOI 10.1093/brain/123.5.968; HOLICK MF, 1987, ARCH DERMATOL, V123, P1677, DOI 10.1001/archderm.123.12.1677; KURTZKE JF, 1979, NEUROLOGY, V29, P1228, DOI 10.1212/WNL.29.9_Part_1.1228; McGrath JJ, 2004, J STEROID BIOCHEM, V89-90, P557, DOI 10.1016/j.jsbmb.2004.03.070; MCLEOD JG, 1994, MED J AUSTRALIA, V160, P117, DOI 10.5694/j.1326-5377.1994.tb126553.x; Rothwell PM, 1998, J NEUROL NEUROSUR PS, V64, P730, DOI 10.1136/jnnp.64.6.730; Sadovnick AD, 1998, CAN J NEUROL SCI, V25, P216, DOI 10.1017/S0317167100034041; SADOVNICK AD, 1994, ACTA NEUROL SCAND, V89, P190; Salemi G, 2000, ACTA NEUROL SCAND, V101, P381, DOI 10.1034/j.1600-0404.2000.90336.x; TEMPLER DI, 1992, ACTA NEUROL SCAND, V85, P107, DOI 10.1111/j.1600-0404.1992.tb04007.x; Torrey EF, 2000, NEUROEPIDEMIOLOGY, V19, P177, DOI 10.1159/000026253; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; van der Mei IAF, 2003, BRIT MED J, V327, P316, DOI 10.1136/bmj.327.7410.316; Vieth R, 2001, EUR J CLIN NUTR, V55, P1901; Wiberg MA, 1994, J ORTHOMOL MED, V9, P71; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100	25	335	343	2	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2005	330	7483					120	123		10.1136/bmj.38301.686030.63	http://dx.doi.org/10.1136/bmj.38301.686030.63			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889PM	15585537	Green Published, Bronze			2022-12-28	WOS:000226454900016
J	Gartenberg, MR; Neumann, FR; Laroche, T; Blaszczyk, M; Gasser, SM				Gartenberg, MR; Neumann, FR; Laroche, T; Blaszczyk, M; Gasser, SM			Sir-mediated repression can occur independently of chromosomal and subnuclear contexts	CELL			English	Article							YEAST KU; NUCLEAR ARCHITECTURE; SILENCING PROTEINS; TELOMERES; CHROMATIN; DYNAMICS; ORGANIZATION; MOTION; GENES; LOCI	Epigenetic mechanisms silence the HM mating-type loci in budding yeast. These loci are tightly linked to telomeres, which are also repressed and held together in clusters at the nuclear periphery, much like mammalian heterochromatin. Yeast telomere anchoring can occur in the absence of silent chromatin through the DNA end binding factor Ku. Here we examine whether silent chromatin binds the nuclear periphery independently of telomeres and whether silencing persists in the absence of anchorage. HMR was excised from the chromosome by inducible site-specific recombination and tracked by real-time fluorescence microscopy. Silent rings associate with the nuclear envelope, while nonsilent rings move freely throughout the nucleus. Silent chromatin anchorage requires the action of either Ku or Esc1. In the absence of both proteins, rings move throughout the nucleoplasm yet remain silent. Thus, transcriptional repression can be sustained without perinuclear anchoring.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; Canc Inst New Jersey, New Brunswick, NJ 08901 USA; Univ Geneva, Dept Biol Mol, CH-1211 Geneva, Switzerland; Univ Geneva, Frontiers Genet NCCR Program, CH-1211 Geneva, Switzerland; Univ Lausanne, Inst Appl Math, CH-1015 Lausanne, Switzerland	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of Geneva; University of Geneva; University of Lausanne	Gartenberg, MR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	gartenbe@umdnj.edu		Gartenberg, Marc/0000-0003-0713-7993; Neumann, Frank/0000-0002-0138-6836; Gasser, Susan/0000-0003-3610-9123	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054102] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051402, GM54102] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ai WD, 2002, MOL CELL, V10, P1295, DOI 10.1016/S1097-2765(02)00695-0; Andrulis ED, 2002, MOL CELL BIOL, V22, P8292, DOI 10.1128/MCB.22.23.8292-8301.2002; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Gribnau J, 2003, GENE DEV, V17, P759, DOI 10.1101/gad.1059603; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Hediger F, 2004, METHOD ENZYMOL, V375, P345; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Hediger F, 2002, J STRUCT BIOL, V140, P79, DOI 10.1016/S1047-8477(02)00533-6; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Holmes SG, 1997, GENETICS, V145, P605; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Laroche T, 2000, J STRUCT BIOL, V129, P159, DOI 10.1006/jsbi.2000.4240; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Maillet L, 2001, EMBO REP, V2, P203, DOI 10.1093/embo-reports/kve044; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Marcand S, 1996, GENE DEV, V10, P1297, DOI 10.1101/gad.10.11.1297; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Scherf A, 2001, CURR OPIN MICROBIOL, V4, P409, DOI 10.1016/S1369-5274(00)00227-7; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Tham WH, 2001, MOL CELL, V8, P189, DOI 10.1016/S1097-2765(01)00287-8; THOMPSON JS, 1994, MOL CELL BIOL, V14, P446, DOI 10.1128/MCB.14.1.446; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692	49	145	149	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					955	967		10.1016/j.cell.2004.11.008	http://dx.doi.org/10.1016/j.cell.2004.11.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620354	Bronze			2022-12-28	WOS:000226109700008
J	McKinnell, LW; Rudnicki, MA				McKinnell, LW; Rudnicki, MA			Molecular mechanisms of muscle atrophy	CELL			English	Editorial Material							NF-KAPPA-B; FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; UBIQUITIN LIGASES; DISUSE ATROPHY; HYPERTROPHY; ACTIVATION; EXPRESSION; PATHWAY; ATROGIN-1	Skeletal muscle atrophy has extreme adverse consequences. Molecular mechanisms that mediate the process of atrophy are not well defined. Recent studies have focused on diverse molecular cascades that control the activation of ubiquitin ligases, indicating that the involvement of the ubiquitin proteasome may be common to a range of atrophic stimuli.	Ottawa Hlth Res Inst, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute	Rudnicki, MA (corresponding author), Ottawa Hlth Res Inst, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ohri.ca		Rudnicki, Michael/0000-0002-3866-5249				Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4	19	103	117	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2004	119	7					907	910		10.1016/j.cell.2004.12.007	http://dx.doi.org/10.1016/j.cell.2004.12.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	884TQ	15620349	Bronze			2022-12-28	WOS:000226109700003
J	Helffrich, G; Kaneshima, S				Helffrich, G; Kaneshima, S			Seismological constraints on core composition from Fe-O-S liquid immiscibility	SCIENCE			English	Article							IRON-SULFUR COMPOUND; EARTHS OUTER CORE; HIGH-PRESSURE; INNER-CORE; TRAVEL-TIMES; MANTLE BOUNDARY; DENSITY; SYSTEM; MODEL; TEMPERATURES	Earth's core is composed primarily of iron (Fe) with about 10% by weight of lighter elements. The lighter elements are progressively enriched in the liquid outer core as the core cools and the inner core crystallizes. Thermodynamic modeling of Fe-O-S liquids shows that immiscible liquids can exist at outer-core pressures (136 to 330 gigapascals) at temperatures below 5200 kelvin and lead to layering in the outer core if the concentrations of the lighter elements are high enough. We found no evidence for layering in the outer core in the travel times and wave forms of P4KP seismic waves that reflect internally in the core. The absence of layers therefore constrains outer-core compositions in the Fe-O-S system to be no richer than 6 +/- 1 weight % (wt %) 0 and 2 to 15 wt % S. A single core liquid composition of 10.5 +/- 3.5 wt % S and 1.5 +/- 1.5 wt % O is compatible with wave speeds and densities throughout the outer core.	Univ Bristol, Bristol BS8 1RJ, Avon, England; Tokyo Inst Technol, Meguro Ku, Tokyo 1526551, Japan	University of Bristol; Tokyo Institute of Technology	Helffrich, G (corresponding author), Univ Bristol, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	george@geology.bristol.ac.uk		Helffrich, George/0000-0002-7363-4552	Natural Environment Research Council [NER/O/S/2001/01227] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alfe D, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165118; BIRCH F, 1952, J GEOPHYS RES, V57, P227, DOI 10.1029/JZ057i002p00227; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; BOEHLER R, 1992, EARTH PLANET SC LETT, V111, P217, DOI 10.1016/0012-821X(92)90180-4; CREAGER KC, 1992, NATURE, V356, P309, DOI 10.1038/356309a0; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; FEI YW, 1995, SCIENCE, V268, P1892, DOI 10.1126/science.268.5219.1892; Fei YW, 2000, AM MINERAL, V85, P1830; Fei YW, 1997, SCIENCE, V275, P1621, DOI 10.1126/science.275.5306.1621; GUBBINS D, 1979, GEOPHYS J ROY ASTR S, V59, P57, DOI 10.1111/j.1365-246X.1979.tb02553.x; HARVIE CE, 1987, GEOCHIM COSMOCHIM AC, V51, P1045, DOI 10.1016/0016-7037(87)90199-2; HILTY DC, 1952, JOM-J MIN MET MAT S, V4, P1307; Holland KG, 1997, SCIENCE, V275, P1623, DOI 10.1126/science.275.5306.1623; Kaneshima S, 1998, J GEOPHYS RES-SOL EA, V103, P4825, DOI 10.1029/97JB02565; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; KIND R, 1976, J GEOPHYS-Z GEOPHYS, V42, P191; Kress V, 2000, CONTRIB MINERAL PETR, V139, P316, DOI 10.1007/s004100000143; KRESS V, 1997, CONTRIB MINERAL PETR, V127, P127; Labrosse S, 1997, PHYS EARTH PLANET IN, V99, P1, DOI 10.1016/S0031-9201(96)03207-4; LAY T, 1990, GEOPHYS RES LETT, V17, P2001, DOI 10.1029/GL017i011p02001; Li J, 2001, EARTH PLANET SC LETT, V193, P509, DOI 10.1016/S0012-821X(01)00521-0; Lister JR, 1998, PHYS EARTH PLANET IN, V105, P5, DOI 10.1016/S0031-9201(97)00082-4; LOPER DE, 1978, GEOPHYS J ROY ASTRON, V54, P398; Masters G, 2003, PHYS EARTH PLANET IN, V140, P159, DOI 10.1016/j.pepi.2003.07.008; MORELLI A, 1993, GEOPHYS J INT, V112, P178, DOI 10.1111/j.1365-246X.1993.tb01448.x; Okuchi T, 1997, SCIENCE, V278, P1781, DOI 10.1126/science.278.5344.1781; Park J, 2000, B SEISMOL SOC AM, V90, P1507, DOI 10.1785/0119990122; POIRIER JP, 1994, PHYS EARTH PLANET IN, V85, P319, DOI 10.1016/0031-9201(94)90120-1; Raghavan V., 1988, PHASE DIAGRAMS TER 2; Rubie DC, 2004, NATURE, V429, P58, DOI 10.1038/nature02473; Schimmel M, 1997, GEOPHYS J INT, V130, P497, DOI 10.1111/j.1365-246X.1997.tb05664.x; SHEARER P, 1990, GEOPHYS J INT, V102, P491, DOI 10.1111/j.1365-246X.1990.tb04481.x; SOLOMATOV VS, 1993, J GEOPHYS RES-PLANET, V98, P5375, DOI 10.1029/92JE02948; SOURIAU A, 1989, GEOPHYS J INT, V98, P39, DOI 10.1111/j.1365-246X.1989.tb05512.x; Stacey FD, 1999, PHYS EARTH PLANET IN, V110, P83, DOI 10.1016/S0031-9201(98)00141-1; STEVENSON DJ, 1987, GEOPHYS J INT, V88, P311, DOI 10.1111/j.1365-246X.1987.tb01383.x; STEVENSON DJ, 1981, SCIENCE, V214, P611, DOI 10.1126/science.214.4521.611; Urakawa S., 1987, HIGH PRESS RES MINER, V39, P95, DOI DOI 10.1029/GM039P0095; USSELMAN TM, 1975, AM J SCI, V275, P278, DOI 10.2475/ajs.275.3.278; VIDALE JE, 1992, NATURE, V356, P678, DOI 10.1038/356678a0; WOOD BJ, 1993, EARTH PLANET SC LETT, V117, P593, DOI 10.1016/0012-821X(93)90105-I; Zerr A, 1998, SCIENCE, V281, P243, DOI 10.1126/science.281.5374.243	42	58	60	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	2004	306	5705					2239	2242		10.1126/science.1101109	http://dx.doi.org/10.1126/science.1101109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618514				2022-12-28	WOS:000225950000041
J	Petroff, Y				Petroff, Y			The electronic structure of liquid lead	SCIENCE			English	Editorial Material									Minist Res, F-75231 Paris 05, France		Petroff, Y (corresponding author), Minist Res, 1 Rue Descartes, F-75231 Paris 05, France.	petroff@esrf.fr						Baumberger F, 2004, SCIENCE, V306, P2221, DOI 10.1126/science.1103984; Baumberger F, 2003, SURF SCI, V532, P82, DOI 10.1016/S0039-6028(03)00129-8; BERNAL JD, 1964, PROC R SOC LON SER-A, V280, P299, DOI 10.1098/rspa.1964.0147; FRANK FC, 1952, PROC R SOC LON SER-A, V215, P43, DOI 10.1098/rspa.1952.0194; MOTT NF, 1967, ADV PHYS, V16, P49, DOI 10.1080/00018736700101265; Reichert H, 2000, NATURE, V408, P839, DOI 10.1038/35048537; Rotenberg E, 2000, NATURE, V406, P602, DOI 10.1038/35020519	7	1	1	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	2004	306	5705					2200	2201		10.1126/science.1106676	http://dx.doi.org/10.1126/science.1106676			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	882PE	15618506				2022-12-28	WOS:000225950000028
J	Lubbe, J; Milingou, M				Lubbe, J; Milingou, M			Tacrolimus ointment, alcohol, and facial flushing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland	University of Geneva	Lubbe, J (corresponding author), Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland.								0	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2740	2740		10.1056/NEJMicm040139	http://dx.doi.org/10.1056/NEJMicm040139			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616208				2022-12-28	WOS:000225877300009
J	Morris, PJ				Morris, PJ			Transplantation - A medical miracle of the 20th century	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HOMOTRANSPLANTATION		Royal Coll Surgeons England, Ctr Evidence Transplantat, Clin Effectiveness Unit, London WC2A 3PN, England	Royal College of Surgeons of England	Morris, PJ (corresponding author), Royal Coll Surgeons England, Ctr Evidence Transplantat, Clin Effectiveness Unit, London WC2A 3PN, England.							Bradley JA, 2001, SPR SP SURG SER, P1; Hamilton D, 1999, TRANSPLANTATION, P1; HUME DM, 1955, J CLIN INVEST, V34, P327, DOI 10.1172/JCI103085; MERRILL JP, 1956, JAMA-J AM MED ASSOC, V160, P277, DOI 10.1001/jama.1956.02960390027008; Tilney NL., 2003, TRANSPLANT MYTH REAL	5	106	109	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2678	2680		10.1056/NEJMp048256	http://dx.doi.org/10.1056/NEJMp048256			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616201				2022-12-28	WOS:000225877300002
J	Sayegh, MH; Carpenter, CB				Sayegh, MH; Carpenter, CB			Transplantation 50 years later - Progress, challenges, and promises	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EARLY CYCLOSPORINE WITHDRAWAL; RENAL-ALLOGRAFT RECIPIENTS; SIROLIMUS-BASED THERAPY; KIDNEY-TRANSPLANTATION; DIABETES-MELLITUS; UNITED-STATES; SUCCESSFUL HOMOTRANSPLANTATION; INDIRECT ALLORECOGNITION; IMMUNOLOGICAL-TOLERANCE; CARDIOVASCULAR-DISEASE		Brigham & Womens Hosp, Transplantat Res Ctr, Boston, MA 02115 USA; Childrens Hosp Boston, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Sayegh, MH (corresponding author), Brigham & Womens Hosp, Transplantat Res Ctr, 75 Francis St, Boston, MA 02115 USA.			Sayegh, Mohamed/0000-0002-2847-588X				Baker RJ, 2001, J IMMUNOL, V167, P7199, DOI 10.4049/jimmunol.167.12.7199; Bostom AD, 2002, AM J TRANSPLANT, V2, P491, DOI 10.1034/j.1600-6143.2002.20602.x; Briscoe DDM, 2002, NAT MED, V8, P220, DOI 10.1038/nm0302-220; Cane EJ, 1996, NEW ENGL J MED, V334, P815, DOI 10.1056/NEJM199603283341302; Ciubotariu R, 1998, J CLIN INVEST, V101, P398, DOI 10.1172/JCI1117; Cosio FG, 2001, KIDNEY INT, V59, P732, DOI 10.1046/j.1523-1755.2001.059002732.x; Delmonico FL, 2004, NEW ENGL J MED, V350, P1812, DOI 10.1056/NEJMp038228; Denton MD, 1999, LANCET, V353, P1083, DOI 10.1016/S0140-6736(98)07493-5; Fishman JA, 2002, NEW ENGL J MED, V347, P527, DOI 10.1056/NEJMe020076; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; HAMBURGER J, 1962, AM J MED, V32, P854, DOI 10.1016/0002-9343(62)90032-3; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Harlan DM, 2004, NEW ENGL J MED, V350, P2104; Holman E, 1924, SURG GYNECOL OBSTET, V38, P100; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Kasiske BL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013295.11876.C9; Kirk AD, 2003, TRANSPLANTATION, V76, P120, DOI 10.1097/01.TP.0000071362.99021.D9; Knechtle SJ, 2003, AM J TRANSPLANT, V3, P722, DOI 10.1034/j.1600-6143.2003.00120.x; Kreis H, 2004, J AM SOC NEPHROL, V15, P809, DOI 10.1097/01.ASN.0000113248.59077.76; Lakkis FG, 2003, J AM SOC NEPHROL, V14, P2402, DOI 10.1097/01.ASN.0000085020.78117.70; Li BG, 2001, NEW ENGL J MED, V344, P947, DOI 10.1056/NEJM200103293441301; Matthews JB, 2003, AM J TRANSPLANT, V3, P794, DOI 10.1046/j.1600-6135.2003.0154.x; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Meier-Kriesche HU, 2003, TRANSPLANTATION, V75, P1291, DOI 10.1097/01.TP.0000061602.03327.E2; MERRILL JP, 1956, JAMA-J AM MED ASSOC, V160, P277, DOI 10.1001/jama.1956.02960390027008; MERRILL JP, 1960, NEW ENGL J MED, V262, P1251, DOI 10.1056/NEJM196006232622501; MERRILL JP, 1952, NEW ENGL J MED, V246, P17, DOI 10.1056/NEJM195201032460105; Morris PJ, 2004, NEW ENGL J MED, V351, P2678, DOI 10.1056/NEJMp048256; Mota A, 2004, AM J TRANSPLANT, V4, P953, DOI 10.1111/j.1600-6143.2004.00446.x; MURRAY JE, 1963, NEW ENGL J MED, V268, P1315, DOI 10.1056/NEJM196306132682401; MURRAY JE, 1958, ANN SURG, V148, P343, DOI 10.1097/00000658-195809000-00004; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Neylan JF, 1999, J AM SOC NEPHROL, V10, P2237; Ojo AO, 2004, AM J TRANSPLANT, V4, P27, DOI 10.1111/j.1600-6135.2004.00396.x; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; *ORG PROC TRANSPL, 1993, OPTN SRTR 2003 ANN R; *ORG PROC TRANSPL, 2002, OPTN SRTR 2003 ANN R; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Reznik SI, 2001, AM J TRANSPLANT, V1, P228, DOI 10.1034/j.1600-6143.2001.001003228.x; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Rothstein DM, 2004, IMMUNOL REV, V197, P243; Salama AD, 2001, J CLIN INVEST, V108, P943, DOI 10.1172/JCI200114142; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sayegh MH, 1998, NEW ENGL J MED, V338, P1813, DOI 10.1056/NEJM199806183382506; SCHWARTZ R, 1959, NATURE, V183, P1682, DOI 10.1038/1831682a0; SCHWARTZ R, 1959, J CLIN INVEST, V38, P1394, DOI 10.1172/JCI103915; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Starzl TE, 2003, LANCET, V361, P1502, DOI 10.1016/S0140-6736(03)13175-3; Steele DJR, 1996, J EXP MED, V183, P699, DOI 10.1084/jem.183.2.699; Vella JP, 1997, TRANSPLANTATION, V64, P795, DOI 10.1097/00007890-199709270-00001; Vincenti F, 2003, J AM SOC NEPHROL, V14, P1940, DOI 10.1097/01.ASN.0000076844.59963.CF	53	317	348	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2761	2766		10.1056/NEJMon043418	http://dx.doi.org/10.1056/NEJMon043418			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616214				2022-12-28	WOS:000225877300016
J	Sullenger, BA				Sullenger, BA			Riboswitches - To kill or save the messenger	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENE-EXPRESSION		Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University	Sullenger, BA (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.							Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Werstuck G, 1998, SCIENCE, V282, P296, DOI 10.1126/science.282.5387.296; Yen L, 2004, NATURE, V431, P471, DOI 10.1038/nature02844	5	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2004	351	26					2759	2760		10.1056/NEJMcibr043522	http://dx.doi.org/10.1056/NEJMcibr043522			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881OR	15616213				2022-12-28	WOS:000225877300015
J	Sharp, D				Sharp, D			Safe bubbly	LANCET			English	Editorial Material							EYE; INJURY		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							*AM AC OPHTH, 2004, POP OP BOTTL BUBBL R; ARCHER D, 1967, LANCET, V2, P487; BRAZIER DJ, 1984, LANCET, V2, P1335; Kuhn F, 1998, OPHTHALMOLOGE, V95, P332, DOI 10.1007/s003470050282	4	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2165	2165		10.1016/S0140-6736(04)17610-1	http://dx.doi.org/10.1016/S0140-6736(04)17610-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610790				2022-12-28	WOS:000225799700010
J	Diamond, J				Diamond, J			The astonishing micropygmies	SCIENCE			English	Editorial Material							INDONESIA; HOMININ; FLORES		Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Diamond, J (corresponding author), Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA.	jdiamond@geog.ucla.edu						Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Jones R., 1977, SUNDA SAHUL PREHISTO, P317; Jones R., 1977, SUNDA SAHUL PREHISTO, P113; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Sim R, 1994, ARCHAEOLOGY IN THE NORTH, P358	6	14	14	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2004	306	5704					2047	2048		10.1126/science.1107565	http://dx.doi.org/10.1126/science.1107565			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604394				2022-12-28	WOS:000225841000046
J	Hann, CL; Schmidt, EP				Hann, CL; Schmidt, EP			Toxic neutrophils in Streptococcus pneumoniae sepsis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Hann, CL (corresponding author), Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA.			Schmidt, Eric/0000-0002-7360-0504					0	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2636	2636		10.1056/NEJMicm040332	http://dx.doi.org/10.1056/NEJMicm040332			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602024				2022-12-28	WOS:000225726100011
J	Khunti, K; Samani, NJ				Khunti, K; Samani, NJ			Coronary heart disease in people of south-Asian origin	LANCET			English	Editorial Material							TYPE-2 DIABETES-MELLITUS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; HYPERTENSION; CHILDREN		Univ Leicester, Dept Hlth Sci, Leicester LE5 4PW, Leics, England	University of Leicester	Khunti, K (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE5 4PW, Leics, England.	kk22@le.ac.uk	/ABC-9527-2021	Khunti, Kamlesh/0000-0003-2343-7099				Anand S S, 2000, Indian Heart J, V52, pS35; BHATNAGAR D, 1995, LANCET, V345, P405; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Ehtisham S, 2000, DIABETIC MED, V17, P867, DOI 10.1046/j.1464-5491.2000.00409.x; Neel JV, 1998, PERSPECT BIOL MED, V42, P44; PETERSEN S, 2004, CORONARY HEAT DIS ST; *S AS HLTH FDN UK, 2004, PREV TREATM REH CARD; Saxena S, 2004, ARCH DIS CHILD, V89, P30; SHAUKAT N, 1995, FIBRINOLYSIS, V9, P55, DOI 10.1016/S0268-9499(08)80046-X; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; WILLIAMS B, 1995, LANCET, V345, P401, DOI 10.1016/S0140-6736(95)90394-1	12	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2004	364	9451					2077	2078		10.1016/S0140-6736(04)17563-6	http://dx.doi.org/10.1016/S0140-6736(04)17563-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TR	15589295				2022-12-28	WOS:000225742300006
J	Peccianti, M; Conti, C; Assanto, G; De Luca, A; Umeton, C				Peccianti, M; Conti, C; Assanto, G; De Luca, A; Umeton, C			Routing of anisotropic spatial solitons and modulational instability in liquid crystals	NATURE			English	Article							SOLITARY WAVES; NONLINEARITY; LIGHT	In certain materials, the spontaneous spreading of a laser beam ( owing to diffraction) can be compensated for by the interplay of optical intensity and material nonlinearity. The resulting nondiffracting beams are called 'spatial solitons' (refs 1 - 3), and they have been observed in various bulk media(4-6). In nematic liquid crystals(7-9), solitons can be produced at milliwatt power levels(10-12) and have been investigated for both practical applications(13) and as a means of exploring fundamental aspects of light interactions with soft matter(14,15). Spatial solitons effectively operate as waveguides, and so can be considered as a means of channelling optical information along the self-sustaining filament. But actual steering of these solitons within the medium has proved more problematic, being limited to tilts of just a fraction of a degree(16-20). Here we report the results of an experimental and theoretical investigation of voltage-controlled 'walk-off' and steering of self-localized light in nematic liquid crystals. We find not only that the propagation direction of individual spatial solitons can be tuned by several degrees, but also that an array of direction-tunable solitons can be generated by modulation instability(21-25). Such control capabilities might find application in reconfigurable optical interconnects, optical tweezers and optical surgical techniques.	Univ Roma Tre, INFM, Nonlinear Opt & Optoelect Lab, I-00146 Rome, Italy; Univ Roma Tre, Dept Elect Engn, I-00146 Rome, Italy; Univ Calabria, Dept Phys, I-87036 Arcavacata Di Rende, CS, Italy; Univ Calabria, INFM, Ctr Excellence CEMIFCAL, LICRYL, I-87036 Arcavacata Di Rende, CS, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Roma Tre University; Roma Tre University; University of Calabria; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Calabria	Assanto, G (corresponding author), Univ Roma Tre, INFM, Nonlinear Opt & Optoelect Lab, Via Vasca Navale 84, I-00146 Rome, Italy.	assanto@ele.uniroma3.it	De Luca, Antonio/P-6976-2018; Assanto, Gaetano/B-6344-2014; Conti, Claudio/E-9899-2012; Peccianti, Marco/F-7127-2011	De Luca, Antonio/0000-0003-2428-9075; Conti, Claudio/0000-0003-2583-3415; Peccianti, Marco/0000-0001-8894-496X				Assanto G, 2003, OPT PHOTONICS NEWS, V14, P44, DOI 10.1364/OPN.14.2.000044; BJORKHOL.JE, 1974, PHYS REV LETT, V32, P129, DOI 10.1103/PhysRevLett.32.129; Boardman A. D., 2001, SOLITON DRIVEN PHOTO; CAMPILLO AJ, 1973, APPL PHYS LETT, V23, P628, DOI 10.1063/1.1654772; Conti C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.113902; Conti C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.073901; Crosignani B, 2002, OPT PHOTONICS NEWS, V13, P38, DOI 10.1364/OPN.13.2.000038; DUREE GC, 1993, PHYS REV LETT, V71, P533, DOI 10.1103/PhysRevLett.71.533; Fleischer JW, 2003, NATURE, V422, P147, DOI 10.1038/nature01452; Friedrich L, 1998, OPT LETT, V23, P1438, DOI 10.1364/OL.23.001438; Henninot JF, 2002, MOL CRYST LIQ CRYST, V375, P631, DOI 10.1080/10587250210613; Karpierz MA, 1998, MOL CRYST LIQ CRYS A, V320, P157, DOI 10.1080/10587259808024392; Kip D, 2000, SCIENCE, V290, P495, DOI 10.1126/science.290.5491.495; Kivshar YS, 2003, OPTICAL SOLITONS; Mamaev AV, 1996, PHYS REV LETT, V76, P2262, DOI 10.1103/PhysRevLett.76.2262; Nayfeh A. H, 1993, INTRO PERTURBATION T; Peccianti M, 2000, APPL PHYS LETT, V77, P7, DOI 10.1063/1.126859; Peccianti M, 2002, APPL PHYS LETT, V81, P3335, DOI 10.1063/1.1519101; Peccianti M, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.025602; Schiek R, 2001, PHYS REV LETT, V86, P4528, DOI 10.1103/PhysRevLett.86.4528; Schiek R, 1999, OPT LETT, V24, P83, DOI 10.1364/OL.24.000083; Simoni F., 1997, NONLINEAR OPTICAL PR; Stegeman GI, 1999, SCIENCE, V286, P1518, DOI 10.1126/science.286.5444.1518; Stegeman GIA, 2000, IEEE J SEL TOP QUANT, V6, P1419, DOI 10.1109/2944.902197; TABIRYAN NV, 1986, MOL CRYST LIQ CRYST, V136, P1, DOI 10.1080/00268948608074569; Torruellas WE, 1996, APPL PHYS LETT, V68, P1449, DOI 10.1063/1.116250; TORRUELLAS WE, 1995, PHYS REV LETT, V74, P5036, DOI 10.1103/PhysRevLett.74.5036; TORRUELLAS WE, 1995, OPT LETT, V20, P1949, DOI 10.1364/OL.20.001949; Trillo S., 2001, SPATIAL SOLITONS; WEBER MJ, 1995, CRC HDB LASER SCI S, V2	30	307	310	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2004	432	7018					733	737		10.1038/nature03101	http://dx.doi.org/10.1038/nature03101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15592407				2022-12-28	WOS:000225597200042
J	Rose, PG; Nerenstone, S; Brady, MF; Clarke-Pearson, D; Olt, G; Rubin, SC; Moore, DH; Small, JM				Rose, PG; Nerenstone, S; Brady, MF; Clarke-Pearson, D; Olt, G; Rubin, SC; Moore, DH; Small, JM		Gynecologic Oncology Grp	Secondary surgical cytoreduction for advanced ovarian carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; STAGE-III; NEOADJUVANT CHEMOTHERAPY; DEBULKING SURGERY; CANCER; CISPLATIN; PACLITAXEL; CYCLOPHOSPHAMIDE; SURVIVAL; CARBOPLATIN	Background: We evaluated the effect of adding secondary cytoreductive surgery to postoperative chemotherapy on progression-free survival and overall survival among patients who had advanced ovarian cancer and residual tumor exceeding 1 cm in diameter after primary surgery. Methods: Women were enrolled within six weeks after primary surgery. If, after three cycles of postoperative paclitaxel plus cisplatin, a patient had no evidence of progressive disease, she was randomly assigned to undergo secondary cytoreductive surgery followed by three more cycles of chemotherapy or three more cycles of chemotherapy alone. Results: We enrolled 550 women. After completing three cycles of postoperative chemotherapy, 216 eligible patients were randomly assigned to receive secondary surgical cytoreduction followed by chemotherapy and 208 to receive chemotherapy alone. Surgery was declined by or medically contraindicated in 15 patients who were assigned to secondary surgery (7 percent). As of March 2003, 296 patients had died and 82 had progressive disease. The likelihood of progression-free survival in the group assigned to secondary surgery plus chemotherapy, as compared with the chemotherapy-alone group, was 1.07 (95 percent confidence interval, 0.87 to 1.31; P=0.54), and the relative risk of death was 0.99 (95 percent confidence interval, 0.79 to 1.24; P=0.92). Conclusions: For patients with advanced ovarian carcinoma in whom primary cytoreductive surgery was considered to be maximal, the addition of secondary cytoreductive surgery to postoperative chemotherapy with paclitaxel plus cisplatin does not improve progression-free survival or overall survival.	Case Western Reserve Univ, Cleveland, OH 44106 USA; Metrohlth Med Ctr, Div Gynecol Oncol, Cleveland, OH USA; Univ Connecticut, Dept Med, Hartford, CT 06112 USA; Hartford Hosp, Hartford, CT 06115 USA; Roswell Pk Canc Inst, Gynecol Oncol Grp, Stat & Data Ctr, Buffalo, NY 14263 USA; Duke Univ, Med Ctr, Div Gynecol Oncol, Durham, NC USA; Penn State Univ, Milton S Hershey Med Ctr, Div Gynecol Oncol, Hershey, PA 17033 USA; Univ Penn, Ctr Canc, Div Gynecol Oncol, Philadelphia, PA 19104 USA; Indiana Univ, Sch Med, Div Gynecol Oncol, Indianapolis, IN USA; UniPath & Colorado Gynecol Oncol, Denver, CO USA	Case Western Reserve University; MetroHealth System; University of Connecticut; Hartford Hospital; Roswell Park Cancer Institute; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Pennsylvania; Indiana University System; Indiana University-Purdue University Indianapolis	Rose, PG (corresponding author), Gynecol Oncol Grp, Adm Off, 4 Penn Ctr,1600 JFK Blvd,Suite 1020, Philadelphia, PA 19103 USA.		Rubin, Stephen/U-8535-2019	Rubin, Stephen/0000-0003-3688-5333	NATIONAL CANCER INSTITUTE [U10CA027469, U10CA037517] Funding Source: NIH RePORTER; NCI NIH HHS [CA 37517, CA 27469] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERTELSEN K, 1990, GYNECOL ONCOL, V38, P203, DOI 10.1016/0090-8258(90)90042-J; BLESSING JA, 1984, CHEMOTHERAPY GYNECOL, P68; Boente M P, 1996, Cancer Treat Res, V82, P337; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; DELGADO G, 1984, GYNECOL ONCOL, V18, P293, DOI 10.1016/0090-8258(84)90040-4; Eisenhauer EA, 1997, ANN ONCOL, V8, P963, DOI 10.1023/A:1008240421028; GRIFFITHS CT, 1975, NATL CANCER I MONOGR, P101; HACKER NF, 1983, OBSTET GYNECOL, V61, P413; HOSKINS WJ, 1994, AM J OBSTET GYNECOL, V170, P974, DOI 10.1016/S0002-9378(94)70090-7; JACOB JH, 1991, GYNECOL ONCOL, V42, P146, DOI 10.1016/0090-8258(91)90335-3; LAWTON FG, 1989, OBSTET GYNECOL, V73, P61; Markman M, 2001, J CLIN ONCOL, V19, P1001, DOI 10.1200/JCO.2001.19.4.1001; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Muggia FM, 2000, J CLIN ONCOL, V18, P106, DOI 10.1200/JCO.2000.18.1.106; Neijt J P, 1985, Prog Clin Biol Res, V201, P217; NG LW, 1990, GYNECOL ONCOL, V38, P358, DOI 10.1016/0090-8258(90)90073-T; Onnis A., 1996, European Journal of Gynaecological Oncology, V17, P393; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; PREFONTAINE M, 1994, GYNECOL ONCOL, V55, P87, DOI 10.1006/gyno.1994.1253; RAJU KS, 1982, AM J OBSTET GYNECOL, V144, P650, DOI 10.1016/0002-9378(82)90432-X; Reynolds T, 1999, J NATL CANCER I, V91, P1182, DOI 10.1093/jnci/91.14.1182; Rubin SC, 1999, OBSTET GYNECOL, V93, P21, DOI 10.1016/S0029-7844(98)00334-2; Schwartz PE, 1999, GYNECOL ONCOL, V72, P93, DOI 10.1006/gyno.1998.5236; Surwit E, 1996, INT J GYNECOL CANCER, V6, P356, DOI 10.1046/j.1525-1438.1996.06050356.x; VANDERBURG MEL, 1995, NEW ENGL J MED, V332, P629, DOI 10.1056/NEJM199503093321002; Vergote I, 1998, GYNECOL ONCOL, V71, P431, DOI 10.1006/gyno.1998.5213; VOGEL SE, 1984, CANCER, V54, P2220; WILS J, 1986, J CLIN ONCOL, V4, P1068, DOI 10.1200/JCO.1986.4.7.1068; Winter WE, 2004, GYNECOL ONCOL, V94, P495, DOI 10.1016/j.ygyno.2004.04.008	30	277	291	2	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2004	351	24					2489	2497		10.1056/NEJMoa041125	http://dx.doi.org/10.1056/NEJMoa041125			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877TE	15590951				2022-12-28	WOS:000225593100004
J	Smith, MD; Wolff, MJ; Lemmon, MT; Spanovich, N; Banfield, D; Budney, CJ; Clancy, RT; Ghosh, A; Landis, GA; Smith, P; Whitney, B; Christensen, PR; Squyres, SW				Smith, MD; Wolff, MJ; Lemmon, MT; Spanovich, N; Banfield, D; Budney, CJ; Clancy, RT; Ghosh, A; Landis, GA; Smith, P; Whitney, B; Christensen, PR; Squyres, SW			First atmospheric science results from the Mars exploration rovers Mini-TES	SCIENCE			English	Article							THERMAL EMISSION SPECTROMETER; ATMOSPHERIC TEMPERATURES; AEROBRAKING	Thermal infrared spectra of the martian atmosphere taken by the Miniature Thermal Emission Spectrometer (Mini-TES) were used to determine the atmospheric temperatures in the planetary boundary layer and the column-integrated optical depth of aerosols. Mini-TES observations show the diurnal variation of the martian boundary layer thermal structure, including a near-surface superadiabatic layer during the afternoon and an inversion layer at night. Upward-looking Mini-TES observations show warm and cool parcels of air moving through the Mini-TES field of view on a time scale of 30 seconds. The retrieved dust optical depth shows a downward trend at both sites.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Space Sci Inst, Boulder, CO 80301 USA; Texas A&M Univ, College Stn, TX 77843 USA; Univ Arizona, Tucson, AZ 85721 USA; Cornell Univ, Ithaca, NY 14853 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Arizona State Univ, Tempe, AZ 85287 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Texas A&M University System; Texas A&M University College Station; University of Arizona; Cornell University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; Arizona State University; Arizona State University-Tempe	Smith, MD (corresponding author), NASA, Goddard Space Flight Ctr, Code 661, Greenbelt, MD 20771 USA.	Michael.D.Smith@nasa.gov	Lemmon, Mark T/E-9983-2010; Banfield, Don J/I-3523-2018; Lemmon, Mark/X-2333-2019; Smith, Michael/C-8875-2012	Lemmon, Mark T/0000-0002-4504-5136; Banfield, Don J/0000-0003-2664-0164; Lemmon, Mark/0000-0002-4504-5136; 				Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Conrath BJ, 2000, J GEOPHYS RES-PLANET, V105, P9509, DOI 10.1029/1999JE001095; Hess S. L., 1977, Journal of Geophysical Research, V82, P4559, DOI 10.1029/JS082i028p04559; Murphy JR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015214; Schofield JT, 1997, SCIENCE, V278, P1752, DOI 10.1126/science.278.5344.1752; Smith MD, 2000, J GEOPHYS RES-PLANET, V105, P9539, DOI 10.1029/1999JE001097; Smith MD, 1996, ICARUS, V124, P586, DOI 10.1006/icar.1996.0232; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Smith MD, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001522; Wolff MJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002057	10	90	90	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1750	1753		10.1126/science.1104257	http://dx.doi.org/10.1126/science.1104257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15576612				2022-12-28	WOS:000225630800044
J	Chen, CL; Hsu, LI; Chiou, HY; Hsueh, YM; Chen, SY; Wu, MM; Chen, CJ				Chen, CL; Hsu, LI; Chiou, HY; Hsueh, YM; Chen, SY; Wu, MM; Chen, CJ		Blackfoot Dis Study Grp	Ingested arsenic, cigarette smoking, and lung cancer risk - A follow-up study in arseniasis-endemic areas in Taiwan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVALENCE; DISEASE	Context Arsenic has been documented as a lung carcinogen in humans in only a few follow-up studies, which were limited by a small number of cases or the lack of information on cigarette smoking. Objectives To elucidate the dose-response relationship between ingested arsenic and lung cancer and to assess the effect of cigarette smoking on the arsenic-lung cancer association. Design, Setting, and Participants A total of 2503 residents in southwestern and 8088 in northeastern arseniasis-endemic areas in Taiwan were followed up for an average period of 8 years. Information on arsenic exposure, cigarette smoking, and other risk factors was collected at enrollment through standardized questionnaire interview. Main Outcome Measures The incidence of lung cancer was ascertained through linkage with national cancer registry profiles in Taiwan (January 1985-December 2000). The joint effect of arsenic and cigarette smoking was estimated by both etiologic fraction and synergy index. Results There were 139 newly diagnosed lung cancer cases during a follow-up period of 83 783 person-years. After adjustment for cigarette smoking and other risk factors, there was a monotonic trend of lung cancer risk by arsenic level in drinking water of less than 10 to 700 mug/L or more (P<.001). The relative risk was 3.29 (95% confidence interval, 1.60-6.78) for the highest arsenic level compared with the lowest. The etiologic fraction of lung cancer attributable to the joint exposure of ingested arsenic and cigarette smoking ranged from 32% to 55%. The synergy indices ranged from 1.62 to 2.52, indicating a synergistic effect of ingested arsenic and cigarette smoking on lung cancer. Conclusions There was a significant dose-response trend of ingested arsenic on lung cancer risk, which was more prominent among cigarette smokers. The risk assessment of lung cancer induced by ingested arsenic should take cigarette smoking into consideration.	Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10018, Taiwan; Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; Natl Hlth Res Inst, Div Biostat & Bioinformat, Taipei, Taiwan	National Taiwan University; Taipei Medical University; National Health Research Institutes - Taiwan	Chen, CL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, 1 Jen Ai Rd,Sect 1, Taipei 10018, Taiwan.	cjchen@ha.mc.ntu.edu.tw	Chen, Chien-Jen/N-4723-2019; Chen, Chien-Jen/C-6976-2008	Chiou, Hung Yi/0000-0002-4545-9697				BLACKWELL R. QUENTIN, 1961, JOUR FORMOSAN MED ASSOC, V60, P1143; BOYLE P, 1995, LUNG CANCER, V12, P167, DOI 10.1016/0169-5002(95)00443-5; Chen KP, 1962, MEMOIRS COLLEGE MED, V8, P115; Chiou HY, 1997, STROKE, V28, P1717, DOI 10.1161/01.STR.28.9.1717; HERTZPICCIOTTO I, 1992, EPIDEMIOLOGY, V3, P23, DOI 10.1097/00001648-199201000-00006; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; *INT AG RES CANC, 1980, IARC MON EV CARC RIS, V23, P139; Kuo T.L., 1964, REPORTS I PATHOLOGY, V20, P7; LAI MS, 1994, AM J EPIDEMIOL, V139, P484, DOI 10.1093/oxfordjournals.aje.a117031; LO MC, 1977, 2 TAIW PROV I ENV SA; MACCARTHY P, 1987, ANAL CHEM, V59, pR308, DOI 10.1021/ac00139a017; Natelson S, 1961, MICROTECHNIQUES CLIN, V2nd, P113; Tseng W. P., 1961, MEMOIRS NATIONAL TAI, V7, P1; WALKER AM, 1981, INT J EPIDEMIOL, V10, P81, DOI 10.1093/ije/10.1.81; *WHO INT PROGR SOU, 2001, ARS ARS COMP	15	197	201	2	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					2984	2990		10.1001/jama.292.24.2984	http://dx.doi.org/10.1001/jama.292.24.2984			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613666	Bronze			2022-12-28	WOS:000225841900032
J	Young, DC; Hade, EM				Young, DC; Hade, EM			Holidays, birthdays, and postponement of cancer death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY; OCCASIONS; SURVIVAL	Context Articles in the medical literature and lay press have supported a belief that individuals, including those dying of cancer, can temporarily postpone their death to survive a major holiday or other significant event, but results and effects have been variable. Objective To determine whether, for the patient dying of cancer, a "death takes a holiday" effect showing a reduction in deaths in the week before a significant event was associated with Christmas, the US holiday of Thanksgiving, or the date of the individual's birthday. Design, Setting, and Subjects Analysis of death certificate data for all 1269474 persons dying in Ohio from 1989-2000, including 309221 persons dying with cancer noted as the leading cause of death. Main Outcome Measure We measured the total number of cancer deaths in the 2 weeks centered on the event of interest and the proportion of these deaths that occurred in the week before the event to determine whether this proportion was significantly different from 0.5 by using an exact binomial test. Results The proportion of persons dying of cancer in the week before Christmas, Thanksgiving, and the individual's birthday was not significantly different from the proportion dying in the week after the event (P=.52, .26, and .06, respectively). However, among black individuals there was an increase in cancer deaths in the week before Thanksgiving (P=.01), whereas women showed an increase in cancer deaths in the week before their birthday (P=.05). There was no statistically significant excess of deaths in the postevent week in any subgroup. Conclusion We found no evidence, in contrast to previous studies, that cancer patients are able to postpone their deaths to survive significant religious, social, or personal events.	Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Young, DC (corresponding author), Ohio State Univ, Ctr Comprehens Canc, M410 Starling Loving Hall,320 W 10th Ave, Columbus, OH 43210 USA.	young-8@medctr.osu.edu		Hade, Erinn/0000-0001-8977-6443	NCI NIH HHS [P30CA16058] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anson J, 2001, SOC SCI MED, V52, P83, DOI 10.1016/S0277-9536(00)00125-8; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; HOEL DG, 1993, JNCI-J NATL CANCER I, V85, P1063, DOI 10.1093/jnci/85.13.1063; IDLER EL, 1992, AM J SOCIOL, V97, P1052, DOI 10.1086/229861; Keatinge W R, 2002, Int J Circumpolar Health, V61, P292; Kosmin B. A., 2001, AM RELIG IDENTIFICAT; Lee P, 2000, SOC BIOL, V47, P127; Petticrew M, 2002, BRIT MED J, V325, P1066, DOI 10.1136/bmj.325.7372.1066; PHILLIPS DP, 1988, LANCET, V2, P728; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; PHILLIPS DP, 1973, AM SOCIOL REV, V38, P678, DOI 10.2307/2094131; PHILLIPS DP, 1992, PSYCHOSOM MED, V54, P532, DOI 10.1097/00006842-199209000-00001; PYLE E, 2004, COLUMBUS DISPATCH, V133, pA1; Schofield P, 2004, CANCER-AM CANCER SOC, V100, P1276, DOI 10.1002/cncr.20076; Seretakis D, 1997, JAMA-J AM MED ASSOC, V278, P1012, DOI 10.1001/jama.278.12.1012; Skala JA, 2004, PSYCHOSOM MED, V66, P382, DOI 10.1097/01.psy.0000127874.31062.4e; Smith G, 2004, PSYCHOSOM MED, V66, P378, DOI 10.1097/01.psy.0000127875.38685.ba; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124	18	27	27	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2004	292	24					3012	3016		10.1001/jama.292.24.3012	http://dx.doi.org/10.1001/jama.292.24.3012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881CV	15613670				2022-12-28	WOS:000225841900036
J	de Koning, TJ; Klomp, LWJ; van Oppen, ACC; Beemer, FA; Dorland, L; van den Berg, IET; Berger, R				de Koning, TJ; Klomp, LWJ; van Oppen, ACC; Beemer, FA; Dorland, L; van den Berg, IET; Berger, R			Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency	LANCET			English	Article							DEHYDROGENASE-DEFICIENCY; L-SERINE	3-phosphoglycerate-dehydrogenase (3-PGDH) deficiency is an L-serine biosynthesis disorder, characterised by congenital microcephaly, severe psychomotor retardation, and intractable seizures. We report prenatal diagnosis of an affected fetus by DNA mutation analysis. Ultrasound assessment showed a reduction in fetal head circumference from the 75th percentile at 20 weeks' gestation to the 29th percentile at 26 weeks. L-serine was then given to the mother, which resulted in an enlarged fetal head circumference to the 76th percentile at 31 weeks. At birth, the girl's head circumference was normal, and at 48 months' follow-up, her psychomotor development has been unremarkable. 3-PGDH deficiency is an inborn metabolic error that can be successfully treated antenatally.	Univ Med Ctr Utrecht, Dept Metab Dis, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Obstet, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Koning, TJ (corresponding author), Univ Med Ctr Utrecht, Dept Paediat Metab Dis, KC 03-063-0,POB 85090, NL-3508 AB Utrecht, Netherlands.	t.dekoning@wkz.azu.nl	De Koning, Tom J/AAE-1323-2020	De Koning, Tom J/0000-0001-5609-1309				De Koning TJ, 2002, J INHERIT METAB DIS, V25, P119, DOI 10.1023/A:1015624726822; Furuya S, 2000, P NATL ACAD SCI USA, V97, P11528, DOI 10.1073/pnas.200364497; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; Ronzoni S, 1999, AM J OBSTET GYNECOL, V181, P477, DOI 10.1016/S0002-9378(99)70581-8; Walter JH, 1996, LANCET, V348, P558, DOI 10.1016/S0140-6736(05)64790-3	6	84	85	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 18	2004	364	9452					2221	2222		10.1016/S0140-6736(04)17596-X	http://dx.doi.org/10.1016/S0140-6736(04)17596-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610810				2022-12-28	WOS:000225799700032
J	Liebeschuetz, S; Bamber, S; Ewer, K; Deeks, J; Pathan, AA; Lalvani, A				Liebeschuetz, S; Bamber, S; Ewer, K; Deeks, J; Pathan, AA; Lalvani, A			Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PULMONARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; TYPE-1 INFECTION; ZAMBIAN CHILDREN; RAPID DETECTION; HIV-INFECTION; ENUMERATION; SEROPREVALENCE; POPULATION	Background Childhood tuberculosis often presents non-specifically and is a common differential diagnosis in high prevalence areas. Current diagnostic tools have poor sensitivity and cannot reliably exclude tuberculosis, so overdiagnosis is common. HIV co-infection exacerbates this problem and accounts for an increasing proportion of paediatric tuberculosis worldwide. Methods We assessed the usefulness of a T-cell-based rapid blood test for Mycobacterium tuberculosis infection, the enzyme-linked immunospot assay (ELISPOT), in routine clinical practice. We did a prospective blinded study of 293 African children with suspected tuberculosis in kwaZulu-Natal, a region with high HIV prevalence. Children had full clinical assessment, ELISPOT, and a tuberculin skin test. Test results were compared with final clinical and microbiological diagnoses. Results In children with tuberculosis, sensitivity of ELISPOT was 83% (95% Cl 75-89, n=133), significantly higher (p<0.001) than the 63% (54-72) sensitivity of tuberculin skin test (n=116). Sensitivity of tuberculin skin test fell significantly in children younger than 3 years (to 51%), with HIV co-infection (36%), or with malnutrition (44%). Sensitivity of ELISPOT, which was not significantly adversely affected by these factors, was 85%, 73%, and 78%, respectively in these subgroups. In 116 children with both test results available, sensitivity of the two tests combined was 91% (85-95). Conclusions Diagnostic sensitivity of ELISPOT is higher than that of the skin test and is less affected by factors frequently associated with childhood tuberculosis in developing countries. Used together with the skin test, ELISPOT provides a clinically useful diagnostic sensitivity in African children with suspected tuberculosis.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Ngwelezana Hosp, Empangeni, KwaZulu Natal, South Africa; Univ Oxford, Ctr Stat Med, Oxford, England	University of Oxford; University of Oxford	Lalvani, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Level 7, Oxford OX3 9DU, England.	ajit.lalvani@ndm.ox.ac.uk	Ewer, Katie J/B-4328-2011; Deeks, Jon/AAV-5745-2020	Ewer, Katie J/0000-0001-9827-9836; Deeks, Jon/0000-0002-8850-1971; Lalvani, Ajit/0000-0002-2396-246X				[Anonymous], 1998, S AFRICA DEMOGRAPHIC; Barnes PF, 2001, AM J RESP CRIT CARE, V163, P807, DOI 10.1164/ajrccm.163.4.ed0201c; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; CHINTU C, 1993, PEDIATR INFECT DIS J, V12, P499, DOI 10.1097/00006454-199306000-00008; Coovadia HM, 1998, INT J TUBERC LUNG D, V2, P844; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; Donald PR, 2002, CURR OPIN PULM MED, V8, P178, DOI 10.1097/00063198-200205000-00005; DONALD PR, 1985, S AFR MED J, V67, P588; Drobniewski FA, 2003, LANCET INFECT DIS, V3, P141, DOI 10.1016/S1473-3099(03)00544-9; ELLIOTT AM, 1993, J TROP MED HYG, V96, P1; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; FOURIE PB, 1983, TUBERCLE, V64, P167, DOI 10.1016/0041-3879(83)90012-0; Girardi E, 2000, AIDS, V14, pS47; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Horwood C, 2003, B WORLD HEALTH ORGAN, V81, P858; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Jeena PM, 1996, TUBERCLE LUNG DIS, V77, P437, DOI 10.1016/S0962-8479(96)90117-3; Lalvani A, 2003, THORAX, V58, P916, DOI 10.1136/thorax.58.11.916; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Liu XQ, 2004, INFECT IMMUN, V72, P2574, DOI 10.1128/IAI.72.5.2574-2581.2004; Lockman S, 1999, INT J TUBERC LUNG D, V3, P23; LUO C, 1994, TUBERCLE LUNG DIS, V75, P110, DOI 10.1016/0962-8479(94)90039-6; Madhi SA, 2000, INT J TUBERC LUNG D, V4, P448; Mukadi YD, 1997, AIDS, V11, P1151, DOI 10.1097/00002030-199709000-00011; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; RAVIGLIONE MC, 1997, AIDS, V11, P115; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Small PM, 2000, LANCET, V356, P1048, DOI 10.1016/S0140-6736(00)02724-0; van Rie A, 1999, ARCH DIS CHILD, V80, P433, DOI 10.1136/adc.80.5.433; Zar HJ, 2000, ARCH DIS CHILD, V82, P305, DOI 10.1136/adc.82.4.305	33	288	315	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2004	364	9452					2196	2203		10.1016/S0140-6736(04)17592-2	http://dx.doi.org/10.1016/S0140-6736(04)17592-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610806				2022-12-28	WOS:000225799700028
J	Rugg-Gunn, FJ; Simister, RJ; Squirrell, M; Holdright, DR; Duncan, JS				Rugg-Gunn, FJ; Simister, RJ; Squirrell, M; Holdright, DR; Duncan, JS			Cardiac arrhythmias in focal epilepsy: a prospective long-term study	LANCET			English	Article							SUDDEN UNEXPECTED DEATH; HEART-RATE; ECG ABNORMALITIES; ICTAL BRADYCARDIA; RISK-FACTORS; SEIZURES; VARIABILITY; PREVALENCE; MODULATION; DIAGNOSIS	Background Patients with epilepsy are at risk of sudden unexpected death. Neurogenic cardiac arrhythmias have been postulated as a cause. Electrocardiograms (ECG) can be monitored by use of an implantable loop recorder for up to 18 months. We aimed to determine the frequency of cardiac arrhythmias in patients with refractory focal seizures over an extended period. Methods 20 patients received an implantable loop recorder at one hospital in the UK. Devices were programmed to record automatically if bradycardia (<40 beats per min) or tachycardia (>140 beats per min) were detected. Additionally, in the event of a seizure, patients and relatives could initiate ECG recording with an external activator device. Data were analysed at regular intervals and correlated with seizure diaries. Findings More than 220 000 patient-hours were monitored over 24 months, during which ECGs were captured on implantable loop recorders in 377 seizures. One patient withdrew from the study. In 16 patients, median heart rate during habitual seizures exceeded 100 beats per min. Ictal bradycardia (<40 beats per min) was rare, occurring in eight (2.1%) recorded events, in seven patients. Four patients (21%) had bradycardia or periods of asystole with subsequent permanent pacemaker insertion. Three of these four (16% of total) had potentially fatal asystole. Interpretation Clinical characteristics of patients with peri-ictal cardiac abnormalities are closely similar to those at greatest risk of sudden unexpected death in epilepsy. Asystole might underlie many of these deaths, which would have important implications for the investigation of similar patients and affect present cardiac-pacing policies.	UCL, Neurol Inst, Dept Clin & Expt Epilepsy, London, England; UCL, Natl Soc Epilepsy, London, England; UCL Hosp, Heart Hosp, Dept Cardiol, London, England	University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Duncan, JS (corresponding author), Natl Hosp Neurol & Neurosurg, Dept Clin & Expt Epilepsy, Queen Sq, London WC1N 3BG, England.	j.duncan@ion.ucl.ac.uk		Duncan, John S/0000-0002-1373-0681; Simister, Robert/0000-0003-0578-6711	Medical Research Council [G9805989] Funding Source: Medline; MRC [G9805989] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ansakorpi H, 2002, J NEUROL NEUROSUR PS, V72, P26, DOI 10.1136/jnnp.72.1.26; BAHARAV A, 1995, NEUROLOGY, V45, P1183, DOI 10.1212/WNL.45.6.1183; Bigger JT, 1996, CIRCULATION, V93, P2142, DOI 10.1161/01.CIR.93.12.2142; BJORNSTAD H, 1994, CARDIOLOGY, V84, P42, DOI 10.1159/000176327; BLUMHARDT LD, 1986, LANCET, V1, P1051; Camm AJ, 1996, CIRCULATION, V93, P1043; Darbin O, 2002, EPILEPSIA, V43, P336, DOI 10.1046/j.1528-1157.2002.34801.x; Hennessy MJ, 2001, NEUROLOGY, V57, P1650, DOI 10.1212/WNL.57.9.1650; Hilz MJ, 2002, BRAIN, V125, P985, DOI 10.1093/brain/awf092; Hilz MJ, 2001, ANN NEUROL, V49, P575, DOI 10.1002/ana.1006; JOHNSTON SC, 1995, ANN NEUROL, V37, P531, DOI 10.1002/ana.410370416; Langan Y, 2000, J NEUROL NEUROSUR PS, V68, P211, DOI 10.1136/jnnp.68.2.211; LEESTMA JE, 1989, ANN NEUROL, V26, P195, DOI 10.1002/ana.410260203; Lhatoo SD, 2001, ANN NEUROL, V49, P336; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; MAMELI O, 1993, EPILEPSY RES, V15, P171, DOI 10.1016/0920-1211(93)90053-A; Naritoku DK, 2003, EPILEPSIA, V44, P912, DOI 10.1046/j.1528-1157.2003.48302.x; Nashef L, 1996, J NEUROL NEUROSUR PS, V60, P297, DOI 10.1136/jnnp.60.3.297; NASHEF L, 1995, J NEUROL NEUROSUR PS, V58, P462, DOI 10.1136/jnnp.58.4.462; Nashef L, 1996, LANCET, V348, P1324, DOI 10.1016/S0140-6736(05)65402-5; Nei M, 2000, EPILEPSIA, V41, P542, DOI 10.1111/j.1528-1157.2000.tb00207.x; Nilsson L, 1999, LANCET, V353, P888, DOI 10.1016/S0140-6736(98)05114-9; Opherk C, 2002, EPILEPSY RES, V52, P117, DOI 10.1016/S0920-1211(02)00215-2; OPPENHEIMER SM, 1990, ARCH NEUROL-CHICAGO, V47, P513, DOI 10.1001/archneur.1990.00530050029008; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Pedley TA, 2002, LANCET, V359, P1790, DOI 10.1016/S0140-6736(02)08726-3; Reeves AL, 1996, EPILEPSIA, V37, P983, DOI 10.1111/j.1528-1157.1996.tb00536.x; Rocamora R, 2003, EPILEPSIA, V44, P179, DOI 10.1046/j.1528-1157.2003.15101.x; Rugg-Gunn FJ, 2000, J NEUROL NEUROSUR PS, V68, P108, DOI 10.1136/jnnp.68.1.108; SLEIGHT P, 1995, CLIN SCI, V88, P103, DOI 10.1042/cs0880103; SWARTZ CM, 1994, J NEUROL NEUROSUR PS, V57, P97, DOI 10.1136/jnnp.57.1.97; TERRENCE CF, 1981, ANN NEUROL, V9, P458, DOI 10.1002/ana.410090508; Timmings PL, 1998, SEIZURE-EUR J EPILEP, V7, P289, DOI 10.1016/S1059-1311(98)80020-4; Tinuper P, 2001, BRAIN, V124, P2361, DOI 10.1093/brain/124.12.2361; Walczak T, 2003, DRUG SAFETY, V26, P673, DOI 10.2165/00002018-200326100-00001; Walczak TS, 2001, NEUROLOGY, V56, P519, DOI 10.1212/WNL.56.4.519; WANNAMAKER BB, 1985, EPILEPSIA, V26, pS31, DOI 10.1111/j.1528-1157.1985.tb05722.x; Zaidi A, 1999, SEIZURE-EUR J EPILEP, V8, P184, DOI 10.1053/seiz.1998.0261; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408; Zijlmans M, 2002, EPILEPSIA, V43, P847, DOI 10.1046/j.1528-1157.2002.37801.x	40	256	303	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2004	364	9452					2212	2219		10.1016/S0140-6736(04)17594-6	http://dx.doi.org/10.1016/S0140-6736(04)17594-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	880OS	15610808				2022-12-28	WOS:000225799700030
J	Fish, J; Raule, N; Attardi, G				Fish, J; Raule, N; Attardi, G			Discovery of a major D-loop replication origin reveals two modes of human mtDNA synthesis	SCIENCE			English	Article							MITOCHONDRIAL-DNA REPLICATION; MOUSE L-CELLS; SEQUENCE; BUBBLE; BURST; REGION	Mammalian mitochondrial DNA mtDNA, replication has long been considered to occur by asymmetric synthesis of the two strands, starting at the multiple origins of the strand-displacement loop (D-loop). We report the discovery of a major replication origin at position 57 in the D-loop of several human cell lines (HeLa, A549, and 143B.TK-) and immortalized lymphocytes. The nascent chains starting at this origin, in contrast to those initiated at the previously described origins, do not terminate prematurely at the 3' end of the D-loop but proceed well beyond this control point, behaving as "true" replicating strands. This origin is mainly responsible for mtDNA maintenance under steady-state conditions, whereas mtDNA synthesis from the formerly identified D-loop origins may be more important for recovery after mtDNA depletion and for accelerating mtDNA replication in response to physiological demands.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Attardi, G (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	attardi@cattech.edu		Fish, Jennifer/0000-0002-2654-2583	NIGMS NIH HHS [GM11726] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BOGENHAGEN D, 1978, J MOL BIOL, V119, P49, DOI 10.1016/0022-2836(78)90269-3; Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4; Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; BROWN GG, 1986, J MOL BIOL, V192, P503, DOI 10.1016/0022-2836(86)90272-X; Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CREWS S, 1979, NATURE, V277, P192, DOI 10.1038/277192a0; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6; Kai Y, 1999, BBA-GENE STRUCT EXPR, V1446, P126, DOI 10.1016/S0167-4781(99)00015-9; Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275; KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891; Ohsato T, 1999, BIOCHEM BIOPH RES CO, V255, P1, DOI 10.1006/bbrc.1998.0133; ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737; WISEMAN A, 1978, MOL GEN GENET, V167, P51, DOI 10.1007/BF00270321; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399	22	92	97	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2098	2101		10.1126/science.1102077	http://dx.doi.org/10.1126/science.1102077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604407				2022-12-28	WOS:000225841000064
J	Kim, MY; Mauro, S; Gevry, N; Lis, JT; Kraus, WL				Kim, MY; Mauro, S; Gevry, N; Lis, JT; Kraus, WL			NAD(+)-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1	CELL			English	Article							POLY(ADP-RIBOSE) POLYMERASE; HISTONE; DNA; CATALYSIS; DOMAINS; H-1; ACF	PARP-1 is the most abundantly expressed member of a family of proteins that catalyze the transfer of ADPribose units from NAD(+) to target proteins. Herein, we describe previously uncharacterized nucleosome binding properties of PARP-1 that promote the formation of compact, transcriptionally repressed chromatin structures. PARP-1 binds in a specific manner to nucleosomes and modulates chromatin structure through NAD(+)-dependent automodification, without modifying core histories or promoting the disassembly of nucleosomes. The automodification activity of PARP-1 is potently stimulated by nucleosomes, causing the release of PARP-1 from chromatin. The NAD+-dependent activities of PARP-1 are reversed by PARG, a poly(ADPribose) glycohydrolase, and are inhibited by ATP. In vivo, PARP-1 incorporation is associated with transcriptionally repressed chromatin domains that are spatially distinct from both histone H1-repressed domains and actively transcribed regions. Thus, PARP-1 functions both as a structural component of chromatin and a modulator of chromatin structure through its intrinsic enzymatic activity.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Kraus, WL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	wlk5@cornell.edu	Kim, Mi Young/C-1829-2011		NIDDK NIH HHS [DK58110, R01 DK069710, DK069710] Funding Source: Medline; NIGMS NIH HHS [GM25232] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058110, R56DK069710, R01DK069710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025232, R01GM025232] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Cheung E, 2002, MOL CELL BIOL, V22, P2463, DOI 10.1128/MCB.22.8.2463-2471.2002; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; GRADWOHL G, 1987, BIOCHEM BIOPH RES CO, V148, P913, DOI 10.1016/S0006-291X(87)80219-X; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; HOM PJ, 2002, SCIENCE, V297, P1824; HULETSKY A, 1989, J BIOL CHEM, V264, P8878; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1996, MOL CELL BIOL, V16, P3112; Jiang LJ, 1998, P NATL ACAD SCI USA, V95, P9146, DOI 10.1073/pnas.95.16.9146; Kellum R, 2003, CURR TOP MICROBIOL, V274, P53; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Kraus WL, 1999, STEROID NUCL RECEPTO, P167; Kun E, 2004, BIOCHEMISTRY-US, V43, P210, DOI 10.1021/bi0301791; Kun E, 2002, J BIOL CHEM, V277, P39066, DOI 10.1074/jbc.C200410200; Lis JT, 2000, GENE DEV, V14, P792; LOETSCHER P, 1987, P NATL ACAD SCI USA, V84, P1286, DOI 10.1073/pnas.84.5.1286; MILLER DS, 1986, J BIOL CHEM, V261, P13911; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Oei SL, 2001, BIOCHEM BIOPH RES CO, V284, P450, DOI 10.1006/bbrc.2001.4985; OGATA N, 1981, J BIOL CHEM, V256, P4135; PARANJPE AC, 1995, WORLD PSYCHOL, V1, P9; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; REALINI CA, 1992, J BIOL CHEM, V267, P18858; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; ROLLI V, 2000, DNA DAMAGE STRESS SI, P335; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; Surtees JA, 2001, J BIOL CHEM, V276, P12385, DOI 10.1074/jbc.M009370200; Travers A, 1999, TRENDS BIOCHEM SCI, V24, P4, DOI 10.1016/S0968-0004(98)01339-5; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; WILLIAMS GT, 1985, EXP CELL RES, V160, P419, DOI 10.1016/0014-4827(85)90189-2; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Zhang QH, 2002, SCIENCE, V295, P1895	41	434	440	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2004	119	6					803	814		10.1016/j.cell.2004.11.002	http://dx.doi.org/10.1016/j.cell.2004.11.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	881ZD	15607977	Bronze			2022-12-28	WOS:000225907200011
J	Whalen, PJ; Kagan, J; Cook, RG; Davis, FC; Kim, H; Polis, S; McLaren, DG; Somerville, LH; McLean, AA; Maxwell, JS; Johnstone, T				Whalen, PJ; Kagan, J; Cook, RG; Davis, FC; Kim, H; Polis, S; McLaren, DG; Somerville, LH; McLean, AA; Maxwell, JS; Johnstone, T			Human amygdala responsivity to masked fearful eye whites	SCIENCE			English	Article							EXPRESSIONS; FACES		Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Univ Wisconsin, Waisman Ctr, WM Keck Lab Brain Imaging & Behav, Madison, WI 53706 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Tufts Univ, Dept Psychol, Medford, MA 02155 USA; Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Tufts University; Dartmouth College	Whalen, PJ (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.	pwhaten@wisc.edu	McLaren, Donald/G-9906-2011; Maxwell, Jeffrey/D-2482-2009; Johnstone, Tom/C-5909-2011	Johnstone, Tom/0000-0001-8635-8158	PHS HHS [069315, 01866] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADOLPHS R, IN PRESS NATURE; Ekman P., 1976, PICTURES FACIAL AFFE; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; KIM H, IN PRESS J COGN NEUR; LeDoux J. E., 1996, EMOTIONAL BRAIN; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; Sekuler AB, 2004, CURR BIOL, V14, P391, DOI 10.1016/j.cub.2004.02.028; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Whalen PJ, 1998, J NEUROSCI, V18, P411; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912	10	549	563	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2004	306	5704					2061	2061		10.1126/science.1103617	http://dx.doi.org/10.1126/science.1103617			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881CM	15604401				2022-12-28	WOS:000225841000053
J	Lipinski, C; Hopkins, A				Lipinski, C; Hopkins, A			Navigating chemical space for biology and medicine	NATURE			English	Article							MOLECULAR-PROPERTIES; ASSAY TECHNOLOGIES; SELECTION CRITERIA; CLICK CHEMISTRY; LEAD DISCOVERY; X-RAY; DRUG; PREDICTION; INHIBITORS; LIBRARIES	Despite over a century of applying organic synthesis to the search for drugs, we are still far from even a cursory examination of the vast number of possible small molecules that could be created. Indeed, a thorough examination of all 'chemical space' is practically impossible. Given this, what are the best strategies for identifying small molecules that modulate biological targets? And how might such strategies differ, depending on whether the primary goal is to understand biological systems or to develop potential drugs?	Pfizer Inc, Global R&D, Groton Labs, Groton, CT 06340 USA; Pfizer Ltd, Global R&D, Sandwich Labs, Sandwich CT13 9NJ, Kent, England	Pfizer; Pfizer	Lipinski, C (corresponding author), Pfizer Inc, Global R&D, Groton Labs, Eastern Point Rd, Groton, CT 06340 USA.	christopher_a_lipinski@groton.pfizer.com; andrew.hopkins@pfizer.com		Lipinski, Christopher/0000-0001-7355-7254				Ajay, 1998, J MED CHEM, V41, P3314, DOI 10.1021/jm970666c; ANDREWS PR, 1984, J MED CHEM, V27, P1648, DOI 10.1021/jm00378a021; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511; Baurin N, 2004, J CHEM INF COMP SCI, V44, P643, DOI 10.1021/ci034260m; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Blundell TL, 2002, NAT REV DRUG DISCOV, V1, P45, DOI 10.1038/nrd706; BUNIN BA, 1992, J AM CHEM SOC, V114, P10997, DOI 10.1021/ja00053a067; Crews CM, 1999, TRENDS BIOCHEM SCI, V24, P317, DOI 10.1016/S0968-0004(99)01425-5; Dolle RE, 2003, J COMB CHEM, V5, P693, DOI 10.1021/cc0340224; Egan WJ, 2002, CURR OPIN DRUG DISC, V5, P540; Engels MFM, 2002, J BIOMOL SCREEN, V7, P341; Erlanson DA, 2004, ANNU REV BIOPH BIOM, V33, P199, DOI 10.1146/annurev.biophys.33.110502.140409; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Graddis T. J., 2002, Current Pharmaceutical Biotechnology, V3, P285, DOI 10.2174/1389201023378148; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Harper G, 2001, J CHEM INF COMP SCI, V41, P1295, DOI 10.1021/ci000397q; Hopkins AL, 2003, E SCHERING RES FDN W, V42, P11; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Horn JR, 2004, J MOL BIOL, V336, P1283, DOI 10.1016/j.jmb.2003.12.068; Horrobin DF, 2003, NAT REV DRUG DISCOV, V2, P151, DOI 10.1038/nrd1012; Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Krejsa CM, 2003, CURR OPIN DRUG DISC, V6, P470; Lajiness MS, 2004, CURR OPIN DRUG DISC, V7, P470; Lesuisse D, 2002, J MED CHEM, V45, P2379, DOI 10.1021/jm010927p; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; LIPINSKI CA, 2003, METHODS PRINCIPLES M, V18, P215; Lipper R.A., 1999, MOD DRUG DISCOV, V2, P55; Lobato MN, 2004, CURR MOL MED, V4, P519, DOI 10.2174/1566524043360384; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; Morphy R, 2004, DRUG DISCOV TODAY, V9, P641, DOI 10.1016/S1359-6446(04)03163-0; Muegge I, 2003, MED RES REV, V23, P302, DOI 10.1002/med.10041; Muegge I, 2001, J MED CHEM, V44, P1841, DOI 10.1021/jm015507e; Nienaber VL, 2000, NAT BIOTECHNOL, V18, P1105, DOI 10.1038/80319; Oprea TI, 2002, CURR OPIN CHEM BIOL, V6, P384, DOI 10.1016/S1367-5931(02)00329-0; Oprea TI, 2001, J COMB CHEM, V3, P157, DOI 10.1021/cc0000388; Podlogar B L, 2001, Curr Opin Drug Discov Devel, V4, P102; Proudfoot JR, 2002, BIOORG MED CHEM LETT, V12, P1647, DOI 10.1016/S0960-894X(02)00244-5; Rader C, 2001, DRUG DISCOV TODAY, V6, P36, DOI 10.1016/S1359-6446(00)01595-6; Raju T N, 2000, Lancet, V355, P1022, DOI 10.1016/S0140-6736(05)74775-9; Rees DC, 2004, NAT REV DRUG DISCOV, V3, P660, DOI 10.1038/nrd1467; Rishton GM, 2003, DRUG DISCOV TODAY, V8, P86, DOI 10.1016/S1359644602025722; Rishton GM, 1997, DRUG DISCOV TODAY, V2, P382, DOI 10.1016/S1359-6446(97)01083-0; Schreiber SL, 1998, BIOORGAN MED CHEM, V6, P1127, DOI 10.1016/S0968-0896(98)00126-6; Shokat K, 2002, DRUG DISCOV TODAY, V7, P872, DOI 10.1016/S1359-6446(02)02391-7; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Sills MA, 2002, J BIOMOL SCREEN, V7, P191, DOI 10.1177/108705710200700304; Sneader W., 1996, DRUG PROTOTYPES THEI; Swayze EE, 2002, J MED CHEM, V45, P3816, DOI 10.1021/jm0255466; Swinney DC, 2004, NAT REV DRUG DISCOV, V3, P801, DOI 10.1038/nrd1500; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; VANGESTEL S, 1986, DRUG DEVELOP RES, V8, P1, DOI 10.1002/ddr.430080103; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Vieth M, 2004, J MED CHEM, V47, P224, DOI 10.1021/jm030267j; Walters WP, 2002, ADV DRUG DELIVER REV, V54, P255, DOI 10.1016/S0169-409X(02)00003-0; Walters WP, 1999, CURR OPIN CHEM BIOL, V3, P384, DOI 10.1016/S1367-5931(99)80058-1; Wang J, 1999, J COMB CHEM, V1, P524, DOI 10.1021/cc990032m; WEININGER D, 1998, ENCY COMPUTATIONAL C, V1, P425; Wermuth CG, 2004, J MED CHEM, V47, P1303, DOI 10.1021/jm030480f; Williams Michael, 2004, Curr Opin Investig Drugs, V5, P29; Wu X, 2003, J BIOMOL SCREEN, V8, P381, DOI 10.1177/1087057103256466; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987; ZAMBROWICZ BP, DRUG DISCOV TODAY TA, V3, P198	66	720	739	5	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2004	432	7019					855	861		10.1038/nature03193	http://dx.doi.org/10.1038/nature03193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879QY	15602551				2022-12-28	WOS:000225733500042
J	Spielberger, R; Stiff, P; Bensinger, W; Gentile, T; Weisdorf, D; Kewalramani, T; Shea, T; Yanovich, S; Hansen, K; Noga, S; McCarty, J; LeMaistre, CF; Sung, EC; Blazar, BR; Elhardt, D; Chen, MG; Emmanouilides, C				Spielberger, R; Stiff, P; Bensinger, W; Gentile, T; Weisdorf, D; Kewalramani, T; Shea, T; Yanovich, S; Hansen, K; Noga, S; McCarty, J; LeMaistre, CF; Sung, EC; Blazar, BR; Elhardt, D; Chen, MG; Emmanouilides, C			Palifermin for oral mucositis after intensive therapy for hematologic cancers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; KERATINOCYTE GROWTH-FACTOR; TOTAL-BODY IRRADIATION; NON-HODGKINS-LYMPHOMA; HIGH-DOSE ETOPOSIDE; PREPARATORY REGIMEN; DOUBLE-BLIND; CHEMOTHERAPY; PROPHYLAXIS	BACKGROUND: Oral mucositis is a complication of intensive chemotherapy and radiotherapy with no effective treatment. We tested the ability of palifermin (recombinant human keratinocyte growth factor) to decrease oral mucosal injury induced by cytotoxic therapy. METHODS: This double-blind study compared the effect of palifermin with that of a placebo on the development of oral mucositis in 212 patients with hematologic cancers; 106 patients received palifermin (60 microg per kilogram of body weight per day) and 106 received a placebo intravenously for three consecutive days immediately before the initiation of conditioning therapy (fractionated total-body irradiation plus high-dose chemotherapy) and after autologous hematopoietic stem-cell transplantation. Oral mucositis was evaluated daily for 28 days after transplantation. RESULTS: The incidence of oral mucositis of World Health Organization (WHO) grade 3 or 4 was 63 percent in the palifermin group and 98 percent in the placebo group (P<0.001). Among patients with this degree of mucositis, the median duration of mucositis was 6 days (range, 1 to 22) in the palifermin group and 9 days (range, 1 to 27) in the placebo group. Among all patients, regardless of the occurrence of mucositis, the median duration of oral mucositis of WHO grade 3 or 4 was 3 days (range, 0 to 22) in the palifermin group and 9 days (range, 0 to 27) in the placebo group (P<0.001). As compared with placebo, palifermin was associated with significant reductions in the incidence of grade 4 oral mucositis (20 percent vs. 62 percent, P<0.001), patient-reported soreness of the mouth and throat (area-under-the-curve score, 29.0 [range, 0 to 98] vs. 46.8 [range, 0 to 110]; P<0.001), the use of opioid analgesics (median, 212 mg of morphine equivalents [range, 0 to 9418] vs. 535 mg of morphine equivalents [range, 0 to 9418], P<0.001), and the incidence of use of total parenteral nutrition (31 percent vs. 55 percent, P<0.001). Adverse events, mainly rash, pruritus, erythema, mouth and tongue disorders, and taste alteration, were mild to moderate in severity and were transient. CONCLUSIONS: Palifermin reduced the duration and severity of oral mucositis after intensive chemotherapy and radiotherapy for hematologic cancers.	City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA; Loyola Univ, Med Ctr, Maywood, IL 60153 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; SUNY Upstate Med Univ, Syracuse, NY USA; Univ Minnesota, Minneapolis, MN USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Univ N Carolina, Chapel Hill, NC USA; Georgetown Univ, Ctr Canc, Washington, DC USA; NW Marrow Transplant Ctr, Portland, OR USA; Sinai Hosp Baltimore, Baltimore, MD USA; Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA; Texas Transplant Inst, San Antonio, TX USA; Univ Calif Los Angeles, Dept Hematol Oncol, Los Angeles, CA USA; Amgen Corp, Thousand Oaks, CA 91320 USA	City of Hope; Loyola University Chicago; Fred Hutchinson Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Georgetown University; Sinai Hospital of Baltimore; Virginia Commonwealth University; University of California System; University of California Los Angeles; Amgen	Spielberger, R (corresponding author), City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, 1500 E Duarte Rd, Duarte, CA 91010 USA.	rspielberger@coh.org	Stiff, Patrick/S-2676-2019	Sung, Eric C./0000-0002-0725-1801				Antin JH, 2002, BONE MARROW TRANSPL, V29, P373, DOI 10.1038/sj.bmt.1703394; ARMSTRONG TS, 1994, CANCER NURS, V17, P403; Bellm LA, 2000, SUPPORT CARE CANCER, V8, P33; BLUME KG, 1987, BLOOD, V69, P1015; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Dazzi C, 2003, ANN ONCOL, V14, P559, DOI 10.1093/annonc/mdg177; Donnelly JP, 2003, ANN ONCOL, V14, P505, DOI 10.1093/annonc/mdg179; Farrell CL, 1999, INT J RADIAT BIOL, V75, P609; Farrell CL, 1998, CANCER RES, V58, P933; Filicko J, 2003, BONE MARROW TRANSPL, V31, P1, DOI 10.1038/sj.bmt.1703776; Foncuberta MC, 2001, J IMMUNOTHER, V24, P384, DOI 10.1097/00002371-200107000-00014; HORNING SJ, 1994, J CLIN ONCOL, V12, P2552, DOI 10.1200/JCO.1994.12.12.2552; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; KOLBINSON DA, 1988, ORAL SURG ORAL MED O, V66, P130, DOI 10.1016/0030-4220(88)90080-1; LACHENBRUCH P A, 1976, Biometrische Zeitschrift, V18, P351; LANDIS JR, 1978, INT STAT REV, V46, P237, DOI 10.2307/1402373; McGuire D B, 1993, Oncol Nurs Forum, V20, P1493; Meropol NJ, 2003, J CLIN ONCOL, V21, P1452, DOI 10.1200/JCO.2003.10.079; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Moroni E, 2002, J HEMATOTH STEM CELL, V11, P19, DOI 10.1089/152581602753448513; National Cancer Institute, 1999, NAT CANC I COMM TOX; Rapoport AP, 1999, J CLIN ONCOL, V17, P2446, DOI 10.1200/JCO.1999.17.8.2446; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; SEZER O, 2000, P AN M AM SOC CLIN, V19, pA56; SNYDER DS, 1993, BLOOD, V82, P2920; Sonis ST, 2001, J CLIN ONCOL, V19, P2201, DOI 10.1200/JCO.2001.19.8.2201; Sonis ST, 1998, ORAL ONCOL, V34, P39, DOI 10.1016/S1368-8375(97)00053-5; Spielberger R.T., 2001, P AN M AM SOC CLIN, V20, p7a; Stiff P, 2001, BONE MARROW TRANSPL, V27, pS3, DOI 10.1038/sj.bmt.1702863; Stiff PJ, 1998, J CLIN ONCOL, V16, P48, DOI 10.1200/JCO.1998.16.1.48; *WCCNR, 1998, CAN ONCOL NURS J, V8, P160; WOO SB, 1993, CANCER, V72, P1612, DOI 10.1002/1097-0142(19930901)72:5<1612::AID-CNCR2820720520>3.0.CO;2-Q; ZERBE MB, 1992, CANCER NURS, V15, P196	33	584	617	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2004	351	25					2590	2598		10.1056/NEJMoa040125	http://dx.doi.org/10.1056/NEJMoa040125			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879OC	15602019	Green Published			2022-12-28	WOS:000225726100006
J	Chiang, TC				Chiang, TC			Physics - Superconductivity in thin films	SCIENCE			English	Editorial Material									Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chiang, TC (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	chiang@mri.uiuc.edu	Chiang, Tai C/H-5528-2011					BLATT JM, 1963, PHYS REV LETT, V10, P332, DOI 10.1103/PhysRevLett.10.332; BURNS MJ, 1984, SOLID STATE COMMUN, V51, P865, DOI 10.1016/0038-1098(84)91089-5; Chiang TC, 2000, SURF SCI REP, V39, P181, DOI 10.1016/S0167-5729(00)00006-6; Goldman AM, 1998, PHYS TODAY, V51, P39, DOI 10.1063/1.882069; Guo Y, 2004, SCIENCE, V306, P1915, DOI 10.1126/science.1105130; Luh DA, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.256802; ORR BG, 1984, PHYS REV LETT, V53, P2046, DOI 10.1103/PhysRevLett.53.2046; Pfennigstorf O, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.045412; Valla T, 2000, J PHYS-CONDENS MAT, V12, pL477, DOI 10.1088/0953-8984/12/28/105; Wei CM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.233408	10	44	44	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2004	306	5703					1900	1901		10.1126/science.1106675	http://dx.doi.org/10.1126/science.1106675			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	879DC	15591192				2022-12-28	WOS:000225695600032
J	Abbasi, NR; Shaw, HM; Rigel, DS; Friedman, RJ; McCarthy, WH; Osman, I; Kopf, AW; Polsky, D				Abbasi, NR; Shaw, HM; Rigel, DS; Friedman, RJ; McCarthy, WH; Osman, I; Kopf, AW; Polsky, D			Early diagnosis of cutaneous melanoma - Revisiting the ABCD criteria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SMALL MALIGNANT MELANOMAS; DNA PLOIDY ANALYSIS; CLINICOPATHOLOGICAL CORRELATION; 7-POINT CHECKLIST; PIGMENTED LESIONS; MELANOCYTIC NEVI; FEATURES; DIAMETER; SKIN; RECOGNITION	Context The incidence of cutaneous melanoma has increased over the past several decades, making its early diagnosis a continuing public health priority. The ABCD (Asymmetry, Border irregularity, Color variegation, Diameter >6 mm) acronym for the appraisal of cutaneous pigmented lesions was devised in 1985 and has been widely adopted but requires reexamination in light of recent data regarding the existence of small-diameter (less than or equal to6 mm) melanomas. Evidence Acquisition Cochrane Library and PubMed searches for the period 19802004 were conducted using search terms ABCD and melanoma and small-diameter melanoma. Bibliographies of retrieved articles were also used to identify additional relevant information. Evidence Synthesis Available data do not support the utility of lowering the diameter criterion of ABCD from the current greater than 6 mm guideline. However, the data support expansion to ABCDE to emphasize the significance of evolving pigmented lesions in the natural history of melanoma. Physicians and patients with nevi should be attentive to changes (evolving) of size, shape, symptoms (itching, tenderness), Surface (especially bleeding), and shades of color. Conclusions The ABCD criteria for the gross inspection of pigmented skin lesions and early diagnosis of cutaneous melanoma should be expanded to ABCDE (to include "evolving"), No change to the existing diameter criterion is required at this time.	NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA; Royal Prince Alfred Hosp, Sydney Melanoma Unit, Sydney, NSW, Australia	New York University; Melanoma Institute Australia; University of Sydney	Polsky, D (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, 550 1st Ave H-100, New York, NY 10016 USA.	David.Polsky@med.nyu.edu	Polsky, David/AAO-6254-2020	Polsky, David/0000-0001-9554-5289	NIAMS NIH HHS [K08 AR02129] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002129] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AM AC DERM, ABCDS MOL MEL; *AM CANC SOC, ABCD RUL EARL DET ME; [Anonymous], WHAT YOU NEED KNOW M; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; BARNHILL RL, 1992, J AM ACAD DERMATOL, V26, P185, DOI 10.1016/0190-9622(92)70023-9; BERGMAN R, 1992, J AM ACAD DERMATOL, V26, P462, DOI 10.1016/0190-9622(92)70073-O; Bevona C, 2002, DERMATOL CLIN, V20, P589, DOI 10.1016/S0733-8635(02)00037-2; Bono A, 1999, MELANOMA RES, V9, P583, DOI 10.1097/00008390-199912000-00007; Branstrom R, 2002, J AM ACAD DERMATOL, V46, P667, DOI 10.1067/mjd.2002.120463; Brodell RT, 2001, ARCH DERMATOL, V137, P227; CASSILETH BR, 1987, J GEN INTERN MED, V2, P1, DOI 10.1007/BF02596240; Chamberlain AJ, 2003, J AM ACAD DERMATOL, V48, P694, DOI 10.1067/mjd.2003.216; Chamberlain AJ, 2002, ARCH DERMATOL, V138, P609, DOI 10.1001/archderm.138.5.609; DOHERTY VR, 1986, BRIT MED J, V292, P987, DOI 10.1136/bmj.292.6526.987; Fernandez EM, 2004, DERMATOL SURG, V30, P1219, DOI 10.1111/j.1524-4725.2004.30379.x; FITZPATRICK TB, 1988, PIGMENT CELL, V9, P110; Francken AB, 2004, ANN SURG ONCOL, V11, P426, DOI 10.1245/ASO.2004.07.014; FRIEDMAN RJ, 1985, CA-CANCER J CLIN, V35, P130, DOI 10.3322/canjclin.35.3.130; GERSHENWALD JE, 2003, CUTANEOUS MELANOMA, P25; Gonzalez A, 1996, J CUTAN PATHOL, V23, P126, DOI 10.1111/j.1600-0560.1996.tb01285.x; Grichnik JM, 2001, DERMATOL CLIN, V19, P319, DOI 10.1016/S0733-8635(05)70269-2; GROB JJ, 2002, 20 WORLD C DERM JUL; Harris JM, 2001, J GEN INTERN MED, V16, P50, DOI 10.1046/j.1525-1497.2001.00615.x; Hazen B P, 1999, Dermatol Online J, V5, P3; HEALSMITH MF, 1994, BRIT J DERMATOL, V130, P48, DOI 10.1111/j.1365-2133.1994.tb06881.x; KAMINO H, 1990, J AM ACAD DERMATOL, V22, P1032, DOI 10.1016/0190-9622(90)70147-A; Kelly John W, 2003, Aust Fam Physician, V32, P706; KOH HK, 1992, J AM ACAD DERMATOL, V26, P914, DOI 10.1016/0190-9622(92)70132-Y; KOPF AW, 1987, J DERMATOL SURG ONC, V13, P345, DOI 10.1111/j.1524-4725.1987.tb03726.x; Lucas CR, 2003, J AM ACAD DERMATOL, V48, P663, DOI 10.1067/mjd.2003.283; MACKIE RM, 1990, BRIT MED J, V301, P1005, DOI 10.1136/bmj.301.6759.1005; MARGHOOB AA, 1995, J AM ACAD DERMATOL, V32, P682, DOI 10.1016/S0190-9622(05)80002-7; Marghoob AA, 2003, J AM ACAD DERMATOL, V49, P777, DOI 10.1016/S0190-9622(03)02470-8; MCGOVERN TW, 1992, J DERMATOL SURG ONC, V18, P22, DOI 10.1111/j.1524-4725.1992.tb03296.x; MOYNIHAN GD, 1994, J AM ACAD DERMATOL, V30, P510, DOI 10.1016/S0190-9622(08)81963-9; *NAT CANC I, INC MEL SKIN; Oliveria SA, 1999, J CLIN EPIDEMIOL, V52, P1111, DOI 10.1016/S0895-4356(99)00083-9; Porras BH, 1997, SEMIN CUTAN MED SURG, V16, P88, DOI 10.1016/S1085-5629(97)80002-8; RHODES AR, 1987, JAMA-J AM MED ASSOC, V258, P3146, DOI 10.1001/jama.258.21.3146; RIGEL DS, 1993, J AM ACAD DERMATOL, V29, P1060, DOI 10.1016/S0190-9622(08)82059-2; SCHMOECKEL C, 1991, J AM ACAD DERMATOL, V24, P1036, DOI 10.1016/S0190-9622(08)80138-7; SHAW HM, 1992, J AM ACAD DERMATOL, V27, P679, DOI 10.1016/0190-9622(92)70236-9; SILVERMAN MK, 1992, J AM ACAD DERMATOL, V27, P214, DOI 10.1016/0190-9622(92)70173-D; *SKIN CANC FDN, ABCDS MOL MEL; Thomas L, 1998, DERMATOLOGY, V197, P11, DOI 10.1159/000017969; Whited JD, 1998, JAMA-J AM MED ASSOC, V279, P696, DOI 10.1001/jama.279.9.696	46	353	367	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2004	292	22					2771	2776		10.1001/jama.292.22.2771	http://dx.doi.org/10.1001/jama.292.22.2771			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877CY	15585738				2022-12-28	WOS:000225546600027
J	Ji, Q; Ji, SA; Cheng, YN; You, HL; Lu, JC; Liu, YQ; Yuan, CX				Ji, Q; Ji, SA; Cheng, YN; You, HL; Lu, JC; Liu, YQ; Yuan, CX			Pterosaur egg with a leathery shell	NATURE			English	Editorial Material									Nanjing Univ, Dept Earth Sci, Nanjing 210093, Peoples R China; Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; Natl Museum Nat Sci, Taichung 404, Taiwan; China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China	Nanjing University; Chinese Academy of Geological Sciences; China University of Geosciences	Ji, Q (corresponding author), Nanjing Univ, Dept Earth Sci, Nanjing 210093, Peoples R China.	jirod@cags.net.cn		You, Hai-Lu/0000-0003-2203-6461				Bennett SC, 1996, J VERTEBR PALEONTOL, V16, P432, DOI 10.1080/02724634.1996.10011332; Carpenter K., 1999, EGGS NESTS BABY DINO; Ji Q., 2004, MESOZOIC JEHOL BIOTA; Lu Jun-Chang, 2003, Memoir of the Fukui Prefectural Dinosaur Museum, V2, P153; UNWIN DM, 2001, GEOL SOC SP PUBL, V217, P139; Wang XL, 2004, NATURE, V429, P621, DOI 10.1038/429621a; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Zelenitsky DK, 2002, CRETACEOUS RES, V23, P297, DOI 10.1006/cres.2002.1010; ZHAO Z, 1978, VERTEBRAT PALASIATIC, V16, P213	9	40	47	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2004	432	7017					572	572		10.1038/432572a	http://dx.doi.org/10.1038/432572a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875PL	15577900	Green Published			2022-12-28	WOS:000225433200031
J	Sloan, FA; Berman, S; Rosenbaum, S; Chalk, RA; Giffin, RB				Sloan, FA; Berman, S; Rosenbaum, S; Chalk, RA; Giffin, RB			The fragility of the US vaccine supply	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES; INSURANCE; CHILDREN; CLINICS; POLICY; COST		Duke Univ, Dept Econ, Durham, NC 27706 USA; Univ Colorado, Sch Med, Childrens Outcomes Res Program, Denver, CO USA; Childrens Hosp, Denver, CO 80218 USA; George Washington Univ, Med Ctr, Dept Hlth Policy, Washington, DC 20037 USA; Natl Acad, Div Behav & Social Sci & Educ, Washington, DC USA; Natl Acad, Inst Med, Washington, DC USA	Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; George Washington University; National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine	Sloan, FA (corresponding author), Duke Univ, Dept Econ, Durham, NC 27706 USA.							[Anonymous], SUPPLYING VACCINES E; Carpenter DP, 2004, HEALTH AFFAIR, V23, P52, DOI 10.1377/hlthaff.23.1.52; Ekwueme DU, 2000, ARCH PEDIAT ADOL MED, V154, P797, DOI 10.1001/archpedi.154.8.797; Finkelstein A, 2004, Q J ECON, V119, P527, DOI 10.1162/0033553041382166; Fontanesi J, 2001, AM J MED QUAL, V16, P196, DOI 10.1177/106286060101600603; FOULKES MA, 2002, JORDAN REPORT ACCELE, P50; FREED GL, 2003, PEDIATRICS, V2, P399; *GEN ACC OFF, 2002, GAO02987; Glazner JE, 2001, PUBLIC HEALTH REP, V116, P219, DOI 10.1093/phr/116.3.219; GRABOWSKI HG, 1997, SEARCH NEW VACCINES; HINMAN AR, 2004, I MED REPORT FINANCI; Holahan John, 2003, CHANGES HLTH CARE CO; *I MED, 2003, FIN VACC 21 CENT ASS; Jacobs RJ, 2001, PREV MED, V33, P639, DOI 10.1006/pmed.2001.0938; KREMER M, 2003, W9833 NAT BUR EC RES; LIEU TA, 1994, PEDIATRICS, V93, P373; McGuire Thomas G, 2003, Int J Health Care Finance Econ, V3, P207, DOI 10.1023/A:1025336903645; Peter G, 2003, JAMA-J AM MED ASSOC, V290, P3122; Wiktorowicz ME, 2003, J HEALTH POLIT POLIC, V28, P615, DOI 10.1215/03616878-28-4-615; Zimmerman RK, 1997, JAMA-J AM MED ASSOC, V278, P996, DOI 10.1001/jama.278.12.996; 2002, MMWR MORB MORTAL WKL, V51, P664; 2002, MMWR MORB MORTAL WKL, V51, P1019; [No title captured]; 2004, MMWR MORB MORTAL WKL, V53, P177	24	23	24	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2004	351	23					2443	2447		10.1056/NEJMsb033394	http://dx.doi.org/10.1056/NEJMsb033394			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875OC	15575064				2022-12-28	WOS:000225429000018
